25902	HMR136_HSU33271_4_tr0_r1_1_gPRT		Comparison report between HSU33271_P4 and Q8TEN4unique head  	Sequence name: Q8TEN4                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for HSU33271_P4, comprising a first     	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment of: 25902 x Q8TEN4   ..                            
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment segment 1/1:                                       
						GAPAAGSHSPGRQTPAGTPATASMQGEESLRILVEPEGDSFPLMEISTCETEASEQWDYV 	                                                            
						LVAQRHTQRDPRQARQQQFLEELRRKGFHIKVIRDQKQVFFGIRADNSVFGLYRTLLLEP 	                     Quality: 3175.00                      Escore:       0                                               
						EGPAPHAELAAPTTIPVTTSLRIRIVNFVVMNNKTSAGETFEDLMKDGVFEARFPLHK   	             Matching length:     330                Total length:     365                                               
						having the sequence corresponding to amino acids 1 - 178 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.39                                               
						HSU33271_P4, a second amino acid sequence being at least 90 %	    Total Percent Similarity:   90.41      Total Percent Identity:   89.86                                               
						GEGRLKKTWARWRHMFREQPVDEIRNYFGEKVALYFVWLGWYTYMLVPAALTGLLVFLSG 	                        Gaps:       1                        
						FSLFEASQISKEICEAHDILMCPLGDHSRRYQRLSETCTFAKVCRLRVHPRACGRWERCI 	                                                            
						HPKRGRSRPGALQSCSAFPTGLTGRPSPSPPAHFLSPPAPFPGFPASLPGSPAPLPSSPT 	Alignment:                                                   
						SSPAHLSPPQLTHLFDNDGTVVFAIFMALW                               	                  .         .         .         .         .  
						homologous to corresponding to amino acids 35 - 244 of       	     178 KGEGRLKKTWARWRHMFREQPVDEIRNYFGEKVALYFVWLGWYTYMLVPA 227                                                          
						Q8TEN4, which also corresponds to amino acids 179 - 388 of   	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU33271_P4, a third amino acid sequence being at least 90 % 	      34 QGEGRLKKTWARWRHMFREQPVDEIRNYFGEKVALYFVWLGWYTYMLVPA 83                                                           
						ATVFLEIWKRQRARVVLHWDLYVWDEEQEEMALQLINCPDYKLRPYQHSYLRSTVILVLT 	                  .         .         .         .         .  
						LLMICLMIGMAHVLVVYRVLASALFSSSAVPFLEEQVTTAVVVTGALVHYVTIVIMTK   	     228 ALTGLLVFLSGFSLFEASQISKEICEAHDILMCPLGDHSRRYQRLSETCT 277                                                          
						homologous to corresponding to amino acids 280 - 397 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8TEN4, which also corresponds to amino acids 389 - 506 of   	      84 ALTGLLVFLSGFSLFEASQISKEICEAHDILMCPLGDHSRRYQRLSETCT 133                                                          
						HSU33271_P4, and a fourth amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     278 FAKVCRLRVHPRACGRWERCIHPKRGRSRPGALQSCSAFPTGLTGRPSPS 327                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     134 FAKVCRLRVHPRACGRWERCIHPKRGRSRPGALQSCSAFPTGLTGRPSPS 183                                                          
						VGPGAGQARAGGSTGAPVSPFGALLRRSTGAWP corresponding to amino     	                  .         .         .         .         .  
						acids 507 - 539 of HSU33271_P4, wherein said first amino acid	     328 PPAHFLSPPAPFPGFPASLPGSPAPLPSSPTSSPAHLSPPQLTHLFDNDG 377                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fourth amino acid sequence are contiguous and in	     184 PPAHFLSPPAPFPGFPASLPGSPAPLPSSPTSSPAHLSPPQLTHLFDNDG 233                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of HSU33271_P4, comprising a polypeptide being at least 	     378 TVVFAIFMALW...................................ATVF 392                                                          
						70%, optionally at least about 80%, preferably at least about	         |||||||||||                                   ||||  
						85%, more preferably at least about 90% and most preferably  	     234 TVVFAIFMALWGELLRDASAGPGEVPAQAPRSTWRSAVMPLLAPAAATVF 283                                                          
						GAPAAGSHSPGRQTPAGTPATASMQGEESLRILVEPEGDSFPLMEISTCETEASEQWDYV 	                  .         .         .         .         .  
						LVAQRHTQRDPRQARQQQFLEELRRKGFHIKVIRDQKQVFFGIRADNSVFGLYRTLLLEP 	     393 LEIWKRQRARVVLHWDLYVWDEEQEEMALQLINCPDYKLRPYQHSYLRST 442                                                          
						EGPAPHAELAAPTTIPVTTSLRIRIVNFVVMNNKTSAGETFEDLMKDGVFEARFPLHK   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence of             	     284 LEIWKRQRARVVLHWDLYVWDEEQEEMALQLINCPDYKLRPYQHSYLRST 333                                                          
						HSU33271_P4.3.An isolated chimeric polypeptide encoding for  	                  .         .         .         .         .  
						an edge portion of HSU33271_P4, comprising a polypeptide     	     443 VILVLTLLMICLMIGMAHVLVVYRVLASALFSSSAVPFLEEQVTTAVVVT 492                                                          
						having a length "n", wherein n is at least about 10 amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, optionally at least about 20 amino acids in 	     334 VILVLTLLMICLMIGMAHVLVVYRVLASALFSSSAVPFLEEQVTTAVVVT 383                                                          
						length, preferably at least about 30 amino acids in length,  	                  .                                          
						more preferably at least about 40 amino acids in length and  	     493 GALVHYVTIVIMTKV                                    507                                                          
						most preferably at least about 50 amino acids in length,     	         ||||||||||||||:                                     
						wherein at least two amino acids comprise WA, having a       	     384 GALVHYVTIVIMTKI                                    398                                                          
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 388-x to 389; and ending at any of amino acid   	                                                            
						numbers 389+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						HSU33271_P4, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						VGPGAGQARAGGSTGAPVSPFGALLRRSTGAWP in HSU33271_P4.            	                                                            

25900	HMR136_HSU33271_6_tr0_r1_1_gPRT		Comparison report between HSU33271_P6 and Q8TEN4unique head  	Sequence name: Q8TEN4                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for HSU33271_P6, comprising a first     	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment of: 25900 x Q8TEN4   ..                            
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment segment 1/1:                                       
						GAPAAGSHSPGRQTPAGTPATASMQGEESLRILVEPEGDSFPLMEISTCETEASEQWDYV 	                                                            
						LVAQRHTQRDPRQARQQQFLEELRRKGFHIKVIRDQKQVFFGIRADNSVFGLYRTLLLEP 	                     Quality: 3175.00                      Escore:       0                                               
						EGPAPHAELAAPTTIPVTTSLRIRIVNFVVMNNKTSAGETFEDLMKDGVFEARFPLHK   	             Matching length:     330                Total length:     365                                               
						having the sequence corresponding to amino acids 1 - 178 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.39                                               
						HSU33271_P6, a second amino acid sequence being at least 90 %	    Total Percent Similarity:   90.41      Total Percent Identity:   89.86                                               
						GEGRLKKTWARWRHMFREQPVDEIRNYFGEKVALYFVWLGWYTYMLVPAALTGLLVFLSG 	                        Gaps:       1                        
						FSLFEASQISKEICEAHDILMCPLGDHSRRYQRLSETCTFAKVCRLRVHPRACGRWERCI 	                                                            
						HPKRGRSRPGALQSCSAFPTGLTGRPSPSPPAHFLSPPAPFPGFPASLPGSPAPLPSSPT 	Alignment:                                                   
						SSPAHLSPPQLTHLFDNDGTVVFAIFMALW                               	                  .         .         .         .         .  
						homologous to corresponding to amino acids 35 - 244 of       	     178 KGEGRLKKTWARWRHMFREQPVDEIRNYFGEKVALYFVWLGWYTYMLVPA 227                                                          
						Q8TEN4, which also corresponds to amino acids 179 - 388 of   	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU33271_P6, a third amino acid sequence being at least 90 % 	      34 QGEGRLKKTWARWRHMFREQPVDEIRNYFGEKVALYFVWLGWYTYMLVPA 83                                                           
						ATVFLEIWKRQRARVVLHWDLYVWDEEQEEMALQLINCPDYKLRPYQHSYLRSTVILVLT 	                  .         .         .         .         .  
						LLMICLMIGMAHVLVVYRVLASALFSSSAVPFLEEQVTTAVVVTGALVHYVTIVIMTK   	     228 ALTGLLVFLSGFSLFEASQISKEICEAHDILMCPLGDHSRRYQRLSETCT 277                                                          
						homologous to corresponding to amino acids 280 - 397 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8TEN4, which also corresponds to amino acids 389 - 506 of   	      84 ALTGLLVFLSGFSLFEASQISKEICEAHDILMCPLGDHSRRYQRLSETCT 133                                                          
						HSU33271_P6, and a fourth amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     278 FAKVCRLRVHPRACGRWERCIHPKRGRSRPGALQSCSAFPTGLTGRPSPS 327                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     134 FAKVCRLRVHPRACGRWERCIHPKRGRSRPGALQSCSAFPTGLTGRPSPS 183                                                          
						VGPGAGQARAGGSTGAPVSPFGALLRRSTGAWP corresponding to amino     	                  .         .         .         .         .  
						acids 507 - 539 of HSU33271_P6, wherein said first amino acid	     328 PPAHFLSPPAPFPGFPASLPGSPAPLPSSPTSSPAHLSPPQLTHLFDNDG 377                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fourth amino acid sequence are contiguous and in	     184 PPAHFLSPPAPFPGFPASLPGSPAPLPSSPTSSPAHLSPPQLTHLFDNDG 233                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of HSU33271_P6, comprising a polypeptide being at least 	     378 TVVFAIFMALW...................................ATVF 392                                                          
						70%, optionally at least about 80%, preferably at least about	         |||||||||||                                   ||||  
						85%, more preferably at least about 90% and most preferably  	     234 TVVFAIFMALWGELLRDASAGPGEVPAQAPRSTWRSAVMPLLAPAAATVF 283                                                          
						GAPAAGSHSPGRQTPAGTPATASMQGEESLRILVEPEGDSFPLMEISTCETEASEQWDYV 	                  .         .         .         .         .  
						LVAQRHTQRDPRQARQQQFLEELRRKGFHIKVIRDQKQVFFGIRADNSVFGLYRTLLLEP 	     393 LEIWKRQRARVVLHWDLYVWDEEQEEMALQLINCPDYKLRPYQHSYLRST 442                                                          
						EGPAPHAELAAPTTIPVTTSLRIRIVNFVVMNNKTSAGETFEDLMKDGVFEARFPLHK   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence of             	     284 LEIWKRQRARVVLHWDLYVWDEEQEEMALQLINCPDYKLRPYQHSYLRST 333                                                          
						HSU33271_P6.3.An isolated chimeric polypeptide encoding for  	                  .         .         .         .         .  
						an edge portion of HSU33271_P6, comprising a polypeptide     	     443 VILVLTLLMICLMIGMAHVLVVYRVLASALFSSSAVPFLEEQVTTAVVVT 492                                                          
						having a length "n", wherein n is at least about 10 amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, optionally at least about 20 amino acids in 	     334 VILVLTLLMICLMIGMAHVLVVYRVLASALFSSSAVPFLEEQVTTAVVVT 383                                                          
						length, preferably at least about 30 amino acids in length,  	                  .                                          
						more preferably at least about 40 amino acids in length and  	     493 GALVHYVTIVIMTKV                                    507                                                          
						most preferably at least about 50 amino acids in length,     	         ||||||||||||||:                                     
						wherein at least two amino acids comprise WA, having a       	     384 GALVHYVTIVIMTKI                                    398                                                          
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 388-x to 389; and ending at any of amino acid   	                                                            
						numbers 389+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						HSU33271_P6, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						VGPGAGQARAGGSTGAPVSPFGALLRRSTGAWP in HSU33271_P6.            	                                                            

26928	HMR136_HSU38371_1_tr0_r1_1_gPRT		Comparison report between HSU38371_P1 and HAP1_HUMANpartial  	Sequence name: HAP1_HUMAN                                    
						WT sequence followed by mismatch and a featuring a skipped   	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSU38371_P1, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MRP corresponding to amino acids 1 -	Alignment of: 26928 x HAP1_HUMAN   ..                        
						3 of HAP1_HUMAN, which also corresponds to amino acids 1 - 3 	                                                            
						of HSU38371_P1, a bridging amino acid K corresponding to     	Alignment segment 1/1:                                       
						amino acid 4 of HSU38371_P1, a second amino acid sequence    	                                                            
						RLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQFLSEA 	                     Quality: 5698.00                      Escore:       0                                               
						RTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGRGTGK 	             Matching length:     603                Total length:     671                                               
						AAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYLLEE  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:   89.87      Total Percent Identity:   89.72                                               
						acids 5 - 183 of HAP1_HUMAN, which also corresponds to amino 	                        Gaps:       2                        
						acids 5 - 183 of HSU38371_P1, a third amino acid sequence    	                                                            
						RERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLYSDS 	Alignment:                                                   
						DEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEALQE 	                  .         .         .         .         .  
						KLRLLEEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRLENYER 	       1 MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						QQQEVARLQAQVLKLQQRCRMYGAETEKLQKQLASEKEIQMQLQEE               	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       1 MRPRRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						acids 200 - 425 of HAP1_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 184 - 409 of HSU38371_P1, and a fourth amino acid	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ETLPGFQETLAEELRTSLRRMISDPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEEGLMLAADIMRGEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVEL 	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ELDEATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQKGECPHGA 	                  .         .         .         .         .  
						LPAASRTSCRSSCR                                               	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 478 - 671 of HAP1_HUMAN, which also corresponds  	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						to amino acids 410 - 603 of HSU38371_P1, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEE................R 184                                                          
						sequence, third amino acid sequence and fourth amino acid    	         |||||||||||||||||||||||||||||||||                |  
						sequence are contiguous and in a sequential order.2.An       	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEELLPPVWESVTYGMVLQR 200                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HSU38371_P1, comprising a polypeptide having a length "n",   	     185 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 234                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     201 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     235 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 284                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise ER, having a structure as  	     251 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						183-x to 184; and ending at any of amino acid numbers 184+   	     285 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 334                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     301 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 350                                                          
						HSU38371_P1, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     335 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 384                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     351 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 400                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     385 YGAETEKLQKQLASEKEIQMQLQEE......................... 409                                                          
						at least two amino acids comprise EE, having a structure as  	         |||||||||||||||||||||||||                           
						follows: a sequence starting from any of amino acid numbers  	     401 YGAETEKLQKQLASEKEIQMQLQEESVWVGSQLQDLREKYMDCGGMLIEM 450                                                          
						409-x to 410; and ending at any of amino acid numbers 410+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     410 ...........................ETLPGFQETLAEELRTSLRRMIS 432                                                          
						                                                            	                                    |||||||||||||||||||||||  
						                                                            	     451 QEEVKTLRQQPPVSTGSATHYPYSVPLETLPGFQETLAEELRTSLRRMIS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     433 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 482                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     483 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 532                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     533 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 582                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 650                                                          
						                                                            	                  .         .                                
						                                                            	     583 GECPHGALPAASRTSCRSSCR                              603                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     651 GECPHGALPAASRTSCRSSCR                              671                                                          

26930	HMR136_HSU38371_2_tr0_r1_1_gPRT		Comparison report between HSU38371_P2 and HAP1_HUMANpartial  	Sequence name: HAP1_HUMAN                                    
						WT sequence followed by mismatch and a featuring a skipped   	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSU38371_P2, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MRP corresponding to amino acids 1 -	Alignment of: 26930 x HAP1_HUMAN   ..                        
						3 of HAP1_HUMAN, which also corresponds to amino acids 1 - 3 	                                                            
						of HSU38371_P2, a bridging amino acid K corresponding to     	Alignment segment 1/1:                                       
						amino acid 4 of HSU38371_P2, a second amino acid sequence    	                                                            
						RLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQFLSEA 	                     Quality: 5698.00                      Escore:       0                                               
						RTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGRGTGK 	             Matching length:     603                Total length:     671                                               
						AAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYLLEE  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:   89.87      Total Percent Identity:   89.72                                               
						acids 5 - 183 of HAP1_HUMAN, which also corresponds to amino 	                        Gaps:       2                        
						acids 5 - 183 of HSU38371_P2, a third amino acid sequence    	                                                            
						RERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLYSDS 	Alignment:                                                   
						DEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEALQE 	                  .         .         .         .         .  
						KLRLLEEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRLENYER 	       1 MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						QQQEVARLQAQVLKLQQRCRMYGAETEKLQKQLASEKEIQMQLQEE               	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       1 MRPRRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						acids 200 - 425 of HAP1_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 184 - 409 of HSU38371_P2, and a fourth amino acid	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ETLPGFQETLAEELRTSLRRMISDPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEEGLMLAADIMRGEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVEL 	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ELDEATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQKGECPHGA 	                  .         .         .         .         .  
						LPAASRTSCRSSCR                                               	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 478 - 671 of HAP1_HUMAN, which also corresponds  	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						to amino acids 410 - 603 of HSU38371_P2, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEE................R 184                                                          
						sequence, third amino acid sequence and fourth amino acid    	         |||||||||||||||||||||||||||||||||                |  
						sequence are contiguous and in a sequential order.2.An       	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEELLPPVWESVTYGMVLQR 200                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HSU38371_P2, comprising a polypeptide having a length "n",   	     185 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 234                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     201 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     235 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 284                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise ER, having a structure as  	     251 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						183-x to 184; and ending at any of amino acid numbers 184+   	     285 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 334                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     301 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 350                                                          
						HSU38371_P2, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     335 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 384                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     351 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 400                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     385 YGAETEKLQKQLASEKEIQMQLQEE......................... 409                                                          
						at least two amino acids comprise EE, having a structure as  	         |||||||||||||||||||||||||                           
						follows: a sequence starting from any of amino acid numbers  	     401 YGAETEKLQKQLASEKEIQMQLQEESVWVGSQLQDLREKYMDCGGMLIEM 450                                                          
						409-x to 410; and ending at any of amino acid numbers 410+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     410 ...........................ETLPGFQETLAEELRTSLRRMIS 432                                                          
						                                                            	                                    |||||||||||||||||||||||  
						                                                            	     451 QEEVKTLRQQPPVSTGSATHYPYSVPLETLPGFQETLAEELRTSLRRMIS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     433 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 482                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     483 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 532                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     533 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 582                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 650                                                          
						                                                            	                  .         .                                
						                                                            	     583 GECPHGALPAASRTSCRSSCR                              603                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     651 GECPHGALPAASRTSCRSSCR                              671                                                          

26932	HMR136_HSU38371_3_tr0_r1_1_gPRT		Comparison report between HSU38371_P3 and HAP1_HUMANpartial  	Sequence name: HAP1_HUMAN                                    
						WT sequence followed by mismatch and a featuring a skipped   	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSU38371_P3, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MRP corresponding to amino acids 1 -	Alignment of: 26932 x HAP1_HUMAN   ..                        
						3 of HAP1_HUMAN, which also corresponds to amino acids 1 - 3 	                                                            
						of HSU38371_P3, a bridging amino acid K corresponding to     	Alignment segment 1/1:                                       
						amino acid 4 of HSU38371_P3, a second amino acid sequence    	                                                            
						RLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQFLSEA 	                     Quality: 5698.00                      Escore:       0                                               
						RTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGRGTGK 	             Matching length:     603                Total length:     671                                               
						AAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYLLEE  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:   89.87      Total Percent Identity:   89.72                                               
						acids 5 - 183 of HAP1_HUMAN, which also corresponds to amino 	                        Gaps:       2                        
						acids 5 - 183 of HSU38371_P3, a third amino acid sequence    	                                                            
						RERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLYSDS 	Alignment:                                                   
						DEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEALQE 	                  .         .         .         .         .  
						KLRLLEEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRLENYER 	       1 MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						QQQEVARLQAQVLKLQQRCRMYGAETEKLQKQLASEKEIQMQLQEE               	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       1 MRPRRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						acids 200 - 425 of HAP1_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 184 - 409 of HSU38371_P3, and a fourth amino acid	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ETLPGFQETLAEELRTSLRRMISDPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEEGLMLAADIMRGEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVEL 	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ELDEATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQKGECPHGA 	                  .         .         .         .         .  
						LPAASRTSCRSSCR                                               	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 478 - 671 of HAP1_HUMAN, which also corresponds  	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						to amino acids 410 - 603 of HSU38371_P3, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEE................R 184                                                          
						sequence, third amino acid sequence and fourth amino acid    	         |||||||||||||||||||||||||||||||||                |  
						sequence are contiguous and in a sequential order.2.An       	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEELLPPVWESVTYGMVLQR 200                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HSU38371_P3, comprising a polypeptide having a length "n",   	     185 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 234                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     201 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     235 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 284                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise ER, having a structure as  	     251 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						183-x to 184; and ending at any of amino acid numbers 184+   	     285 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 334                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     301 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 350                                                          
						HSU38371_P3, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     335 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 384                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     351 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 400                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     385 YGAETEKLQKQLASEKEIQMQLQEE......................... 409                                                          
						at least two amino acids comprise EE, having a structure as  	         |||||||||||||||||||||||||                           
						follows: a sequence starting from any of amino acid numbers  	     401 YGAETEKLQKQLASEKEIQMQLQEESVWVGSQLQDLREKYMDCGGMLIEM 450                                                          
						409-x to 410; and ending at any of amino acid numbers 410+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     410 ...........................ETLPGFQETLAEELRTSLRRMIS 432                                                          
						                                                            	                                    |||||||||||||||||||||||  
						                                                            	     451 QEEVKTLRQQPPVSTGSATHYPYSVPLETLPGFQETLAEELRTSLRRMIS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     433 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 482                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     483 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 532                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     533 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 582                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 650                                                          
						                                                            	                  .         .                                
						                                                            	     583 GECPHGALPAASRTSCRSSCR                              603                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     651 GECPHGALPAASRTSCRSSCR                              671                                                          

26934	HMR136_HSU38371_4_tr0_r1_1_gPRT		Comparison report between HSU38371_P4 and HAP1_HUMANpartial  	Sequence name: HAP1_HUMAN                                    
						WT sequence followed by mismatch, featuring a skipped exon   	                                                            
						and a followed by a unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for HSU38371_P4, comprising a first     	                                                            
						amino acid sequence being at least 90 % homologous to MRP    	Alignment of: 26934 x HAP1_HUMAN   ..                        
						corresponding to amino acids 1 - 3 of HAP1_HUMAN, which also 	                                                            
						corresponds to amino acids 1 - 3 of HSU38371_P4, a bridging  	Alignment segment 1/1:                                       
						amino acid K corresponding to amino acid 4 of HSU38371_P4, a 	                                                            
						RLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQFLSEA 	                     Quality: 5484.00                      Escore:       0                                               
						RTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGRGTGK 	             Matching length:     582                Total length:     650                                               
						AAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYLLEE  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:   89.54      Total Percent Identity:   89.38                                               
						corresponding to amino acids 5 - 183 of HAP1_HUMAN, which    	                        Gaps:       2                        
						also corresponds to amino acids 5 - 183 of HSU38371_P4, a    	                                                            
						RERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLYSDS 	Alignment:                                                   
						DEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEALQE 	                  .         .         .         .         .  
						KLRLLEEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRLENYER 	       1 MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						QQQEVARLQAQVLKLQQRCRMYGAETEKLQKQLASEKEIQMQLQEE               	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	       1 MRPRRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						corresponding to amino acids 200 - 425 of HAP1_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 184 - 409 of HSU38371_P4, a  	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ETLPGFQETLAEELRTSLRRMISDPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEEGLMLAADIMRGEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVEL 	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ELDEATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK        	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						corresponding to amino acids 478 - 650 of HAP1_HUMAN, which  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 410 - 582 of HSU38371_P4, and	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						a fifth amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEE................R 184                                                          
						90% and most preferably at least 95% homologous to a         	         |||||||||||||||||||||||||||||||||                |  
						polypeptide having the sequence EPQPWT corresponding to amino	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEELLPPVWESVTYGMVLQR 200                                                          
						acids 583 - 588 of HSU38371_P4, wherein said first amino acid	                  .         .         .         .         .  
						sequence, bridging amino acid, second amino acid sequence,   	     185 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 234                                                          
						third amino acid sequence, fourth amino acid sequence and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence are contiguous and in a sequential 	     201 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 250                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	                  .         .         .         .         .  
						portion of HSU38371_P4, comprising a polypeptide having a    	     235 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 284                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     251 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 300                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     285 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 334                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise ER, having a structure as  	     301 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 350                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						183-x to 184; and ending at any of amino acid numbers 184+   	     335 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 384                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     351 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 400                                                          
						HSU38371_P4, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     385 YGAETEKLQKQLASEKEIQMQLQEE......................... 409                                                          
						optionally at least about 20 amino acids in length,          	         |||||||||||||||||||||||||                           
						preferably at least about 30 amino acids in length, more     	     401 YGAETEKLQKQLASEKEIQMQLQEESVWVGSQLQDLREKYMDCGGMLIEM 450                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     410 ...........................ETLPGFQETLAEELRTSLRRMIS 432                                                          
						at least two amino acids comprise EE, having a structure as  	                                    |||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     451 QEEVKTLRQQPPVSTGSATHYPYSVPLETLPGFQETLAEELRTSLRRMIS 500                                                          
						409-x to 410; and ending at any of amino acid numbers 410+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     433 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 482                                                          
						polypeptide encoding for a tail of HSU38371_P4, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     501 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 550                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     483 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 532                                                          
						to the sequence EPQPWT in HSU38371_P4.                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     533 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 582                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 650                                                          

26936	HMR136_HSU38371_7_tr0_r1_1_gPRT		Comparison report between HSU38371_P7 and HAPP_HUMANunique   	Sequence name: HAPP_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HSU38371_P7, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 26936 x HAPP_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQF 	Alignment segment 1/1:                                       
						LSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGR 	                                                            
						GTGKAAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYL 	                     Quality: 1241.00                      Escore:       0                                               
						LEERERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLY 	             Matching length:     126                Total length:     126                                               
						SDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQEKLRLL                                                     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 308 of  	                        Gaps:       0                        
						HSU38371_P7, and a second amino acid sequence being at least 	                                                            
						EEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRLEGYERQQKEI 	Alignment:                                                   
						TQLQAEITKLQQRCQSYGAQTEKLQQQLASEKGVHPESLRAGSHMQDYGSRPRERQEDGK 	                  .         .         .         .         .  
						SHRQRS                                                       	     309 EEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRL 358                                                          
						90 % homologous to corresponding to amino acids 1 - 126 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HAPP_HUMAN, which also corresponds to amino acids 309 - 434  	       1 EEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRL 50                                                           
						of HSU38371_P7, wherein said first amino acid sequence and   	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	     359 EGYERQQKEITQLQAEITKLQQRCQSYGAQTEKLQQQLASEKGVHPESLR 408                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU38371_P7, comprising a polypeptide being at least 70%,    	      51 EGYERQQKEITQLQAEITKLQQRCQSYGAQTEKLQQQLASEKGVHPESLR 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .                                
						more preferably at least about 90% and most preferably at    	     409 AGSHMQDYGSRPRERQEDGKSHRQRS                         434                                                          
						MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQF 	         ||||||||||||||||||||||||||                          
						LSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGR 	     101 AGSHMQDYGSRPRERQEDGKSHRQRS                         126                                                          
						GTGKAAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYL 	                                                            
						LEERERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLY 	                                                            
						SDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEA 	                                                            
						LQEKLRLL                                                     	                                                            
						least about 95% homologous to the sequence of HSU38371_P7.   	                                                            

26938	HMR136_HSU38371_8_tr0_r1_1_gPRT		Comparison report between HSU38371_P8 and HAP1_HUMANpartial  	Sequence name: HAP1_HUMAN                                    
						WT sequence followed by mismatch, featuring a skipped exon   	                                                            
						and a followed by a unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for HSU38371_P8, comprising a first     	                                                            
						amino acid sequence being at least 90 % homologous to MRP    	Alignment of: 26938 x HAP1_HUMAN   ..                        
						corresponding to amino acids 1 - 3 of HAP1_HUMAN, which also 	                                                            
						corresponds to amino acids 1 - 3 of HSU38371_P8, a bridging  	Alignment segment 1/1:                                       
						amino acid K corresponding to amino acid 4 of HSU38371_P8, a 	                                                            
						RLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQFLSEA 	                     Quality: 4828.00                      Escore:       0                                               
						RTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGRGTGK 	             Matching length:     524                Total length:     650                                               
						AAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYLLEE  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.81                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:   80.62      Total Percent Identity:   80.46                                               
						corresponding to amino acids 5 - 183 of HAP1_HUMAN, which    	                        Gaps:       3                        
						also corresponds to amino acids 5 - 183 of HSU38371_P8, a    	                                                            
						RERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLYSDS 	Alignment:                                                   
						DEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEALQE 	                  .         .         .         .         .  
						KLRLLEEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRLENYER 	       1 MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						QQQEVARLQAQVLKLQQRCRMYGAETEKLQKQLASEKEIQMQLQEE               	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	       1 MRPRRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						corresponding to amino acids 200 - 425 of HAP1_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 184 - 409 of HSU38371_P8, a  	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						ETLPGFQETLAEELRTSLRRMISDPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEEGLMLAADIMRGEDFTPAEELVPQEELGAAKK                           	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 478 - 571 of HAP1_HUMAN, which  	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						also corresponds to amino acids 410 - 503 of HSU38371_P8, a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 90 % homologous to  	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						QLANWQDAHYRRQLRWKMLQK corresponding to amino acids 630 - 650 	                  .         .         .         .         .  
						of HAP1_HUMAN, which also corresponds to amino acids 504 -   	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEE................R 184                                                          
						524 of HSU38371_P8, and a sixth amino acid sequence being at 	         |||||||||||||||||||||||||||||||||                |  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEELLPPVWESVTYGMVLQR 200                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence EPQPWT       	     185 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 234                                                          
						corresponding to amino acids 525 - 530 of HSU38371_P8,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, bridging amino acid, 	     201 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 250                                                          
						second amino acid sequence, third amino acid sequence, fourth	                  .         .         .         .         .  
						amino acid sequence, fifth amino acid sequence and sixth     	     235 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 284                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated chimeric polypeptide encoding for an edge	     251 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 300                                                          
						portion of HSU38371_P8, comprising a polypeptide having a    	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     285 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 334                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     301 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 350                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     335 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 384                                                          
						at least two amino acids comprise ER, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     351 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 400                                                          
						183-x to 184; and ending at any of amino acid numbers 184+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     385 YGAETEKLQKQLASEKEIQMQLQEE......................... 409                                                          
						chimeric polypeptide encoding for an edge portion of         	         |||||||||||||||||||||||||                           
						HSU38371_P8, comprising a polypeptide having a length "n",   	     401 YGAETEKLQKQLASEKEIQMQLQEESVWVGSQLQDLREKYMDCGGMLIEM 450                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     410 ...........................ETLPGFQETLAEELRTSLRRMIS 432                                                          
						preferably at least about 30 amino acids in length, more     	                                    |||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     451 QEEVKTLRQQPPVSTGSATHYPYSVPLETLPGFQETLAEELRTSLRRMIS 500                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise EE, having a structure as  	     433 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 482                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						409-x to 410; and ending at any of amino acid numbers 410+   	     501 DPVYFMERNYEMPRGDTSSLRYDFRYSEDREQVRGFEAEEGLMLAADIMR 550                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	     483 GEDFTPAEELVPQEELGAAKK............................. 503                                                          
						HSU38371_P8, comprising a polypeptide having a length "n",   	         |||||||||||||||||||||                               
						wherein n is at least about 10 amino acids in length,        	     551 GEDFTPAEELVPQEELGAAKKVPAEEGVMEEAELVSEETEGWEEVELELD 600                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     504 .............................QLANWQDAHYRRQLRWKMLQK 524                                                          
						preferably at least about 40 amino acids in length and most  	                                      |||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     601 EATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQK 650                                                          
						at least two amino acids comprise KQ, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						503-x to 504; and ending at any of amino acid numbers 504+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                                                            
						polypeptide encoding for a tail of HSU38371_P8, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence EPQPWT in HSU38371_P8.                       	                                                            

26926	HMR136_HSU38371_9_tr0_r1_1_gPRT		Comparison report between HSU38371_P9 and HAP1_HUMANpartial  	Sequence name: HAP1_HUMAN                                    
						WT sequence followed by mismatch, featuring a skipped exon   	                                                            
						and a followed by a unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for HSU38371_P9, comprising a first     	                                                            
						amino acid sequence being at least 90 % homologous to MRP    	Alignment of: 26926 x HAP1_HUMAN   ..                        
						corresponding to amino acids 1 - 3 of HAP1_HUMAN, which also 	                                                            
						corresponds to amino acids 1 - 3 of HSU38371_P9, a bridging  	Alignment segment 1/1:                                       
						amino acid K corresponding to amino acid 4 of HSU38371_P9, a 	                                                            
						RLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRVGSRATSGTQFLSEA 	                     Quality: 4217.00                      Escore:       0                                               
						RTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNSDAPWTRFVFQGPFGSRATGRGTGK 	             Matching length:     453                Total length:     521                                               
						AAGIWKTPAAYVGRRPGVSGPERAAFIRELEEALCPNLPPPVKKITQEDVKVMLYLLEE  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:   86.95      Total Percent Identity:   86.76                                               
						corresponding to amino acids 5 - 183 of HAP1_HUMAN, which    	                        Gaps:       2                        
						also corresponds to amino acids 5 - 183 of HSU38371_P9, a    	                                                            
						RERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRDELLQLYSDS 	Alignment:                                                   
						DEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLISQEALLHQHHCPQLEALQE 	                  .         .         .         .         .  
						KLRLLEEENHQLREEASQLDTLEDEEQMLILECVEQFSEASQQMAELSEVLVLRLENYER 	       1 MRPKRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						QQQEVARLQAQVLKLQQRCRMYGAETEKLQKQLASEKEIQMQLQEE               	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	       1 MRPRRLGRCCAGSRLGPGDPAALTCAPSPSASPAPEPSAQPQARGTGQRV 50                                                           
						corresponding to amino acids 200 - 425 of HAP1_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 184 - 409 of HSU38371_P9, a  	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						fourth amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETLPGFQETLAEELRTSLRRMISDPVYFMERNYEMPRGDTSSLR corresponding to	      51 GSRATSGTQFLSEARTGARPASEAGAKAGARRPSAFSAIQGDVRSMPDNS 100                                                          
						amino acids 478 - 521 of HAP1_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 410 - 453 of HSU38371_P9, and a fifth amino   	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						acid sequence being at least 70%, optionally at least 80%,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 DAPWTRFVFQGPFGSRATGRGTGKAAGIWKTPAAYVGRRPGVSGPERAAF 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence APAVDLRWVEKTLSLLYSPQVAGSSR corresponding 	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEE................R 184                                                          
						to amino acids 454 - 479 of HSU38371_P9, wherein said first  	         |||||||||||||||||||||||||||||||||                |  
						amino acid sequence, bridging amino acid, second amino acid  	     151 IRELEEALCPNLPPPVKKITQEDVKVMLYLLEELLPPVWESVTYGMVLQR 200                                                          
						sequence, third amino acid sequence, fourth amino acid       	                  .         .         .         .         .  
						sequence and fifth amino acid sequence are contiguous and in 	     185 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 234                                                          
						a sequential order.2.An isolated chimeric polypeptide        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of HSU38371_P9, comprising a    	     201 ERDLNTAARIGQSLVKQNSVLMEENSKLEALLGSAKEEILYLRHQVNLRD 250                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     235 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 284                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     251 ELLQLYSDSDEEDEDEEEEEEEKEAEEEQEEEEAEEDLQCAHPCDAPKLI 300                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise ER, having 	     285 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 334                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 183-x to 184; and ending at any of amino acid   	     301 SQEALLHQHHCPQLEALQEKLRLLEEENHQLREEASQLDTLEDEEQMLIL 350                                                          
						numbers 184+ ((n-2) - x), in which x varies from 0 to        	                  .         .         .         .         .  
						n-2.3.An isolated chimeric polypeptide encoding for an edge  	     335 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 384                                                          
						portion of HSU38371_P9, comprising a polypeptide having a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     351 ECVEQFSEASQQMAELSEVLVLRLENYERQQQEVARLQAQVLKLQQRCRM 400                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     385 YGAETEKLQKQLASEKEIQMQLQEE......................... 409                                                          
						preferably at least about 40 amino acids in length and most  	         |||||||||||||||||||||||||                           
						preferably at least about 50 amino acids in length, wherein  	     401 YGAETEKLQKQLASEKEIQMQLQEESVWVGSQLQDLREKYMDCGGMLIEM 450                                                          
						at least two amino acids comprise EE, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     410 ...........................ETLPGFQETLAEELRTSLRRMIS 432                                                          
						409-x to 410; and ending at any of amino acid numbers 410+   	                                    |||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     451 QEEVKTLRQQPPVSTGSATHYPYSVPLETLPGFQETLAEELRTSLRRMIS 500                                                          
						polypeptide encoding for a tail of HSU38371_P9, comprising a 	                  .         .                                
						polypeptide being at least 70%, optionally at least about    	     433 DPVYFMERNYEMPRGDTSSLR                              453                                                          
						80%, preferably at least about 85%, more preferably at least 	         |||||||||||||||||||||                               
						about 90% and most preferably at least about 95% homologous  	     501 DPVYFMERNYEMPRGDTSSLR                              521                                                          
						to the sequence APAVDLRWVEKTLSLLYSPQVAGSSR in HSU38371_P9.   	                                                            

3475	HMR136_HSU38442_7_tr0_r1_1_gPRT		Comparison report between HSU38442_P7 and Q96BU8unique head  	Sequence name: Q96BU8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU38442_P7, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 3475 x Q96BU8   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MFPGNRGPASER corresponding to amino acids	Alignment segment 1/1:                                       
						1 - 12 of HSU38442_P7, and a second amino acid sequence being	                                                            
						WHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPIIASLSFGATR 	                     Quality: 1355.00                      Escore:       0                                               
						TFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQADWQHRVPKEYHSREPRVNLT 	             Matching length:     133                Total length:     133                                               
						FRTVYPDPRGAPW                                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						at least 90 % homologous to corresponding to amino acids 7 - 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						139 of Q96BU8, which also corresponds to amino acids 13 - 145	                        Gaps:       0                        
						of HSU38442_P7, wherein said first amino acid sequence and   	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						HSU38442_P7, comprising a polypeptide being at least 70%,    	      13 WHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPI 62                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	       7 WHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPI 56                                                           
						least about 95% homologous to the sequence MFPGNRGPASER of   	                  .         .         .         .         .  
						HSU38442_P7.                                                 	      63 IASLSFGATRTFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQA 112                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      57 IASLSFGATRTFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQA 106                                                          
						                                                            	                  .         .         .                      
						                                                            	     113 DWQHRVPKEYHSREPRVNLTFRTVYPDPRGAPW                  145                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     107 DWQHRVPKEYHSREPRVNLTFRTVYPDPRGAPW                  139                                                          

						Comparison report between HSU38442_P7 and Q96Q83unique head  	Sequence name: Q96Q83                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU38442_P7, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 3475 x Q96Q83   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MFPGNRGPASER corresponding to amino acids	Alignment segment 1/1:                                       
						1 - 12 of HSU38442_P7, and a second amino acid sequence being	                                                            
						WHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPIIASLSFGATR 	                     Quality: 1355.00                      Escore:       0                                               
						TFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQADWQHRVPKEYHSREPRVNLT 	             Matching length:     133                Total length:     133                                               
						FRTVYPDPRGAPW                                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						at least 90 % homologous to corresponding to amino acids 154 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						- 286 of Q96Q83, which also corresponds to amino acids 13 -  	                        Gaps:       0                        
						145 of HSU38442_P7, wherein said first amino acid sequence   	                                                            
						and second amino acid sequence are contiguous and in a       	Alignment:                                                   
						sequential order.2.An isolated polypeptide encoding for a    	                  .         .         .         .         .  
						head of HSU38442_P7, comprising a polypeptide being at least 	      13 WHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPI 62                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     154 WHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPI 203                                                          
						at least about 95% homologous to the sequence MFPGNRGPASER of	                  .         .         .         .         .  
						HSU38442_P7.                                                 	      63 IASLSFGATRTFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQA 112                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     204 IASLSFGATRTFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQA 253                                                          
						                                                            	                  .         .         .                      
						                                                            	     113 DWQHRVPKEYHSREPRVNLTFRTVYPDPRGAPW                  145                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     254 DWQHRVPKEYHSREPRVNLTFRTVYPDPRGAPW                  286                                                          

27904	HMR136_HSU40983_11_tr0_r1_1_gPRT		Comparison report between HSU40983_P11 and Q96P05partial WT  	Sequence name: Q96P05                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HSU40983_P11, comprising a first    	Sequence documentation:                                      
						MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKKSLEEAEIYFK 	                                                            
						ININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDALLHAIRKEVVGAVELLLNHKK 	Alignment of: 27904 x Q96P05   ..                            
						PSGEKQVPPILLDKQFSEFTPDITPIILAAHTNNYEIIKLLVQKGVSVPRPHEVRCNCVE 	                                                            
						CVSSSDVDSLRHSRSRLNIYKALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSE 	Alignment segment 1/1:                                       
						YEELSRQCKQFAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKE  	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2879.00                      Escore:       0                                               
						corresponding to amino acids 1 - 299 of Q96P05, which also   	             Matching length:     299                Total length:     299                                               
						corresponds to amino acids 1 - 299 of HSU40983_P11, and a    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence VSVARLDPS corresponding to   	Alignment:                                                   
						amino acids 300 - 308 of HSU40983_P11, wherein said first    	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	       1 MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKK 50                                                           
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of HSU40983_P11, comprising a	       1 MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKK 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 SLEEAEIYFKININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDAL 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VSVARLDPS in HSU40983_P11.                   	      51 SLEEAEIYFKININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDAL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 HTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 HTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQ 250                                                          
						                                                            	                  .         .         .         .            
						                                                            	     251 FAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKE  299                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     251 FAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKE  299                                                          

						Comparison report between HSU40983_P11 and Q96P04partial WT  	Sequence name: Q96P04                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HSU40983_P11, comprising a first    	Sequence documentation:                                      
						MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKKSLEEAEIYFK 	                                                            
						ININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDALLHAIRKEVVGAVELLLNHKK 	Alignment of: 27904 x Q96P04   ..                            
						PSGEKQVPPILLDKQFSEFTPDITPIILAAHTNNYEIIKLLVQKGVSVPRPHEVRCNCVE 	                                                            
						CVSSSDVDSLRHSRSRLNIYKALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSE 	Alignment segment 1/1:                                       
						YEELSRQCKQFAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKE  	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2886.00                      Escore:       0                                               
						corresponding to amino acids 1 - 299 of Q96P04, which also   	             Matching length:     301                Total length:     301                                               
						corresponds to amino acids 1 - 299 of HSU40983_P11, and a    	 Matching Percent Similarity:   99.67   Matching Percent Identity:   99.67                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:   99.67      Total Percent Identity:   99.67                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence VSVARLDPS corresponding to   	Alignment:                                                   
						amino acids 300 - 308 of HSU40983_P11, wherein said first    	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	       1 MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKK 50                                                           
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of HSU40983_P11, comprising a	       1 MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKK 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 SLEEAEIYFKININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDAL 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VSVARLDPS in HSU40983_P11.                   	      51 SLEEAEIYFKININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDAL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 HTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 HTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKEV 300                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     251 FAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKEA 300                                                          
						                                                            	                                                             
						                                                            	     301 S                                                  301                                                          
						                                                            	         |                                                   
						                                                            	     301 S                                                  301                                                          

						Comparison report between HSU40983_P11 and TRP4_HUMANpartial 	Sequence name: TRP4_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU40983_P11, comprising a first    	Sequence documentation:                                      
						MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKKSLEEAEIYFK 	                                                            
						ININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDALLHAIRKEVVGAVELLLNHKK 	Alignment of: 27904 x TRP4_HUMAN   ..                        
						PSGEKQVPPILLDKQFSEFTPDITPIILAAHTNNYEIIKLLVQKGVSVPRPHEVRCNCVE 	                                                            
						CVSSSDVDSLRHSRSRLNIYKALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSE 	Alignment segment 1/1:                                       
						YEELSRQCKQFAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKE  	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2879.00                      Escore:       0                                               
						corresponding to amino acids 1 - 299 of TRP4_HUMAN, which    	             Matching length:     299                Total length:     299                                               
						also corresponds to amino acids 1 - 299 of HSU40983_P11, and 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						a second amino acid sequence being at least 70%, optionally  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						at least 80%, preferably at least 85%, more preferably at    	                        Gaps:       0                        
						least 90% and most preferably at least 95% homologous to a   	                                                            
						polypeptide having the sequence VSVARLDPS corresponding to   	Alignment:                                                   
						amino acids 300 - 308 of HSU40983_P11, wherein said first    	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	       1 MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKK 50                                                           
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of HSU40983_P11, comprising a	       1 MAQFYYKRNVNAPYRDRIPLRIVRAESELSPSEKAYLNAVEKGDYASVKK 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 SLEEAEIYFKININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDAL 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VSVARLDPS in HSU40983_P11.                   	      51 SLEEAEIYFKININCIDPLGRTALLIAIENENLELIELLLSFNVYVGDAL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 HTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 HTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KALASPSLIALSSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQ 250                                                          
						                                                            	                  .         .         .         .            
						                                                            	     251 FAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKE  299                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     251 FAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKE  299                                                          

27908	HMR136_HSU40983_2_tr0_r1_1_gPRT		Comparison report between HSU40983_P2 and TRP4_HUMANpartial  	Sequence name: TRP4_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HSU40983_P2, comprising a first     	                                                            
						MWDGGLQDYIHDWWNLMDFVMNSLYLATISLKIVAFVKYSALNPRESWDMWHPTLVAEAL 	Alignment of: 27908 x TRP4_HUMAN   ..                        
						FAIANIFSSLRLISLFTANSHLGPLQISLGRMLLDILKFLFIYCLVLLAFANGLNQLYFY 	                                                            
						YEETKGLTCKGIRCEKQNNAFSTLFETLQSLFWSIFGLINLYVTNVKAQHEFTEFVGATM 	Alignment segment 1/1:                                       
						FGTYNVISLVVLLNMLIAMMNNSYQLIADHADIEWKFARTKLWMSYFEEGGTLPTPFNVI 	                                                            
						PSPKSLWYLIKWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAA 	                     Quality: 5458.00                      Escore:       0                                               
						MIRDAKTEEGLTEENFKELKQDISSFRFEVLGLLRGSKLSTIQSANASKESSNSADSDEK 	             Matching length:     557                Total length:     557                                               
						SDSEGNSKDKKKNFSLFDLTTLIHPRSAAIASERHNISNGSALVVQEPPREKQRKVNFVT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DIKNFGLFHRRSKQNAAEQNANQIFSVSEEVARQQAAGPLERNIQLESRGLASRGDLSIP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLSEQCVLVDHRERNTDTLGLQVGKRVCPFKSEKVVVEDTVPIIPKEKHAKEEDSSIDYD 	                        Gaps:       0                        
						LNLPDTVTHEDYVTTRL                                            	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 421 - 977 of TRP4_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 1 - 557 of HSU40983_P2.      	       1 MWDGGLQDYIHDWWNLMDFVMNSLYLATISLKIVAFVKYSALNPRESWDM 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     421 MWDGGLQDYIHDWWNLMDFVMNSLYLATISLKIVAFVKYSALNPRESWDM 470                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WHPTLVAEALFAIANIFSSLRLISLFTANSHLGPLQISLGRMLLDILKFL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     471 WHPTLVAEALFAIANIFSSLRLISLFTANSHLGPLQISLGRMLLDILKFL 520                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FIYCLVLLAFANGLNQLYFYYEETKGLTCKGIRCEKQNNAFSTLFETLQS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     521 FIYCLVLLAFANGLNQLYFYYEETKGLTCKGIRCEKQNNAFSTLFETLQS 570                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LFWSIFGLINLYVTNVKAQHEFTEFVGATMFGTYNVISLVVLLNMLIAMM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     571 LFWSIFGLINLYVTNVKAQHEFTEFVGATMFGTYNVISLVVLLNMLIAMM 620                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NNSYQLIADHADIEWKFARTKLWMSYFEEGGTLPTPFNVIPSPKSLWYLI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     621 NNSYQLIADHADIEWKFARTKLWMSYFEEGGTLPTPFNVIPSPKSLWYLI 670                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     671 KWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAA 720                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 MIRDAKTEEGLTEENFKELKQDISSFRFEVLGLLRGSKLSTIQSANASKE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     721 MIRDAKTEEGLTEENFKELKQDISSFRFEVLGLLRGSKLSTIQSANASKE 770                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SSNSADSDEKSDSEGNSKDKKKNFSLFDLTTLIHPRSAAIASERHNISNG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     771 SSNSADSDEKSDSEGNSKDKKKNFSLFDLTTLIHPRSAAIASERHNISNG 820                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 SALVVQEPPREKQRKVNFVTDIKNFGLFHRRSKQNAAEQNANQIFSVSEE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     821 SALVVQEPPREKQRKVNFVTDIKNFGLFHRRSKQNAAEQNANQIFSVSEE 870                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VARQQAAGPLERNIQLESRGLASRGDLSIPGLSEQCVLVDHRERNTDTLG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     871 VARQQAAGPLERNIQLESRGLASRGDLSIPGLSEQCVLVDHRERNTDTLG 920                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LQVGKRVCPFKSEKVVVEDTVPIIPKEKHAKEEDSSIDYDLNLPDTVTHE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     921 LQVGKRVCPFKSEKVVVEDTVPIIPKEKHAKEEDSSIDYDLNLPDTVTHE 970                                                          
						                                                            	                                                             
						                                                            	     551 DYVTTRL                                            557                                                          
						                                                            	         |||||||                                             
						                                                            	     971 DYVTTRL                                            977                                                          

27906	HMR136_HSU40983_3_tr0_r1_1_gPRT		Comparison report between HSU40983_P3 and TRP4_HUMANpartial  	Sequence name: TRP4_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HSU40983_P3, comprising a first     	                                                            
						MWDGGLQDYIHDWWNLMDFVMNSLYLATISLKIVAFVKYSALNPRESWDMWHPTLVAEAL 	Alignment of: 27906 x TRP4_HUMAN   ..                        
						FAIANIFSSLRLISLFTANSHLGPLQISLGRMLLDILKFLFIYCLVLLAFANGLNQLYFY 	                                                            
						YEETKGLTCKGIRCEKQNNAFSTLFETLQSLFWSIFGLINLYVTNVKAQHEFTEFVGATM 	Alignment segment 1/1:                                       
						FGTYNVISLVVLLNMLIAMMNNSYQLIADHADIEWKFARTKLWMSYFEEGGTLPTPFNVI 	                                                            
						PSPKSLWYLIKWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAA 	                     Quality: 5458.00                      Escore:       0                                               
						MIRDAKTEEGLTEENFKELKQDISSFRFEVLGLLRGSKLSTIQSANASKESSNSADSDEK 	             Matching length:     557                Total length:     557                                               
						SDSEGNSKDKKKNFSLFDLTTLIHPRSAAIASERHNISNGSALVVQEPPREKQRKVNFVT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DIKNFGLFHRRSKQNAAEQNANQIFSVSEEVARQQAAGPLERNIQLESRGLASRGDLSIP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLSEQCVLVDHRERNTDTLGLQVGKRVCPFKSEKVVVEDTVPIIPKEKHAKEEDSSIDYD 	                        Gaps:       0                        
						LNLPDTVTHEDYVTTRL                                            	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 421 - 977 of TRP4_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 1 - 557 of HSU40983_P3.      	       1 MWDGGLQDYIHDWWNLMDFVMNSLYLATISLKIVAFVKYSALNPRESWDM 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     421 MWDGGLQDYIHDWWNLMDFVMNSLYLATISLKIVAFVKYSALNPRESWDM 470                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WHPTLVAEALFAIANIFSSLRLISLFTANSHLGPLQISLGRMLLDILKFL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     471 WHPTLVAEALFAIANIFSSLRLISLFTANSHLGPLQISLGRMLLDILKFL 520                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FIYCLVLLAFANGLNQLYFYYEETKGLTCKGIRCEKQNNAFSTLFETLQS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     521 FIYCLVLLAFANGLNQLYFYYEETKGLTCKGIRCEKQNNAFSTLFETLQS 570                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LFWSIFGLINLYVTNVKAQHEFTEFVGATMFGTYNVISLVVLLNMLIAMM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     571 LFWSIFGLINLYVTNVKAQHEFTEFVGATMFGTYNVISLVVLLNMLIAMM 620                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NNSYQLIADHADIEWKFARTKLWMSYFEEGGTLPTPFNVIPSPKSLWYLI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     621 NNSYQLIADHADIEWKFARTKLWMSYFEEGGTLPTPFNVIPSPKSLWYLI 670                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     671 KWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAA 720                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 MIRDAKTEEGLTEENFKELKQDISSFRFEVLGLLRGSKLSTIQSANASKE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     721 MIRDAKTEEGLTEENFKELKQDISSFRFEVLGLLRGSKLSTIQSANASKE 770                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SSNSADSDEKSDSEGNSKDKKKNFSLFDLTTLIHPRSAAIASERHNISNG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     771 SSNSADSDEKSDSEGNSKDKKKNFSLFDLTTLIHPRSAAIASERHNISNG 820                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 SALVVQEPPREKQRKVNFVTDIKNFGLFHRRSKQNAAEQNANQIFSVSEE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     821 SALVVQEPPREKQRKVNFVTDIKNFGLFHRRSKQNAAEQNANQIFSVSEE 870                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VARQQAAGPLERNIQLESRGLASRGDLSIPGLSEQCVLVDHRERNTDTLG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     871 VARQQAAGPLERNIQLESRGLASRGDLSIPGLSEQCVLVDHRERNTDTLG 920                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LQVGKRVCPFKSEKVVVEDTVPIIPKEKHAKEEDSSIDYDLNLPDTVTHE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     921 LQVGKRVCPFKSEKVVVEDTVPIIPKEKHAKEEDSSIDYDLNLPDTVTHE 970                                                          
						                                                            	                                                             
						                                                            	     551 DYVTTRL                                            557                                                          
						                                                            	         |||||||                                             
						                                                            	     971 DYVTTRL                                            977                                                          

3715	HMR136_HSU41804_3_tr0_r1_1_gPRT		Comparison report between HSU41804_P3 and Q13445partial WT   	Sequence name: Q13445                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HSU41804_P3, comprising a first amino acid      	                                                            
						MLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVNFWSAVNVAVLL 	Alignment of: 3715 x Q13445   ..                             
						LVAVLQVCTLKRFFQDKRPVPT                                       	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 146 - 227 of Q13445, which also corresponds to   	                                                            
						amino acids 1 - 82 of HSU41804_P3.                           	                     Quality:  788.00                      Escore:       0                                               
						                                                            	             Matching length:      82                Total length:      82                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVNF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     146 MLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVNF 195                                                          
						                                                            	                  .         .         .                      
						                                                            	      51 WSAVNVAVLLLVAVLQVCTLKRFFQDKRPVPT                   82                                                           
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     196 WSAVNVAVLLLVAVLQVCTLKRFFQDKRPVPT                   227                                                          

3717	HMR136_HSU41804_5_tr0_r1_1_gPRT		Comparison report between HSU41804_P5 and Q13445partial WT   	Sequence name: Q13445                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HSU41804_P5, comprising a first amino acid      	                                                            
						MLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVNFWSAVNVAVLL 	Alignment of: 3717 x Q13445   ..                             
						LVAVLQVCTLKRFFQDKRPVPT                                       	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 146 - 227 of Q13445, which also corresponds to   	                                                            
						amino acids 1 - 82 of HSU41804_P5.                           	                     Quality:  788.00                      Escore:       0                                               
						                                                            	             Matching length:      82                Total length:      82                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVNF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     146 MLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVNF 195                                                          
						                                                            	                  .         .         .                      
						                                                            	      51 WSAVNVAVLLLVAVLQVCTLKRFFQDKRPVPT                   82                                                           
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     196 WSAVNVAVLLLVAVLQVCTLKRFFQDKRPVPT                   227                                                          

28179	HMR136_HSU41898_5_tr0_r1_1_gPRT		Comparison report between HSU41898_P5 and CAC83728partial WT 	Sequence name: CAC83728                                      
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for HSU41898_P5, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MESGTSSPQPPQLDPLDAFPQKGLEPGDIAVLVLYFLFVLAVGLW corresponding  	Alignment of: 28179 x CAC83728   ..                          
						to amino acids 1 - 45 of CAC83728, which also corresponds to 	                                                            
						amino acids 1 - 45 of HSU41898_P5, a second amino acid       	Alignment segment 1/1:                                       
						VGASLFASNVGSGHFIGLAGSGAATGISVSAYELNGLFSVLMLAWIFLPIYIAGQVTTMP 	                                                            
						EYLRKRFGGIRIPIILAVLYLFIYIFTKISVDMYAGAIFIQQSLHLDLYLAIVGLLAITA 	                     Quality: 6178.00                      Escore:       0                                               
						VYTVAGGLAAVIYTDALQTLIMLIGALTLMGYSFAAVGGMEGLKEKYFLALASNRSENSS 	             Matching length:     651                Total length:     675                                               
						CGLPREDAFHIFRDPLTSDLPWPGVLFGMSIPSLWYWCTDQVIVQRTLAAKNLSHAKGGA 	 Matching Percent Similarity:   99.85   Matching Percent Identity:   99.85                                               
						LMAAYLKVLPLFIMVFPGMVSRILFPDQVACADPEICQKICSNPSGCSDIAYPKLVLELL 	    Total Percent Similarity:   96.30      Total Percent Identity:   96.30                                               
						P                                                            	                        Gaps:       1                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 70 - 370 of CAC83728, which also corresponds to  	Alignment:                                                   
						amino acids 46 - 346 of HSU41898_P5, a bridging amino acid T 	                  .         .         .         .         .  
						corresponding to amino acid 347 of HSU41898_P5, and a third  	       1 MESGTSSPQPPQLDPLDAFPQKGLEPGDIAVLVLYFLFVLAVGLW..... 45                                                           
						GLRGLMMAVMVAALMSSLTSIFNSASTIFTMDLWNHLRPRASEKELMIVGRVFVLLLVLV 	         |||||||||||||||||||||||||||||||||||||||||||||       
						SILWIPVVQASQGGQLFIYIQSISSYLQPPVAVVFIMGCFWKRTNEKGAFWGLISGLLLG 	       1 MESGTSSPQPPQLDPLDAFPQKGLEPGDIAVLVLYFLFVLAVGLWSTVKT 50                                                           
						LVRLVLDFIYVQPRCDQPDERPVLVKSIHYLYFSMILSTVTLITVSTVSWFTEPPSKEMV 	                  .         .         .         .         .  
						SHLTWFTRHDPVVQKEQAPPAAPLSLTLSQNGMPEASSSSSVQFEMVQENTSKTHSCDMT 	      46 ...................VGASLFASNVGSGHFIGLAGSGAATGISVSA 76                                                           
						PKQSKVVKAILWLCGIQEKGKEELPARAEAIIVSLEENPLVKTLLDVNLIFCVSCAIFIW 	                            |||||||||||||||||||||||||||||||  
						GYFA                                                         	      51 KRDTVKGYFLAGGDMVWWPVGASLFASNVGSGHFIGLAGSGAATGISVSA 100                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 372 - 675 of CAC83728, which    	      77 YELNGLFSVLMLAWIFLPIYIAGQVTTMPEYLRKRFGGIRIPIILAVLYL 126                                                          
						also corresponds to amino acids 348 - 651 of HSU41898_P5,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     101 YELNGLFSVLMLAWIFLPIYIAGQVTTMPEYLRKRFGGIRIPIILAVLYL 150                                                          
						sequence, bridging amino acid and third amino acid sequence  	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	     127 FIYIFTKISVDMYAGAIFIQQSLHLDLYLAIVGLLAITAVYTVAGGLAAV 176                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU41898_P5, comprising a polypeptide having a length "n",   	     151 FIYIFTKISVDMYAGAIFIQQSLHLDLYLAIVGLLAITAVYTVAGGLAAV 200                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     177 IYTDALQTLIMLIGALTLMGYSFAAVGGMEGLKEKYFLALASNRSENSSC 226                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     201 IYTDALQTLIMLIGALTLMGYSFAAVGGMEGLKEKYFLALASNRSENSSC 250                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise WV, having a structure as  	     227 GLPREDAFHIFRDPLTSDLPWPGVLFGMSIPSLWYWCTDQVIVQRTLAAK 276                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						45-x to 46; and ending at any of amino acid numbers 46+      	     251 GLPREDAFHIFRDPLTSDLPWPGVLFGMSIPSLWYWCTDQVIVQRTLAAK 300                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     277 NLSHAKGGALMAAYLKVLPLFIMVFPGMVSRILFPDQVACADPEICQKIC 326                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NLSHAKGGALMAAYLKVLPLFIMVFPGMVSRILFPDQVACADPEICQKIC 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     327 SNPSGCSDIAYPKLVLELLPTGLRGLMMAVMVAALMSSLTSIFNSASTIF 376                                                          
						                                                            	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						                                                            	     351 SNPSGCSDIAYPKLVLELLPPGLRGLMMAVMVAALMSSLTSIFNSASTIF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 TMDLWNHLRPRASEKELMIVGRVFVLLLVLVSILWIPVVQASQGGQLFIY 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TMDLWNHLRPRASEKELMIVGRVFVLLLVLVSILWIPVVQASQGGQLFIY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 IQSISSYLQPPVAVVFIMGCFWKRTNEKGAFWGLISGLLLGLVRLVLDFI 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IQSISSYLQPPVAVVFIMGCFWKRTNEKGAFWGLISGLLLGLVRLVLDFI 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 YVQPRCDQPDERPVLVKSIHYLYFSMILSTVTLITVSTVSWFTEPPSKEM 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 YVQPRCDQPDERPVLVKSIHYLYFSMILSTVTLITVSTVSWFTEPPSKEM 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     527 VSHLTWFTRHDPVVQKEQAPPAAPLSLTLSQNGMPEASSSSSVQFEMVQE 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VSHLTWFTRHDPVVQKEQAPPAAPLSLTLSQNGMPEASSSSSVQFEMVQE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     577 NTSKTHSCDMTPKQSKVVKAILWLCGIQEKGKEELPARAEAIIVSLEENP 626                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NTSKTHSCDMTPKQSKVVKAILWLCGIQEKGKEELPARAEAIIVSLEENP 650                                                          
						                                                            	                  .         .                                
						                                                            	     627 LVKTLLDVNLIFCVSCAIFIWGYFA                          651                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     651 LVKTLLDVNLIFCVSCAIFIWGYFA                          675                                                          

						Comparison report between HSU41898_P5 and Q8WWX8partial WT   	Sequence name: Q8WWX8                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for HSU41898_P5, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MESGTSSPQPPQLDPLDAFPQKGLEPGDIAVLVLYFLFVLAVGLW corresponding  	Alignment of: 28179 x Q8WWX8   ..                            
						to amino acids 1 - 45 of Q8WWX8, which also corresponds to   	                                                            
						amino acids 1 - 45 of HSU41898_P5, and a second amino acid   	Alignment segment 1/1:                                       
						VGASLFASNVGSGHFIGLAGSGAATGISVSAYELNGLFSVLMLAWIFLPIYIAGQVTTMP 	                                                            
						EYLRKRFGGIRIPIILAVLYLFIYIFTKISVDMYAGAIFIQQSLHLDLYLAIVGLLAITA 	                     Quality: 6191.00                      Escore:       0                                               
						VYTVAGGLAAVIYTDALQTLIMLIGALTLMGYSFAAVGGMEGLKEKYFLALASNRSENSS 	             Matching length:     651                Total length:     675                                               
						CGLPREDAFHIFRDPLTSDLPWPGVLFGMSIPSLWYWCTDQVIVQRTLAAKNLSHAKGGA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LMAAYLKVLPLFIMVFPGMVSRILFPDQVACADPEICQKICSNPSGCSDIAYPKLVLELL 	    Total Percent Similarity:   96.44      Total Percent Identity:   96.44                                               
						PTGLRGLMMAVMVAALMSSLTSIFNSASTIFTMDLWNHLRPRASEKELMIVGRVFVLLLV 	                        Gaps:       1                        
						LVSILWIPVVQASQGGQLFIYIQSISSYLQPPVAVVFIMGCFWKRTNEKGAFWGLISGLL 	                                                            
						LGLVRLVLDFIYVQPRCDQPDERPVLVKSIHYLYFSMILSTVTLITVSTVSWFTEPPSKE 	Alignment:                                                   
						MVSHLTWFTRHDPVVQKEQAPPAAPLSLTLSQNGMPEASSSSSVQFEMVQENTSKTHSCD 	                  .         .         .         .         .  
						MTPKQSKVVKAILWLCGIQEKGKEELPARAEAIIVSLEENPLVKTLLDVNLIFCVSCAIF 	       1 MESGTSSPQPPQLDPLDAFPQKGLEPGDIAVLVLYFLFVLAVGLW..... 45                                                           
						IWGYFA                                                       	         |||||||||||||||||||||||||||||||||||||||||||||       
						sequence being at least 90 % homologous to corresponding to  	       1 MESGTSSPQPPQLDPLDAFPQKGLEPGDIAVLVLYFLFVLAVGLWSTVKT 50                                                           
						amino acids 70 - 675 of Q8WWX8, which also corresponds to    	                  .         .         .         .         .  
						amino acids 46 - 651 of HSU41898_P5, wherein said first amino	      46 ...................VGASLFASNVGSGHFIGLAGSGAATGISVSA 76                                                           
						acid sequence and second amino acid sequence are contiguous  	                            |||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated chimeric polypeptide 	      51 KRDTVKGYFLAGGDMVWWPVGASLFASNVGSGHFIGLAGSGAATGISVSA 100                                                          
						encoding for an edge portion of HSU41898_P5, comprising a    	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	      77 YELNGLFSVLMLAWIFLPIYIAGQVTTMPEYLRKRFGGIRIPIILAVLYL 126                                                          
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     101 YELNGLFSVLMLAWIFLPIYIAGQVTTMPEYLRKRFGGIRIPIILAVLYL 150                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	     127 FIYIFTKISVDMYAGAIFIQQSLHLDLYLAIVGLLAITAVYTVAGGLAAV 176                                                          
						length, wherein at least two amino acids comprise WV, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	     151 FIYIFTKISVDMYAGAIFIQQSLHLDLYLAIVGLLAITAVYTVAGGLAAV 200                                                          
						acid numbers 45-x to 46; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 46+ ((n-2) - x), in which x varies from 0 to n-2.    	     177 IYTDALQTLIMLIGALTLMGYSFAAVGGMEGLKEKYFLALASNRSENSSC 226                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IYTDALQTLIMLIGALTLMGYSFAAVGGMEGLKEKYFLALASNRSENSSC 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     227 GLPREDAFHIFRDPLTSDLPWPGVLFGMSIPSLWYWCTDQVIVQRTLAAK 276                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GLPREDAFHIFRDPLTSDLPWPGVLFGMSIPSLWYWCTDQVIVQRTLAAK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     277 NLSHAKGGALMAAYLKVLPLFIMVFPGMVSRILFPDQVACADPEICQKIC 326                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NLSHAKGGALMAAYLKVLPLFIMVFPGMVSRILFPDQVACADPEICQKIC 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     327 SNPSGCSDIAYPKLVLELLPTGLRGLMMAVMVAALMSSLTSIFNSASTIF 376                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SNPSGCSDIAYPKLVLELLPTGLRGLMMAVMVAALMSSLTSIFNSASTIF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 TMDLWNHLRPRASEKELMIVGRVFVLLLVLVSILWIPVVQASQGGQLFIY 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TMDLWNHLRPRASEKELMIVGRVFVLLLVLVSILWIPVVQASQGGQLFIY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 IQSISSYLQPPVAVVFIMGCFWKRTNEKGAFWGLISGLLLGLVRLVLDFI 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IQSISSYLQPPVAVVFIMGCFWKRTNEKGAFWGLISGLLLGLVRLVLDFI 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 YVQPRCDQPDERPVLVKSIHYLYFSMILSTVTLITVSTVSWFTEPPSKEM 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 YVQPRCDQPDERPVLVKSIHYLYFSMILSTVTLITVSTVSWFTEPPSKEM 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     527 VSHLTWFTRHDPVVQKEQAPPAAPLSLTLSQNGMPEASSSSSVQFEMVQE 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VSHLTWFTRHDPVVQKEQAPPAAPLSLTLSQNGMPEASSSSSVQFEMVQE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     577 NTSKTHSCDMTPKQSKVVKAILWLCGIQEKGKEELPARAEAIIVSLEENP 626                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NTSKTHSCDMTPKQSKVVKAILWLCGIQEKGKEELPARAEAIIVSLEENP 650                                                          
						                                                            	                  .         .                                
						                                                            	     627 LVKTLLDVNLIFCVSCAIFIWGYFA                          651                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     651 LVKTLLDVNLIFCVSCAIFIWGYFA                          675                                                          

28508	HMR136_HSU43408_2_tr0_r1_1_gPRT		Comparison report between HSU43408_P2 and Q8IYI4partial WT   	Sequence name: Q8IYI4                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HSU43408_P2, comprising a first amino acid      	                                                            
						MGTELGDFLREVSVMMNLEHPHVLRLHGLVLGQPLQMVMELAPLGSLHARLTAPAPTPPL 	Alignment of: 28508 x Q8IYI4   ..                            
						LVALLCLFLRQLAGAMAYLGARGLVHRDLATRNLLLASPRTIKVADFGLVRPLGGARGRY 	                                                            
						VMGGPRPIPYAWCAPESLRHGAFSSASDVWMFGVTLWEMFSGGEEPWAGVPPYLILQRLE 	Alignment segment 1/1:                                       
						DRARLPRPPLCSRALYSLALRCWAPHPADRPSFSHLEGLLQEAGPSEACCVRDVTEPGAL 	                                                            
						RMETGDPITVIEGSPDSTIWKGQNGRTFKVGSFPASAVTLADAGGLPATRPVHRGTPARG 	                     Quality: 4972.00                      Escore:       0                                               
						DQHPGSIDGDRKKANLWDAPPARGQRRNMPLERMKGISRSLESVLSLGPRPTGGGSSPPE 	             Matching length:     504                Total length:     504                                               
						IRQARAVPQGPPGLPPRPPLSSSSPQPSQPSRERLPWPKRKPPHNHPMGMPGARKAAALS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GGLLSDPELQRKIMEVELSVHGVTHQECQTALGATGGDVVSAIRNLKVDQLFHLSSRSRA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DCWRILEHYQWDLSAASRYVLARP                                     	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 158 - 661 of Q8IYI4, which also corresponds to   	Alignment:                                                   
						amino acids 1 - 504 of HSU43408_P2.                          	                  .         .         .         .         .  
						                                                            	       1 MGTELGDFLREVSVMMNLEHPHVLRLHGLVLGQPLQMVMELAPLGSLHAR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     158 MGTELGDFLREVSVMMNLEHPHVLRLHGLVLGQPLQMVMELAPLGSLHAR 207                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LTAPAPTPPLLVALLCLFLRQLAGAMAYLGARGLVHRDLATRNLLLASPR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     208 LTAPAPTPPLLVALLCLFLRQLAGAMAYLGARGLVHRDLATRNLLLASPR 257                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TIKVADFGLVRPLGGARGRYVMGGPRPIPYAWCAPESLRHGAFSSASDVW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     258 TIKVADFGLVRPLGGARGRYVMGGPRPIPYAWCAPESLRHGAFSSASDVW 307                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MFGVTLWEMFSGGEEPWAGVPPYLILQRLEDRARLPRPPLCSRALYSLAL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     308 MFGVTLWEMFSGGEEPWAGVPPYLILQRLEDRARLPRPPLCSRALYSLAL 357                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RCWAPHPADRPSFSHLEGLLQEAGPSEACCVRDVTEPGALRMETGDPITV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     358 RCWAPHPADRPSFSHLEGLLQEAGPSEACCVRDVTEPGALRMETGDPITV 407                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IEGSPDSTIWKGQNGRTFKVGSFPASAVTLADAGGLPATRPVHRGTPARG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     408 IEGSPDSTIWKGQNGRTFKVGSFPASAVTLADAGGLPATRPVHRGTPARG 457                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DQHPGSIDGDRKKANLWDAPPARGQRRNMPLERMKGISRSLESVLSLGPR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     458 DQHPGSIDGDRKKANLWDAPPARGQRRNMPLERMKGISRSLESVLSLGPR 507                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PTGGGSSPPEIRQARAVPQGPPGLPPRPPLSSSSPQPSQPSRERLPWPKR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     508 PTGGGSSPPEIRQARAVPQGPPGLPPRPPLSSSSPQPSQPSRERLPWPKR 557                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KPPHNHPMGMPGARKAAALSGGLLSDPELQRKIMEVELSVHGVTHQECQT 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     558 KPPHNHPMGMPGARKAAALSGGLLSDPELQRKIMEVELSVHGVTHQECQT 607                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ALGATGGDVVSAIRNLKVDQLFHLSSRSRADCWRILEHYQWDLSAASRYV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     608 ALGATGGDVVSAIRNLKVDQLFHLSSRSRADCWRILEHYQWDLSAASRYV 657                                                          
						                                                            	                                                             
						                                                            	     501 LARP                                               504                                                          
						                                                            	         ||||                                                
						                                                            	     658 LARP                                               661                                                          

28510	HMR136_HSU43408_3_tr0_r1_1_gPRT		Comparison report between HSU43408_P3 and Q8IYI4partial WT   	Sequence name: Q8IYI4                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HSU43408_P3, comprising a first     	Sequence documentation:                                      
						MLPEAGSLWLLKLLRDIQLAQFYWPILEELNVTRPEHFDFVKPEDLDGIGMGRPAQRRLS 	                                                            
						EALKRLRSGPKSKNWVYKILGGFAPEHKEPTLPSDSPRHLPEPEGGLKCLIPEGAVCRGE 	Alignment of: 28510 x Q8IYI4   ..                            
						LLGSGCFGVVHRGLWTLPSGKSVPVAVKSLRVGPEGPMGTELGDFLREVSVMMNLEHPHV 	                                                            
						LRLHGLVLGQPLQMVMELAPLGSLHARLTAPAPTPPLLVALLCLFLRQLAGAMAYLGARG 	Alignment segment 1/1:                                       
						LVHRDLATRNLLLASPRTIKVADFGLVRPLGGARGRYVMGGPRPIPYAWCAPESLRHGAF 	                                                            
						SSASDVWMFGVTLWEMFSGGEEPWAGVPPYLILQRLEDRARLPRPPLCSRALYSLALRCW 	                     Quality: 3745.00                      Escore:       0                                               
						APHPADRPSFSHLEGLLQE                                          	             Matching length:     381                Total length:     381                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:   99.74   Matching Percent Identity:   99.74                                               
						corresponding to amino acids 1 - 379 of Q8IYI4, which also   	    Total Percent Similarity:   99.74      Total Percent Identity:   99.74                                               
						corresponds to amino acids 1 - 379 of HSU43408_P3, and a     	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence VGTPDLTRYTVPLPSIRSPRVPCED    	       1 MLPEAGSLWLLKLLRDIQLAQFYWPILEELNVTRPEHFDFVKPEDLDGIG 50                                                           
						corresponding to amino acids 380 - 404 of HSU43408_P3,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	       1 MLPEAGSLWLLKLLRDIQLAQFYWPILEELNVTRPEHFDFVKPEDLDGIG 50                                                           
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HSU43408_P3,     	      51 MGRPAQRRLSEALKRLRSGPKSKNWVYKILGGFAPEHKEPTLPSDSPRHL 100                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	      51 MGRPAQRRLSEALKRLRSGPKSKNWVYKILGGFAPEHKEPTLPSDSPRHL 100                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     101 PEPEGGLKCLIPEGAVCRGELLGSGCFGVVHRGLWTLPSGKSVPVAVKSL 150                                                          
						VGTPDLTRYTVPLPSIRSPRVPCED in HSU43408_P3.                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 PEPEGGLKCLIPEGAVCRGELLGSGCFGVVHRGLWTLPSGKSVPVAVKSL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RVGPEGPMGTELGDFLREVSVMMNLEHPHVLRLHGLVLGQPLQMVMELAP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RVGPEGPMGTELGDFLREVSVMMNLEHPHVLRLHGLVLGQPLQMVMELAP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LGSLHARLTAPAPTPPLLVALLCLFLRQLAGAMAYLGARGLVHRDLATRN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LGSLHARLTAPAPTPPLLVALLCLFLRQLAGAMAYLGARGLVHRDLATRN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LLLASPRTIKVADFGLVRPLGGARGRYVMGGPRPIPYAWCAPESLRHGAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LLLASPRTIKVADFGLVRPLGGARGRYVMGGPRPIPYAWCAPESLRHGAF 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SSASDVWMFGVTLWEMFSGGEEPWAGVPPYLILQRLEDRARLPRPPLCSR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SSASDVWMFGVTLWEMFSGGEEPWAGVPPYLILQRLEDRARLPRPPLCSR 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     351 ALYSLALRCWAPHPADRPSFSHLEGLLQEVG                    381                                                          
						                                                            	         ||||||||||||||||||||||||||||| |                     
						                                                            	     351 ALYSLALRCWAPHPADRPSFSHLEGLLQEAG                    381                                                          

4113	HMR136_HSU44128_0_tr0_r1_1_gPRT		Comparison report between HSU44128_P0 and                    	Sequence name: S123_HUMAN_V2                                 
						S123_HUMAN_V2unique head followed by partial WT sequence a   	                                                            
						mismatch and a featuring a skipped exon plus extra amino     	Sequence documentation:                                      
						acids.1.An isolated chimeric polypeptide encoding for        	                                                            
						HSU44128_P0, comprising a first amino acid sequence being at 	Alignment of: 4113 x S123_HUMAN_V2   ..                      
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence PSLDTQAT     	                                                            
						corresponding to amino acids 1 - 8 of HSU44128_P0, a second  	                     Quality: 9685.00                      Escore:       0                                               
						MAELPTTETPGDATLCSGRFTISTLLSSDEPSPPAAYDSSHPSHLTHSSTFCMRTFGYNT 	             Matching length:    1004                Total length:    1021                                               
						IDVVPTYEHYANSTQPGEPRKVRPTLADLHSFLKQEGRHLHALAFDSRPSHEMTDGLVEG 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.80                                               
						EAGTSSEKNPEEPVRFGWVKGVMIRCMLNIWGVILYLRLPWITAQAGIVLTWIIILLSVT 	    Total Percent Similarity:   98.24      Total Percent Identity:   98.14                                               
						VTSITGLSISAISTNGKVKSGGTYFLISRSLGPELGGSIGLIFAFANAVGVAMHTVGFAE 	                        Gaps:       1                        
						TVRDLLQEYGAPIVDPINDIRII                                      	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 1 - 263 of S123_HUMAN_V2, which 	                  .         .         .         .         .  
						also corresponds to amino acids 9 - 271 of HSU44128_P0, a    	       9 MAELPTTETPGDATLCSGRFTISTLLSSDEPSPPAAYDSSHPSHLTHSST 58                                                           
						bridging amino acid A corresponding to amino acid 272 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU44128_P0, a third amino acid sequence being at least 90 % 	       1 MAELPTTETPGDATLCSGRFTISTLLSSDEPSPPAAYDSSHPSHLTHSST 50                                                           
						VVSVTVLLAISLAGMEWESKAQVLFFLVIMVSFANYLVGTLIPPSEDKASKGFFSYRADI 	                  .         .         .         .         .  
						FVQNLVPDWRGPDGTFFGMFSIFFPSATGILAGANISGDLKDPAIAIPKGTLMAIFWTTI 	      59 FCMRTFGYNTIDVVPTYEHYANSTQPGEPRKVRPTLADLHSFLKQEGRHL 108                                                          
						SYLAISATIGSCVVRDASGVLNDTVTPGWGACEGLACSYGWNFTECTQQHSCHYGLINYY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QTMSMVSGFAPLITAGIFGATLSSALACLVSAAKVFQCLCEDQLYPLIGFFGKGYGKNKE 	      51 FCMRTFGYNTIDVVPTYEHYANSTQPGEPRKVRPTLADLHSFLKQEGRHL 100                                                          
						PVRGYLLAYAIAVAFIIIAELNTIAPIISNFFLCSYALINFSCFHASITNSPGWRPSFQY 	                  .         .         .         .         .  
						YNKWAALFGAIISVVIMFLLTWWAALIAIGVVLFLLLYVIYKKPEVNWGSSVQAGSYNLA 	     109 HALAFDSRPSHEMTDGLVEGEAGTSSEKNPEEPVRFGWVKGVMIRCMLNI 158                                                          
						LSYSVGLNEVEDHIKNYRPQCLVLTGPPNFRPALVDFVGTFTRNLSLMICGHVLIGPHKQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RMPELQLIANGHTKWLNKRKIKAFYSDVIAEDLRRGVQILMQAAGLGRMKPNILVVGFKK 	     101 HALAFDSRPSHEMTDGLVEGEAGTSSEKNPEEPVRFGWVKGVMIRCMLNI 150                                                          
						NWQSAHPATVEDYIGILHDAFDFNYGVCVMRMREGLNVSKMMQAH                	                  .         .         .         .         .  
						homologous to corresponding to amino acids 265 - 789 of      	     159 WGVILYLRLPWITAQAGIVLTWIIILLSVTVTSITGLSISAISTNGKVKS 208                                                          
						S123_HUMAN_V2, which also corresponds to amino acids 273 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						797 of HSU44128_P0, a fourth amino acid sequence bridging    	     151 WGVILYLRLPWITAQAGIVLTWIIILLSVTVTSITGLSISAISTNGKVKS 200                                                          
						amino acid sequence comprising of M, and a fifth amino acid  	                  .         .         .         .         .  
						DPKALVKEEQATTIFQSEQGKKTIDIYWLFDDGGLTLLIPYLLGRKRRWSKCKIRVFVGG 	     209 GGTYFLISRSLGPELGGSIGLIFAFANAVGVAMHTVGFAETVRDLLQEYG 258                                                          
						QINRMDQERKAIISLLSKFRLGFHEVHILPDINQNPRAEHTKRFEDMIAPFRLNDGFKDE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATVNEMRRDCPWKISDEEITKNRVKSLRQVRLNEIVLDYSRDAALIVITLPIGRKGKCPS 	     201 GGTYFLISRSLGPELGGSIGLIFAFANAVGVAMHTVGFAETVRDLLQEYG 250                                                          
						SLYMAWLETLSQDLRPPVILIRGNQENVLTFYCQ                           	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     259 APIVDPINDIRIIAVVSVTVLLAISLAGMEWESKAQVLFFLVIMVSFANY 308                                                          
						amino acids 808 - 1021 of S123_HUMAN_V2, which also          	         ||||||||||||| ||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 799 - 1012 of HSU44128_P0, wherein	     251 APIVDPINDIRIIGVVSVTVLLAISLAGMEWESKAQVLFFLVIMVSFANY 300                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						bridging amino acid, third amino acid sequence, fourth amino 	     309 LVGTLIPPSEDKASKGFFSYRADIFVQNLVPDWRGPDGTFFGMFSIFFPS 358                                                          
						acid sequence and fifth amino acid sequence are contiguous   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     301 LVGTLIPPSEDKASKGFFSYRADIFVQNLVPDWRGPDGTFFGMFSIFFPS 350                                                          
						for a head of HSU44128_P0, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     359 ATGILAGANISGDLKDPAIAIPKGTLMAIFWTTISYLAISATIGSCVVRD 408                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     351 ATGILAGANISGDLKDPAIAIPKGTLMAIFWTTISYLAISATIGSCVVRD 400                                                          
						PSLDTQAT of HSU44128_P0.3.An isolated polypeptide encoding   	                  .         .         .         .         .  
						for an edge portion of HSU44128_P0, comprising a polypeptide 	     409 ASGVLNDTVTPGWGACEGLACSYGWNFTECTQQHSCHYGLINYYQTMSMV 458                                                          
						having a length "n", wherein n is at least about 10 amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, optionally at least about 20 amino acids in 	     401 ASGVLNDTVTPGWGACEGLACSYGWNFTECTQQHSCHYGLINYYQTMSMV 450                                                          
						length, preferably at least about 30 amino acids in length,  	                  .         .         .         .         .  
						more preferably at least about 40 amino acids in length and  	     459 SGFAPLITAGIFGATLSSALACLVSAAKVFQCLCEDQLYPLIGFFGKGYG 508                                                          
						most preferably at least about 50 amino acids in length,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein at least two amino acids comprise HMD having a       	     451 SGFAPLITAGIFGATLSSALACLVSAAKVFQCLCEDQLYPLIGFFGKGYG 500                                                          
						structure as follows (numbering according to HSU44128_P0): a 	                  .         .         .         .         .  
						sequence starting from any of amino acid numbers 797-x to    	     509 KNKEPVRGYLLAYAIAVAFIIIAELNTIAPIISNFFLCSYALINFSCFHA 558                                                          
						797; and ending at any of amino acid numbers 799 + ((n-2) -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						x), in which x varies from 0 to n-2.                         	     501 KNKEPVRGYLLAYAIAVAFIIIAELNTIAPIISNFFLCSYALINFSCFHA 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     559 SITNSPGWRPSFQYYNKWAALFGAIISVVIMFLLTWWAALIAIGVVLFLL 608                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SITNSPGWRPSFQYYNKWAALFGAIISVVIMFLLTWWAALIAIGVVLFLL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     609 LYVIYKKPEVNWGSSVQAGSYNLALSYSVGLNEVEDHIKNYRPQCLVLTG 658                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LYVIYKKPEVNWGSSVQAGSYNLALSYSVGLNEVEDHIKNYRPQCLVLTG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     659 PPNFRPALVDFVGTFTRNLSLMICGHVLIGPHKQRMPELQLIANGHTKWL 708                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 PPNFRPALVDFVGTFTRNLSLMICGHVLIGPHKQRMPELQLIANGHTKWL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     709 NKRKIKAFYSDVIAEDLRRGVQILMQAAGLGRMKPNILVVGFKKNWQSAH 758                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NKRKIKAFYSDVIAEDLRRGVQILMQAAGLGRMKPNILVVGFKKNWQSAH 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     759 PATVEDYIGILHDAFDFNYGVCVMRMREGLNVSKMMQAHM.......... 798                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||:            
						                                                            	     751 PATVEDYIGILHDAFDFNYGVCVMRMREGLNVSKMMQAHINPVFDPAEDG 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     799 .......DPKALVKEEQATTIFQSEQGKKTIDIYWLFDDGGLTLLIPYLL 841                                                          
						                                                            	                |||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 KEASARVDPKALVKEEQATTIFQSEQGKKTIDIYWLFDDGGLTLLIPYLL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     842 GRKRRWSKCKIRVFVGGQINRMDQERKAIISLLSKFRLGFHEVHILPDIN 891                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 GRKRRWSKCKIRVFVGGQINRMDQERKAIISLLSKFRLGFHEVHILPDIN 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     892 QNPRAEHTKRFEDMIAPFRLNDGFKDEATVNEMRRDCPWKISDEEITKNR 941                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 QNPRAEHTKRFEDMIAPFRLNDGFKDEATVNEMRRDCPWKISDEEITKNR 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     942 VKSLRQVRLNEIVLDYSRDAALIVITLPIGRKGKCPSSLYMAWLETLSQD 991                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 VKSLRQVRLNEIVLDYSRDAALIVITLPIGRKGKCPSSLYMAWLETLSQD 1000                                                         
						                                                            	                  .         .                                
						                                                            	     992 LRPPVILIRGNQENVLTFYCQ                              1012                                                         
						                                                            	         |||||||||||||||||||||                               
						                                                            	    1001 LRPPVILIRGNQENVLTFYCQ                              1021                                                         

28934	HMR136_HSU45285_9_tr0_r1_1_gPRT		Comparison report between HSU45285_P9 and VPP3_HUMANpartial  	Sequence name: VPP3_HUMAN                                    
						WT sequence followed by mismatch.1.An isolated chimeric      	                                                            
						polypeptide encoding for HSU45285_P9, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MGSMFRSEEVALVQLFLPTAAAYTCVSRLGELGLVEFRDLNASVSAFQRRFVVDV      	Alignment of: 28934 x VPP3_HUMAN   ..                        
						corresponding to amino acids 1 - 55 of VPP3_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 55 of HSU45285_P9, a bridging 	Alignment segment 1/1:                                       
						amino acid R corresponding to amino acid 56 of HSU45285_P9,  	                                                            
						and a second amino acid sequence being at least 90 %         	                     Quality: 5450.00                      Escore:       0                                               
						RCEELEKTFTFLQEEVRRAGLVLPPPKGRLPAPPPRDLLRIQEETERLAQELRDVRGNQQ 	             Matching length:     558                Total length:     558                                               
						ALRAQLHQLQLHAAVLRQGHEPQLAAAHTDGASERTPLLQAPGGPHQDLRVNFVAGAVEP 	 Matching Percent Similarity:   99.82   Matching Percent Identity:   99.82                                               
						HKAPALERLLWRACRGFLIASFRELEQPLEHPVTGEPATWMTFLISYWGEQIGQKIRKIT 	    Total Percent Similarity:   99.82      Total Percent Identity:   99.82                                               
						DCFHCHVFPFLQQEEARLGALQQLQQQSQELQEVLGETERFLSQVLGRVLQLLPPGQVQV 	                        Gaps:       0                        
						HKMKAVYLALNQCSVSTTHKCLIAEAWCSVRDLPALQEALRDSSMEEGVSAVAHRIPCRD 	                                                            
						MPPTLIRTNRFTASFQGIVDAYGVGRYQEVNPAPYTIITFPFLFAVMFGDVGHGLLMFLF 	Alignment:                                                   
						ALAMVLAENRPAVKAAQNEIWQTFFRGRYLLLLMGLFSIYTGFIYNECFSRATSIFPSGW 	                  .         .         .         .         .  
						SVAAMANQSGWSDAFLAQHTMLTLDPNVTGVFLGPYPFGIDPIWSLAANHLSFLNSFKMK 	       1 MGSMFRSEEVALVQLFLPTAAAYTCVSRLGELGLVEFRDLNASVSAFQRR 50                                                           
						MSVILGVVHMAFGVVLGVFNHV                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 57 - 558 of       	       1 MGSMFRSEEVALVQLFLPTAAAYTCVSRLGELGLVEFRDLNASVSAFQRR 50                                                           
						VPP3_HUMAN, which also corresponds to amino acids 57 - 558 of	                  .         .         .         .         .  
						HSU45285_P9, wherein said first amino acid sequence, bridging	      51 FVVDVRRCEELEKTFTFLQEEVRRAGLVLPPPKGRLPAPPPRDLLRIQEE 100                                                          
						amino acid and second amino acid sequence are contiguous and 	         ||||| ||||||||||||||||||||||||||||||||||||||||||||  
						in a sequential order.                                       	      51 FVVDVWRCEELEKTFTFLQEEVRRAGLVLPPPKGRLPAPPPRDLLRIQEE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TERLAQELRDVRGNQQALRAQLHQLQLHAAVLRQGHEPQLAAAHTDGASE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TERLAQELRDVRGNQQALRAQLHQLQLHAAVLRQGHEPQLAAAHTDGASE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RTPLLQAPGGPHQDLRVNFVAGAVEPHKAPALERLLWRACRGFLIASFRE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RTPLLQAPGGPHQDLRVNFVAGAVEPHKAPALERLLWRACRGFLIASFRE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LEQPLEHPVTGEPATWMTFLISYWGEQIGQKIRKITDCFHCHVFPFLQQE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LEQPLEHPVTGEPATWMTFLISYWGEQIGQKIRKITDCFHCHVFPFLQQE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EARLGALQQLQQQSQELQEVLGETERFLSQVLGRVLQLLPPGQVQVHKMK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EARLGALQQLQQQSQELQEVLGETERFLSQVLGRVLQLLPPGQVQVHKMK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AVYLALNQCSVSTTHKCLIAEAWCSVRDLPALQEALRDSSMEEGVSAVAH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AVYLALNQCSVSTTHKCLIAEAWCSVRDLPALQEALRDSSMEEGVSAVAH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RIPCRDMPPTLIRTNRFTASFQGIVDAYGVGRYQEVNPAPYTIITFPFLF 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RIPCRDMPPTLIRTNRFTASFQGIVDAYGVGRYQEVNPAPYTIITFPFLF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AVMFGDVGHGLLMFLFALAMVLAENRPAVKAAQNEIWQTFFRGRYLLLLM 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 AVMFGDVGHGLLMFLFALAMVLAENRPAVKAAQNEIWQTFFRGRYLLLLM 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GLFSIYTGFIYNECFSRATSIFPSGWSVAAMANQSGWSDAFLAQHTMLTL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GLFSIYTGFIYNECFSRATSIFPSGWSVAAMANQSGWSDAFLAQHTMLTL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 DPNVTGVFLGPYPFGIDPIWSLAANHLSFLNSFKMKMSVILGVVHMAFGV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DPNVTGVFLGPYPFGIDPIWSLAANHLSFLNSFKMKMSVILGVVHMAFGV 550                                                          
						                                                            	                                                             
						                                                            	     551 VLGVFNHV                                           558                                                          
						                                                            	         ||||||||                                            
						                                                            	     551 VLGVFNHV                                           558                                                          

8452	HMR136_HSU49379_1_tr0_r1_1_gPRT		Comparison report between HSU49379_P1 and KDGE_HUMANpartial  	Sequence name: KDGE_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HSU49379_P1, comprising a first     	Sequence documentation:                                      
						MEAERRPAPGSPSEGLFADGHLILWTLCSVLLPVFITFWCSLQRSRRQLHRRDIFRKSKH 	                                                            
						GWRDTDLFSQPTYCCVCAQHILQGAFCDCCGLRVDEGCLRKADKRFQCKEIMLKNDTKVL 	Alignment of: 8452 x KDGE_HUMAN   ..                         
						DAMPHHWIRGNVPLCSYCMVCKQQCGCQPKLCDYRCIWCQKTVHDECMKNSLKNEKCDFG 	                                                            
						EFKNLIIPPSYLTSINQMRKDKKTDYEVLASKLGKQWTPLIILANSRSGTNMGEGLLGEF 	Alignment segment 1/1:                                       
						RILLNPVQVFDVTKTPPIKALQLCTLLPYYSARVLVCGGDGTVGWVLDAVDDMKIKGQEK 	                                                            
						YIPQVAVLPLGTGNDLSNTLGWGTGYAGEIPVAQVLRNVMEADGIKLDRWKVQVTNKGYY 	                     Quality: 4807.00                      Escore:       0                                               
						NLRKPKEFTMNNYFSVGPDALMALNFHAHREKAPSLFSSRILNKAVYLFYGTKDCLVQEC 	             Matching length:     487                Total length:     567                                               
						KDLNKKVE                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   85.89      Total Percent Identity:   85.89                                               
						corresponding to amino acids 1 - 428 of KDGE_HUMAN, which    	                        Gaps:       1                        
						also corresponds to amino acids 1 - 428 of HSU49379_P1, and a	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						LILKCSMMPMQVDGEPWAQGPCTVTITHKTHAMMLYFSGEQTDDDISSTSDQEDIKATE  	                  .         .         .         .         .  
						corresponding to amino acids 509 - 567 of KDGE_HUMAN, which  	       1 MEAERRPAPGSPSEGLFADGHLILWTLCSVLLPVFITFWCSLQRSRRQLH 50                                                           
						also corresponds to amino acids 429 - 487 of HSU49379_P1,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	       1 MEAERRPAPGSPSEGLFADGHLILWTLCSVLLPVFITFWCSLQRSRRQLH 50                                                           
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	      51 RRDIFRKSKHGWRDTDLFSQPTYCCVCAQHILQGAFCDCCGLRVDEGCLR 100                                                          
						HSU49379_P1, comprising a polypeptide having a length "n",   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	      51 RRDIFRKSKHGWRDTDLFSQPTYCCVCAQHILQGAFCDCCGLRVDEGCLR 100                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     101 KADKRFQCKEIMLKNDTKVLDAMPHHWIRGNVPLCSYCMVCKQQCGCQPK 150                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     101 KADKRFQCKEIMLKNDTKVLDAMPHHWIRGNVPLCSYCMVCKQQCGCQPK 150                                                          
						at least two amino acids comprise EL, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     151 LCDYRCIWCQKTVHDECMKNSLKNEKCDFGEFKNLIIPPSYLTSINQMRK 200                                                          
						428-x to 429; and ending at any of amino acid numbers 429+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     151 LCDYRCIWCQKTVHDECMKNSLKNEKCDFGEFKNLIIPPSYLTSINQMRK 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DKKTDYEVLASKLGKQWTPLIILANSRSGTNMGEGLLGEFRILLNPVQVF 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DKKTDYEVLASKLGKQWTPLIILANSRSGTNMGEGLLGEFRILLNPVQVF 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DVTKTPPIKALQLCTLLPYYSARVLVCGGDGTVGWVLDAVDDMKIKGQEK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DVTKTPPIKALQLCTLLPYYSARVLVCGGDGTVGWVLDAVDDMKIKGQEK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YIPQVAVLPLGTGNDLSNTLGWGTGYAGEIPVAQVLRNVMEADGIKLDRW 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 YIPQVAVLPLGTGNDLSNTLGWGTGYAGEIPVAQVLRNVMEADGIKLDRW 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KVQVTNKGYYNLRKPKEFTMNNYFSVGPDALMALNFHAHREKAPSLFSSR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KVQVTNKGYYNLRKPKEFTMNNYFSVGPDALMALNFHAHREKAPSLFSSR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ILNKAVYLFYGTKDCLVQECKDLNKKVE...................... 428                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     401 ILNKAVYLFYGTKDCLVQECKDLNKKVELELDGERVALPSLEGIIVLNIG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     428 .................................................. 428                                                          
						                                                            	                                                            
						                                                            	     451 YWGGGCRLWEGMGDETYPLARHDDGLLEVVGVYGSFHCAQIQVKLANPFR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     429 ........LILKCSMMPMQVDGEPWAQGPCTVTITHKTHAMMLYFSGEQT 470                                                          
						                                                            	                 ||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 IGQAHTVRLILKCSMMPMQVDGEPWAQGPCTVTITHKTHAMMLYFSGEQT 550                                                          
						                                                            	                  .                                          
						                                                            	     471 DDDISSTSDQEDIKATE                                  487                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     551 DDDISSTSDQEDIKATE                                  567                                                          

8613	HMR136_HSU50529_3_tr0_r1_1_gPRT		Comparison report between HSU50529_P3 and Q9Y3H6unique head  	Sequence name: Q9Y3H6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU50529_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 8613 x Q9Y3H6   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						NGCSMQDRYVSNGFCEVRERCWKDHCMDKHNGTDRFVNQQFQEEKLNKLQKLLILLRGLP 	Alignment segment 1/1:                                       
						GSGKTTLSRILLGQNRDGIVFSTDDYFHHQDGYRYNVNQLGDAHDWNQNRAKQAIDQGRS 	                                                            
						PVIIDNTNIQAWEMKPYVEVAIGKGYRVEFHEPETWWKFDPEELEKRNKHGVSRKKIAQM 	                     Quality: 6146.00                      Escore:       0                                               
						LDRYEYQMSISIVMNSVEPSHKSTQRPPPPQGRQ                           	             Matching length:     616                Total length:     616                                               
						having the sequence corresponding to amino acids 1 - 214 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HSU50529_P3, and a second amino acid sequence being at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RERVLKKTGHRLSKTKQKRNRKRNKKQNSQNRIMEENSLEFLSDLTPGDQDPSQSEEEDI 	                        Gaps:       0                        
						EKTRRESEYPFIDGLQNEVGDFVTGYKEKRWKNKDPKDSFQNVMSIVELDNTPKNYLSKE 	                                                            
						GDNLFVSLLLRPNEISVTCPILTQNLSCVTTDDCSGMKVEKHIRNRHTIALDTQDLSAET 	Alignment:                                                   
						SCLFMKKREIVDKNLSHEPILCHQHGIRMSDKVLREEQVYTTKINHWAFFTTNLSDEDLQ 	                  .         .         .         .         .  
						LGSDRQPYFGSWPAGPHKFICEQRPKKDRACKLAGPDSRGQWIQMIFTSVAASEPGNNPE 	     215 RERVLKKTGHRLSKTKQKRNRKRNKKQNSQNRIMEENSLEFLSDLTPGDQ 264                                                          
						ILTDKLLIGNEDFSPPPETMDSFIETNLFRSCLPQPDIPKNALESTKNKKRRKKRIFNLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PNFDLLGQSRIGVKEREKCDLLTKNHGLKITLGEEKDRISERNSEEENKQKLMTFDHHPL 	      20 RERVLKKTGHRLSKTKQKRNRKRNKKQNSQNRIMEENSLEFLSDLTPGDQ 69                                                           
						WFYLDIIKATPLNIDGQRYSHCLSFNRLRCSASLYKNYIPSFVLHNLSSIWKPSFTNKKL 	                  .         .         .         .         .  
						FLTFESQTRVGNKLNDAGFISPEILHSHPDTSCSLGVTSDFHFLNERFDRKLKRWEEPKE 	     265 DPSQSEEEDIEKTRRESEYPFIDGLQNEVGDFVTGYKEKRWKNKDPKDSF 314                                                          
						LPAEDSQDLTSTDYRSLELPLSQGFAFQLVKLFGSPGVPMESLLPDDYVVPLDWKTLKMI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YLQWKMSVEKRQKKIG                                             	      70 DPSQSEEEDIEKTRRESEYPFIDGLQNEVGDFVTGYKEKRWKNKDPKDSF 119                                                          
						90 % homologous to corresponding to amino acids 20 - 635 of  	                  .         .         .         .         .  
						Q9Y3H6, which also corresponds to amino acids 215 - 830 of   	     315 QNVMSIVELDNTPKNYLSKEGDNLFVSLLLRPNEISVTCPILTQNLSCVT 364                                                          
						HSU50529_P3, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     120 QNVMSIVELDNTPKNYLSKEGDNLFVSLLLRPNEISVTCPILTQNLSCVT 169                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						HSU50529_P3, comprising a polypeptide being at least 70%,    	     365 TDDCSGMKVEKHIRNRHTIALDTQDLSAETSCLFMKKREIVDKNLSHEPI 414                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     170 TDDCSGMKVEKHIRNRHTIALDTQDLSAETSCLFMKKREIVDKNLSHEPI 219                                                          
						NGCSMQDRYVSNGFCEVRERCWKDHCMDKHNGTDRFVNQQFQEEKLNKLQKLLILLRGLP 	                  .         .         .         .         .  
						GSGKTTLSRILLGQNRDGIVFSTDDYFHHQDGYRYNVNQLGDAHDWNQNRAKQAIDQGRS 	     415 LCHQHGIRMSDKVLREEQVYTTKINHWAFFTTNLSDEDLQLGSDRQPYFG 464                                                          
						PVIIDNTNIQAWEMKPYVEVAIGKGYRVEFHEPETWWKFDPEELEKRNKHGVSRKKIAQM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDRYEYQMSISIVMNSVEPSHKSTQRPPPPQGRQ                           	     220 LCHQHGIRMSDKVLREEQVYTTKINHWAFFTTNLSDEDLQLGSDRQPYFG 269                                                          
						least about 95% homologous to the sequence of HSU50529_P3.   	                  .         .         .         .         .  
						                                                            	     465 SWPAGPHKFICEQRPKKDRACKLAGPDSRGQWIQMIFTSVAASEPGNNPE 514                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     270 SWPAGPHKFICEQRPKKDRACKLAGPDSRGQWIQMIFTSVAASEPGNNPE 319                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     515 ILTDKLLIGNEDFSPPPETMDSFIETNLFRSCLPQPDIPKNALESTKNKK 564                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     320 ILTDKLLIGNEDFSPPPETMDSFIETNLFRSCLPQPDIPKNALESTKNKK 369                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     565 RRKKRIFNLVPNFDLLGQSRIGVKEREKCDLLTKNHGLKITLGEEKDRIS 614                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     370 RRKKRIFNLVPNFDLLGQSRIGVKEREKCDLLTKNHGLKITLGEEKDRIS 419                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     615 ERNSEEENKQKLMTFDHHPLWFYLDIIKATPLNIDGQRYSHCLSFNRLRC 664                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 ERNSEEENKQKLMTFDHHPLWFYLDIIKATPLNIDGQRYSHCLSFNRLRC 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     665 SASLYKNYIPSFVLHNLSSIWKPSFTNKKLFLTFESQTRVGNKLNDAGFI 714                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 SASLYKNYIPSFVLHNLSSIWKPSFTNKKLFLTFESQTRVGNKLNDAGFI 519                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     715 SPEILHSHPDTSCSLGVTSDFHFLNERFDRKLKRWEEPKELPAEDSQDLT 764                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     520 SPEILHSHPDTSCSLGVTSDFHFLNERFDRKLKRWEEPKELPAEDSQDLT 569                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     765 STDYRSLELPLSQGFAFQLVKLFGSPGVPMESLLPDDYVVPLDWKTLKMI 814                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     570 STDYRSLELPLSQGFAFQLVKLFGSPGVPMESLLPDDYVVPLDWKTLKMI 619                                                          
						                                                            	                  .                                          
						                                                            	     815 YLQWKMSVEKRQKKIG                                   830                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     620 YLQWKMSVEKRQKKIG                                   635                                                          

8615	HMR136_HSU50529_4_tr0_r1_1_gPRT		Comparison report between HSU50529_P4 and Q9Y3H6unique head  	Sequence name: Q9Y3H6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU50529_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 8615 x Q9Y3H6   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						NGCSMQDRYVSNGFCEVRERCWKDHCMDKHNGTDRFVNQQFQEEKLNKLQKLLILLRGLP 	Alignment segment 1/1:                                       
						GSGKTTLSRILLGQNRDGIVFSTDDYFHHQDGYRYNVNQLGDAHDWNQNRAKQAIDQGRS 	                                                            
						PVIIDNTNIQAWEMKPYVEVAIGKGYRVEFHEPETWWKFDPEELEKRNKHGVSRKKIAQM 	                     Quality: 6146.00                      Escore:       0                                               
						LDRYEYQMSISIVMNSVEPSHKSTQRPPPPQGRQ                           	             Matching length:     616                Total length:     616                                               
						having the sequence corresponding to amino acids 1 - 214 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HSU50529_P4, and a second amino acid sequence being at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RERVLKKTGHRLSKTKQKRNRKRNKKQNSQNRIMEENSLEFLSDLTPGDQDPSQSEEEDI 	                        Gaps:       0                        
						EKTRRESEYPFIDGLQNEVGDFVTGYKEKRWKNKDPKDSFQNVMSIVELDNTPKNYLSKE 	                                                            
						GDNLFVSLLLRPNEISVTCPILTQNLSCVTTDDCSGMKVEKHIRNRHTIALDTQDLSAET 	Alignment:                                                   
						SCLFMKKREIVDKNLSHEPILCHQHGIRMSDKVLREEQVYTTKINHWAFFTTNLSDEDLQ 	                  .         .         .         .         .  
						LGSDRQPYFGSWPAGPHKFICEQRPKKDRACKLAGPDSRGQWIQMIFTSVAASEPGNNPE 	     215 RERVLKKTGHRLSKTKQKRNRKRNKKQNSQNRIMEENSLEFLSDLTPGDQ 264                                                          
						ILTDKLLIGNEDFSPPPETMDSFIETNLFRSCLPQPDIPKNALESTKNKKRRKKRIFNLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PNFDLLGQSRIGVKEREKCDLLTKNHGLKITLGEEKDRISERNSEEENKQKLMTFDHHPL 	      20 RERVLKKTGHRLSKTKQKRNRKRNKKQNSQNRIMEENSLEFLSDLTPGDQ 69                                                           
						WFYLDIIKATPLNIDGQRYSHCLSFNRLRCSASLYKNYIPSFVLHNLSSIWKPSFTNKKL 	                  .         .         .         .         .  
						FLTFESQTRVGNKLNDAGFISPEILHSHPDTSCSLGVTSDFHFLNERFDRKLKRWEEPKE 	     265 DPSQSEEEDIEKTRRESEYPFIDGLQNEVGDFVTGYKEKRWKNKDPKDSF 314                                                          
						LPAEDSQDLTSTDYRSLELPLSQGFAFQLVKLFGSPGVPMESLLPDDYVVPLDWKTLKMI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YLQWKMSVEKRQKKIG                                             	      70 DPSQSEEEDIEKTRRESEYPFIDGLQNEVGDFVTGYKEKRWKNKDPKDSF 119                                                          
						90 % homologous to corresponding to amino acids 20 - 635 of  	                  .         .         .         .         .  
						Q9Y3H6, which also corresponds to amino acids 215 - 830 of   	     315 QNVMSIVELDNTPKNYLSKEGDNLFVSLLLRPNEISVTCPILTQNLSCVT 364                                                          
						HSU50529_P4, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     120 QNVMSIVELDNTPKNYLSKEGDNLFVSLLLRPNEISVTCPILTQNLSCVT 169                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						HSU50529_P4, comprising a polypeptide being at least 70%,    	     365 TDDCSGMKVEKHIRNRHTIALDTQDLSAETSCLFMKKREIVDKNLSHEPI 414                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     170 TDDCSGMKVEKHIRNRHTIALDTQDLSAETSCLFMKKREIVDKNLSHEPI 219                                                          
						NGCSMQDRYVSNGFCEVRERCWKDHCMDKHNGTDRFVNQQFQEEKLNKLQKLLILLRGLP 	                  .         .         .         .         .  
						GSGKTTLSRILLGQNRDGIVFSTDDYFHHQDGYRYNVNQLGDAHDWNQNRAKQAIDQGRS 	     415 LCHQHGIRMSDKVLREEQVYTTKINHWAFFTTNLSDEDLQLGSDRQPYFG 464                                                          
						PVIIDNTNIQAWEMKPYVEVAIGKGYRVEFHEPETWWKFDPEELEKRNKHGVSRKKIAQM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDRYEYQMSISIVMNSVEPSHKSTQRPPPPQGRQ                           	     220 LCHQHGIRMSDKVLREEQVYTTKINHWAFFTTNLSDEDLQLGSDRQPYFG 269                                                          
						least about 95% homologous to the sequence of HSU50529_P4.   	                  .         .         .         .         .  
						                                                            	     465 SWPAGPHKFICEQRPKKDRACKLAGPDSRGQWIQMIFTSVAASEPGNNPE 514                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     270 SWPAGPHKFICEQRPKKDRACKLAGPDSRGQWIQMIFTSVAASEPGNNPE 319                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     515 ILTDKLLIGNEDFSPPPETMDSFIETNLFRSCLPQPDIPKNALESTKNKK 564                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     320 ILTDKLLIGNEDFSPPPETMDSFIETNLFRSCLPQPDIPKNALESTKNKK 369                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     565 RRKKRIFNLVPNFDLLGQSRIGVKEREKCDLLTKNHGLKITLGEEKDRIS 614                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     370 RRKKRIFNLVPNFDLLGQSRIGVKEREKCDLLTKNHGLKITLGEEKDRIS 419                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     615 ERNSEEENKQKLMTFDHHPLWFYLDIIKATPLNIDGQRYSHCLSFNRLRC 664                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 ERNSEEENKQKLMTFDHHPLWFYLDIIKATPLNIDGQRYSHCLSFNRLRC 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     665 SASLYKNYIPSFVLHNLSSIWKPSFTNKKLFLTFESQTRVGNKLNDAGFI 714                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 SASLYKNYIPSFVLHNLSSIWKPSFTNKKLFLTFESQTRVGNKLNDAGFI 519                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     715 SPEILHSHPDTSCSLGVTSDFHFLNERFDRKLKRWEEPKELPAEDSQDLT 764                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     520 SPEILHSHPDTSCSLGVTSDFHFLNERFDRKLKRWEEPKELPAEDSQDLT 569                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     765 STDYRSLELPLSQGFAFQLVKLFGSPGVPMESLLPDDYVVPLDWKTLKMI 814                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     570 STDYRSLELPLSQGFAFQLVKLFGSPGVPMESLLPDDYVVPLDWKTLKMI 619                                                          
						                                                            	                  .                                          
						                                                            	     815 YLQWKMSVEKRQKKIG                                   830                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     620 YLQWKMSVEKRQKKIG                                   635                                                          

9949	HMR136_HSU56978_4_tr0_r1_1_gPRT		Comparison report between HSU56978_P4 and FGF8_HUMANpartial  	Sequence name: FGF8_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HSU56978_P4, comprising a first     	                                                            
						MAEDGDPFAKLIVETDTFGSRVRVRGAETGLYICMNKKGKLIAKSNGKGKDCVFTEIVLE 	Alignment of: 9949 x FGF8_HUMAN   ..                         
						NNYTALQNAKYEGWYMAFTRKGRPRKGSKTRQHQREVHFMKRLPRGHHTTEQSLRFEFLN 	                                                            
						YPPFTRSLRGSQRTWAPEPR                                         	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 94 - 233 of FGF8_HUMAN, which   	                     Quality: 1402.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 140 of HSU56978_P4.      	             Matching length:     140                Total length:     140                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAEDGDPFAKLIVETDTFGSRVRVRGAETGLYICMNKKGKLIAKSNGKGK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      94 MAEDGDPFAKLIVETDTFGSRVRVRGAETGLYICMNKKGKLIAKSNGKGK 143                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DCVFTEIVLENNYTALQNAKYEGWYMAFTRKGRPRKGSKTRQHQREVHFM 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     144 DCVFTEIVLENNYTALQNAKYEGWYMAFTRKGRPRKGSKTRQHQREVHFM 193                                                          
						                                                            	                  .         .         .         .            
						                                                            	     101 KRLPRGHHTTEQSLRFEFLNYPPFTRSLRGSQRTWAPEPR           140                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     194 KRLPRGHHTTEQSLRFEFLNYPPFTRSLRGSQRTWAPEPR           233                                                          

10855	HMR136_HSU59058_1_tr0_r1_1_gPRT		Comparison report between HSU59058_P1 and CRBA_HUMANunique   	Sequence name: CRBA_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HSU59058_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 10855 x CRBA_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MPSPQGHIGFEHHEQTLHVFGS corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 22 of HSU59058_P1, and a second amino acid   	                                                            
						WIGYEHTSFCGQQFILERGEYPRWDAWSGSNAYHIERLMSFRPICSANHKESKMTIFEKE 	                     Quality: 1515.00                      Escore:       0                                               
						NFIGRQWEISDDYPSLQAMGWFNNEVGSMKIQSGAWVCYQYPGYRGYQYILECDHHGGDY 	             Matching length:     145                Total length:     145                                               
						KHWREWGSHAQTSQIQSIRRIQQ                                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.31                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.31                                               
						amino acids 73 - 215 of CRBA_HUMAN, which also corresponds to	                        Gaps:       0                        
						amino acids 23 - 165 of HSU59058_P1, wherein said first amino	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of HSU59058_P1, comprising a polypeptide being at 	      21 GSWIGYEHTSFCGQQFILERGEYPRWDAWSGSNAYHIERLMSFRPICSAN 70                                                           
						least 70%, optionally at least about 80%, preferably at least	         |:||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      71 GAWIGYEHTSFCGQQFILERGEYPRWDAWSGSNAYHIERLMSFRPICSAN 120                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						MPSPQGHIGFEHHEQTLHVFGS of HSU59058_P1.                       	      71 HKESKMTIFEKENFIGRQWEISDDYPSLQAMGWFNNEVGSMKIQSGAWVC 120                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 HKESKMTIFEKENFIGRQWEISDDYPSLQAMGWFNNEVGSMKIQSGAWVC 170                                                          
						                                                            	                  .         .         .         .            
						                                                            	     121 YQYPGYRGYQYILECDHHGGDYKHWREWGSHAQTSQIQSIRRIQQ      165                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     171 YQYPGYRGYQYILECDHHGGDYKHWREWGSHAQTSQIQSIRRIQQ      215                                                          

11069	HMR136_HSU59325_2_tr0_r1_1_gPRT		Comparison report between HSU59325_P2 and CADI_HUMANpartial  	Sequence name: CADI_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU59325_P2, comprising a first     	Sequence documentation:                                      
						MKITSTSCICPVLVCLCFVQRCYGTAHHSSIKVMRNQTKHIEGETEVHHRPKRGWVWNQF 	                                                            
						FVLEEHMGPDPQYVGKLHSNSDKGDGSVKYILTGEGAGTIFIIDDTTGDIHSTKSLDREQ 	Alignment of: 11069 x CADI_HUMAN   ..                        
						KTHYVLHAQAIDRRTNKPLEPESEFIIKVQDINDNAPKFTDGPYIVTVPEMSDMGTSVLQ 	                                                            
						VTATDADDPTYGNSARVVYSILQGQPYFSVDPKTGVIRTALHNMDREAREHYSVVIQAKD 	Alignment segment 1/1:                                       
						MAGQVGGLSGSTTVNITLTDVNDNPPRFPQKHYQLYVPESAQVGSAVGKIKANDADTGSN 	                                                            
						ADMTYSIINGDGMGIFSISTDKETREGILSLKKPLNYEKKKSYTLNIEGANTHLDFRFSH 	                     Quality: 5323.00                      Escore:       0                                               
						LGPFKDATMLKIIVGDVDEPPLFSMPSYLMEVYENAKIGTVVGTVLAQDPDSTNSLVRYF 	             Matching length:     543                Total length:     543                                               
						INYNVEDDRFFNIDANTGTIRTTKVLDREETPWYNITVTASEIDNPDLLSHVTVGIRVLD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VNDNPPELAREYDIIVCENSKPGQVIHTISATDKDDFANGPRFNFFLDERLPVNPNFTLK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DNE                                                          	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 543 of CADI_HUMAN, which    	Alignment:                                                   
						also corresponds to amino acids 1 - 543 of HSU59325_P2, and a	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	       1 MKITSTSCICPVLVCLCFVQRCYGTAHHSSIKVMRNQTKHIEGETEVHHR 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MKITSTSCICPVLVCLCFVQRCYGTAHHSSIKVMRNQTKHIEGETEVHHR 50                                                           
						polypeptide having the sequence                              	                  .         .         .         .         .  
						GEHIYTYLFIYVVSALTLYVIGFILIYTQTSCKSAFKVSLMLLCYDL corresponding	      51 PKRGWVWNQFFVLEEHMGPDPQYVGKLHSNSDKGDGSVKYILTGEGAGTI 100                                                          
						to amino acids 544 - 590 of HSU59325_P2, wherein said first  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	      51 PKRGWVWNQFFVLEEHMGPDPQYVGKLHSNSDKGDGSVKYILTGEGAGTI 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of HSU59325_P2, comprising a 	     101 FIIDDTTGDIHSTKSLDREQKTHYVLHAQAIDRRTNKPLEPESEFIIKVQ 150                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 FIIDDTTGDIHSTKSLDREQKTHYVLHAQAIDRRTNKPLEPESEFIIKVQ 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     151 DINDNAPKFTDGPYIVTVPEMSDMGTSVLQVTATDADDPTYGNSARVVYS 200                                                          
						GEHIYTYLFIYVVSALTLYVIGFILIYTQTSCKSAFKVSLMLLCYDL in           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU59325_P2.                                                 	     151 DINDNAPKFTDGPYIVTVPEMSDMGTSVLQVTATDADDPTYGNSARVVYS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ILQGQPYFSVDPKTGVIRTALHNMDREAREHYSVVIQAKDMAGQVGGLSG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ILQGQPYFSVDPKTGVIRTALHNMDREAREHYSVVIQAKDMAGQVGGLSG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 STTVNITLTDVNDNPPRFPQKHYQLYVPESAQVGSAVGKIKANDADTGSN 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 STTVNITLTDVNDNPPRFPQKHYQLYVPESAQVGSAVGKIKANDADTGSN 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ADMTYSIINGDGMGIFSISTDKETREGILSLKKPLNYEKKKSYTLNIEGA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ADMTYSIINGDGMGIFSISTDKETREGILSLKKPLNYEKKKSYTLNIEGA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NTHLDFRFSHLGPFKDATMLKIIVGDVDEPPLFSMPSYLMEVYENAKIGT 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NTHLDFRFSHLGPFKDATMLKIIVGDVDEPPLFSMPSYLMEVYENAKIGT 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VVGTVLAQDPDSTNSLVRYFINYNVEDDRFFNIDANTGTIRTTKVLDREE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VVGTVLAQDPDSTNSLVRYFINYNVEDDRFFNIDANTGTIRTTKVLDREE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 TPWYNITVTASEIDNPDLLSHVTVGIRVLDVNDNPPELAREYDIIVCENS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 TPWYNITVTASEIDNPDLLSHVTVGIRVLDVNDNPPELAREYDIIVCENS 500                                                          
						                                                            	                  .         .         .         .            
						                                                            	     501 KPGQVIHTISATDKDDFANGPRFNFFLDERLPVNPNFTLKDNE        543                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     501 KPGQVIHTISATDKDDFANGPRFNFFLDERLPVNPNFTLKDNE        543                                                          

14347	HMR136_HSU70987_7_tr0_r1_1_gPRT		Comparison report between HSU70987_P7 and DOK1_HUMANpartial  	Sequence name: DOK1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU70987_P7, comprising a first     	Sequence documentation:                                      
						MDGAVMEGPLFLQSQRFGTKRWRKTWAVLYPASPHGVARLEFFDHKGSSSGGGRGSSRRL 	                                                            
						DCKVIRLAECVSVAPVTVETPPEPGATAFRLDTAQRSHLLAADAPSSAAWVQTLCRNAFP 	Alignment of: 14347 x DOK1_HUMAN   ..                        
						KGSWTLAPTDNPPKLSALEMLENSLYSPTWEGSQFWVTVQRTEAAERCGLHGSYVLRVEA 	                                                            
						ERLTLLTVGAQSQILEPLLSWPYTLLRRYGRDKV                           	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 214 of DOK1_HUMAN, which    	                     Quality: 2105.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 214 of HSU70987_P7, and a	             Matching length:     214                Total length:     214                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       0                        
						polypeptide having the sequence QGLSGRA corresponding to     	                                                            
						amino acids 215 - 221 of HSU70987_P7, wherein said first     	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	       1 MDGAVMEGPLFLQSQRFGTKRWRKTWAVLYPASPHGVARLEFFDHKGSSS 50                                                           
						polypeptide encoding for a tail of HSU70987_P7, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       1 MDGAVMEGPLFLQSQRFGTKRWRKTWAVLYPASPHGVARLEFFDHKGSSS 50                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      51 GGGRGSSRRLDCKVIRLAECVSVAPVTVETPPEPGATAFRLDTAQRSHLL 100                                                          
						to the sequence QGLSGRA in HSU70987_P7.                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 GGGRGSSRRLDCKVIRLAECVSVAPVTVETPPEPGATAFRLDTAQRSHLL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AADAPSSAAWVQTLCRNAFPKGSWTLAPTDNPPKLSALEMLENSLYSPTW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 AADAPSSAAWVQTLCRNAFPKGSWTLAPTDNPPKLSALEMLENSLYSPTW 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EGSQFWVTVQRTEAAERCGLHGSYVLRVEAERLTLLTVGAQSQILEPLLS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EGSQFWVTVQRTEAAERCGLHGSYVLRVEAERLTLLTVGAQSQILEPLLS 200                                                          
						                                                            	                  .                                          
						                                                            	     201 WPYTLLRRYGRDKV                                     214                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     201 WPYTLLRRYGRDKV                                     214                                                          

15069	HMR136_HSU76388_1_tr0_r1_1_gPRT		Comparison report between HSU76388_P1 and Q8N2B7unique head  	Sequence name: Q8N2B7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU76388_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15069 x Q8N2B7   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MDYSYDEDLDELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKHYTCTESQSCKIDKT 	Alignment segment 1/1:                                       
						QRKRCPFCRFQKCLTVGMRLEAVRADRMRGGRNKFGPMYKRDRALKQQKKAQIRANGFKL 	                                                            
						ETGPPMGVPPPPPPAPDYVLPPSLHGPEPKGLAAGPPAGPLGDFGAPALPMAVPGAHGPL 	                     Quality: 1268.00                      Escore:       0                                               
						AGYLYPAFPGRAIKSEYPEPYASPPQPGLPYGYPEPFSGGPNVPELILQLLQLEPDEDQV 	             Matching length:     132                Total length:     132                                               
						RARILGCLQEPTKSRPDQPAAFGLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.24                                               
						CWSELLVFDHIYRQVQHGKEGSILLVTGQE                               	    Total Percent Similarity:  100.00      Total Percent Identity:   99.24                                               
						having the sequence corresponding to amino acids 1 - 330 of  	                        Gaps:       0                        
						HSU76388_P1, and a second amino acid sequence being at least 	                                                            
						VELTTVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFSLDLKFLNNHILV 	Alignment:                                                   
						KDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEVRALSMQAKEYLYHKHLGNEMPRNN 	                  .         .         .         .         .  
						LLIEMLQAKQT                                                  	     330 EVELTTVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFSL 379                                                          
						90 % homologous to corresponding to amino acids 56 - 186 of  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8N2B7, which also corresponds to amino acids 331 - 461 of   	      55 QVELTTVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFSL 104                                                          
						HSU76388_P1, wherein said first amino acid sequence and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	     380 DLKFLNNHILVKDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEVRAL 429                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU76388_P1, comprising a polypeptide being at least 70%,    	     105 DLKFLNNHILVKDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEVRAL 154                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .                      
						more preferably at least about 90% and most preferably at    	     430 SMQAKEYLYHKHLGNEMPRNNLLIEMLQAKQT                   461                                                          
						MDYSYDEDLDELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKHYTCTESQSCKIDKT 	         ||||||||||||||||||||||||||||||||                    
						QRKRCPFCRFQKCLTVGMRLEAVRADRMRGGRNKFGPMYKRDRALKQQKKAQIRANGFKL 	     155 SMQAKEYLYHKHLGNEMPRNNLLIEMLQAKQT                   186                                                          
						ETGPPMGVPPPPPPAPDYVLPPSLHGPEPKGLAAGPPAGPLGDFGAPALPMAVPGAHGPL 	                                                            
						AGYLYPAFPGRAIKSEYPEPYASPPQPGLPYGYPEPFSGGPNVPELILQLLQLEPDEDQV 	                                                            
						RARILGCLQEPTKSRPDQPAAFGLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQN 	                                                            
						CWSELLVFDHIYRQVQHGKEGSILLVTGQE                               	                                                            
						least about 95% homologous to the sequence of HSU76388_P1.   	                                                            

15071	HMR136_HSU76388_2_tr0_r1_1_gPRT		Comparison report between HSU76388_P2 and Q8N2B7unique head  	Sequence name: Q8N2B7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU76388_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15071 x Q8N2B7   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MDYSYDEDLDELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKHYTCTESQSCKIDKT 	Alignment segment 1/1:                                       
						QRKRCPFCRFQKCLTVGMRLEAVRADRMRGGRNKFGPMYKRDRALKQQKKAQIRANGFKL 	                                                            
						ETGPPMGVPPPPPPAPDYVLPPSLHGPEPKGLAAGPPAGPLGDFGAPALPMAVPGAHGPL 	                     Quality: 1268.00                      Escore:       0                                               
						AGYLYPAFPGRAIKSEYPEPYASPPQPGLPYGYPEPFSGGPNVPELILQLLQLEPDEDQV 	             Matching length:     132                Total length:     132                                               
						RARILGCLQEPTKSRPDQPAAFGLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.24                                               
						CWSELLVFDHIYRQVQHGKEGSILLVTGQE                               	    Total Percent Similarity:  100.00      Total Percent Identity:   99.24                                               
						having the sequence corresponding to amino acids 1 - 330 of  	                        Gaps:       0                        
						HSU76388_P2, and a second amino acid sequence being at least 	                                                            
						VELTTVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFSLDLKFLNNHILV 	Alignment:                                                   
						KDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEVRALSMQAKEYLYHKHLGNEMPRNN 	                  .         .         .         .         .  
						LLIEMLQAKQT                                                  	     330 EVELTTVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFSL 379                                                          
						90 % homologous to corresponding to amino acids 56 - 186 of  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8N2B7, which also corresponds to amino acids 331 - 461 of   	      55 QVELTTVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFSL 104                                                          
						HSU76388_P2, wherein said first amino acid sequence and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	     380 DLKFLNNHILVKDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEVRAL 429                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU76388_P2, comprising a polypeptide being at least 70%,    	     105 DLKFLNNHILVKDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEVRAL 154                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .                      
						more preferably at least about 90% and most preferably at    	     430 SMQAKEYLYHKHLGNEMPRNNLLIEMLQAKQT                   461                                                          
						MDYSYDEDLDELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKHYTCTESQSCKIDKT 	         ||||||||||||||||||||||||||||||||                    
						QRKRCPFCRFQKCLTVGMRLEAVRADRMRGGRNKFGPMYKRDRALKQQKKAQIRANGFKL 	     155 SMQAKEYLYHKHLGNEMPRNNLLIEMLQAKQT                   186                                                          
						ETGPPMGVPPPPPPAPDYVLPPSLHGPEPKGLAAGPPAGPLGDFGAPALPMAVPGAHGPL 	                                                            
						AGYLYPAFPGRAIKSEYPEPYASPPQPGLPYGYPEPFSGGPNVPELILQLLQLEPDEDQV 	                                                            
						RARILGCLQEPTKSRPDQPAAFGLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQN 	                                                            
						CWSELLVFDHIYRQVQHGKEGSILLVTGQE                               	                                                            
						least about 95% homologous to the sequence of HSU76388_P2.   	                                                            

15177	HMR136_HSU77086_4_tr0_r1_1_gPRT		Comparison report between HSU77086_P4 and O15245unique head  	Sequence name: O15245                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU77086_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15177 x O15245   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MAGCMTRPALPSSL corresponding to amino    	Alignment segment 1/1:                                       
						acids 1 - 14 of HSU77086_P4, and a second amino acid sequence	                                                            
						RFGRKLCLLGTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGYTLITEFVGSG 	                     Quality: 3702.00                      Escore:       0                                               
						SRRTVAIMYQMAFTVGLVALTGLAYALPHWRWLQLAVSLPTFLFLLYYWCVPESPRWLLS 	             Matching length:     383                Total length:     383                                               
						QKRNTEAIKIMDHIAQKNGKLPPADLKMLSLEEDVTEKLSPSFADLFRTPRLRKRTFILM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YLWFTDSVLYQGLILHMGATSGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LAGAACLVMIFISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSS 	                        Gaps:       0                        
						LCDIGGIITPFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVALPETMKDAENL 	                                                            
						GRKAKPKENTIYLKVQTSEPSGT                                      	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 172 - 554 of O15245, which also corresponds to amino   	      15 RFGRKLCLLGTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGY 64                                                           
						acids 15 - 397 of HSU77086_P4, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	     172 RFGRKLCLLGTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGY 221                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of HSU77086_P4, comprising a polypeptide being at least 	      65 TLITEFVGSGSRRTVAIMYQMAFTVGLVALTGLAYALPHWRWLQLAVSLP 114                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     222 TLITEFVGSGSRRTVAIMYQMAFTVGLVALTGLAYALPHWRWLQLAVSLP 271                                                          
						at least about 95% homologous to the sequence MAGCMTRPALPSSL 	                  .         .         .         .         .  
						of HSU77086_P4.                                              	     115 TFLFLLYYWCVPESPRWLLSQKRNTEAIKIMDHIAQKNGKLPPADLKMLS 164                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 TFLFLLYYWCVPESPRWLLSQKRNTEAIKIMDHIAQKNGKLPPADLKMLS 321                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     165 LEEDVTEKLSPSFADLFRTPRLRKRTFILMYLWFTDSVLYQGLILHMGAT 214                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     322 LEEDVTEKLSPSFADLFRTPRLRKRTFILMYLWFTDSVLYQGLILHMGAT 371                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     215 SGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNLLAGAACLVMI 264                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     372 SGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNLLAGAACLVMI 421                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     265 FISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSS 314                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     422 FISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSS 471                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     315 LCDIGGIITPFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVAL 364                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     472 LCDIGGIITPFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVAL 521                                                          
						                                                            	                  .         .         .                      
						                                                            	     365 PETMKDAENLGRKAKPKENTIYLKVQTSEPSGT                  397                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     522 PETMKDAENLGRKAKPKENTIYLKVQTSEPSGT                  554                                                          

						Comparison report between HSU77086_P4 and O15395unique head  	Sequence name: O15395                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HSU77086_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15177 x O15395   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MAGCMTRPALPSSL corresponding to amino    	Alignment segment 1/1:                                       
						acids 1 - 14 of HSU77086_P4, and a second amino acid sequence	                                                            
						RFGRKLCLLGTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGYTLITEFVGSG 	                     Quality: 3702.00                      Escore:       0                                               
						SRRTVAIMYQMAFTVGLVALTGLAYALPHWRWLQLAVSLPTFLFLLYYWCVPESPRWLLS 	             Matching length:     383                Total length:     383                                               
						QKRNTEAIKIMDHIAQKNGKLPPADLKMLSLEEDVTEKLSPSFADLFRTPRLRKRTFILM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YLWFTDSVLYQGLILHMGATSGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LAGAACLVMIFISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSS 	                        Gaps:       0                        
						LCDIGGIITPFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVALPETMKDAENL 	                                                            
						GRKAKPKENTIYLKVQTSEPSGT                                      	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 172 - 554 of O15395, which also corresponds to amino   	      15 RFGRKLCLLGTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGY 64                                                           
						acids 15 - 397 of HSU77086_P4, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	     172 RFGRKLCLLGTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGY 221                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of HSU77086_P4, comprising a polypeptide being at least 	      65 TLITEFVGSGSRRTVAIMYQMAFTVGLVALTGLAYALPHWRWLQLAVSLP 114                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     222 TLITEFVGSGSRRTVAIMYQMAFTVGLVALTGLAYALPHWRWLQLAVSLP 271                                                          
						at least about 95% homologous to the sequence MAGCMTRPALPSSL 	                  .         .         .         .         .  
						of HSU77086_P4.                                              	     115 TFLFLLYYWCVPESPRWLLSQKRNTEAIKIMDHIAQKNGKLPPADLKMLS 164                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 TFLFLLYYWCVPESPRWLLSQKRNTEAIKIMDHIAQKNGKLPPADLKMLS 321                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     165 LEEDVTEKLSPSFADLFRTPRLRKRTFILMYLWFTDSVLYQGLILHMGAT 214                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     322 LEEDVTEKLSPSFADLFRTPRLRKRTFILMYLWFTDSVLYQGLILHMGAT 371                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     215 SGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNLLAGAACLVMI 264                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     372 SGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNLLAGAACLVMI 421                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     265 FISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSS 314                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     422 FISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSS 471                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     315 LCDIGGIITPFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVAL 364                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     472 LCDIGGIITPFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVAL 521                                                          
						                                                            	                  .         .         .                      
						                                                            	     365 PETMKDAENLGRKAKPKENTIYLKVQTSEPSGT                  397                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     522 PETMKDAENLGRKAKPKENTIYLKVQTSEPSGT                  554                                                          

16236	HMR136_HSU86136_10_tr0_r1_1_gPRT		Comparison report between HSU86136_P10 and Q99973partial WT  	Sequence name: Q99973                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HSU86136_P10, comprising a first amino acid     	                                                            
						MEPRAAGQPGSELLVVTVGLDGATRLWHPLLVCQTHTLLGHSGPVRAAAVSETSGLMLTA 	Alignment of: 16236 x Q99973   ..                            
						SEDGSVRLWQVPKEADDTCIPRSSAAVTAVAWAPDGSMAVSGNQAGELILWQEAKAVATA 	                                                            
						QAPGHIGALIWSSAHTFFVLSADEKISEWQVKLRKGSAPGNLSLHLNRILQEDLGVLTSL 	Alignment segment 1/1:                                       
						DWAPDGHFLILAKADLKLLCMKPGDAPSEIWSSYTENPMILSTHKEYGIFVLQPKDPGVL 	                                                            
						SFLRQKESGEFEERLNFDINLENPSRTLISITQAKPESESSFLCASSDGILWNLAKCSPE 	                     Quality: 4227.00                      Escore:       0                                               
						GEWTTGNMWQKKANTPETQTPGTDPSTCRESDASMDSDASMDSEPTPHLKTRQRRKIHSG 	             Matching length:     431                Total length:     431                                               
						SVTALHVLPELLVTASKDRDVKLWERPSMQLLGLFRCEGSVSCLEPWLGANSTLQLAVGD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VQGNVYFLNWE                                                  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 2197 - 2627 of Q99973, which also corresponds to 	                                                            
						amino acids 1 - 431 of HSU86136_P10.                         	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEPRAAGQPGSELLVVTVGLDGATRLWHPLLVCQTHTLLGHSGPVRAAAV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2197 MEPRAAGQPGSELLVVTVGLDGATRLWHPLLVCQTHTLLGHSGPVRAAAV 2246                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 SETSGLMLTASEDGSVRLWQVPKEADDTCIPRSSAAVTAVAWAPDGSMAV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2247 SETSGLMLTASEDGSVRLWQVPKEADDTCIPRSSAAVTAVAWAPDGSMAV 2296                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SGNQAGELILWQEAKAVATAQAPGHIGALIWSSAHTFFVLSADEKISEWQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2297 SGNQAGELILWQEAKAVATAQAPGHIGALIWSSAHTFFVLSADEKISEWQ 2346                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VKLRKGSAPGNLSLHLNRILQEDLGVLTSLDWAPDGHFLILAKADLKLLC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2347 VKLRKGSAPGNLSLHLNRILQEDLGVLTSLDWAPDGHFLILAKADLKLLC 2396                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     201 MKPGDAPSEIWSSYTENPMILSTHKEYGIFVLQPKDPGVLSFLRQKESGE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2397 MKPGDAPSEIWSSYTENPMILSTHKEYGIFVLQPKDPGVLSFLRQKESGE 2446                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FEERLNFDINLENPSRTLISITQAKPESESSFLCASSDGILWNLAKCSPE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2447 FEERLNFDINLENPSRTLISITQAKPESESSFLCASSDGILWNLAKCSPE 2496                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GEWTTGNMWQKKANTPETQTPGTDPSTCRESDASMDSDASMDSEPTPHLK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2497 GEWTTGNMWQKKANTPETQTPGTDPSTCRESDASMDSDASMDSEPTPHLK 2546                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     351 TRQRRKIHSGSVTALHVLPELLVTASKDRDVKLWERPSMQLLGLFRCEGS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2547 TRQRRKIHSGSVTALHVLPELLVTASKDRDVKLWERPSMQLLGLFRCEGS 2596                                                         
						                                                            	                  .         .         .                      
						                                                            	     401 VSCLEPWLGANSTLQLAVGDVQGNVYFLNWE                    431                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    2597 VSCLEPWLGANSTLQLAVGDVQGNVYFLNWE                    2627                                                         

16362	HMR136_HSU86759_1_tr0_r1_1_gPRT		Comparison report between HSU86759_P1 and O00634partial WT   	Sequence name: O00634                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HSU86759_P1, comprising a first amino acid      	                                                            
						MELYRLSGRRSGGVCLNCRHNTAGRHCHYCREGFYRDPGRALSDRRACRACDCHPVGAAG 	Alignment of: 16362 x O00634   ..                            
						KTCNQTTGQCPCKDGVTGLTCNRCAPGFQQSRSPVAPCVKTPIPGPTEDSSPVQPQDCDS 	                                                            
						HCKPARGSYRISLKKFCKKDYAVQVAVGARGEARGAWTRFPVAVLAVFRSGEERARRGSS 	Alignment segment 1/1:                                       
						ALWVPAGDAACGCPRLLPGRRYLLLGGGPGAAAGGAGGRGPGLIAARGSLVLPWRDAWTR 	                                                            
						RLRRLQRRERRGRCSAA                                            	                     Quality: 2569.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     257                Total length:     257                                               
						amino acids 324 - 580 of O00634, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 257 of HSU86759_P1.                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MELYRLSGRRSGGVCLNCRHNTAGRHCHYCREGFYRDPGRALSDRRACRA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 MELYRLSGRRSGGVCLNCRHNTAGRHCHYCREGFYRDPGRALSDRRACRA 373                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 CDCHPVGAAGKTCNQTTGQCPCKDGVTGLTCNRCAPGFQQSRSPVAPCVK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     374 CDCHPVGAAGKTCNQTTGQCPCKDGVTGLTCNRCAPGFQQSRSPVAPCVK 423                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPIPGPTEDSSPVQPQDCDSHCKPARGSYRISLKKFCKKDYAVQVAVGAR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     424 TPIPGPTEDSSPVQPQDCDSHCKPARGSYRISLKKFCKKDYAVQVAVGAR 473                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GEARGAWTRFPVAVLAVFRSGEERARRGSSALWVPAGDAACGCPRLLPGR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     474 GEARGAWTRFPVAVLAVFRSGEERARRGSSALWVPAGDAACGCPRLLPGR 523                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RYLLLGGGPGAAAGGAGGRGPGLIAARGSLVLPWRDAWTRRLRRLQRRER 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     524 RYLLLGGGPGAAAGGAGGRGPGLIAARGSLVLPWRDAWTRRLRRLQRRER 573                                                          
						                                                            	                                                             
						                                                            	     251 RGRCSAA                                            257                                                          
						                                                            	         |||||||                                             
						                                                            	     574 RGRCSAA                                            580                                                          

16358	HMR136_HSU86759_2_tr0_r1_1_gPRT		Comparison report between HSU86759_P2 and O00634partial WT   	Sequence name: O00634                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HSU86759_P2, comprising a first     	Sequence documentation:                                      
						MPGWPWGLLLTAGTLFAALSPGPPAPADPCHDEGGAPRGCVPGLVNAALGREVLASSTCG 	                                                            
						RPATRACDASDPRRAHSPALLTSPGGTASPLCWRSESLPRAPLNVTLTVPLGKAFELVFV 	Alignment of: 16358 x O00634   ..                            
						SLRFCSAPPASVALLKSQDHGRSWAPLGFFSSHCDLDYGRLPAPANGPAGPGPEALCFPA 	                                                            
						PLAQPDGSGLLAFSMQDSSPPGLDLDSSPVLQDW                           	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 214 of O00634, which also   	                     Quality: 2118.00                      Escore:       0                                               
						corresponds to amino acids 1 - 214 of HSU86759_P2, and a     	             Matching length:     214                Total length:     214                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       0                        
						polypeptide having the sequence                              	                                                            
						LAPATAMPAAAASTWSCTDCPAAAAGVSVSTAGTTPPAATATTAGRASIETLAVP      	Alignment:                                                   
						corresponding to amino acids 215 - 269 of HSU86759_P2,       	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	       1 MPGWPWGLLLTAGTLFAALSPGPPAPADPCHDEGGAPRGCVPGLVNAALG 50                                                           
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of HSU86759_P2,     	       1 MPGWPWGLLLTAGTLFAALSPGPPAPADPCHDEGGAPRGCVPGLVNAALG 50                                                           
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	      51 REVLASSTCGRPATRACDASDPRRAHSPALLTSPGGTASPLCWRSESLPR 100                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	      51 REVLASSTCGRPATRACDASDPRRAHSPALLTSPGGTASPLCWRSESLPR 100                                                          
						LAPATAMPAAAASTWSCTDCPAAAAGVSVSTAGTTPPAATATTAGRASIETLAVP in   	                  .         .         .         .         .  
						HSU86759_P2.                                                 	     101 APLNVTLTVPLGKAFELVFVSLRFCSAPPASVALLKSQDHGRSWAPLGFF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 APLNVTLTVPLGKAFELVFVSLRFCSAPPASVALLKSQDHGRSWAPLGFF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SSHCDLDYGRLPAPANGPAGPGPEALCFPAPLAQPDGSGLLAFSMQDSSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SSHCDLDYGRLPAPANGPAGPGPEALCFPAPLAQPDGSGLLAFSMQDSSP 200                                                          
						                                                            	                  .                                          
						                                                            	     201 PGLDLDSSPVLQDW                                     214                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     201 PGLDLDSSPVLQDW                                     214                                                          

16360	HMR136_HSU86759_3_tr0_r1_1_gPRT		Comparison report between HSU86759_P3 and O00634partial WT   	Sequence name: O00634                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HSU86759_P3, comprising a first amino acid      	                                                            
						MELYRLSGRRSGGVCLNCRHNTAGRHCHYCREGFYRDPGRALSDRRACRACDCHPVGAAG 	Alignment of: 16360 x O00634   ..                            
						KTCNQTTGQCPCKDGVTGLTCNRCAPGFQQSRSPVAPCVKTPIPGPTEDSSPVQPQDCDS 	                                                            
						HCKPARGSYRISLKKFCKKDYAVQVAVGARGEARGAWTRFPVAVLAVFRSGEERARRGSS 	Alignment segment 1/1:                                       
						ALWVPAGDAACGCPRLLPGRRYLLLGGGPGAAAGGAGGRGPGLIAARGSLVLPWRDAWTR 	                                                            
						RLRRLQRRERRGRCSAA                                            	                     Quality: 2569.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     257                Total length:     257                                               
						amino acids 324 - 580 of O00634, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 257 of HSU86759_P3.                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MELYRLSGRRSGGVCLNCRHNTAGRHCHYCREGFYRDPGRALSDRRACRA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 MELYRLSGRRSGGVCLNCRHNTAGRHCHYCREGFYRDPGRALSDRRACRA 373                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 CDCHPVGAAGKTCNQTTGQCPCKDGVTGLTCNRCAPGFQQSRSPVAPCVK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     374 CDCHPVGAAGKTCNQTTGQCPCKDGVTGLTCNRCAPGFQQSRSPVAPCVK 423                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPIPGPTEDSSPVQPQDCDSHCKPARGSYRISLKKFCKKDYAVQVAVGAR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     424 TPIPGPTEDSSPVQPQDCDSHCKPARGSYRISLKKFCKKDYAVQVAVGAR 473                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GEARGAWTRFPVAVLAVFRSGEERARRGSSALWVPAGDAACGCPRLLPGR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     474 GEARGAWTRFPVAVLAVFRSGEERARRGSSALWVPAGDAACGCPRLLPGR 523                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RYLLLGGGPGAAAGGAGGRGPGLIAARGSLVLPWRDAWTRRLRRLQRRER 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     524 RYLLLGGGPGAAAGGAGGRGPGLIAARGSLVLPWRDAWTRRLRRLQRRER 573                                                          
						                                                            	                                                             
						                                                            	     251 RGRCSAA                                            257                                                          
						                                                            	         |||||||                                             
						                                                            	     574 RGRCSAA                                            580                                                          

16738	HMR136_HSU91935_2_tr0_r1_1_gPRT		Comparison report between HSU91935_P2 and                    	Sequence name: RPF1_HUMAN_V1                                 
						RPF1_HUMAN_V1partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSU91935_P2, comprising a first amino acid sequence being at 	                                                            
						MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDTPSKLFGARGN 	Alignment of: 16738 x RPF1_HUMAN_V1   ..                     
						PALSDPGTPDQHQASQTHPPFPVGPQPLLTAQQLASAVAGVMPGGPPALNQPILIPFNMA 	                                                            
						GQLGGQQGLVLTLPTANLTNIQGLVAAAAAGGIMTLPLQNLQATSSLNSQLQQLQLQLQQ 	Alignment segment 1/1:                                       
						QQQQQQQQQPPPSTNQHPQPAPQAPSQSQQQPLQPTPPQQPPPASQQPPAPTSQLQQAPQ 	                                                            
						PQQHQPHSHSQNQNQPSPTQQSSSPPQKPSQSPGHGLPSPLTPPNPLQLVNNPLASQAAA 	                     Quality: 4498.00                      Escore:       0                                               
						AAAAMSSIASSQAFGNALSSLQGVTGQLVTNAQGQIIGTIPLMPNPGPSSQAASGTQGLQ 	             Matching length:     460                Total length:     460                                               
						VQPITPQLLTNAQGQIIATVIGNQILPVINTQGITLSPIKPGQQLHQPSQTSVGQAASQG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NLLHLAHSQASMSQSPVRQASSSSSSSSSSSALSVGQLVS                     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 1 - 460	                        Gaps:       0                        
						of RPF1_HUMAN_V1, which also corresponds to amino acids 1 -  	                                                            
						460 of HSU91935_P2, and a second amino acid sequence being at	Alignment:                                                   
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	       1 MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDT 50                                                           
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVRGNKREHACGRVGVCVQ corresponding to amino acids 461 - 479 of	       1 MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDT 50                                                           
						HSU91935_P2, wherein said first amino acid sequence and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 PSKLFGARGNPALSDPGTPDQHQASQTHPPFPVGPQPLLTAQQLASAVAG 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSU91935_P2, comprising a polypeptide being at least 70%,    	      51 PSKLFGARGNPALSDPGTPDQHQASQTHPPFPVGPQPLLTAQQLASAVAG 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 VMPGGPPALNQPILIPFNMAGQLGGQQGLVLTLPTANLTNIQGLVAAAAA 150                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVRGNKREHACGRVGVCVQ in HSU91935_P2.                          	     101 VMPGGPPALNQPILIPFNMAGQLGGQQGLVLTLPTANLTNIQGLVAAAAA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GGIMTLPLQNLQATSSLNSQLQQLQLQLQQQQQQQQQQQPPPSTNQHPQP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GGIMTLPLQNLQATSSLNSQLQQLQLQLQQQQQQQQQQQPPPSTNQHPQP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 APQAPSQSQQQPLQPTPPQQPPPASQQPPAPTSQLQQAPQPQQHQPHSHS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 APQAPSQSQQQPLQPTPPQQPPPASQQPPAPTSQLQQAPQPQQHQPHSHS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QNQNQPSPTQQSSSPPQKPSQSPGHGLPSPLTPPNPLQLVNNPLASQAAA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QNQNQPSPTQQSSSPPQKPSQSPGHGLPSPLTPPNPLQLVNNPLASQAAA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AAAAMSSIASSQAFGNALSSLQGVTGQLVTNAQGQIIGTIPLMPNPGPSS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AAAAMSSIASSQAFGNALSSLQGVTGQLVTNAQGQIIGTIPLMPNPGPSS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QAASGTQGLQVQPITPQLLTNAQGQIIATVIGNQILPVINTQGITLSPIK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QAASGTQGLQVQPITPQLLTNAQGQIIATVIGNQILPVINTQGITLSPIK 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PGQQLHQPSQTSVGQAASQGNLLHLAHSQASMSQSPVRQASSSSSSSSSS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 PGQQLHQPSQTSVGQAASQGNLLHLAHSQASMSQSPVRQASSSSSSSSSS 450                                                          
						                                                            	                  .                                          
						                                                            	     451 SALSVGQLVS                                         460                                                          
						                                                            	         ||||||||||                                          
						                                                            	     451 SALSVGQLVS                                         460                                                          

16742	HMR136_HSU91935_3_tr0_r1_1_gPRT		Comparison report between HSU91935_P3 and                    	Sequence name: RPF1_HUMAN_V1                                 
						RPF1_HUMAN_V1partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSU91935_P3, comprising a first amino acid sequence being at 	                                                            
						MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDTPSKLFGARGN 	Alignment of: 16742 x RPF1_HUMAN_V1   ..                     
						PALSDPGTPDQHQASQTHPPFPVGPQPLLTAQQLASAVAGVMPGGPPALNQPILIPFNMA 	                                                            
						GQLGGQQGLVLTLPTANLTNIQGLVAAAAAGGIMTLPLQNLQATSSLNSQLQQLQLQLQQ 	Alignment segment 1/1:                                       
						QQQQQQQQQPPPSTNQHPQPAPQAPSQSQQQPLQPTPPQQPPPASQQPPAPTSQLQQAPQ 	                                                            
						PQQHQPHSHSQNQNQPSPTQQSSSPPQKPSQSPGHGLPSPLTPPNPLQLVNNPLASQAAA 	                     Quality: 3972.00                      Escore:       0                                               
						AAAAMSSIASSQAFGNALSSLQGVTGQLVTNAQGQIIGTIPLMPNPGPSSQAASGTQGLQ 	             Matching length:     405                Total length:     405                                               
						VQPITPQLLTNAQGQIIATVIGNQILPVINTQGITLSPIKPGQQ                 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.75                                               
						least 90 % homologous to corresponding to amino acids 1 - 404	    Total Percent Similarity:  100.00      Total Percent Identity:   99.75                                               
						of RPF1_HUMAN_V1, which also corresponds to amino acids 1 -  	                        Gaps:       0                        
						404 of HSU91935_P3, and a second amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment:                                                   
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	       1 MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDT 50                                                           
						ILKRQRVRWMGLIWRRSENLPKLLKSGACPLA corresponding to amino acids	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						405 - 436 of HSU91935_P3, wherein said first amino acid      	       1 MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDT 50                                                           
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 PSKLFGARGNPALSDPGTPDQHQASQTHPPFPVGPQPLLTAQQLASAVAG 100                                                          
						tail of HSU91935_P3, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 PSKLFGARGNPALSDPGTPDQHQASQTHPPFPVGPQPLLTAQQLASAVAG 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	     101 VMPGGPPALNQPILIPFNMAGQLGGQQGLVLTLPTANLTNIQGLVAAAAA 150                                                          
						ILKRQRVRWMGLIWRRSENLPKLLKSGACPLA in HSU91935_P3.             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VMPGGPPALNQPILIPFNMAGQLGGQQGLVLTLPTANLTNIQGLVAAAAA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GGIMTLPLQNLQATSSLNSQLQQLQLQLQQQQQQQQQQQPPPSTNQHPQP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GGIMTLPLQNLQATSSLNSQLQQLQLQLQQQQQQQQQQQPPPSTNQHPQP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 APQAPSQSQQQPLQPTPPQQPPPASQQPPAPTSQLQQAPQPQQHQPHSHS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 APQAPSQSQQQPLQPTPPQQPPPASQQPPAPTSQLQQAPQPQQHQPHSHS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QNQNQPSPTQQSSSPPQKPSQSPGHGLPSPLTPPNPLQLVNNPLASQAAA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QNQNQPSPTQQSSSPPQKPSQSPGHGLPSPLTPPNPLQLVNNPLASQAAA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AAAAMSSIASSQAFGNALSSLQGVTGQLVTNAQGQIIGTIPLMPNPGPSS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AAAAMSSIASSQAFGNALSSLQGVTGQLVTNAQGQIIGTIPLMPNPGPSS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QAASGTQGLQVQPITPQLLTNAQGQIIATVIGNQILPVINTQGITLSPIK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QAASGTQGLQVQPITPQLLTNAQGQIIATVIGNQILPVINTQGITLSPIK 400                                                          
						                                                            	                                                             
						                                                            	     401 PGQQI                                              405                                                          
						                                                            	         ||||:                                               
						                                                            	     401 PGQQL                                              405                                                          

16736	HMR136_HSU91935_4_tr0_r1_1_gPRT		Comparison report between HSU91935_P4 and RPF1_HUMANpartial  	Sequence name: RPF1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU91935_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDTPSKLF      	Alignment of: 16736 x RPF1_HUMAN   ..                        
						corresponding to amino acids 1 - 55 of RPF1_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 55 of HSU91935_P4, and a      	Alignment segment 1/1:                                       
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	                     Quality:  523.00                      Escore:       0                                               
						90% and most preferably at least 95% homologous to a         	             Matching length:      55                Total length:      55                                               
						polypeptide having the sequence ALILIGI corresponding to     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 56 - 62 of HSU91935_P4, wherein said first amino 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence and second amino acid sequence are contiguous  	                        Gaps:       0                        
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a tail of HSU91935_P4, comprising a polypeptide being at 	Alignment:                                                   
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	       1 MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDT 50                                                           
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALILIGI in HSU91935_P4.                                      	       1 MIAGQVSKPLLSVRSEMNAELRGEDKAATSDSELNEPLLAPVESNDSEDT 50                                                           
						                                                            	                                                             
						                                                            	      51 PSKLF                                              55                                                           
						                                                            	         |||||                                               
						                                                            	      51 PSKLF                                              55                                                           

17215	HMR136_HSU95025_2_tr0_r1_1_gPRT		Comparison report between HSU95025_P2 and MGR8_HUMANpartial  	Sequence name: MGR8_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU95025_P2, comprising a first     	Sequence documentation:                                      
						MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGGLFPVHAKGER 	                                                            
						GVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFV 	Alignment of: 17215 x MGR8_HUMAN   ..                        
						QALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTA 	                                                            
						PELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISR 	Alignment segment 1/1:                                       
						EIGGVCIAQSQKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQS 	                                                            
						GHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTLANNRRNVWFA 	                     Quality: 8777.00                      Escore:       0                                               
						EFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEGKVQFVIDAVYSMAYALHNMH 	             Matching length:     896                Total length:     896                                               
						KDLCPGYIGLCPRMSTIDGKELLGYIRAVNFNGSAGTPVTFNENGDAPGRYDIFQYQITN 	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.67                                               
						KSTEYKVIGHWTNQLHLKVEDMQWAHREHTHPASVCSLPCKPGERKKTVKGVPCCWHCER 	    Total Percent Similarity:   99.89      Total Percent Identity:   99.67                                               
						CEGYNYQVDELSCELCPLDQRPNMNRTGCQLIPIIKLEWHSPWAVVPVFVAILGIIATTF 	                        Gaps:       0                        
						VIVTFVRYNDTPIVRASGRELSYVLLTGIFLCYSITFLMIAAPDTIICSFRRVFLGLGMC 	                                                            
						FSYAALLTKTNRIHRIFEQGKKSVTAPKFISPASQLVITFSLISVQLLGVFVWFVVDPPH 	Alignment:                                                   
						IIIDYGEQRTLDPEKARGVLKCDISDLSLICSLGYSILLMVTCTVYAIKTRGVPETFNEA 	                  .         .         .         .         .  
						KPIGFTMYTTCIIWLAFIPIFFGTAQSAEKMYIQTTTLTVSMSLSASVSLGMLYMPKVYI 	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						IIFHPEQNVQKRKRSFKAVVTAATMQSKLIQKGNDRPNGEVKSELCESLETN         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						corresponding to amino acids 1 - 892 of MGR8_HUMAN, which    	                  .         .         .         .         .  
						also corresponds to amino acids 1 - 892 of HSU95025_P2, and a	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						second amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence SKSSVEFPMVKSGSTS             	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						corresponding to amino acids 893 - 908 of HSU95025_P2,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HSU95025_P2,     	     151 IGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDS 200                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     151 IGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDS 200                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence SKSSVEFPMVKSGSTS in     	     201 YQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVCIAQS 250                                                          
						HSU95025_P2.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 YQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVCIAQS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEG 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVN 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 FNGSAGTPVTFNENGDAPGRYDIFQYQITNKSTEYKVIGHWTNQLHLKVE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 FNGSAGTPVTFNENGDAPGRYDIFQYQITNKSTEYKVIGHWTNQLHLKVE 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 DMQWAHREHTHPASVCSLPCKPGERKKTVKGVPCCWHCERCEGYNYQVDE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DMQWAHREHTHPASVCSLPCKPGERKKTVKGVPCCWHCERCEGYNYQVDE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LSCELCPLDQRPNMNRTGCQLIPIIKLEWHSPWAVVPVFVAILGIIATTF 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LSCELCPLDQRPNMNRTGCQLIPIIKLEWHSPWAVVPVFVAILGIIATTF 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 VIVTFVRYNDTPIVRASGRELSYVLLTGIFLCYSITFLMIAAPDTIICSF 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 VIVTFVRYNDTPIVRASGRELSYVLLTGIFLCYSITFLMIAAPDTIICSF 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RRVFLGLGMCFSYAALLTKTNRIHRIFEQGKKSVTAPKFISPASQLVITF 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 RRVFLGLGMCFSYAALLTKTNRIHRIFEQGKKSVTAPKFISPASQLVITF 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 SLISVQLLGVFVWFVVDPPHIIIDYGEQRTLDPEKARGVLKCDISDLSLI 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SLISVQLLGVFVWFVVDPPHIIIDYGEQRTLDPEKARGVLKCDISDLSLI 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 CSLGYSILLMVTCTVYAIKTRGVPETFNEAKPIGFTMYTTCIIWLAFIPI 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 CSLGYSILLMVTCTVYAIKTRGVPETFNEAKPIGFTMYTTCIIWLAFIPI 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 FFGTAQSAEKMYIQTTTLTVSMSLSASVSLGMLYMPKVYIIIFHPEQNVQ 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 FFGTAQSAEKMYIQTTTLTVSMSLSASVSLGMLYMPKVYIIIFHPEQNVQ 850                                                          
						                                                            	                  .         .         .         .            
						                                                            	     851 KRKRSFKAVVTAATMQSKLIQKGNDRPNGEVKSELCESLETNSKSS     896                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||: |:      
						                                                            	     851 KRKRSFKAVVTAATMQSKLIQKGNDRPNGEVKSELCESLETNTSST     896                                                          

17213	HMR136_HSU95025_3_tr0_r1_1_gPRT		Comparison report between HSU95025_P3 and MGR8_HUMANpartial  	Sequence name: MGR8_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU95025_P3, comprising a first     	Sequence documentation:                                      
						MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGGLFPVHAKGER 	                                                            
						GVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFV 	Alignment of: 17213 x MGR8_HUMAN   ..                        
						QALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTA 	                                                            
						PELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISR 	Alignment segment 1/1:                                       
						EIGGVCIAQSQKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQS 	                                                            
						GHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTLANNRRNVWFA 	                     Quality: 4431.00                      Escore:       0                                               
						EFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEGKVQFVIDAVYSMAYALHNMH 	             Matching length:     453                Total length:     453                                               
						KDLCPGYIGLCPRMSTIDGKELLGYIRAVNFNG                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 453 of MGR8_HUMAN, which    	                        Gaps:       0                        
						also corresponds to amino acids 1 - 453 of HSU95025_P3, and a	                                                            
						second amino acid sequence being at least 70%, optionally at 	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CRRGIQMSLPWPTLFTPSFSSSWAVLALLSLLMKTEMLLDVMISSSIK             	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						corresponding to amino acids 454 - 501 of HSU95025_P3,       	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of HSU95025_P3,     	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						CRRGIQMSLPWPTLFTPSFSSSWAVLALLSLLMKTEMLLDVMISSSIK in          	                  .         .         .         .         .  
						HSU95025_P3.                                                 	     151 IGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVCIAQS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 YQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVCIAQS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEG 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVN 450                                                          
						                                                            	                                                             
						                                                            	     451 FNG                                                453                                                          
						                                                            	         |||                                                 
						                                                            	     451 FNG                                                453                                                          

17211	HMR136_HSU95025_4_tr0_r1_1_gPRT		Comparison report between HSU95025_P4 and MGR8_HUMANpartial  	Sequence name: MGR8_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU95025_P4, comprising a first     	Sequence documentation:                                      
						MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGGLFPVHAKGER 	                                                            
						GVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFV 	Alignment of: 17211 x MGR8_HUMAN   ..                        
						QALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTA 	                                                            
						PELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISR 	Alignment segment 1/1:                                       
						EIG                                                          	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2353.00                      Escore:       0                                               
						corresponding to amino acids 1 - 243 of MGR8_HUMAN, which    	             Matching length:     243                Total length:     243                                               
						also corresponds to amino acids 1 - 243 of HSU95025_P4, and a	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	Alignment:                                                   
						YPSLFGIQGCLHECFAILCQVVYQFLLLMQLSDAQTVY corresponding to amino	                  .         .         .         .         .  
						acids 244 - 281 of HSU95025_P4, wherein said first amino acid	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						tail of HSU95025_P4, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						YPSLFGIQGCLHECFAILCQVVYQFLLLMQLSDAQTVY in HSU95025_P4.       	                  .         .         .         .         .  
						                                                            	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDS 200                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 YQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIG        243                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     201 YQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIG        243                                                          

17207	HMR136_HSU95025_9_tr0_r1_1_gPRT		Comparison report between HSU95025_P9 and MGR8_HUMANpartial  	Sequence name: MGR8_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HSU95025_P9, comprising a first     	Sequence documentation:                                      
						MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGGLFPVHAKGER 	                                                            
						GVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFV 	Alignment of: 17207 x MGR8_HUMAN   ..                        
						QALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFK           	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 170 of MGR8_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 170 of HSU95025_P9, and a	                     Quality: 1651.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     171                Total length:     171                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.42                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:   99.42                                               
						polypeptide having the sequence VGKGIVFLTIVKEQ corresponding 	                        Gaps:       0                        
						to amino acids 171 - 184 of HSU95025_P9, wherein said first  	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of HSU95025_P9, comprising a 	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGG 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VGKGIVFLTIVKEQ in HSU95025_P9.               	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 LFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGV 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGV 150                                                          
						                                                            	                  .         .                                
						                                                            	     151 IGAAASSVSIMVANILRLFKV                              171                                                          
						                                                            	         ||||||||||||||||||||:                               
						                                                            	     151 IGAAASSVSIMVANILRLFKI                              171                                                          

23485	HMR136_HSUFOR_5_tr0_r1_1_gPRT		Comparison report between HSUFOR_P5 and Q8N5L2partial WT     	Sequence name: Q8N5L2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HSUFOR_P5, comprising a first amino 	Sequence documentation:                                      
						MAWRCPRMGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQLQV 	                                                            
						QGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSLQLSDTGQYQCLVF 	Alignment of: 23485 x Q8N5L2   ..                            
						LGHQTFVSQPGYVGLEGLPYFLEEPEDRTVAANTPFNLSCQAQGPPEPVDLLWLQDAVPL 	                                                            
						ATAPGHGPQRSLHVPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTE 	Alignment segment 1/1:                                       
						LEVAWTPGLSGIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLH 	                                                            
						PHTPYHIRVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPRAPL 	                     Quality: 7242.00                      Escore:       0                                               
						QGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVAAYTAAGDGPWSLP 	             Matching length:     732                Total length:     732                                               
						VPLEAWRPGQAQPVHQLVKEPSTPAFSWPWWYVLLGAVVAAACVLILALFLVHRRKKETR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YGEVFEPTVERGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TLGEGEFGAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRL 	                        Gaps:       0                        
						IGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIASGM 	                                                            
						EYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 	Alignment:                                                   
						LADRVYTSKSDV                                                 	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	       1 MAWRCPRMGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGL 50                                                           
						to amino acids 1 - 732 of Q8N5L2, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 732 of HSUFOR_P5, and a second amino acid    	       1 MAWRCPRMGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGL 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      51 TGTLRCQLQVQGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVS 100                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VCLDVAVLGAKSPGPAKFYRAAGRFGEHTEGLASCPGA   	      51 TGTLRCQLQVQGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVS 100                                                          
						corresponding to amino acids 733 - 770 of HSUFOR_P5, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	     101 QLRITSLQLSDTGQYQCLVFLGHQTFVSQPGYVGLEGLPYFLEEPEDRTV 150                                                          
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of HSUFOR_P5, comprising a   	     101 QLRITSLQLSDTGQYQCLVFLGHQTFVSQPGYVGLEGLPYFLEEPEDRTV 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     151 AANTPFNLSCQAQGPPEPVDLLWLQDAVPLATAPGHGPQRSLHVPGLNKT 200                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VCLDVAVLGAKSPGPAKFYRAAGRFGEHTEGLASCPGA in    	     151 AANTPFNLSCQAQGPPEPVDLLWLQDAVPLATAPGHGPQRSLHVPGLNKT 200                                                          
						HSUFOR_P5.                                                   	                  .         .         .         .         .  
						                                                            	     201 SSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTPGLS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTPGLS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PHTPYHIRVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PHTPYHIRVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAF 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VHWQEPRAPLQGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VHWQEPRAPLQGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 NLTVCVAAYTAAGDGPWSLPVPLEAWRPGQAQPVHQLVKEPSTPAFSWPW 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 NLTVCVAAYTAAGDGPWSLPVPLEAWRPGQAQPVHQLVKEPSTPAFSWPW 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 WYVLLGAVVAAACVLILALFLVHRRKKETRYGEVFEPTVERGELVVRYRV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 WYVLLGAVVAAACVLILALFLVHRRKKETRYGEVFEPTVERGELVVRYRV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAV 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 MEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 MEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 IGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 IGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 KFMADIASGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNG 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KFMADIASGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNG 700                                                          
						                                                            	                  .         .         .                      
						                                                            	     701 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDV                   732                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     701 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDV                   732                                                          

						Comparison report between HSUFOR_P5 and UFO_HUMAN_V2unique   	Sequence name: UFO_HUMAN_V2                                  
						head followed by partial WT sequence a mismatch and a        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HSUFOR_P5, comprising a first amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 23485 x UFO_HUMAN_V2   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MAWRCPR corresponding to amino acids 1 - 	                                                            
						7 of HSUFOR_P5, a second amino acid sequence being at least  	                     Quality: 7150.00                      Escore:       0                                               
						MGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQLQVQGEPPEV 	             Matching length:     725                Total length:     725                                               
						HWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSLQLSDTGQYQCLVFLGHQTFV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						SQPGYVGLEGLPYFLEEPEDRTVAANTPFNLSCQAQGPPEPVDLLWLQDAVPLATAPGHG 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.86                                               
						PQRSLHVPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTP 	                        Gaps:       0                        
						GLSGIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLHPHTPYHI 	                                                            
						RVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPRAPLQGTLLGY 	Alignment:                                                   
						RLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVAAYTAAGDGPWSLPVPLEAWR 	                  .         .         .         .         .  
						PG                                                           	       8 MGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQ 57                                                           
						90 % homologous to corresponding to amino acids 1 - 422 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						UFO_HUMAN_V2, which also corresponds to amino acids 8 - 429  	       1 MGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQ 50                                                           
						of HSUFOR_P5, a bridging amino acid Q corresponding to amino 	                  .         .         .         .         .  
						acid 430 of HSUFOR_P5, a third amino acid sequence being at  	      58 LQVQGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSL 107                                                          
						AQPVHQLVKEPSTPAFSWPWWYVLLGAVVAAACVLILALFLVHRRKKETRYGEVFEPTVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAV 	      51 LQVQGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSL 100                                                          
						MEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQGSER 	                  .         .         .         .         .  
						ESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIASGMEYLSTKRFIH 	     108 QLSDTGQYQCLVFLGHQTFVSQPGYVGLEGLPYFLEEPEDRTVAANTPFN 157                                                          
						RDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTSKS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DV                                                           	     101 QLSDTGQYQCLVFLGHQTFVSQPGYVGLEGLPYFLEEPEDRTVAANTPFN 150                                                          
						least 90 % homologous to corresponding to amino acids 424 -  	                  .         .         .         .         .  
						725 of UFO_HUMAN_V2, which also corresponds to amino acids   	     158 LSCQAQGPPEPVDLLWLQDAVPLATAPGHGPQRSLHVPGLNKTSSFSCEA 207                                                          
						431 - 732 of HSUFOR_P5, and a fourth amino acid sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least 80%, preferably at   	     151 LSCQAQGPPEPVDLLWLQDAVPLATAPGHGPQRSLHVPGLNKTSSFSCEA 200                                                          
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     208 HNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTPGLSGIYPLTH 257                                                          
						VCLDVAVLGAKSPGPAKFYRAAGRFGEHTEGLASCPGA corresponding to amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 733 - 770 of HSUFOR_P5, wherein said first amino acid  	     201 HNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTPGLSGIYPLTH 250                                                          
						sequence, second amino acid sequence, bridging amino acid,   	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     258 CTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLHPHTPYHI 307                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of HSUFOR_P5, comprising a   	     251 CTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLHPHTPYHI 300                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     308 RVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPR 357                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MAWRCPR of HSUFOR_P5.3.An isolated           	     301 RVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPR 350                                                          
						polypeptide encoding for a tail of HSUFOR_P5, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     358 APLQGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVA 407                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     351 APLQGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVA 400                                                          
						to the sequence VCLDVAVLGAKSPGPAKFYRAAGRFGEHTEGLASCPGA in    	                  .         .         .         .         .  
						HSUFOR_P5.                                                   	     408 AYTAAGDGPWSLPVPLEAWRPGQAQPVHQLVKEPSTPAFSWPWWYVLLGA 457                                                          
						                                                            	         ||||||||||||||||||||||:|||||||||||||||||||||||||||  
						                                                            	     401 AYTAAGDGPWSLPVPLEAWRPGEAQPVHQLVKEPSTPAFSWPWWYVLLGA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     458 VVAAACVLILALFLVHRRKKETRYGEVFEPTVERGELVVRYRVRKSYSRR 507                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 VVAAACVLILALFLVHRRKKETRYGEVFEPTVERGELVVRYRVRKSYSRR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     508 TTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAVMEGQLNQ 557                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAVMEGQLNQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     558 DDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQG 607                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     608 SERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIA 657                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     658 SGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGR 707                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 SGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGR 700                                                          
						                                                            	                  .         .                                
						                                                            	     708 IAKMPVKWIAIESLADRVYTSKSDV                          732                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     701 IAKMPVKWIAIESLADRVYTSKSDV                          725                                                          

7772	HMR136_HSVACB_1_tr0_r1_1_gPRT		Comparison report between HSVACB_P1 and ANX8_HUMANunique     	Sequence name: ANX8_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HSVACB_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7772 x ANX8_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MPRRLERKLQEPDVWSPSRGQPVSLHLREKGAPEVKE    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 37 of HSVACB_P1, and a      	                                                            
						MAWWKAWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTKRSNTQRQQIA 	                     Quality: 3161.00                      Escore:       0                                               
						KSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAKELHDAMKGLGTKEGVIIEIL 	             Matching length:     327                Total length:     327                                               
						ASRTKNQLREIMKAYEEDYGSSLEEDIQADTSGYLERILVCLLQGSRDDVSSFVDPALAL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QDAQDLYAAGEKIRGTDEMKFITILCTRSATHLLRVFEEYEKIANKSIEDSIKSETHGSL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EEAMLTVVKCTQNLHSYFAERLYYAMKGAGTRDGTLIRNIVSRSEIDLNLIKCHFKKMYG 	                        Gaps:       0                        
						KTLSSMIMEDTSGDYKNALLSLVGSDP                                  	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						corresponding to amino acids 1 - 327 of ANX8_HUMAN, which    	                  .         .         .         .         .  
						also corresponds to amino acids 38 - 364 of HSVACB_P1,       	      38 MAWWKAWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTK 87                                                           
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	       1 MAWWKAWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTK 50                                                           
						isolated polypeptide encoding for a head of HSVACB_P1,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	      88 RSNTQRQQIAKSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAK 137                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	      51 RSNTQRQQIAKSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAK 100                                                          
						about 95% homologous to the sequence                         	                  .         .         .         .         .  
						MPRRLERKLQEPDVWSPSRGQPVSLHLREKGAPEVKE of HSVACB_P1.          	     138 ELHDAMKGLGTKEGVIIEILASRTKNQLREIMKAYEEDYGSSLEEDIQAD 187                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ELHDAMKGLGTKEGVIIEILASRTKNQLREIMKAYEEDYGSSLEEDIQAD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     188 TSGYLERILVCLLQGSRDDVSSFVDPALALQDAQDLYAAGEKIRGTDEMK 237                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 TSGYLERILVCLLQGSRDDVSSFVDPALALQDAQDLYAAGEKIRGTDEMK 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     238 FITILCTRSATHLLRVFEEYEKIANKSIEDSIKSETHGSLEEAMLTVVKC 287                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FITILCTRSATHLLRVFEEYEKIANKSIEDSIKSETHGSLEEAMLTVVKC 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     288 TQNLHSYFAERLYYAMKGAGTRDGTLIRNIVSRSEIDLNLIKCHFKKMYG 337                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 TQNLHSYFAERLYYAMKGAGTRDGTLIRNIVSRSEIDLNLIKCHFKKMYG 300                                                          
						                                                            	                  .         .                                
						                                                            	     338 KTLSSMIMEDTSGDYKNALLSLVGSDP                        364                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     301 KTLSSMIMEDTSGDYKNALLSLVGSDP                        327                                                          

7776	HMR136_HSVACB_10_tr0_r1_1_gPRT		Comparison report between HSVACB_P10 and ANX8_HUMANunique    	Sequence name: ANX8_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSVACB_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7776 x ANX8_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						QSPGARGRQAGVALPWEGLHPHTQVSGLLTPQLQEPDVWSPSRGQPVSLHLREKGAPEVK 	Alignment segment 1/1:                                       
						E                                                            	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 1782.00                      Escore:       0                                               
						to amino acids 1 - 61 of HSVACB_P10, a second amino acid     	             Matching length:     184                Total length:     184                                               
						MAWWKAWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTKRSNTQRQQIA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAKELHDAMKGLGTKEGVIIEIL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ASRTKNQLREIMKAYEEDYGSSLEEDIQADTSGYLERILVCLLQGSRDDVSSFVDPALAL 	                        Gaps:       0                        
						QDAQ                                                         	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 1 - 184 of ANX8_HUMAN, which also corresponds to 	                  .         .         .         .         .  
						amino acids 62 - 245 of HSVACB_P10, and a third amino acid   	      62 MAWWKAWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTK 111                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MAWWKAWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTK 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence SPLHSV corresponding to amino acids 246 -	     112 RSNTQRQQIAKSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAK 161                                                          
						251 of HSVACB_P10, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	      51 RSNTQRQQIAKSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAK 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of HSVACB_P10, comprising a  	     162 ELHDAMKGLGTKEGVIIEILASRTKNQLREIMKAYEEDYGSSLEEDIQAD 211                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 ELHDAMKGLGTKEGVIIEILASRTKNQLREIMKAYEEDYGSSLEEDIQAD 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .                      
						QSPGARGRQAGVALPWEGLHPHTQVSGLLTPQLQEPDVWSPSRGQPVSLHLREKGAPEVK 	     212 TSGYLERILVCLLQGSRDDVSSFVDPALALQDAQ                 245                                                          
						E                                                            	         ||||||||||||||||||||||||||||||||||                  
						to the sequence of HSVACB_P10.3.An isolated polypeptide      	     151 TSGYLERILVCLLQGSRDDVSSFVDPALALQDAQ                 184                                                          
						encoding for a tail of HSVACB_P10, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						SPLHSV in HSVACB_P10.                                        	                                                            

9204	HMR136_HSVASCAS_1_tr0_r1_1_gPRT		Comparison report between HSVASCAS_P1 and Q15858partial WT   	Sequence name: Q15858                                        
						sequence followed by unique insertion and a mismatch.1.An    	                                                            
						isolated chimeric polypeptide encoding for HSVASCAS_P1,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	Alignment of: 9204 x Q15858   ..                             
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPPDWTKNVEYTFTGIYTFESLVKILARGFCVGE 	Alignment segment 1/1:                                       
						FTFLRDPWNWLDFVVIVFAYLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQ 	                                                            
						SVKKLSDVMILTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 	                     Quality: 19236.00                      Escore:       0                                              
						KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQ 	             Matching length:    1977                Total length:    1988                                               
						DYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKE 	 Matching Percent Similarity:   99.95   Matching Percent Identity:   99.95                                               
						LEFQQMLDRLKKEQEEAEAIAAAAAEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRR 	    Total Percent Similarity:   99.40      Total Percent Identity:   99.40                                               
						KKKNQKKLSSGEEKGDAEKLSKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIR 	                        Gaps:       1                        
						GSLFSARRSSRTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 	                                                            
						NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPE              	Alignment:                                                   
						homologous to corresponding to amino acids 1 - 647 of Q15858,	                  .         .         .         .         .  
						which also corresponds to amino acids 1 - 647 of HSVASCAS_P1,	       1 MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPS 50                                                           
						a second amino acid sequence being at least 70%, optionally  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 80%, preferably at least 85%, more preferably at    	       1 MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPS 50                                                           
						least 90% and most preferably at least 95% homologous to a   	                  .         .         .         .         .  
						polypeptide having the sequence VIIDKATSDDS corresponding to 	      51 SDLEAGKQLPFIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRF 100                                                          
						amino acids 648 - 658 of HSVASCAS_P1, a third amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GTTNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTVEELEESRQKCPPWWYRFA 	      51 SDLEAGKQLPFIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRF 100                                                          
						HKFLIWNCSPYWIKFKKCIYFIVMDPFVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAI 	                  .         .         .         .         .  
						GNLVFTGIFAAEMVLKLIAMDPYEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFR 	     101 NATPALYMLSPFSPLRRISIKILVHSLFSMLIMCTILTNCIFMTMNNPPD 150                                                          
						LLRVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						INDDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLV 	     101 NATPALYMLSPFSPLRRISIKILVHSLFSMLIMCTILTNCIFMTMNNPPD 150                                                          
						VLNLFLALLLSSFSSDNLTAIEEDPDANNLQIAVTRIKKGINYVKQTLREFILKAFSKKP 	                  .         .         .         .         .  
						KISREIRQAEDLNTKKENYISNHTLAEMSKGHNFLKEKDKISGFGSSVDKHLMEDSDGQS 	     151 WTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFAY 200                                                          
						FIHNPSLTVTVPIAPGESDLENMNAEELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEAEAEPMNSDEPEACFTDGCV                                       	     151 WTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFAY 200                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 648 - 1149 of Q15858, which also corresponds to  	     201 LTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMI 250                                                          
						amino acids 659 - 1160 of HSVASCAS_P1, a bridging amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						W corresponding to amino acid 1161 of HSVASCAS_P1, and a     	     201 LTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMI 250                                                          
						RFSCCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVLMILLSSGALAFEDIYIERKKT 	                  .         .         .         .         .  
						IKIILEYADKIFTYIFILEMLLKWIAYGYKTYFTNAWCWLDFLIVDVSLVTLVANTLGYS 	     251 LTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 300                                                          
						DLGPIKSLRTLRALRPLRALSRFEGMRVVVNALIGAIPSIMNVLLVCLIFWLIFSIMGVN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LFAGKFYECINTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNFDNVGLGYLSLLQ 	     251 LTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 300                                                          
						VATFKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLNLFIGVIIDNFN 	                  .         .         .         .         .  
						QQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPGNKIQGCIFDLVTNQAFDISI 	     301 KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWA 350                                                          
						MVLICLNMVTMMVEKEGQSQHMTEVLYWINVVFIILFTGECVLKLISLRHYYFTVGWNIF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DFVVVIISIVGMFLADLIETYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMSL 	     301 KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWA 350                                                          
						PALFNIGLLLFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGWD 	                  .         .         .         .         .  
						GLLAPILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLVVVNMYIAVILE 	     351 FLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAV 400                                                          
						NFSVATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFSKLSDFAAALDPPLLIAKPNKV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDSLRSQMEERFMSANPSKVSYEPIT 	     351 FLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAV 400                                                          
						TTLKRKQEDVSATVIQRAYRRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNENS 	                  .         .         .         .         .  
						SPEKTDATSSTTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK              	     401 VAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAAAEYTSI 450                                                          
						fourth amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1151 - 1977 of Q15858, which    	     401 VAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAAAEYTSI 450                                                          
						also corresponds to amino acids 1162 - 1988 of HSVASCAS_P1,  	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     451 RRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKL 500                                                          
						sequence, third amino acid sequence, bridging amino acid and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence are contiguous and in a sequential	     451 RRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKL 500                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	                  .         .         .         .         .  
						of HSVASCAS_P1, comprising an amino acid sequence being at   	     501 SKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSS 550                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     501 SKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSS 550                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						encoding for VIIDKATSDDS, corresponding to HSVASCAS_P1.      	     551 RTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPEVII 650                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     601 NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPE... 647                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DKATSDDSGTTNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTV 700                                                          
						                                                            	                 ||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     648 ........GTTNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTV 689                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 EELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDPFVDLAI 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     690 EELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDPFVDLAI 739                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDP 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     740 TICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDP 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 YEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWP 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 YEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWP 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 TLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKIN 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 TLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKIN 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 DDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMM 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 DDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMM 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 VMVIGNLVVLNLFLALLLSSFSSDNLTAIEEDPDANNLQIAVTRIKKGIN 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 VMVIGNLVVLNLFLALLLSSFSSDNLTAIEEDPDANNLQIAVTRIKKGIN 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 YVKQTLREFILKAFSKKPKISREIRQAEDLNTKKENYISNHTLAEMSKGH 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 YVKQTLREFILKAFSKKPKISREIRQAEDLNTKKENYISNHTLAEMSKGH 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 NFLKEKDKISGFGSSVDKHLMEDSDGQSFIHNPSLTVTVPIAPGESDLEN 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1040 NFLKEKDKISGFGSSVDKHLMEDSDGQSFIHNPSLTVTVPIAPGESDLEN 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 MNAEELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEEAEAEPMNSDE 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1090 MNAEELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEEAEAEPMNSDE 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 PEACFTDGCVWRFSCCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVL 1200                                                         
						                                                            	         |||||||||| |||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 PEACFTDGCVRRFSCCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVL 1189                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 MILLSSGALAFEDIYIERKKTIKIILEYADKIFTYIFILEMLLKWIAYGY 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1190 MILLSSGALAFEDIYIERKKTIKIILEYADKIFTYIFILEMLLKWIAYGY 1239                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 KTYFTNAWCWLDFLIVDVSLVTLVANTLGYSDLGPIKSLRTLRALRPLRA 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1240 KTYFTNAWCWLDFLIVDVSLVTLVANTLGYSDLGPIKSLRTLRALRPLRA 1289                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 LSRFEGMRVVVNALIGAIPSIMNVLLVCLIFWLIFSIMGVNLFAGKFYEC 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1290 LSRFEGMRVVVNALIGAIPSIMNVLLVCLIFWLIFSIMGVNLFAGKFYEC 1339                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 INTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNFDNVGLGYLSLL 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1340 INTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNFDNVGLGYLSLL 1389                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 QVATFKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLN 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1390 QVATFKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLN 1439                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 LFIGVIIDNFNQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRP 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1440 LFIGVIIDNFNQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRP 1489                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 GNKIQGCIFDLVTNQAFDISIMVLICLNMVTMMVEKEGQSQHMTEVLYWI 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1490 GNKIQGCIFDLVTNQAFDISIMVLICLNMVTMMVEKEGQSQHMTEVLYWI 1539                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 NVVFIILFTGECVLKLISLRHYYFTVGWNIFDFVVVIISIVGMFLADLIE 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1540 NVVFIILFTGECVLKLISLRHYYFTVGWNIFDFVVVIISIVGMFLADLIE 1589                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 TYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMSLPALFNIGLL 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1590 TYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMSLPALFNIGLL 1639                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 LFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGW 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1640 LFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGW 1689                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 DGLLAPILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLV 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1690 DGLLAPILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLV 1739                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 VVNMYIAVILENFSVATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFS 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1740 VVNMYIAVILENFSVATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFS 1789                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 KLSDFAAALDPPLLIAKPNKVQLIAMDLPMVSGDRIHCLDILFAFTKRVL 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1790 KLSDFAAALDPPLLIAKPNKVQLIAMDLPMVSGDRIHCLDILFAFTKRVL 1839                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1851 GESGEMDSLRSQMEERFMSANPSKVSYEPITTTLKRKQEDVSATVIQRAY 1900                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1840 GESGEMDSLRSQMEERFMSANPSKVSYEPITTTLKRKQEDVSATVIQRAY 1889                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1901 RRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNENSSPEKTDATS 1950                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1890 RRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNENSSPEKTDATS 1939                                                         
						                                                            	                  .         .         .                      
						                                                            	    1951 STTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK             1988                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1940 STTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK             1977                                                         

						Comparison report between HSVASCAS_P1 and Q8WTU1unique head  	Sequence name: Q8WTU1                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSVASCAS_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9204 x Q8WTU1   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	Alignment segment 1/1:                                       
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPP                                	                     Quality: 1092.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     115                Total length:     115                                               
						to amino acids 1 - 149 of HSVASCAS_P1, a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DWTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFAYLTEFVNLGN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMILTVFCLSVFALIGL      	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 115 of Q8WTU1, which also corresponds to     	Alignment:                                                   
						amino acids 150 - 264 of HSVASCAS_P1, and a third amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     150 DWTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFA 199                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 DWTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFA 50                                                           
						QLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFRKYFYYLEGSKDALLCGFSTDSGQC 	                  .         .         .         .         .  
						PEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVV 	     200 YLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVM 249                                                          
						VIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKLSKSE 	      51 YLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVM 100                                                          
						SEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSSRTSLFSFKGRGRDI 	                  .                                          
						GSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSSNISQASRSPPMLPVNGKMHSAVDC 	     250 ILTVFCLSVFALIGL                                    264                                                          
						NGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGTTNQIHKKRRCSSYLLSEDMLNDPN 	         |||||||||||||||                                     
						LRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDP 	     101 ILTVFCLSVFALIGL                                    115                                                          
						FVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDPYEYF 	                                                            
						QVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIGNSVG 	                                                            
						ALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKINDDCTLPRWHMNDFFHSFLIVFRVL 	                                                            
						CGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVLNLFLALLLSSFSSDNLTAIEEDPD 	                                                            
						ANNLQIAVTRIKKGINYVKQTLREFILKAFSKKPKISREIRQAEDLNTKKENYISNHTLA 	                                                            
						EMSKGHNFLKEKDKISGFGSSVDKHLMEDSDGQSFIHNPSLTVTVPIAPGESDLENMNAE 	                                                            
						ELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEEAEAEPMNSDEPEACFTDGCVWRFS 	                                                            
						CCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVLMILLSSGALAFEDIYIERKKTIKI 	                                                            
						ILEYADKIFTYIFILEMLLKWIAYGYKTYFTNAWCWLDFLIVDVSLVTLVANTLGYSDLG 	                                                            
						PIKSLRTLRALRPLRALSRFEGMRVVVNALIGAIPSIMNVLLVCLIFWLIFSIMGVNLFA 	                                                            
						GKFYECINTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNFDNVGLGYLSLLQVAT 	                                                            
						FKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLNLFIGVIIDNFNQQK 	                                                            
						KKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPGNKIQGCIFDLVTNQAFDISIMVL 	                                                            
						ICLNMVTMMVEKEGQSQHMTEVLYWINVVFIILFTGECVLKLISLRHYYFTVGWNIFDFV 	                                                            
						VVIISIVGMFLADLIETYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMSLPAL 	                                                            
						FNIGLLLFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGWDGLL 	                                                            
						APILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLVVVNMYIAVILENFS 	                                                            
						VATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFSKLSDFAAALDPPLLIAKPNKVQLI 	                                                            
						AMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDSLRSQMEERFMSANPSKVSYEPITTTL 	                                                            
						KRKQEDVSATVIQRAYRRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNENSSPE 	                                                            
						KTDATSSTTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK                 	                                                            
						having the sequence corresponding to amino acids 265 - 1988  	                                                            
						of HSVASCAS_P1, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HSVASCAS_P1, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	                                                            
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPP                                	                                                            
						to the sequence of HSVASCAS_P1.3.An isolated polypeptide     	                                                            
						encoding for a tail of HSVASCAS_P1, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						QLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFRKYFYYLEGSKDALLCGFSTDSGQC 	                                                            
						PEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVV 	                                                            
						VIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAA 	                                                            
						AEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKLSKSE 	                                                            
						SEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSSRTSLFSFKGRGRDI 	                                                            
						GSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSSNISQASRSPPMLPVNGKMHSAVDC 	                                                            
						NGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGTTNQIHKKRRCSSYLLSEDMLNDPN 	                                                            
						LRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDP 	                                                            
						FVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDPYEYF 	                                                            
						QVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIGNSVG 	                                                            
						ALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKINDDCTLPRWHMNDFFHSFLIVFRVL 	                                                            
						CGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVLNLFLALLLSSFSSDNLTAIEEDPD 	                                                            
						ANNLQIAVTRIKKGINYVKQTLREFILKAFSKKPKISREIRQAEDLNTKKENYISNHTLA 	                                                            
						EMSKGHNFLKEKDKISGFGSSVDKHLMEDSDGQSFIHNPSLTVTVPIAPGESDLENMNAE 	                                                            
						ELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEEAEAEPMNSDEPEACFTDGCVWRFS 	                                                            
						CCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVLMILLSSGALAFEDIYIERKKTIKI 	                                                            
						ILEYADKIFTYIFILEMLLKWIAYGYKTYFTNAWCWLDFLIVDVSLVTLVANTLGYSDLG 	                                                            
						PIKSLRTLRALRPLRALSRFEGMRVVVNALIGAIPSIMNVLLVCLIFWLIFSIMGVNLFA 	                                                            
						GKFYECINTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNFDNVGLGYLSLLQVAT 	                                                            
						FKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLNLFIGVIIDNFNQQK 	                                                            
						KKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPGNKIQGCIFDLVTNQAFDISIMVL 	                                                            
						ICLNMVTMMVEKEGQSQHMTEVLYWINVVFIILFTGECVLKLISLRHYYFTVGWNIFDFV 	                                                            
						VVIISIVGMFLADLIETYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMSLPAL 	                                                            
						FNIGLLLFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGWDGLL 	                                                            
						APILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLVVVNMYIAVILENFS 	                                                            
						VATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFSKLSDFAAALDPPLLIAKPNKVQLI 	                                                            
						AMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDSLRSQMEERFMSANPSKVSYEPITTTL 	                                                            
						KRKQEDVSATVIQRAYRRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNENSSPE 	                                                            
						KTDATSSTTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK                 	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HSVASCAS_P1.                                              	                                                            

						Comparison report between HSVASCAS_P1 and Q8WWN4unique head  	Sequence name: Q8WWN4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSVASCAS_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9204 x Q8WWN4   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	Alignment segment 1/1:                                       
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPPDWTKNVEYTFTGIYTFESLVKILARGFCVGE 	                     Quality:  605.00                      Escore:       0                                               
						FTFLRDPWNWLDFVVIVFAYLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQ 	             Matching length:      61                Total length:      61                                               
						SVKKLSDVMILTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKE 	                        Gaps:       0                        
						LEFQQMLDRLKKEQEEAEAIAAAAAEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRR 	                                                            
						KKKNQKKLSSGEEKGDAEKLSKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIR 	Alignment:                                                   
						GSLFSARRSSRTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 	                  .         .         .         .         .  
						NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGT 	    1340 VNLFAGKFYECINTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNF 1389                                                         
						TNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FLIWNCSPYWIKFKKCIYFIVMDPFVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGN 	       1 VNLFAGKFYECINTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNF 50                                                           
						LVFTGIFAAEMVLKLIAMDPYEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLL 	                  .                                          
						RVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKIN 	    1390 DNVGLGYLSLL                                        1400                                                         
						DDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVL 	         |||||||||||                                         
						NLFLALLLSSFSSDNLTAIEEDPDANNLQIAVTRIKKGINYVKQTLREFILKAFSKKPKI 	      51 DNVGLGYLSLL                                        61                                                           
						SREIRQAEDLNTKKENYISNHTLAEMSKGHNFLKEKDKISGFGSSVDKHLMEDSDGQSFI 	                                                            
						HNPSLTVTVPIAPGESDLENMNAEELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEE 	                                                            
						AEAEPMNSDEPEACFTDGCVWRFSCCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVL 	                                                            
						MILLSSGALAFEDIYIERKKTIKIILEYADKIFTYIFILEMLLKWIAYGYKTYFTNAWCW 	                                                            
						LDFLIVDVSLVTLVANTLGYSDLGPIKSLRTLRALRPLRALSRFEGMRVVVNALIGAIPS 	                                                            
						IMNVLLVCLIFWLIFSIMG                                          	                                                            
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 1339 of HSVASCAS_P1, a second amino acid  	                                                            
						VNLFAGKFYECINTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNFDNVGLGYLSL 	                                                            
						L                                                            	                                                            
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 61 of Q8WWN4, which also corresponds to amino	                                                            
						acids 1340 - 1400 of HSVASCAS_P1, and a third amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						QVATFKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLNLFIGVIIDNF 	                                                            
						NQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPGNKIQGCIFDLVTNQAFDIS 	                                                            
						IMVLICLNMVTMMVEKEGQSQHMTEVLYWINVVFIILFTGECVLKLISLRHYYFTVGWNI 	                                                            
						FDFVVVIISIVGMFLADLIETYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMS 	                                                            
						LPALFNIGLLLFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGW 	                                                            
						DGLLAPILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLVVVNMYIAVIL 	                                                            
						ENFSVATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFSKLSDFAAALDPPLLIAKPNK 	                                                            
						VQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDSLRSQMEERFMSANPSKVSYEPI 	                                                            
						TTTLKRKQEDVSATVIQRAYRRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNEN 	                                                            
						SSPEKTDATSSTTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK             	                                                            
						having the sequence corresponding to amino acids 1401 - 1988 	                                                            
						of HSVASCAS_P1, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HSVASCAS_P1, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	                                                            
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPPDWTKNVEYTFTGIYTFESLVKILARGFCVGE 	                                                            
						FTFLRDPWNWLDFVVIVFAYLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQ 	                                                            
						SVKKLSDVMILTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 	                                                            
						KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQ 	                                                            
						DYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKE 	                                                            
						LEFQQMLDRLKKEQEEAEAIAAAAAEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRR 	                                                            
						KKKNQKKLSSGEEKGDAEKLSKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIR 	                                                            
						GSLFSARRSSRTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 	                                                            
						NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGT 	                                                            
						TNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHK 	                                                            
						FLIWNCSPYWIKFKKCIYFIVMDPFVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGN 	                                                            
						LVFTGIFAAEMVLKLIAMDPYEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLL 	                                                            
						RVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKIN 	                                                            
						DDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVL 	                                                            
						NLFLALLLSSFSSDNLTAIEEDPDANNLQIAVTRIKKGINYVKQTLREFILKAFSKKPKI 	                                                            
						SREIRQAEDLNTKKENYISNHTLAEMSKGHNFLKEKDKISGFGSSVDKHLMEDSDGQSFI 	                                                            
						HNPSLTVTVPIAPGESDLENMNAEELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEE 	                                                            
						AEAEPMNSDEPEACFTDGCVWRFSCCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVL 	                                                            
						MILLSSGALAFEDIYIERKKTIKIILEYADKIFTYIFILEMLLKWIAYGYKTYFTNAWCW 	                                                            
						LDFLIVDVSLVTLVANTLGYSDLGPIKSLRTLRALRPLRALSRFEGMRVVVNALIGAIPS 	                                                            
						IMNVLLVCLIFWLIFSIMG                                          	                                                            
						to the sequence of HSVASCAS_P1.3.An isolated polypeptide     	                                                            
						encoding for a tail of HSVASCAS_P1, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						QVATFKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLNLFIGVIIDNF 	                                                            
						NQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPGNKIQGCIFDLVTNQAFDIS 	                                                            
						IMVLICLNMVTMMVEKEGQSQHMTEVLYWINVVFIILFTGECVLKLISLRHYYFTVGWNI 	                                                            
						FDFVVVIISIVGMFLADLIETYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMS 	                                                            
						LPALFNIGLLLFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGW 	                                                            
						DGLLAPILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLVVVNMYIAVIL 	                                                            
						ENFSVATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFSKLSDFAAALDPPLLIAKPNK 	                                                            
						VQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDSLRSQMEERFMSANPSKVSYEPI 	                                                            
						TTTLKRKQEDVSATVIQRAYRRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNEN 	                                                            
						SSPEKTDATSSTTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK             	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HSVASCAS_P1.                                              	                                                            

9202	HMR136_HSVASCAS_2_tr0_r1_1_gPRT		Comparison report between HSVASCAS_P2 and Q15858partial WT   	Sequence name: Q15858                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						HSVASCAS_P2, comprising a first amino acid sequence being at 	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	Alignment of: 9202 x Q15858   ..                             
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPPDWTKNVEYTFTGIYTFESLVKILARGFCVGE 	Alignment segment 1/1:                                       
						FTFLRDPWNWLDFVVIVFAYLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQ 	                                                            
						SVKKLSDVMILTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 	                     Quality: 9216.00                      Escore:       0                                               
						KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQ 	             Matching length:     950                Total length:     961                                               
						DYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKE 	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.89                                               
						LEFQQMLDRLKKEQEEAEAIAAAAAEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRR 	    Total Percent Similarity:   98.75      Total Percent Identity:   98.75                                               
						KKKNQKKLSSGEEKGDAEKLSKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIR 	                        Gaps:       1                        
						GSLFSARRSSRTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 	                                                            
						NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPE              	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 1 - 647	                  .         .         .         .         .  
						of Q15858, which also corresponds to amino acids 1 - 647 of  	       1 MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPS 50                                                           
						HSVASCAS_P2, a second amino acid sequence being at least 70%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	       1 MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPS 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence VIIDKATSDDS  	      51 SDLEAGKQLPFIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRF 100                                                          
						corresponding to amino acids 648 - 658 of HSVASCAS_P2, a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GTTNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTVEELEESRQKCPPWWYRFA 	      51 SDLEAGKQLPFIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRF 100                                                          
						HKFLIWNCSPYWIKFKKCIYFIVMDPFVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAI 	                  .         .         .         .         .  
						GNLVFTGIFAAEMVLKLIAMDPYEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFR 	     101 NATPALYMLSPFSPLRRISIKILVHSLFSMLIMCTILTNCIFMTMNNPPD 150                                                          
						LLRVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						INDDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLV 	     101 NATPALYMLSPFSPLRRISIKILVHSLFSMLIMCTILTNCIFMTMNNPPD 150                                                          
						V                                                            	                  .         .         .         .         .  
						third amino acid sequence being at least 90 % homologous to  	     151 WTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFAY 200                                                          
						corresponding to amino acids 648 - 948 of Q15858, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 659 - 959 of HSVASCAS_P2, and a   	     151 WTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFAY 200                                                          
						fourth amino acid sequence being at least 70%, optionally at 	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     201 LTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMI 250                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence CNQMFMHFNFSVEIIL             	     201 LTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMI 250                                                          
						corresponding to amino acids 960 - 975 of HSVASCAS_P2,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     251 LTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 300                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     251 LTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR 300                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						HSVASCAS_P2, comprising an amino acid sequence being at least	     301 KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWA 350                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     301 KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWA 350                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						VIIDKATSDDS, corresponding to HSVASCAS_P2.3.An isolated      	     351 FLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAV 400                                                          
						polypeptide encoding for a tail of HSVASCAS_P2, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     351 FLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAV 400                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     401 VAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAAAEYTSI 450                                                          
						to the sequence CNQMFMHFNFSVEIIL in HSVASCAS_P2.             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAAAEYTSI 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 RRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSS 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 RTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPEVII 650                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     601 NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPE... 647                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DKATSDDSGTTNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTV 700                                                          
						                                                            	                 ||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     648 ........GTTNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTV 689                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 EELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDPFVDLAI 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     690 EELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDPFVDLAI 739                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDP 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     740 TICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDP 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 YEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWP 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 YEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWP 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 TLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKIN 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 TLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKIN 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 DDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMM 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 DDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMM 939                                                          
						                                                            	                  .                                          
						                                                            	     951 VMVIGNLVVCN                                        961                                                          
						                                                            	         ||||||||| |                                         
						                                                            	     940 VMVIGNLVVLN                                        950                                                          

						Comparison report between HSVASCAS_P2 and Q8WTU1unique head  	Sequence name: Q8WTU1                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSVASCAS_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9202 x Q8WTU1   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	Alignment segment 1/1:                                       
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPP                                	                     Quality: 1092.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     115                Total length:     115                                               
						to amino acids 1 - 149 of HSVASCAS_P2, a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DWTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFAYLTEFVNLGN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMILTVFCLSVFALIGL      	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 115 of Q8WTU1, which also corresponds to     	Alignment:                                                   
						amino acids 150 - 264 of HSVASCAS_P2, and a third amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     150 DWTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFA 199                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 DWTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFA 50                                                           
						QLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFRKYFYYLEGSKDALLCGFSTDSGQC 	                  .         .         .         .         .  
						PEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVV 	     200 YLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVM 249                                                          
						VIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKLSKSE 	      51 YLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVM 100                                                          
						SEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSSRTSLFSFKGRGRDI 	                  .                                          
						GSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSSNISQASRSPPMLPVNGKMHSAVDC 	     250 ILTVFCLSVFALIGL                                    264                                                          
						NGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGTTNQIHKKRRCSSYLLSEDMLNDPN 	         |||||||||||||||                                     
						LRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDP 	     101 ILTVFCLSVFALIGL                                    115                                                          
						FVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDPYEYF 	                                                            
						QVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIGNSVG 	                                                            
						ALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKINDDCTLPRWHMNDFFHSFLIVFRVL 	                                                            
						CGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVCNQMFMHFNFSVEIIL          	                                                            
						having the sequence corresponding to amino acids 265 - 975 of	                                                            
						HSVASCAS_P2, wherein said first amino acid sequence, second  	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HSVASCAS_P2, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP 	                                                            
						FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI 	                                                            
						KILVHSLFSMLIMCTILTNCIFMTMNNPP                                	                                                            
						to the sequence of HSVASCAS_P2.3.An isolated polypeptide     	                                                            
						encoding for a tail of HSVASCAS_P2, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						QLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFRKYFYYLEGSKDALLCGFSTDSGQC 	                                                            
						PEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQDYWENLYQQTLRAAGKTYMIFFVV 	                                                            
						VIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAIAAAA 	                                                            
						AEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKLSKSE 	                                                            
						SEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSSRTSLFSFKGRGRDI 	                                                            
						GSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSSNISQASRSPPMLPVNGKMHSAVDC 	                                                            
						NGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGTTNQIHKKRRCSSYLLSEDMLNDPN 	                                                            
						LRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFIVMDP 	                                                            
						FVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDPYEYF 	                                                            
						QVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIGNSVG 	                                                            
						ALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKINDDCTLPRWHMNDFFHSFLIVFRVL 	                                                            
						CGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVCNQMFMHFNFSVEIIL          	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HSVASCAS_P2.                                              	                                                            

97	HMR136_HSVHNF1_1_tr0_r1_1_gPRT		Comparison report between HSVHNF1_P1 and HNFB_HUMANpartial   	Sequence name: HNFB_HUMAN                                    
						WT sequence featuring skipped exon and a with a short unique 	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						HSVHNF1_P1, comprising a first amino acid sequence being at  	                                                            
						MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSPGSGAEPDTKP 	Alignment of: 97 x HNFB_HUMAN   ..                           
						VFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNTEEAAEQRAEVDRMLSEDPWR 	                                                            
						AAKMIKGYMQQHNIPQREVVDVTGLNQSHLSQHLNKGTPMKTQKRAALYTWYVRKQREIL 	Alignment segment 1/1:                                       
						RQ                                                           	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 182	                     Quality: 5063.00                      Escore:       0                                               
						of HNFB_HUMAN, which also corresponds to amino acids 1 - 182 	             Matching length:     531                Total length:     558                                               
						of HSVHNF1_P1, a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAYDRQKNPSKEEREALVEEC 	    Total Percent Similarity:   95.16      Total Percent Identity:   95.16                                               
						NRAECLQRGVSPSKAHGLGSNLVTEVRVYNWFANRRKEEAFRQKLAMDAYSSNQTHSLNP 	                        Gaps:       2                        
						LLSHGSPHHQPSSSPPNKLSGVRYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPAS 	                                                            
						LDPGHNLLSPDGKM                                               	Alignment:                                                   
						% homologous to corresponding to amino acids 209 - 402 of    	                  .         .         .         .         .  
						HNFB_HUMAN, which also corresponds to amino acids 183 - 376  	       1 MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSP 50                                                           
						of HSVHNF1_P1, a third amino acid sequence being at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MVSKLTSLQQELLSALLSSGVTKEVLVQALEELLPSPNFGVKLETLPLSP 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence Q            	      51 GSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNT 100                                                          
						corresponding to amino acids 377 - 377 of HSVHNF1_P1, and a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLNTSQAQSVPVINSV 	      51 GSGAEPDTKPVFHTLTNGHAKGRLSGDEGSEDGDDYDTPPILKELQALNT 100                                                          
						AGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQPFMAAVTQLQNSHMYAHKQEPPQY 	                  .         .         .         .         .  
						SHTSRFPSAMVVTDTSSISTLTNMSSSKQCPLQAW                          	     101 EEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHL 150                                                          
						fourth amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 403 - 557 of HNFB_HUMAN, which  	     101 EEAAEQRAEVDRMLSEDPWRAAKMIKGYMQQHNIPQREVVDVTGLNQSHL 150                                                          
						also corresponds to amino acids 378 - 532 of HSVHNF1_P1,     	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     151 SQHLNKGTPMKTQKRAALYTWYVRKQREILRQ.................. 182                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||                    
						sequence are contiguous and in a sequential order.2.An       	     151 SQHLNKGTPMKTQKRAALYTWYVRKQREILRQFNQTVQSSGNMTDKSSQD 200                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HSVHNF1_P1, comprising a polypeptide having a length "n",    	     183 ........FSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAY 224                                                          
						wherein n is at least about 10 amino acids in length,        	                 ||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     201 QLLFLFPEFSQQSHGPGQSDDACSEPTNKKMRRNRFKWGPASQQILYQAY 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     225 DRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWF 274                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise QF, having a structure as  	     251 DRQKNPSKEEREALVEECNRAECLQRGVSPSKAHGLGSNLVTEVRVYNWF 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						182-x to 183; and ending at any of amino acid numbers 183+   	     275 ANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGV 324                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HSVHNF1_P1,      	     301 ANRRKEEAFRQKLAMDAYSSNQTHSLNPLLSHGSPHHQPSSSPPNKLSGV 350                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     325 RYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDG 374                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence encoding for Q,   	     351 RYSQQGNNEITSSSTISHHGNSAMVTSQSVLQQVSPASLDPGHNLLSPDG 400                                                          
						corresponding to HSVHNF1_P1.                                 	                  .         .         .         .         .  
						                                                            	     375 KMQISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLN 424                                                          
						                                                            	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KM.ISVSGGGLPPVSTLTNIHSLSHHNPQQSQNLIMTPLSGVMAIAQSLN 449                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     425 TSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQP 474                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 TSQAQSVPVINSVAGSLAALQPVQFSQQLHSPHQQPLMQQSPGSHMAQQP 499                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     475 FMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSS 524                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     500 FMAAVTQLQNSHMYAHKQEPPQYSHTSRFPSAMVVTDTSSISTLTNMSSS 549                                                          
						                                                            	                                                             
						                                                            	     525 KQCPLQAW                                           532                                                          
						                                                            	         ||||||||                                            
						                                                            	     550 KQCPLQAW                                           557                                                          

19110	HMR136_HSY17108_3_tr0_r1_1_gPRT		Comparison report between HSY17108_P3 and RHB1_HUMANunique   	Sequence name: RHB1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HSY17108_P3, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19110 x RHB1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MDRSSLLQLIQEQ	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 13 of HSY17108_P3, a second 	                                                            
						ISSKRSSSFKRAIANGQRALPRDGPLDEPGLGVYKRFVRYVAYEILPCEVDRRWYFYRHR 	                     Quality: 1929.00                      Escore:       0                                               
						SCPPPVFMASVTLAQIIVFLCYGARLNKWVLQTYHPEYMKSPLVYHPGHRARAWRFLTYM 	             Matching length:     196                Total length:     196                                               
						FMHVGLEQLGFNALLQLMIGVPLEMVHGLLRISLLYLAGVLAGSLTVSITDMRAPVVGGS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GGVYALCSAHLANVVM                                             	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 133 - 328 of RHB1_HUMAN, which  	                                                            
						also corresponds to amino acids 14 - 209 of HSY17108_P3, and 	Alignment:                                                   
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      14 ISSKRSSSFKRAIANGQRALPRDGPLDEPGLGVYKRFVRYVAYEILPCEV 63                                                           
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	     133 ISSKRSSSFKRAIANGQRALPRDGPLDEPGLGVYKRFVRYVAYEILPCEV 182                                                          
						VTGLPGGGRGEGPQVSLTTSRLHTPIELGWDEMSLQVAEDGAGLGVQ corresponding	                  .         .         .         .         .  
						to amino acids 210 - 256 of HSY17108_P3, wherein said first  	      64 DRRWYFYRHRSCPPPVFMASVTLAQIIVFLCYGARLNKWVLQTYHPEYMK 113                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     183 DRRWYFYRHRSCPPPVFMASVTLAQIIVFLCYGARLNKWVLQTYHPEYMK 232                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						HSY17108_P3, comprising a polypeptide being at least 70%,    	     114 SPLVYHPGHRARAWRFLTYMFMHVGLEQLGFNALLQLMIGVPLEMVHGLL 163                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     233 SPLVYHPGHRARAWRFLTYMFMHVGLEQLGFNALLQLMIGVPLEMVHGLL 282                                                          
						least about 95% homologous to the sequence MDRSSLLQLIQEQ of  	                  .         .         .         .            
						HSY17108_P3.3.An isolated polypeptide encoding for a tail of 	     164 RISLLYLAGVLAGSLTVSITDMRAPVVGGSGGVYALCSAHLANVVM     209                                                          
						HSY17108_P3, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||      
						optionally at least about 80%, preferably at least about 85%,	     283 RISLLYLAGVLAGSLTVSITDMRAPVVGGSGGVYALCSAHLANVVM     328                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						VTGLPGGGRGEGPQVSLTTSRLHTPIELGWDEMSLQVAEDGAGLGVQ in           	                                                            
						HSY17108_P3.                                                 	                                                            

19108	HMR136_HSY17108_5_tr0_r1_1_gPRT		Comparison report between HSY17108_P5 and RHB1_HUMANunique   	Sequence name: RHB1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion, featuring a skipped exon and a followed by a      	Sequence documentation:                                      
						unique tail.1.An isolated chimeric polypeptide encoding for  	                                                            
						HSY17108_P5, comprising a first amino acid sequence being at 	Alignment of: 19108 x RHB1_HUMAN   ..                        
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence MDRSSLLQLIQE 	                                                            
						corresponding to amino acids 1 - 12 of HSY17108_P5, a second 	                     Quality: 2195.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     243                Total length:     255                                               
						QQLDPENTGFIGADTFTGLVHSHELPLDPAKLDMLVALAQSNEQGQVCYQELVDL      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 78 - 132 of RHB1_HUMAN, which   	    Total Percent Similarity:   95.29      Total Percent Identity:   95.29                                               
						also corresponds to amino acids 13 - 67 of HSY17108_P5, a    	                        Gaps:       2                        
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence VSAT corresponding to amino  	      13 QQLDPENTGFIGADTFTGLVHSHELPLDPAKLDMLVALAQSNEQGQVCYQ 62                                                           
						acids 68 - 71 of HSY17108_P5, a fourth amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISSKRSSSFKRAIANGQRALPRDGPLDEPGLGVYKRFVRYVAYEILPCEVDRRWYFYRHR 	      78 QQLDPENTGFIGADTFTGLVHSHELPLDPAKLDMLVALAQSNEQGQVCYQ 127                                                          
						SCPPPVFMASVTLAQIIVFLCYGARLNKWVLQTYHPEYMKSPLVYHPGHRARAWRFLTYM 	                  .         .         .         .         .  
						FMHVGLEQLGFNALLQLMIGVPLEMVHGLLRISLLYLAGVLA                   	      63 ELVDLVSATISSKRSSSFKRAIANGQRALPRDGPLDEPGLGVYKRFVRYV 112                                                          
						being at least 90 % homologous to corresponding to amino     	         |||||    |||||||||||||||||||||||||||||||||||||||||  
						acids 133 - 294 of RHB1_HUMAN, which also corresponds to     	     128 ELVDL....ISSKRSSSFKRAIANGQRALPRDGPLDEPGLGVYKRFVRYV 173                                                          
						amino acids 72 - 233 of HSY17108_P5, a fifth amino acid      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     113 AYEILPCEVDRRWYFYRHRSCPPPVFMASVTLAQIIVFLCYGARLNKWVL 162                                                          
						DMRAPVVGGSGGVYALCSAHLANVVM corresponding to amino acids 303 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						328 of RHB1_HUMAN, which also corresponds to amino acids 234 	     174 AYEILPCEVDRRWYFYRHRSCPPPVFMASVTLAQIIVFLCYGARLNKWVL 223                                                          
						- 259 of HSY17108_P5, and a sixth amino acid sequence being  	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     163 QTYHPEYMKSPLVYHPGHRARAWRFLTYMFMHVGLEQLGFNALLQLMIGV 212                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 95% homologous to a polypeptide having the sequence    	     224 QTYHPEYMKSPLVYHPGHRARAWRFLTYMFMHVGLEQLGFNALLQLMIGV 273                                                          
						VTGLPGGGRGEGPQVSLTTSRLHTPIELGWDEMSLQVAEDGAGLGVQ corresponding	                  .         .         .         .         .  
						to amino acids 260 - 306 of HSY17108_P5, wherein said first  	     213 PLEMVHGLLRISLLYLAGVLA........DMRAPVVGGSGGVYALCSAHL 254                                                          
						amino acid sequence, second amino acid sequence, third amino 	         |||||||||||||||||||||        |||||||||||||||||||||  
						acid sequence, fourth amino acid sequence, fifth amino acid  	     274 PLEMVHGLLRISLLYLAGVLAGSLTVSITDMRAPVVGGSGGVYALCSAHL 323                                                          
						sequence and sixth amino acid sequence are contiguous and in 	                                                             
						a sequential order.2.An isolated polypeptide encoding for a  	     255 ANVVM                                              259                                                          
						head of HSY17108_P5, comprising a polypeptide being at least 	         |||||                                               
						70%, optionally at least about 80%, preferably at least about	     324 ANVVM                                              328                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence MDRSSLLQLIQE of	                                                            
						HSY17108_P5.3.An isolated polypeptide encoding for an edge   	                                                            
						portion of HSY17108_P5, comprising an amino acid sequence    	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for VSAT, corresponding to HSY17108_P5.4.An isolated	                                                            
						chimeric polypeptide encoding for an edge portion of         	                                                            
						HSY17108_P5, comprising a polypeptide having a length "n",   	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise AD, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						233-x to 234; and ending at any of amino acid numbers 234+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                                                            
						polypeptide encoding for a tail of HSY17108_P5, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence                                              	                                                            
						VTGLPGGGRGEGPQVSLTTSRLHTPIELGWDEMSLQVAEDGAGLGVQ in           	                                                            
						HSY17108_P5.                                                 	                                                            

21846	HMR136_HUM2C18_4_tr0_r1_1_gPRT		Comparison report between HUM2C18_P4 and CPCI_HUMANpartial   	Sequence name: CPCI_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUM2C18_P4, comprising a first amino	Sequence documentation:                                      
						MDPAVALVLCLSCLFLLSLWRQSSGRGRLPSGPTPLPIIGNILQLDVKDMSKSLTNFSKV 	                                                            
						YGPVFTVYFGLKPIVVLHGYEAVKEALIDHGEEFSGRGSFPVAEKVNKGLGILFSNGKRW 	Alignment of: 21846 x CPCI_HUMAN   ..                        
						KEIRRFCLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTN                     	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 160 of CPCI_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 160 of HUM2C18_P4, and a second amino acid	                     Quality: 1556.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     160                Total length:     160                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence GHDHNNIPDFCAAQ corresponding to amino    	                        Gaps:       0                        
						acids 161 - 174 of HUM2C18_P4, wherein said first amino acid 	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of HUM2C18_P4, comprising a polypeptide being at least  	       1 MDPAVALVLCLSCLFLLSLWRQSSGRGRLPSGPTPLPIIGNILQLDVKDM 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       1 MDPAVALVLCLSCLFLLSLWRQSSGRGRLPSGPTPLPIIGNILQLDVKDM 50                                                           
						at least about 95% homologous to the sequence GHDHNNIPDFCAAQ 	                  .         .         .         .         .  
						in HUM2C18_P4.                                               	      51 SKSLTNFSKVYGPVFTVYFGLKPIVVLHGYEAVKEALIDHGEEFSGRGSF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 SKSLTNFSKVYGPVFTVYFGLKPIVVLHGYEAVKEALIDHGEEFSGRGSF 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVAEKVNKGLGILFSNGKRWKEIRRFCLMTLRNFGMGKRSIEDRVQEEAR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 PVAEKVNKGLGILFSNGKRWKEIRRFCLMTLRNFGMGKRSIEDRVQEEAR 150                                                          
						                                                            	                  .                                          
						                                                            	     151 CLVEELRKTN                                         160                                                          
						                                                            	         ||||||||||                                          
						                                                            	     151 CLVEELRKTN                                         160                                                          

22068	HMR136_HUM33DPTP_1_tr0_r1_1_gPRT		Comparison report between HUM33DPTP_P1 and PHOS_HUMANunique  	Sequence name: PHOS_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUM33DPTP_P1, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 22068 x PHOS_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						KKANNSQEPSPQLASSVASTRSMPESLDSPTSGRPGVTTHSTRTPGTEIQTVSPQIISNP 	Alignment segment 1/1:                                       
						VPK                                                          	                                                            
						having the sequence corresponding to amino acids 1 - 63 of   	                     Quality: 2414.00                      Escore:       0                                               
						HUM33DPTP_P1, and a second amino acid sequence being at least	             Matching length:     246                Total length:     246                                               
						MEEAKSQSLEEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEILRQMSSPQSRN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQDMHQKLSFGPRYGFVYELETG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KQFLETIEKELKITTIVVHIYEDGIKGCDALNSSLTCLAAEYPIVKFCKIKASNTGAGDR 	                        Gaps:       0                        
						FSLDVLPTLLIYKGGELISNFISVAEQFAEEFFAGDVESFLNEYGLLPEREVHVLEHTKI 	                                                            
						EEEDVE                                                       	Alignment:                                                   
						90 % homologous to corresponding to amino acids 1 - 246 of   	                  .         .         .         .         .  
						PHOS_HUMAN, which also corresponds to amino acids 64 - 309 of	      64 MEEAKSQSLEEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEIL 113                                                          
						HUM33DPTP_P1, wherein said first amino acid sequence and     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	       1 MEEAKSQSLEEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEIL 50                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						HUM33DPTP_P1, comprising a polypeptide being at least 70%,   	     114 RQMSSPQSRNGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQD 163                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 RQMSSPQSRNGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQD 100                                                          
						KKANNSQEPSPQLASSVASTRSMPESLDSPTSGRPGVTTHSTRTPGTEIQTVSPQIISNP 	                  .         .         .         .         .  
						VPK                                                          	     164 MHQKLSFGPRYGFVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDA 213                                                          
						least about 95% homologous to the sequence of HUM33DPTP_P1.  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MHQKLSFGPRYGFVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 LNSSLTCLAAEYPIVKFCKIKASNTGAGDRFSLDVLPTLLIYKGGELISN 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LNSSLTCLAAEYPIVKFCKIKASNTGAGDRFSLDVLPTLLIYKGGELISN 200                                                          
						                                                            	                  .         .         .         .            
						                                                            	     264 FISVAEQFAEEFFAGDVESFLNEYGLLPEREVHVLEHTKIEEEDVE     309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     201 FISVAEQFAEEFFAGDVESFLNEYGLLPEREVHVLEHTKIEEEDVE     246                                                          

						Comparison report between HUM33DPTP_P1 and Q9UP22unique head 	Sequence name: Q9UP22                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HUM33DPTP_P1, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 22068 x Q9UP22   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						KKANNSQEPSPQLASSVASTRSMPESLDSPTSGRPGVTTHSTRTPGTEIQTVSPQIISNP 	Alignment segment 1/1:                                       
						VPKMEEAKSQSLEEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEILRQ      	                                                            
						having the sequence corresponding to amino acids 1 - 115 of  	                     Quality: 1898.00                      Escore:       0                                               
						HUM33DPTP_P1, and a second amino acid sequence being at least	             Matching length:     194                Total length:     194                                               
						MSSPQSRNGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQDMHQKLSFGPRYG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDALNSSLTCLAAEYPIVKFCKIKA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SNTGAGDRFSLDVLPTLLIYKGGELISNFISVAEQFAEEFFAGDVESFLNEYGLLPEREV 	                        Gaps:       0                        
						HVLEHTKIEEEDVE                                               	                                                            
						90 % homologous to corresponding to amino acids 1 - 194 of   	Alignment:                                                   
						Q9UP22, which also corresponds to amino acids 116 - 309 of   	                  .         .         .         .         .  
						HUM33DPTP_P1, wherein said first amino acid sequence and     	     116 MSSPQSRNGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQDMH 165                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       1 MSSPQSRNGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQDMH 50                                                           
						HUM33DPTP_P1, comprising a polypeptide being at least 70%,   	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     166 QKLSFGPRYGFVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDALN 215                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKANNSQEPSPQLASSVASTRSMPESLDSPTSGRPGVTTHSTRTPGTEIQTVSPQIISNP 	      51 QKLSFGPRYGFVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDALN 100                                                          
						VPKMEEAKSQSLEEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEILRQ      	                  .         .         .         .         .  
						least about 95% homologous to the sequence of HUM33DPTP_P1.  	     216 SSLTCLAAEYPIVKFCKIKASNTGAGDRFSLDVLPTLLIYKGGELISNFI 265                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSLTCLAAEYPIVKFCKIKASNTGAGDRFSLDVLPTLLIYKGGELISNFI 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	     266 SVAEQFAEEFFAGDVESFLNEYGLLPEREVHVLEHTKIEEEDVE       309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     151 SVAEQFAEEFFAGDVESFLNEYGLLPEREVHVLEHTKIEEEDVE       194                                                          

						Comparison report between HUM33DPTP_P1 and Q9UP23unique head 	Sequence name: Q9UP23                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						HUM33DPTP_P1, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22068 x Q9UP23   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						KKANNSQEPSPQLASSVASTRS corresponding to amino acids 1 - 22 of	                                                            
						HUM33DPTP_P1, a second amino acid sequence being at least 90 	                     Quality: 2676.00                      Escore:       0                                               
						% homologous to MPESLDSPTSGRPGVTTHSTRTPGTEIQT corresponding  	             Matching length:     283                Total length:     287                                               
						to amino acids 1 - 29 of Q9UP23, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 23 - 51 of HUM33DPTP_P1, a third amino acid      	    Total Percent Similarity:   98.61      Total Percent Identity:   98.61                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       1                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence VSPQ corresponding to amino acids 52 - 55	                  .         .         .         .         .  
						of HUM33DPTP_P1, and a fourth amino acid sequence being at   	      23 MPESLDSPTSGRPGVTTHSTRTPGTEIQTVSPQIISNPVPKMEEAKSQSL 72                                                           
						IISNPVPKMEEAKSQSLEEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEILRQ 	         |||||||||||||||||||||||||||||    |||||||||||||||||  
						MSSPQSRNGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQDMHQKLSFGPRYG 	       1 MPESLDSPTSGRPGVTTHSTRTPGTEIQT....IISNPVPKMEEAKSQSL 46                                                           
						FVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDALNSSLTCLAAEYPIVKFCKIKA 	                  .         .         .         .         .  
						SNTGAGDRFSLDVLPTLLIYKGGELISNFISVAEQFAEEFFAGDVESFLNEYGLLPEREV 	      73 EEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEILRQMSSPQSR 122                                                          
						HVLEHTKIEEEDVE                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 30 -   	      47 EEDFEGQATHTGPKGVINDWRKFKLESQDSDSIPPSKKEILRQMSSPQSR 96                                                           
						283 of Q9UP23, which also corresponds to amino acids 56 - 309	                  .         .         .         .         .  
						of HUM33DPTP_P1, wherein said first amino acid sequence,     	     123 NGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQDMHQKLSFGP 172                                                          
						second amino acid sequence, third amino acid sequence and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence are contiguous and in a sequential	      97 NGKDSKERVSRKMSIQEYELIHKEKEDENCLRKYRRQCMQDMHQKLSFGP 146                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						HUM33DPTP_P1, comprising a polypeptide being at least 70%,   	     173 RYGFVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDALNSSLTCLA 222                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     147 RYGFVYELETGKQFLETIEKELKITTIVVHIYEDGIKGCDALNSSLTCLA 196                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						KKANNSQEPSPQLASSVASTRS of HUM33DPTP_P1.3.An isolated         	     223 AEYPIVKFCKIKASNTGAGDRFSLDVLPTLLIYKGGELISNFISVAEQFA 272                                                          
						polypeptide encoding for an edge portion of HUM33DPTP_P1,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     197 AEYPIVKFCKIKASNTGAGDRFSLDVLPTLLIYKGGELISNFISVAEQFA 246                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .                      
						more preferably at least about 90% and most preferably at    	     273 EEFFAGDVESFLNEYGLLPEREVHVLEHTKIEEEDVE              309                                                          
						least about 95% homologous to the sequence encoding for VSPQ,	         |||||||||||||||||||||||||||||||||||||               
						corresponding to HUM33DPTP_P1.                               	     247 EEFFAGDVESFLNEYGLLPEREVHVLEHTKIEEEDVE              283                                                          

1810	HMR136_HUM3HBDH_12_tr0_r1_1_gPRT		Comparison report between HUM3HBDH_P12 and BDH_HUMANpartial  	Sequence name: BDH_HUMAN                                     
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUM3HBDH_P12, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MLATRLSRPLSRLPGKTLSACDRENGA corresponding to amino acids 1 - 	Alignment of: 1810 x BDH_HUMAN   ..                          
						27 of BDH_HUMAN, which also corresponds to amino acids 1 - 27	                                                            
						of HUM3HBDH_P12, and a second amino acid sequence being at   	Alignment segment 1/1:                                       
						SDRLRTVQLNVCSSEEVEKVVEIVRSSLKDPEKGMWGLVNNAGISTFGEVEFTSLETYKQ 	                                                            
						VAEVNLWGTVRMTKSFLPLIRRAKGRVVNISSMLGRMANPARSPYCITKFGVEAFSDCLR 	                     Quality: 2523.00                      Escore:       0                                               
						YEMYPLGVKVSVVEPGNFIAATSLYSPESIQAIAKKMWEELPEVVRKDYGKKYFDEKIAK 	             Matching length:     267                Total length:     343                                               
						METYCSSGSTDTSPVIDAVTHALTATTPYTRYHPMDYYWWLRMQIMTHLPGAISDMIYIR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 104 -  	    Total Percent Similarity:   77.84      Total Percent Identity:   77.84                                               
						343 of BDH_HUMAN, which also corresponds to amino acids 28 - 	                        Gaps:       1                        
						267 of HUM3HBDH_P12, wherein said first amino acid sequence  	                                                            
						and second amino acid sequence are contiguous and in a       	Alignment:                                                   
						sequential order.2.An isolated chimeric polypeptide encoding 	                  .         .         .         .         .  
						for an edge portion of HUM3HBDH_P12, comprising a polypeptide	       1 MLATRLSRPLSRLPGKTLSACDRENGA....................... 27                                                           
						having a length "n", wherein n is at least about 10 amino    	         |||||||||||||||||||||||||||                         
						acids in length, optionally at least about 20 amino acids in 	       1 MLATRLSRPLSRLPGKTLSACDRENGARRPLLLGSTSFIPIGRRTYASAA 50                                                           
						length, preferably at least about 30 amino acids in length,  	                  .         .         .         .         .  
						more preferably at least about 40 amino acids in length and  	      27 .................................................. 27                                                           
						most preferably at least about 50 amino acids in length,     	                                                            
						wherein at least two amino acids comprise AS, having a       	      51 EPVGSKAVLVTGCDSGFGFSLAKHLHSKGFLVFAGCLMKDKGHDGVKELD 100                                                          
						structure as follows: a sequence starting from any of amino  	                  .         .         .         .         .  
						acid numbers 27-x to 28; and ending at any of amino acid     	      28 ...SDRLRTVQLNVCSSEEVEKVVEIVRSSLKDPEKGMWGLVNNAGISTF 74                                                           
						numbers 28+ ((n-2) - x), in which x varies from 0 to n-2.    	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SLNSDRLRTVQLNVCSSEEVEKVVEIVRSSLKDPEKGMWGLVNNAGISTF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      75 GEVEFTSLETYKQVAEVNLWGTVRMTKSFLPLIRRAKGRVVNISSMLGRM 124                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GEVEFTSLETYKQVAEVNLWGTVRMTKSFLPLIRRAKGRVVNISSMLGRM 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     125 ANPARSPYCITKFGVEAFSDCLRYEMYPLGVKVSVVEPGNFIAATSLYSP 174                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ANPARSPYCITKFGVEAFSDCLRYEMYPLGVKVSVVEPGNFIAATSLYSP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     175 ESIQAIAKKMWEELPEVVRKDYGKKYFDEKIAKMETYCSSGSTDTSPVID 224                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 ESIQAIAKKMWEELPEVVRKDYGKKYFDEKIAKMETYCSSGSTDTSPVID 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     225 AVTHALTATTPYTRYHPMDYYWWLRMQIMTHLPGAISDMIYIR        267                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     301 AVTHALTATTPYTRYHPMDYYWWLRMQIMTHLPGAISDMIYIR        343                                                          

2061	HMR136_HUM60RO_10_tr0_r1_1_gPRT		Comparison report between HUM60RO_P10 and RO60_HUMANpartial  	Sequence name: RO60_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUM60RO_P10, comprising a first     	                                                            
						MVPCPVTTDMTLQQVLMAMSQIPAGGTDCSLPMIWAQKTNTPADVFIVFTDNETFAGGVH 	Alignment of: 2061 x RO60_HUMAN   ..                         
						PAIALREYRKKMDIPAKLIVCGMTSNGFTIADPDDRGMLDMCGFDTGALDVIRNFTLDMI 	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 419 - 538 of RO60_HUMAN, which  	                                                            
						also corresponds to amino acids 1 - 120 of HUM60RO_P10.      	                     Quality: 1184.00                      Escore:       0                                               
						                                                            	             Matching length:     120                Total length:     120                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVPCPVTTDMTLQQVLMAMSQIPAGGTDCSLPMIWAQKTNTPADVFIVFT 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     419 MVPCPVTTDMTLQQVLMAMSQIPAGGTDCSLPMIWAQKTNTPADVFIVFT 468                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DNETFAGGVHPAIALREYRKKMDIPAKLIVCGMTSNGFTIADPDDRGMLD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     469 DNETFAGGVHPAIALREYRKKMDIPAKLIVCGMTSNGFTIADPDDRGMLD 518                                                          
						                                                            	                  .         .                                
						                                                            	     101 MCGFDTGALDVIRNFTLDMI                               120                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     519 MCGFDTGALDVIRNFTLDMI                               538                                                          

23217	HMR136_HUM9G8SF_16_tr0_r1_1_gPRT		Comparison report between HUM9G8SF_P16 and SFR7_HUMANpartial 	Sequence name: SFR7_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P16, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23217 x SFR7_HUMAN   ..                        
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of SFR7_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 129 of HUM9G8SF_P16, and 	                     Quality: 1295.00                      Escore:       0                                               
						a second amino acid sequence being at least 70%, optionally  	             Matching length:     129                Total length:     129                                               
						at least 80%, preferably at least 85%, more preferably at    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90% and most preferably at least 95% homologous to a   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P16, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P16 and AAN87842partial   	Sequence name: AAN87842                                      
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P16, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23217 x AAN87842   ..                          
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of AAN87842, which also 	                                                            
						corresponds to amino acids 1 - 129 of HUM9G8SF_P16, and a    	                     Quality: 1295.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     129                Total length:     129                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P16, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P16 and AAP35391partial   	Sequence name: AAP35391                                      
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P16, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23217 x AAP35391   ..                          
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of AAP35391, which also 	                                                            
						corresponds to amino acids 1 - 129 of HUM9G8SF_P16, and a    	                     Quality: 1295.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     129                Total length:     129                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P16, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P16 and Q8NB80partial WT  	Sequence name: Q8NB80                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUM9G8SF_P16, comprising a first amino acid sequence being at	                                                            
						least 90 % homologous to                                     	Alignment of: 23217 x Q8NB80   ..                            
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPP corresponding	                                                            
						to amino acids 1 - 47 of Q8NB80, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 47 of HUM9G8SF_P16, a bridging amino acid G  	                                                            
						corresponding to amino acid 48 of HUM9G8SF_P16, a second     	                     Quality: 1292.00                      Escore:       0                                               
						FAFVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYE 	             Matching length:     131                Total length:     131                                               
						CGEKGHYAYDCHRYSRRRRSR                                        	 Matching Percent Similarity:   99.24   Matching Percent Identity:   98.47                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   99.24      Total Percent Identity:   98.47                                               
						corresponding to amino acids 49 - 129 of Q8NB80, which also  	                        Gaps:       0                        
						corresponds to amino acids 49 - 129 of HUM9G8SF_P16, and a   	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						polypeptide having the sequence YLF corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||| ||  
						acids 130 - 132 of HUM9G8SF_P16, wherein said first amino    	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPRFA 50                                                           
						acid sequence, bridging amino acid, second amino acid        	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUM9G8SF_P16, comprising a polypeptide being at least	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .                      
						85%, more preferably at least about 90% and most preferably  	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSRYL                    131                                                          
						at least about 95% homologous to the sequence YLF in         	         |||||||||||||||||||||||||||||:|                     
						HUM9G8SF_P16.                                                	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSRFL                    131                                                          

23215	HMR136_HUM9G8SF_21_tr0_r1_1_gPRT		Comparison report between HUM9G8SF_P21 and SFR7_HUMANpartial 	Sequence name: SFR7_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P21, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23215 x SFR7_HUMAN   ..                        
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of SFR7_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 129 of HUM9G8SF_P21, and 	                     Quality: 1295.00                      Escore:       0                                               
						a second amino acid sequence being at least 70%, optionally  	             Matching length:     129                Total length:     129                                               
						at least 80%, preferably at least 85%, more preferably at    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90% and most preferably at least 95% homologous to a   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P21, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P21 and AAN87842partial   	Sequence name: AAN87842                                      
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P21, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23215 x AAN87842   ..                          
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of AAN87842, which also 	                                                            
						corresponds to amino acids 1 - 129 of HUM9G8SF_P21, and a    	                     Quality: 1295.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     129                Total length:     129                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P21, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P21 and AAP35391partial   	Sequence name: AAP35391                                      
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P21, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23215 x AAP35391   ..                          
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of AAP35391, which also 	                                                            
						corresponds to amino acids 1 - 129 of HUM9G8SF_P21, and a    	                     Quality: 1295.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     129                Total length:     129                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P21, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P21 and Q8NB80partial WT  	Sequence name: Q8NB80                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUM9G8SF_P21, comprising a first amino acid sequence being at	                                                            
						least 90 % homologous to                                     	Alignment of: 23215 x Q8NB80   ..                            
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPP corresponding	                                                            
						to amino acids 1 - 47 of Q8NB80, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 47 of HUM9G8SF_P21, a bridging amino acid G  	                                                            
						corresponding to amino acid 48 of HUM9G8SF_P21, a second     	                     Quality: 1292.00                      Escore:       0                                               
						FAFVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYE 	             Matching length:     131                Total length:     131                                               
						CGEKGHYAYDCHRYSRRRRSR                                        	 Matching Percent Similarity:   99.24   Matching Percent Identity:   98.47                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   99.24      Total Percent Identity:   98.47                                               
						corresponding to amino acids 49 - 129 of Q8NB80, which also  	                        Gaps:       0                        
						corresponds to amino acids 49 - 129 of HUM9G8SF_P21, and a   	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						polypeptide having the sequence YLF corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||| ||  
						acids 130 - 132 of HUM9G8SF_P21, wherein said first amino    	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPRFA 50                                                           
						acid sequence, bridging amino acid, second amino acid        	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUM9G8SF_P21, comprising a polypeptide being at least	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .                      
						85%, more preferably at least about 90% and most preferably  	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSRYL                    131                                                          
						at least about 95% homologous to the sequence YLF in         	         |||||||||||||||||||||||||||||:|                     
						HUM9G8SF_P21.                                                	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSRFL                    131                                                          

23213	HMR136_HUM9G8SF_26_tr0_r1_1_gPRT		Comparison report between HUM9G8SF_P26 and SFR7_HUMANpartial 	Sequence name: SFR7_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P26, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23213 x SFR7_HUMAN   ..                        
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of SFR7_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 129 of HUM9G8SF_P26, and 	                     Quality: 1295.00                      Escore:       0                                               
						a second amino acid sequence being at least 70%, optionally  	             Matching length:     129                Total length:     129                                               
						at least 80%, preferably at least 85%, more preferably at    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90% and most preferably at least 95% homologous to a   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P26, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P26 and AAN87842partial   	Sequence name: AAN87842                                      
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P26, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23213 x AAN87842   ..                          
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of AAN87842, which also 	                                                            
						corresponds to amino acids 1 - 129 of HUM9G8SF_P26, and a    	                     Quality: 1295.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     129                Total length:     129                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P26, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P26 and AAP35391partial   	Sequence name: AAP35391                                      
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUM9G8SF_P26, comprising a 	Sequence documentation:                                      
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDA 	                                                            
						EDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYECGEKGHYAYDCH 	Alignment of: 23213 x AAP35391   ..                          
						RYSRRRRSR                                                    	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 129 of AAP35391, which also 	                                                            
						corresponds to amino acids 1 - 129 of HUM9G8SF_P26, and a    	                     Quality: 1295.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     129                Total length:     129                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence YLF corresponding to amino   	                        Gaps:       0                        
						acids 130 - 132 of HUM9G8SF_P26, wherein said first amino    	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.                                   	                  .         .         .         .         .  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSR                      129                                                          

						Comparison report between HUM9G8SF_P26 and Q8NB80partial WT  	Sequence name: Q8NB80                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUM9G8SF_P26, comprising a first amino acid sequence being at	                                                            
						least 90 % homologous to                                     	Alignment of: 23213 x Q8NB80   ..                            
						MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPP corresponding	                                                            
						to amino acids 1 - 47 of Q8NB80, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 47 of HUM9G8SF_P26, a bridging amino acid G  	                                                            
						corresponding to amino acid 48 of HUM9G8SF_P26, a second     	                     Quality: 1292.00                      Escore:       0                                               
						FAFVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPFDPNDRCYE 	             Matching length:     131                Total length:     131                                               
						CGEKGHYAYDCHRYSRRRRSR                                        	 Matching Percent Similarity:   99.24   Matching Percent Identity:   98.47                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   99.24      Total Percent Identity:   98.47                                               
						corresponding to amino acids 49 - 129 of Q8NB80, which also  	                        Gaps:       0                        
						corresponds to amino acids 49 - 129 of HUM9G8SF_P26, and a   	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFA 50                                                           
						polypeptide having the sequence YLF corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||| ||  
						acids 130 - 132 of HUM9G8SF_P26, wherein said first amino    	       1 MSRYGRYGGETKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPRFA 50                                                           
						acid sequence, bridging amino acid, second amino acid        	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUM9G8SF_P26, comprising a polypeptide being at least	      51 FVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRPF 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .                      
						85%, more preferably at least about 90% and most preferably  	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSRYL                    131                                                          
						at least about 95% homologous to the sequence YLF in         	         |||||||||||||||||||||||||||||:|                     
						HUM9G8SF_P26.                                                	     101 DPNDRCYECGEKGHYAYDCHRYSRRRRSRFL                    131                                                          

24061	HMR136_HUMA2XICOL_6_tr0_r1_1_gPRT		Comparison report between HUMA2XICOL_P6 and CA2B_HUMANunique 	Sequence name: CA2B_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMA2XICOL_P6, comprising a first   	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 24061 x CA2B_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence LPFRTHSLCVFQ corresponding to amino acids	Alignment segment 1/1:                                       
						1 - 12 of HUMA2XICOL_P6, and a second amino acid sequence    	                                                            
						GDPGAIGAPGKTGPVGPAGPAGKPGPDGLRGLPGSVGQQGRPGATGQAGPPGPVGPPGLP 	                     Quality: 3909.00                      Escore:       0                                               
						GLRGDAGAKGEKGHPGLIGLIGPPGEQGEKGDRGLPGPQGSPGQKGEMGIPGASGPIGPG 	             Matching length:     399                Total length:     399                                               
						GPPGLPGPAGPKGAKGATGPGGPKGEKGVQGPPGHPGPPGEVIQPLPIQMPKKTRRSVDG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.75                                               
						SRLMQEDEAIPTGGAPGSPGGLEEIFGSLDSLREEIEQMRRPTGTQDSPARTCQDLKLCH 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.75                                               
						PELPDGEYWVDPNQGCARDAFRVFCNFTAGGETCVTPRDDVTQFSYVDSEGSPVGVVQLT 	                        Gaps:       0                        
						FLRLLSVSAHQDVSYPCSGAARDGPLRLRGANEDELSPETSPYVKEFRDGCQTQQGRTVL 	                                                            
						EVRTPVLEQLPVLDASFSDLGAPPRRGGVLLGPVCFMG                       	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 1339 - 1736 of CA2B_HUMAN, which also corresponds to   	      12 QGDPGAIGAPGKTGPVGPAGPAGKPGPDGLRGLPGSVGQQGRPGATGQAG 61                                                           
						amino acids 13 - 410 of HUMA2XICOL_P6, wherein said first    	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	    1338 KGDPGAIGAPGKTGPVGPAGPAGKPGPDGLRGLPGSVGQQGRPGATGQAG 1387                                                         
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of HUMA2XICOL_P6, comprising 	      62 PPGPVGPPGLPGLRGDAGAKGEKGHPGLIGLIGPPGEQGEKGDRGLPGPQ 111                                                          
						a polypeptide being at least 70%, optionally at least about  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	    1388 PPGPVGPPGLPGLRGDAGAKGEKGHPGLIGLIGPPGEQGEKGDRGLPGPQ 1437                                                         
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence LPFRTHSLCVFQ of HUMA2XICOL_P6.               	     112 GSPGQKGEMGIPGASGPIGPGGPPGLPGPAGPKGAKGATGPGGPKGEKGV 161                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1438 GSPGQKGEMGIPGASGPIGPGGPPGLPGPAGPKGAKGATGPGGPKGEKGV 1487                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     162 QGPPGHPGPPGEVIQPLPIQMPKKTRRSVDGSRLMQEDEAIPTGGAPGSP 211                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1488 QGPPGHPGPPGEVIQPLPIQMPKKTRRSVDGSRLMQEDEAIPTGGAPGSP 1537                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     212 GGLEEIFGSLDSLREEIEQMRRPTGTQDSPARTCQDLKLCHPELPDGEYW 261                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1538 GGLEEIFGSLDSLREEIEQMRRPTGTQDSPARTCQDLKLCHPELPDGEYW 1587                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     262 VDPNQGCARDAFRVFCNFTAGGETCVTPRDDVTQFSYVDSEGSPVGVVQL 311                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1588 VDPNQGCARDAFRVFCNFTAGGETCVTPRDDVTQFSYVDSEGSPVGVVQL 1637                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     312 TFLRLLSVSAHQDVSYPCSGAARDGPLRLRGANEDELSPETSPYVKEFRD 361                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1638 TFLRLLSVSAHQDVSYPCSGAARDGPLRLRGANEDELSPETSPYVKEFRD 1687                                                         
						                                                            	                  .         .         .         .            
						                                                            	     362 GCQTQQGRTVLEVRTPVLEQLPVLDASFSDLGAPPRRGGVLLGPVCFMG  410                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	    1688 GCQTQQGRTVLEVRTPVLEQLPVLDASFSDLGAPPRRGGVLLGPVCFMG  1736                                                         

24198	HMR136_HUMA5NICRC_3_tr0_r1_1_gPRT		Comparison report between HUMA5NICRC_P3 and                  	Sequence name: ACH5_HUMAN                                    
						ACH5_HUMANpartial WT sequence (truncation of last part or    	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMA5NICRC_P3, comprising a	                                                            
						MKFGSWTYDGSQVDIILEDQDVDKRDFFDNGEWEIVSATGSKGNRTDSCCWYPYVTYSFV 	Alignment of: 24198 x ACH5_HUMAN   ..                        
						IKRLPLFYTLFLIIPCIGLSFLTVLVFYLPSNEGEKICLCTSVLVSLTVFLLVIEEIIPS 	                                                            
						SSKVIPLIGEYLVFTMIFVTLSIMVTVFAINIHHRSSSTHNAMAPLVRKIFLHTLPKLLC 	Alignment segment 1/1:                                       
						MRSHVDRYFTQKEETESGSGPKSSRNTLEAALDSIRYITRHIMKENDVREVVEDWKFIAQ 	                                                            
						VLDRMFLWTFLFVSIVGSLGLFVPVIYKWANILIPVHIGNANK                  	                     Quality: 2764.00                      Escore:       0                                               
						first amino acid sequence being at least 90 % homologous to  	             Matching length:     283                Total length:     283                                               
						corresponding to amino acids 186 - 468 of ACH5_HUMAN, which  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 283 of HUMA5NICRC_P3.    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKFGSWTYDGSQVDIILEDQDVDKRDFFDNGEWEIVSATGSKGNRTDSCC 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     186 MKFGSWTYDGSQVDIILEDQDVDKRDFFDNGEWEIVSATGSKGNRTDSCC 235                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WYPYVTYSFVIKRLPLFYTLFLIIPCIGLSFLTVLVFYLPSNEGEKICLC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     236 WYPYVTYSFVIKRLPLFYTLFLIIPCIGLSFLTVLVFYLPSNEGEKICLC 285                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TSVLVSLTVFLLVIEEIIPSSSKVIPLIGEYLVFTMIFVTLSIMVTVFAI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     286 TSVLVSLTVFLLVIEEIIPSSSKVIPLIGEYLVFTMIFVTLSIMVTVFAI 335                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NIHHRSSSTHNAMAPLVRKIFLHTLPKLLCMRSHVDRYFTQKEETESGSG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     336 NIHHRSSSTHNAMAPLVRKIFLHTLPKLLCMRSHVDRYFTQKEETESGSG 385                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PKSSRNTLEAALDSIRYITRHIMKENDVREVVEDWKFIAQVLDRMFLWTF 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     386 PKSSRNTLEAALDSIRYITRHIMKENDVREVVEDWKFIAQVLDRMFLWTF 435                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 LFVSIVGSLGLFVPVIYKWANILIPVHIGNANK                  283                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     436 LFVSIVGSLGLFVPVIYKWANILIPVHIGNANK                  468                                                          

24726	HMR136_HUMAACA_1_tr0_r1_1_gPRT		Comparison report between HUMAACA_P1 and CRAA_HUMANpartial   	Sequence name: CRAA_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMAACA_P1, comprising a first amino	Sequence documentation:                                      
						MDVTIQHPWFKRTLGPFYPSRLFDQFFGEGLFEYDLLPFLSSTISPYYRQSLFRTVLDSG 	                                                            
						ISE                                                          	Alignment of: 24726 x CRAA_HUMAN   ..                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 63 of CRAA_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 63 of HUMAACA_P1, and a second amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  630.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      63                Total length:      63                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence LMTHVCFVRHQPHTGNPKSSPSRFDPTGTSSSSSSM     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 64 - 99 of HUMAACA_P1, wherein  	                        Gaps:       0                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						polypeptide encoding for a tail of HUMAACA_P1, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	       1 MDVTIQHPWFKRTLGPFYPSRLFDQFFGEGLFEYDLLPFLSSTISPYYRQ 50                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	       1 MDVTIQHPWFKRTLGPFYPSRLFDQFFGEGLFEYDLLPFLSSTISPYYRQ 50                                                           
						to the sequence LMTHVCFVRHQPHTGNPKSSPSRFDPTGTSSSSSSM in      	                  .                                          
						HUMAACA_P1.                                                  	      51 SLFRTVLDSGISE                                      63                                                           
						                                                            	         |||||||||||||                                       
						                                                            	      51 SLFRTVLDSGISE                                      63                                                           

24724	HMR136_HUMAACA_4_tr0_r1_1_gPRT		Comparison report between HUMAACA_P4 and CRAA_HUMANunique    	Sequence name: CRAA_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMAACA_P4, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 24724 x CRAA_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MSSACPRLAKLLASLLRCPAKAKRTGNGRPPPHPTTGLLSEPR corresponding to 	                                                            
						amino acids 1 - 43 of HUMAACA_P4, and a second amino acid    	                     Quality: 1082.00                      Escore:       0                                               
						VRSDRDKFVIFLDVKHFSPEDLTVKVQDDFVEIHGKHNERQDDHGYISREFHRRYRLPSN 	             Matching length:     110                Total length:     110                                               
						VDQSALSCSLSADGMLTFCGPKIQTGLDATHAERAIPVSREEKPTSAPSS           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 64 - 173 of CRAA_HUMAN, which also corresponds to	                        Gaps:       0                        
						amino acids 44 - 153 of HUMAACA_P4, wherein said first amino 	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of HUMAACA_P4, comprising a polypeptide being at  	      44 VRSDRDKFVIFLDVKHFSPEDLTVKVQDDFVEIHGKHNERQDDHGYISRE 93                                                           
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      64 VRSDRDKFVIFLDVKHFSPEDLTVKVQDDFVEIHGKHNERQDDHGYISRE 113                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						MSSACPRLAKLLASLLRCPAKAKRTGNGRPPPHPTTGLLSEPR of HUMAACA_P4.   	      94 FHRRYRLPSNVDQSALSCSLSADGMLTFCGPKIQTGLDATHAERAIPVSR 143                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     114 FHRRYRLPSNVDQSALSCSLSADGMLTFCGPKIQTGLDATHAERAIPVSR 163                                                          
						                                                            	                  .                                          
						                                                            	     144 EEKPTSAPSS                                         153                                                          
						                                                            	         ||||||||||                                          
						                                                            	     164 EEKPTSAPSS                                         173                                                          

25287	HMR136_HUMAAPA_8_tr0_r1_1_gPRT		Comparison report between HUMAAPA_P8 and PA1F_HUMAN_V1unique 	Sequence name: PA1F_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMAAPA_P8, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 25287 x PA1F_HUMAN_V1   ..                     
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MFLPLQ corresponding to amino acids 1 - 6	Alignment segment 1/1:                                       
						of HUMAAPA_P8, and a second amino acid sequence being at     	                                                            
						WRVDSAATSGYEIGNPPDYRGQSCMKRHGIPMSHVARQITKEDFATFDYILCMDESNLRD 	                     Quality: 1205.00                      Escore:       0                                               
						LNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDFETVYQQCVRCCRAFLEKAH  	             Matching length:     119                Total length:     119                                               
						least 90 % homologous to corresponding to amino acids 40 -   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						158 of PA1F_HUMAN_V1, which also corresponds to amino acids 7	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						- 125 of HUMAAPA_P8, wherein said first amino acid sequence  	                        Gaps:       0                        
						and second amino acid sequence are contiguous and in a       	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	Alignment:                                                   
						head of HUMAAPA_P8, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       7 WRVDSAATSGYEIGNPPDYRGQSCMKRHGIPMSHVARQITKEDFATFDYI 56                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence MFLPLQ of      	      40 WRVDSAATSGYEIGNPPDYRGQSCMKRHGIPMSHVARQITKEDFATFDYI 89                                                           
						HUMAAPA_P8.                                                  	                  .         .         .         .         .  
						                                                            	      57 LCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDF 106                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      90 LCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDF 139                                                          
						                                                            	                  .                                          
						                                                            	     107 ETVYQQCVRCCRAFLEKAH                                125                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     140 ETVYQQCVRCCRAFLEKAH                                158                                                          

3144	HMR136_HUMACTINBI_24_tr0_r1_1_gPRT		Comparison report between HUMACTINBI_P24 and Q9UEV9unique    	Sequence name: Q9UEV9                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMACTINBI_P24, comprising a first  	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 3144 x Q9UEV9   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence GQCVPLSRNAEGHNLSDVLNS corresponding to   	Alignment segment 1/1:                                       
						amino acids 1 - 21 of HUMACTINBI_P24, and a second amino acid	                                                            
						QESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPDKYAVRFIPHENGVH 	                     Quality: 2986.00                      Escore:       0                                               
						TIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTRAGPG 	             Matching length:     311                Total length:     311                                               
						TLSVTIEGPSKVKMDCQETPEGYKVMYTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQR 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.04                                               
						LVSPGSANETSSILVESVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLV 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.04                                               
						DCSKAGSNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEHIPGS 	                        Gaps:       0                        
						PFHVTVP                                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 2296 - 2602 of Q9UEV9, which also corresponds to 	                  .         .         .         .         .  
						amino acids 22 - 328 of HUMACTINBI_P24, wherein said first   	      18 VLNSQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPD 67                                                           
						amino acid sequence and second amino acid sequence are       	         |:: ||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	    2292 VMSLQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPD 2341                                                         
						polypeptide encoding for a head of HUMACTINBI_P24, comprising	                  .         .         .         .         .  
						a polypeptide being at least 70%, optionally at least about  	      68 KYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYG 117                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	    2342 KYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYG 2391                                                         
						to the sequence GQCVPLSRNAEGHNLSDVLNS of HUMACTINBI_P24.     	                  .         .         .         .         .  
						                                                            	     118 TGLEGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKVM 167                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2392 TGLEGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKVM 2441                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     168 YTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSSILVE 217                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2442 YTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSSILVE 2491                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     218 SVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKAG 267                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2492 SVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKAG 2541                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     268 SNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEH 317                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2542 SNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEH 2591                                                         
						                                                            	                  .                                          
						                                                            	     318 IPGSPFHVTVP                                        328                                                          
						                                                            	         |||||||||||                                         
						                                                            	    2592 IPGSPFHVTVP                                        2602                                                         

						Comparison report between HUMACTINBI_P24 and O75369unique    	Sequence name: O75369                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMACTINBI_P24, comprising a first  	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 3144 x O75369   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence GQCVPLSRNAEGHNLSDVLNS corresponding to   	Alignment segment 1/1:                                       
						amino acids 1 - 21 of HUMACTINBI_P24, and a second amino acid	                                                            
						QESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPDKYAVRFIPHENGVH 	                     Quality: 2986.00                      Escore:       0                                               
						TIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTRAGPG 	             Matching length:     311                Total length:     311                                               
						TLSVTIEGPSKVKMDCQETPEGYKVMYTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQR 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.04                                               
						LVSPGSANETSSILVESVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLV 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.04                                               
						DCSKAGSNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEHIPGS 	                        Gaps:       0                        
						PFHVTVP                                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 2296 - 2602 of O75369, which also corresponds to 	                  .         .         .         .         .  
						amino acids 22 - 328 of HUMACTINBI_P24, wherein said first   	      18 VLNSQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPD 67                                                           
						amino acid sequence and second amino acid sequence are       	         |:: ||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	    2292 VMSLQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPD 2341                                                         
						polypeptide encoding for a head of HUMACTINBI_P24, comprising	                  .         .         .         .         .  
						a polypeptide being at least 70%, optionally at least about  	      68 KYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYG 117                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	    2342 KYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYG 2391                                                         
						to the sequence GQCVPLSRNAEGHNLSDVLNS of HUMACTINBI_P24.     	                  .         .         .         .         .  
						                                                            	     118 TGLEGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKVM 167                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2392 TGLEGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKVM 2441                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     168 YTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSSILVE 217                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2442 YTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSSILVE 2491                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     218 SVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKAG 267                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2492 SVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKAG 2541                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     268 SNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEH 317                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2542 SNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEH 2591                                                         
						                                                            	                  .                                          
						                                                            	     318 IPGSPFHVTVP                                        328                                                          
						                                                            	         |||||||||||                                         
						                                                            	    2592 IPGSPFHVTVP                                        2602                                                         

						Comparison report between HUMACTINBI_P24 and Q9NRB5unique    	Sequence name: Q9NRB5                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMACTINBI_P24, comprising a first  	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 3144 x Q9NRB5   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence GQCVPLSRNAEGHNLSDVLNS corresponding to   	Alignment segment 1/1:                                       
						amino acids 1 - 21 of HUMACTINBI_P24, and a second amino acid	                                                            
						QESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPDKYAVRFIPHENGVH 	                     Quality: 2983.00                      Escore:       0                                               
						TIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTRAGPG 	             Matching length:     311                Total length:     311                                               
						TLSVTIEGPSKVKMDCQETPEGYKVMYTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQR 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.04                                               
						LVSPGSANETSSILVESVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLV 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.04                                               
						DCSKAGSNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEHIPGS 	                        Gaps:       0                        
						PFHVTVP                                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 366 - 672 of Q9NRB5, which also corresponds to   	                  .         .         .         .         .  
						amino acids 22 - 328 of HUMACTINBI_P24, wherein said first   	      18 VLNSQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPD 67                                                           
						amino acid sequence and second amino acid sequence are       	         |:: ||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     362 VVSLQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECHVSELEPD 411                                                          
						polypeptide encoding for a head of HUMACTINBI_P24, comprising	                  .         .         .         .         .  
						a polypeptide being at least 70%, optionally at least about  	      68 KYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYG 117                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     412 KYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYG 461                                                          
						to the sequence GQCVPLSRNAEGHNLSDVLNS of HUMACTINBI_P24.     	                  .         .         .         .         .  
						                                                            	     118 TGLEGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKVM 167                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     462 TGLEGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKVM 511                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     168 YTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSSILVE 217                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     512 YTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSSILVE 561                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     218 SVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKAG 267                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     562 SVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKAG 611                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     268 SNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEH 317                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     612 SNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWGEEH 661                                                          
						                                                            	                  .                                          
						                                                            	     318 IPGSPFHVTVP                                        328                                                          
						                                                            	         |||||||||||                                         
						                                                            	     662 IPGSPFHVTVP                                        672                                                          

						Comparison report between HUMACTINBI_P24 and Q13706unique    	Sequence name: Q13706                                        
						head followed by partial WT sequence a mismatch and a        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMACTINBI_P24, comprising a first amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 3144 x Q13706   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						GQCVPLSRNAEGHNLSDVLNSQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECH 	                                                            
						VSELEPDKYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYGTGL 	                     Quality: 1422.00                      Escore:       0                                               
						EGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKV               	             Matching length:     148                Total length:     148                                               
						having the sequence corresponding to amino acids 1 - 166 of  	 Matching Percent Similarity:   99.32   Matching Percent Identity:   99.32                                               
						HUMACTINBI_P24, a second amino acid sequence being at least  	    Total Percent Similarity:   99.32      Total Percent Identity:   99.32                                               
						90 % homologous to                                           	                        Gaps:       0                        
						MYTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETS corresponding 	                                                            
						to amino acids 1 - 46 of Q13706, which also corresponds to   	Alignment:                                                   
						amino acids 167 - 212 of HUMACTINBI_P24, a bridging amino    	                  .         .         .         .         .  
						acid S corresponding to amino acid 213 of HUMACTINBI_P24, a  	     167 MYTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSSILV 216                                                          
						ILVESVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKAGSNMLLI 	         |||||||||||||||||||||||||||||||||||||||||||||| |||  
						GVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWG                    	       1 MYTPMAPGNYLISVKYGGPNHIVGSPFKAKVTGQRLVSPGSANETSCILV 50                                                           
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 48 - 148 of Q13706, which also  	     217 ESVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKA 266                                                          
						corresponds to amino acids 214 - 314 of HUMACTINBI_P24, and a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 70%, optionally at 	      51 ESVTRSSTETCYSAIPKASSDASKVTSKGAGLSKAFVGQKSSFLVDCSKA 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .            
						90% and most preferably at least 95% homologous to a         	     267 GSNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWG   314                                                          
						polypeptide having the sequence EEHIPGSPFHVTVP corresponding 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						to amino acids 315 - 328 of HUMACTINBI_P24, wherein said     	     101 GSNMLLIGVHGPTTPCEEVSMKHVGNQQYNVTYVVKERGDYVLAVKWG   148                                                          
						first amino acid sequence, second amino acid sequence,       	                                                            
						bridging amino acid, third amino acid sequence and fourth    	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						HUMACTINBI_P24, comprising a polypeptide being at least 70%, 	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						GQCVPLSRNAEGHNLSDVLNSQESGLKVNQPASFAIRLNGAKGKIDAKVHSPSGAVEECH 	                                                            
						VSELEPDKYAVRFIPHENGVHTIDVKFNGSHVVGSPFKVRVGEPGQAGNPALVSAYGTGL 	                                                            
						EGGTTGIQSEFFINTTRAGPGTLSVTIEGPSKVKMDCQETPEGYKV               	                                                            
						least about 95% homologous to the sequence of                	                                                            
						HUMACTINBI_P24.3.An isolated polypeptide encoding for a tail 	                                                            
						of HUMACTINBI_P24, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence EEHIPGSPFHVTVP 	                                                            
						in HUMACTINBI_P24.                                           	                                                            

3146	HMR136_HUMACTINBI_34_tr0_r1_1_gPRT		Comparison report between HUMACTINBI_P34 and Q9UEV9partial   	Sequence name: Q9UEV9                                        
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUMACTINBI_P34, comprising 	Sequence documentation:                                      
						MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRLIALLEVLSQK 	                                                            
						RMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILH 	Alignment of: 3146 x Q9UEV9   ..                             
						YSISMPVWEDEGDDDAKKQTPKQRLLGWIQNKIPYLPITNFNQNWQDGKALGALVDSCAP 	                                                            
						GLCPDWESWDPQKPVDNAREAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKA 	Alignment segment 1/1:                                       
						KLKPGAPLKPKLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 	                                                            
						EEAQVTPDSDKNKTYSVEYLPKVTGLHKV                                	                     Quality: 3276.00                      Escore:       0                                               
						a first amino acid sequence being at least 90 % homologous to	             Matching length:     329                Total length:     329                                               
						corresponding to amino acids 1 - 329 of Q9UEV9, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 329 of HUMACTINBI_P34, and a  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence R corresponding to amino     	                  .         .         .         .         .  
						acids 330 - 330 of HUMACTINBI_P34, wherein said first amino  	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						acid sequence and second amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.                                   	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	                  .         .                                
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKV                      329                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKV                      329                                                          

						Comparison report between HUMACTINBI_P34 and O75369partial   	Sequence name: O75369                                        
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUMACTINBI_P34, comprising 	Sequence documentation:                                      
						MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRLIALLEVLSQK 	                                                            
						RMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILH 	Alignment of: 3146 x O75369   ..                             
						YSISMPVWEDEGDDDAKKQTPKQRLLGWIQNKIPYLPITNFNQNWQDGKALGALVDSCAP 	                                                            
						GLCPDWESWDPQKPVDNAREAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKA 	Alignment segment 1/1:                                       
						KLKPGAPLKPKLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 	                                                            
						EEAQVTPDSDKNKTYSVEYLPKVTGLHKV                                	                     Quality: 3276.00                      Escore:       0                                               
						a first amino acid sequence being at least 90 % homologous to	             Matching length:     329                Total length:     329                                               
						corresponding to amino acids 1 - 329 of O75369, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 329 of HUMACTINBI_P34, and a  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence R corresponding to amino     	                  .         .         .         .         .  
						acids 330 - 330 of HUMACTINBI_P34, wherein said first amino  	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						acid sequence and second amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.                                   	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	                  .         .                                
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKV                      329                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKV                      329                                                          

3142	HMR136_HUMACTINBI_4_tr0_r1_1_gPRT		Comparison report between HUMACTINBI_P4 and Q9UEV9partial WT 	Sequence name: Q9UEV9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMACTINBI_P4, comprising a first   	Sequence documentation:                                      
						MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRLIALLEVLSQK 	                                                            
						RMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILH 	Alignment of: 3142 x Q9UEV9   ..                             
						YSISMPVWEDEGDDDAKKQTPKQRLLGWIQNKIPYLPITNFNQNWQDGKALGALVDSCAP 	                                                            
						GLCPDWESWDPQKPVDNAREAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKA 	Alignment segment 1/1:                                       
						KLKPGAPLKPKLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 	                                                            
						EEAQVTPDSDKNKTYSVEYLPKVTGLHKVTVLFAGQHISKSPFEVSVDKAQGDASKVTAK 	                     Quality: 9388.00                      Escore:       0                                               
						GPGLEAVGNIANKPTYFDIYTAGAGVGDIGVEVEDPQGKNTVELLVEDKGNQVYRCVYKP 	             Matching length:     954                Total length:     954                                               
						MQPGPHVVKIFFAGDTIPKSPFVVQVGEACNPNACRASGRGLQPKGVRIRETTDFKVDTK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AAGSGELGVTMKGPKGLEELVKQKDFLDGVYAFEYYPSTPGRYSIAITWGGHHIPKSPFE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VQVGPEAGMQKVRAWGPGLHGGIVGRSADFVVESIGSEVGSLGFAIEGPSQAKIEYNDQN 	                        Gaps:       0                        
						DGSCDVKYWPKEPGEYAVHIMCDDEDIKDSPYMAFIHPATGGYNPDLVRAYGPGLEKSGC 	                                                            
						IVNNLAEFTVDPKDAGKAPLKIFAQDGEGQRIDIQMKNRMDGTYACSYTPVKAIKHTIAV 	Alignment:                                                   
						VWGGVNIPHSPYRVNIGQGSHPQKVKVFGPGVERSGLKANEPTHFTVDCTEAGEGDVSVG 	                  .         .         .         .         .  
						IKCDARVLSEDEEDVDFDIIHNANDTFTVKYVPPAAGRYTIKVLFASQEIPASPFRVKVD 	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						PSHDASKVKAEGPGLSKAGVENGKPTHFTVYTKGAGKAPLNVQFNSPLPGDAVKDLDIID 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NYDYSHTVKYTPTQQGNMQVLVTYGGDPIPKSPFTVGVAAPLDLSKIKLNGLEN       	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 1 - 954 of Q9UEV9, which also   	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						corresponds to amino acids 1 - 954 of HUMACTINBI_P4, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 70%, optionally at 	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEGPRSRPRRWSRGQACRVHHRYQRSWYWRSGLNGGRSVRGQNRVLRQW            	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						corresponding to amino acids 955 - 1003 of HUMACTINBI_P4,    	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of HUMACTINBI_P4,   	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						SEGPRSRPRRWSRGQACRVHHRYQRSWYWRSGLNGGRSVRGQNRVLRQW in         	                  .         .         .         .         .  
						HUMACTINBI_P4.                                               	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKVTVLFAGQHISKSPFEVSVDKA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKVTVLFAGQHISKSPFEVSVDKA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QGDASKVTAKGPGLEAVGNIANKPTYFDIYTAGAGVGDIGVEVEDPQGKN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QGDASKVTAKGPGLEAVGNIANKPTYFDIYTAGAGVGDIGVEVEDPQGKN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 TVELLVEDKGNQVYRCVYKPMQPGPHVVKIFFAGDTIPKSPFVVQVGEAC 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TVELLVEDKGNQVYRCVYKPMQPGPHVVKIFFAGDTIPKSPFVVQVGEAC 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NPNACRASGRGLQPKGVRIRETTDFKVDTKAAGSGELGVTMKGPKGLEEL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NPNACRASGRGLQPKGVRIRETTDFKVDTKAAGSGELGVTMKGPKGLEEL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VKQKDFLDGVYAFEYYPSTPGRYSIAITWGGHHIPKSPFEVQVGPEAGMQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VKQKDFLDGVYAFEYYPSTPGRYSIAITWGGHHIPKSPFEVQVGPEAGMQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 KVRAWGPGLHGGIVGRSADFVVESIGSEVGSLGFAIEGPSQAKIEYNDQN 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 KVRAWGPGLHGGIVGRSADFVVESIGSEVGSLGFAIEGPSQAKIEYNDQN 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 DGSCDVKYWPKEPGEYAVHIMCDDEDIKDSPYMAFIHPATGGYNPDLVRA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DGSCDVKYWPKEPGEYAVHIMCDDEDIKDSPYMAFIHPATGGYNPDLVRA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 YGPGLEKSGCIVNNLAEFTVDPKDAGKAPLKIFAQDGEGQRIDIQMKNRM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 YGPGLEKSGCIVNNLAEFTVDPKDAGKAPLKIFAQDGEGQRIDIQMKNRM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 DGTYACSYTPVKAIKHTIAVVWGGVNIPHSPYRVNIGQGSHPQKVKVFGP 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 DGTYACSYTPVKAIKHTIAVVWGGVNIPHSPYRVNIGQGSHPQKVKVFGP 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 GVERSGLKANEPTHFTVDCTEAGEGDVSVGIKCDARVLSEDEEDVDFDII 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 GVERSGLKANEPTHFTVDCTEAGEGDVSVGIKCDARVLSEDEEDVDFDII 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 HNANDTFTVKYVPPAAGRYTIKVLFASQEIPASPFRVKVDPSHDASKVKA 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 HNANDTFTVKYVPPAAGRYTIKVLFASQEIPASPFRVKVDPSHDASKVKA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 EGPGLSKAGVENGKPTHFTVYTKGAGKAPLNVQFNSPLPGDAVKDLDIID 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 EGPGLSKAGVENGKPTHFTVYTKGAGKAPLNVQFNSPLPGDAVKDLDIID 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 NYDYSHTVKYTPTQQGNMQVLVTYGGDPIPKSPFTVGVAAPLDLSKIKLN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 NYDYSHTVKYTPTQQGNMQVLVTYGGDPIPKSPFTVGVAAPLDLSKIKLN 950                                                          
						                                                            	                                                             
						                                                            	     951 GLEN                                               954                                                          
						                                                            	         ||||                                                
						                                                            	     951 GLEN                                               954                                                          

						Comparison report between HUMACTINBI_P4 and O75369partial WT 	Sequence name: O75369                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMACTINBI_P4, comprising a first   	Sequence documentation:                                      
						MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRLIALLEVLSQK 	                                                            
						RMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILH 	Alignment of: 3142 x O75369   ..                             
						YSISMPVWEDEGDDDAKKQTPKQRLLGWIQNKIPYLPITNFNQNWQDGKALGALVDSCAP 	                                                            
						GLCPDWESWDPQKPVDNAREAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKA 	Alignment segment 1/1:                                       
						KLKPGAPLKPKLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 	                                                            
						EEAQVTPDSDKNKTYSVEYLPKVTGLHKVTVLFAGQHISKSPFEVSVDKAQGDASKVTAK 	                     Quality: 9388.00                      Escore:       0                                               
						GPGLEAVGNIANKPTYFDIYTAGAGVGDIGVEVEDPQGKNTVELLVEDKGNQVYRCVYKP 	             Matching length:     954                Total length:     954                                               
						MQPGPHVVKIFFAGDTIPKSPFVVQVGEACNPNACRASGRGLQPKGVRIRETTDFKVDTK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AAGSGELGVTMKGPKGLEELVKQKDFLDGVYAFEYYPSTPGRYSIAITWGGHHIPKSPFE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VQVGPEAGMQKVRAWGPGLHGGIVGRSADFVVESIGSEVGSLGFAIEGPSQAKIEYNDQN 	                        Gaps:       0                        
						DGSCDVKYWPKEPGEYAVHIMCDDEDIKDSPYMAFIHPATGGYNPDLVRAYGPGLEKSGC 	                                                            
						IVNNLAEFTVDPKDAGKAPLKIFAQDGEGQRIDIQMKNRMDGTYACSYTPVKAIKHTIAV 	Alignment:                                                   
						VWGGVNIPHSPYRVNIGQGSHPQKVKVFGPGVERSGLKANEPTHFTVDCTEAGEGDVSVG 	                  .         .         .         .         .  
						IKCDARVLSEDEEDVDFDIIHNANDTFTVKYVPPAAGRYTIKVLFASQEIPASPFRVKVD 	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						PSHDASKVKAEGPGLSKAGVENGKPTHFTVYTKGAGKAPLNVQFNSPLPGDAVKDLDIID 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NYDYSHTVKYTPTQQGNMQVLVTYGGDPIPKSPFTVGVAAPLDLSKIKLNGLEN       	       1 MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRL 50                                                           
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 1 - 954 of O75369, which also   	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						corresponds to amino acids 1 - 954 of HUMACTINBI_P4, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 70%, optionally at 	      51 IALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSK 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEGPRSRPRRWSRGQACRVHHRYQRSWYWRSGLNGGRSVRGQNRVLRQW            	     101 AIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQ 150                                                          
						corresponding to amino acids 955 - 1003 of HUMACTINBI_P4,    	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of HUMACTINBI_P4,   	     151 NKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNARE 200                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     201 AMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKP 250                                                          
						SEGPRSRPRRWSRGQACRVHHRYQRSWYWRSGLNGGRSVRGQNRVLRQW in         	                  .         .         .         .         .  
						HUMACTINBI_P4.                                               	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKVTVLFAGQHISKSPFEVSVDKA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EEAQVTPDSDKNKTYSVEYLPKVTGLHKVTVLFAGQHISKSPFEVSVDKA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QGDASKVTAKGPGLEAVGNIANKPTYFDIYTAGAGVGDIGVEVEDPQGKN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QGDASKVTAKGPGLEAVGNIANKPTYFDIYTAGAGVGDIGVEVEDPQGKN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 TVELLVEDKGNQVYRCVYKPMQPGPHVVKIFFAGDTIPKSPFVVQVGEAC 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TVELLVEDKGNQVYRCVYKPMQPGPHVVKIFFAGDTIPKSPFVVQVGEAC 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NPNACRASGRGLQPKGVRIRETTDFKVDTKAAGSGELGVTMKGPKGLEEL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NPNACRASGRGLQPKGVRIRETTDFKVDTKAAGSGELGVTMKGPKGLEEL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VKQKDFLDGVYAFEYYPSTPGRYSIAITWGGHHIPKSPFEVQVGPEAGMQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VKQKDFLDGVYAFEYYPSTPGRYSIAITWGGHHIPKSPFEVQVGPEAGMQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 KVRAWGPGLHGGIVGRSADFVVESIGSEVGSLGFAIEGPSQAKIEYNDQN 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 KVRAWGPGLHGGIVGRSADFVVESIGSEVGSLGFAIEGPSQAKIEYNDQN 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 DGSCDVKYWPKEPGEYAVHIMCDDEDIKDSPYMAFIHPATGGYNPDLVRA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DGSCDVKYWPKEPGEYAVHIMCDDEDIKDSPYMAFIHPATGGYNPDLVRA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 YGPGLEKSGCIVNNLAEFTVDPKDAGKAPLKIFAQDGEGQRIDIQMKNRM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 YGPGLEKSGCIVNNLAEFTVDPKDAGKAPLKIFAQDGEGQRIDIQMKNRM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 DGTYACSYTPVKAIKHTIAVVWGGVNIPHSPYRVNIGQGSHPQKVKVFGP 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 DGTYACSYTPVKAIKHTIAVVWGGVNIPHSPYRVNIGQGSHPQKVKVFGP 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 GVERSGLKANEPTHFTVDCTEAGEGDVSVGIKCDARVLSEDEEDVDFDII 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 GVERSGLKANEPTHFTVDCTEAGEGDVSVGIKCDARVLSEDEEDVDFDII 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 HNANDTFTVKYVPPAAGRYTIKVLFASQEIPASPFRVKVDPSHDASKVKA 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 HNANDTFTVKYVPPAAGRYTIKVLFASQEIPASPFRVKVDPSHDASKVKA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 EGPGLSKAGVENGKPTHFTVYTKGAGKAPLNVQFNSPLPGDAVKDLDIID 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 EGPGLSKAGVENGKPTHFTVYTKGAGKAPLNVQFNSPLPGDAVKDLDIID 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 NYDYSHTVKYTPTQQGNMQVLVTYGGDPIPKSPFTVGVAAPLDLSKIKLN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 NYDYSHTVKYTPTQQGNMQVLVTYGGDPIPKSPFTVGVAAPLDLSKIKLN 950                                                          
						                                                            	                                                             
						                                                            	     951 GLEN                                               954                                                          
						                                                            	         ||||                                                
						                                                            	     951 GLEN                                               954                                                          

26475	HMR136_HUMACYPRO_10_tr0_r1_1_gPRT		Comparison report between HUMACYPRO_P10 and                  	Sequence name: ACY1_HUMAN                                    
						ACY1_HUMANpartial WT sequence (truncation of last part or    	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMACYPRO_P10, comprising a	                                                            
						MSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFS 	Alignment of: 26475 x ACY1_HUMAN   ..                        
						RVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVFLRGV 	                                                            
						DIYTRLLPALASVPALPSDS                                         	Alignment segment 1/1:                                       
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 269 - 408 of ACY1_HUMAN, which  	                     Quality: 1396.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 140 of HUMACYPRO_P10.    	             Matching length:     140                Total length:     140                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTD 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     269 MSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTD 318                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DSNPWWAAFSRVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRT 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     319 DSNPWWAAFSRVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRT 368                                                          
						                                                            	                  .         .         .         .            
						                                                            	     101 PVLLHDHDERLHEAVFLRGVDIYTRLLPALASVPALPSDS           140                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     369 PVLLHDHDERLHEAVFLRGVDIYTRLLPALASVPALPSDS           408                                                          

26473	HMR136_HUMACYPRO_7_tr0_r1_1_gPRT		Comparison report between HUMACYPRO_P7 and ACY1_HUMANunique  	Sequence name: ACY1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMACYPRO_P7, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 26473 x ACY1_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence GPSSHPCPQ corresponding to amino acids 1 	Alignment segment 1/1:                                       
						- 9 of HUMACYPRO_P7, and a second amino acid sequence being  	                                                            
						EHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHRFPRTIHMTFVPDEE 	                     Quality: 3189.00                      Escore:       0                                               
						VGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAFTVFYSERSPWWVRVTSTGRPGHAS 	             Matching length:     324                Total length:     324                                               
						RFMEDTAAEKLHKVVNSILAFREKEWQRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPAT 	 Matching Percent Similarity:   99.38   Matching Percent Identity:   99.07                                               
						MSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFS 	    Total Percent Similarity:   99.38      Total Percent Identity:   99.07                                               
						RVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVFLRGV 	                        Gaps:       0                        
						DIYTRLLPALASVPALPSDS                                         	                                                            
						at least 90 % homologous to corresponding to amino acids 89 -	Alignment:                                                   
						408 of ACY1_HUMAN, which also corresponds to amino acids 10 -	                  .         .         .         .         .  
						329 of HUMACYPRO_P7, wherein said first amino acid sequence  	       6 PCPQEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHR 55                                                           
						and second amino acid sequence are contiguous and in a       	         |  :||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	      85 PVFKEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHR 134                                                          
						head of HUMACYPRO_P7, comprising a polypeptide being at least	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      56 FPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAF 105                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence GPSSHPCPQ of   	     135 FPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAF 184                                                          
						HUMACYPRO_P7.                                                	                  .         .         .         .         .  
						                                                            	     106 TVFYSERSPWWVRVTSTGRPGHASRFMEDTAAEKLHKVVNSILAFREKEW 155                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     185 TVFYSERSPWWVRVTSTGRPGHASRFMEDTAAEKLHKVVNSILAFREKEW 234                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     156 QRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPATMSASFDFRVAPDVDFK 205                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     235 QRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPATMSASFDFRVAPDVDFK 284                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     206 AFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFSRVCKDM 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     285 AFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFSRVCKDM 334                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 NLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVF 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     335 NLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVF 384                                                          
						                                                            	                  .         .                                
						                                                            	     306 LRGVDIYTRLLPALASVPALPSDS                           329                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     385 LRGVDIYTRLLPALASVPALPSDS                           408                                                          

3373	HMR136_HUMADDUCA_13_tr0_r1_1_gPRT		Comparison report between HUMADDUCA_P13 and Q96D30partial WT 	Sequence name: Q96D30                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMADDUCA_P13, comprising a first   	Sequence documentation:                                      
						MIQEQFKKGKNPTGLLALQQIADFMTTNVPNVYPAAPQGGMAALNMSLGMVTPVNDLRGS 	                                                            
						DSIAYDKGEKLLRCKLAAFYRLADLFGWSQLIYNHITTRVNSEQEHFLIVPFGLLYSEVT 	Alignment of: 3373 x Q96D30   ..                             
						ASSLVKINLQGDIVDRGSTNLGVNQAGFTLHSAIYAARPDVKCVVHIHTPAGAAVSAMKC 	                                                            
						GLLPISPEALSLGEVAYHDYHGILVDEEEKVLIQKNLGPKSKVLILRNHGLVSVGESVEE 	Alignment segment 1/1:                                       
						AFYYIHNLVVACEIQVRTLASAGGPDNLVLLNPEKYKAKSRSPGSPVGEGTGSPPKWQIG 	                                                            
						EQEFEALMRMLDNLGYRT                                           	                     Quality: 3073.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     318                Total length:     318                                               
						corresponding to amino acids 74 - 391 of Q96D30, which also  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 318 of HUMADDUCA_P13, and a   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						GYPYRYPALREKSKKYSDVEVPASVTGYSFASDGDSGTCSPLRHSFQKQQREKTRWLNSG 	                  .         .         .         .         .  
						RGDEASEEGQNGSSPKSKTKVWTNITHDHVKPLLQSLSSGVCVPSCITNCLVCAYLTVHS 	       1 MIQEQFKKGKNPTGLLALQQIADFMTTNVPNVYPAAPQGGMAALNMSLGM 50                                                           
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						319 - 438 of HUMADDUCA_P13, wherein said first amino acid    	      74 MIQEQFKKGKNPTGLLALQQIADFMTTNVPNVYPAAPQGGMAALNMSLGM 123                                                          
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 VTPVNDLRGSDSIAYDKGEKLLRCKLAAFYRLADLFGWSQLIYNHITTRV 100                                                          
						tail of HUMADDUCA_P13, comprising a polypeptide being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     124 VTPVNDLRGSDSIAYDKGEKLLRCKLAAFYRLADLFGWSQLIYNHITTRV 173                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						GYPYRYPALREKSKKYSDVEVPASVTGYSFASDGDSGTCSPLRHSFQKQQREKTRWLNSG 	     101 NSEQEHFLIVPFGLLYSEVTASSLVKINLQGDIVDRGSTNLGVNQAGFTL 150                                                          
						RGDEASEEGQNGSSPKSKTKVWTNITHDHVKPLLQSLSSGVCVPSCITNCLVCAYLTVHS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence in  	     174 NSEQEHFLIVPFGLLYSEVTASSLVKINLQGDIVDRGSTNLGVNQAGFTL 223                                                          
						HUMADDUCA_P13.                                               	                  .         .         .         .         .  
						                                                            	     151 HSAIYAARPDVKCVVHIHTPAGAAVSAMKCGLLPISPEALSLGEVAYHDY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     224 HSAIYAARPDVKCVVHIHTPAGAAVSAMKCGLLPISPEALSLGEVAYHDY 273                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 HGILVDEEEKVLIQKNLGPKSKVLILRNHGLVSVGESVEEAFYYIHNLVV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     274 HGILVDEEEKVLIQKNLGPKSKVLILRNHGLVSVGESVEEAFYYIHNLVV 323                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ACEIQVRTLASAGGPDNLVLLNPEKYKAKSRSPGSPVGEGTGSPPKWQIG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 ACEIQVRTLASAGGPDNLVLLNPEKYKAKSRSPGSPVGEGTGSPPKWQIG 373                                                          
						                                                            	                  .                                          
						                                                            	     301 EQEFEALMRMLDNLGYRT                                 318                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     374 EQEFEALMRMLDNLGYRT                                 391                                                          

						Comparison report between HUMADDUCA_P13 and AAH42998partial  	Sequence name: AAH42998                                      
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMADDUCA_P13, comprising a first   	Sequence documentation:                                      
						MIQEQFKKGKNPTGLLALQQIADFMTTNVPNVYPAAPQGGMAALNMSLGMVTPVNDLRGS 	                                                            
						DSIAYDKGEKLLRCKLAAFYRLADLFGWSQLIYNHITTRVNSEQEHFLIVPFGLLYSEVT 	Alignment of: 3373 x AAH42998   ..                           
						ASSLVKINLQGDIVDRGSTNLGVNQAGFTLHSAIYAARPDVKCVVHIHTPAGAAVSAMKC 	                                                            
						GLLPISPEALSLGEVAYHDYHGILVDEEEKVLIQKNLGPKSKVLILRNHGLVSVGESVEE 	Alignment segment 1/1:                                       
						AFYYIHNLVVACEIQVRTLASAGGPDNLVLLNPEKYKAKSRSPGSPVGEGTGSPPKWQIG 	                                                            
						EQEFEALMRMLDNLGYRTGYPYRYPALREKSKKYSDVEVPASVTGYSFASDGDSGTCSPL 	                     Quality: 3870.00                      Escore:       0                                               
						RHSFQKQQREKTRWLNSGRGDEASEEGQNGSSPKSKTK                       	             Matching length:     398                Total length:     398                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 74 - 471 of AAH42998, which also	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 398 of HUMADDUCA_P13, and a   	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	       1 MIQEQFKKGKNPTGLLALQQIADFMTTNVPNVYPAAPQGGMAALNMSLGM 50                                                           
						VWTNITHDHVKPLLQSLSSGVCVPSCITNCLVCAYLTVHS corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 399 - 438 of HUMADDUCA_P13, wherein said first   	      74 MIQEQFKKGKNPTGLLALQQIADFMTTNVPNVYPAAPQGGMAALNMSLGM 123                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      51 VTPVNDLRGSDSIAYDKGEKLLRCKLAAFYRLADLFGWSQLIYNHITTRV 100                                                          
						polypeptide encoding for a tail of HUMADDUCA_P13, comprising 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a polypeptide being at least 70%, optionally at least about  	     124 VTPVNDLRGSDSIAYDKGEKLLRCKLAAFYRLADLFGWSQLIYNHITTRV 173                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 NSEQEHFLIVPFGLLYSEVTASSLVKINLQGDIVDRGSTNLGVNQAGFTL 150                                                          
						to the sequence VWTNITHDHVKPLLQSLSSGVCVPSCITNCLVCAYLTVHS in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMADDUCA_P13.                                               	     174 NSEQEHFLIVPFGLLYSEVTASSLVKINLQGDIVDRGSTNLGVNQAGFTL 223                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 HSAIYAARPDVKCVVHIHTPAGAAVSAMKCGLLPISPEALSLGEVAYHDY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     224 HSAIYAARPDVKCVVHIHTPAGAAVSAMKCGLLPISPEALSLGEVAYHDY 273                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 HGILVDEEEKVLIQKNLGPKSKVLILRNHGLVSVGESVEEAFYYIHNLVV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     274 HGILVDEEEKVLIQKNLGPKSKVLILRNHGLVSVGESVEEAFYYIHNLVV 323                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ACEIQVRTLASAGGPDNLVLLNPEKYKAKSRSPGSPVGEGTGSPPKWQIG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 ACEIQVRTLASAGGPDNLVLLNPEKYKAKSRSPGSPVGEGTGSPPKWQIG 373                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EQEFEALMRMLDNLGYRTGYPYRYPALREKSKKYSDVEVPASVTGYSFAS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     374 EQEFEALMRMLDNLGYRTGYPYRYPALREKSKKYSDVEVPASVTGYSFAS 423                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 DGDSGTCSPLRHSFQKQQREKTRWLNSGRGDEASEEGQNGSSPKSKTK   398                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     424 DGDSGTCSPLRHSFQKQQREKTRWLNSGRGDEASEEGQNGSSPKSKTK   471                                                          

3641	HMR136_HUMADPRFIA_43_tr0_r1_1_gPRT		Comparison report between HUMADPRFIA_P43 and                 	Sequence name: ARF1_HUMAN_V1                                 
						ARF1_HUMAN_V1partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMADPRFIA_P43, comprising a first amino acid sequence being 	                                                            
						MGNIFANLFKGLFGKKEMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKN 	Alignment of: 3641 x ARF1_HUMAN_V1   ..                      
						ISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAV 	                                                            
						LLVFANKQ                                                     	Alignment segment 1/1:                                       
						at least 90 % homologous to corresponding to amino acids 1 - 	                                                            
						128 of ARF1_HUMAN_V1, which also corresponds to amino acids 1	                     Quality: 1235.00                      Escore:       0                                               
						- 128 of HUMADPRFIA_P43, and a second amino acid sequence    	             Matching length:     128                Total length:     128                                               
						being at least 70%, optionally at least 80%, preferably at   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 85%, more preferably at least 90% and most preferably  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						at least 95% homologous to a polypeptide having the sequence 	                        Gaps:       0                        
						PARVRFAIEKDNLYFFLLYFDKH corresponding to amino acids 129 -   	                                                            
						151 of HUMADPRFIA_P43, wherein said first amino acid sequence	Alignment:                                                   
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	       1 MGNIFANLFKGLFGKKEMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIG 50                                                           
						tail of HUMADPRFIA_P43, comprising a polypeptide being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	       1 MGNIFANLFKGLFGKKEMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIG 50                                                           
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	      51 FNVETVEYKNISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVVDSNDRERV 100                                                          
						PARVRFAIEKDNLYFFLLYFDKH in HUMADPRFIA_P43.                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FNVETVEYKNISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVVDSNDRERV 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 NEAREELMRMLAEDELRDAVLLVFANKQ                       128                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     101 NEAREELMRMLAEDELRDAVLLVFANKQ                       128                                                          

28301	HMR136_HUMAF9X_2_tr0_r1_1_gPRT		Comparison report between HUMAF9X_P2 and AF9_HUMANshort      	Sequence name: AF9_HUMAN                                     
						unique head followed by partial WT sequence1.An isolated     	                                                            
						chimeric polypeptide encoding for HUMAF9X_P2, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 28301 x AF9_HUMAN   ..                         
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MCA corresponding to amino   	Alignment segment 1/1:                                       
						acids 1 - 3 of HUMAF9X_P2, and a second amino acid sequence  	                                                            
						VQVKLELGHRAQVRKKPTVEGFTHDWMVFVRGPEHSNIQHFVEKVVFHLHESFPRPKRVC 	                     Quality: 5549.00                      Escore:       0                                               
						KDPPYKVEESGYAGFILPIEVYFKNKEEPRKVRFDYDLFLHLEGHPPVNHLRCEKLTFNN 	             Matching length:     564                Total length:     564                                               
						PTEDFRRKLLKAGGDPNRSIHTSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.82                                               
						SSSSTSFSKPHKLMKEHKEKPSKDSREHKSAFKEPSRDHNKSSKESSKKPKENKPLKEEK 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.82                                               
						IVPKMAFKEPKPMSKEPKPDSNLLTITSGQDKKAPSKRPPISDSEELSAKKRKKSSSEAL 	                        Gaps:       0                        
						FKSFSSAPPLILTCSADKKQIKDKSHVKMGKVKIESETSEKKKSTLPPFDDIVDPNDSDV 	                                                            
						EENISSKSDSEQPSPASSSSSSSSSFTPSQTRQQGPLRSIMKDLHSDDNEEESDEVEDND 	Alignment:                                                   
						NDSEMERPVNRGGSRSRRVSLSDGSDSESSSASSPLHHEPPPPLLKTNNNQILEVKSPIK 	                  .         .         .         .         .  
						QSKSDKQIKNGECDKAYLDELVELHRRLMTLRERHILQQIVNLIEETGHFHITNTTFDFD 	       2 CAVQVKLELGHRAQVRKKPTVEGFTHDWMVFVRGPEHSNIQHFVEKVVFH 51                                                           
						LCSLDKTTVRKLQSYLETSGTS                                       	         |:||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       5 CSVQVKLELGHRAQVRKKPTVEGFTHDWMVFVRGPEHSNIQHFVEKVVFH 54                                                           
						acids 7 - 568 of AF9_HUMAN, which also corresponds to amino  	                  .         .         .         .         .  
						acids 4 - 565 of HUMAF9X_P2, wherein said first amino acid   	      52 LHESFPRPKRVCKDPPYKVEESGYAGFILPIEVYFKNKEEPRKVRFDYDL 101                                                          
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.                                          	      55 LHESFPRPKRVCKDPPYKVEESGYAGFILPIEVYFKNKEEPRKVRFDYDL 104                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     102 FLHLEGHPPVNHLRCEKLTFNNPTEDFRRKLLKAGGDPNRSIHTSSSSSS 151                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     105 FLHLEGHPPVNHLRCEKLTFNNPTEDFRRKLLKAGGDPNRSIHTSSSSSS 154                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     152 SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSTSFSKPHKLMKEHK 201                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     155 SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSTSFSKPHKLMKEHK 204                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     202 EKPSKDSREHKSAFKEPSRDHNKSSKESSKKPKENKPLKEEKIVPKMAFK 251                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     205 EKPSKDSREHKSAFKEPSRDHNKSSKESSKKPKENKPLKEEKIVPKMAFK 254                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     252 EPKPMSKEPKPDSNLLTITSGQDKKAPSKRPPISDSEELSAKKRKKSSSE 301                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     255 EPKPMSKEPKPDSNLLTITSGQDKKAPSKRPPISDSEELSAKKRKKSSSE 304                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     302 ALFKSFSSAPPLILTCSADKKQIKDKSHVKMGKVKIESETSEKKKSTLPP 351                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     305 ALFKSFSSAPPLILTCSADKKQIKDKSHVKMGKVKIESETSEKKKSTLPP 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     352 FDDIVDPNDSDVEENISSKSDSEQPSPASSSSSSSSSFTPSQTRQQGPLR 401                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 FDDIVDPNDSDVEENISSKSDSEQPSPASSSSSSSSSFTPSQTRQQGPLR 404                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     402 SIMKDLHSDDNEEESDEVEDNDNDSEMERPVNRGGSRSRRVSLSDGSDSE 451                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     405 SIMKDLHSDDNEEESDEVEDNDNDSEMERPVNRGGSRSRRVSLSDGSDSE 454                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     452 SSSASSPLHHEPPPPLLKTNNNQILEVKSPIKQSKSDKQIKNGECDKAYL 501                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     455 SSSASSPLHHEPPPPLLKTNNNQILEVKSPIKQSKSDKQIKNGECDKAYL 504                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     502 DELVELHRRLMTLRERHILQQIVNLIEETGHFHITNTTFDFDLCSLDKTT 551                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     505 DELVELHRRLMTLRERHILQQIVNLIEETGHFHITNTTFDFDLCSLDKTT 554                                                          
						                                                            	                  .                                          
						                                                            	     552 VRKLQSYLETSGTS                                     565                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     555 VRKLQSYLETSGTS                                     568                                                          

4046	HMR136_HUMAGCGB_8_tr0_r1_1_gPRT		Comparison report between HUMAGCGB_P8 and Q8NDT2unique head  	Sequence name: Q8NDT2                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMAGCGB_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4046 x Q8NDT2   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKRQSERDSSPSGRGSSSSAKRPREREREAEAGGRRAAHKASGGAKHPVPARARDKPRGS 	Alignment segment 1/1:                                       
						GSGGGGHRDGRGTGDANHRASSGRSSGSGAGGGGRGGKASGDPGASGMSPRASPLPPPPP 	                                                            
						PPGAEPACPGSSAAAPEYKTLLISSLSPALPAEH                           	                     Quality: 4591.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     469                Total length:     469                                               
						to amino acids 1 - 154 of HUMAGCGB_P8, a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LEDRLFHQFKRFGEISLRLSHTPELGRVAYVNFRHPQDAREARQHALARQLLLYDRPLKV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EPVYLRGGGGSSRRSSSSSAAASTPPPGPPAPADPLGYLPLHGGYQYKQRSLSPVAAPPL 	                        Gaps:       0                        
						REPRARHAAAAFALDAAAAAAVGLSRERALDYYGLYDDRGRPYGYPAVCEEDLMPEDDQR 	                                                            
						ATRNLFIGNLDHSVSEVELRRAFEKYGIIEEVVIKRPARGQGGAYAFLKFQNLDMAHRAK 	Alignment:                                                   
						VAMSGRVIGRNPIKIGYGKANPTTRLWVGGLGPNTSLAALAREFDRFGSIRTIDHVKGDS 	                  .         .         .         .         .  
						FAYIQYESLDAAQAACAKMRGFPLGGPDRRLRVDFAKAEETRYPQQYQPSPLPVHYELLT 	     155 LEDRLFHQFKRFGEISLRLSHTPELGRVAYVNFRHPQDAREARQHALARQ 204                                                          
						DGYTRHRNLDADLVRDRTPPHLLYSDRDRTFLEGDWTSPSKSSDRRNSLEGYSRSVRSRS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GERWGADGDRGLPKPWEERRKRRSLSSDRGRTTHSPYEERSRTKGSGQQ            	       1 LEDRLFHQFKRFGEISLRLSHTPELGRVAYVNFRHPQDAREARQHALARQ 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 469 of Q8NDT2, which also corresponds to     	     205 LLLYDRPLKVEPVYLRGGGGSSRRSSSSSAAASTPPPGPPAPADPLGYLP 254                                                          
						amino acids 155 - 623 of HUMAGCGB_P8, and a third amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 LLLYDRPLKVEPVYLRGGGGSSRRSSSSSAAASTPPPGPPAPADPLGYLP 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     255 LHGGYQYKQRSLSPVAAPPLREPRARHAAAAFALDAAAAAAVGLSRERAL 304                                                          
						having the sequence DQGVQQQLPQQQQTWG corresponding to amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 624 - 639 of HUMAGCGB_P8, wherein said first amino acid	     101 LHGGYQYKQRSLSPVAAPPLREPRARHAAAAFALDAAAAAAVGLSRERAL 150                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     305 DYYGLYDDRGRPYGYPAVCEEDLMPEDDQRATRNLFIGNLDHSVSEVELR 354                                                          
						isolated polypeptide encoding for a head of HUMAGCGB_P8,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     151 DYYGLYDDRGRPYGYPAVCEEDLMPEDDQRATRNLFIGNLDHSVSEVELR 200                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     355 RAFEKYGIIEEVVIKRPARGQGGAYAFLKFQNLDMAHRAKVAMSGRVIGR 404                                                          
						MKRQSERDSSPSGRGSSSSAKRPREREREAEAGGRRAAHKASGGAKHPVPARARDKPRGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSGGGGHRDGRGTGDANHRASSGRSSGSGAGGGGRGGKASGDPGASGMSPRASPLPPPPP 	     201 RAFEKYGIIEEVVIKRPARGQGGAYAFLKFQNLDMAHRAKVAMSGRVIGR 250                                                          
						PPGAEPACPGSSAAAPEYKTLLISSLSPALPAEH                           	                  .         .         .         .         .  
						about 95% homologous to the sequence of HUMAGCGB_P8.3.An     	     405 NPIKIGYGKANPTTRLWVGGLGPNTSLAALAREFDRFGSIRTIDHVKGDS 454                                                          
						isolated polypeptide encoding for a tail of HUMAGCGB_P8,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     251 NPIKIGYGKANPTTRLWVGGLGPNTSLAALAREFDRFGSIRTIDHVKGDS 300                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     455 FAYIQYESLDAAQAACAKMRGFPLGGPDRRLRVDFAKAEETRYPQQYQPS 504                                                          
						about 95% homologous to the sequence DQGVQQQLPQQQQTWG in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMAGCGB_P8.                                                 	     301 FAYIQYESLDAAQAACAKMRGFPLGGPDRRLRVDFAKAEETRYPQQYQPS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     505 PLPVHYELLTDGYTRHRNLDADLVRDRTPPHLLYSDRDRTFLEGDWTSPS 554                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PLPVHYELLTDGYTRHRNLDADLVRDRTPPHLLYSDRDRTFLEGDWTSPS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     555 KSSDRRNSLEGYSRSVRSRSGERWGADGDRGLPKPWEERRKRRSLSSDRG 604                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KSSDRRNSLEGYSRSVRSRSGERWGADGDRGLPKPWEERRKRRSLSSDRG 450                                                          
						                                                            	                  .                                          
						                                                            	     605 RTTHSPYEERSRTKGSGQQ                                623                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     451 RTTHSPYEERSRTKGSGQQ                                469                                                          

28512	HMR136_HUMAGGCRB_7_tr0_r1_1_gPRT		Comparison report between HUMAGGCRB_P7 and Q96CC6partial WT  	Sequence name: Q96CC6                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMAGGCRB_P7, comprising a first amino acid sequence being at	                                                            
						MSEARRDSTSSLQRKKPPWLKLDIPSAVPLTAEEPSFLQPLRRQAFLRSVSMPAETAHIS 	Alignment of: 28512 x Q96CC6   ..                            
						SPHHELRRPVLQRQTSITQTIRRGTADWFGVSKDSDSTQKWQRKSIRHCSQRYGKLKPQV 	                                                            
						LRELDLPSQDNVSLTSTETPPPLYVGPCQLGMQKIIDPLARGRAFRVADDTAEGLSAPHT 	Alignment segment 1/1:                                       
						PVTPGAASLCSFSSSRSGFHRLPRRRKRESVAKMSFRAAAALMKGRSVRDGTFRRA     	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 236	                     Quality: 6039.00                      Escore:       0                                               
						of Q96CC6, which also corresponds to amino acids 1 - 236 of  	             Matching length:     607                Total length:     607                                               
						HUMAGGCRB_P7, a bridging amino acid Q corresponding to amino 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						acid 237 of HUMAGGCRB_P7, a second amino acid sequence being 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.84                                               
						RRSFTPASFLEEDTTDFPDELDTSFFAREGILHEELSTYPDEVFESPSEAALKDWEKAPE 	                        Gaps:       0                        
						QADLTGGALDRSELERSHLMLPLERGWRKQKEGAAAPQPKVRLRQEVVSTAGPRRGQRIA 	                                                            
						VPVRKLFAREKRPYGLGMVGRLTNRTYRKRIDSFVKRQIEDMDDHRPFFTYWLTFVHSLV 	Alignment:                                                   
						TILAVCIYGIAPVGFSQHETVDSVLRNRGVYENVKYVQQENFWIGPSSEALIHLGAKFSP 	                  .         .         .         .         .  
						CMRQDPQVHSFIRSAREREKHSACCVRNDRSGCVQTSEEECSSTLAVWVKWPIHPSAPEL 	       1 MSEARRDSTSSLQRKKPPWLKLDIPSAVPLTAEEPSFLQPLRRQAFLRSV 50                                                           
						AGHKRQFGSVCHQDPRVCDEPSSEDPHEWPEDITKWPICTKNSAGNHTNHPHMDCVITGR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PCCIGTKGRC                                                   	       1 MSEARRDSTSSLQRKKPPWLKLDIPSAVPLTAEEPSFLQPLRRQAFLRSV 50                                                           
						at least 90 % homologous to corresponding to amino acids 238 	                  .         .         .         .         .  
						- 607 of Q96CC6, which also corresponds to amino acids 238 - 	      51 SMPAETAHISSPHHELRRPVLQRQTSITQTIRRGTADWFGVSKDSDSTQK 100                                                          
						607 of HUMAGGCRB_P7, and a third amino acid sequence being at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	      51 SMPAETAHISSPHHELRRPVLQRQTSITQTIRRGTADWFGVSKDSDSTQK 100                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     101 WQRKSIRHCSQRYGKLKPQVLRELDLPSQDNVSLTSTETPPPLYVGPCQL 150                                                          
						TAWMMCVGSCLFSTPRCLTSSTACGYPSSCTPGSCTAWCPSASR corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 608 - 651 of HUMAGGCRB_P7, wherein said first    	     101 WQRKSIRHCSQRYGKLKPQVLRELDLPSQDNVSLTSTETPPPLYVGPCQL 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	     151 GMQKIIDPLARGRAFRVADDTAEGLSAPHTPVTPGAASLCSFSSSRSGFH 200                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUMAGGCRB_P7, comprising a polypeptide being at least	     151 GMQKIIDPLARGRAFRVADDTAEGLSAPHTPVTPGAASLCSFSSSRSGFH 200                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     201 RLPRRRKRESVAKMSFRAAAALMKGRSVRDGTFRRAQRRSFTPASFLEED 250                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||:|||||||||||||  
						TAWMMCVGSCLFSTPRCLTSSTACGYPSSCTPGSCTAWCPSASR in HUMAGGCRB_P7.	     201 RLPRRRKRESVAKMSFRAAAALMKGRSVRDGTFRRARRRSFTPASFLEED 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TTDFPDELDTSFFAREGILHEELSTYPDEVFESPSEAALKDWEKAPEQAD 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 TTDFPDELDTSFFAREGILHEELSTYPDEVFESPSEAALKDWEKAPEQAD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LTGGALDRSELERSHLMLPLERGWRKQKEGAAAPQPKVRLRQEVVSTAGP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LTGGALDRSELERSHLMLPLERGWRKQKEGAAAPQPKVRLRQEVVSTAGP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RRGQRIAVPVRKLFAREKRPYGLGMVGRLTNRTYRKRIDSFVKRQIEDMD 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RRGQRIAVPVRKLFAREKRPYGLGMVGRLTNRTYRKRIDSFVKRQIEDMD 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DHRPFFTYWLTFVHSLVTILAVCIYGIAPVGFSQHETVDSVLRNRGVYEN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 DHRPFFTYWLTFVHSLVTILAVCIYGIAPVGFSQHETVDSVLRNRGVYEN 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VKYVQQENFWIGPSSEALIHLGAKFSPCMRQDPQVHSFIRSAREREKHSA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 VKYVQQENFWIGPSSEALIHLGAKFSPCMRQDPQVHSFIRSAREREKHSA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 CCVRNDRSGCVQTSEEECSSTLAVWVKWPIHPSAPELAGHKRQFGSVCHQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 CCVRNDRSGCVQTSEEECSSTLAVWVKWPIHPSAPELAGHKRQFGSVCHQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPRVCDEPSSEDPHEWPEDITKWPICTKNSAGNHTNHPHMDCVITGRPCC 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPRVCDEPSSEDPHEWPEDITKWPICTKNSAGNHTNHPHMDCVITGRPCC 600                                                          
						                                                            	                                                             
						                                                            	     601 IGTKGRC                                            607                                                          
						                                                            	         |||||||                                             
						                                                            	     601 IGTKGRC                                            607                                                          

						Comparison report between HUMAGGCRB_P7 and Q9H6E1partial WT  	Sequence name: Q9H6E1                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMAGGCRB_P7, comprising a first amino acid sequence being at	                                                            
						MSEARRDSTSSLQRKKPPWLKLDIPSAVPLTAEEPSFLQPLRRQAFLRSVSMPAETAHIS 	Alignment of: 28512 x Q9H6E1   ..                            
						SPHHELRRPVLQRQTSITQTIRRGTADWFGVSKDSDSTQKWQRKSIRHCSQRYGKLKPQV 	                                                            
						LRELDLPSQDNVSLTSTETPPPLYVGPCQLGMQKIIDPLARGRAFRVADDTAEGLSAPHT 	Alignment segment 1/1:                                       
						PVTPGAASLCSFSSSRSGFHRLPRRRKRESVAKMSFRAAAALMKGRSVRDGTFRRAQRRS 	                                                            
						FTPASFLEEDTTDFPDELDTSFFAREGILHEELSTYPDEVFESPSEAALKDWEKAPEQAD 	                     Quality: 6040.00                      Escore:       0                                               
						LTGGALDRSELERSHLMLPLERGWRKQKEGAAAPQPKVRLRQEVVSTAGPRRGQRIAVPV 	             Matching length:     607                Total length:     607                                               
						RKLFAREKRPYGLGMVGRLTNRTYRKRIDSFVKRQIEDMDDHRPFFTYWLTFVHSLV    	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.84                                               
						least 90 % homologous to corresponding to amino acids 1 - 417	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						of Q9H6E1, which also corresponds to amino acids 1 - 417 of  	                        Gaps:       0                        
						HUMAGGCRB_P7, a bridging amino acid T corresponding to amino 	                                                            
						acid 418 of HUMAGGCRB_P7, a second amino acid sequence being 	Alignment:                                                   
						ILAVCIYGIAPVGFSQHETVDSVLRNRGVYENVKYVQQENFWIGPSSEALIHLGAKFSPC 	                  .         .         .         .         .  
						MRQDPQVHSFIRSAREREKHSACCVRNDRSGCVQTSEEECSSTLAVWVKWPIHPSAPELA 	       1 MSEARRDSTSSLQRKKPPWLKLDIPSAVPLTAEEPSFLQPLRRQAFLRSV 50                                                           
						GHKRQFGSVCHQDPRVCDEPSSEDPHEWPEDITKWPICTKNSAGNHTNHPHMDCVITGRP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CCIGTKGRC                                                    	       1 MSEARRDSTSSLQRKKPPWLKLDIPSAVPLTAEEPSFLQPLRRQAFLRSV 50                                                           
						at least 90 % homologous to corresponding to amino acids 419 	                  .         .         .         .         .  
						- 607 of Q9H6E1, which also corresponds to amino acids 419 - 	      51 SMPAETAHISSPHHELRRPVLQRQTSITQTIRRGTADWFGVSKDSDSTQK 100                                                          
						607 of HUMAGGCRB_P7, and a third amino acid sequence being at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	      51 SMPAETAHISSPHHELRRPVLQRQTSITQTIRRGTADWFGVSKDSDSTQK 100                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     101 WQRKSIRHCSQRYGKLKPQVLRELDLPSQDNVSLTSTETPPPLYVGPCQL 150                                                          
						TAWMMCVGSCLFSTPRCLTSSTACGYPSSCTPGSCTAWCPSASR corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 608 - 651 of HUMAGGCRB_P7, wherein said first    	     101 WQRKSIRHCSQRYGKLKPQVLRELDLPSQDNVSLTSTETPPPLYVGPCQL 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	     151 GMQKIIDPLARGRAFRVADDTAEGLSAPHTPVTPGAASLCSFSSSRSGFH 200                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUMAGGCRB_P7, comprising a polypeptide being at least	     151 GMQKIIDPLARGRAFRVADDTAEGLSAPHTPVTPGAASLCSFSSSRSGFH 200                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     201 RLPRRRKRESVAKMSFRAAAALMKGRSVRDGTFRRAQRRSFTPASFLEED 250                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TAWMMCVGSCLFSTPRCLTSSTACGYPSSCTPGSCTAWCPSASR in HUMAGGCRB_P7.	     201 RLPRRRKRESVAKMSFRAAAALMKGRSVRDGTFRRAQRRSFTPASFLEED 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TTDFPDELDTSFFAREGILHEELSTYPDEVFESPSEAALKDWEKAPEQAD 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 TTDFPDELDTSFFAREGILHEELSTYPDEVFESPSEAALKDWEKAPEQAD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LTGGALDRSELERSHLMLPLERGWRKQKEGAAAPQPKVRLRQEVVSTAGP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LTGGALDRSELERSHLMLPLERGWRKQKEGAAAPQPKVRLRQEVVSTAGP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RRGQRIAVPVRKLFAREKRPYGLGMVGRLTNRTYRKRIDSFVKRQIEDMD 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RRGQRIAVPVRKLFAREKRPYGLGMVGRLTNRTYRKRIDSFVKRQIEDMD 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DHRPFFTYWLTFVHSLVTILAVCIYGIAPVGFSQHETVDSVLRNRGVYEN 450                                                          
						                                                            	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						                                                            	     401 DHRPFFTYWLTFVHSLVAILAVCIYGIAPVGFSQHETVDSVLRNRGVYEN 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VKYVQQENFWIGPSSEALIHLGAKFSPCMRQDPQVHSFIRSAREREKHSA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 VKYVQQENFWIGPSSEALIHLGAKFSPCMRQDPQVHSFIRSAREREKHSA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 CCVRNDRSGCVQTSEEECSSTLAVWVKWPIHPSAPELAGHKRQFGSVCHQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 CCVRNDRSGCVQTSEEECSSTLAVWVKWPIHPSAPELAGHKRQFGSVCHQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPRVCDEPSSEDPHEWPEDITKWPICTKNSAGNHTNHPHMDCVITGRPCC 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPRVCDEPSSEDPHEWPEDITKWPICTKNSAGNHTNHPHMDCVITGRPCC 600                                                          
						                                                            	                                                             
						                                                            	     601 IGTKGRC                                            607                                                          
						                                                            	         |||||||                                             
						                                                            	     601 IGTKGRC                                            607                                                          

8617	HMR136_HUMALK5A_3_tr0_r1_1_gPRT		Comparison report between HUMALK5A_P3 and TGR1_HUMANpartial  	Sequence name: TGR1_HUMAN                                    
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for HUMALK5A_P3, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTT corresponding  	Alignment of: 8617 x TGR1_HUMAN   ..                         
						to amino acids 70 - 114 of TGR1_HUMAN, which also corresponds	                                                            
						to amino acids 1 - 45 of HUMALK5A_P3, a second amino acid    	Alignment segment 1/1:                                       
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                     Quality: 4183.00                      Escore:       0                                               
						most preferably at least 95% homologous to a polypeptide     	             Matching length:     434                Total length:     438                                               
						having the sequence GPFS corresponding to amino acids 46 - 49	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of HUMALK5A_P3, and a third amino acid sequence being at     	    Total Percent Similarity:   99.09      Total Percent Identity:   99.09                                               
						VKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEG 	                        Gaps:       1                        
						TTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIF 	                                                            
						SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 	Alignment:                                                   
						YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 	                  .         .         .         .         .  
						AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 	       1 MCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTGPFSV 50                                                           
						CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 	         |||||||||||||||||||||||||||||||||||||||||||||    |  
						WYANGAARLTALRIKKTLSQLSQQEGIKM                                	      70 MCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTT....V 115                                                          
						least 90 % homologous to corresponding to amino acids 115 -  	                  .         .         .         .         .  
						503 of TGR1_HUMAN, which also corresponds to amino acids 50 -	      51 KSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPS 100                                                          
						438 of HUMALK5A_P3, wherein said first amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	     116 KSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPS 165                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of HUMALK5A_P3,     	     101 LDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGR 150                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     166 LDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGR 215                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for GPFS,	     151 FGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 200                                                          
						corresponding to HUMALK5A_P3.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     216 FGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 265                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     266 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 315                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     316 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 365                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     366 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 415                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     416 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 465                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 VMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM             438                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     466 VMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM             503                                                          

9111	HMR136_HUMALR_10_tr0_r1_1_gPRT		Comparison report between HUMALR_P10 and                     	Sequence name: AKA1_HUMAN_V1                                 
						AKA1_HUMAN_V1partial WT sequence featuring skipped exon.1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMALR_P10,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKYALSVGYRHIDCAAIYGNEPEIGEAL 	Alignment of: 9111 x AKA1_HUMAN_V1   ..                      
						KEDVGPGKAVPREELFVTSKLWNTKHHPEDVEPALRKTLADLQLEYLDLYLMHWPYAFER 	                                                            
						GDNPFPKNADGTICYDSTHYKETWKALEALVAKGL                          	Alignment segment 1/1:                                       
						homologous to corresponding to amino acids 1 - 155 of        	                                                            
						AKA1_HUMAN_V1, which also corresponds to amino acids 1 - 155 	                     Quality: 2848.00                      Escore:       0                                               
						of HUMALR_P10, and a second amino acid sequence being at     	             Matching length:     296                Total length:     325                                               
						VECHPYLAQNELIAHCQARGLEVTAYSPLGSSDRAWRDPDEPVLLEEPVVLALAEKYGRS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PAQILLRWQVQRKVICIPKSITPSRILQNIKVFDFTFSPEEMKQLNALNKNWRYIVPMLT 	    Total Percent Similarity:   91.08      Total Percent Identity:   91.08                                               
						VDGKRVPRDAGHPLYPFNDPY                                        	                        Gaps:       1                        
						least 90 % homologous to corresponding to amino acids 185 -  	                                                            
						325 of AKA1_HUMAN_V1, which also corresponds to amino acids  	Alignment:                                                   
						156 - 296 of HUMALR_P10, wherein said first amino acid       	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKYALSVGYRHIDCAAIY 50                                                           
						a sequential order.2.An isolated chimeric polypeptide        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of HUMALR_P10, comprising a     	       1 MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKYALSVGYRHIDCAAIY 50                                                           
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	      51 GNEPEIGEALKEDVGPGKAVPREELFVTSKLWNTKHHPEDVEPALRKTLA 100                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	      51 GNEPEIGEALKEDVGPGKAVPREELFVTSKLWNTKHHPEDVEPALRKTLA 100                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise LV, having 	     101 DLQLEYLDLYLMHWPYAFERGDNPFPKNADGTICYDSTHYKETWKALEAL 150                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 155-x to 156; and ending at any of amino acid   	     101 DLQLEYLDLYLMHWPYAFERGDNPFPKNADGTICYDSTHYKETWKALEAL 150                                                          
						numbers 156+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     151 VAKGL.............................VECHPYLAQNELIAHC 171                                                          
						                                                            	         |||||                             ||||||||||||||||  
						                                                            	     151 VAKGLVQALGLSNFNSRQIDDILSVASVRPAVLQVECHPYLAQNELIAHC 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     172 QARGLEVTAYSPLGSSDRAWRDPDEPVLLEEPVVLALAEKYGRSPAQILL 221                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 QARGLEVTAYSPLGSSDRAWRDPDEPVLLEEPVVLALAEKYGRSPAQILL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     222 RWQVQRKVICIPKSITPSRILQNIKVFDFTFSPEEMKQLNALNKNWRYIV 271                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RWQVQRKVICIPKSITPSRILQNIKVFDFTFSPEEMKQLNALNKNWRYIV 300                                                          
						                                                            	                  .         .                                
						                                                            	     272 PMLTVDGKRVPRDAGHPLYPFNDPY                          296                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     301 PMLTVDGKRVPRDAGHPLYPFNDPY                          325                                                          

9109	HMR136_HUMALR_11_tr0_r1_1_gPRT		Comparison report between HUMALR_P11 and                     	Sequence name: AKA1_HUMAN_V1                                 
						AKA1_HUMAN_V1partial WT sequence featuring skipped exon.1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMALR_P11,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						homologous to MAASCVLLHTGQKMPLIGLGTWKSEPGQ corresponding to  	Alignment of: 9109 x AKA1_HUMAN_V1   ..                      
						amino acids 1 - 28 of AKA1_HUMAN_V1, which also corresponds  	                                                            
						to amino acids 1 - 28 of HUMALR_P11, and a second amino acid 	Alignment segment 1/1:                                       
						AVPREELFVTSKLWNTKHHPEDVEPALRKTLADLQLEYLDLYLMHWPYAFERGDNPFPKN 	                                                            
						ADGTICYDSTHYKETWKALEALVAKGLVQALGLSNFNSRQIDDILSVASVRPAVLQVECH 	                     Quality: 2733.00                      Escore:       0                                               
						PYLAQNELIAHCQARGLEVTAYSPLGSSDRAWRDPDEPVLLEEPVVLALAEKYGRSPAQI 	             Matching length:     285                Total length:     325                                               
						LLRWQVQRKVICIPKSITPSRILQNIKVFDFTFSPEEMKQLNALNKNWRYIVPMLTVDGK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RVPRDAGHPLYPFNDPY                                            	    Total Percent Similarity:   87.69      Total Percent Identity:   87.69                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 69 - 325 of AKA1_HUMAN_V1, which also corresponds	                                                            
						to amino acids 29 - 285 of HUMALR_P11, wherein said first    	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MAASCVLLHTGQKMPLIGLGTWKSEPGQ...................... 28                                                           
						polypeptide encoding for an edge portion of HUMALR_P11,      	         ||||||||||||||||||||||||||||                        
						comprising a polypeptide having a length "n", wherein n is at	       1 MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKYALSVGYRHIDCAAIY 50                                                           
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      29 ..................AVPREELFVTSKLWNTKHHPEDVEPALRKTLA 60                                                           
						amino acids in length, more preferably at least about 40     	                           ||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	      51 GNEPEIGEALKEDVGPGKAVPREELFVTSKLWNTKHHPEDVEPALRKTLA 100                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise QA, having a structure as follows: a sequence       	      61 DLQLEYLDLYLMHWPYAFERGDNPFPKNADGTICYDSTHYKETWKALEAL 110                                                          
						starting from any of amino acid numbers 28-x to 29; and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 29+ ((n-2) - x), in which	     101 DLQLEYLDLYLMHWPYAFERGDNPFPKNADGTICYDSTHYKETWKALEAL 150                                                          
						x varies from 0 to n-2.                                      	                  .         .         .         .         .  
						                                                            	     111 VAKGLVQALGLSNFNSRQIDDILSVASVRPAVLQVECHPYLAQNELIAHC 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VAKGLVQALGLSNFNSRQIDDILSVASVRPAVLQVECHPYLAQNELIAHC 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 QARGLEVTAYSPLGSSDRAWRDPDEPVLLEEPVVLALAEKYGRSPAQILL 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 QARGLEVTAYSPLGSSDRAWRDPDEPVLLEEPVVLALAEKYGRSPAQILL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 RWQVQRKVICIPKSITPSRILQNIKVFDFTFSPEEMKQLNALNKNWRYIV 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RWQVQRKVICIPKSITPSRILQNIKVFDFTFSPEEMKQLNALNKNWRYIV 300                                                          
						                                                            	                  .         .                                
						                                                            	     261 PMLTVDGKRVPRDAGHPLYPFNDPY                          285                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     301 PMLTVDGKRVPRDAGHPLYPFNDPY                          325                                                          

9309	HMR136_HUMAMGY_1_tr0_r1_1_gPRT		Comparison report between HUMAMGY_P1 and AMEY_HUMANpartial   	Sequence name: AMEY_HUMAN                                    
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for HUMAMGY_P1, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MGTWILFACLVGAAFAMPLPPHPGHPGYINFSYE corresponding to amino    	Alignment of: 9309 x AMEY_HUMAN   ..                         
						acids 1 - 34 of AMEY_HUMAN, which also corresponds to amino  	                                                            
						acids 1 - 34 of HUMAMGY_P1, a second amino acid sequence     	Alignment segment 1/1:                                       
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	                     Quality: 1923.00                      Escore:       0                                               
						at least 95% homologous to a polypeptide having the sequence 	             Matching length:     192                Total length:     206                                               
						NSHSQAINVDRIAL corresponding to amino acids 35 - 48 of       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HUMAMGY_P1, and a third amino acid sequence being at least 90	    Total Percent Similarity:   93.20      Total Percent Identity:   93.20                                               
						VLTPLKWYQSMIRPPYSSYGYEPMGGWLHHQIIPVVSQQHPLTHTLQSHHHIPVVPAQQP 	                        Gaps:       1                        
						RVRQQALMPVPGQQSMTPTQHHQPNLPLPAQQPFQPQPVQPQPHQPMQPQPPVQPMQPLL 	                                                            
						PQPPLPPMFPLRPLPPILPDLHLEAWPATDKTKQEEVD                       	Alignment:                                                   
						% homologous to corresponding to amino acids 35 - 192 of     	                  .         .         .         .         .  
						AMEY_HUMAN, which also corresponds to amino acids 49 - 206 of	       1 MGTWILFACLVGAAFAMPLPPHPGHPGYINFSYENSHSQAINVDRIALVL 50                                                           
						HUMAMGY_P1, wherein said first amino acid sequence, second   	         ||||||||||||||||||||||||||||||||||              ||  
						amino acid sequence and third amino acid sequence are        	       1 MGTWILFACLVGAAFAMPLPPHPGHPGYINFSYE..............VL 36                                                           
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of HUMAMGY_P1,      	      51 TPLKWYQSMIRPPYSSYGYEPMGGWLHHQIIPVVSQQHPLTHTLQSHHHI 100                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      37 TPLKWYQSMIRPPYSSYGYEPMGGWLHHQIIPVVSQQHPLTHTLQSHHHI 86                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     101 PVVPAQQPRVRQQALMPVPGQQSMTPTQHHQPNLPLPAQQPFQPQPVQPQ 150                                                          
						NSHSQAINVDRIAL, corresponding to HUMAMGY_P1.                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      87 PVVPAQQPRVRQQALMPVPGQQSMTPTQHHQPNLPLPAQQPFQPQPVQPQ 136                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PHQPMQPQPPVQPMQPLLPQPPLPPMFPLRPLPPILPDLHLEAWPATDKT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     137 PHQPMQPQPPVQPMQPLLPQPPLPPMFPLRPLPPILPDLHLEAWPATDKT 186                                                          
						                                                            	                                                             
						                                                            	     201 KQEEVD                                             206                                                          
						                                                            	         ||||||                                              
						                                                            	     187 KQEEVD                                             192                                                          

9311	HMR136_HUMAMGY_2_tr0_r1_1_gPRT		Comparison report between HUMAMGY_P2 and AMEY_HUMANpartial   	Sequence name: AMEY_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMAMGY_P2, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGTWILFACLVGAAFAMPLPPHPGHPGYINFSYEVLTPLKWYQSMIRPP            	Alignment of: 9311 x AMEY_HUMAN   ..                         
						corresponding to amino acids 1 - 49 of AMEY_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 49 of HUMAMGY_P2, and a second	Alignment segment 1/1:                                       
						HPLTHTLQSHHHIPVVPAQQPRVRQQALMPVPGQQSMTPTQHHQPNLPLPAQQPFQPQPV 	                                                            
						QPQPHQPMQPQPPVQPMQPLLPQPPLPPMFPLRPLPPILPDLHLEAWPATDKTKQEEVD  	                     Quality: 1671.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     168                Total length:     192                                               
						corresponding to amino acids 74 - 192 of AMEY_HUMAN, which   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 50 - 168 of HUMAMGY_P2,      	    Total Percent Similarity:   87.50      Total Percent Identity:   87.50                                               
						wherein said first amino acid sequence and second amino acid 	                        Gaps:       1                        
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	Alignment:                                                   
						HUMAMGY_P2, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	       1 MGTWILFACLVGAAFAMPLPPHPGHPGYINFSYEVLTPLKWYQSMIRPP. 49                                                           
						optionally at least about 20 amino acids in length,          	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						preferably at least about 30 amino acids in length, more     	       1 MGTWILFACLVGAAFAMPLPPHPGHPGYINFSYEVLTPLKWYQSMIRPPY 50                                                           
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      50 .......................HPLTHTLQSHHHIPVVPAQQPRVRQQA 76                                                           
						at least two amino acids comprise PH, having a structure as  	                                |||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	      51 SSYGYEPMGGWLHHQIIPVVSQQHPLTHTLQSHHHIPVVPAQQPRVRQQA 100                                                          
						49-x to 50; and ending at any of amino acid numbers 50+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      77 LMPVPGQQSMTPTQHHQPNLPLPAQQPFQPQPVQPQPHQPMQPQPPVQPM 126                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LMPVPGQQSMTPTQHHQPNLPLPAQQPFQPQPVQPQPHQPMQPQPPVQPM 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	     127 QPLLPQPPLPPMFPLRPLPPILPDLHLEAWPATDKTKQEEVD         168                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     151 QPLLPQPPLPPMFPLRPLPPILPDLHLEAWPATDKTKQEEVD         192                                                          

4861	HMR136_HUMAMINOP_4_tr0_r1_1_gPRT		Comparison report between HUMAMINOP_P4 and                   	Sequence name: AMPE_HUMAN_V1                                 
						AMPE_HUMAN_V1partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMAMINOP_P4, comprising a first amino acid sequence being at	                                                            
						MNFAEREGSKRYCIQTKHVAILCAVVVGVGLIVGLAVGLTRSCDSSGDGGPGTAPAPSHL 	Alignment of: 4861 x AMPE_HUMAN_V1   ..                      
						PSSTASPSGPPAQDQDICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVS 	                                                            
						ISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPS 	Alignment segment 1/1:                                       
						SGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGRVKSIVATDHEPTDARKSFPCFDEPNKK 	                                                            
						ATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRI 	                     Quality: 7362.00                      Escore:       0                                               
						SNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAME 	             Matching length:     743                Total length:     743                                               
						NWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFAS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTR 	                        Gaps:       0                        
						QMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSE 	                                                            
						KEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLID 	Alignment:                                                   
						DAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYF 	                  .         .         .         .         .  
						QGQVKPIADSLGWNDAGDHVTKL                                      	       1 MNFAEREGSKRYCIQTKHVAILCAVVVGVGLIVGLAVGLTRSCDSSGDGG 50                                                           
						least 90 % homologous to corresponding to amino acids 1 - 743	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of AMPE_HUMAN_V1, which also corresponds to amino acids 1 -  	       1 MNFAEREGSKRYCIQTKHVAILCAVVVGVGLIVGLAVGLTRSCDSSGDGG 50                                                           
						743 of HUMAMINOP_P4, and a second amino acid sequence being  	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	      51 PGTAPAPSHLPSSTASPSGPPAQDQDICPASEDESGQWKNFRLPDFVNPV 100                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 95% homologous to a polypeptide having the sequence    	      51 PGTAPAPSHLPSSTASPSGPPAQDQDICPASEDESGQWKNFRLPDFVNPV 100                                                          
						FSLFNN corresponding to amino acids 744 - 749 of             	                  .         .         .         .         .  
						HUMAMINOP_P4, wherein said first amino acid sequence and     	     101 HYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRP 150                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     101 HYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRP 150                                                          
						HUMAMINOP_P4, comprising a polypeptide being at least 70%,   	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     151 SGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSL 200                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence FSLFNN in         	     151 SGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSL 200                                                          
						HUMAMINOP_P4.                                                	                  .         .         .         .         .  
						                                                            	     201 VGFYRTTYTENGRVKSIVATDHEPTDARKSFPCFDEPNKKATYTISITHP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VGFYRTTYTENGRVKSIVATDHEPTDARKSFPCFDEPNKKATYTISITHP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRI 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 IPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWF 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 DDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQK 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQK 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVN 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSE 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 KEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTF 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 KEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTF 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 SSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 SSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVT 700                                                          
						                                                            	                  .         .         .         .            
						                                                            	     701 YIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKL        743                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     701 YIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKL        743                                                          

10485	HMR136_HUMANK_11_tr0_r1_1_gPRT		Comparison report between HUMANK_P11 and                     	Sequence name: ANK1_HUMAN_V1                                 
						ANK1_HUMAN_V1partial WT sequence followed by unique insertion	                                                            
						and a followed by a unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for HUMANK_P11, comprising a first amino	                                                            
						MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLHLASKEGHVKM 	Alignment of: 10485 x ANK1_HUMAN_V1   ..                     
						VVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNYGANVNAQSQKGFTPLYMAAQ 	                                                            
						ENHLEVVKFLLENGANQNVATEDGFTPLAVALQQGHENVVAHLINYGTKGKVRLPALHIA 	Alignment segment 1/1:                                       
						ARNDDTRTAAVLLQNDPNPDVLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGI 	                                                            
						TPLHIASRRGNVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 	                     Quality: 17780.00                      Escore:       0                                              
						KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGHHRVAKVLLDK 	             Matching length:    1848                Total length:    1856                                               
						GAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAVTESGLTPLHVASFMGHLPIV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 	    Total Percent Similarity:   99.57      Total Percent Identity:   99.57                                               
						GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPL 	                        Gaps:       1                        
						HVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 	                                                            
						NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQAN 	Alignment:                                                   
						GNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFL 	                  .         .         .         .         .  
						LQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYI 	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						SVTDVLKVVTDETSFVLVSDKHRMSFPETVDEILDVSEDE                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						to amino acids 1 - 820 of ANK1_HUMAN_V1, which also          	                  .         .         .         .         .  
						corresponds to amino acids 1 - 820 of HUMANK_P11, a second   	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence GTAHITIM corresponding to amino acids 821	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						- 828 of HUMANK_P11, a third amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GEELISFKAERRDSRDVDEEKELLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQA 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						SKEYDEDSLIPSSPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPP 	                  .         .         .         .         .  
						RTCAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVEIPHFASHG 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						RGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGSLEELEKKRVCRIITTDFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQATFPENAVTKRVKLALQAQPVPDELVTK 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						LLGNQATFSPIVTVEPRRRKFHRPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGT 	                  .         .         .         .         .  
						DQAQWEDITGTTKLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMA 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						KFVIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMSLFAELSGN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSFLRKAMKYEDTQHILCHLN 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						ITMPPCAKGSGAEDRRRTPTPLALRYSILSESTPGSLSGTEQAEMKMAVISEHLGLSWAE 	                  .         .         .         .         .  
						LARELQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIV 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						NMLEGSGRQSRNLKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WNEVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAEDSDATGHEW 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						KLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEEGQRSEEKLPGSKRQDDAT 	                  .         .         .         .         .  
						GAGQDSENEVSLVSGHQRGQARITHSPTVSQVTERSQDRLQDWDADGSIVSYLQDAAQGS 	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						WQEEVTQGPHSFQGTSTMTEGLEPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GQEEQVQEAKNTFTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSA 	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						DAAQEHEE                                                     	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 821 -  	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						1848 of ANK1_HUMAN_V1, which also corresponds to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						829 - 1856 of HUMANK_P11, and a fourth amino acid sequence   	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LCAKAHPPGAGQGAGGERGPLLRLAWLHAPAASRSR corresponding to amino  	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						acids 1857 - 1892 of HUMANK_P11, wherein said first amino    	                  .         .         .         .         .  
						acid sequence, second amino acid sequence, third amino acid  	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for an 	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						edge portion of HUMANK_P11, comprising an amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						encoding for GTAHITIM, corresponding to HUMANK_P11.3.An      	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HUMANK_P11,      	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						LCAKAHPPGAGQGAGGERGPLLRLAWLHAPAASRSR in HUMANK_P11.          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KHRMSFPETVDEILDVSEDEGTAHITIMGEELISFKAERRDSRDVDEEKE 850                                                          
						                                                            	         ||||||||||||||||||||        ||||||||||||||||||||||  
						                                                            	     801 KHRMSFPETVDEILDVSEDE........GEELISFKAERRDSRDVDEEKE 842                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     843 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 892                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     893 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 942                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     943 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 992                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     993 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1042                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1043 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1092                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1093 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1142                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1143 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1192                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1193 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1242                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1243 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1292                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1293 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1342                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1343 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1392                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1393 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1442                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1443 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1492                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1493 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1542                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1543 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1592                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1593 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1642                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1643 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1692                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1693 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1742                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1743 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1792                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1793 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1842                                                         
						                                                            	                                                             
						                                                            	    1851 AQEHEE                                             1856                                                         
						                                                            	         ||||||                                              
						                                                            	    1843 AQEHEE                                             1848                                                         

10493	HMR136_HUMANK_12_tr0_r1_1_gPRT		Comparison report between HUMANK_P12 and                     	Sequence name: ANK1_HUMAN_V1                                 
						ANK1_HUMAN_V1partial WT sequence followed by unique insertion	                                                            
						and a followed by a unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for HUMANK_P12, comprising a first amino	                                                            
						MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLHLASKEGHVKM 	Alignment of: 10493 x ANK1_HUMAN_V1   ..                     
						VVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNYGANVNAQSQKGFTPLYMAAQ 	                                                            
						ENHLEVVKFLLENGANQNVATEDGFTPLAVALQQGHENVVAHLINYGTKGKVRLPALHIA 	Alignment segment 1/1:                                       
						ARNDDTRTAAVLLQNDPNPDVLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGI 	                                                            
						TPLHIASRRGNVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 	                     Quality: 18026.00                      Escore:       0                                              
						KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGHHRVAKVLLDK 	             Matching length:    1873                Total length:    1881                                               
						GAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAVTESGLTPLHVASFMGHLPIV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 	    Total Percent Similarity:   99.57      Total Percent Identity:   99.57                                               
						GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPL 	                        Gaps:       1                        
						HVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 	                                                            
						NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQAN 	Alignment:                                                   
						GNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFL 	                  .         .         .         .         .  
						LQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYI 	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						SVTDVLKVVTDETSFVLVSDKHRMSFPETVDEILDVSEDE                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						to amino acids 1 - 820 of ANK1_HUMAN_V1, which also          	                  .         .         .         .         .  
						corresponds to amino acids 1 - 820 of HUMANK_P12, a second   	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence GTAHITIM corresponding to amino acids 821	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						- 828 of HUMANK_P12, a third amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GEELISFKAERRDSRDVDEEKELLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQA 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						SKEYDEDSLIPSSPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPP 	                  .         .         .         .         .  
						RTCAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVEIPHFASHG 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						RGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGSLEELEKKRVCRIITTDFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQATFPENAVTKRVKLALQAQPVPDELVTK 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						LLGNQATFSPIVTVEPRRRKFHRPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGT 	                  .         .         .         .         .  
						DQAQWEDITGTTKLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMA 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						KFVIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMSLFAELSGN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSFLRKAMKYEDTQHILCHLN 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						ITMPPCAKGSGAEDRRRTPTPLALRYSILSESTPGSLSGTEQAEMKMAVISEHLGLSWAE 	                  .         .         .         .         .  
						LARELQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIV 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						NMLEGSGRQSRNLKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WNEVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAEDSDATGHEW 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						KLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEEGQRSEEKLPGSKRQDDAT 	                  .         .         .         .         .  
						GAGQDSENEVSLVSGHQRGQARITHSPTVSQVTERSQDRLQDWDADGSIVSYLQDAAQGS 	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						WQEEVTQGPHSFQGTSTMTEGLEPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GQEEQVQEAKNTFTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSA 	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						DAAQEHEEVTVEGPLEDPSELEVDIDYFMKHSK                            	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 821 -  	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						1873 of ANK1_HUMAN_V1, which also corresponds to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						829 - 1881 of HUMANK_P12, and a fourth amino acid sequence   	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						VLRRPRPWGTQRHHCCLALPGRLRDTSLHSPLYELSLQSLFSLVGSVSATSVWPPFDLLP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFCPSLRSVLLSVSAAVCRWS                                        	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						corresponding to amino acids 1882 - 1962 of HUMANK_P12,      	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence and fourth amino acid    	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						HUMANK_P12, comprising an amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						GTAHITIM, corresponding to HUMANK_P12.3.An isolated          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of HUMANK_P12, comprising a  	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLRRPRPWGTQRHHCCLALPGRLRDTSLHSPLYELSLQSLFSLVGSVSATSVWPPFDLLP 	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						VFCPSLRSVLLSVSAAVCRWS                                        	                  .         .         .         .         .  
						to the sequence in HUMANK_P12.                               	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KHRMSFPETVDEILDVSEDEGTAHITIMGEELISFKAERRDSRDVDEEKE 850                                                          
						                                                            	         ||||||||||||||||||||        ||||||||||||||||||||||  
						                                                            	     801 KHRMSFPETVDEILDVSEDE........GEELISFKAERRDSRDVDEEKE 842                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     843 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 892                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     893 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 942                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     943 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 992                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     993 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1042                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1043 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1092                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1093 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1142                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1143 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1192                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1193 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1242                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1243 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1292                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1293 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1342                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1343 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1392                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1393 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1442                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1443 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1492                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1493 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1542                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1543 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1592                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1593 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1642                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1643 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1692                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1693 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1742                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1743 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1792                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1793 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1842                                                         
						                                                            	                  .         .         .                      
						                                                            	    1851 AQEHEEVTVEGPLEDPSELEVDIDYFMKHSK                    1881                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1843 AQEHEEVTVEGPLEDPSELEVDIDYFMKHSK                    1873                                                         

10487	HMR136_HUMANK_3_tr0_r1_1_gPRT		Comparison report between HUMANK_P3 and ANK1_HUMAN_V1partial 	Sequence name: ANK1_HUMAN_V1                                 
						WT sequence followed by unique insertion and a followed by a 	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						HUMANK_P3, comprising a first amino acid sequence being at   	                                                            
						MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLHLASKEGHVKM 	Alignment of: 10487 x ANK1_HUMAN_V1   ..                     
						VVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNYGANVNAQSQKGFTPLYMAAQ 	                                                            
						ENHLEVVKFLLENGANQNVATEDGFTPLAVALQQGHENVVAHLINYGTKGKVRLPALHIA 	Alignment segment 1/1:                                       
						ARNDDTRTAAVLLQNDPNPDVLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGI 	                                                            
						TPLHIASRRGNVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 	                     Quality: 17792.00                      Escore:       0                                              
						KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGHHRVAKVLLDK 	             Matching length:    1853                Total length:    1861                                               
						GAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAVTESGLTPLHVASFMGHLPIV 	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.84                                               
						KNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 	    Total Percent Similarity:   99.46      Total Percent Identity:   99.41                                               
						GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPL 	                        Gaps:       1                        
						HVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 	                                                            
						NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQAN 	Alignment:                                                   
						GNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFL 	                  .         .         .         .         .  
						LQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYI 	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						SVTDVLKVVTDETSFVLVSDKHRMSFPETVDEILDVSEDE                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 820	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						of ANK1_HUMAN_V1, which also corresponds to amino acids 1 -  	                  .         .         .         .         .  
						820 of HUMANK_P3, a second amino acid sequence being at least	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						homologous to a polypeptide having the sequence GTAHITIM     	                  .         .         .         .         .  
						corresponding to amino acids 821 - 828 of HUMANK_P3, a third 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						GEELISFKAERRDSRDVDEEKELLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKEYDEDSLIPSSPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPP 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						RTCAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVEIPHFASHG 	                  .         .         .         .         .  
						RGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGSLEELEKKRVCRIITTDFP 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						LYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQATFPENAVTKRVKLALQAQPVPDELVTK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLGNQATFSPIVTVEPRRRKFHRPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGT 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						DQAQWEDITGTTKLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMA 	                  .         .         .         .         .  
						KFVIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMSLFAELSGN 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						LVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSFLRKAMKYEDTQHILCHLN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ITMPPCAKGSGAEDRRRTPTPLALRYSILSESTPGSLSGTEQAEMKMAVISEHLGLSWAE 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						LARELQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIV 	                  .         .         .         .         .  
						NMLEGSGRQSRNLKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQY 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						WNEVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAEDSDATGHEW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEEGQRSEEKLPGSKRQDDAT 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						GAGQDSENEVSLVSGHQRGQARITHSPTVSQVTERSQDRLQDWDADGSIVSYLQDAAQGS 	                  .         .         .         .         .  
						WQEEVTQGPHSFQGTSTMTEGLEPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQ 	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						GQEEQVQEAKNTFTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DAAQEHEEV                                                    	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 821 - 1849 of ANK1_HUMAN_V1,    	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						which also corresponds to amino acids 829 - 1857 of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMANK_P3, and a fourth amino acid sequence being at least   	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELRGSGLQPDLIEGRKGAQIVKRASLKRGKQ corresponding to amino acids 	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						1858 - 1888 of HUMANK_P3, wherein said first amino acid      	                  .         .         .         .         .  
						sequence, second amino acid sequence, third amino acid       	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for an 	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						edge portion of HUMANK_P3, comprising an amino acid sequence 	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						encoding for GTAHITIM, corresponding to HUMANK_P3.3.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HUMANK_P3,       	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						ELRGSGLQPDLIEGRKGAQIVKRASLKRGKQ in HUMANK_P3.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KHRMSFPETVDEILDVSEDEGTAHITIMGEELISFKAERRDSRDVDEEKE 850                                                          
						                                                            	         ||||||||||||||||||||        ||||||||||||||||||||||  
						                                                            	     801 KHRMSFPETVDEILDVSEDE........GEELISFKAERRDSRDVDEEKE 842                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     843 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 892                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     893 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 942                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     943 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 992                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     993 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1042                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1043 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1092                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1093 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1142                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1143 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1192                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1193 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1242                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1243 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1292                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1293 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1342                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1343 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1392                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1393 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1442                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1443 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1492                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1493 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1542                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1543 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1592                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1593 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1642                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1643 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1692                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1693 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1742                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1743 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1792                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1793 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1842                                                         
						                                                            	                  .                                          
						                                                            	    1851 AQEHEEVELRG                                        1861                                                         
						                                                            	         ||||||| : |                                         
						                                                            	    1843 AQEHEEVTVEG                                        1853                                                         

10491	HMR136_HUMANK_5_tr0_r1_1_gPRT		Comparison report between HUMANK_P5 and ANK1_HUMAN_V1partial 	Sequence name: ANK1_HUMAN_V1                                 
						WT sequence followed by unique insertion and a followed by a 	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						HUMANK_P5, comprising a first amino acid sequence being at   	                                                            
						MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLHLASKEGHVKM 	Alignment of: 10491 x ANK1_HUMAN_V1   ..                     
						VVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNYGANVNAQSQKGFTPLYMAAQ 	                                                            
						ENHLEVVKFLLENGANQNVATEDGFTPLAVALQQGHENVVAHLINYGTKGKVRLPALHIA 	Alignment segment 1/1:                                       
						ARNDDTRTAAVLLQNDPNPDVLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGI 	                                                            
						TPLHIASRRGNVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 	                     Quality: 18026.00                      Escore:       0                                              
						KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGHHRVAKVLLDK 	             Matching length:    1873                Total length:    1881                                               
						GAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAVTESGLTPLHVASFMGHLPIV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 	    Total Percent Similarity:   99.57      Total Percent Identity:   99.57                                               
						GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPL 	                        Gaps:       1                        
						HVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 	                                                            
						NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQAN 	Alignment:                                                   
						GNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFL 	                  .         .         .         .         .  
						LQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYI 	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						SVTDVLKVVTDETSFVLVSDKHRMSFPETVDEILDVSEDE                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 820	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						of ANK1_HUMAN_V1, which also corresponds to amino acids 1 -  	                  .         .         .         .         .  
						820 of HUMANK_P5, a second amino acid sequence being at least	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						homologous to a polypeptide having the sequence GTAHITIM     	                  .         .         .         .         .  
						corresponding to amino acids 821 - 828 of HUMANK_P5, a third 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						GEELISFKAERRDSRDVDEEKELLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKEYDEDSLIPSSPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPP 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						RTCAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVEIPHFASHG 	                  .         .         .         .         .  
						RGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGSLEELEKKRVCRIITTDFP 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						LYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQATFPENAVTKRVKLALQAQPVPDELVTK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLGNQATFSPIVTVEPRRRKFHRPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGT 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						DQAQWEDITGTTKLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMA 	                  .         .         .         .         .  
						KFVIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMSLFAELSGN 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						LVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSFLRKAMKYEDTQHILCHLN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ITMPPCAKGSGAEDRRRTPTPLALRYSILSESTPGSLSGTEQAEMKMAVISEHLGLSWAE 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						LARELQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIV 	                  .         .         .         .         .  
						NMLEGSGRQSRNLKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQY 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						WNEVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAEDSDATGHEW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEEGQRSEEKLPGSKRQDDAT 	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						GAGQDSENEVSLVSGHQRGQARITHSPTVSQVTERSQDRLQDWDADGSIVSYLQDAAQGS 	                  .         .         .         .         .  
						WQEEVTQGPHSFQGTSTMTEGLEPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQ 	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						GQEEQVQEAKNTFTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DAAQEHEEVTVEGPLEDPSELEVDIDYFMKHSK                            	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 821 - 1873 of ANK1_HUMAN_V1,    	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						which also corresponds to amino acids 829 - 1881 of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMANK_P5, and a fourth amino acid sequence being at least   	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						VLRRPRPWGTQRHHCCLALPGRLRDTSLHSPLYELSLQSLFSLVGSVSATSVWPPFDLLP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFCPSLRSVLLSVSAAVCRWS                                        	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1882 - 1962 of HUMANK_P5, wherein said first  	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						amino acid sequence, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and fourth amino acid sequence are contiguous  	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for an edge portion of HUMANK_P5, comprising an amino acid   	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for GTAHITIM, corresponding to             	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						HUMANK_P5.3.An isolated polypeptide encoding for a tail of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMANK_P5, comprising a polypeptide being at least 70%,      	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						VLRRPRPWGTQRHHCCLALPGRLRDTSLHSPLYELSLQSLFSLVGSVSATSVWPPFDLLP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFCPSLRSVLLSVSAAVCRWS                                        	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						least about 95% homologous to the sequence in HUMANK_P5.     	                  .         .         .         .         .  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KHRMSFPETVDEILDVSEDEGTAHITIMGEELISFKAERRDSRDVDEEKE 850                                                          
						                                                            	         ||||||||||||||||||||        ||||||||||||||||||||||  
						                                                            	     801 KHRMSFPETVDEILDVSEDE........GEELISFKAERRDSRDVDEEKE 842                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     843 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 892                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     893 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 942                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     943 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 992                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     993 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1042                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1043 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1092                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1093 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1142                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1143 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1192                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1193 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1242                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1243 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1292                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1293 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1342                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1343 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1392                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1393 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1442                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1443 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1492                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1493 LKPDRRHTDRDYSLSPSQMNGYSSLQDELLSPASLGCALSSPLRADQYWN 1542                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1543 EVAVLDAIPLAATEHDTMLEMSDMQVWSAGLTPSLVTAEDSSLECSKAED 1592                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1593 SDATGHEWKLEGALSEEPRGPELGSLELVEDDTVDSDATNGLIDLLEQEE 1642                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1643 GQRSEEKLPGSKRQDDATGAGQDSENEVSLVSGHQRGQARITHSPTVSQV 1692                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1693 TERSQDRLQDWDADGSIVSYLQDAAQGSWQEEVTQGPHSFQGTSTMTEGL 1742                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1743 EPGGSQEYEKVLVSVSEHTWTEQPEAESSQADRDRRQQGQEEQVQEAKNT 1792                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1793 FTQVVQGNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSSADA 1842                                                         
						                                                            	                  .         .         .                      
						                                                            	    1851 AQEHEEVTVEGPLEDPSELEVDIDYFMKHSK                    1881                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1843 AQEHEEVTVEGPLEDPSELEVDIDYFMKHSK                    1873                                                         

10489	HMR136_HUMANK_7_tr0_r1_1_gPRT		Comparison report between HUMANK_P7 and ANK1_HUMAN_V1partial 	Sequence name: ANK1_HUMAN_V1                                 
						WT sequence followed by unique insertion and a followed by a 	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						HUMANK_P7, comprising a first amino acid sequence being at   	                                                            
						MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLHLASKEGHVKM 	Alignment of: 10489 x ANK1_HUMAN_V1   ..                     
						VVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNYGANVNAQSQKGFTPLYMAAQ 	                                                            
						ENHLEVVKFLLENGANQNVATEDGFTPLAVALQQGHENVVAHLINYGTKGKVRLPALHIA 	Alignment segment 1/1:                                       
						ARNDDTRTAAVLLQNDPNPDVLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGI 	                                                            
						TPLHIASRRGNVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 	                     Quality: 14523.00                      Escore:       0                                              
						KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGHHRVAKVLLDK 	             Matching length:    1513                Total length:    1521                                               
						GAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAVTESGLTPLHVASFMGHLPIV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 	    Total Percent Similarity:   99.47      Total Percent Identity:   99.47                                               
						GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPL 	                        Gaps:       1                        
						HVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 	                                                            
						NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQAN 	Alignment:                                                   
						GNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFL 	                  .         .         .         .         .  
						LQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYI 	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						SVTDVLKVVTDETSFVLVSDKHRMSFPETVDEILDVSEDE                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 820	       1 MPYSVGFREADAATSFLRAARSGNLDKALDHLRNGVDINTCNQNGLNGLH 50                                                           
						of ANK1_HUMAN_V1, which also corresponds to amino acids 1 -  	                  .         .         .         .         .  
						820 of HUMANK_P7, a second amino acid sequence being at least	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      51 LASKEGHVKMVVELLHKEIILETTTKKGNTALHIAALAGQDEVVRELVNY 100                                                          
						homologous to a polypeptide having the sequence GTAHITIM     	                  .         .         .         .         .  
						corresponding to amino acids 821 - 828 of HUMANK_P7, a third 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						GEELISFKAERRDSRDVDEEKELLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKEYDEDSLIPSSPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPP 	     101 GANVNAQSQKGFTPLYMAAQENHLEVVKFLLENGANQNVATEDGFTPLAV 150                                                          
						RTCAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVEIPHFASHG 	                  .         .         .         .         .  
						RGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGSLEELEKKRVCRIITTDFP 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						LYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQATFPENAVTKRVKLALQAQPVPDELVTK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLGNQATFSPIVTVEPRRRKFHRPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGT 	     151 ALQQGHENVVAHLINYGTKGKVRLPALHIAARNDDTRTAAVLLQNDPNPD 200                                                          
						DQAQWEDITGTTKLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMA 	                  .         .         .         .         .  
						KFVIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMSLFAELSGN 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						LVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSFLRKAMKYEDTQHILCHLN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ITMPPCAKGSGAEDRRRTPTPLALRYSILSESTPGSLSGTEQAEMKMAVISEHLGLSWAE 	     201 VLSKTGFTPLHIAAHYENLNVAQLLLNRGASVNFTPQNGITPLHIASRRG 250                                                          
						LARELQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIV 	                  .         .         .         .         .  
						NMLEGSGRQSRNLKPDRRHTDRDYSLSPSQMNG                            	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 821 - 1513 of ANK1_HUMAN_V1,    	     251 NVIMVRLLLDRGAQIETKTKDELTPLHCAARNGHVRISEILLDHGAPIQA 300                                                          
						which also corresponds to amino acids 829 - 1521 of          	                  .         .         .         .         .  
						HUMANK_P7, and a fourth amino acid sequence being at least   	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     301 KTKNGLSPIHMAAQGDHLDCVRLLLQYDAEIDDITLDHLTPLHVAAHCGH 350                                                          
						homologous to a polypeptide having the sequence GRSEVRREAARF 	                  .         .         .         .         .  
						corresponding to amino acids 1522 - 1533 of HUMANK_P7,       	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence and fourth amino acid    	     351 HRVAKVLLDKGAKPNSRALNGFTPLHIACKKNHVRVMELLLKTGASIDAV 400                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						HUMANK_P7, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     401 TESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHT 450                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						GTAHITIM, corresponding to HUMANK_P7.3.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of HUMANK_P7, comprising a   	     451 EVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 500                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence GRSEVRREAARF in HUMANK_P7.                   	     501 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAW 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIV 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KHRMSFPETVDEILDVSEDEGTAHITIMGEELISFKAERRDSRDVDEEKE 850                                                          
						                                                            	         ||||||||||||||||||||        ||||||||||||||||||||||  
						                                                            	     801 KHRMSFPETVDEILDVSEDE........GEELISFKAERRDSRDVDEEKE 842                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     843 LLDFVPKLDQVVESPAIPRIPCAMPETVVIRSEEQEQASKEYDEDSLIPS 892                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     893 SPATETSDNISPVASPVHTGFLVSFMVDARGGSMRGSRHNGLRVVIPPRT 942                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     943 CAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVE 992                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     993 IPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGS 1042                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1043 LEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQ 1092                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1093 ATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFH 1142                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1143 RPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTT 1192                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1193 KLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKELTAVPYMAKF 1242                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1243 VIFAKMNDPREGRLRCYCMTDDKVDKTLEQHENFVEVARSRDIEVLEGMS 1292                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1293 LFAELSGNLVPVKKAAQQRSFHFQSFRENRLAMPVKVRDSSREPGGSLSF 1342                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1343 LRKAMKYEDTQHILCHLNITMPPCAKGSGAEDRRRTPTPLALRYSILSES 1392                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1393 TPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNS 1442                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1443 LLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRN 1492                                                         
						                                                            	                  .         .                                
						                                                            	    1501 LKPDRRHTDRDYSLSPSQMNG                              1521                                                         
						                                                            	         |||||||||||||||||||||                               
						                                                            	    1493 LKPDRRHTDRDYSLSPSQMNG                              1513                                                         

11707	HMR136_HUMANTNCB_10_tr0_r1_1_gPRT		Comparison report between HUMANTNCB_P10 and                  	Sequence name: TR2A_HUMAN                                    
						TR2A_HUMANpartial WT sequence followed by unique             	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						HUMANTNCB_P10, comprising a first amino acid sequence being  	                                                            
						at least 90 % homologous to MSDVEENNFEGR corresponding to    	Alignment of: 11707 x TR2A_HUMAN   ..                        
						amino acids 1 - 12 of TR2A_HUMAN, which also corresponds to  	                                                            
						amino acids 1 - 12 of HUMANTNCB_P10, a second amino acid     	Alignment segment 1/1:                                       
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                     Quality: 2708.00                      Escore:       0                                               
						most preferably at least 95% homologous to a polypeptide     	             Matching length:     282                Total length:     311                                               
						having the sequence ASLCLLRGVGPRRGWAGGGGRELPSVRIV            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 13 - 41 of HUMANTNCB_P10, and a 	    Total Percent Similarity:   90.68      Total Percent Identity:   90.68                                               
						ESRSQSKSPTGTPARVKSESRSGSRSPSRVSKHSESHSRSRSKSRSRSRRHSHRRYTRSR 	                        Gaps:       1                        
						SHSHSHRRRSRSRSYTPEYRRRRSRSHSPMSNRRRHTGSRANPDPNTCLGVFGLSLYTTE 	                                                            
						RDLREVFSRYGPLSGVNVVYDQRTGRSRGFAFVYFERIDDSKEAMERANGMELDGRRIRV 	Alignment:                                                   
						DYSITKRAHTPTPGIYMGRPTHSGGGGGGGGGGGGGGGGRRRDSYYDRGYDRGYDRYEDY 	                  .         .         .         .         .  
						DYRYRRRSPSPYYSRYRSRSRSRSYSPRRY                               	       1 MSDVEENNFEGRASLCLLRGVGPRRGWAGGGGRELPSVRIVESRSQSKSP 50                                                           
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||                             |||||||||  
						corresponding to amino acids 13 - 282 of TR2A_HUMAN, which   	       1 MSDVEENNFEGR.............................ESRSQSKSP 21                                                           
						also corresponds to amino acids 42 - 311 of HUMANTNCB_P10,   	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      51 TGTPARVKSESRSGSRSPSRVSKHSESHSRSRSKSRSRSRRHSHRRYTRS 100                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for an 	      22 TGTPARVKSESRSGSRSPSRVSKHSESHSRSRSKSRSRSRRHSHRRYTRS 71                                                           
						edge portion of HUMANTNCB_P10, comprising an amino acid      	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least about 80%,  	     101 RSHSHSHRRRSRSRSYTPEYRRRRSRSHSPMSNRRRHTGSRANPDPNTCL 150                                                          
						preferably at least about 85%, more preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least about 95% homologous to the 	      72 RSHSHSHRRRSRSRSYTPEYRRRRSRSHSPMSNRRRHTGSRANPDPNTCL 121                                                          
						sequence encoding for ASLCLLRGVGPRRGWAGGGGRELPSVRIV,         	                  .         .         .         .         .  
						corresponding to HUMANTNCB_P10.                              	     151 GVFGLSLYTTERDLREVFSRYGPLSGVNVVYDQRTGRSRGFAFVYFERID 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     122 GVFGLSLYTTERDLREVFSRYGPLSGVNVVYDQRTGRSRGFAFVYFERID 171                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DSKEAMERANGMELDGRRIRVDYSITKRAHTPTPGIYMGRPTHSGGGGGG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 DSKEAMERANGMELDGRRIRVDYSITKRAHTPTPGIYMGRPTHSGGGGGG 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GGGGGGGGGGRRRDSYYDRGYDRGYDRYEDYDYRYRRRSPSPYYSRYRSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 GGGGGGGGGGRRRDSYYDRGYDRGYDRYEDYDYRYRRRSPSPYYSRYRSR 271                                                          
						                                                            	                  .                                          
						                                                            	     301 SRSRSYSPRRY                                        311                                                          
						                                                            	         |||||||||||                                         
						                                                            	     272 SRSRSYSPRRY                                        282                                                          

11704	HMR136_HUMANTNCB_7_tr0_r1_1_gPRT		Comparison report between HUMANTNCB_P7 and TR2A_HUMANpartial 	Sequence name: TR2A_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMANTNCB_P7, comprising a first    	                                                            
						MSNRRRHTGSRANPDPNTCLGVFGLSLYTTERDLREVFSRYGPLSGVNVVYDQRTGRSRG 	Alignment of: 11704 x TR2A_HUMAN   ..                        
						FAFVYFERIDDSKEAMERANGMELDGRRIRVDYSITKRAHTPTPGIYMGRPTHSGGGGGG 	                                                            
						GGGGGGGGGGRRRDSYYDRGYDRGYDRYEDYDYRYRRRSPSPYYSRYRSRSRSRSYSPRR 	Alignment segment 1/1:                                       
						Y                                                            	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 1798.00                      Escore:       0                                               
						corresponding to amino acids 102 - 282 of TR2A_HUMAN, which  	             Matching length:     181                Total length:     181                                               
						also corresponds to amino acids 1 - 181 of HUMANTNCB_P7.     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSNRRRHTGSRANPDPNTCLGVFGLSLYTTERDLREVFSRYGPLSGVNVV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 MSNRRRHTGSRANPDPNTCLGVFGLSLYTTERDLREVFSRYGPLSGVNVV 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YDQRTGRSRGFAFVYFERIDDSKEAMERANGMELDGRRIRVDYSITKRAH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 YDQRTGRSRGFAFVYFERIDDSKEAMERANGMELDGRRIRVDYSITKRAH 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPTPGIYMGRPTHSGGGGGGGGGGGGGGGGRRRDSYYDRGYDRGYDRYED 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 TPTPGIYMGRPTHSGGGGGGGGGGGGGGGGRRRDSYYDRGYDRGYDRYED 251                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 YDYRYRRRSPSPYYSRYRSRSRSRSYSPRRY                    181                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     252 YDYRYRRRSPSPYYSRYRSRSRSRSYSPRRY                    282                                                          

11894	HMR136_HUMANX3_11_tr0_r1_1_gPRT		Comparison report between HUMANX3_P11 and ANX3_HUMANpartial  	Sequence name: ANX3_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMANX3_P11, comprising a first     	Sequence documentation:                                      
						MASIWVGHRGTVRDYPDFSPSVDAEAIQKAIRGIGTDEKMLISILTERSNAQRQLIVKEY 	                                                            
						QAAYGKELKDDLKGDLSGHFEHLMVALVTPPAVFDAKQLKKSMKGAGTNEDALIEILTTR 	Alignment of: 11894 x ANX3_HUMAN   ..                        
						TSRQMKDISQAYYTVYKKSLGDDISSETSGDFRKALLTLAD                    	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 161 of ANX3_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 161 of HUMANX3_P11, and a	                     Quality: 1538.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     163                Total length:     163                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:   99.39   Matching Percent Identity:   99.39                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:   99.39      Total Percent Identity:   99.39                                               
						polypeptide having the sequence VRFYFL corresponding to amino	                        Gaps:       0                        
						acids 162 - 167 of HUMANX3_P11, wherein said first amino acid	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of HUMANX3_P11, comprising a polypeptide being at least 	       1 MASIWVGHRGTVRDYPDFSPSVDAEAIQKAIRGIGTDEKMLISILTERSN 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       1 MASIWVGHRGTVRDYPDFSPSVDAEAIQKAIRGIGTDEKMLISILTERSN 50                                                           
						at least about 95% homologous to the sequence VRFYFL in      	                  .         .         .         .         .  
						HUMANX3_P11.                                                 	      51 AQRQLIVKEYQAAYGKELKDDLKGDLSGHFEHLMVALVTPPAVFDAKQLK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 AQRQLIVKEYQAAYGKELKDDLKGDLSGHFEHLMVALVTPPAVFDAKQLK 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KSMKGAGTNEDALIEILTTRTSRQMKDISQAYYTVYKKSLGDDISSETSG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KSMKGAGTNEDALIEILTTRTSRQMKDISQAYYTVYKKSLGDDISSETSG 150                                                          
						                                                            	                  .                                          
						                                                            	     151 DFRKALLTLADVR                                      163                                                          
						                                                            	         ||||||||||| |                                       
						                                                            	     151 DFRKALLTLADGR                                      163                                                          

11892	HMR136_HUMANX3_9_tr0_r1_1_gPRT		Comparison report between HUMANX3_P9 and ANX3_HUMANpartial   	Sequence name: ANX3_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMANX3_P9, comprising a first amino	                                                            
						MVALVTPPAVFDAKQLKKSMKGAGTNEDALIEILTTRTSRQMKDISQAYYTVYKKSLGDD 	Alignment of: 11892 x ANX3_HUMAN   ..                        
						ISSETSGDFRKALLTLADGRRDESLKVDEHLAKQDAQILYKAGENRWGTDEDKFTEILCL 	                                                            
						RSFPQLKLTFDEYRNISQKDIVDSIKGELSGHFEDLLLAIVNCVRNTPAFLAERLHRALK 	Alignment segment 1/1:                                       
						GIGTDEFTLNRIMVSRSEIDLLDIRTEFKKHYGYSLYSAIKSDTSGDYEITLLKICGGDD 	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2297.00                      Escore:       0                                               
						to amino acids 84 - 323 of ANX3_HUMAN, which also corresponds	             Matching length:     240                Total length:     240                                               
						to amino acids 1 - 240 of HUMANX3_P9.                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVALVTPPAVFDAKQLKKSMKGAGTNEDALIEILTTRTSRQMKDISQAYY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      84 MVALVTPPAVFDAKQLKKSMKGAGTNEDALIEILTTRTSRQMKDISQAYY 133                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TVYKKSLGDDISSETSGDFRKALLTLADGRRDESLKVDEHLAKQDAQILY 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     134 TVYKKSLGDDISSETSGDFRKALLTLADGRRDESLKVDEHLAKQDAQILY 183                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KAGENRWGTDEDKFTEILCLRSFPQLKLTFDEYRNISQKDIVDSIKGELS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     184 KAGENRWGTDEDKFTEILCLRSFPQLKLTFDEYRNISQKDIVDSIKGELS 233                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GHFEDLLLAIVNCVRNTPAFLAERLHRALKGIGTDEFTLNRIMVSRSEID 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     234 GHFEDLLLAIVNCVRNTPAFLAERLHRALKGIGTDEFTLNRIMVSRSEID 283                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 LLDIRTEFKKHYGYSLYSAIKSDTSGDYEITLLKICGGDD           240                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     284 LLDIRTEFKKHYGYSLYSAIKSDTSGDYEITLLKICGGDD           323                                                          

12044	HMR136_HUMANXVIII_4_tr0_r1_1_gPRT		Comparison report between HUMANXVIII_P4 and                  	Sequence name: ANX8_HUMAN_V4                                 
						ANX8_HUMAN_V4unique head followed by partial WT sequence     	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMANXVIII_P4, comprising a first amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 12044 x ANX8_HUMAN_V4   ..                     
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						CLGGAWEPQEMPKARQSPGARGRQAGVALPWAGLHPHTQVSGLLTPQLQEPDVWSPSRGQ 	                                                            
						PVSLHLPGKGAPEVKE                                             	                     Quality: 1784.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 76 of   	             Matching length:     184                Total length:     184                                               
						HUMANXVIII_P4, a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MAWWKSWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTKRSNTQRQQIA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAKELHDAMKGLGTKEGVIIEIL 	                        Gaps:       0                        
						ASRTKNQLREIMKAYEEDYGSSLEEDIQADTSGYLERILVCLLQGSRDDVSSFVDPGLAL 	                                                            
						QDAQ                                                         	Alignment:                                                   
						% homologous to corresponding to amino acids 1 - 184 of      	                  .         .         .         .         .  
						ANX8_HUMAN_V4, which also corresponds to amino acids 77 - 260	      77 MAWWKSWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTK 126                                                          
						of HUMANXVIII_P4, and a third amino acid sequence being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	       1 MAWWKSWIEQEGVTVKSSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTK 50                                                           
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence SPLHSV       	     127 RSNTQRQQIAKSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAK 176                                                          
						corresponding to amino acids 261 - 266 of HUMANXVIII_P4,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	      51 RSNTQRQQIAKSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAK 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     177 ELHDAMKGLGTKEGVIIEILASRTKNQLREIMKAYEEDYGSSLEEDIQAD 226                                                          
						head of HUMANXVIII_P4, comprising a polypeptide being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     101 ELHDAMKGLGTKEGVIIEILASRTKNQLREIMKAYEEDYGSSLEEDIQAD 150                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .                      
						CLGGAWEPQEMPKARQSPGARGRQAGVALPWAGLHPHTQVSGLLTPQLQEPDVWSPSRGQ 	     227 TSGYLERILVCLLQGSRDDVSSFVDPGLALQDAQ                 260                                                          
						PVSLHLPGKGAPEVKE                                             	         ||||||||||||||||||||||||||||||||||                  
						preferably at least about 95% homologous to the sequence of  	     151 TSGYLERILVCLLQGSRDDVSSFVDPGLALQDAQ                 184                                                          
						HUMANXVIII_P4.3.An isolated polypeptide encoding for a tail  	                                                            
						of HUMANXVIII_P4, comprising a polypeptide being at least    	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence SPLHSV in      	                                                            
						HUMANXVIII_P4.                                               	                                                            

12425	HMR136_HUMAP2_15_tr0_r1_1_gPRT		Comparison report between HUMAP2_P15 and AP2A_HUMANshort     	Sequence name: AP2A_HUMAN                                    
						unique head followed by partial WT sequence featuring a      	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						HUMAP2_P15, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12425 x AP2A_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MK           	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 2 of HUMAP2_P15, a second   	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2740.00                      Escore:       0                                               
						MLWKLTDNIKYEDCE corresponding to amino acids 1 - 15 of       	             Matching length:     292                Total length:     437                                               
						AP2A_HUMAN, which also corresponds to amino acids 3 - 17 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HUMAP2_P15, and a third amino acid sequence being at least 90	    Total Percent Similarity:   66.82      Total Percent Identity:   66.82                                               
						HVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVPGRLSL 	                        Gaps:       1                        
						LSSTSKYKVTVAEVQRRLSPPECLNASLLGGVLRRAKSKNGGRSLREKLDKIGLNLPAGR 	                                                            
						RKAANVTLLTSLVEGEAVHLARDFGYVCETEFPAKAVAEFLNRQHSDPNEQVTRKNMLLA 	Alignment:                                                   
						TKQICKEFTDLLAQDRSPLGNSRPNPILEPGIQSCLTHFNLISHGFGSPAVCAAVTALQN 	                  .         .         .         .         .  
						YLTEALKAMDKMYLSNNPNSHTDNNAKSSDKEEKHRK                        	       3 MLWKLTDNIKYEDCE................................... 17                                                           
						% homologous to corresponding to amino acids 161 - 437 of    	         |||||||||||||||                                     
						AP2A_HUMAN, which also corresponds to amino acids 18 - 294 of	       1 MLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPN 50                                                           
						HUMAP2_P15, wherein said first amino acid sequence, second   	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	      17 .................................................. 17                                                           
						contiguous and in a sequential order.2.An isolated chimeric  	                                                            
						polypeptide encoding for an edge portion of HUMAP2_P15,      	      51 ADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQR 100                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	      17 .................................................. 17                                                           
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	     101 QSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSGLGDLSIH 150                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	      18 ..........HVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNL 57                                                           
						comprise EH, having a structure as follows: a sequence       	                   ||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 17-x to 18; and      	     151 SLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNL 200                                                          
						ending at any of amino acid numbers 18+ ((n-2) - x), in which	                  .         .         .         .         .  
						x varies from 0 to n-2.                                      	      58 FGGVVNPNEVFCSVPGRLSLLSSTSKYKVTVAEVQRRLSPPECLNASLLG 107                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FGGVVNPNEVFCSVPGRLSLLSSTSKYKVTVAEVQRRLSPPECLNASLLG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     108 GVLRRAKSKNGGRSLREKLDKIGLNLPAGRRKAANVTLLTSLVEGEAVHL 157                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GVLRRAKSKNGGRSLREKLDKIGLNLPAGRRKAANVTLLTSLVEGEAVHL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     158 ARDFGYVCETEFPAKAVAEFLNRQHSDPNEQVTRKNMLLATKQICKEFTD 207                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ARDFGYVCETEFPAKAVAEFLNRQHSDPNEQVTRKNMLLATKQICKEFTD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     208 LLAQDRSPLGNSRPNPILEPGIQSCLTHFNLISHGFGSPAVCAAVTALQN 257                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LLAQDRSPLGNSRPNPILEPGIQSCLTHFNLISHGFGSPAVCAAVTALQN 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     258 YLTEALKAMDKMYLSNNPNSHTDNNAKSSDKEEKHRK              294                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     401 YLTEALKAMDKMYLSNNPNSHTDNNAKSSDKEEKHRK              437                                                          

12588	HMR136_HUMAPA_14_tr0_r1_1_gPRT		Comparison report between HUMAPA_P14 and A4_HUMANpartial WT  	Sequence name: A4_HUMAN                                      
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for HUMAPA_P14, comprising a first amino	Sequence documentation:                                      
						MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTK 	                                                            
						TCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVG 	Alignment of: 12588 x A4_HUMAN   ..                          
						EFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFR 	                                                            
						GVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEE 	Alignment segment 1/1:                                       
						EADDDEDDEDGDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPC 	                                                            
						RAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARD 	                     Quality: 7444.00                      Escore:       0                                               
						PVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQA 	             Matching length:     762                Total length:     770                                               
						KNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITAL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYER 	    Total Percent Similarity:   98.96      Total Percent Identity:   98.96                                               
						MNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTET 	                        Gaps:       1                        
						KTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGLTTRPGSGLTN 	                                                            
						IKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITL 	Alignment:                                                   
						VMLKKKQYTSIHHGVV                                             	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	       1 MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNG 50                                                           
						to amino acids 1 - 736 of A4_HUMAN, which also corresponds to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 736 of HUMAPA_P14, and a second amino acid   	       1 MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNG 50                                                           
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						EERHLSKMQQNGYENPTYKFFEQMQN corresponding to amino acids 745 -	      51 KWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKR 100                                                          
						770 of A4_HUMAN, which also corresponds to amino acids 737 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						762 of HUMAPA_P14, wherein said first amino acid sequence and	      51 KWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKR 100                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated chimeric polypeptide encoding for an edge	     101 GRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHW 150                                                          
						portion of HUMAPA_P14, comprising a polypeptide having a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     101 GRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHW 150                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     151 HTVAKETCSEKSTNLHDYGMLLPCGIDKFRGVEFVCCPLAEESDNVDSAD 200                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     151 HTVAKETCSEKSTNLHDYGMLLPCGIDKFRGVEFVCCPLAEESDNVDSAD 200                                                          
						at least two amino acids comprise VE, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     201 AEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDED 250                                                          
						736-x to 737; and ending at any of amino acid numbers 737+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     201 AEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDED 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANER 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANER 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 QQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 QQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 EQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 EQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYN 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 VPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTET 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTET 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 KTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGL 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 KTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGL 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 TTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKG 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 TTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 AIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVV........EERHLS 742                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||        ||||||  
						                                                            	     701 AIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVVEVDAAVTPEERHLS 750                                                          
						                                                            	                  .         .                                
						                                                            	     743 KMQQNGYENPTYKFFEQMQN                               762                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     751 KMQQNGYENPTYKFFEQMQN                               770                                                          

12797	HMR136_HUMAPLA_5_tr0_r1_1_gPRT		Comparison report between HUMAPLA_P5 and A2AP_HUMANpartial   	Sequence name: A2AP_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMAPLA_P5, comprising a first amino	                                                            
						MMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVVLVPTHFEWNVSQVLANLSWDTLHPPL 	Alignment of: 12797 x A2AP_HUMAN   ..                        
						VWERPTKVRLPKLYLKHQMDLVATLSQLGLQELFQAPDLRGISEQSLVVSGVQHQSTLEL 	                                                            
						SEVGVEAAAATSIAMSRMSLSSFSVNRPFLFFIFEDTTGLPLFVGSVRNPNPSAPRELKE 	Alignment segment 1/1:                                       
						QQDSPGNKDFLQSLKGFPRGDKLFGPDLKLVPPMEEDYPQFGSPK                	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2228.00                      Escore:       0                                               
						to amino acids 267 - 491 of A2AP_HUMAN, which also           	             Matching length:     225                Total length:     225                                               
						corresponds to amino acids 1 - 225 of HUMAPLA_P5.            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVVLVPTHFEWNVSQVLAN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 MMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVVLVPTHFEWNVSQVLAN 316                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LSWDTLHPPLVWERPTKVRLPKLYLKHQMDLVATLSQLGLQELFQAPDLR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     317 LSWDTLHPPLVWERPTKVRLPKLYLKHQMDLVATLSQLGLQELFQAPDLR 366                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GISEQSLVVSGVQHQSTLELSEVGVEAAAATSIAMSRMSLSSFSVNRPFL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     367 GISEQSLVVSGVQHQSTLELSEVGVEAAAATSIAMSRMSLSSFSVNRPFL 416                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FFIFEDTTGLPLFVGSVRNPNPSAPRELKEQQDSPGNKDFLQSLKGFPRG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     417 FFIFEDTTGLPLFVGSVRNPNPSAPRELKEQQDSPGNKDFLQSLKGFPRG 466                                                          
						                                                            	                  .         .                                
						                                                            	     201 DKLFGPDLKLVPPMEEDYPQFGSPK                          225                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     467 DKLFGPDLKLVPPMEEDYPQFGSPK                          491                                                          

13305	HMR136_HUMARDE_1_tr0_r1_1_gPRT		Comparison report between HUMARDE_P1 and                     	Sequence name: AAAD_HUMAN_V1                                 
						AAAD_HUMAN_V1partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMARDE_P1, comprising a   	                                                            
						MVRFWSEYFTTDRSLEKAMLSRQHVPVESSHLFKFINWSSLLPERFIKGHVYNNPNYGSS 	Alignment of: 13305 x AAAD_HUMAN_V1   ..                     
						ELAKKYPGFLDVRAAPLLADDNKLRGLPLTYVITCQYDLLRDDGLMYVTRLRNTGVQVTH 	                                                            
						NHVEDGFHGAFSFLGLKISHRLINQYIEWLKENL                           	Alignment segment 1/1:                                       
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 246 - 399 of AAAD_HUMAN_V1,     	                     Quality: 1529.00                      Escore:       0                                               
						which also corresponds to amino acids 1 - 154 of HUMARDE_P1. 	             Matching length:     154                Total length:     154                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVRFWSEYFTTDRSLEKAMLSRQHVPVESSHLFKFINWSSLLPERFIKGH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     246 MVRFWSEYFTTDRSLEKAMLSRQHVPVESSHLFKFINWSSLLPERFIKGH 295                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VYNNPNYGSSELAKKYPGFLDVRAAPLLADDNKLRGLPLTYVITCQYDLL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     296 VYNNPNYGSSELAKKYPGFLDVRAAPLLADDNKLRGLPLTYVITCQYDLL 345                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RDDGLMYVTRLRNTGVQVTHNHVEDGFHGAFSFLGLKISHRLINQYIEWL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     346 RDDGLMYVTRLRNTGVQVTHNHVEDGFHGAFSFLGLKISHRLINQYIEWL 395                                                          
						                                                            	                                                             
						                                                            	     151 KENL                                               154                                                          
						                                                            	         ||||                                                
						                                                            	     396 KENL                                               399                                                          

13480	HMR136_HUMARGCAA_2_tr0_r1_1_gPRT		Comparison report between HUMARGCAA_P2 and ABL2_HUMANpartial 	Sequence name: ABL2_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMARGCAA_P2, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFTQH         	Alignment of: 13480 x ABL2_HUMAN   ..                        
						corresponding to amino acids 1 - 52 of ABL2_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 52 of HUMARGCAA_P2, and a     	Alignment segment 1/1:                                       
						EALHRPYGCDVEPQALNEAIRWSSKENLLGATESDPNLFVALYDFVASGDNTLSITKGEK 	                                                            
						LRVLGYNQNGEWSEVRSKNGQGWVPSNYITPVNSLEKHSWYHGPVSRSAAEYLLSSLING 	                     Quality: 11276.00                      Escore:       0                                              
						SFLVRESESSPGQLSISLRYEGRVYHYRINTTADGKVYVTAESRFSTLAELVHHHSTVAD 	             Matching length:    1161                Total length:    1182                                               
						GLVTTLHYPAPKCNKPTVYGVSPIHDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL 	    Total Percent Similarity:   98.22      Total Percent Identity:   98.22                                               
						RECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRL 	                        Gaps:       1                        
						MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 	                                                            
						VYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDSSISEEVA 	Alignment:                                                   
						EELGRAASSSSVVPYLPRLPILPSKTRTLKKQVENKENIEGAQDATENSASSLAPGFIRG 	                  .         .         .         .         .  
						AQASSGSPALPRKQRDKSPSSLLEDAKETCFTRDRKGGFFSSFMKKRNAPTPPKRSSSFR 	       1 MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFT 50                                                           
						EMENQPHKKYELTGNFSSVASLQHADGFSFTPAQQEANLVPPKCYGGSFAQRNLCNDDGG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGGGSGTAGGGWSGITGFFTPRLIKKTLGLRAGKPTASDDTSKPFPRSNSTSSMSSGLPE 	       1 MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFT 50                                                           
						QDRMAMTLPRNCQRSKLQLERTVSTSSQPEENVDRANDMLPKKSEESAAPSRERPKAKLL 	                  .         .         .         .         .  
						PRGATALPLRTPSGDLAITEKDPPGVGVAGVAAAPKGKEKNGGARLGMAGVPEDGEQPGW 	      51 QH.....................EALHRPYGCDVEPQALNEAIRWSSKEN 79                                                           
						PSPAKAAPVLPTTHNHKVPVLISPTLKHTPADVQLIGTDSQGNKFKLLSEHQVTSSGDKD 	         ||                     |||||||||||||||||||||||||||  
						RPRRVKPKCAPPPPPVMRLLQHPSICSDPTEEPTALTAGQSTSETQEGGKKAALGAVPIS 	      51 QHDHFASCVEDGFEGDKTGGSSPEALHRPYGCDVEPQALNEAIRWSSKEN 100                                                          
						GKAGRPVMPPPQVPLPTSSISPAKMANGTAGTKVALRKTKQAAEKISADKISKEALLECA 	                  .         .         .         .         .  
						DLLSSALTEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQELQVS 	      80 LLGATESDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNQNGEWSEVRS 129                                                          
						SAAAGVPGTNPVLNNLLSCVQEISDVVQR                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 90 % homologous to 	     101 LLGATESDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNQNGEWSEVRS 150                                                          
						corresponding to amino acids 74 - 1182 of ABL2_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 53 - 1161 of HUMARGCAA_P2,   	     130 KNGQGWVPSNYITPVNSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRES 179                                                          
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     151 KNGQGWVPSNYITPVNSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRES 200                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMARGCAA_P2, comprising a polypeptide having a length "n",  	     180 ESSPGQLSISLRYEGRVYHYRINTTADGKVYVTAESRFSTLAELVHHHST 229                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     201 ESSPGQLSISLRYEGRVYHYRINTTADGKVYVTAESRFSTLAELVHHHST 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     230 VADGLVTTLHYPAPKCNKPTVYGVSPIHDKWEMERTDITMKHKLGGGQYG 279                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise HE, having a structure as  	     251 VADGLVTTLHYPAPKCNKPTVYGVSPIHDKWEMERTDITMKHKLGGGQYG 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						52-x to 53; and ending at any of amino acid numbers 53+      	     280 EVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 329                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     330 CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 379                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     380 EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 429                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     430 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEK 479                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEK 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     480 GYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDSSISE 529                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDSSISE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     530 EVAEELGRAASSSSVVPYLPRLPILPSKTRTLKKQVENKENIEGAQDATE 579                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EVAEELGRAASSSSVVPYLPRLPILPSKTRTLKKQVENKENIEGAQDATE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     580 NSASSLAPGFIRGAQASSGSPALPRKQRDKSPSSLLEDAKETCFTRDRKG 629                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NSASSLAPGFIRGAQASSGSPALPRKQRDKSPSSLLEDAKETCFTRDRKG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     630 GFFSSFMKKRNAPTPPKRSSSFREMENQPHKKYELTGNFSSVASLQHADG 679                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 GFFSSFMKKRNAPTPPKRSSSFREMENQPHKKYELTGNFSSVASLQHADG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     680 FSFTPAQQEANLVPPKCYGGSFAQRNLCNDDGGGGGGSGTAGGGWSGITG 729                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 FSFTPAQQEANLVPPKCYGGSFAQRNLCNDDGGGGGGSGTAGGGWSGITG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     730 FFTPRLIKKTLGLRAGKPTASDDTSKPFPRSNSTSSMSSGLPEQDRMAMT 779                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FFTPRLIKKTLGLRAGKPTASDDTSKPFPRSNSTSSMSSGLPEQDRMAMT 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     780 LPRNCQRSKLQLERTVSTSSQPEENVDRANDMLPKKSEESAAPSRERPKA 829                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 LPRNCQRSKLQLERTVSTSSQPEENVDRANDMLPKKSEESAAPSRERPKA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     830 KLLPRGATALPLRTPSGDLAITEKDPPGVGVAGVAAAPKGKEKNGGARLG 879                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 KLLPRGATALPLRTPSGDLAITEKDPPGVGVAGVAAAPKGKEKNGGARLG 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     880 MAGVPEDGEQPGWPSPAKAAPVLPTTHNHKVPVLISPTLKHTPADVQLIG 929                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 MAGVPEDGEQPGWPSPAKAAPVLPTTHNHKVPVLISPTLKHTPADVQLIG 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     930 TDSQGNKFKLLSEHQVTSSGDKDRPRRVKPKCAPPPPPVMRLLQHPSICS 979                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 TDSQGNKFKLLSEHQVTSSGDKDRPRRVKPKCAPPPPPVMRLLQHPSICS 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     980 DPTEEPTALTAGQSTSETQEGGKKAALGAVPISGKAGRPVMPPPQVPLPT 1029                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 DPTEEPTALTAGQSTSETQEGGKKAALGAVPISGKAGRPVMPPPQVPLPT 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1030 SSISPAKMANGTAGTKVALRKTKQAAEKISADKISKEALLECADLLSSAL 1079                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 SSISPAKMANGTAGTKVALRKTKQAAEKISADKISKEALLECADLLSSAL 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1080 TEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQEL 1129                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 TEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQEL 1150                                                         
						                                                            	                  .         .         .                      
						                                                            	    1130 QVSSAAAGVPGTNPVLNNLLSCVQEISDVVQR                   1161                                                         
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	    1151 QVSSAAAGVPGTNPVLNNLLSCVQEISDVVQR                   1182                                                         

13924	HMR136_HUMARGNP_15_tr0_r1_1_gPRT		Comparison report between HUMARGNP_P15 and SFRB_HUMANpartial 	Sequence name: SFRB_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMARGNP_P15, comprising a first    	Sequence documentation:                                      
						MSNTTVVPSTAGPGPSGGPGGGGGGGGGGGGTEVIQVTNVSPSASSEQMRTLFGFLGKID 	                                                            
						ELRLFPPDDSPLPVSSRVCFVKFHDPDSAVVAQHLTNTVFVDRALIVVPYAEG        	Alignment of: 13924 x SFRB_HUMAN   ..                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 113 of SFRB_HUMAN, which    	Alignment segment 1/1:                                       
						also corresponds to amino acids 1 - 113 of HUMARGNP_P15, and 	                                                            
						a second amino acid sequence being at least 70%, optionally  	                     Quality: 1082.00                      Escore:       0                                               
						at least 80%, preferably at least 85%, more preferably at    	             Matching length:     113                Total length:     113                                               
						least 90% and most preferably at least 95% homologous to a   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence LCFV corresponding to amino  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 114 - 117 of HUMARGNP_P15, wherein said first amino    	                        Gaps:       0                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	Alignment:                                                   
						for a tail of HUMARGNP_P15, comprising a polypeptide being at	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	       1 MSNTTVVPSTAGPGPSGGPGGGGGGGGGGGGTEVIQVTNVSPSASSEQMR 50                                                           
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence LCFV	       1 MSNTTVVPSTAGPGPSGGPGGGGGGGGGGGGTEVIQVTNVSPSASSEQMR 50                                                           
						in HUMARGNP_P15.                                             	                  .         .         .         .         .  
						                                                            	      51 TLFGFLGKIDELRLFPPDDSPLPVSSRVCFVKFHDPDSAVVAQHLTNTVF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 TLFGFLGKIDELRLFPPDDSPLPVSSRVCFVKFHDPDSAVVAQHLTNTVF 100                                                          
						                                                            	                  .                                          
						                                                            	     101 VDRALIVVPYAEG                                      113                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     101 VDRALIVVPYAEG                                      113                                                          

13922	HMR136_HUMARGNP_6_tr0_r1_1_gPRT		Comparison report between HUMARGNP_P6 and SFRB_HUMANpartial  	Sequence name: SFRB_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMARGNP_P6, comprising a first     	Sequence documentation:                                      
						MSNTTVVPSTAGPGPSGGPGGGGGGGGGGGGTEVIQVTNVSPSASSEQMRTLFGFLGKID 	                                                            
						ELRLFPPDDSPLPVSSRVCFVKFHDPDSAVVAQHLTNTVFVDRALIVVPYAEG        	Alignment of: 13922 x SFRB_HUMAN   ..                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 113 of SFRB_HUMAN, which    	Alignment segment 1/1:                                       
						also corresponds to amino acids 1 - 113 of HUMARGNP_P6, and a	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1082.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     113                Total length:     113                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence LCFV corresponding to amino  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 114 - 117 of HUMARGNP_P6, wherein said first amino acid	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of HUMARGNP_P6, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MSNTTVVPSTAGPGPSGGPGGGGGGGGGGGGTEVIQVTNVSPSASSEQMR 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence LCFV in        	       1 MSNTTVVPSTAGPGPSGGPGGGGGGGGGGGGTEVIQVTNVSPSASSEQMR 50                                                           
						HUMARGNP_P6.                                                 	                  .         .         .         .         .  
						                                                            	      51 TLFGFLGKIDELRLFPPDDSPLPVSSRVCFVKFHDPDSAVVAQHLTNTVF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 TLFGFLGKIDELRLFPPDDSPLPVSSRVCFVKFHDPDSAVVAQHLTNTVF 100                                                          
						                                                            	                  .                                          
						                                                            	     101 VDRALIVVPYAEG                                      113                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     101 VDRALIVVPYAEG                                      113                                                          

14349	HMR136_HUMARXA_20_tr0_r1_1_gPRT		Comparison report between HUMARXA_P20 and                    	Sequence name: ALDR_HUMAN_V1                                 
						ALDR_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						featuring a skipped exon.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for HUMARXA_P20, comprising a first amino acid      	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 14349 x ALDR_HUMAN_V1   ..                     
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MGCLLFSLKHSLSHQIQQLRNSFLPRGARASVGGGKNPLPLGPGGRSIPADPWGRPPRHP 	                                                            
						QRNQSEGSFAQRRANRRRPFCRPHGLFKGTRRGQGRTVLGGGLGSAAA             	                     Quality: 1123.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 108 of  	             Matching length:     123                Total length:     316                                               
						HUMARXA_P20, a second amino acid sequence being at least 90 %	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQ 	    Total Percent Similarity:   38.92      Total Percent Identity:   38.92                                               
						EKLREQVVKREELFIVSKLWCT                                       	                        Gaps:       1                        
						homologous to corresponding to amino acids 1 - 82 of         	                                                            
						ALDR_HUMAN_V1, which also corresponds to amino acids 109 -   	Alignment:                                                   
						190 of HUMARXA_P20, and a third amino acid sequence being at 	                  .         .         .         .         .  
						least 90 % homologous to                                     	     109 MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQ 158                                                          
						VFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 276 - 316 of ALDR_HUMAN_V1, which also           	       1 MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQ 50                                                           
						corresponds to amino acids 191 - 231 of HUMARXA_P20, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	     159 NENEVGVAIQEKLREQVVKREELFIVSKLWCT.................. 190                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||                    
						sequential order.2.An isolated polypeptide encoding for a    	      51 NENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDL 100                                                          
						head of HUMARXA_P20, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     190 .................................................. 190                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						MGCLLFSLKHSLSHQIQQLRNSFLPRGARASVGGGKNPLPLGPGGRSIPADPWGRPPRHP 	     101 KLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVD 150                                                          
						QRNQSEGSFAQRRANRRRPFCRPHGLFKGTRRGQGRTVLGGGLGSAAA             	                  .         .         .         .         .  
						at least about 95% homologous to the sequence of             	     190 .................................................. 190                                                          
						HUMARXA_P20.3.An isolated chimeric polypeptide encoding for  	                                                            
						an edge portion of HUMARXA_P20, comprising a polypeptide     	     151 EGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYC 200                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     190 .................................................. 190                                                          
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	     201 QSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLI 250                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise TV, having a       	     191 .........................VFDFELSSQDMTTLLSYNRNWRVCA 215                                                          
						structure as follows: a sequence starting from any of amino  	                                  |||||||||||||||||||||||||  
						acid numbers 190-x to 191; and ending at any of amino acid   	     251 RFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCA 300                                                          
						numbers 191+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .                                          
						                                                            	     216 LLSCTSHKDYPFHEEF                                   231                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     301 LLSCTSHKDYPFHEEF                                   316                                                          

15073	HMR136_HUMASFB_3_tr0_r1_1_gPRT		Comparison report between HUMASFB_P3 and ARSB_HUMANpartial   	Sequence name: ARSB_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMASFB_P3, comprising a first amino	Sequence documentation:                                      
						MGPRGAASLPRGPGPRRLLLPVVLPLLLLLLLAPPGSGAGASRPPHLVFLLADDLGWNDV 	                                                            
						GFHGSRIRTPHLDALA                                             	Alignment of: 15073 x ARSB_HUMAN   ..                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 76 of ARSB_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 76 of HUMASFB_P3, and a second amino acid 	                                                            
						IRTGLQHQIIWPCQPSCVPLDEKLLPQLLKEAGYTTHMVGKWHLGMYRKECLPTRRGFDT 	                     Quality: 4963.00                      Escore:       0                                               
						YFGYLLGSEDYYSHERCTLIDALNVTRCALDFRDGEEVATGYKNMYSTNIFTKRAIALIT 	             Matching length:     505                Total length:     533                                               
						NHPPEKPLFLYLALQSVHEPLQVPEEYLKPYDFIQDKNRHHYAGMVSLMDEAVGNVTAAL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KSSGLWNNTVFIFSTDNGGQTLAGGNNWPLRGRKWSLWEGGVRGVGFVASPLLKQKGVKN 	    Total Percent Similarity:   94.75      Total Percent Identity:   94.75                                               
						RELIHISDWLPTLVKLARGHTNGTKPLDGFDVWKTISEGSPSPRIELLHNIDPNFVDSSP 	                        Gaps:       1                        
						CPRNSMAPAKDDSSLPEYSAFNTSVHAAIRHGNWKLLTGYPGCGYWFPPPSQYNVSEIPS 	                                                            
						SDPPTKTLWLFDIDRDPEERHDLSREYPHIVTKLLSRLQFYHKHSVPVYFPAQDPRCDPK 	Alignment:                                                   
						ATGVWGPWM                                                    	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       1 MGPRGAASLPRGPGPRRLLLPVVLPLLLLLLLAPPGSGAGASRPPHLVFL 50                                                           
						amino acids 105 - 533 of ARSB_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 77 - 505 of HUMASFB_P3, wherein said first    	       1 MGPRGAASLPRGPGPRRLLLPVVLPLLLLLLLAPPGSGAGASRPPHLVFL 50                                                           
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	      51 LADDLGWNDVGFHGSRIRTPHLDALA........................ 76                                                           
						polypeptide encoding for an edge portion of HUMASFB_P3,      	         ||||||||||||||||||||||||||                          
						comprising a polypeptide having a length "n", wherein n is at	      51 LADDLGWNDVGFHGSRIRTPHLDALAAGGVLLDNYYTQPLCTPSRSQLLT 100                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      77 ....IRTGLQHQIIWPCQPSCVPLDEKLLPQLLKEAGYTTHMVGKWHLGM 122                                                          
						amino acids in length, more preferably at least about 40     	             ||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     101 GRYQIRTGLQHQIIWPCQPSCVPLDEKLLPQLLKEAGYTTHMVGKWHLGM 150                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise AI, having a structure as follows: a sequence       	     123 YRKECLPTRRGFDTYFGYLLGSEDYYSHERCTLIDALNVTRCALDFRDGE 172                                                          
						starting from any of amino acid numbers 76-x to 77; and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 77+ ((n-2) - x), in which	     151 YRKECLPTRRGFDTYFGYLLGSEDYYSHERCTLIDALNVTRCALDFRDGE 200                                                          
						x varies from 0 to n-2.                                      	                  .         .         .         .         .  
						                                                            	     173 EVATGYKNMYSTNIFTKRAIALITNHPPEKPLFLYLALQSVHEPLQVPEE 222                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EVATGYKNMYSTNIFTKRAIALITNHPPEKPLFLYLALQSVHEPLQVPEE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     223 YLKPYDFIQDKNRHHYAGMVSLMDEAVGNVTAALKSSGLWNNTVFIFSTD 272                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YLKPYDFIQDKNRHHYAGMVSLMDEAVGNVTAALKSSGLWNNTVFIFSTD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     273 NGGQTLAGGNNWPLRGRKWSLWEGGVRGVGFVASPLLKQKGVKNRELIHI 322                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NGGQTLAGGNNWPLRGRKWSLWEGGVRGVGFVASPLLKQKGVKNRELIHI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     323 SDWLPTLVKLARGHTNGTKPLDGFDVWKTISEGSPSPRIELLHNIDPNFV 372                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SDWLPTLVKLARGHTNGTKPLDGFDVWKTISEGSPSPRIELLHNIDPNFV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     373 DSSPCPRNSMAPAKDDSSLPEYSAFNTSVHAAIRHGNWKLLTGYPGCGYW 422                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 DSSPCPRNSMAPAKDDSSLPEYSAFNTSVHAAIRHGNWKLLTGYPGCGYW 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     423 FPPPSQYNVSEIPSSDPPTKTLWLFDIDRDPEERHDLSREYPHIVTKLLS 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 FPPPSQYNVSEIPSSDPPTKTLWLFDIDRDPEERHDLSREYPHIVTKLLS 500                                                          
						                                                            	                  .         .         .                      
						                                                            	     473 RLQFYHKHSVPVYFPAQDPRCDPKATGVWGPWM                  505                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     501 RLQFYHKHSVPVYFPAQDPRCDPKATGVWGPWM                  533                                                          

15989	HMR136_HUMATPAC_1_tr0_r1_1_gPRT		Comparison report between HUMATPAC_P1 and Q13818unique head  	Sequence name: Q13818                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMATPAC_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15989 x Q13818   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MGRGAGREYSPAATTAENGGGKKKQKEKELDELKKEVAMDDHKLSLDELGRKYQVDLSKG 	Alignment segment 1/1:                                       
						LTNQRAQDVLARDGPNALTPPPTTPEWVKFCRQLFGGFSILLWIGAILCFLAYGIQAAME 	                                                            
						DEPSNDNLYLGVVLAAVVIVTGCFSYYQEAKSSKIMDSFKNMVPQQALVIRGGEKMQINV 	                     Quality:  446.00                      Escore:       0                                               
						QEVVLGDLVEIKGGDRVPADLRLISAQGCKVDNSSLTGESEPQSRSPDFTHENPLETRNI 	             Matching length:      45                Total length:      45                                               
						CFFSTNCVEGTARGIVIATGDSTVMGRIASLTSGLAVGQTPIAAEIEHFIHLITVVAVFL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GVTFFALSLLLGYGWLEAIIFLIGIIVANVPEGLLATVTVCLTLTAKRMARKNCLVKNLE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AVETLGSTSTICSDKTGTLTQNRMTVAHMWFDMTVYEADTTEEQTGKTFTKSSDTWFMLA 	                        Gaps:       0                        
						RIAGLCNRADFKANQEILPIAKRATTGDASESALLKFIEQSYSSVAEMREKNPKVAEIPF 	                                                            
						NSTNKYQMSIHLREDSSQTHVLMMKGAPERILEFCSTFLLNGQEYSMNDEMKEAFQNAYL 	Alignment:                                                   
						ELGGLGERVLGFCFLNLPSSFSK                                      	                  .         .         .         .            
						homologous to a polypeptide having the sequence corresponding	     564 GFPFNTDEINFPMDNLCFVGLISMIDPPRAAVPDAVSKCRSAGIK      608                                                          
						to amino acids 1 - 563 of HUMATPAC_P1, a second amino acid   	         |||||||||||||||||||||||||||||||||||||||||||||       
						sequence being at least 90 % homologous to                   	       1 GFPFNTDEINFPMDNLCFVGLISMIDPPRAAVPDAVSKCRSAGIK      45                                                           
						GFPFNTDEINFPMDNLCFVGLISMIDPPRAAVPDAVSKCRSAGIK corresponding  	                                                            
						to amino acids 1 - 45 of Q13818, which also corresponds to   	                                                            
						amino acids 564 - 608 of HUMATPAC_P1, and a third amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						VIMVTGDHPITAKAIAKGVGIISEGTETAEEVAARLKIPISKVDASAAKAIVVHGAELKD 	                                                            
						IQSKQLDQILQNHPEIVFARTSPQQKLIIVEGCQRLGAVVAVTGDGVNDSPALKKADIGI 	                                                            
						AMGISGSDVSKQAADMILLDDNFASIVTGVEEGRLIFDNLKKSIMYTLTSNIPEITPFLM 	                                                            
						FIILGIPLPLGTITILCIDLGTDMVPAISLAYESAESDIMKRLPRNPKTDNLVNHRLIGM 	                                                            
						AYGQIGMIQALAGFFTYFVILAENGFRPVDLLGIRLHWEDKYLNDLEDSYGQQWTYEQRK 	                                                            
						VVEFTCQTAFFVTIVVVQWADLIISKTRRNSLFQQGMRNKVLIFGILEETLLAAFLSYTP 	                                                            
						GMDVALRMYPLKITWWLCAIPYSILIFVYDEIRKLLIRQHPDGWVERETYY          	                                                            
						having the sequence corresponding to amino acids 609 - 1019  	                                                            
						of HUMATPAC_P1, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMATPAC_P1, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MGRGAGREYSPAATTAENGGGKKKQKEKELDELKKEVAMDDHKLSLDELGRKYQVDLSKG 	                                                            
						LTNQRAQDVLARDGPNALTPPPTTPEWVKFCRQLFGGFSILLWIGAILCFLAYGIQAAME 	                                                            
						DEPSNDNLYLGVVLAAVVIVTGCFSYYQEAKSSKIMDSFKNMVPQQALVIRGGEKMQINV 	                                                            
						QEVVLGDLVEIKGGDRVPADLRLISAQGCKVDNSSLTGESEPQSRSPDFTHENPLETRNI 	                                                            
						CFFSTNCVEGTARGIVIATGDSTVMGRIASLTSGLAVGQTPIAAEIEHFIHLITVVAVFL 	                                                            
						GVTFFALSLLLGYGWLEAIIFLIGIIVANVPEGLLATVTVCLTLTAKRMARKNCLVKNLE 	                                                            
						AVETLGSTSTICSDKTGTLTQNRMTVAHMWFDMTVYEADTTEEQTGKTFTKSSDTWFMLA 	                                                            
						RIAGLCNRADFKANQEILPIAKRATTGDASESALLKFIEQSYSSVAEMREKNPKVAEIPF 	                                                            
						NSTNKYQMSIHLREDSSQTHVLMMKGAPERILEFCSTFLLNGQEYSMNDEMKEAFQNAYL 	                                                            
						ELGGLGERVLGFCFLNLPSSFSK                                      	                                                            
						to the sequence of HUMATPAC_P1.3.An isolated polypeptide     	                                                            
						encoding for a tail of HUMATPAC_P1, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						VIMVTGDHPITAKAIAKGVGIISEGTETAEEVAARLKIPISKVDASAAKAIVVHGAELKD 	                                                            
						IQSKQLDQILQNHPEIVFARTSPQQKLIIVEGCQRLGAVVAVTGDGVNDSPALKKADIGI 	                                                            
						AMGISGSDVSKQAADMILLDDNFASIVTGVEEGRLIFDNLKKSIMYTLTSNIPEITPFLM 	                                                            
						FIILGIPLPLGTITILCIDLGTDMVPAISLAYESAESDIMKRLPRNPKTDNLVNHRLIGM 	                                                            
						AYGQIGMIQALAGFFTYFVILAENGFRPVDLLGIRLHWEDKYLNDLEDSYGQQWTYEQRK 	                                                            
						VVEFTCQTAFFVTIVVVQWADLIISKTRRNSLFQQGMRNKVLIFGILEETLLAAFLSYTP 	                                                            
						GMDVALRMYPLKITWWLCAIPYSILIFVYDEIRKLLIRQHPDGWVERETYY          	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMATPAC_P1.                                              	                                                            

2415	HMR136_HUMB94_7_tr0_r1_1_gPRT		Comparison report between HUMB94_P7 and TNP2_HUMANunique     	Sequence name: TNP2_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMB94_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 2415 x TNP2_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence GPSVWAGPECAPSGFA corresponding to amino  	Alignment segment 1/1:                                       
						acids 1 - 16 of HUMB94_P7, and a second amino acid sequence  	                                                            
						SYQRAFNEFLERGKQLTNYRANVIANINNCLSFRMSMEQNWQVPQDTLSLLLGPLGELKS 	                     Quality: 2487.00                      Escore:       0                                               
						HGFDTLLQNLHEDLKPLFKRFTHTRWAAPVETLENIIATVDTRLPEFSELQGCFREELME 	             Matching length:     260                Total length:     260                                               
						ALHLHLVKEYIIQLSKGRLVLKTAEQQQQLAGYILANADTIQHFCTQHGSPATWLQPALP 	 Matching Percent Similarity:   99.23   Matching Percent Identity:   98.46                                               
						TLAEIIRLQDPSAIKIEVATYATCYPDFSKGHLSAILAIKGNLSNSEVKRIRSILDVSMG 	    Total Percent Similarity:   99.23      Total Percent Identity:   98.46                                               
						AQEPSRPLFSLIKVG                                              	                        Gaps:       0                        
						being at least 90 % homologous to corresponding to amino     	                                                            
						acids 400 - 654 of TNP2_HUMAN, which also corresponds to     	Alignment:                                                   
						amino acids 17 - 271 of HUMB94_P7, wherein said first amino  	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      12 PSGFASYQRAFNEFLERGKQLTNYRANVIANINNCLSFRMSMEQNWQVPQ 61                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         |: : |||||||||||||||||||||||||||||||||||||||||||||  
						for a head of HUMB94_P7, comprising a polypeptide being at   	     395 PAFLRSYQRAFNEFLERGKQLTNYRANVIANINNCLSFRMSMEQNWQVPQ 444                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      62 DTLSLLLGPLGELKSHGFDTLLQNLHEDLKPLFKRFTHTRWAAPVETLEN 111                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GPSVWAGPECAPSGFA of HUMB94_P7.                               	     445 DTLSLLLGPLGELKSHGFDTLLQNLHEDLKPLFKRFTHTRWAAPVETLEN 494                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     112 IIATVDTRLPEFSELQGCFREELMEALHLHLVKEYIIQLSKGRLVLKTAE 161                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     495 IIATVDTRLPEFSELQGCFREELMEALHLHLVKEYIIQLSKGRLVLKTAE 544                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     162 QQQQLAGYILANADTIQHFCTQHGSPATWLQPALPTLAEIIRLQDPSAIK 211                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     545 QQQQLAGYILANADTIQHFCTQHGSPATWLQPALPTLAEIIRLQDPSAIK 594                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     212 IEVATYATCYPDFSKGHLSAILAIKGNLSNSEVKRIRSILDVSMGAQEPS 261                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     595 IEVATYATCYPDFSKGHLSAILAIKGNLSNSEVKRIRSILDVSMGAQEPS 644                                                          
						                                                            	                  .                                          
						                                                            	     262 RPLFSLIKVG                                         271                                                          
						                                                            	         ||||||||||                                          
						                                                            	     645 RPLFSLIKVG                                         654                                                          

9206	HMR136_HUMBCL3AA_4_tr0_r1_1_gPRT		Comparison report between HUMBCL3AA_P4 and BCL3_HUMANunique  	Sequence name: BCL3_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMBCL3AA_P4, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9206 x BCL3_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MPRCPAGA     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of HUMBCL3AA_P4, a second 	                                                            
						MDEGPVDLRTRPKAAGLPGAALPLRKRPLRAPSPEPAAPRGAAGLVVPLDPLRGGCDLPA 	                     Quality: 2793.00                      Escore:       0                                               
						VPGPPHGLARPEALYYPGALLPLYPTRAMGSPFPLVNLPTPLYPMMCPMEHPLSADIAMA 	             Matching length:     289                Total length:     289                                               
						TRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQ            	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 289 of BCL3_HUMAN, which    	Alignment:                                                   
						also corresponds to amino acids 9 - 297 of HUMBCL3AA_P4, and 	                  .         .         .         .         .  
						a third amino acid sequence being at least 70%, optionally at	       9 MDEGPVDLRTRPKAAGLPGAALPLRKRPLRAPSPEPAAPRGAAGLVVPLD 58                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MDEGPVDLRTRPKAAGLPGAALPLRKRPLRAPSPEPAAPRGAAGLVVPLD 50                                                           
						VFSPHHHPPHPPSLPPGTPLDSPWLLPISSFLPHLHPPSCPLLGSSEALAGRCPPPQLQE 	                  .         .         .         .         .  
						AAEGDGGADLGLMRRGPPALWGQPFWKL                                 	      59 PLRGGCDLPAVPGPPHGLARPEALYYPGALLPLYPTRAMGSPFPLVNLPT 108                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						298 - 385 of HUMBCL3AA_P4, wherein said first amino acid     	      51 PLRGGCDLPAVPGPPHGLARPEALYYPGALLPLYPTRAMGSPFPLVNLPT 100                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     109 PLYPMMCPMEHPLSADIAMATRADEDGDTPLHIAVVQGNLPAVHRLVNLF 158                                                          
						isolated polypeptide encoding for a head of HUMBCL3AA_P4,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     101 PLYPMMCPMEHPLSADIAMATRADEDGDTPLHIAVVQGNLPAVHRLVNLF 150                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     159 QQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTA 208                                                          
						about 95% homologous to the sequence MPRCPAGA of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMBCL3AA_P4.3.An isolated polypeptide encoding for a tail of	     151 QQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTA 200                                                          
						HUMBCL3AA_P4, comprising a polypeptide being at least 70%,   	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     209 AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETV 258                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFSPHHHPPHPPSLPPGTPLDSPWLLPISSFLPHLHPPSCPLLGSSEALAGRCPPPQLQE 	     201 AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETV 250                                                          
						AAEGDGGADLGLMRRGPPALWGQPFWKL                                 	                  .         .         .                      
						least about 95% homologous to the sequence in HUMBCL3AA_P4.  	     259 QLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQ            297                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     251 QLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQ            289                                                          

5803	HMR136_HUMBCTHA_14_tr0_r1_1_gPRT		Comparison report between HUMBCTHA_P14 and AAP35834partial   	Sequence name: AAP35834                                      
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMBCTHA_P14, comprising a first    	Sequence documentation:                                      
						MAELDPFGAPAGAPGGPALGNGVAGAGEEDPAAAFLAQQESEIAGIENDEAFAILDGGAP 	                                                            
						GPQPHGEPPGGPDAVDGVMNGEYYQESNGPTDSYAAISQVDRLQSEPESIRKWREEQMER 	Alignment of: 5803 x AAP35834   ..                           
						LEALDANSRKQEAEWKEKAIKELEEWYARQDEQLQKTKANNRAAEEAFVNDIDES      	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 175 of AAP35834, which also 	                                                            
						corresponds to amino acids 1 - 175 of HUMBCTHA_P14, and a    	                     Quality: 1713.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     175                Total length:     175                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence PRWCTEEPPCGNTTSAIS           	                        Gaps:       0                        
						corresponding to amino acids 176 - 193 of HUMBCTHA_P14,      	                                                            
						wherein said first amino acid sequence and second amino acid 	Alignment:                                                   
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HUMBCTHA_P14,    	       1 MAELDPFGAPAGAPGGPALGNGVAGAGEEDPAAAFLAQQESEIAGIENDE 50                                                           
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	       1 MAELDPFGAPAGAPGGPALGNGVAGAGEEDPAAAFLAQQESEIAGIENDE 50                                                           
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence PRWCTEEPPCGNTTSAIS in   	      51 AFAILDGGAPGPQPHGEPPGGPDAVDGVMNGEYYQESNGPTDSYAAISQV 100                                                          
						HUMBCTHA_P14.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 AFAILDGGAPGPQPHGEPPGGPDAVDGVMNGEYYQESNGPTDSYAAISQV 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DRLQSEPESIRKWREEQMERLEALDANSRKQEAEWKEKAIKELEEWYARQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 DRLQSEPESIRKWREEQMERLEALDANSRKQEAEWKEKAIKELEEWYARQ 150                                                          
						                                                            	                  .         .                                
						                                                            	     151 DEQLQKTKANNRAAEEAFVNDIDES                          175                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     151 DEQLQKTKANNRAAEEAFVNDIDES                          175                                                          

12232	HMR136_HUMBF7A_9_tr0_r1_1_gPRT		Comparison report between HUMBF7A_P9 and TGM2_HUMANpartial   	Sequence name: TGM2_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMBF7A_P9, comprising a first amino	Sequence documentation:                                      
						MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFS 	                                                            
						VVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTPANAPIGLYRLSLE 	Alignment of: 12232 x TGM2_HUMAN   ..                        
						ASTGYQGSSFVLGHFILLFNAWCP                                     	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 144 of TGM2_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 144 of HUMBF7A_P9, and a second amino acid	                     Quality: 5249.00                      Escore:       0                                               
						VLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPD 	             Matching length:     545                Total length:     687                                               
						LQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLA 	    Total Percent Similarity:   79.33      Total Percent Identity:   79.33                                               
						EKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGT 	                        Gaps:       1                        
						KYLLNLNLEPFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLEN 	                                                            
						PEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGE 	Alignment:                                                   
						EVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA                    	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       1 MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNY 50                                                           
						amino acids 287 - 687 of TGM2_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 145 - 545 of HUMBF7A_P9, wherein said first   	       1 MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNY 50                                                           
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	      51 EASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTL 100                                                          
						polypeptide encoding for an edge portion of HUMBF7A_P9,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	      51 EASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTL 100                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     101 SLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCP...... 144                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||        
						amino acids in length and most preferably at least about 50  	     101 SLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYL 150                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise PV, having a structure as follows: a sequence       	     144 .................................................. 144                                                          
						starting from any of amino acid numbers 144-x to 145; and    	                                                            
						ending at any of amino acid numbers 145+ ((n-2) - x), in     	     151 DSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVN 200                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     144 .................................................. 144                                                          
						                                                            	                                                            
						                                                            	     201 PKFLKNAGRDCSRRSSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     145 ....................................VLRCLGIPTRVVTN 158                                                          
						                                                            	                                             ||||||||||||||  
						                                                            	     251 PMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTN 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 YNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPG 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 YNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 YEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNAD 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 YEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNAD 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 VVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSS 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 EEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTA 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 EEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLEPFSEKSVPLCILYEK 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 EEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLEPFSEKSVPLCILYEK 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     409 YRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQK 458                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 YRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQK 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     459 RKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKV 508                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKV 650                                                          
						                                                            	                  .         .         .                      
						                                                            	     509 RMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA              545                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     651 RMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA              687                                                          

15306	HMR136_HUMBGLUKIN_4_tr0_r1_1_gPRT		Comparison report between HUMBGLUKIN_P4 and                  	Sequence name: HXK4_HUMAN                                    
						HXK4_HUMANpartial WT sequence featuring skipped exon.1.An    	                                                            
						isolated chimeric polypeptide encoding for HUMBGLUKIN_P4,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPT 	Alignment of: 15306 x HXK4_HUMAN   ..                        
						YVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAE 	                                                            
						M                                                            	Alignment segment 1/1:                                       
						homologous to corresponding to amino acids 1 - 121 of        	                                                            
						HXK4_HUMAN, which also corresponds to amino acids 1 - 121 of 	                     Quality: 4266.00                      Escore:       0                                               
						HUMBGLUKIN_P4, and a second amino acid sequence being at     	             Matching length:     448                Total length:     465                                               
						MKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWG 	    Total Percent Similarity:   96.34      Total Percent Identity:   96.34                                               
						AFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHG 	                        Gaps:       1                        
						EASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRA 	                                                            
						AHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITF 	Alignment:                                                   
						IESEEGSGRGAALVSAVACKKACMLGQ                                  	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 139 -  	       1 MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETH 50                                                           
						465 of HXK4_HUMAN, which also corresponds to amino acids 122 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 448 of HUMBGLUKIN_P4, wherein said first amino acid        	       1 MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETH 50                                                           
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated chimeric polypeptide        	      51 EEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWS 100                                                          
						encoding for an edge portion of HUMBGLUKIN_P4, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	      51 EEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWS 100                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     101 VKTKHQMYSIPEDAMTGTAEM.................MKHKKLPLGFTF 133                                                          
						length, more preferably at least about 40 amino acids in     	         |||||||||||||||||||||                 ||||||||||||  
						length and most preferably at least about 50 amino acids in  	     101 VKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTF 150                                                          
						length, wherein at least two amino acids comprise MM, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     134 SFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVV 183                                                          
						acid numbers 121-x to 122; and ending at any of amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 122+ ((n-2) - x), in which x varies from 0 to n-2.   	     151 SFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     184 AMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGR 233                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     234 MCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGE 283                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     284 LVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYN 333                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     334 ILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSED 383                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSED 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     384 VMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAA 433                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAA 450                                                          
						                                                            	                  .                                          
						                                                            	     434 LVSAVACKKACMLGQ                                    448                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     451 LVSAVACKKACMLGQ                                    465                                                          

15308	HMR136_HUMBGLUKIN_5_tr0_r1_1_gPRT		Comparison report between HUMBGLUKIN_P5 and                  	Sequence name: HXK4_HUMAN                                    
						HXK4_HUMANpartial WT sequence (truncation of last part or    	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMBGLUKIN_P5, comprising a	                                                            
						MLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPL 	Alignment of: 15308 x HXK4_HUMAN   ..                        
						GFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDT 	                                                            
						VATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGEL 	Alignment segment 1/1:                                       
						DEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRT 	                                                            
						RGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGL 	                     Quality: 3706.00                      Escore:       0                                               
						AGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSG 	             Matching length:     379                Total length:     379                                               
						RGAALVSAVACKKACMLGQ                                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						first amino acid sequence being at least 90 % homologous to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 87 - 465 of HXK4_HUMAN, which   	                        Gaps:       0                        
						also corresponds to amino acids 1 - 379 of HUMBGLUKIN_P5.    	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      87 MLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDK 136                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     137 HQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLR 186                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYME 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     187 DAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYME 236                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     237 EMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQ 286                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 QLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVS 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 QVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGL 386                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEI 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     387 AGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEI 436                                                          
						                                                            	                  .         .                                
						                                                            	     351 TFIESEEGSGRGAALVSAVACKKACMLGQ                      379                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     437 TFIESEEGSGRGAALVSAVACKKACMLGQ                      465                                                          

17373	HMR136_HUMBMP1A_13_tr0_r1_1_gPRT		Comparison report between HUMBMP1A_P13 and BMP1_HUMANpartial 	Sequence name: BMP1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMBMP1A_P13, comprising a first    	Sequence documentation:                                      
						MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAAAFLGDIALDE 	                                                            
						EDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQSTNGQPQRGACGRWRGRSRSRR 	Alignment of: 17373 x BMP1_HUMAN   ..                        
						AATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTY 	                                                            
						RPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVREN 	Alignment segment 1/1:                                       
						IQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 	                                                            
						QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVWRISVTPGEKI 	                     Quality: 8644.00                      Escore:       0                                               
						ILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSKLPEPIVSTDSRLWVEFRSSS 	             Matching length:     858                Total length:     858                                               
						NWVGKGFFAVYEAICGGDVKKDYGHIQSPNYPDDYRPSKVCIWRIQVSEGFHVGLTFQSF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EIERHDSCAYDYLEVRDGHSESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AVNFFKEVDECSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 	                        Gaps:       0                        
						SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVEVRSGLTADSK 	                                                            
						LHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHFFSDKDECSKDNGGCQQDCVN 	Alignment:                                                   
						TFGSYECQCRSGFVLHDNKHDCKEAGCDHKVTSTSGTITSPNWPDKYPSKKECTWAISST 	                  .         .         .         .         .  
						PGHRVKLTFMEMDIESQPECAYDHLEVFDGRDAKAPVLGRFCGSKKPEPVLATGSRMFLR 	       1 MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAA 50                                                           
						FYSDNSVQRKGFQASHAT                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAA 50                                                           
						corresponding to amino acids 1 - 858 of BMP1_HUMAN, which    	                  .         .         .         .         .  
						also corresponds to amino acids 1 - 858 of HUMBMP1A_P13, and 	      51 AFLGDIALDEEDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQST 100                                                          
						a second amino acid sequence being at least 70%, optionally  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 80%, preferably at least 85%, more preferably at    	      51 AFLGDIALDEEDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQST 100                                                          
						least 90% and most preferably at least 95% homologous to a   	                  .         .         .         .         .  
						polypeptide having the sequence VWRQQLPWGCGL corresponding to	     101 NGQPQRGACGRWRGRSRSRRAATSRPERVWPDGVIPFVIGGNFTGSQRAV 150                                                          
						amino acids 859 - 870 of HUMBMP1A_P13, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	     101 NGQPQRGACGRWRGRSRSRRAATSRPERVWPDGVIPFVIGGNFTGSQRAV 150                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of HUMBMP1A_P13, comprising a	     151 FRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAIS 200                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     151 FRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAIS 200                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VWRQQLPWGCGL in HUMBMP1A_P13.                	     201 IGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVW 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVW 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSK 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPN 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 YPDDYRPSKVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 YPDDYRPSKVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGFAVNFFKEVDE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 ESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGFAVNFFKEVDE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 CSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHF 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHF 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 FSDKDECSKDNGGCQQDCVNTFGSYECQCRSGFVLHDNKHDCKEAGCDHK 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 FSDKDECSKDNGGCQQDCVNTFGSYECQCRSGFVLHDNKHDCKEAGCDHK 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VTSTSGTITSPNWPDKYPSKKECTWAISSTPGHRVKLTFMEMDIESQPEC 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 VTSTSGTITSPNWPDKYPSKKECTWAISSTPGHRVKLTFMEMDIESQPEC 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 AYDHLEVFDGRDAKAPVLGRFCGSKKPEPVLATGSRMFLRFYSDNSVQRK 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 AYDHLEVFDGRDAKAPVLGRFCGSKKPEPVLATGSRMFLRFYSDNSVQRK 850                                                          
						                                                            	                                                             
						                                                            	     851 GFQASHAT                                           858                                                          
						                                                            	         ||||||||                                            
						                                                            	     851 GFQASHAT                                           858                                                          

17377	HMR136_HUMBMP1A_25_tr0_r1_1_gPRT		Comparison report between HUMBMP1A_P25 and BMP1_HUMANpartial 	Sequence name: BMP1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMBMP1A_P25, comprising a first    	Sequence documentation:                                      
						MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAAAFLGDIALDE 	                                                            
						EDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQSTNGQPQRGACGRWRGRSRSRR 	Alignment of: 17377 x BMP1_HUMAN   ..                        
						AATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTY 	                                                            
						RPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVREN 	Alignment segment 1/1:                                       
						IQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 	                                                            
						QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVWRISVTPGEKI 	                     Quality: 7050.00                      Escore:       0                                               
						ILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSKLPEPIVSTDSRLWVEFRSSS 	             Matching length:     702                Total length:     702                                               
						NWVGKGFFAVYEAICGGDVKKDYGHIQSPNYPDDYRPSKVCIWRIQVSEGFHVGLTFQSF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EIERHDSCAYDYLEVRDGHSESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AVNFFKEVDECSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 	                        Gaps:       0                        
						SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVEVRSGLTADSK 	                                                            
						LHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHFFS                   	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 1 - 702 of BMP1_HUMAN, which    	       1 MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAA 50                                                           
						also corresponds to amino acids 1 - 702 of HUMBMP1A_P25, and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a second amino acid sequence being at least 70%, optionally  	       1 MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAA 50                                                           
						at least 80%, preferably at least 85%, more preferably at    	                  .         .         .         .         .  
						least 90% and most preferably at least 95% homologous to a   	      51 AFLGDIALDEEDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQST 100                                                          
						polypeptide having the sequence GIPGLPSS corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 703 - 710 of HUMBMP1A_P25, wherein said first    	      51 AFLGDIALDEEDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQST 100                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     101 NGQPQRGACGRWRGRSRSRRAATSRPERVWPDGVIPFVIGGNFTGSQRAV 150                                                          
						polypeptide encoding for a tail of HUMBMP1A_P25, comprising a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     101 NGQPQRGACGRWRGRSRSRRAATSRPERVWPDGVIPFVIGGNFTGSQRAV 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     151 FRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAIS 200                                                          
						to the sequence GIPGLPSS in HUMBMP1A_P25.                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAIS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 IGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVW 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVW 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSK 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPN 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 YPDDYRPSKVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 YPDDYRPSKVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGFAVNFFKEVDE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 ESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGFAVNFFKEVDE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 CSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHF 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHF 700                                                          
						                                                            	                                                             
						                                                            	     701 FS                                                 702                                                          
						                                                            	         ||                                                  
						                                                            	     701 FS                                                 702                                                          

17371	HMR136_HUMBMP1A_7_tr0_r1_1_gPRT		Comparison report between HUMBMP1A_P7 and BMP1_HUMANpartial  	Sequence name: BMP1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMBMP1A_P7, comprising a first     	Sequence documentation:                                      
						MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAAAFLGDIALDE 	                                                            
						EDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQSTNGQPQRGACGRWRGRSRSRR 	Alignment of: 17371 x BMP1_HUMAN   ..                        
						AATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTY 	                                                            
						RPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVREN 	Alignment segment 1/1:                                       
						IQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 	                                                            
						QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVWRISVTPGEKI 	                     Quality: 7050.00                      Escore:       0                                               
						ILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSKLPEPIVSTDSRLWVEFRSSS 	             Matching length:     702                Total length:     702                                               
						NWVGKGFFAVYEAICGGDVKKDYGHIQSPNYPDDYRPSKVCIWRIQVSEGFHVGLTFQSF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EIERHDSCAYDYLEVRDGHSESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AVNFFKEVDECSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 	                        Gaps:       0                        
						SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVEVRSGLTADSK 	                                                            
						LHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHFFS                   	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 1 - 702 of BMP1_HUMAN, which    	       1 MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAA 50                                                           
						also corresponds to amino acids 1 - 702 of HUMBMP1A_P7, and a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 70%, optionally at 	       1 MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAA 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      51 AFLGDIALDEEDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQST 100                                                          
						polypeptide having the sequence GSCILKPPLWLPCTPA             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 703 - 718 of HUMBMP1A_P7,       	      51 AFLGDIALDEEDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQST 100                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     101 NGQPQRGACGRWRGRSRSRRAATSRPERVWPDGVIPFVIGGNFTGSQRAV 150                                                          
						isolated polypeptide encoding for a tail of HUMBMP1A_P7,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     101 NGQPQRGACGRWRGRSRSRRAATSRPERVWPDGVIPFVIGGNFTGSQRAV 150                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     151 FRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAIS 200                                                          
						about 95% homologous to the sequence GSCILKPPLWLPCTPA in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMBMP1A_P7.                                                 	     151 FRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAIS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 IGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVW 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVW 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSK 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPN 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 YPDDYRPSKVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 YPDDYRPSKVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGFAVNFFKEVDE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 ESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGFAVNFFKEVDE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 CSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHF 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHF 700                                                          
						                                                            	                                                             
						                                                            	     701 FS                                                 702                                                          
						                                                            	         ||                                                  
						                                                            	     701 FS                                                 702                                                          

17375	HMR136_HUMBMP1A_9_tr0_r1_1_gPRT		Comparison report between HUMBMP1A_P9 and BMP1_HUMANunique   	Sequence name: BMP1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMBMP1A_P9, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17375 x BMP1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MTSTASCITLGTHSPVFSLFF corresponding to amino acids 1 - 21 of 	                                                            
						HUMBMP1A_P9, a second amino acid sequence being at least 90 %	                     Quality: 4298.00                      Escore:       0                                               
						RGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEY 	             Matching length:     428                Total length:     428                                               
						PNGYSAHMHCVWRISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCG 	 Matching Percent Similarity:   99.77   Matching Percent Identity:   99.53                                               
						SKLPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPNYPDDYRPS 	    Total Percent Similarity:   99.77      Total Percent Identity:   99.53                                               
						KVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHSESSTLIGRYCGYEKPDDI 	                        Gaps:       0                        
						KSTSSRLWLKFVSDGSINKAGFAVNFFKEVDECSRPNRGGCEQRCLNTLGSYKCSCDPGY 	                                                            
						ELAPDKRRCEAACGGFLTKLNGSITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFET 	Alignment:                                                   
						EGNDVCKYDFVEVRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKA 	                  .         .         .         .         .  
						HFFS                                                         	      20 FFRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPACGETL 69                                                           
						homologous to corresponding to amino acids 279 - 702 of      	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						BMP1_HUMAN, which also corresponds to amino acids 22 - 445 of	     277 FSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPACGETL 326                                                          
						HUMBMP1A_P9, and a third amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	      70 QDSTGNFSSPEYPNGYSAHMHCVWRISVTPGEKIILNFTSLDLYRSRLCW 119                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     327 QDSTGNFSSPEYPNGYSAHMHCVWRISVTPGEKIILNFTSLDLYRSRLCW 376                                                          
						EKRPALQPPRGRPHQLKFRVQKRNRTPQ corresponding to amino acids 446	                  .         .         .         .         .  
						- 473 of HUMBMP1A_P9, wherein said first amino acid sequence,	     120 YDYVEVRDGFWRKAPLRGRFCGSKLPEPIVSTDSRLWVEFRSSSNWVGKG 169                                                          
						second amino acid sequence and third amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     377 YDYVEVRDGFWRKAPLRGRFCGSKLPEPIVSTDSRLWVEFRSSSNWVGKG 426                                                          
						polypeptide encoding for a head of HUMBMP1A_P9, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     170 FFAVYEAICGGDVKKDYGHIQSPNYPDDYRPSKVCIWRIQVSEGFHVGLT 219                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     427 FFAVYEAICGGDVKKDYGHIQSPNYPDDYRPSKVCIWRIQVSEGFHVGLT 476                                                          
						to the sequence MTSTASCITLGTHSPVFSLFF of HUMBMP1A_P9.3.An    	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HUMBMP1A_P9,     	     220 FQSFEIERHDSCAYDYLEVRDGHSESSTLIGRYCGYEKPDDIKSTSSRLW 269                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     477 FQSFEIERHDSCAYDYLEVRDGHSESSTLIGRYCGYEKPDDIKSTSSRLW 526                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     270 LKFVSDGSINKAGFAVNFFKEVDECSRPNRGGCEQRCLNTLGSYKCSCDP 319                                                          
						EKRPALQPPRGRPHQLKFRVQKRNRTPQ in HUMBMP1A_P9.                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     527 LKFVSDGSINKAGFAVNFFKEVDECSRPNRGGCEQRCLNTLGSYKCSCDP 576                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     320 GYELAPDKRRCEAACGGFLTKLNGSITSPGWPKEYPPNKNCIWQLVAPTQ 369                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     577 GYELAPDKRRCEAACGGFLTKLNGSITSPGWPKEYPPNKNCIWQLVAPTQ 626                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     370 YRISLQFDFFETEGNDVCKYDFVEVRSGLTADSKLHGKFCGSEKPEVITS 419                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     627 YRISLQFDFFETEGNDVCKYDFVEVRSGLTADSKLHGKFCGSEKPEVITS 676                                                          
						                                                            	                  .         .                                
						                                                            	     420 QYNNMRVEFKSDNTVSKKGFKAHFFSEK                       447                                                          
						                                                            	         ||||||||||||||||||||||||||:|                        
						                                                            	     677 QYNNMRVEFKSDNTVSKKGFKAHFFSDK                       704                                                          

18116	HMR136_HUMBP180AA_1_tr0_r1_1_gPRT		Comparison report between HUMBP180AA_P1 and Q99018unique     	Sequence name: Q99018                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMBP180AA_P1, comprising a first amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 18116 x Q99018   ..                            
						85%, more preferably at least 90% and most preferably at     	                                                            
						MDVTKKNKRDGTEVTERIVTETVTTRLTSLPPKGGTSNGYAKTASLGGGSRLEKQSLTHG 	Alignment segment 1/1:                                       
						SSGYINSTGSTRGHASTSSYRRAHSPASTLPNSPGSTFERKTHVTRHAYEGSSSGNSSPE 	                                                            
						YPRKEFASSSTRGRSQTRESEIRVRLQSASPSTRWTELDDVKRLLKGSRSASVSPTRNSS 	                     Quality: 3461.00                      Escore:       0                                               
						NTLPIPKKGTVETKIVTASSQSVSGTYDAMILDANLPSHVWSSTLPAGSSMGTYHNNMTT 	             Matching length:     348                Total length:     348                                               
						QSSSLLNTNAYSAGSVFGVPNNMASCSPTLHPGLSTSSSVFGMQNNLAPSLTTLSHGTTT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TSTAYGVKKNMPQSPAAVNTGVSTSAACTTSVQSDDLLHKDCKFLILEKDNTPAKKEMEL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LIMTKDSGKVFTASPASIAATSFSEDTLKKEKQAAYNADSGLKAEANGDLKTVSTKGKTT 	                        Gaps:       0                        
						TADIHSYSSSGGGGSGGGGGVGGAGGGPWGPAPAWCPCGSCCSWWKWLLGLLLTWLLLLG 	                                                            
						LLFGLIALAEEVRKLKARVDELERIRR                                  	Alignment:                                                   
						least 95% homologous to a polypeptide having the sequence    	                  .         .         .         .         .  
						corresponding to amino acids 1 - 507 of HUMBP180AA_P1, a     	     508 SILPYGDSMDRIEKDRLQGMAPAAGADLDKIGLHSDSQEELWMFVRKKLM 557                                                          
						SILPYGDSMDRIEKDRLQGMAPAAGADLDKIGLHSDSQEELWMFVRKKLMMEQENGNLRG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SPGPKGDMGSPGPKGDRGFPGTPGIPGPLGHPGPQGPKGQKGSVGDPGMEGPMGQRGREG 	       1 SILPYGDSMDRIEKDRLQGMAPAAGADLDKIGLHSDSQEELWMFVRKKLM 50                                                           
						PMGPRGEAGPPGSGEKGERGAAGEPGPHGPPGVPGSVGPKGSSGSPGPQGPPGPVGLQGL 	                  .         .         .         .         .  
						RGEVGLPGVKGDKGPMGPPGPKGDQGEKGPRGLTGEPGMRGLPGAVGEPGAKGAMGPAGP 	     558 MEQENGNLRGSPGPKGDMGSPGPKGDRGFPGTPGIPGPLGHPGPQGPKGQ 607                                                          
						DGHQGPRGEQGLTGMPGIRGPPGPSGDPGKPGLTGPQGPQGLPGTPGRPGIKGEPGAPGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IVTSEGSSMLTVPGPPGPPGAMGPPGPPGAPGPAGPAGLPGHQEVLNL             	      51 MEQENGNLRGSPGPKGDMGSPGPKGDRGFPGTPGIPGPLGHPGPQGPKGQ 100                                                          
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 1 - 348 of Q99018, which also   	     608 KGSVGDPGMEGPMGQRGREGPMGPRGEAGPPGSGEKGERGAAGEPGPHGP 657                                                          
						corresponds to amino acids 508 - 855 of HUMBP180AA_P1, and a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 70%, optionally at  	     101 KGSVGDPGMEGPMGQRGREGPMGPRGEAGPPGSGEKGERGAAGEPGPHGP 150                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     658 PGVPGSVGPKGSSGSPGPQGPPGPVGLQGLRGEVGLPGVKGDKGPMGPPG 707                                                          
						QGPPGPPGPRGPPGPSIPGPPGPRGPPGEGLPGPPGPPGSFLSNSETFLSGPPGPPGPPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PKGDQGPPGPRGHQGEQGLPGFSTSGSSSFGLNLQGPPGPPGPQGPKGDKGDPGVPGALG 	     151 PGVPGSVGPKGSSGSPGPQGPPGPVGLQGLRGEVGLPGVKGDKGPMGPPG 200                                                          
						IPSGPSEGGSSSTMYVSGPPGPPGPPGPPGSISSSGQEIQQYISEYMQSDSIRSYLSGVQ 	                  .         .         .         .         .  
						GPPGPPGPPGPVTTITGETFDYSELASHVVSYLRTSGYGVSLFSSSISSEDILAVLQRDD 	     708 PKGDQGEKGPRGLTGEPGMRGLPGAVGEPGAKGAMGPAGPDGHQGPRGEQ 757                                                          
						VRQYLRQYLMGPRGPPGPPGASGDGSLLSLDYAELSSRILSYMSSSGISIGLPGPPGPPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPGTSYEELLSLLRAAGLSFIPGPPGPPGPPGPRGPPGVSGALATYAAENSDSFRSELIS 	     201 PKGDQGEKGPRGLTGEPGMRGLPGAVGEPGAKGAMGPAGPDGHQGPRGEQ 250                                                          
						YLTSPDVRSFIVGPPGPPGPQGPPGDSRLLSTDASHSRGSSSSSHSSSVRRGSSYSSSMS 	                  .         .         .         .         .  
						TGGGGAGSLGAGGAFGEAAGDRGPYGTDIGPGGGYGAAAEGGMYAGNGGLLGADFAGDLD 	     758 GLTGMPGIRGPPGPSGDPGKPGLTGPQGPQGLPGTPGRPGIKGEPGAPGK 807                                                          
						YNELAVRVSESMQRQGLLQGMAYTVQGPPGQPGPQGPPGISKVFSAYSNVTADLMDFFQT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YGAIQGPPGQKGEMGTPGPKGDRGPAGPPGHPGPPGPRGHKGEKGDKGDQVYAGRRRRRS 	     251 GLTGMPGIRGPPGPSGDPGKPGLTGPQGPQGLPGTPGRPGIKGEPGAPGK 300                                                          
						IAVKP                                                        	                  .         .         .         .            
						polypeptide having the sequence corresponding to amino acids 	     808 IVTSEGSSMLTVPGPPGPPGAMGPPGPPGAPGPAGPAGLPGHQEVLNL   855                                                          
						856 - 1460 of HUMBP180AA_P1, wherein said first amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						sequence, second amino acid sequence and third amino acid    	     301 IVTSEGSSMLTVPGPPGPPGAMGPPGPPGAPGPAGPAGLPGHQEVLNL   348                                                          
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of HUMBP180AA_P1,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MDVTKKNKRDGTEVTERIVTETVTTRLTSLPPKGGTSNGYAKTASLGGGSRLEKQSLTHG 	                                                            
						SSGYINSTGSTRGHASTSSYRRAHSPASTLPNSPGSTFERKTHVTRHAYEGSSSGNSSPE 	                                                            
						YPRKEFASSSTRGRSQTRESEIRVRLQSASPSTRWTELDDVKRLLKGSRSASVSPTRNSS 	                                                            
						NTLPIPKKGTVETKIVTASSQSVSGTYDAMILDANLPSHVWSSTLPAGSSMGTYHNNMTT 	                                                            
						QSSSLLNTNAYSAGSVFGVPNNMASCSPTLHPGLSTSSSVFGMQNNLAPSLTTLSHGTTT 	                                                            
						TSTAYGVKKNMPQSPAAVNTGVSTSAACTTSVQSDDLLHKDCKFLILEKDNTPAKKEMEL 	                                                            
						LIMTKDSGKVFTASPASIAATSFSEDTLKKEKQAAYNADSGLKAEANGDLKTVSTKGKTT 	                                                            
						TADIHSYSSSGGGGSGGGGGVGGAGGGPWGPAPAWCPCGSCCSWWKWLLGLLLTWLLLLG 	                                                            
						LLFGLIALAEEVRKLKARVDELERIRR                                  	                                                            
						about 95% homologous to the sequence of HUMBP180AA_P1.3.An   	                                                            
						isolated polypeptide encoding for a tail of HUMBP180AA_P1,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						QGPPGPPGPRGPPGPSIPGPPGPRGPPGEGLPGPPGPPGSFLSNSETFLSGPPGPPGPPG 	                                                            
						PKGDQGPPGPRGHQGEQGLPGFSTSGSSSFGLNLQGPPGPPGPQGPKGDKGDPGVPGALG 	                                                            
						IPSGPSEGGSSSTMYVSGPPGPPGPPGPPGSISSSGQEIQQYISEYMQSDSIRSYLSGVQ 	                                                            
						GPPGPPGPPGPVTTITGETFDYSELASHVVSYLRTSGYGVSLFSSSISSEDILAVLQRDD 	                                                            
						VRQYLRQYLMGPRGPPGPPGASGDGSLLSLDYAELSSRILSYMSSSGISIGLPGPPGPPG 	                                                            
						LPGTSYEELLSLLRAAGLSFIPGPPGPPGPPGPRGPPGVSGALATYAAENSDSFRSELIS 	                                                            
						YLTSPDVRSFIVGPPGPPGPQGPPGDSRLLSTDASHSRGSSSSSHSSSVRRGSSYSSSMS 	                                                            
						TGGGGAGSLGAGGAFGEAAGDRGPYGTDIGPGGGYGAAAEGGMYAGNGGLLGADFAGDLD 	                                                            
						YNELAVRVSESMQRQGLLQGMAYTVQGPPGQPGPQGPPGISKVFSAYSNVTADLMDFFQT 	                                                            
						YGAIQGPPGQKGEMGTPGPKGDRGPAGPPGHPGPPGPRGHKGEKGDKGDQVYAGRRRRRS 	                                                            
						IAVKP                                                        	                                                            
						about 95% homologous to the sequence in HUMBP180AA_P1.       	                                                            

18400	HMR136_HUMBPP_1_tr0_r1_1_gPRT		Comparison report between HUMBPP_P1 and OPSB_HUMANpartial WT 	Sequence name: OPSB_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for HUMBPP_P1, comprising a first amino 	Sequence documentation:                                      
						MRKMSEEEFYLFKNISSVGPWDGPQYHIAPVWAFYLQAAFMGTVFLIGFPLNAMVLVATL 	                                                            
						RYKKLRQPLNYILVNVSFGGFLLCIFSVFPVFVASCNGYFVFGRHVCALEGFLGTVAGLV 	Alignment of: 18400 x OPSB_HUMAN   ..                        
						TGWSLAFLAFERYIVICKPFGNFRFSSKHALTVVLATWTIGIGVSIPPFFGWSRFIPEGL 	                                                            
						QCSCGPDWYTVGTKYRSESYTWFLFIFCFIVPLSLICFSYTQLLRALKAVAAQQQESATT 	Alignment segment 1/1:                                       
						QKAERE                                                       	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2727.00                      Escore:       0                                               
						to amino acids 1 - 246 of OPSB_HUMAN, which also corresponds 	             Matching length:     285                Total length:     348                                               
						to amino acids 1 - 246 of HUMBPP_P1, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to                   	    Total Percent Similarity:   81.90      Total Percent Identity:   81.90                                               
						FQACIMKMVCGKAMTDESDTCSSQKTEVSTVSSTQVGPN corresponding to     	                        Gaps:       1                        
						amino acids 310 - 348 of OPSB_HUMAN, which also corresponds  	                                                            
						to amino acids 247 - 285 of HUMBPP_P1, wherein said first    	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MRKMSEEEFYLFKNISSVGPWDGPQYHIAPVWAFYLQAAFMGTVFLIGFP 50                                                           
						polypeptide encoding for an edge portion of HUMBPP_P1,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	       1 MRKMSEEEFYLFKNISSVGPWDGPQYHIAPVWAFYLQAAFMGTVFLIGFP 50                                                           
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      51 LNAMVLVATLRYKKLRQPLNYILVNVSFGGFLLCIFSVFPVFVASCNGYF 100                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	      51 LNAMVLVATLRYKKLRQPLNYILVNVSFGGFLLCIFSVFPVFVASCNGYF 100                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise EF, having a structure as follows: a sequence       	     101 VFGRHVCALEGFLGTVAGLVTGWSLAFLAFERYIVICKPFGNFRFSSKHA 150                                                          
						starting from any of amino acid numbers 246-x to 247; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 247+ ((n-2) - x), in     	     101 VFGRHVCALEGFLGTVAGLVTGWSLAFLAFERYIVICKPFGNFRFSSKHA 150                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     151 LTVVLATWTIGIGVSIPPFFGWSRFIPEGLQCSCGPDWYTVGTKYRSESY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LTVVLATWTIGIGVSIPPFFGWSRFIPEGLQCSCGPDWYTVGTKYRSESY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TWFLFIFCFIVPLSLICFSYTQLLRALKAVAAQQQESATTQKAERE.... 246                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     201 TWFLFIFCFIVPLSLICFSYTQLLRALKAVAAQQQESATTQKAEREVSRM 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     246 .................................................. 246                                                          
						                                                            	                                                            
						                                                            	     251 VVVMVGSFCVCYVPYAAFAMYMVNNRNHGLDLRLVTIPSFFSKSACIYNP 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     247 .........FQACIMKMVCGKAMTDESDTCSSQKTEVSTVSSTQVGPN   285                                                          
						                                                            	                  |||||||||||||||||||||||||||||||||||||||    
						                                                            	     301 IIYCFMNKQFQACIMKMVCGKAMTDESDTCSSQKTEVSTVSSTQVGPN   348                                                          

18553	HMR136_HUMBRAF_5_tr0_r1_1_gPRT		Comparison report between HUMBRAF_P5 and KRAB_HUMANunique    	Sequence name: KRAB_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMBRAF_P5, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18553 x KRAB_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence LLLLNVYIFLFTNL corresponding to amino    	Alignment segment 1/1:                                       
						acids 1 - 14 of HUMBRAF_P5, and a second amino acid sequence 	                                                            
						GSTTGLSATPPASLPGSLTNVKALQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEI 	                     Quality: 3673.00                      Escore:       0                                               
						PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 	             Matching length:     374                Total length:     374                                               
						ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 	                        Gaps:       0                        
						MAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPK 	                                                            
						TPIQAGGYGAFPVH                                               	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 392 - 765 of KRAB_HUMAN, which also corresponds to     	      15 GSTTGLSATPPASLPGSLTNVKALQKSPGPQRERKSSSSSEDRNRMKTLG 64                                                           
						amino acids 15 - 388 of HUMBRAF_P5, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	     392 GSTTGLSATPPASLPGSLTNVKALQKSPGPQRERKSSSSSEDRNRMKTLG 441                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of HUMBRAF_P5, comprising a polypeptide being at  	      65 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTP 114                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     442 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTP 491                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						LLLLNVYIFLFTNL of HUMBRAF_P5.                                	     115 QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH 164                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 QQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH 541                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     165 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 214                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 591                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     215 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 264                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     592 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 641                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     265 GIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 314                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     642 GIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 691                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     315 MAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTED 364                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     692 MAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTED 741                                                          
						                                                            	                  .         .                                
						                                                            	     365 FSLYACASPKTPIQAGGYGAFPVH                           388                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     742 FSLYACASPKTPIQAGGYGAFPVH                           765                                                          

761	HMR136_HUMBSHATP_4_tr0_r1_1_gPRT		Comparison report between HUMBSHATP_P4 and VAB2_HUMANpartial 	Sequence name: VAB2_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMBSHATP_P4, comprising a first    	                                                            
						MGQPINPQCRIYPEEMIQTGISAIDGMNSIARGQKIPIFSAAGLPHNEIAAQICRQAGLV 	Alignment of: 761 x VAB2_HUMAN   ..                          
						KKSKDVVDYSEENFAIVFAAMGVNMETARFFKSDFEENGSMDNVCLFLNLANDPTIERII 	                                                            
						TPRLALTTAEFLAYQCEKHVLVILTDMSSYAEALREVSAAREEVPGRRGFPGYMYTDLAT 	Alignment segment 1/1:                                       
						IYERAGRVEGRNGSITQIPILTMPNDDITHPIPDLTGYITEGQIYVDRQLHNRQIYPPIN 	                                                            
						VLPSLSRLMKSAIGEGMTRKDHADVSNQLYACYAIGKDVQAMKAVVGEEALTSDDLLYLE 	                     Quality: 3493.00                      Escore:       0                                               
						FLQKFERNFIAQGPYENRTVFETLDIGWQLLRIFPKEMLKRIPQSTLSEFYPRDSAKH   	             Matching length:     358                Total length:     358                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 154 - 511 of VAB2_HUMAN, which  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 358 of HUMBSHATP_P4.     	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGQPINPQCRIYPEEMIQTGISAIDGMNSIARGQKIPIFSAAGLPHNEIA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     154 MGQPINPQCRIYPEEMIQTGISAIDGMNSIARGQKIPIFSAAGLPHNEIA 203                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AQICRQAGLVKKSKDVVDYSEENFAIVFAAMGVNMETARFFKSDFEENGS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     204 AQICRQAGLVKKSKDVVDYSEENFAIVFAAMGVNMETARFFKSDFEENGS 253                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MDNVCLFLNLANDPTIERIITPRLALTTAEFLAYQCEKHVLVILTDMSSY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     254 MDNVCLFLNLANDPTIERIITPRLALTTAEFLAYQCEKHVLVILTDMSSY 303                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AEALREVSAAREEVPGRRGFPGYMYTDLATIYERAGRVEGRNGSITQIPI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 AEALREVSAAREEVPGRRGFPGYMYTDLATIYERAGRVEGRNGSITQIPI 353                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LTMPNDDITHPIPDLTGYITEGQIYVDRQLHNRQIYPPINVLPSLSRLMK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 LTMPNDDITHPIPDLTGYITEGQIYVDRQLHNRQIYPPINVLPSLSRLMK 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SAIGEGMTRKDHADVSNQLYACYAIGKDVQAMKAVVGEEALTSDDLLYLE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 SAIGEGMTRKDHADVSNQLYACYAIGKDVQAMKAVVGEEALTSDDLLYLE 453                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FLQKFERNFIAQGPYENRTVFETLDIGWQLLRIFPKEMLKRIPQSTLSEF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     454 FLQKFERNFIAQGPYENRTVFETLDIGWQLLRIFPKEMLKRIPQSTLSEF 503                                                          
						                                                            	                                                             
						                                                            	     351 YPRDSAKH                                           358                                                          
						                                                            	         ||||||||                                            
						                                                            	     504 YPRDSAKH                                           511                                                          

763	HMR136_HUMBSHATP_6_tr0_r1_1_gPRT		Comparison report between HUMBSHATP_P6 and VAB2_HUMANpartial 	Sequence name: VAB2_HUMAN                                    
						WT sequence featuring skipped exon plus extra amino          	                                                            
						acids.1.An isolated chimeric polypeptide encoding for        	Sequence documentation:                                      
						HUMBSHATP_P6, comprising a first amino acid sequence being at	                                                            
						least 90 % homologous to MALRAMRGIVNGAAPELPVPT corresponding 	Alignment of: 763 x VAB2_HUMAN   ..                          
						to amino acids 1 - 21 of VAB2_HUMAN, which also corresponds  	                                                            
						to amino acids 1 - 21 of HUMBSHATP_P6, a second amino acid   	Alignment segment 1/1:                                       
						sequence bridging amino acid sequence comprising of A, and a 	                                                            
						YKTVSGVNGPLVILDHVKFPRYAEIVHLTLPDGTKRSGQVLEVSGSKAVVQVFEGTSGID 	                     Quality: 4606.00                      Escore:       0                                               
						AKKTSCEFTGDILRTPVSEDMLGRVFNGSGKPIDRGPVVLAEDFLDIMGQPINPQCRIYP 	             Matching length:     487                Total length:     511                                               
						EEMIQTGISAIDGMNSIARGQKIPIFSAAGLPHNEIAAQICRQAGLVKKSKDVVDYSEEN 	 Matching Percent Similarity:   99.79   Matching Percent Identity:   99.79                                               
						FAIVFAAMGVNMETARFFKSDFEENGSMDNVCLFLNLANDPTIERIITPRLALTTAEFLA 	    Total Percent Similarity:   95.11      Total Percent Identity:   95.11                                               
						YQCEKHVLVILTDMSSYAEALREVSAAREEVPGRRGFPGYMYTDLATIYERAGRVEGRNG 	                        Gaps:       1                        
						SITQIPILTMPNDDITHPIPDLTGYITEGQIYVDRQLHNRQIYPPINVLPSLSRLMKSAI 	                                                            
						GEGMTRKDHADVSNQLYACYAIGKDVQAMKAVVGEEALTSDDLLYLEFLQKFERNFIAQG 	Alignment:                                                   
						PYENRTVFETLDIGWQLLRIFPKEMLKRIPQSTLSEFYPRDSAKH                	                  .         .         .         .         .  
						third amino acid sequence being at least 90 % homologous to  	       1 MALRAMRGIVNGAAPELPVPT........................AYKTV 26                                                           
						corresponding to amino acids 47 - 511 of VAB2_HUMAN, which   	         |||||||||||||||||||||                         ||||  
						also corresponds to amino acids 23 - 487 of HUMBSHATP_P6,    	       1 MALRAMRGIVNGAAPELPVPTGGPAVGAREQALAVSRNYLSQPRLTYKTV 50                                                           
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	      27 SGVNGPLVILDHVKFPRYAEIVHLTLPDGTKRSGQVLEVSGSKAVVQVFE 76                                                           
						a sequential order.2.An isolated polypeptide encoding for an 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of HUMBSHATP_P6, comprising a polypeptide having	      51 SGVNGPLVILDHVKFPRYAEIVHLTLPDGTKRSGQVLEVSGSKAVVQVFE 100                                                          
						a length "n", wherein n is at least about 10 amino acids in  	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      77 GTSGIDAKKTSCEFTGDILRTPVSEDMLGRVFNGSGKPIDRGPVVLAEDF 126                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     101 GTSGIDAKKTSCEFTGDILRTPVSEDMLGRVFNGSGKPIDRGPVVLAEDF 150                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TAY having a structure as  	     127 LDIMGQPINPQCRIYPEEMIQTGISAIDGMNSIARGQKIPIFSAAGLPHN 176                                                          
						follows (numbering according to HUMBSHATP_P6): a sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 21-x to 21; and      	     151 LDIMGQPINPQCRIYPEEMIQTGISAIDGMNSIARGQKIPIFSAAGLPHN 200                                                          
						ending at any of amino acid numbers 23 + ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     177 EIAAQICRQAGLVKKSKDVVDYSEENFAIVFAAMGVNMETARFFKSDFEE 226                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EIAAQICRQAGLVKKSKDVVDYSEENFAIVFAAMGVNMETARFFKSDFEE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     227 NGSMDNVCLFLNLANDPTIERIITPRLALTTAEFLAYQCEKHVLVILTDM 276                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NGSMDNVCLFLNLANDPTIERIITPRLALTTAEFLAYQCEKHVLVILTDM 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     277 SSYAEALREVSAAREEVPGRRGFPGYMYTDLATIYERAGRVEGRNGSITQ 326                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SSYAEALREVSAAREEVPGRRGFPGYMYTDLATIYERAGRVEGRNGSITQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     327 IPILTMPNDDITHPIPDLTGYITEGQIYVDRQLHNRQIYPPINVLPSLSR 376                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPILTMPNDDITHPIPDLTGYITEGQIYVDRQLHNRQIYPPINVLPSLSR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 LMKSAIGEGMTRKDHADVSNQLYACYAIGKDVQAMKAVVGEEALTSDDLL 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LMKSAIGEGMTRKDHADVSNQLYACYAIGKDVQAMKAVVGEEALTSDDLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 YLEFLQKFERNFIAQGPYENRTVFETLDIGWQLLRIFPKEMLKRIPQSTL 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 YLEFLQKFERNFIAQGPYENRTVFETLDIGWQLLRIFPKEMLKRIPQSTL 500                                                          
						                                                            	                  .                                          
						                                                            	     477 SEFYPRDSAKH                                        487                                                          
						                                                            	         |||||||||||                                         
						                                                            	     501 SEFYPRDSAKH                                        511                                                          

20205	HMR136_HUMC8AS_2_tr0_r1_1_gPRT		Comparison report between HUMC8AS_P2 and CO8A_HUMANpartial   	Sequence name: CO8A_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMC8AS_P2, comprising a first amino	                                                            
						MRKDDIMLDEGMLQSLMELPDQYNYGMYAKFINDYGTHYITSGSMGGIYEYILVIDKAKM 	Alignment of: 20205 x CO8A_HUMAN   ..                        
						ESLGITSRDITTCFGGSLGIQYEDKINVGGGLSGDHCKKFGGGKTERARKAMAVEDIISR 	                                                            
						VRGGSSGWSGGLAQNRSTITYRSWGRSLKYNPVVIDFEMQPIHEVLRHTSLGPLEAKRQN 	Alignment segment 1/1:                                       
						LRRALDQYLMEFNACRCGPCFNNGVPILEGTSCRCQCRLGSLGAACEQTQTEGAKADGSW 	                                                            
						SCWSSWSVCRAGIQERRRECDNPAPQNGGASCPGRKVQTQAC                   	                     Quality: 2817.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     282                Total length:     282                                               
						to amino acids 303 - 584 of CO8A_HUMAN, which also           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 282 of HUMC8AS_P2.            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRKDDIMLDEGMLQSLMELPDQYNYGMYAKFINDYGTHYITSGSMGGIYE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     303 MRKDDIMLDEGMLQSLMELPDQYNYGMYAKFINDYGTHYITSGSMGGIYE 352                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YILVIDKAKMESLGITSRDITTCFGGSLGIQYEDKINVGGGLSGDHCKKF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     353 YILVIDKAKMESLGITSRDITTCFGGSLGIQYEDKINVGGGLSGDHCKKF 402                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GGGKTERARKAMAVEDIISRVRGGSSGWSGGLAQNRSTITYRSWGRSLKY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     403 GGGKTERARKAMAVEDIISRVRGGSSGWSGGLAQNRSTITYRSWGRSLKY 452                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NPVVIDFEMQPIHEVLRHTSLGPLEAKRQNLRRALDQYLMEFNACRCGPC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     453 NPVVIDFEMQPIHEVLRHTSLGPLEAKRQNLRRALDQYLMEFNACRCGPC 502                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FNNGVPILEGTSCRCQCRLGSLGAACEQTQTEGAKADGSWSCWSSWSVCR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     503 FNNGVPILEGTSCRCQCRLGSLGAACEQTQTEGAKADGSWSCWSSWSVCR 552                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 AGIQERRRECDNPAPQNGGASCPGRKVQTQAC                   282                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     553 AGIQERRRECDNPAPQNGGASCPGRKVQTQAC                   584                                                          

20484	HMR136_HUMC8BS_2_tr0_r1_1_gPRT		Comparison report between HUMC8BS_P2 and CO8B_HUMAN_V1unique 	Sequence name: CO8B_HUMAN_V1                                 
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMC8BS_P2, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20484 x CO8B_HUMAN_V1   ..                     
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						ICSWGQKLTVALTAQACYGSSSLCGISCHIGK corresponding to amino acids	                                                            
						1 - 32 of HUMC8BS_P2, a second amino acid sequence being at  	                     Quality: 5210.00                      Escore:       0                                               
						MKNSRTWAWRAPVELFLLCAALGCLSLPGSRGERPHSFGSNAVNKSFAKSRQMRSVDVTL 	             Matching length:     525                Total length:     591                                               
						MPIDCELSSWSSWTTCDPCQKKRYRYAYLLQPSQFHGEPCNFSDKEVEDCVTNRPCGSQV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RCEGFVCAQTGRCVNRRLLCNGDNDCGDQSDEANCRRIYKKCQHEMDQYWGIGSLASGIN 	    Total Percent Similarity:   88.83      Total Percent Identity:   88.83                                               
						LFTNSFEGPVLDHRYYAGGCSPHYILNTRFRKPYNVESYTPQ                   	                        Gaps:       1                        
						least 90 % homologous to corresponding to amino acids 1 - 222	                                                            
						of CO8B_HUMAN_V1, which also corresponds to amino acids 33 - 	Alignment:                                                   
						254 of HUMC8BS_P2, and a third amino acid sequence being at  	                  .         .         .         .         .  
						KSVFLHARSDLEVAHYKLKPRSLMLHYEFLQRVKRLPLEYSYGEYRDLFRDFGTHYITEA 	      33 MKNSRTWAWRAPVELFLLCAALGCLSLPGSRGERPHSFGSNAVNKSFAKS 82                                                           
						VLGGIYEYTLVMNKEAMERGDYTLNNVHACAKNDFKIGGAIEEVYVSLGVSVGKCRGILN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EIKDRNKRDTMVEDLVVLVRGGASEHITTLAYQELPTADLMQEWGDAVQYNPAIIKVKVE 	       1 MKNSRTWAWRAPVELFLLCAALGCLSLPGSRGERPHSFGSNAVNKSFAKS 50                                                           
						PLYELVTATDFAYSSTVRQNMKQALEEFQKEVSSCHCAPCQGNGVPVLKGSRCDCICPVG 	                  .         .         .         .         .  
						SQGLACEVSYRKNTPIDGKWNCWSNWSSCSGRRKTRQRQCNNPPPQNGGSPCSGPASETL 	      83 RQMRSVDVTLMPIDCELSSWSSWTTCDPCQKKRYRYAYLLQPSQFHGEPC 132                                                          
						DCS                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 289 -  	      51 RQMRSVDVTLMPIDCELSSWSSWTTCDPCQKKRYRYAYLLQPSQFHGEPC 100                                                          
						591 of CO8B_HUMAN_V1, which also corresponds to amino acids  	                  .         .         .         .         .  
						255 - 557 of HUMC8BS_P2, wherein said first amino acid       	     133 NFSDKEVEDCVTNRPCGSQVRCEGFVCAQTGRCVNRRLLCNGDNDCGDQS 182                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     101 NFSDKEVEDCVTNRPCGSQVRCEGFVCAQTGRCVNRRLLCNGDNDCGDQS 150                                                          
						isolated polypeptide encoding for a head of HUMC8BS_P2,      	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     183 DEANCRRIYKKCQHEMDQYWGIGSLASGINLFTNSFEGPVLDHRYYAGGC 232                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     151 DEANCRRIYKKCQHEMDQYWGIGSLASGINLFTNSFEGPVLDHRYYAGGC 200                                                          
						about 95% homologous to the sequence                         	                  .         .         .         .         .  
						ICSWGQKLTVALTAQACYGSSSLCGISCHIGK of HUMC8BS_P2.3.An isolated 	     233 SPHYILNTRFRKPYNVESYTPQ............................ 254                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||                              
						HUMC8BS_P2, comprising a polypeptide having a length "n",    	     201 SPHYILNTRFRKPYNVESYTPQTQGKYEFILKEYESYSDFERNVTEKMAS 250                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     255 ......................................KSVFLHARSDLE 266                                                          
						preferably at least about 30 amino acids in length, more     	                                               ||||||||||||  
						preferably at least about 40 amino acids in length and most  	     251 KSGFSFGFKIPGIFELGISSQSDRGKHYIRRTKRFSHTKSVFLHARSDLE 300                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise QK, having a structure as  	     267 VAHYKLKPRSLMLHYEFLQRVKRLPLEYSYGEYRDLFRDFGTHYITEAVL 316                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						254-x to 255; and ending at any of amino acid numbers 255+   	     301 VAHYKLKPRSLMLHYEFLQRVKRLPLEYSYGEYRDLFRDFGTHYITEAVL 350                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     317 GGIYEYTLVMNKEAMERGDYTLNNVHACAKNDFKIGGAIEEVYVSLGVSV 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 GGIYEYTLVMNKEAMERGDYTLNNVHACAKNDFKIGGAIEEVYVSLGVSV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     367 GKCRGILNEIKDRNKRDTMVEDLVVLVRGGASEHITTLAYQELPTADLMQ 416                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GKCRGILNEIKDRNKRDTMVEDLVVLVRGGASEHITTLAYQELPTADLMQ 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     417 EWGDAVQYNPAIIKVKVEPLYELVTATDFAYSSTVRQNMKQALEEFQKEV 466                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EWGDAVQYNPAIIKVKVEPLYELVTATDFAYSSTVRQNMKQALEEFQKEV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     467 SSCHCAPCQGNGVPVLKGSRCDCICPVGSQGLACEVSYRKNTPIDGKWNC 516                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SSCHCAPCQGNGVPVLKGSRCDCICPVGSQGLACEVSYRKNTPIDGKWNC 550                                                          
						                                                            	                  .         .         .         .            
						                                                            	     517 WSNWSSCSGRRKTRQRQCNNPPPQNGGSPCSGPASETLDCS          557                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     551 WSNWSSCSGRRKTRQRQCNNPPPQNGGSPCSGPASETLDCS          591                                                          

21487	HMR136_HUMCA8A_1_tr0_r1_1_gPRT		Comparison report between HUMCA8A_P1 and CAD8_HUMANpartial   	Sequence name: CAD8_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCA8A_P1, comprising a first amino	Sequence documentation:                                      
						MPERLAEMLLDLWTPLIILWITLPPCIYMAPMNQSQVLMSGSPLELNSLGEEQRILNRSK 	                                                            
						RGWVWNQMFVLEEFSGPEPILVGRLHTDLDPGSKKIKYILSGDGAGTIFQINDVTGDIHA 	Alignment of: 21487 x CAD8_HUMAN   ..                        
						IKRLDREEKAEYTLTAQAVDWETSKPLEPPSEFIIKVQDINDNAPEFLNGPYHATVPEMS 	                                                            
						ILGTSVTNVTATDADDPVYGNSAKLVYSILEGQPYFSIEPETAIIKTALPNMDREAKEEY 	Alignment segment 1/1:                                       
						LVVIQAKDMGGHSGGLSGTTTLTVTLTDVNDNPPKFAQSLYHFSVPEDVVLGTAIGRVKA 	                                                            
						NDQDIGENAQSSYDIIDGDGTALFEITSDAQAQDGIIRLRKPLDFETKKSYTLKVEAANV 	                     Quality: 6738.00                      Escore:       0                                               
						HIDPRFSGRGPFKDTATVKIVVEDADEPPVFSSPTYLLEVHENAALNSVIGQVTARDPDI 	             Matching length:     697                Total length:     697                                               
						TSSPIRFSIDRHTDLERQFNINADDGKITLATPLDRELSVWHNITIIATEIRNHSQISRV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PVAIKVLDVNDNAPEFASEYEAFLCENGKPGQVIQTVSAMDKDDPKNGHYFLYSLLPEMV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						NNPNFTIKKNEDNSLSILAKHNGFNRQKQEVYLLPIIISDSGNPPLSSTSTLTIRVCGCS 	                        Gaps:       0                        
						NDGVVQSCNVEAYVLPIGLSMGALIAILACIILLLVIVVLFVTLRRHKNEPLIIKDDEDV 	                                                            
						RENIIRYDDEGGGEEDTEAFDIATLQNPDGINGFLPR                        	Alignment:                                                   
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 697 of CAD8_HUMAN, which also corresponds 	       1 MPERLAEMLLDLWTPLIILWITLPPCIYMAPMNQSQVLMSGSPLELNSLG 50                                                           
						to amino acids 1 - 697 of HUMCA8A_P1, and a second amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 MPERLAEMLLDLWTPLIILWITLPPCIYMAPMNQSQVLMSGSPLELNSLG 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 EEQRILNRSKRGWVWNQMFVLEEFSGPEPILVGRLHTDLDPGSKKIKYIL 100                                                          
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WGLPIQWWEERNPIQTCLFSRSRIPRSLLFIFFHKDTKINCITQWTT corresponding	      51 EEQRILNRSKRGWVWNQMFVLEEFSGPEPILVGRLHTDLDPGSKKIKYIL 100                                                          
						to amino acids 698 - 744 of HUMCA8A_P1, wherein said first   	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	     101 SGDGAGTIFQINDVTGDIHAIKRLDREEKAEYTLTAQAVDWETSKPLEPP 150                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of HUMCA8A_P1, comprising a  	     101 SGDGAGTIFQINDVTGDIHAIKRLDREEKAEYTLTAQAVDWETSKPLEPP 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     151 SEFIIKVQDINDNAPEFLNGPYHATVPEMSILGTSVTNVTATDADDPVYG 200                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	     151 SEFIIKVQDINDNAPEFLNGPYHATVPEMSILGTSVTNVTATDADDPVYG 200                                                          
						WGLPIQWWEERNPIQTCLFSRSRIPRSLLFIFFHKDTKINCITQWTT in           	                  .         .         .         .         .  
						HUMCA8A_P1.                                                  	     201 NSAKLVYSILEGQPYFSIEPETAIIKTALPNMDREAKEEYLVVIQAKDMG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NSAKLVYSILEGQPYFSIEPETAIIKTALPNMDREAKEEYLVVIQAKDMG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GHSGGLSGTTTLTVTLTDVNDNPPKFAQSLYHFSVPEDVVLGTAIGRVKA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GHSGGLSGTTTLTVTLTDVNDNPPKFAQSLYHFSVPEDVVLGTAIGRVKA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NDQDIGENAQSSYDIIDGDGTALFEITSDAQAQDGIIRLRKPLDFETKKS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NDQDIGENAQSSYDIIDGDGTALFEITSDAQAQDGIIRLRKPLDFETKKS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YTLKVEAANVHIDPRFSGRGPFKDTATVKIVVEDADEPPVFSSPTYLLEV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 YTLKVEAANVHIDPRFSGRGPFKDTATVKIVVEDADEPPVFSSPTYLLEV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 HENAALNSVIGQVTARDPDITSSPIRFSIDRHTDLERQFNINADDGKITL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 HENAALNSVIGQVTARDPDITSSPIRFSIDRHTDLERQFNINADDGKITL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ATPLDRELSVWHNITIIATEIRNHSQISRVPVAIKVLDVNDNAPEFASEY 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ATPLDRELSVWHNITIIATEIRNHSQISRVPVAIKVLDVNDNAPEFASEY 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 EAFLCENGKPGQVIQTVSAMDKDDPKNGHYFLYSLLPEMVNNPNFTIKKN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 EAFLCENGKPGQVIQTVSAMDKDDPKNGHYFLYSLLPEMVNNPNFTIKKN 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 EDNSLSILAKHNGFNRQKQEVYLLPIIISDSGNPPLSSTSTLTIRVCGCS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EDNSLSILAKHNGFNRQKQEVYLLPIIISDSGNPPLSSTSTLTIRVCGCS 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 NDGVVQSCNVEAYVLPIGLSMGALIAILACIILLLVIVVLFVTLRRHKNE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NDGVVQSCNVEAYVLPIGLSMGALIAILACIILLLVIVVLFVTLRRHKNE 650                                                          
						                                                            	                  .         .         .         .            
						                                                            	     651 PLIIKDDEDVRENIIRYDDEGGGEEDTEAFDIATLQNPDGINGFLPR    697                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     651 PLIIKDDEDVRENIIRYDDEGGGEEDTEAFDIATLQNPDGINGFLPR    697                                                          

21485	HMR136_HUMCA8A_3_tr0_r1_1_gPRT		Comparison report between HUMCA8A_P3 and CAD8_HUMANpartial   	Sequence name: CAD8_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCA8A_P3, comprising a first amino	Sequence documentation:                                      
						MPERLAEMLLDLWTPLIILWITLPPCIYMAPMNQSQVLMSGSPLELNSLGEEQRILNRSK 	                                                            
						RGWVWNQMFVLEEFSGPEPILVGRLHTDLDPGSKKIKYILSGDGAGTIFQINDVTGDIHA 	Alignment of: 21485 x CAD8_HUMAN   ..                        
						IKRLDREEKAEYTLTAQAVDWETSKPLEPPSEFIIKVQDINDNAPEFLNGPYHATVPEMS 	                                                            
						ILGTSVTNVTATDADDPVYGNSAKLVYSILEGQPYFSIEPETAIIKTALPNMDREAKEEY 	Alignment segment 1/1:                                       
						LVVIQAKDMGGHSGGLSGTTTLTVTLTDVNDNPPKFAQSLYHFSVPEDVVLGTAIGRVKA 	                                                            
						NDQDIGENAQSSYDIIDGDGTALFEITSDAQAQDGIIRLRKPLDFETKKSYTLKVEAANV 	                     Quality: 4553.00                      Escore:       0                                               
						HIDPRFSGRGPFKDTATVKIVVEDADEPPVFSSPTYLLEVHENAALNSVIGQVTARDPDI 	             Matching length:     471                Total length:     471                                               
						TSSPIRFSIDRHTDLERQFNINADDGKITLATPLDRELSVWHNITIIATEI          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 471 of CAD8_HUMAN, which also corresponds 	                        Gaps:       0                        
						to amino acids 1 - 471 of HUMCA8A_P3, and a second amino acid	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MPERLAEMLLDLWTPLIILWITLPPCIYMAPMNQSQVLMSGSPLELNSLG 50                                                           
						having the sequence SKCLDLFISSLCD corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 472 - 484 of HUMCA8A_P3, wherein said first amino acid 	       1 MPERLAEMLLDLWTPLIILWITLPPCIYMAPMNQSQVLMSGSPLELNSLG 50                                                           
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 EEQRILNRSKRGWVWNQMFVLEEFSGPEPILVGRLHTDLDPGSKKIKYIL 100                                                          
						tail of HUMCA8A_P3, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 EEQRILNRSKRGWVWNQMFVLEEFSGPEPILVGRLHTDLDPGSKKIKYIL 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence SKCLDLFISSLCD  	     101 SGDGAGTIFQINDVTGDIHAIKRLDREEKAEYTLTAQAVDWETSKPLEPP 150                                                          
						in HUMCA8A_P3.                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SGDGAGTIFQINDVTGDIHAIKRLDREEKAEYTLTAQAVDWETSKPLEPP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SEFIIKVQDINDNAPEFLNGPYHATVPEMSILGTSVTNVTATDADDPVYG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SEFIIKVQDINDNAPEFLNGPYHATVPEMSILGTSVTNVTATDADDPVYG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NSAKLVYSILEGQPYFSIEPETAIIKTALPNMDREAKEEYLVVIQAKDMG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NSAKLVYSILEGQPYFSIEPETAIIKTALPNMDREAKEEYLVVIQAKDMG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GHSGGLSGTTTLTVTLTDVNDNPPKFAQSLYHFSVPEDVVLGTAIGRVKA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GHSGGLSGTTTLTVTLTDVNDNPPKFAQSLYHFSVPEDVVLGTAIGRVKA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NDQDIGENAQSSYDIIDGDGTALFEITSDAQAQDGIIRLRKPLDFETKKS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NDQDIGENAQSSYDIIDGDGTALFEITSDAQAQDGIIRLRKPLDFETKKS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YTLKVEAANVHIDPRFSGRGPFKDTATVKIVVEDADEPPVFSSPTYLLEV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 YTLKVEAANVHIDPRFSGRGPFKDTATVKIVVEDADEPPVFSSPTYLLEV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 HENAALNSVIGQVTARDPDITSSPIRFSIDRHTDLERQFNINADDGKITL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 HENAALNSVIGQVTARDPDITSSPIRFSIDRHTDLERQFNINADDGKITL 450                                                          
						                                                            	                  .         .                                
						                                                            	     451 ATPLDRELSVWHNITIIATEI                              471                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     451 ATPLDRELSVWHNITIIATEI                              471                                                          

23623	HMR136_HUMCAMPDE_4_tr0_r1_1_gPRT		Comparison report between HUMCAMPDE_P4 and CN1B_HUMANpartial 	Sequence name: CN1B_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUMCAMPDE_P4, comprising a 	Sequence documentation:                                      
						MELSPRSPPEMLEESDCPSPLELKSAPSKKMWIKLRSLLRYMVKQLENGEINIEELKKNL 	                                                            
						EYTASLLEAVYIDETRQILDTEDELQELRSDAVPSEVRDWLASTFTQQARAKGRRAEEKP 	Alignment of: 23623 x CN1B_HUMAN   ..                        
						KFRSIVHAVQAGIFVERMFRRTYTSVGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHAL 	                                                            
						RTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLL 	Alignment segment 1/1:                                       
						RTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSV 	                                                            
						FRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPK 	                     Quality: 4481.00                      Escore:       0                                               
						ALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQS 	             Matching length:     458                Total length:     458                                               
						QIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQP                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						first amino acid sequence being at least 90 % homologous to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 458 of CN1B_HUMAN, which    	                        Gaps:       0                        
						also corresponds to amino acids 1 - 458 of HUMCAMPDE_P4, and 	                                                            
						a second amino acid sequence being at least 70%, optionally  	Alignment:                                                   
						at least 80%, preferably at least 85%, more preferably at    	                  .         .         .         .         .  
						least 90% and most preferably at least 95% homologous to a   	       1 MELSPRSPPEMLEESDCPSPLELKSAPSKKMWIKLRSLLRYMVKQLENGE 50                                                           
						polypeptide having the sequence R corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 459 - 459 of HUMCAMPDE_P4, wherein said first amino    	       1 MELSPRSPPEMLEESDCPSPLELKSAPSKKMWIKLRSLLRYMVKQLENGE 50                                                           
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.                                   	      51 INIEELKKNLEYTASLLEAVYIDETRQILDTEDELQELRSDAVPSEVRDW 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 INIEELKKNLEYTASLLEAVYIDETRQILDTEDELQELRSDAVPSEVRDW 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LASTFTQQARAKGRRAEEKPKFRSIVHAVQAGIFVERMFRRTYTSVGPTY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LASTFTQQARAKGRRAEEKPKFRSIVHAVQAGIFVERMFRRTYTSVGPTY 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 STAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 STAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTAL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 FRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTAL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADE 450                                                          
						                                                            	                                                             
						                                                            	     451 DSKSKNQP                                           458                                                          
						                                                            	         ||||||||                                            
						                                                            	     451 DSKSKNQP                                           458                                                          

23219	HMR136_HUMCAM_13_tr0_r1_1_gPRT		Comparison report between HUMCAM_P13 and                     	Sequence name: CALM_HUMAN_V1                                 
						CALM_HUMAN_V1partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMCAM_P13, comprising a   	                                                            
						MINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMT 	Alignment of: 23219 x CALM_HUMAN_V1   ..                     
						NLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK                       	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 52 - 149 of CALM_HUMAN_V1, which	                                                            
						also corresponds to amino acids 1 - 98 of HUMCAM_P13.        	                     Quality:  956.00                      Escore:       0                                               
						                                                            	             Matching length:      98                Total length:      98                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYI 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      52 MINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYI 101                                                          
						                                                            	                  .         .         .         .            
						                                                            	      51 SAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK   98                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     102 SAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK   149                                                          

2305	HMR136_HUMCAP_3_tr0_r1_1_gPRT		Comparison report between HUMCAP_P3 and PTN3_HUMANpartial WT 	Sequence name: PTN3_HUMAN                                    
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for HUMCAP_P3, comprising a first amino 	Sequence documentation:                                      
						MDICEGRLTCPLNSAVVLASYAVQSHFGDYNSSIHHPGYLSDSHFIPDQNEDFLTKVESL 	                                                            
						HEQHSGLKQSEAESCYINIARTLDFYGVELHSGRDLHNLDLMIGIASAGVAVYRKYICTS 	Alignment of: 2305 x PTN3_HUMAN   ..                         
						FYPWVNILKISFKRKKFFIHQRQKQAESREHIVAFNMLNYRSCKNLWKSCVEHHTFFQAK 	                                                            
						KLLPQEKNVLSQYWTMGSRNTKKSVNNQYCKKVIGGMVWNPAMRRSLSVEHLETKSLPSR 	Alignment segment 1/1:                                       
						SPPITPNWRSPRLRHEIRKPRHSSADNLANEMTYITETEDVFYTYKGSLAPQDSDSEVSQ 	                                                            
						NRSPHQESLSENNPAQSYLTQKSSSSVSPSSNAPGSCSPDGVDQQLLDDFHRVTKGGSTE 	                     Quality: 7780.00                      Escore:       0                                               
						DASQYYCDKNDNGDSYLVLIRITPDEDGKFGFNLKGGVDQKMPLVVSRINPESPADTCIP 	             Matching length:     782                Total length:     782                                               
						KLNEGDQIVLINGRDISEHTHDQVVMFIKASRESHSRELALVIRRRAVRSFADFKSEDEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.87                                               
						NQLFPEAIFPMCPEGGDTLEGSMAQLKKGLESGTVLIQFEQLYRKKPGLAITFAKLPQNL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.87                                               
						DKNRYKDVLPYDTTRVLLQGNEDYINASYVNMEIPAANLVNKYIATQGPLPHTCAQFWQV 	                        Gaps:       0                        
						VWDQKLSLIVMLTTLTERGRTKCHQYWPDPPDVMNHGGFHIQCQSEDCTIAYVSREMLVT 	                                                            
						NTQTGEEHTVTHLQYVAWPDHG                                       	Alignment:                                                   
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 132 - 813 of PTN3_HUMAN, which also           	       1 MDICEGRLTCPLNSAVVLASYAVQSHFGDYNSSIHHPGYLSDSHFIPDQN 50                                                           
						corresponds to amino acids 1 - 682 of HUMCAP_P3, a bridging  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid V corresponding to amino acid 683 of HUMCAP_P3,   	     132 MDICEGRLTCPLNSAVVLASYAVQSHFGDYNSSIHHPGYLSDSHFIPDQN 181                                                          
						and a second amino acid sequence being at least 90 %         	                  .         .         .         .         .  
						PDDSSDFLEFVNYVRSLRVDSEPVLVHCSAGIGRTGVLVTMETAMCLTERNLPIYPLDIV 	      51 EDFLTKVESLHEQHSGLKQSEAESCYINIARTLDFYGVELHSGRDLHNLD 100                                                          
						RKMRDQRAMMVQTSSQYKFVCEAILRVYEEGLVQMLDPS                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 815 - 913 of      	     182 EDFLTKVESLHEQHSGLKQSEAESCYINIARTLDFYGVELHSGRDLHNLD 231                                                          
						PTN3_HUMAN, which also corresponds to amino acids 684 - 782  	                  .         .         .         .         .  
						of HUMCAP_P3, wherein said first amino acid sequence,        	     101 LMIGIASAGVAVYRKYICTSFYPWVNILKISFKRKKFFIHQRQKQAESRE 150                                                          
						bridging amino acid and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.                        	     232 LMIGIASAGVAVYRKYICTSFYPWVNILKISFKRKKFFIHQRQKQAESRE 281                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 HIVAFNMLNYRSCKNLWKSCVEHHTFFQAKKLLPQEKNVLSQYWTMGSRN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     282 HIVAFNMLNYRSCKNLWKSCVEHHTFFQAKKLLPQEKNVLSQYWTMGSRN 331                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TKKSVNNQYCKKVIGGMVWNPAMRRSLSVEHLETKSLPSRSPPITPNWRS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     332 TKKSVNNQYCKKVIGGMVWNPAMRRSLSVEHLETKSLPSRSPPITPNWRS 381                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PRLRHEIRKPRHSSADNLANEMTYITETEDVFYTYKGSLAPQDSDSEVSQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     382 PRLRHEIRKPRHSSADNLANEMTYITETEDVFYTYKGSLAPQDSDSEVSQ 431                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NRSPHQESLSENNPAQSYLTQKSSSSVSPSSNAPGSCSPDGVDQQLLDDF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     432 NRSPHQESLSENNPAQSYLTQKSSSSVSPSSNAPGSCSPDGVDQQLLDDF 481                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 HRVTKGGSTEDASQYYCDKNDNGDSYLVLIRITPDEDGKFGFNLKGGVDQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     482 HRVTKGGSTEDASQYYCDKNDNGDSYLVLIRITPDEDGKFGFNLKGGVDQ 531                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KMPLVVSRINPESPADTCIPKLNEGDQIVLINGRDISEHTHDQVVMFIKA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     532 KMPLVVSRINPESPADTCIPKLNEGDQIVLINGRDISEHTHDQVVMFIKA 581                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SRESHSRELALVIRRRAVRSFADFKSEDELNQLFPEAIFPMCPEGGDTLE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     582 SRESHSRELALVIRRRAVRSFADFKSEDELNQLFPEAIFPMCPEGGDTLE 631                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GSMAQLKKGLESGTVLIQFEQLYRKKPGLAITFAKLPQNLDKNRYKDVLP 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     632 GSMAQLKKGLESGTVLIQFEQLYRKKPGLAITFAKLPQNLDKNRYKDVLP 681                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 YDTTRVLLQGNEDYINASYVNMEIPAANLVNKYIATQGPLPHTCAQFWQV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     682 YDTTRVLLQGNEDYINASYVNMEIPAANLVNKYIATQGPLPHTCAQFWQV 731                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 VWDQKLSLIVMLTTLTERGRTKCHQYWPDPPDVMNHGGFHIQCQSEDCTI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     732 VWDQKLSLIVMLTTLTERGRTKCHQYWPDPPDVMNHGGFHIQCQSEDCTI 781                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 AYVSREMLVTNTQTGEEHTVTHLQYVAWPDHGVPDDSSDFLEFVNYVRSL 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||:|||||||||||||||||  
						                                                            	     782 AYVSREMLVTNTQTGEEHTVTHLQYVAWPDHGIPDDSSDFLEFVNYVRSL 831                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RVDSEPVLVHCSAGIGRTGVLVTMETAMCLTERNLPIYPLDIVRKMRDQR 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     832 RVDSEPVLVHCSAGIGRTGVLVTMETAMCLTERNLPIYPLDIVRKMRDQR 881                                                          
						                                                            	                  .         .         .                      
						                                                            	     751 AMMVQTSSQYKFVCEAILRVYEEGLVQMLDPS                   782                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     882 AMMVQTSSQYKFVCEAILRVYEEGLVQMLDPS                   913                                                          

24200	HMR136_HUMCARAA_4_tr0_r1_1_gPRT		Comparison report between HUMCARAA_P4 and Q9UK77unique head  	Sequence name: Q9UK77                                        
						followed by partial WT sequence a mismatch, with a short     	                                                            
						unique insertion and a followed by a short unique tail.1.An  	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for HUMCARAA_P4,      	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 24200 x Q9UK77   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence MWLPALV      	                                                            
						corresponding to amino acids 1 - 7 of HUMCARAA_P4, a second  	                     Quality: 3638.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to LATL   	             Matching length:     389                Total length:     390                                               
						corresponding to amino acids 8 - 11 of Q9UK77, which also    	 Matching Percent Similarity:   99.49   Matching Percent Identity:   98.71                                               
						corresponds to amino acids 8 - 11 of HUMCARAA_P4, a bridging 	    Total Percent Similarity:   99.23      Total Percent Identity:   98.46                                               
						amino acid A corresponding to amino acid 12 of HUMCARAA_P4, a	                        Gaps:       1                        
						third amino acid sequence being at least 90 % homologous to  	                                                            
						ASAAW corresponding to amino acids 13 - 17 of Q9UK77, which  	Alignment:                                                   
						also corresponds to amino acids 13 - 17 of HUMCARAA_P4, a    	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	       1 MWLPALVLATLAASAAWAGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAI 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         | | |::||||:||||| ||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MLLRAFILATLSASAAW.GHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAI 49                                                           
						polypeptide having the sequence A corresponding to amino     	                  .         .         .         .         .  
						acids 18 - 18 of HUMCARAA_P4, a fifth amino acid sequence    	      51 FLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSE 100                                                          
						GHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMV 	      50 FLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSE 99                                                           
						WIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAA 	                  .         .         .         .         .  
						LRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGVALTSVLVK 	     101 LFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAA 150                                                          
						KGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLKMKFLSLDLQGDPRESQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIPMQLMSYPLSEGQLDQKT 	     100 LFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAA 149                                                          
						AMSLLWKSYPLV                                                 	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     151 STYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALR 200                                                          
						acids 18 - 389 of Q9UK77, which also corresponds to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 19 - 390 of HUMCARAA_P4, and a sixth amino acid        	     150 STYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALR 199                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     201 WVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGV 250                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VRV corresponding to amino acids 391 -   	     200 WVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGV 249                                                          
						393 of HUMCARAA_P4, wherein said first amino acid sequence,  	                  .         .         .         .         .  
						second amino acid sequence, bridging amino acid, third amino 	     251 ALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTL 300                                                          
						acid sequence, fourth amino acid sequence, fifth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and sixth amino acid sequence are contiguous and in 	     250 ALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTL 299                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of HUMCARAA_P4, comprising a polypeptide being at least 	     301 KMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVG 350                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     300 KMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVG 349                                                          
						at least about 95% homologous to the sequence MWLPALV of     	                  .         .         .         .            
						HUMCARAA_P4.3.An isolated polypeptide encoding for an edge   	     351 INKQEFGWLIPMQLMSYPLSEGQLDQKTAMSLLWKSYPLV           390                                                          
						portion of HUMCARAA_P4, comprising an amino acid sequence    	         ||||||||||||||||||||||||||||||||||||||||            
						being at least 70%, optionally at least about 80%, preferably	     350 INKQEFGWLIPMQLMSYPLSEGQLDQKTAMSLLWKSYPLV           389                                                          
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for A, corresponding to HUMCARAA_P4.                	                                                            

						Comparison report between HUMCARAA_P4 and Q96EE8partial WT   	Sequence name: Q96EE8                                        
						sequence with short unique insertion and a followed by a     	                                                            
						short unique tail.1.An isolated chimeric polypeptide encoding	Sequence documentation:                                      
						for HUMCARAA_P4, comprising a first amino acid sequence being	                                                            
						at least 90 % homologous to MWLPALVLATLAASAAW corresponding  	Alignment of: 24200 x Q96EE8   ..                            
						to amino acids 1 - 17 of Q96EE8, which also corresponds to   	                                                            
						amino acids 1 - 17 of HUMCARAA_P4, a second amino acid       	Alignment segment 1/1:                                       
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                     Quality: 3585.00                      Escore:       0                                               
						most preferably at least 95% homologous to a polypeptide     	             Matching length:     388                Total length:     390                                               
						having the sequence A corresponding to amino acids 18 - 18 of	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HUMCARAA_P4, a third amino acid sequence being at least 90 % 	    Total Percent Similarity:   99.49      Total Percent Identity:   99.49                                               
						GHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFV 	                        Gaps:       2                        
						KNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMV 	                                                            
						WIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAA 	Alignment:                                                   
						LRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGVALTSVLVK 	                  .         .         .         .         .  
						KGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLKMKFLSLDLQGDPRESQP 	       1 MWLPALVLATLAASAAWAGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAI 50                                                           
						LLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIPM                 	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 18 - 361 of       	       1 MWLPALVLATLAASAAW.GHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAI 49                                                           
						Q96EE8, which also corresponds to amino acids 19 - 362 of    	                  .         .         .         .         .  
						HUMCARAA_P4, a fourth amino acid sequence being at least 70%,	      51 FLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSE 100                                                          
						optionally at least 80%, preferably at least 85%, more       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      50 FLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSE 99                                                           
						homologous to a polypeptide having the sequence Q            	                  .         .         .         .         .  
						corresponding to amino acids 363 - 363 of HUMCARAA_P4, a     	     101 LFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAA 150                                                          
						fifth amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LMSYPLSEGQLDQKTAMSLLWKSYPLV corresponding to amino acids 362 	     100 LFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAA 149                                                          
						- 388 of Q96EE8, which also corresponds to amino acids 364 - 	                  .         .         .         .         .  
						390 of HUMCARAA_P4, and a sixth amino acid sequence being at 	     151 STYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALR 200                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     150 STYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALR 199                                                          
						homologous to a polypeptide having the sequence VRV          	                  .         .         .         .         .  
						corresponding to amino acids 391 - 393 of HUMCARAA_P4,       	     201 WVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGV 250                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence, fourth amino acid       	     200 WVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGV 249                                                          
						sequence, fifth amino acid sequence and sixth amino acid     	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     251 ALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTL 300                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCARAA_P4, comprising an amino acid sequence being at least	     250 ALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTL 299                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     301 KMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVG 350                                                          
						at least about 95% homologous to the sequence encoding for A,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to HUMCARAA_P4.3.An isolated polypeptide       	     300 KMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVG 349                                                          
						encoding for an edge portion of HUMCARAA_P4, comprising an   	                  .         .         .         .            
						amino acid sequence being at least 70%, optionally at least  	     351 INKQEFGWLIPMQLMSYPLSEGQLDQKTAMSLLWKSYPLV           390                                                          
						about 80%, preferably at least about 85%, more preferably at 	         |||||||||||| |||||||||||||||||||||||||||            
						least about 90% and most preferably at least about 95%       	     350 INKQEFGWLIPM.LMSYPLSEGQLDQKTAMSLLWKSYPLV           388                                                          
						homologous to the sequence encoding for Q, corresponding to  	                                                            
						HUMCARAA_P4.                                                 	                                                            

24443	HMR136_HUMCARMC_2_tr0_r1_1_gPRT		Comparison report between HUMCARMC_P2 and CBPC_HUMANpartial  	Sequence name: CBPC_HUMAN                                    
						WT sequence followed by mismatch and a followed by a unique  	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCARMC_P2, comprising a first amino acid sequence being at 	                                                            
						MRLILPVGLIATTLAIAPVRFDREKVFRVKPQDEKQADIIKDLAKTNELDFWYPGATHHV 	Alignment of: 24443 x CBPC_HUMAN   ..                        
						AANMMVDFRVSEKESQAIQSALDQNKMHYEILIHDLQEEIEKQFDVKEDIPGRHSYAKYN 	                                                            
						NWEKIVAWTEKMMDKYPEMVSRIKIGSTVEDNPLYVLKIGEKNERRKAIF           	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 170	                                                            
						of CBPC_HUMAN, which also corresponds to amino acids 1 - 170 	                     Quality: 3288.00                      Escore:       0                                               
						of HUMCARMC_P2, a bridging amino acid T corresponding to     	             Matching length:     329                Total length:     329                                               
						amino acid 171 of HUMCARMC_P2, a second amino acid sequence  	 Matching Percent Similarity:   99.39   Matching Percent Identity:   99.09                                               
						DCGIHAREWVSPAFCQWFVYQATKTYGRNKIMTKLLDRMNFYILPVFNVDGYIWSWTKNR 	    Total Percent Similarity:   99.39      Total Percent Identity:   99.09                                               
						MWRKNRSKNQNSKCIGTDLNRNFNASWNSIPNTNDPCADNYRGSAPESEKETKAVTNFIR 	                        Gaps:       0                        
						SHLNEIKVYITFHSYSQMLLFPYGYTSKLPPNHEDL                         	                                                            
						being at least 90 % homologous to corresponding to amino     	Alignment:                                                   
						acids 172 - 327 of CBPC_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 172 - 327 of HUMCARMC_P2, and a third amino acid 	       1 MRLILPVGLIATTLAIAPVRFDREKVFRVKPQDEKQADIIKDLAKTNELD 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MRLILPVGLIATTLAIAPVRFDREKVFRVKPQDEKQADIIKDLAKTNELD 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence TRYQVLL corresponding to amino acids 328 	      51 FWYPGATHHVAANMMVDFRVSEKESQAIQSALDQNKMHYEILIHDLQEEI 100                                                          
						- 334 of HUMCARMC_P2, wherein said first amino acid sequence,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid, second amino acid sequence and third    	      51 FWYPGATHHVAANMMVDFRVSEKESQAIQSALDQNKMHYEILIHDLQEEI 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	     101 EKQFDVKEDIPGRHSYAKYNNWEKIVAWTEKMMDKYPEMVSRIKIGSTVE 150                                                          
						HUMCARMC_P2, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     101 EKQFDVKEDIPGRHSYAKYNNWEKIVAWTEKMMDKYPEMVSRIKIGSTVE 150                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence TRYQVLL in        	     151 DNPLYVLKIGEKNERRKAIFTDCGIHAREWVSPAFCQWFVYQATKTYGRN 200                                                          
						HUMCARMC_P2.                                                 	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						                                                            	     151 DNPLYVLKIGEKNERRKAIFMDCGIHAREWVSPAFCQWFVYQATKTYGRN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KIMTKLLDRMNFYILPVFNVDGYIWSWTKNRMWRKNRSKNQNSKCIGTDL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KIMTKLLDRMNFYILPVFNVDGYIWSWTKNRMWRKNRSKNQNSKCIGTDL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NRNFNASWNSIPNTNDPCADNYRGSAPESEKETKAVTNFIRSHLNEIKVY 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NRNFNASWNSIPNTNDPCADNYRGSAPESEKETKAVTNFIRSHLNEIKVY 300                                                          
						                                                            	                  .         .                                
						                                                            	     301 ITFHSYSQMLLFPYGYTSKLPPNHEDLTR                      329                                                          
						                                                            	         ||||||||||||||||||||||||||| :                       
						                                                            	     301 ITFHSYSQMLLFPYGYTSKLPPNHEDLAK                      329                                                          

24445	HMR136_HUMCARMC_3_tr0_r1_1_gPRT		Comparison report between HUMCARMC_P3 and CBPC_HUMANpartial  	Sequence name: CBPC_HUMAN                                    
						WT sequence followed by mismatch and a followed by a short   	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						HUMCARMC_P3, comprising a first amino acid sequence being at 	                                                            
						MRLILPVGLIATTLAIAPVRFDREKVFRVKPQDEKQADIIKDLAKTNELDFWYPGATHHV 	Alignment of: 24445 x CBPC_HUMAN   ..                        
						AANMMVDFRVSEKESQAIQSALDQNKMHYEILIHDLQEEIEKQFDVKEDIPGRHSYAKYN 	                                                            
						NWEKIVAWTEKMMDKYPEMVSRIKIGSTVEDNPLYVLKIGEKNERRKAIF           	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 170	                                                            
						of CBPC_HUMAN, which also corresponds to amino acids 1 - 170 	                     Quality: 2601.00                      Escore:       0                                               
						of HUMCARMC_P3, a bridging amino acid T corresponding to     	             Matching length:     259                Total length:     259                                               
						amino acid 171 of HUMCARMC_P3, a second amino acid sequence  	 Matching Percent Similarity:   99.61   Matching Percent Identity:   99.61                                               
						DCGIHAREWVSPAFCQWFVYQATKTYGRNKIMTKLLDRMNFYILPVFNVDGYIWSWTKNR 	    Total Percent Similarity:   99.61      Total Percent Identity:   99.61                                               
						MWRKNRSKNQNSKCIGTDLNRNFNASWN                                 	                        Gaps:       0                        
						being at least 90 % homologous to corresponding to amino     	                                                            
						acids 172 - 259 of CBPC_HUMAN, which also corresponds to     	Alignment:                                                   
						amino acids 172 - 259 of HUMCARMC_P3, and a third amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MRLILPVGLIATTLAIAPVRFDREKVFRVKPQDEKQADIIKDLAKTNELD 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MRLILPVGLIATTLAIAPVRFDREKVFRVKPQDEKQADIIKDLAKTNELD 50                                                           
						having the sequence CE corresponding to amino acids 260 - 261	                  .         .         .         .         .  
						of HUMCARMC_P3, wherein said first amino acid sequence,      	      51 FWYPGATHHVAANMMVDFRVSEKESQAIQSALDQNKMHYEILIHDLQEEI 100                                                          
						bridging amino acid, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential order.	      51 FWYPGATHHVAANMMVDFRVSEKESQAIQSALDQNKMHYEILIHDLQEEI 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EKQFDVKEDIPGRHSYAKYNNWEKIVAWTEKMMDKYPEMVSRIKIGSTVE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EKQFDVKEDIPGRHSYAKYNNWEKIVAWTEKMMDKYPEMVSRIKIGSTVE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DNPLYVLKIGEKNERRKAIFTDCGIHAREWVSPAFCQWFVYQATKTYGRN 200                                                          
						                                                            	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						                                                            	     151 DNPLYVLKIGEKNERRKAIFMDCGIHAREWVSPAFCQWFVYQATKTYGRN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KIMTKLLDRMNFYILPVFNVDGYIWSWTKNRMWRKNRSKNQNSKCIGTDL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KIMTKLLDRMNFYILPVFNVDGYIWSWTKNRMWRKNRSKNQNSKCIGTDL 250                                                          
						                                                            	                                                             
						                                                            	     251 NRNFNASWN                                          259                                                          
						                                                            	         |||||||||                                           
						                                                            	     251 NRNFNASWN                                          259                                                          

2788	HMR136_HUMCBF_3_tr0_r1_1_gPRT		Comparison report between HUMCBF_P3 and CBF_HUMANpartial WT  	Sequence name: CBF_HUMAN                                     
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCBF_P3, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to                                     	Alignment of: 2788 x CBF_HUMAN   ..                          
						MLDPGLMTCSKQAMFLNLVYKSLKADIVLRRVKAFVK corresponding to amino 	                                                            
						acids 552 - 588 of CBF_HUMAN, which also corresponds to amino	Alignment segment 1/1:                                       
						acids 1 - 37 of HUMCBF_P3, a bridging amino acid R           	                                                            
						corresponding to amino acid 38 of HUMCBF_P3, a second amino  	                     Quality: 4372.00                      Escore:       0                                               
						LLQVTCQQMPPFICGALYLVSEILKAKPGLRSQLDDHPESDDEENFIDANDDEDMEKFTD 	             Matching length:     446                Total length:     446                                               
						ADKETEIVKKLETEETVPETDVETKKPEVASWVHFDNLKGGKQLNKYDPFSRNPLFCGAE 	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						NTSLWELKKLSVHFHPSVALFAKTILQGNYIQYSGDPLQDFTLMRFLDRFVYRNPKPHKG 	    Total Percent Similarity:   99.78      Total Percent Identity:   99.78                                               
						KENTDSVVMQPKRKHFIKDIRHLPVNSKEFLAKEESQIPVDEVFFHRYYKKVAVKEKQKR 	                        Gaps:       0                        
						DADEESIEDVDDEEFEELIDTFEDDNCFSSGKDDMDFAGNVKKRTKGAKDNTLDEDSEGS 	                                                            
						DDELGNLDDDEVSLGSMDDEEFAEVDEDGGTFMDVLDDESESVPELEVHSKVSTKKSKRK 	Alignment:                                                   
						GTDDFDFAGSFQGPRKKKRNLNDSSLFVSAEEFGHLLDENMGSKFDNI             	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	       1 MLDPGLMTCSKQAMFLNLVYKSLKADIVLRRVKAFVKRLLQVTCQQMPPF 50                                                           
						to amino acids 590 - 997 of CBF_HUMAN, which also corresponds	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						to amino acids 39 - 446 of HUMCBF_P3, and a third amino acid 	     552 MLDPGLMTCSKQAMFLNLVYKSLKADIVLRRVKAFVKGLLQVTCQQMPPF 601                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      51 ICGALYLVSEILKAKPGLRSQLDDHPESDDEENFIDANDDEDMEKFTDAD 100                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence                                          	     602 ICGALYLVSEILKAKPGLRSQLDDHPESDDEENFIDANDDEDMEKFTDAD 651                                                          
						GMNAMANKDNASLKQLRWEAERDDWLHNRDAKSIIKKKKHFKKKRIKTTQKTKKQRK    	                  .         .         .         .         .  
						corresponding to amino acids 447 - 503 of HUMCBF_P3, wherein 	     101 KETEIVKKLETEETVPETDVETKKPEVASWVHFDNLKGGKQLNKYDPFSR 150                                                          
						said first amino acid sequence, bridging amino acid, second  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     652 KETEIVKKLETEETVPETDVETKKPEVASWVHFDNLKGGKQLNKYDPFSR 701                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of HUMCBF_P3, comprising a   	     151 NPLFCGAENTSLWELKKLSVHFHPSVALFAKTILQGNYIQYSGDPLQDFT 200                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     702 NPLFCGAENTSLWELKKLSVHFHPSVALFAKTILQGNYIQYSGDPLQDFT 751                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     201 LMRFLDRFVYRNPKPHKGKENTDSVVMQPKRKHFIKDIRHLPVNSKEFLA 250                                                          
						GMNAMANKDNASLKQLRWEAERDDWLHNRDAKSIIKKKKHFKKKRIKTTQKTKKQRK in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCBF_P3.                                                   	     752 LMRFLDRFVYRNPKPHKGKENTDSVVMQPKRKHFIKDIRHLPVNSKEFLA 801                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEESQIPVDEVFFHRYYKKVAVKEKQKRDADEESIEDVDDEEFEELIDTF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     802 KEESQIPVDEVFFHRYYKKVAVKEKQKRDADEESIEDVDDEEFEELIDTF 851                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDDNCFSSGKDDMDFAGNVKKRTKGAKDNTLDEDSEGSDDELGNLDDDEV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     852 EDDNCFSSGKDDMDFAGNVKKRTKGAKDNTLDEDSEGSDDELGNLDDDEV 901                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SLGSMDDEEFAEVDEDGGTFMDVLDDESESVPELEVHSKVSTKKSKRKGT 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     902 SLGSMDDEEFAEVDEDGGTFMDVLDDESESVPELEVHSKVSTKKSKRKGT 951                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 DDFDFAGSFQGPRKKKRNLNDSSLFVSAEEFGHLLDENMGSKFDNI     446                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     952 DDFDFAGSFQGPRKKKRNLNDSSLFVSAEEFGHLLDENMGSKFDNI     997                                                          

						Comparison report between HUMCBF_P3 and Q8NE75partial WT     	Sequence name: Q8NE75                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HUMCBF_P3, comprising a first amino acid        	                                                            
						MLDPGLMTCSKQAMFLNLVYKSLKADIVLRRVKAFVKRLLQVTCQQMPPFICGALYLVSE 	Alignment of: 2788 x Q8NE75   ..                             
						ILKAKPGLRSQLDDHPESDDEENFIDANDDEDMEKFTDADKETEIVKKLETEETVPETDV 	                                                            
						ETKKPEVASWVHFDNLKGGKQLNKYDPFSRNPLFCGAENTSLWELKKLSVHFHPSVALFA 	Alignment segment 1/1:                                       
						KTILQGNYIQYSGDPLQDFTLMRFLDRFVYRNPKPHKGKENTDSVVMQPKRKHFIKDIRH 	                                                            
						LPVNSKEFLAKEESQIPVDEVFFHRYYKKVAVKEKQKRDADEESIEDVDDEEFEELIDTF 	                     Quality: 4962.00                      Escore:       0                                               
						EDDNCFSSGKDDMDFAGNVKKRTKGAKDNTLDEDSEGSDDELGNLDDDEVSLGSMDDEEF 	             Matching length:     503                Total length:     503                                               
						AEVDEDGGTFMDVLDDESESVPELEVHSKVSTKKSKRKGTDDFDFAGSFQGPRKKKRNLN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DSSLFVSAEEFGHLLDENMGSKFDNIGMNAMANKDNASLKQLRWEAERDDWLHNRDAKSI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						IKKKKHFKKKRIKTTQKTKKQRK                                      	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 552 - 1054 of Q8NE75, which also corresponds to  	Alignment:                                                   
						amino acids 1 - 503 of HUMCBF_P3.                            	                  .         .         .         .         .  
						                                                            	       1 MLDPGLMTCSKQAMFLNLVYKSLKADIVLRRVKAFVKRLLQVTCQQMPPF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     552 MLDPGLMTCSKQAMFLNLVYKSLKADIVLRRVKAFVKRLLQVTCQQMPPF 601                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ICGALYLVSEILKAKPGLRSQLDDHPESDDEENFIDANDDEDMEKFTDAD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     602 ICGALYLVSEILKAKPGLRSQLDDHPESDDEENFIDANDDEDMEKFTDAD 651                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KETEIVKKLETEETVPETDVETKKPEVASWVHFDNLKGGKQLNKYDPFSR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     652 KETEIVKKLETEETVPETDVETKKPEVASWVHFDNLKGGKQLNKYDPFSR 701                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NPLFCGAENTSLWELKKLSVHFHPSVALFAKTILQGNYIQYSGDPLQDFT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     702 NPLFCGAENTSLWELKKLSVHFHPSVALFAKTILQGNYIQYSGDPLQDFT 751                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LMRFLDRFVYRNPKPHKGKENTDSVVMQPKRKHFIKDIRHLPVNSKEFLA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     752 LMRFLDRFVYRNPKPHKGKENTDSVVMQPKRKHFIKDIRHLPVNSKEFLA 801                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEESQIPVDEVFFHRYYKKVAVKEKQKRDADEESIEDVDDEEFEELIDTF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     802 KEESQIPVDEVFFHRYYKKVAVKEKQKRDADEESIEDVDDEEFEELIDTF 851                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDDNCFSSGKDDMDFAGNVKKRTKGAKDNTLDEDSEGSDDELGNLDDDEV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     852 EDDNCFSSGKDDMDFAGNVKKRTKGAKDNTLDEDSEGSDDELGNLDDDEV 901                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SLGSMDDEEFAEVDEDGGTFMDVLDDESESVPELEVHSKVSTKKSKRKGT 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     902 SLGSMDDEEFAEVDEDGGTFMDVLDDESESVPELEVHSKVSTKKSKRKGT 951                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DDFDFAGSFQGPRKKKRNLNDSSLFVSAEEFGHLLDENMGSKFDNIGMNA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     952 DDFDFAGSFQGPRKKKRNLNDSSLFVSAEEFGHLLDENMGSKFDNIGMNA 1001                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 MANKDNASLKQLRWEAERDDWLHNRDAKSIIKKKKHFKKKRIKTTQKTKK 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1002 MANKDNASLKQLRWEAERDDWLHNRDAKSIIKKKKHFKKKRIKTTQKTKK 1051                                                         
						                                                            	                                                             
						                                                            	     501 QRK                                                503                                                          
						                                                            	         |||                                                 
						                                                            	    1052 QRK                                                1054                                                         

2923	HMR136_HUMCCDPKB_21_tr0_r1_1_gPRT		Comparison report between HUMCCDPKB_P21 and KCCG_HUMANunique 	Sequence name: KCCG_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion, featuring a skipped exon plus extra amino acids   	Sequence documentation:                                      
						and a followed by a unique tail.1.An isolated chimeric       	                                                            
						polypeptide encoding for HUMCCDPKB_P21, comprising a first   	Alignment of: 2923 x KCCG_HUMAN   ..                         
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment segment 1/1:                                       
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MTCVFCLV corresponding to amino acids 1 -	                     Quality: 2186.00                      Escore:       0                                               
						8 of HUMCCDPKB_P21, a second amino acid sequence being at    	             Matching length:     243                Total length:     286                                               
						GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.59                                               
						ITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSL 	    Total Percent Similarity:   84.97      Total Percent Identity:   84.62                                               
						LNKKSDGGVKPQSNNKNSL                                          	                        Gaps:       2                        
						least 90 % homologous to corresponding to amino acids 201 -  	                                                            
						339 of KCCG_HUMAN, which also corresponds to amino acids 9 - 	Alignment:                                                   
						147 of HUMCCDPKB_P21, a third amino acid sequence being at   	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	       9 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 58                                                           
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     201 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 250                                                          
						VSPAQEPAPLQTAM corresponding to amino acids 148 - 161 of     	                  .         .         .         .         .  
						HUMCCDPKB_P21, a fourth amino acid sequence being at least 90	      59 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 108                                                          
						% homologous to EPQTTVVHNATDGIKGSTESCNTTTEDEDLK corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 340 - 370 of KCCG_HUMAN, which also           	     251 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 300                                                          
						corresponds to amino acids 162 - 192 of HUMCCDPKB_P21, a     	                  .         .         .         .         .  
						fifth amino acid sequence bridging amino acid sequence       	     109 KGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSLVSPAQEPAPLQ 158                                                          
						comprising of V, a sixth amino acid sequence being at least  	         |||||||||||||||||||||||||||||||||||||||             
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	     301 KGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSL........... 339                                                          
						NSKPIHTTILNP                                                 	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 401 - 472 of 	     159 TAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLK................ 192                                                          
						KCCG_HUMAN, which also corresponds to amino acids 194 - 265  	            |||||||||||||||||||||||||||||||                  
						of HUMCCDPKB_P21, and a seventh amino acid sequence being at 	     340 ...EPQTTVVHNATDGIKGSTESCNTTTEDEDLKARSPEGRSSRDRTAPS 386                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     193 .............VRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFE 229                                                          
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	                      :||||||||||||||||||||||||||||||||||||  
						Q                                                            	     387 AGMQPQPSLCSSAMRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFE 436                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .                      
						to amino acids 266 - 326 of HUMCCDPKB_P21, wherein said first	     230 PEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNP               265                                                          
						amino acid sequence, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||                
						acid sequence, fourth amino acid sequence, fifth amino acid  	     437 PEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNP               472                                                          
						sequence, sixth amino acid sequence and seventh amino acid   	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of HUMCCDPKB_P21,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MTCVFCLV of             	                                                            
						HUMCCDPKB_P21.3.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P21, comprising an amino acid sequence  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for VSPAQEPAPLQTAM, corresponding to                	                                                            
						HUMCCDPKB_P21.4.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P21, comprising a polypeptide having a  	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KVR having a structure as  	                                                            
						follows (numbering according to HUMCCDPKB_P21): a sequence   	                                                            
						starting from any of amino acid numbers 192-x to 192; and    	                                                            
						ending at any of amino acid numbers 194 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.5.An isolated polypeptide       	                                                            
						encoding for a tail of HUMCCDPKB_P21, comprising a           	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	                                                            
						Q                                                            	                                                            
						to the sequence in HUMCCDPKB_P21.                            	                                                            

						Comparison report between HUMCCDPKB_P21 and Q13280unique     	Sequence name: Q13280                                        
						head followed by partial WT sequence featuring a skipped exon	                                                            
						plus extra amino acids.1.An isolated chimeric polypeptide    	Sequence documentation:                                      
						encoding for HUMCCDPKB_P21, comprising a first amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 2923 x Q13280   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MTCVFCLVGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQM 	                                                            
						LTINPAKRITADQALKHPWVCQR                                      	                     Quality: 2281.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 83 of   	             Matching length:     243                Total length:     281                                               
						HUMCCDPKB_P21, a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.59                                               
						STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNN 	    Total Percent Similarity:   86.48      Total Percent Identity:   86.12                                               
						KNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLK            	                        Gaps:       1                        
						% homologous to corresponding to amino acids 1 - 109 of      	                                                            
						Q13280, which also corresponds to amino acids 84 - 192 of    	Alignment:                                                   
						HUMCCDPKB_P21, a third amino acid sequence bridging amino    	                  .         .         .         .         .  
						acid sequence comprising of V, and a fourth amino acid       	      84 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKS 133                                                          
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNV 	       1 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKS 50                                                           
						HYHCSGAPAAPLQ                                                	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     134 DGGVKPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCN 183                                                          
						amino acids 149 - 281 of Q13280, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 194 - 326 of HUMCCDPKB_P21, wherein said first   	      51 DGGVKPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCN 100                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .         .         .  
						acid sequence and fourth amino acid sequence are contiguous  	     184 TTTEDEDLK......................................VRK 195                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         |||||||||                                      :||  
						for a head of HUMCCDPKB_P21, comprising a polypeptide being  	     101 TTTEDEDLKAAPLRTGNGSSVPEGRSSRDRTAPSAGMQPQPSLCSSAMRK 150                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     196 QEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKF 245                                                          
						MTCVFCLVGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTINPAKRITADQALKHPWVCQR                                      	     151 QEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKF 200                                                          
						preferably at least about 95% homologous to the sequence of  	                  .         .         .         .         .  
						HUMCCDPKB_P21.3.An isolated polypeptide encoding for an edge 	     246 YFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTS 295                                                          
						portion of HUMCCDPKB_P21, comprising a polypeptide having a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     201 YFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTS 250                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .                      
						preferably at least about 30 amino acids in length, more     	     296 QSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                    326                                                          
						preferably at least about 40 amino acids in length and most  	         |||||||||||||||||||||||||||||||                     
						preferably at least about 50 amino acids in length, wherein  	     251 QSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                    281                                                          
						at least two amino acids comprise KVR having a structure as  	                                                            
						follows (numbering according to HUMCCDPKB_P21): a sequence   	                                                            
						starting from any of amino acid numbers 192-x to 192; and    	                                                            
						ending at any of amino acid numbers 194 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between HUMCCDPKB_P21 and Q8WU40unique     	Sequence name: Q8WU40                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMCCDPKB_P21, comprising a first   	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 2923 x Q8WU40   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MTCVFCLV corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of HUMCCDPKB_P21, and a second amino acid sequence being at	                                                            
						GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKR 	                     Quality: 3151.00                      Escore:       0                                               
						ITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSL 	             Matching length:     318                Total length:     318                                               
						LNKKSDGGVKPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTED 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EDLKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						NLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDG 	                        Gaps:       0                        
						KWLNVHYHCSGAPAAPLQ                                           	                                                            
						least 90 % homologous to corresponding to amino acids 139 -  	Alignment:                                                   
						456 of Q8WU40, which also corresponds to amino acids 9 - 326 	                  .         .         .         .         .  
						of HUMCCDPKB_P21, wherein said first amino acid sequence and 	       9 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 58                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     139 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 188                                                          
						HUMCCDPKB_P21, comprising a polypeptide being at least 70%,  	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      59 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 108                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence MTCVFCLV of       	     189 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 238                                                          
						HUMCCDPKB_P21.                                               	                  .         .         .         .         .  
						                                                            	     109 KGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSLVSPAQEPAPLQ 158                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 KGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSLVSPAQEPAPLQ 288                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 TAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQLIEA 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     289 TAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQLIEA 338                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 INNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPI 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     339 INNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPI 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 HTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDG 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     389 HTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDG 438                                                          
						                                                            	                  .                                          
						                                                            	     309 KWLNVHYHCSGAPAAPLQ                                 326                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     439 KWLNVHYHCSGAPAAPLQ                                 456                                                          

						Comparison report between HUMCCDPKB_P21 and O00561unique     	Sequence name: O00561                                        
						head followed by partial WT sequence a mismatch, followed by 	                                                            
						a unique insertion and a followed by a unique tail.1.An      	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for HUMCCDPKB_P21,    	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 2923 x O00561   ..                             
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence MTCVFCLV     	                                                            
						corresponding to amino acids 1 - 8 of HUMCCDPKB_P21, a second	                     Quality: 1591.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     173                Total length:     196                                               
						GVILYILLVGYPPFWDEDQHKLYQQIKAG corresponding to amino acids   	 Matching Percent Similarity:   99.42   Matching Percent Identity:   99.42                                               
						134 - 162 of O00561, which also corresponds to amino acids 9 	    Total Percent Similarity:   87.76      Total Percent Identity:   87.76                                               
						- 37 of HUMCCDPKB_P21, a bridging amino acid A corresponding 	                        Gaps:       1                        
						to amino acid 38 of HUMCCDPKB_P21, a third amino acid        	                                                            
						YDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVEC 	Alignment:                                                   
						LRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVK                     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       9 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 58                                                           
						amino acids 164 - 263 of O00561, which also corresponds to   	         ||||||||||||||||||||||||||||| ||||||||||||||||||||  
						amino acids 39 - 138 of HUMCCDPKB_P21, a fourth amino acid   	     134 GVILYILLVGYPPFWDEDQHKLYQQIKAGTYDFPSPEWDTVTPEAKNLIN 183                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      59 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 108                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence PQSNNKNSLVSPAQEPAPLQTAM corresponding to 	     184 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 233                                                          
						amino acids 139 - 161 of HUMCCDPKB_P21, a fifth amino acid   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     109 KGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSLVSPAQEPAPLQ 158                                                          
						EPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQ corresponding to 	         ||||||||||||||||||||||||||||||                      
						amino acids 264 - 306 of O00561, which also corresponds to   	     234 KGAILTTMLVSRNFSAAKSLLNKKSDGGVK.................... 263                                                          
						amino acids 162 - 204 of HUMCCDPKB_P21, and a sixth amino    	                  .         .         .         .            
						acid sequence being at least 70%, optionally at least 80%,   	     159 TAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQ     204                                                          
						preferably at least 85%, more preferably at least 90% and    	            |||||||||||||||||||||||||||||||||||||||||||      
						most preferably at least 95% homologous to a polypeptide     	     264 ...EPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQ     306                                                          
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	                                                            
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                                                            
						LQ                                                           	                                                            
						having the sequence corresponding to amino acids 205 - 326 of	                                                            
						HUMCCDPKB_P21, wherein said first amino acid sequence, second	                                                            
						amino acid sequence, bridging amino acid, third amino acid   	                                                            
						sequence, fourth amino acid sequence, fifth amino acid       	                                                            
						sequence and sixth amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of HUMCCDPKB_P21, comprising a polypeptide being at     	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						MTCVFCLV of HUMCCDPKB_P21.3.An isolated polypeptide encoding 	                                                            
						for an edge portion of HUMCCDPKB_P21, comprising an amino    	                                                            
						acid sequence being at least 70%, optionally at least about  	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence encoding for PQSNNKNSLVSPAQEPAPLQTAM,        	                                                            
						corresponding to HUMCCDPKB_P21.4.An isolated polypeptide     	                                                            
						encoding for a tail of HUMCCDPKB_P21, comprising a           	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	                                                            
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                                                            
						LQ                                                           	                                                            
						to the sequence in HUMCCDPKB_P21.                            	                                                            

2925	HMR136_HUMCCDPKB_23_tr0_r1_1_gPRT		Comparison report between HUMCCDPKB_P23 and KCCG_HUMANunique 	Sequence name: KCCG_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion, featuring a skipped exon plus extra amino acids   	Sequence documentation:                                      
						and a followed by a unique tail.1.An isolated chimeric       	                                                            
						polypeptide encoding for HUMCCDPKB_P23, comprising a first   	Alignment of: 2925 x KCCG_HUMAN   ..                         
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment segment 1/1:                                       
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MENLWISGPA corresponding to amino acids 1	                     Quality: 1865.00                      Escore:       0                                               
						- 10 of HUMCCDPKB_P23, a second amino acid sequence being at 	             Matching length:     211                Total length:     254                                               
						FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.53                                               
						KFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSL              	    Total Percent Similarity:   83.07      Total Percent Identity:   82.68                                               
						least 90 % homologous to corresponding to amino acids 233 -  	                        Gaps:       2                        
						339 of KCCG_HUMAN, which also corresponds to amino acids 11 -	                                                            
						117 of HUMCCDPKB_P23, a third amino acid sequence being at   	Alignment:                                                   
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      11 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 60                                                           
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSPAQEPAPLQTAM corresponding to amino acids 118 - 131 of     	     233 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 282                                                          
						HUMCCDPKB_P23, a fourth amino acid sequence being at least 90	                  .         .         .         .         .  
						% homologous to EPQTTVVHNATDGIKGSTESCNTTTEDEDLK corresponding	      61 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 110                                                          
						to amino acids 340 - 370 of KCCG_HUMAN, which also           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 132 - 162 of HUMCCDPKB_P23, a     	     283 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 332                                                          
						fifth amino acid sequence bridging amino acid sequence       	                  .         .         .         .         .  
						comprising of V, a sixth amino acid sequence being at least  	     111 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 160                                                          
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	         |||||||              |||||||||||||||||||||||||||||  
						NSKPIHTTILNP                                                 	     333 SNNKNSL..............EPQTTVVHNATDGIKGSTESCNTTTEDED 368                                                          
						90 % homologous to corresponding to amino acids 401 - 472 of 	                  .         .         .         .         .  
						KCCG_HUMAN, which also corresponds to amino acids 164 - 235  	     161 LK.............................VRKQEIIKITEQLIEAINN 181                                                          
						of HUMCCDPKB_P23, and a seventh amino acid sequence being at 	         ||                             :||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     369 LKARSPEGRSSRDRTAPSAGMQPQPSLCSSAMRKQEIIKITEQLIEAINN 418                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	     182 GDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTT 231                                                          
						Q                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     419 GDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTT 468                                                          
						to amino acids 236 - 296 of HUMCCDPKB_P23, wherein said first	                                                             
						amino acid sequence, second amino acid sequence, third amino 	     232 ILNP                                               235                                                          
						acid sequence, fourth amino acid sequence, fifth amino acid  	         ||||                                                
						sequence, sixth amino acid sequence and seventh amino acid   	     469 ILNP                                               472                                                          
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of HUMCCDPKB_P23,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MENLWISGPA of           	                                                            
						HUMCCDPKB_P23.3.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P23, comprising an amino acid sequence  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for VSPAQEPAPLQTAM, corresponding to                	                                                            
						HUMCCDPKB_P23.4.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P23, comprising a polypeptide having a  	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KVR having a structure as  	                                                            
						follows (numbering according to HUMCCDPKB_P23): a sequence   	                                                            
						starting from any of amino acid numbers 162-x to 162; and    	                                                            
						ending at any of amino acid numbers 164 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.5.An isolated polypeptide       	                                                            
						encoding for a tail of HUMCCDPKB_P23, comprising a           	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	                                                            
						Q                                                            	                                                            
						to the sequence in HUMCCDPKB_P23.                            	                                                            

						Comparison report between HUMCCDPKB_P23 and Q13280unique     	Sequence name: Q13280                                        
						head followed by partial WT sequence featuring a skipped exon	                                                            
						plus extra amino acids.1.An isolated chimeric polypeptide    	Sequence documentation:                                      
						encoding for HUMCCDPKB_P23, comprising a first amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 2925 x Q13280   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence                                          	                                                            
						MENLWISGPAFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQR        	                     Quality: 2281.00                      Escore:       0                                               
						corresponding to amino acids 1 - 53 of HUMCCDPKB_P23, a      	             Matching length:     243                Total length:     281                                               
						STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.59                                               
						KNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLK            	    Total Percent Similarity:   86.48      Total Percent Identity:   86.12                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       1                        
						corresponding to amino acids 1 - 109 of Q13280, which also   	                                                            
						corresponds to amino acids 54 - 162 of HUMCCDPKB_P23, a third	Alignment:                                                   
						amino acid sequence bridging amino acid sequence comprising  	                  .         .         .         .         .  
						of V, and a fourth amino acid sequence being at least 90 %   	      54 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKS 103                                                          
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNV 	       1 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKS 50                                                           
						HYHCSGAPAAPLQ                                                	                  .         .         .         .         .  
						homologous to corresponding to amino acids 149 - 281 of      	     104 DGGVKPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCN 153                                                          
						Q13280, which also corresponds to amino acids 164 - 296 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCCDPKB_P23, wherein said first amino acid sequence, second	      51 DGGVKPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCN 100                                                          
						amino acid sequence, third amino acid sequence and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     154 TTTEDEDLK......................................VRK 165                                                          
						order.2.An isolated polypeptide encoding for a head of       	         |||||||||                                      :||  
						HUMCCDPKB_P23, comprising a polypeptide being at least 70%,  	     101 TTTEDEDLKAAPLRTGNGSSVPEGRSSRDRTAPSAGMQPQPSLCSSAMRK 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     166 QEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKF 215                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MENLWISGPAFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQR of     	     151 QEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKF 200                                                          
						HUMCCDPKB_P23.3.An isolated polypeptide encoding for an edge 	                  .         .         .         .         .  
						portion of HUMCCDPKB_P23, comprising a polypeptide having a  	     216 YFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTS 265                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     201 YFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTS 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .                      
						preferably at least about 40 amino acids in length and most  	     266 QSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                    296                                                          
						preferably at least about 50 amino acids in length, wherein  	         |||||||||||||||||||||||||||||||                     
						at least two amino acids comprise KVR having a structure as  	     251 QSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                    281                                                          
						follows (numbering according to HUMCCDPKB_P23): a sequence   	                                                            
						starting from any of amino acid numbers 162-x to 162; and    	                                                            
						ending at any of amino acid numbers 164 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between HUMCCDPKB_P23 and Q8WU40unique     	Sequence name: Q8WU40                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMCCDPKB_P23, comprising a first   	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 2925 x Q8WU40   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MENLWISGPA corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of HUMCCDPKB_P23, and a second amino acid sequence being	                                                            
						FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLR 	                     Quality: 2830.00                      Escore:       0                                               
						KFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSLVSPAQEPAPLQTA 	             Matching length:     286                Total length:     286                                               
						MEPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQLIEAINNGDFEAYTKI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ               	                        Gaps:       0                        
						at least 90 % homologous to corresponding to amino acids 171 	                                                            
						- 456 of Q8WU40, which also corresponds to amino acids 11 -  	Alignment:                                                   
						296 of HUMCCDPKB_P23, wherein said first amino acid sequence 	                  .         .         .         .         .  
						and second amino acid sequence are contiguous and in a       	      11 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 60                                                           
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of HUMCCDPKB_P23, comprising a polypeptide being at     	     171 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 220                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      61 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 110                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MENLWISGPA of HUMCCDPKB_P23.                                 	     221 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 270                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     111 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     271 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 320                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 LKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGM 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     321 LKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGM 370                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 DFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQG 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     371 DFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQG 420                                                          
						                                                            	                  .         .         .                      
						                                                            	     261 RPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ               296                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     421 RPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ               456                                                          

						Comparison report between HUMCCDPKB_P23 and O00561unique     	Sequence name: O00561                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMCCDPKB_P23, comprising a	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 2925 x O00561   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MENLWISGPA corresponding to  	                                                            
						amino acids 1 - 10 of HUMCCDPKB_P23, a second amino acid     	                     Quality: 1279.00                      Escore:       0                                               
						FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLR 	             Matching length:     141                Total length:     164                                               
						KFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVK                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:   85.98      Total Percent Identity:   85.98                                               
						amino acids 166 - 263 of O00561, which also corresponds to   	                        Gaps:       1                        
						amino acids 11 - 108 of HUMCCDPKB_P23, a third amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      11 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 60                                                           
						having the sequence PQSNNKNSLVSPAQEPAPLQTAM corresponding to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 109 - 131 of HUMCCDPKB_P23, a fourth amino acid  	     166 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 215                                                          
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						EPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQ corresponding to 	      61 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 110                                                          
						amino acids 264 - 306 of O00561, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						amino acids 132 - 174 of HUMCCDPKB_P23, and a fifth amino    	     216 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVK.. 263                                                          
						acid sequence being at least 70%, optionally at least 80%,   	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     111 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 160                                                          
						most preferably at least 95% homologous to a polypeptide     	                              |||||||||||||||||||||||||||||  
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	     264 .....................EPQTTVVHNATDGIKGSTESCNTTTEDED 292                                                          
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                  .                                          
						LQ                                                           	     161 LKVRKQEIIKITEQ                                     174                                                          
						having the sequence corresponding to amino acids 175 - 296 of	         ||||||||||||||                                      
						HUMCCDPKB_P23, wherein said first amino acid sequence, second	     293 LKVRKQEIIKITEQ                                     306                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                                                            
						acid sequence and fifth amino acid sequence are contiguous   	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a head of HUMCCDPKB_P23, comprising a polypeptide being  	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						MENLWISGPA of HUMCCDPKB_P23.3.An isolated polypeptide        	                                                            
						encoding for an edge portion of HUMCCDPKB_P23, comprising an 	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for                      	                                                            
						PQSNNKNSLVSPAQEPAPLQTAM, corresponding to HUMCCDPKB_P23.4.An 	                                                            
						isolated polypeptide encoding for a tail of HUMCCDPKB_P23,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	                                                            
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                                                            
						LQ                                                           	                                                            
						about 95% homologous to the sequence in HUMCCDPKB_P23.       	                                                            

2929	HMR136_HUMCCDPKB_24_tr0_r1_1_gPRT		Comparison report between HUMCCDPKB_P24 and                  	Sequence name: KCCG_HUMAN                                    
						KCCG_HUMANpartial WT sequence followed by a unique tail.1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCCDPKB_P24,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	Alignment of: 2929 x KCCG_HUMAN   ..                         
						EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 	                                                            
						LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGY 	Alignment segment 1/1:                                       
						LSPEVLRKDPYGKPVDIWACG                                        	                                                            
						homologous to corresponding to amino acids 1 - 201 of        	                     Quality: 1970.00                      Escore:       0                                               
						KCCG_HUMAN, which also corresponds to amino acids 1 - 201 of 	             Matching length:     201                Total length:     201                                               
						HUMCCDPKB_P24, and a second amino acid sequence being at     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 70%, optionally at least 80%, preferably at least 85%, 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						more preferably at least 90% and most preferably at least 95%	                        Gaps:       0                        
						KPIPRSQLFAVKGPQLPMMARKRHRYSLQVTHVPGVCEIMVFAPGMAVPITPSSLRTSGM 	                                                            
						TLYPSWRGICPRLRGWVVPKEIPGVTW                                  	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 202 - 288 of HUMCCDPKB_P24, wherein said first	       1 MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKL 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKL 50                                                           
						polypeptide encoding for a tail of HUMCCDPKB_P24, comprising 	                  .         .         .         .         .  
						a polypeptide being at least 70%, optionally at least about  	      51 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 100                                                          
						KPIPRSQLFAVKGPQLPMMARKRHRYSLQVTHVPGVCEIMVFAPGMAVPITPSSLRTSGM 	                  .         .         .         .         .  
						TLYPSWRGICPRLRGWVVPKEIPGVTW                                  	     101 DIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG 150                                                          
						to the sequence in HUMCCDPKB_P24.                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 DIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWAC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 AAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWAC 200                                                          
						                                                            	                                                             
						                                                            	     201 G                                                  201                                                          
						                                                            	         |                                                   
						                                                            	     201 G                                                  201                                                          

2927	HMR136_HUMCCDPKB_25_tr0_r1_1_gPRT		Comparison report between HUMCCDPKB_P25 and                  	Sequence name: KCCG_HUMAN                                    
						KCCG_HUMANpartial WT sequence featuring skipped exon,        	                                                            
						followed by a unique insertion, featuring a skipped exon plus	Sequence documentation:                                      
						extra amino acids and a followed by a unique tail.1.An       	                                                            
						isolated chimeric polypeptide encoding for HUMCCDPKB_P25,    	Alignment of: 2927 x KCCG_HUMAN   ..                         
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	Alignment segment 1/1:                                       
						EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 	                                                            
						LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF         	                     Quality: 3763.00                      Escore:       0                                               
						homologous to corresponding to amino acids 1 - 172 of        	             Matching length:     415                Total length:     486                                               
						KCCG_HUMAN, which also corresponds to amino acids 1 - 172 of 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.76                                               
						HUMCCDPKB_P25, a second amino acid sequence being at least 90	    Total Percent Similarity:   85.39      Total Percent Identity:   85.19                                               
						GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKR 	                        Gaps:       3                        
						ITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSL 	                                                            
						LNKKSDGGVKPQSNNKNSL                                          	Alignment:                                                   
						% homologous to corresponding to amino acids 201 - 339 of    	                  .         .         .         .         .  
						KCCG_HUMAN, which also corresponds to amino acids 173 - 311  	       1 MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKL 50                                                           
						of HUMCCDPKB_P25, a third amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKL 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      51 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 100                                                          
						VSPAQEPAPLQTAM corresponding to amino acids 312 - 325 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCCDPKB_P25, a fourth amino acid sequence being at least 90	      51 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 100                                                          
						% homologous to EPQTTVVHNATDGIKGSTESCNTTTEDEDLK corresponding	                  .         .         .         .         .  
						to amino acids 340 - 370 of KCCG_HUMAN, which also           	     101 DIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG 150                                                          
						corresponds to amino acids 326 - 356 of HUMCCDPKB_P25, a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence bridging amino acid sequence       	     101 DIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG 150                                                          
						comprising of V, a sixth amino acid sequence being at least  	                  .         .         .         .         .  
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	     151 AAVKLADFGLAIEVQGEQQAWF............................ 172                                                          
						NSKPIHTTILNP                                                 	         ||||||||||||||||||||||                              
						90 % homologous to corresponding to amino acids 401 - 472 of 	     151 AAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWAC 200                                                          
						KCCG_HUMAN, which also corresponds to amino acids 358 - 429  	                  .         .         .         .         .  
						of HUMCCDPKB_P25, and a seventh amino acid sequence being at 	     173 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 222                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     201 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 250                                                          
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	                  .         .         .         .         .  
						Q                                                            	     223 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 272                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 430 - 490 of HUMCCDPKB_P25, wherein said first	     251 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 300                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .         .         .  
						acid sequence, fourth amino acid sequence, fifth amino acid  	     273 KGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSLVSPAQEPAPLQ 322                                                          
						sequence, sixth amino acid sequence and seventh amino acid   	         |||||||||||||||||||||||||||||||||||||||             
						sequence are contiguous and in a sequential order.2.An       	     301 KGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSL........... 339                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMCCDPKB_P25, comprising a polypeptide having a length "n", 	     323 TAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLK................ 356                                                          
						wherein n is at least about 10 amino acids in length,        	            |||||||||||||||||||||||||||||||                  
						optionally at least about 20 amino acids in length,          	     340 ...EPQTTVVHNATDGIKGSTESCNTTTEDEDLKARSPEGRSSRDRTAPS 386                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     357 .............VRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFE 393                                                          
						preferably at least about 50 amino acids in length, wherein  	                      :||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise FG, having a structure as  	     387 AGMQPQPSLCSSAMRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFE 436                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .                      
						172-x to 173; and ending at any of amino acid numbers 173+   	     394 PEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNP               429                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||                
						polypeptide encoding for an edge portion of HUMCCDPKB_P25,   	     437 PEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNP               472                                                          
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						VSPAQEPAPLQTAM, corresponding to HUMCCDPKB_P25.4.An isolated 	                                                            
						polypeptide encoding for an edge portion of HUMCCDPKB_P25,   	                                                            
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise KVR having a structure as follows (numbering        	                                                            
						according to HUMCCDPKB_P25): a sequence starting from any of 	                                                            
						amino acid numbers 356-x to 356; and ending at any of amino  	                                                            
						acid numbers 358 + ((n-2) - x), in which x varies from 0 to  	                                                            
						n-2.5.An isolated polypeptide encoding for a tail of         	                                                            
						HUMCCDPKB_P25, comprising a polypeptide being at least 70%,  	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	                                                            
						Q                                                            	                                                            
						least about 95% homologous to the sequence in HUMCCDPKB_P25. 	                                                            

2921	HMR136_HUMCCDPKB_31_tr0_r1_1_gPRT		Comparison report between HUMCCDPKB_P31 and KCCG_HUMANunique 	Sequence name: KCCG_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion, featuring a skipped exon plus extra amino acids   	Sequence documentation:                                      
						and a followed by a unique tail.1.An isolated chimeric       	                                                            
						polypeptide encoding for HUMCCDPKB_P31, comprising a first   	Alignment of: 2921 x KCCG_HUMAN   ..                         
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment segment 1/1:                                       
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MENLWISGPA corresponding to amino acids 1	                     Quality: 1865.00                      Escore:       0                                               
						- 10 of HUMCCDPKB_P31, a second amino acid sequence being at 	             Matching length:     211                Total length:     254                                               
						FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.53                                               
						KFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSL              	    Total Percent Similarity:   83.07      Total Percent Identity:   82.68                                               
						least 90 % homologous to corresponding to amino acids 233 -  	                        Gaps:       2                        
						339 of KCCG_HUMAN, which also corresponds to amino acids 11 -	                                                            
						117 of HUMCCDPKB_P31, a third amino acid sequence being at   	Alignment:                                                   
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      11 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 60                                                           
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSPAQEPAPLQTAM corresponding to amino acids 118 - 131 of     	     233 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 282                                                          
						HUMCCDPKB_P31, a fourth amino acid sequence being at least 90	                  .         .         .         .         .  
						% homologous to EPQTTVVHNATDGIKGSTESCNTTTEDEDLK corresponding	      61 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 110                                                          
						to amino acids 340 - 370 of KCCG_HUMAN, which also           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 132 - 162 of HUMCCDPKB_P31, a     	     283 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 332                                                          
						fifth amino acid sequence bridging amino acid sequence       	                  .         .         .         .         .  
						comprising of V, a sixth amino acid sequence being at least  	     111 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 160                                                          
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	         |||||||              |||||||||||||||||||||||||||||  
						NSKPIHTTILNP                                                 	     333 SNNKNSL..............EPQTTVVHNATDGIKGSTESCNTTTEDED 368                                                          
						90 % homologous to corresponding to amino acids 401 - 472 of 	                  .         .         .         .         .  
						KCCG_HUMAN, which also corresponds to amino acids 164 - 235  	     161 LK.............................VRKQEIIKITEQLIEAINN 181                                                          
						of HUMCCDPKB_P31, and a seventh amino acid sequence being at 	         ||                             :||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     369 LKARSPEGRSSRDRTAPSAGMQPQPSLCSSAMRKQEIIKITEQLIEAINN 418                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	     182 GDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTT 231                                                          
						Q                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     419 GDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTT 468                                                          
						to amino acids 236 - 296 of HUMCCDPKB_P31, wherein said first	                                                             
						amino acid sequence, second amino acid sequence, third amino 	     232 ILNP                                               235                                                          
						acid sequence, fourth amino acid sequence, fifth amino acid  	         ||||                                                
						sequence, sixth amino acid sequence and seventh amino acid   	     469 ILNP                                               472                                                          
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of HUMCCDPKB_P31,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MENLWISGPA of           	                                                            
						HUMCCDPKB_P31.3.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P31, comprising an amino acid sequence  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for VSPAQEPAPLQTAM, corresponding to                	                                                            
						HUMCCDPKB_P31.4.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P31, comprising a polypeptide having a  	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KVR having a structure as  	                                                            
						follows (numbering according to HUMCCDPKB_P31): a sequence   	                                                            
						starting from any of amino acid numbers 162-x to 162; and    	                                                            
						ending at any of amino acid numbers 164 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.5.An isolated polypeptide       	                                                            
						encoding for a tail of HUMCCDPKB_P31, comprising a           	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						HVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPL 	                                                            
						Q                                                            	                                                            
						to the sequence in HUMCCDPKB_P31.                            	                                                            

						Comparison report between HUMCCDPKB_P31 and Q13280unique     	Sequence name: Q13280                                        
						head followed by partial WT sequence featuring a skipped exon	                                                            
						plus extra amino acids.1.An isolated chimeric polypeptide    	Sequence documentation:                                      
						encoding for HUMCCDPKB_P31, comprising a first amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 2921 x Q13280   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence                                          	                                                            
						MENLWISGPAFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQR        	                     Quality: 2281.00                      Escore:       0                                               
						corresponding to amino acids 1 - 53 of HUMCCDPKB_P31, a      	             Matching length:     243                Total length:     281                                               
						STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.59                                               
						KNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLK            	    Total Percent Similarity:   86.48      Total Percent Identity:   86.12                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       1                        
						corresponding to amino acids 1 - 109 of Q13280, which also   	                                                            
						corresponds to amino acids 54 - 162 of HUMCCDPKB_P31, a third	Alignment:                                                   
						amino acid sequence bridging amino acid sequence comprising  	                  .         .         .         .         .  
						of V, and a fourth amino acid sequence being at least 90 %   	      54 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKS 103                                                          
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNV 	       1 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKS 50                                                           
						HYHCSGAPAAPLQ                                                	                  .         .         .         .         .  
						homologous to corresponding to amino acids 149 - 281 of      	     104 DGGVKPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCN 153                                                          
						Q13280, which also corresponds to amino acids 164 - 296 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCCDPKB_P31, wherein said first amino acid sequence, second	      51 DGGVKPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCN 100                                                          
						amino acid sequence, third amino acid sequence and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     154 TTTEDEDLK......................................VRK 165                                                          
						order.2.An isolated polypeptide encoding for a head of       	         |||||||||                                      :||  
						HUMCCDPKB_P31, comprising a polypeptide being at least 70%,  	     101 TTTEDEDLKAAPLRTGNGSSVPEGRSSRDRTAPSAGMQPQPSLCSSAMRK 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     166 QEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKF 215                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MENLWISGPAFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQR of     	     151 QEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKF 200                                                          
						HUMCCDPKB_P31.3.An isolated polypeptide encoding for an edge 	                  .         .         .         .         .  
						portion of HUMCCDPKB_P31, comprising a polypeptide having a  	     216 YFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTS 265                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     201 YFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTS 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .                      
						preferably at least about 40 amino acids in length and most  	     266 QSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                    296                                                          
						preferably at least about 50 amino acids in length, wherein  	         |||||||||||||||||||||||||||||||                     
						at least two amino acids comprise KVR having a structure as  	     251 QSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                    281                                                          
						follows (numbering according to HUMCCDPKB_P31): a sequence   	                                                            
						starting from any of amino acid numbers 162-x to 162; and    	                                                            
						ending at any of amino acid numbers 164 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between HUMCCDPKB_P31 and Q8WU40unique     	Sequence name: Q8WU40                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMCCDPKB_P31, comprising a first   	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 2921 x Q8WU40   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MENLWISGPA corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of HUMCCDPKB_P31, and a second amino acid sequence being	                                                            
						FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLR 	                     Quality: 2830.00                      Escore:       0                                               
						KFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQSNNKNSLVSPAQEPAPLQTA 	             Matching length:     286                Total length:     286                                               
						MEPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQLIEAINNGDFEAYTKI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ               	                        Gaps:       0                        
						at least 90 % homologous to corresponding to amino acids 171 	                                                            
						- 456 of Q8WU40, which also corresponds to amino acids 11 -  	Alignment:                                                   
						296 of HUMCCDPKB_P31, wherein said first amino acid sequence 	                  .         .         .         .         .  
						and second amino acid sequence are contiguous and in a       	      11 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 60                                                           
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of HUMCCDPKB_P31, comprising a polypeptide being at     	     171 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 220                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      61 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 110                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MENLWISGPA of HUMCCDPKB_P31.                                 	     221 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 270                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     111 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     271 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 320                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 LKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGM 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     321 LKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGM 370                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 DFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQG 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     371 DFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQG 420                                                          
						                                                            	                  .         .         .                      
						                                                            	     261 RPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ               296                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     421 RPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ               456                                                          

						Comparison report between HUMCCDPKB_P31 and O00561unique     	Sequence name: O00561                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMCCDPKB_P31, comprising a	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 2921 x O00561   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MENLWISGPA corresponding to  	                                                            
						amino acids 1 - 10 of HUMCCDPKB_P31, a second amino acid     	                     Quality: 1279.00                      Escore:       0                                               
						FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLR 	             Matching length:     141                Total length:     164                                               
						KFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVK                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:   85.98      Total Percent Identity:   85.98                                               
						amino acids 166 - 263 of O00561, which also corresponds to   	                        Gaps:       1                        
						amino acids 11 - 108 of HUMCCDPKB_P31, a third amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      11 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 60                                                           
						having the sequence PQSNNKNSLVSPAQEPAPLQTAM corresponding to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 109 - 131 of HUMCCDPKB_P31, a fourth amino acid  	     166 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM 215                                                          
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						EPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQ corresponding to 	      61 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKPQ 110                                                          
						amino acids 264 - 306 of O00561, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						amino acids 132 - 174 of HUMCCDPKB_P31, and a fifth amino    	     216 HRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVK.. 263                                                          
						acid sequence being at least 70%, optionally at least 80%,   	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     111 SNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDED 160                                                          
						most preferably at least 95% homologous to a polypeptide     	                              |||||||||||||||||||||||||||||  
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	     264 .....................EPQTTVVHNATDGIKGSTESCNTTTEDED 292                                                          
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                  .                                          
						LQ                                                           	     161 LKVRKQEIIKITEQ                                     174                                                          
						having the sequence corresponding to amino acids 175 - 296 of	         ||||||||||||||                                      
						HUMCCDPKB_P31, wherein said first amino acid sequence, second	     293 LKVRKQEIIKITEQ                                     306                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                                                            
						acid sequence and fifth amino acid sequence are contiguous   	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a head of HUMCCDPKB_P31, comprising a polypeptide being  	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						MENLWISGPA of HUMCCDPKB_P31.3.An isolated polypeptide        	                                                            
						encoding for an edge portion of HUMCCDPKB_P31, comprising an 	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for                      	                                                            
						PQSNNKNSLVSPAQEPAPLQTAM, corresponding to HUMCCDPKB_P31.4.An 	                                                            
						isolated polypeptide encoding for a tail of HUMCCDPKB_P31,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	                                                            
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                                                            
						LQ                                                           	                                                            
						about 95% homologous to the sequence in HUMCCDPKB_P31.       	                                                            

2919	HMR136_HUMCCDPKB_32_tr0_r1_1_gPRT		Comparison report between HUMCCDPKB_P32 and Q8N4I3partial WT 	Sequence name: Q8N4I3                                        
						sequence followed by mismatch, featuring a skipped exon and a	                                                            
						followed by a unique insertion.1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCCDPKB_P32, comprising a first   	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment of: 2919 x Q8N4I3   ..                             
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKT corresponding to amino   	                                                            
						acids 1 - 35 of Q8N4I3, which also corresponds to amino acids	Alignment segment 1/1:                                       
						1 - 35 of HUMCCDPKB_P32, a bridging amino acid S             	                                                            
						corresponding to amino acid 36 of HUMCCDPKB_P32, a second    	                     Quality: 4684.00                      Escore:       0                                               
						TQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 	             Matching length:     499                Total length:     550                                               
						ELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLA 	 Matching Percent Similarity:   99.80   Matching Percent Identity:   99.80                                               
						DFGLAIEVQGEQQAWF                                             	    Total Percent Similarity:   90.55      Total Percent Identity:   90.55                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       2                        
						corresponding to amino acids 37 - 172 of Q8N4I3, which also  	                                                            
						corresponds to amino acids 37 - 172 of HUMCCDPKB_P32, a third	Alignment:                                                   
						GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKR 	                  .         .         .         .         .  
						ITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSVGRQS 	       1 MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKL 50                                                           
						SAPASPAASAAGLAGQAAKSLLNKKSDGGVKKRKSSSSVHL                    	         ||||||||||||||||||||||||||||||||||| ||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL 50                                                           
						corresponding to amino acids 201 - 361 of Q8N4I3, which also 	                  .         .         .         .         .  
						corresponds to amino acids 173 - 333 of HUMCCDPKB_P32, a     	      51 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 100                                                          
						fourth amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	      51 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 100                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence MPQSNNKNSLVSPAQEPAPLQTA      	     101 DIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG 150                                                          
						corresponding to amino acids 334 - 356 of HUMCCDPKB_P32, and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MEPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQLIEAINNGDFEAYTKI 	     101 DIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG 150                                                          
						CDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYI 	                  .         .         .         .         .  
						RLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ               	     151 AAVKLADFGLAIEVQGEQQAWF............................ 172                                                          
						a fifth amino acid sequence being at least 90 % homologous to	         ||||||||||||||||||||||                              
						corresponding to amino acids 362 - 527 of Q8N4I3, which also 	     151 AAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWAC 200                                                          
						corresponds to amino acids 357 - 522 of HUMCCDPKB_P32,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, bridging amino acid, 	     173 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 222                                                          
						second amino acid sequence, third amino acid sequence, fourth	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and fifth amino acid sequence are        	     201 GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 250                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of HUMCCDPKB_P32,   	     223 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 272                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     251 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 300                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     273 KGAILTTMLVSRNFSVGRQSSAPASPAASAAGLAGQAAKSLLNKKSDGGV 322                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     301 KGAILTTMLVSRNFSVGRQSSAPASPAASAAGLAGQAAKSLLNKKSDGGV 350                                                          
						comprise FG, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 172-x to 173; and    	     323 KKRKSSSSVHLMPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIK 372                                                          
						ending at any of amino acid numbers 173+ ((n-2) - x), in     	         |||||||||||                       ||||||||||||||||  
						which x varies from 0 to n-2.3.An isolated polypeptide       	     351 KKRKSSSSVHL.......................MEPQTTVVHNATDGIK 377                                                          
						encoding for an edge portion of HUMCCDPKB_P32, comprising an 	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     373 GSTESCNTTTEDEDLKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLT 422                                                          
						about 80%, preferably at least about 85%, more preferably at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 90% and most preferably at least about 95%       	     378 GSTESCNTTTEDEDLKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLT 427                                                          
						homologous to the sequence encoding for                      	                  .         .         .         .         .  
						MPQSNNKNSLVSPAQEPAPLQTA, corresponding to HUMCCDPKB_P32.     	     423 SFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAAC 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     428 SFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAAC 477                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     473 IAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ 522                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     478 IAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ 527                                                          

						Comparison report between HUMCCDPKB_P32 and Q13280unique     	Sequence name: Q13280                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a featuring a skipped exon plus extra amino    	Sequence documentation:                                      
						acids.1.An isolated chimeric polypeptide encoding for        	                                                            
						HUMCCDPKB_P32, comprising a first amino acid sequence being  	Alignment of: 2919 x Q13280   ..                             
						at least 70%, optionally at least 80%, preferably at least   	                                                            
						85%, more preferably at least 90% and most preferably at     	Alignment segment 1/1:                                       
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	                                                            
						EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 	                     Quality: 2081.00                      Escore:       0                                               
						LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGVILYILL 	             Matching length:     243                Total length:     313                                               
						VGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.59                                               
						HPWVCQR                                                      	    Total Percent Similarity:   77.64      Total Percent Identity:   77.32                                               
						least 95% homologous to a polypeptide having the sequence    	                        Gaps:       3                        
						corresponding to amino acids 1 - 247 of HUMCCDPKB_P32, a     	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFS corresponding to    	                  .         .         .         .         .  
						amino acids 1 - 40 of Q13280, which also corresponds to amino	     248 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSVGRQSSAPAS 297                                                          
						acids 248 - 287 of HUMCCDPKB_P32, a third amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||            
						being at least 70%, optionally at least 80%, preferably at   	       1 STVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFS.......... 40                                                           
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     298 PAASAAGLAGQAAKSLLNKKSDGGVKKRKSSSSVHLMPQSNNKNSLVSPA 347                                                          
						VGRQSSAPASPAASAAGLAGQ corresponding to amino acids 288 - 308 	                    |||||||||||||||           |||||||||||||  
						of HUMCCDPKB_P32, a fourth amino acid sequence being at least	      41 ...........AAKSLLNKKSDGGVK...........PQSNNKNSLVSPA 68                                                           
						90 % homologous to AAKSLLNKKSDGGVK corresponding to amino    	                  .         .         .         .         .  
						acids 41 - 55 of Q13280, which also corresponds to amino     	     348 QEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLK......... 388                                                          
						acids 309 - 323 of HUMCCDPKB_P32, a fifth amino acid sequence	         |||||||||||||||||||||||||||||||||||||||||           
						being at least 70%, optionally at least 80%, preferably at   	      69 QEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKAAPLRTGNG 118                                                          
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     389 .............................VRKQEIIKITEQLIEAINNGD 409                                                          
						KRKSSSSVHLM corresponding to amino acids 324 - 334 of        	                                      :||||||||||||||||||||  
						HUMCCDPKB_P32, a sixth amino acid sequence being at least 90 	     119 SSVPEGRSSRDRTAPSAGMQPQPSLCSSAMRKQEIIKITEQLIEAINNGD 168                                                          
						% homologous to                                              	                  .         .         .         .         .  
						PQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLK       	     410 FEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTIL 459                                                          
						corresponding to amino acids 56 - 109 of Q13280, which also  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 335 - 388 of HUMCCDPKB_P32, a     	     169 FEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTIL 218                                                          
						seventh amino acid sequence bridging amino acid sequence     	                  .         .         .         .         .  
						comprising of V, and a eight amino acid sequence being at    	     460 NPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNV 509                                                          
						RKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNV 	     219 NPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNV 268                                                          
						HYHCSGAPAAPLQ                                                	                  .                                          
						least 90 % homologous to corresponding to amino acids 149 -  	     510 HYHCSGAPAAPLQ                                      522                                                          
						281 of Q13280, which also corresponds to amino acids 390 -   	         |||||||||||||                                       
						522 of HUMCCDPKB_P32, wherein said first amino acid sequence,	     269 HYHCSGAPAAPLQ                                      281                                                          
						second amino acid sequence, third amino acid sequence, fourth	                                                            
						amino acid sequence, fifth amino acid sequence, sixth amino  	                                                            
						acid sequence, seventh amino acid sequence and eight amino   	                                                            
						acid sequence are contiguous and in a sequential order.2.An  	                                                            
						isolated polypeptide encoding for a head of HUMCCDPKB_P32,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	                                                            
						EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 	                                                            
						LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGVILYILL 	                                                            
						VGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALK 	                                                            
						HPWVCQR                                                      	                                                            
						about 95% homologous to the sequence of HUMCCDPKB_P32.3.An   	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						HUMCCDPKB_P32, comprising an amino acid sequence being at    	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for VGRQSSAPASPAASAAGLAGQ, corresponding to         	                                                            
						HUMCCDPKB_P32.4.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P32, comprising an amino acid sequence  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for KRKSSSSVHLM, corresponding to HUMCCDPKB_P32.5.An	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						HUMCCDPKB_P32, comprising a polypeptide having a length "n", 	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KVR having a structure as  	                                                            
						follows (numbering according to HUMCCDPKB_P32): a sequence   	                                                            
						starting from any of amino acid numbers 388-x to 388; and    	                                                            
						ending at any of amino acid numbers 390 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between HUMCCDPKB_P32 and Q8WU40unique     	Sequence name: Q8WU40                                        
						head followed by partial WT sequence featuring a skipped exon	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for HUMCCDPKB_P32, comprising a first   	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment of: 2919 x Q8WU40   ..                             
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment segment 1/1:                                       
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	                                                            
						EARIC                                                        	                     Quality: 3897.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 65 of   	             Matching length:     425                Total length:     485                                               
						HUMCCDPKB_P32, a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN 	    Total Percent Similarity:   87.63      Total Percent Identity:   87.63                                               
						HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF              	                        Gaps:       3                        
						% homologous to corresponding to amino acids 4 - 110 of      	                                                            
						Q8WU40, which also corresponds to amino acids 66 - 172 of    	Alignment:                                                   
						HUMCCDPKB_P32, a third amino acid sequence being at least 90 	                  .         .         .         .         .  
						GVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKR 	      66 RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 115                                                          
						ITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFS      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 139 - 253 of    	       4 RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 53                                                           
						Q8WU40, which also corresponds to amino acids 173 - 287 of   	                  .         .         .         .         .  
						HUMCCDPKB_P32, a fourth amino acid sequence being at least   	     116 CIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 165                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      54 CIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 103                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						VGRQSSAPASPAASAAGLAGQ corresponding to amino acids 288 - 308 	     166 GEQQAWF............................GVILYILLVGYPPFW 187                                                          
						of HUMCCDPKB_P32, a fifth amino acid sequence being at least 	         |||||||                            |||||||||||||||  
						90 % homologous to AAKSLLNKKSDGGVK corresponding to amino    	     104 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFW 153                                                          
						acids 254 - 268 of Q8WU40, which also corresponds to amino   	                  .         .         .         .         .  
						acids 309 - 323 of HUMCCDPKB_P32, a sixth amino acid sequence	     188 DEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQ 237                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     154 DEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQ 203                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						KRKSSSSVHLM corresponding to amino acids 324 - 334 of        	     238 ALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFS 287                                                          
						HUMCCDPKB_P32, and a seventh amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEI 	     204 ALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFS 253                                                          
						IKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPI 	                  .         .         .         .         .  
						HTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCS 	     288 VGRQSSAPASPAASAAGLAGQAAKSLLNKKSDGGVKKRKSSSSVHLMPQS 337                                                          
						GAPAAPLQ                                                     	                              |||||||||||||||           |||  
						least 90 % homologous to corresponding to amino acids 269 -  	     254 .....................AAKSLLNKKSDGGVK...........PQS 271                                                          
						456 of Q8WU40, which also corresponds to amino acids 335 -   	                  .         .         .         .         .  
						522 of HUMCCDPKB_P32, wherein said first amino acid sequence,	     338 NNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDL 387                                                          
						second amino acid sequence, third amino acid sequence, fourth	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, fifth amino acid sequence, sixth amino  	     272 NNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDL 321                                                          
						acid sequence and seventh amino acid sequence are contiguous 	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	     388 KVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMD 437                                                          
						for a head of HUMCCDPKB_P32, comprising a polypeptide being  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least about 80%, preferably at   	     322 KVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMD 371                                                          
						least about 85%, more preferably at least about 90% and most 	                  .         .         .         .         .  
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	     438 FHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGR 487                                                          
						EARIC                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence of  	     372 FHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGR 421                                                          
						HUMCCDPKB_P32.3.An isolated chimeric polypeptide encoding for	                  .         .         .                      
						an edge portion of HUMCCDPKB_P32, comprising a polypeptide   	     488 PRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                522                                                          
						having a length "n", wherein n is at least about 10 amino    	         |||||||||||||||||||||||||||||||||||                 
						acids in length, optionally at least about 20 amino acids in 	     422 PRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ                456                                                          
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	                                                            
						most preferably at least about 50 amino acids in length,     	                                                            
						wherein at least two amino acids comprise FG, having a       	                                                            
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 172-x to 173; and ending at any of amino acid   	                                                            
						numbers 173+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for an edge portion of	                                                            
						HUMCCDPKB_P32, comprising an amino acid sequence being at    	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for VGRQSSAPASPAASAAGLAGQ, corresponding to         	                                                            
						HUMCCDPKB_P32.5.An isolated polypeptide encoding for an edge 	                                                            
						portion of HUMCCDPKB_P32, comprising an amino acid sequence  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for KRKSSSSVHLM, corresponding to HUMCCDPKB_P32.    	                                                            

						Comparison report between HUMCCDPKB_P32 and O00561unique     	Sequence name: O00561                                        
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon, a mismatch, followed by a unique insertion and a       	Sequence documentation:                                      
						followed by a unique tail.1.An isolated chimeric polypeptide 	                                                            
						encoding for HUMCCDPKB_P32, comprising a first amino acid    	Alignment of: 2919 x O00561   ..                             
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment segment 1/1:                                       
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	                     Quality: 2414.00                      Escore:       0                                               
						EARICRLL                                                     	             Matching length:     278                Total length:     361                                               
						having the sequence corresponding to amino acids 1 - 68 of   	 Matching Percent Similarity:   99.64   Matching Percent Identity:   99.28                                               
						HUMCCDPKB_P32, a second amino acid sequence being at least 90	    Total Percent Similarity:   76.73      Total Percent Identity:   76.45                                               
						KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 	                        Gaps:       3                        
						QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF                 	                                                            
						% homologous to corresponding to amino acids 2 - 105 of      	Alignment:                                                   
						O00561, which also corresponds to amino acids 69 - 172 of    	                  .         .         .         .         .  
						HUMCCDPKB_P32, a third amino acid sequence being at least 90 	      68 LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI 117                                                          
						% homologous to GVILYILLVGYPPFWDEDQHKLYQQIKAG corresponding  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 134 - 162 of O00561, which also corresponds to	       1 MKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI 50                                                           
						amino acids 173 - 201 of HUMCCDPKB_P32, a bridging amino acid	                  .         .         .         .         .  
						A corresponding to amino acid 202 of HUMCCDPKB_P32, a fourth 	     118 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 167                                                          
						YDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVEC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRKFNARRKLKGAILTTMLVSRNFS                                    	      51 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 100                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 164 - 248 of O00561, which also 	     168 QQAWF............................GVILYILLVGYPPFWDE 189                                                          
						corresponds to amino acids 203 - 287 of HUMCCDPKB_P32, a     	         |||||                            |||||||||||||||||  
						fifth amino acid sequence being at least 70%, optionally at  	     101 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDE 150                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     190 DQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQAL 239                                                          
						polypeptide having the sequence VGRQSSAPASPAASAAGLAGQ        	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 288 - 308 of HUMCCDPKB_P32, a   	     151 DQHKLYQQIKAGTYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQAL 200                                                          
						sixth amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						AAKSLLNKKSDGGVK corresponding to amino acids 249 - 263 of    	     240 KHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSVG 289                                                          
						O00561, which also corresponds to amino acids 309 - 323 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						HUMCCDPKB_P32, a seventh amino acid sequence being at least  	     201 KHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFS.. 248                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     290 RQSSAPASPAASAAGLAGQAAKSLLNKKSDGGVKKRKSSSSVHLMPQSNN 339                                                          
						homologous to a polypeptide having the sequence              	                            |||||||||||||||                  
						KRKSSSSVHLMPQSNNKNSLVSPAQEPAPLQTAM corresponding to amino    	     249 ...................AAKSLLNKKSDGGVK................ 263                                                          
						acids 324 - 357 of HUMCCDPKB_P32, a eight amino acid sequence	                  .         .         .         .         .  
						being at least 90 % homologous to                            	     340 KNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKV 389                                                          
						EPQTTVVHNATDGIKGSTESCNTTTEDEDLKVRKQEIIKITEQ corresponding to 	                           ||||||||||||||||||||||||||||||||  
						amino acids 264 - 306 of O00561, which also corresponds to   	     264 ..................EPQTTVVHNATDGIKGSTESCNTTTEDEDLKV 295                                                          
						amino acids 358 - 400 of HUMCCDPKB_P32, a ninth amino acid   	                  .                                          
						sequence being at least 70%, optionally at least 80%,        	     390 RKQEIIKITEQ                                        400                                                          
						preferably at least 85%, more preferably at least 90% and    	         |||||||||||                                         
						most preferably at least 95% homologous to a polypeptide     	     296 RKQEIIKITEQ                                        306                                                          
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	                                                            
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                                                            
						LQ                                                           	                                                            
						having the sequence corresponding to amino acids 401 - 522 of	                                                            
						HUMCCDPKB_P32, wherein said first amino acid sequence, second	                                                            
						amino acid sequence, third amino acid sequence, bridging     	                                                            
						amino acid, fourth amino acid sequence, fifth amino acid     	                                                            
						sequence, sixth amino acid sequence, seventh amino acid      	                                                            
						sequence, eight amino acid sequence and ninth amino acid     	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of HUMCCDPKB_P32,   	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 	                                                            
						EARICRLL                                                     	                                                            
						about 95% homologous to the sequence of HUMCCDPKB_P32.3.An   	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						HUMCCDPKB_P32, comprising a polypeptide having a length "n", 	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise FG, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						172-x to 173; and ending at any of amino acid numbers 173+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                                            
						polypeptide encoding for an edge portion of HUMCCDPKB_P32,   	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						VGRQSSAPASPAASAAGLAGQ, corresponding to HUMCCDPKB_P32.5.An   	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						HUMCCDPKB_P32, comprising an amino acid sequence being at    	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for KRKSSSSVHLMPQSNNKNSLVSPAQEPAPLQTAM,             	                                                            
						corresponding to HUMCCDPKB_P32.6.An isolated polypeptide     	                                                            
						encoding for a tail of HUMCCDPKB_P32, comprising a           	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						LIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILN 	                                                            
						PHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAP 	                                                            
						LQ                                                           	                                                            
						to the sequence in HUMCCDPKB_P32.                            	                                                            

25525	HMR136_HUMCCDR_6_tr0_r1_1_gPRT		Comparison report between HUMCCDR_P6 and AKC4_HUMANpartial   	Sequence name: AKC4_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMCCDR_P6, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MVQPALESSLKKLQLDYVDLYLLHFPMALK corresponding to amino acids  	Alignment of: 25525 x AKC4_HUMAN   ..                        
						94 - 123 of AKC4_HUMAN, which also corresponds to amino acids	                                                            
						1 - 30 of HUMCCDR_P6, and a second amino acid sequence being 	Alignment segment 1/1:                                       
						VMEKCKDAGLAKSIGVSNFNCRQLEMILNKPGLKYKPVCNQVECHPYLNQSKLLDFCKSK 	                                                            
						DIVLVAHSALGTQRHKLW                                           	                     Quality:  977.00                      Escore:       0                                               
						at least 90 % homologous to corresponding to amino acids 150 	             Matching length:     108                Total length:     134                                               
						- 227 of AKC4_HUMAN, which also corresponds to amino acids 31	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						- 108 of HUMCCDR_P6, wherein said first amino acid sequence  	    Total Percent Similarity:   80.60      Total Percent Identity:   80.60                                               
						and second amino acid sequence are contiguous and in a       	                        Gaps:       1                        
						sequential order.2.An isolated chimeric polypeptide encoding 	                                                            
						for an edge portion of HUMCCDR_P6, comprising a polypeptide  	Alignment:                                                   
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	       1 MVQPALESSLKKLQLDYVDLYLLHFPMALK.................... 30                                                           
						length, preferably at least about 30 amino acids in length,  	         ||||||||||||||||||||||||||||||                      
						more preferably at least about 40 amino acids in length and  	      94 MVQPALESSLKKLQLDYVDLYLLHFPMALKPGETPLPKDENGKVIFDTVD 143                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise KV, having a       	      31 ......VMEKCKDAGLAKSIGVSNFNCRQLEMILNKPGLKYKPVCNQVEC 74                                                           
						structure as follows: a sequence starting from any of amino  	               ||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 30-x to 31; and ending at any of amino acid     	     144 LSATWEVMEKCKDAGLAKSIGVSNFNCRQLEMILNKPGLKYKPVCNQVEC 193                                                          
						numbers 31+ ((n-2) - x), in which x varies from 0 to n-2.    	                  .         .         .                      
						                                                            	      75 HPYLNQSKLLDFCKSKDIVLVAHSALGTQRHKLW                 108                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     194 HPYLNQSKLLDFCKSKDIVLVAHSALGTQRHKLW                 227                                                          

25696	HMR136_HUMCCG1PA_13_tr0_r1_1_gPRT		Comparison report between HUMCCG1PA_P13 and                  	Sequence name: T2D1_HUMAN                                    
						T2D1_HUMANpartial WT sequence followed by a unique tail.1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCCG1PA_P13,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MGPGCDLLLRTAATITAAAIMSDTDSDEDSAGGGPFSLAGFLFGNINGAGQLEGESVLDD 	Alignment of: 25696 x T2D1_HUMAN   ..                        
						ECKKHLAGLGALGLGSLITELTANEELTGTDGALVNDEGWVRSTEDAVDYSDINEVAEDE 	                                                            
						SRRYQQTMGSLQPLCHSDYDEDDYDADCEDIDCKLMPPPPPPPGPMKKDKDQDSITGEKV 	Alignment segment 1/1:                                       
						DFSSSSDSESEMGPQEATQAESEDGKLTLPLAGIMQHDATKLLPSVTELFPEFRPGKVLR 	                                                            
						FLRLFGPGKNVPSVWRSARRKRKKKHRELIQEEQIQEVECSVESEVSQKSLWNYDYAPPP 	                     Quality: 16317.00                      Escore:       0                                              
						PPEQCLSDDEITMMAPVESKFSQSTGDIDKVTDTKPRVAEWRYGPARLWYDMLGVPEDGS 	             Matching length:    1645                Total length:    1645                                               
						GFDYGFKLRKTEHEPVIKSRMIEEFRKLEENNGTDLLADENFLMVTQLHWEDDIIWDGED 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VKHKGTKPQRASLAGWLPSSMTRNAMAYNVQQGFAATLDDDKPWYSIFPIDNEDLVYGRW 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EDNIIWDAQAMPRLLEPPVLTLDPNDENLILEIPDEKEEATSNSPSKESKKESSLKKSRI 	                        Gaps:       0                        
						LLGKTGVIKEEPQQNMSQPEVKDPWNLSNDEYYYPKQQGLRGTFGGNIIQHSIPAVELRQ 	                                                            
						PFFPTHMGPIKLRQFHRPPLKKYSFGALSQPGPHSVQPLLKHIKKKAKMREQERQASGGG 	Alignment:                                                   
						EMFFMRTPQDLTGKDGDLILAEYSEENGPLMMQVGMATKIKNYYKRKPGKDPGAPDCKYG 	                  .         .         .         .         .  
						ETVYCHTSPFLGSLHPGQLLQAFENNLFRAPIYLHKMPETDFLIIRTRQGYYIRELVDIF 	       1 MGPGCDLLLRTAATITAAAIMSDTDSDEDSAGGGPFSLAGFLFGNINGAG 50                                                           
						VVGQQCPLFEVPGPNSKRANTHIRDFLQVFIYRLFWKSKDRPRRIRMEDIKKAFPSHSES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIRKRLKLCADFKRTGMDSNWWVLKSDFRLPTEEEIRAMVSPEQCCAYYSMIAAEQRLKD 	       1 MGPGCDLLLRTAATITAAAIMSDTDSDEDSAGGGPFSLAGFLFGNINGAG 50                                                           
						AGYGEKSFFAPEEENEEDFQMKIDDEVRTAPWNTTRAFIAAMKGKCLLEVTGVADPTGCG 	                  .         .         .         .         .  
						EGFSYVKIPNKPTQQKDDKEPQPVKKTVTGTDADLRRLSLKNAKQLLRKFGVPEEEIKKL 	      51 QLEGESVLDDECKKHLAGLGALGLGSLITELTANEELTGTDGALVNDEGW 100                                                          
						SRWEVIDVVRTMSTEQARSGEGPMSKFARGSRFSVAEHQERYKEECQRIFDLQNKVLSST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EVLSTDTDSSSAEDSDFEEMGKNIENMLQNKKTSSQLSREREEQERKELQRMLLAAGSAA 	      51 QLEGESVLDDECKKHLAGLGALGLGSLITELTANEELTGTDGALVNDEGW 100                                                          
						SGNNHRDDDTASVTSLNSSATGRCLKIYRTFRDEEGKEYVRCETVRKPAVIDAYVRIRTT 	                  .         .         .         .         .  
						KDEEFIRKFALFDEQHREEMRKERRRIQEQLRRLKRNQEKEKLKGPPEKKPKKMKERPDL 	     101 VRSTEDAVDYSDINEVAEDESRRYQQTMGSLQPLCHSDYDEDDYDADCED 150                                                          
						KLKCGACGAIGHMRTNKFCPLYYQTNAPPSNPVAMTEEQEEELEKTVIHNDNEELIKVEG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TKIVLGKQLIESADEVRRKSLVLKFPKQQLPPKKKRRVGTTVHCDYLNRPHKSIHRRRTD 	     101 VRSTEDAVDYSDINEVAEDESRRYQQTMGSLQPLCHSDYDEDDYDADCED 150                                                          
						PMVTLSSILESIINDMRDLPNTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYP 	                  .         .         .         .         .  
						SREEFREHLELIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLD 	     151 IDCKLMPPPPPPPGPMKKDKDQDSITGEKVDFSSSSDSESEMGPQEATQA 200                                                          
						DDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICT 	     151 IDCKLMPPPPPPPGPMKKDKDQDSITGEKVDFSSSSDSESEMGPQEATQA 200                                                          
						AKEAALEEAELESLDPMTPGPYTPQ                                    	                  .         .         .         .         .  
						homologous to corresponding to amino acids 1 - 1645 of       	     201 ESEDGKLTLPLAGIMQHDATKLLPSVTELFPEFRPGKVLRFLRLFGPGKN 250                                                          
						T2D1_HUMAN, which also corresponds to amino acids 1 - 1645 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCCG1PA_P13, and a second amino acid sequence being at     	     201 ESEDGKLTLPLAGIMQHDATKLLPSVTELFPEFRPGKVLRFLRLFGPGKN 250                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     251 VPSVWRSARRKRKKKHRELIQEEQIQEVECSVESEVSQKSLWNYDYAPPP 300                                                          
						homologous to a polypeptide having the sequence AKVSEGHGSWWP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1646 - 1657 of HUMCCG1PA_P13,   	     251 VPSVWRSARRKRKKKHRELIQEEQIQEVECSVESEVSQKSLWNYDYAPPP 300                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     301 PPEQCLSDDEITMMAPVESKFSQSTGDIDKVTDTKPRVAEWRYGPARLWY 350                                                          
						isolated polypeptide encoding for a tail of HUMCCG1PA_P13,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     301 PPEQCLSDDEITMMAPVESKFSQSTGDIDKVTDTKPRVAEWRYGPARLWY 350                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     351 DMLGVPEDGSGFDYGFKLRKTEHEPVIKSRMIEEFRKLEENNGTDLLADE 400                                                          
						about 95% homologous to the sequence AKVSEGHGSWWP in         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCCG1PA_P13.                                               	     351 DMLGVPEDGSGFDYGFKLRKTEHEPVIKSRMIEEFRKLEENNGTDLLADE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 NFLMVTQLHWEDDIIWDGEDVKHKGTKPQRASLAGWLPSSMTRNAMAYNV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 NFLMVTQLHWEDDIIWDGEDVKHKGTKPQRASLAGWLPSSMTRNAMAYNV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 QQGFAATLDDDKPWYSIFPIDNEDLVYGRWEDNIIWDAQAMPRLLEPPVL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 QQGFAATLDDDKPWYSIFPIDNEDLVYGRWEDNIIWDAQAMPRLLEPPVL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TLDPNDENLILEIPDEKEEATSNSPSKESKKESSLKKSRILLGKTGVIKE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TLDPNDENLILEIPDEKEEATSNSPSKESKKESSLKKSRILLGKTGVIKE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 EPQQNMSQPEVKDPWNLSNDEYYYPKQQGLRGTFGGNIIQHSIPAVELRQ 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EPQQNMSQPEVKDPWNLSNDEYYYPKQQGLRGTFGGNIIQHSIPAVELRQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PFFPTHMGPIKLRQFHRPPLKKYSFGALSQPGPHSVQPLLKHIKKKAKMR 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PFFPTHMGPIKLRQFHRPPLKKYSFGALSQPGPHSVQPLLKHIKKKAKMR 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EQERQASGGGEMFFMRTPQDLTGKDGDLILAEYSEENGPLMMQVGMATKI 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EQERQASGGGEMFFMRTPQDLTGKDGDLILAEYSEENGPLMMQVGMATKI 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 KNYYKRKPGKDPGAPDCKYGETVYCHTSPFLGSLHPGQLLQAFENNLFRA 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 KNYYKRKPGKDPGAPDCKYGETVYCHTSPFLGSLHPGQLLQAFENNLFRA 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 PIYLHKMPETDFLIIRTRQGYYIRELVDIFVVGQQCPLFEVPGPNSKRAN 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 PIYLHKMPETDFLIIRTRQGYYIRELVDIFVVGQQCPLFEVPGPNSKRAN 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 THIRDFLQVFIYRLFWKSKDRPRRIRMEDIKKAFPSHSESSIRKRLKLCA 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 THIRDFLQVFIYRLFWKSKDRPRRIRMEDIKKAFPSHSESSIRKRLKLCA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 DFKRTGMDSNWWVLKSDFRLPTEEEIRAMVSPEQCCAYYSMIAAEQRLKD 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DFKRTGMDSNWWVLKSDFRLPTEEEIRAMVSPEQCCAYYSMIAAEQRLKD 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AGYGEKSFFAPEEENEEDFQMKIDDEVRTAPWNTTRAFIAAMKGKCLLEV 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AGYGEKSFFAPEEENEEDFQMKIDDEVRTAPWNTTRAFIAAMKGKCLLEV 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 TGVADPTGCGEGFSYVKIPNKPTQQKDDKEPQPVKKTVTGTDADLRRLSL 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 TGVADPTGCGEGFSYVKIPNKPTQQKDDKEPQPVKKTVTGTDADLRRLSL 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 KNAKQLLRKFGVPEEEIKKLSRWEVIDVVRTMSTEQARSGEGPMSKFARG 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KNAKQLLRKFGVPEEEIKKLSRWEVIDVVRTMSTEQARSGEGPMSKFARG 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 SRFSVAEHQERYKEECQRIFDLQNKVLSSTEVLSTDTDSSSAEDSDFEEM 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 SRFSVAEHQERYKEECQRIFDLQNKVLSSTEVLSTDTDSSSAEDSDFEEM 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 GKNIENMLQNKKTSSQLSREREEQERKELQRMLLAAGSAASGNNHRDDDT 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 GKNIENMLQNKKTSSQLSREREEQERKELQRMLLAAGSAASGNNHRDDDT 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 ASVTSLNSSATGRCLKIYRTFRDEEGKEYVRCETVRKPAVIDAYVRIRTT 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 ASVTSLNSSATGRCLKIYRTFRDEEGKEYVRCETVRKPAVIDAYVRIRTT 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 KDEEFIRKFALFDEQHREEMRKERRRIQEQLRRLKRNQEKEKLKGPPEKK 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 KDEEFIRKFALFDEQHREEMRKERRRIQEQLRRLKRNQEKEKLKGPPEKK 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 PKKMKERPDLKLKCGACGAIGHMRTNKFCPLYYQTNAPPSNPVAMTEEQE 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 PKKMKERPDLKLKCGACGAIGHMRTNKFCPLYYQTNAPPSNPVAMTEEQE 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 EELEKTVIHNDNEELIKVEGTKIVLGKQLIESADEVRRKSLVLKFPKQQL 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 EELEKTVIHNDNEELIKVEGTKIVLGKQLIESADEVRRKSLVLKFPKQQL 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 PPKKKRRVGTTVHCDYLNRPHKSIHRRRTDPMVTLSSILESIINDMRDLP 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 PPKKKRRVGTTVHCDYLNRPHKSIHRRRTDPMVTLSSILESIINDMRDLP 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 NTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYPSREEFREHLE 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 NTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYPSREEFREHLE 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 LIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLD 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 LIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLD 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 DDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDL 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 DDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDL 1550                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 ETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVC 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1551 ETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVC 1600                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1601 YQTLTEYDEHLTQLEKDICTAKEAALEEAELESLDPMTPGPYTPQ      1645                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1601 YQTLTEYDEHLTQLEKDICTAKEAALEEAELESLDPMTPGPYTPQ      1645                                                         

25791	HMR136_HUMCCKAR_1_tr0_r1_1_gPRT		Comparison report between HUMCCKAR_P1 and CCKR_HUMANpartial  	Sequence name: CCKR_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCCKAR_P1, comprising a first     	                                                            
						MRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFN 	Alignment of: 25791 x CCKR_HUMAN   ..                        
						LVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQ 	                                                            
						TANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAK 	Alignment segment 1/1:                                       
						ERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRV 	                                                            
						IRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYC 	                     Quality: 3518.00                      Escore:       0                                               
						FMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ    	             Matching length:     357                Total length:     357                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 72 - 428 of CCKR_HUMAN, which   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 357 of HUMCCKAR_P1.      	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFM 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      72 MRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFM 121                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFT 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     122 GTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFT 171                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 IMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIP 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 GIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYL 271                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 QKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVL 321                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     322 FFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYC 371                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHM 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     372 FMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHM 421                                                          
						                                                            	                                                             
						                                                            	     351 SASVPPQ                                            357                                                          
						                                                            	         |||||||                                             
						                                                            	     422 SASVPPQ                                            428                                                          

25906	HMR136_HUMCCKR_1_tr0_r1_1_gPRT		Comparison report between HUMCCKR_P1 and GASR_HUMANpartial   	Sequence name: GASR_HUMAN                                    
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for HUMCCKR_P1, comprising a   	Sequence documentation:                                      
						MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITL 	                                                            
						YAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTF 	Alignment of: 25906 x GASR_HUMAN   ..                        
						IFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWL 	                                                            
						LSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGL 	Alignment segment 1/1:                                       
						ISRELYLGLRFDGDSDSDSQSRVRNQGGLPG                              	                                                            
						first amino acid sequence being at least 90 % homologous to  	                     Quality: 4215.00                      Escore:       0                                               
						corresponding to amino acids 1 - 271 of GASR_HUMAN, which    	             Matching length:     447                Total length:     452                                               
						also corresponds to amino acids 1 - 271 of HUMCCKR_P1, a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:   98.89      Total Percent Identity:   98.89                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       1                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence GAGPR corresponding to amino 	Alignment:                                                   
						acids 272 - 276 of HUMCCKR_P1, and a third amino acid        	                  .         .         .         .         .  
						AVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRV 	       1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTR 50                                                           
						VRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG     	       1 MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTR 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 272 - 447 of GASR_HUMAN, which also corresponds  	      51 ELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSD 100                                                          
						to amino acids 277 - 452 of HUMCCKR_P1, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	      51 ELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSD 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	     101 LLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIAL 150                                                          
						of HUMCCKR_P1, comprising an amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     101 LLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIAL 150                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     151 ERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGP 200                                                          
						encoding for GAGPR, corresponding to HUMCCKR_P1.             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 RVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FDGDSDSDSQSRVRNQGGLPGGAGPRAVHQNGRCRPETGAVGEDSDGCYV 300                                                          
						                                                            	         |||||||||||||||||||||     ||||||||||||||||||||||||  
						                                                            	     251 FDGDSDSDSQSRVRNQGGLPG.....AVHQNGRCRPETGAVGEDSDGCYV 295                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLC 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     296 QLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLC 345                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 WLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     346 WLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHR 395                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 RFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     396 RFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLG 445                                                          
						                                                            	                                                             
						                                                            	     451 PG                                                 452                                                          
						                                                            	         ||                                                  
						                                                            	     446 PG                                                 447                                                          

25904	HMR136_HUMCCKR_3_tr0_r1_1_gPRT		Comparison report between HUMCCKR_P3 and GASR_HUMANpartial   	Sequence name: GASR_HUMAN                                    
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for HUMCCKR_P3, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPG corresponding to amino	Alignment of: 25904 x GASR_HUMAN   ..                        
						acids 234 - 271 of GASR_HUMAN, which also corresponds to     	                                                            
						amino acids 1 - 38 of HUMCCKR_P3, a second amino acid        	Alignment segment 1/1:                                       
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                     Quality: 2002.00                      Escore:       0                                               
						most preferably at least 95% homologous to a polypeptide     	             Matching length:     214                Total length:     219                                               
						having the sequence GAGPR corresponding to amino acids 39 -  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						43 of HUMCCKR_P3, and a third amino acid sequence being at   	    Total Percent Similarity:   97.72      Total Percent Identity:   97.72                                               
						AVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRV 	                        Gaps:       1                        
						VRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYC 	                                                            
						FMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG     	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 272 -  	                  .         .         .         .         .  
						447 of GASR_HUMAN, which also corresponds to amino acids 44 -	       1 MAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGGAGPRAVHQNGR 50                                                           
						219 of HUMCCKR_P3, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||     |||||||  
						second amino acid sequence and third amino acid sequence are 	     234 MAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPG.....AVHQNGR 278                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of HUMCCKR_P3,      	      51 CRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAK 100                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     279 CRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAK 328                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     101 KRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLL 150                                                          
						GAGPR, corresponding to HUMCCKR_P3.                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     329 KRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLL 378                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     379 SYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTP 428                                                          
						                                                            	                  .                                          
						                                                            	     201 SIASLSRLSYTTISTLGPG                                219                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     429 SIASLSRLSYTTISTLGPG                                447                                                          

3150	HMR136_HUMCCND3A_11_tr0_r1_1_gPRT		Comparison report between HUMCCND3A_P11 and                  	Sequence name: CGD3_HUMAN                                    
						CGD3_HUMANpartial WT sequence followed by a unique tail.1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCCND3A_P11,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MELLCCEGTRHAPRAGPDPRLLGDQRVLQSLLRLEERYVPRASYFQCVQREIKPHMRKML 	Alignment of: 3150 x CGD3_HUMAN   ..                         
						AYWMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQLLGAVCMLLASKLRETTPLT 	                                                            
						IEKLCIYTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAHDFLAFILHRLSLPRDRQALVKK 	Alignment segment 1/1:                                       
						HAQTFLALCATD                                                 	                                                            
						homologous to corresponding to amino acids 1 - 192 of        	                     Quality: 1906.00                      Escore:       0                                               
						CGD3_HUMAN, which also corresponds to amino acids 1 - 192 of 	             Matching length:     194                Total length:     194                                               
						HUMCCND3A_P11, and a second amino acid sequence being at     	 Matching Percent Similarity:   99.48   Matching Percent Identity:   99.48                                               
						least 70%, optionally at least 80%, preferably at least 85%, 	    Total Percent Similarity:   99.48      Total Percent Identity:   99.48                                               
						more preferably at least 90% and most preferably at least 95%	                        Gaps:       0                        
						homologous to a polypeptide having the sequence VTAIHL       	                                                            
						corresponding to amino acids 193 - 198 of HUMCCND3A_P11,     	Alignment:                                                   
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	       1 MELLCCEGTRHAPRAGPDPRLLGDQRVLQSLLRLEERYVPRASYFQCVQR 50                                                           
						isolated polypeptide encoding for a tail of HUMCCND3A_P11,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	       1 MELLCCEGTRHAPRAGPDPRLLGDQRVLQSLLRLEERYVPRASYFQCVQR 50                                                           
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	      51 EIKPHMRKMLAYWMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQ 100                                                          
						about 95% homologous to the sequence VTAIHL in HUMCCND3A_P11.	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EIKPHMRKMLAYWMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQ 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LLGAVCMLLASKLRETTPLTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LLGAVCMLLASKLRETTPLTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKW 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 DLAAVIAHDFLAFILHRLSLPRDRQALVKKHAQTFLALCATDVT       194                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||| |        
						                                                            	     151 DLAAVIAHDFLAFILHRLSLPRDRQALVKKHAQTFLALCATDYT       194                                                          

3148	HMR136_HUMCCND3A_5_tr0_r1_1_gPRT		Comparison report between HUMCCND3A_P5 and                   	Sequence name: CGD3_HUMAN_V1                                 
						CGD3_HUMAN_V1unique head followed by partial WT sequence1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCCND3A_P5,     	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 3148 x CGD3_HUMAN_V1   ..                      
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MKSAGGSGRSLLPSPRVCAVVAVMG corresponding to amino acids 1 - 25	                                                            
						of HUMCCND3A_P5, and a second amino acid sequence being at   	                     Quality: 2184.00                      Escore:       0                                               
						VCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQLLGAVCMLLASKLRETTPLTIEKLCI 	             Matching length:     226                Total length:     226                                               
						YTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAHDFLAFILHRLSLPRDRQALVKKHAQTFL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALCATDYTFAMYPPSMIATGSIGAAVQGLGACSMSGDELTELLAGITGTEVDCLRACQEQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						IEAALRESLREAAQTSSSPAPKAPRGSSSQGPSQTSTPTDVTAIHL               	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 67 -   	                                                            
						292 of CGD3_HUMAN_V1, which also corresponds to amino acids  	Alignment:                                                   
						26 - 251 of HUMCCND3A_P5, wherein said first amino acid      	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	      26 VCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQLLGAVCMLLASKLRET 75                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of HUMCCND3A_P5, comprising a polypeptide being at least	      67 VCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQLLGAVCMLLASKLRET 116                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      76 TPLTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAHDFLAFILH 125                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKSAGGSGRSLLPSPRVCAVVAVMG of HUMCCND3A_P5.                   	     117 TPLTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAHDFLAFILH 166                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     126 RLSLPRDRQALVKKHAQTFLALCATDYTFAMYPPSMIATGSIGAAVQGLG 175                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     167 RLSLPRDRQALVKKHAQTFLALCATDYTFAMYPPSMIATGSIGAAVQGLG 216                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     176 ACSMSGDELTELLAGITGTEVDCLRACQEQIEAALRESLREAAQTSSSPA 225                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     217 ACSMSGDELTELLAGITGTEVDCLRACQEQIEAALRESLREAAQTSSSPA 266                                                          
						                                                            	                  .         .                                
						                                                            	     226 PKAPRGSSSQGPSQTSTPTDVTAIHL                         251                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     267 PKAPRGSSSQGPSQTSTPTDVTAIHL                         292                                                          

26942	HMR136_HUMCD63_8_tr0_r1_1_gPRT		Comparison report between HUMCD63_P8 and                     	Sequence name: CD63_HUMAN_V1                                 
						CD63_HUMAN_V1partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMCD63_P8, comprising a   	                                                            
						MITFAIFLSLIMLVEVAAAIAGYVFRDKVMSEFNNNFRQQMENYPKNNHTASILDRMQAD 	Alignment of: 26942 x CD63_HUMAN_V1   ..                     
						FKCCGAANYTDWEKIPSMSKNRVPDSCCINVTVGCGINFNEKAIHKEGCVEKIGGWLRKN 	                                                            
						VLVVAAAALGIAFVEVLGIVFACCLVKSIRSGYEVM                         	Alignment segment 1/1:                                       
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 83 - 238 of CD63_HUMAN_V1, which	                     Quality: 1534.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 156 of HUMCD63_P8.       	             Matching length:     156                Total length:     156                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MITFAIFLSLIMLVEVAAAIAGYVFRDKVMSEFNNNFRQQMENYPKNNHT 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      83 MITFAIFLSLIMLVEVAAAIAGYVFRDKVMSEFNNNFRQQMENYPKNNHT 132                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ASILDRMQADFKCCGAANYTDWEKIPSMSKNRVPDSCCINVTVGCGINFN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     133 ASILDRMQADFKCCGAANYTDWEKIPSMSKNRVPDSCCINVTVGCGINFN 182                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EKAIHKEGCVEKIGGWLRKNVLVVAAAALGIAFVEVLGIVFACCLVKSIR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     183 EKAIHKEGCVEKIGGWLRKNVLVVAAAALGIAFVEVLGIVFACCLVKSIR 232                                                          
						                                                            	                                                             
						                                                            	     151 SGYEVM                                             156                                                          
						                                                            	         ||||||                                              
						                                                            	     233 SGYEVM                                             238                                                          

27476	HMR136_HUMCDC34H_7_tr0_r1_1_gPRT		Comparison report between HUMCDC34H_P7 and UBC3_HUMANpartial 	Sequence name: UBC3_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMCDC34H_P7, comprising a first    	Sequence documentation:                                      
						MARPLVPSSQKALLLELKGLQEEPVEGFRVTLVDEGDLYNWEVAIFGPPNTYYEGGYFKA 	                                                            
						RLKFPIDYPYSPPAFRFLTKMWHPNIYETGDVCISILHPPVDDPQSGELPSERWNPTQNV 	Alignment of: 27476 x UBC3_HUMAN   ..                        
						RTILLSVISLLNEPNTFSPAN                                        	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 141 of UBC3_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 141 of HUMCDC34H_P7, and 	                     Quality: 1929.00                      Escore:       0                                               
						a second amino acid sequence being at least 90 % homologous  	             Matching length:     204                Total length:     236                                               
						VDAERDGVKVPTTLAEYCVKTKAPAPDEGSDLFYDDYYEDGEVEEEADSCFGDDEDDSGT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EES                                                          	    Total Percent Similarity:   86.44      Total Percent Identity:   86.44                                               
						to corresponding to amino acids 174 - 236 of UBC3_HUMAN,     	                        Gaps:       1                        
						which also corresponds to amino acids 142 - 204 of           	                                                            
						HUMCDC34H_P7, wherein said first amino acid sequence and     	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated chimeric polypeptide encoding for an edge	       1 MARPLVPSSQKALLLELKGLQEEPVEGFRVTLVDEGDLYNWEVAIFGPPN 50                                                           
						portion of HUMCDC34H_P7, comprising a polypeptide having a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	       1 MARPLVPSSQKALLLELKGLQEEPVEGFRVTLVDEGDLYNWEVAIFGPPN 50                                                           
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      51 TYYEGGYFKARLKFPIDYPYSPPAFRFLTKMWHPNIYETGDVCISILHPP 100                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	      51 TYYEGGYFKARLKFPIDYPYSPPAFRFLTKMWHPNIYETGDVCISILHPP 100                                                          
						at least two amino acids comprise NV, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     101 VDDPQSGELPSERWNPTQNVRTILLSVISLLNEPNTFSPAN......... 141                                                          
						141-x to 142; and ending at any of amino acid numbers 142+   	         |||||||||||||||||||||||||||||||||||||||||           
						((n-2) - x), in which x varies from 0 to n-2.                	     101 VDDPQSGELPSERWNPTQNVRTILLSVISLLNEPNTFSPANVDASVMYRK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     142 .......................VDAERDGVKVPTTLAEYCVKTKAPAPD 168                                                          
						                                                            	                                |||||||||||||||||||||||||||  
						                                                            	     151 WKESKGKDREYTDIIRKQVLGTKVDAERDGVKVPTTLAEYCVKTKAPAPD 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     169 EGSDLFYDDYYEDGEVEEEADSCFGDDEDDSGTEES               204                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     201 EGSDLFYDDYYEDGEVEEEADSCFGDDEDDSGTEES               236                                                          

27912	HMR136_HUMCDCTRK_12_tr0_r1_1_gPRT		Comparison report between HUMCDCTRK_P12 and CDK9_HUMANunique 	Sequence name: CDK9_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCDCTRK_P12, comprising a first amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 27912 x CDK9_HUMAN   ..                        
						85%, more preferably at least 90% and most preferably at     	                                                            
						MQRDAPPRAPAPAPRLPAPPIGAAASSGGGGGGGSGGGGGGASAAPAPPGLSGTTSPRGP 	Alignment segment 1/1:                                       
						GGGRRAEEAGSAPRGRKWPWRRKWRGRGGAWSAAAAGPGAGAAAAATGGGGGALEAA    	                                                            
						least 95% homologous to a polypeptide having the sequence    	                     Quality: 1970.00                      Escore:       0                                               
						corresponding to amino acids 1 - 117 of HUMCDCTRK_P12, a     	             Matching length:     208                Total length:     208                                               
						MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 	 Matching Percent Similarity:   98.08   Matching Percent Identity:   97.60                                               
						ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 	    Total Percent Similarity:   98.08      Total Percent Identity:   97.60                                               
						FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 	                        Gaps:       0                        
						QPNRYTNRVVTLWYRPPELLLG                                       	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						corresponding to amino acids 1 - 202 of CDK9_HUMAN, which    	                  .         .         .         .         .  
						also corresponds to amino acids 118 - 319 of HUMCDCTRK_P12,  	     118 MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV 167                                                          
						and a third amino acid sequence being at least 70%,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	       1 MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     168 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 217                                                          
						QHGAAPTRPHQSALRLHHP corresponding to amino acids 320 - 338 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCDCTRK_P12, wherein said first amino acid sequence, second	      51 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     218 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 267                                                          
						polypeptide encoding for a head of HUMCDCTRK_P12, comprising 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a polypeptide being at least 70%, optionally at least about  	     101 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     268 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 317                                                          
						MQRDAPPRAPAPAPRLPAPPIGAAASSGGGGGGGSGGGGGGASAAPAPPGLSGTTSPRGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGGRRAEEAGSAPRGRKWPWRRKWRGRGGAWSAAAAGPGAGAAAAATGGGGGALEAA    	     151 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200                                                          
						to the sequence of HUMCDCTRK_P12.3.An isolated polypeptide   	                                                             
						encoding for a tail of HUMCDCTRK_P12, comprising a           	     318 LGQHGAAP                                           325                                                          
						polypeptide being at least 70%, optionally at least about    	         ||:    |                                            
						80%, preferably at least about 85%, more preferably at least 	     201 LGERDYGP                                           208                                                          
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence QHGAAPTRPHQSALRLHHP in HUMCDCTRK_P12.        	                                                            

27910	HMR136_HUMCDCTRK_14_tr0_r1_1_gPRT		Comparison report between HUMCDCTRK_P14 and CDK9_HUMANunique 	Sequence name: CDK9_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCDCTRK_P14, comprising a first amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 27910 x CDK9_HUMAN   ..                        
						85%, more preferably at least 90% and most preferably at     	                                                            
						MQRDAPPRAPAPAPRLPAPPIGAAASSGGGGGGGSGGGGGGASAAPAPPGLSGTTSPRGP 	Alignment segment 1/1:                                       
						GGGRRAEEAGSAPRGRKWPWRRKWRGRGGAWSAAAAGPGAGAAAAATGGGGGALEAA    	                                                            
						least 95% homologous to a polypeptide having the sequence    	                     Quality: 2512.00                      Escore:       0                                               
						corresponding to amino acids 1 - 117 of HUMCDCTRK_P14, a     	             Matching length:     265                Total length:     372                                               
						MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 	    Total Percent Similarity:   71.24      Total Percent Identity:   71.24                                               
						FTLSEIKRVMQMLLNGLYYIHRNK                                     	                        Gaps:       1                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 1 - 144 of CDK9_HUMAN, which    	Alignment:                                                   
						also corresponds to amino acids 118 - 261 of HUMCDCTRK_P14,  	                  .         .         .         .         .  
						and a third amino acid sequence being at least 90 %          	     118 MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV 167                                                          
						VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERV 	       1 MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV 50                                                           
						F                                                            	                  .         .         .         .         .  
						homologous to corresponding to amino acids 252 - 372 of      	     168 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 217                                                          
						CDK9_HUMAN, which also corresponds to amino acids 262 - 382  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of HUMCDCTRK_P14, wherein said first amino acid sequence,    	      51 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100                                                          
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     218 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK...... 261                                                          
						polypeptide encoding for a head of HUMCDCTRK_P14, comprising 	         ||||||||||||||||||||||||||||||||||||||||||||        
						a polypeptide being at least 70%, optionally at least about  	     101 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     261 .................................................. 261                                                          
						MQRDAPPRAPAPAPRLPAPPIGAAASSGGGGGGGSGGGGGGASAAPAPPGLSGTTSPRGP 	                                                            
						GGGRRAEEAGSAPRGRKWPWRRKWRGRGGAWSAAAAGPGAGAAAAATGGGGGALEAA    	     151 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200                                                          
						to the sequence of HUMCDCTRK_P14.3.An isolated chimeric      	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of HUMCDCTRK_P14,   	     261 .................................................. 261                                                          
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	     201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQANTEQHQLALISQLCGSITP 250                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     262 .VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 310                                                          
						amino acids in length and most preferably at least about 50  	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300                                                          
						comprise KV, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 261-x to 262; and    	     311 AQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQIT 360                                                          
						ending at any of amino acid numbers 262+ ((n-2) - x), in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which x varies from 0 to n-2.                                	     301 AQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQIT 350                                                          
						                                                            	                  .         .                                
						                                                            	     361 QQSTNQSRNPATTNQTEFERVF                             382                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     351 QQSTNQSRNPATTNQTEFERVF                             372                                                          

3834	HMR136_HUMCDPK_18_tr0_r1_1_gPRT		Comparison report between HUMCDPK_P18 and CDK4_HUMANpartial  	Sequence name: CDK4_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCDPK_P18, comprising a first     	Sequence documentation:                                      
						MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 	                                                            
						RRLEAFEHPNVVRL                                               	Alignment of: 3834 x CDK4_HUMAN   ..                         
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 74 of CDK4_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 74 of HUMCDPK_P18, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  706.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      75                Total length:      75                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:   98.67                                               
						polypeptide having the sequence                              	    Total Percent Similarity:  100.00      Total Percent Identity:   98.67                                               
						LHSGTELPKFFCSPHMQHLWTCGVLAVSLQRCFVESLSSVETLKPTSWAKSLT        	                        Gaps:       0                        
						corresponding to amino acids 75 - 127 of HUMCDPK_P18, wherein	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of HUMCDPK_P18, comprising a 	       1 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .                                
						to the sequence                                              	      51 ISTVREVALLRRLEAFEHPNVVRLL                          75                                                           
						LHSGTELPKFFCSPHMQHLWTCGVLAVSLQRCFVESLSSVETLKPTSWAKSLT in     	         ||||||||||||||||||||||||:                           
						HUMCDPK_P18.                                                 	      51 ISTVREVALLRRLEAFEHPNVVRLM                          75                                                           

8052	HMR136_HUMCFIX_3_tr0_r1_1_gPRT		Comparison report between HUMCFIX_P3 and FA9_HUMAN_V2unique  	Sequence name: FA9_HUMAN_V2                                  
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCFIX_P3, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 8052 x FA9_HUMAN_V2   ..                       
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence HFHNLLAKV    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 9 of HUMCFIX_P3, a second   	                                                            
						MQRVNMIMAESPGLITICLLGYLLSAECTVFLDHENANKILNRPKRYNSGKLEEFVQGNL 	                     Quality: 4098.00                      Escore:       0                                               
						ERECMEEKCSFEEAREVFENTERTTEFWKQYV                             	             Matching length:     423                Total length:     461                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 92 of FA9_HUMAN_V2, which   	    Total Percent Similarity:   91.76      Total Percent Identity:   91.76                                               
						also corresponds to amino acids 10 - 101 of HUMCFIX_P3, and a	                        Gaps:       1                        
						DVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLT 	                                                            
						RAETVFPDVDYVNSTEAETILDNITQSTQSFNDFTRVVGGEDAKPGQFPWQVVLNGKVDA 	Alignment:                                                   
						FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAIN 	                  .         .         .         .         .  
						KYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQ 	      10 MQRVNMIMAESPGLITICLLGYLLSAECTVFLDHENANKILNRPKRYNSG 59                                                           
						YLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIIS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WGEECAMKGKYGIYTKVSRYVNWIKEKTKLT                              	       1 MQRVNMIMAESPGLITICLLGYLLSAECTVFLDHENANKILNRPKRYNSG 50                                                           
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 131 - 461 of FA9_HUMAN_V2, which	      60 KLEEFVQGNLERECMEEKCSFEEAREVFENTERTTEFWKQYV........ 101                                                          
						also corresponds to amino acids 102 - 432 of HUMCFIX_P3,     	         ||||||||||||||||||||||||||||||||||||||||||          
						wherein said first amino acid sequence, second amino acid    	      51 KLEEFVQGNLERECMEEKCSFEEAREVFENTERTTEFWKQYVDGDQCESN 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     102 ..............................DVTCNIKNGRCEQFCKNSAD 121                                                          
						head of HUMCFIX_P3, comprising a polypeptide being at least  	                                       ||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 PCLNGGSCKDDINSYECWCPFGFEGKNCELDVTCNIKNGRCEQFCKNSAD 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence HFHNLLAKV of   	     122 NKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTRAETVFPDVD 171                                                          
						HUMCFIX_P3.3.An isolated chimeric polypeptide encoding for an	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of HUMCFIX_P3, comprising a polypeptide having a	     151 NKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTRAETVFPDVD 200                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     172 YVNSTEAETILDNITQSTQSFNDFTRVVGGEDAKPGQFPWQVVLNGKVDA 221                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     201 YVNSTEAETILDNITQSTQSFNDFTRVVGGEDAKPGQFPWQVVLNGKVDA 250                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise VD, having a structure as  	     222 FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRII 271                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						101-x to 102; and ending at any of amino acid numbers 102+   	     251 FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRII 300                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     272 PHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGS 321                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     322 GYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFH 371                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 GYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFH 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     372 EGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRY 421                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRY 450                                                          
						                                                            	                  .                                          
						                                                            	     422 VNWIKEKTKLT                                        432                                                          
						                                                            	         |||||||||||                                         
						                                                            	     451 VNWIKEKTKLT                                        461                                                          

4526	HMR136_HUMCG1PA1_12_tr0_r1_1_gPRT		Comparison report between HUMCG1PA1_P12 and                  	Sequence name: CA11_HUMAN_V5                                 
						CA11_HUMAN_V5partial WT sequence featuring skipped exon and a	                                                            
						mismatch.1.An isolated chimeric polypeptide encoding for     	Sequence documentation:                                      
						HUMCG1PA1_P12, comprising a first amino acid sequence being  	                                                            
						MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDRDVWKPEPCRI 	Alignment of: 4526 x CA11_HUMAN_V5   ..                      
						CVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSESPTDQETTGVEGPKGDTGPR 	                                                            
						GPRGPAGPPGRDGIPGQPGLPGPPGPPGPPGPPGLGGNFAPQLSYGYDEKSTGGISVPGP 	Alignment segment 1/1:                                       
						MGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGR 	                                                            
						PGERGPPGPQGARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 	                     Quality: 14202.00                      Escore:       0                                              
						MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGP 	             Matching length:    1446                Total length:    1464                                               
						RGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.93                                               
						QGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPGPAGEEGKRGARGEPGPTGL 	    Total Percent Similarity:   98.77      Total Percent Identity:   98.70                                               
						PGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGL 	                        Gaps:       1                        
						TGSPGSPGPDGKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 	                                                            
						PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGE 	Alignment:                                                   
						QGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGS 	                  .         .         .         .         .  
						QGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGD 	       1 MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDR 50                                                           
						KGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGPAGPAGPPGPI                                                	       1 MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDR 50                                                           
						at least 90 % homologous to corresponding to amino acids 1 - 	                  .         .         .         .         .  
						853 of CA11_HUMAN_V5, which also corresponds to amino acids 1	      51 DVWKPEPCRICVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSE 100                                                          
						- 853 of HUMCG1PA1_P12, a second amino acid sequence being at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPA 	      51 DVWKPEPCRICVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSE 100                                                          
						GEKGSPGADGPAGAPGTPGPQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGAS 	                  .         .         .         .         .  
						GERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAP 	     101 SPTDQETTGVEGPKGDTGPRGPRGPAGPPGRDGIPGQPGLPGPPGPPGPP 150                                                          
						GAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGPIGPPGPRGRT 	     101 SPTDQETTGVEGPKGDTGPRGPRGPAGPPGRDGIPGQPGLPGPPGPPGPP 150                                                          
						GDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRADDANVVRDRDLEV 	                  .         .         .         .         .  
						DTTLKSLSQQIENIRSPEGSRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFC 	     151 GPPGLGGNFAPQLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQG 200                                                          
						NMETGETCVYPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAIQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLKKALLL                      	     151 GPPGLGGNFAPQLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQG 200                                                          
						least 90 % homologous to corresponding to amino acids 872 -  	                  .         .         .         .         .  
						1390 of CA11_HUMAN_V5, which also corresponds to amino acids 	     201 FQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQ 250                                                          
						854 - 1372 of HUMCG1PA1_P12, a bridging amino acid Q         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 1373 of HUMCG1PA1_P12, and a     	     201 FQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQ 250                                                          
						GSNEIEIRAEGNSRFTYSVTVDGCTSHTGAWGKTVIEYKTTKTSRLPIIDVAPLDVGAPD 	                  .         .         .         .         .  
						QEFGFDVGPVCFL                                                	     251 GARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 300                                                          
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1392 - 1464 of CA11_HUMAN_V5,   	     251 GARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 300                                                          
						which also corresponds to amino acids 1374 - 1446 of         	                  .         .         .         .         .  
						HUMCG1PA1_P12, wherein said first amino acid sequence, second	     301 MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVG 350                                                          
						amino acid sequence, bridging amino acid and third amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     301 MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVG 350                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMCG1PA1_P12, comprising a polypeptide having a length "n", 	     351 AKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGAN 400                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     351 AKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGAN 400                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     401 GAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGE 450                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise IG, having a structure as  	     401 GAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGE 450                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						853-x to 854; and ending at any of amino acid numbers 854+   	     451 PGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADG 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 PGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPD 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPD 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 PPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGAN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 PPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGAN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGP 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGP 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 KGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPG 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 KGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPG 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPP 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 GPI..................GATGFPGAAGRVGPPGPSGNAGPPGPPGP 882                                                          
						                                                            	         |||                  |||||||||||||||||||||||||||||  
						                                                            	     851 GPIGNVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGP 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     883 AGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPG 932                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPG 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     933 PQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPM 982                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 PQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPM 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     983 GPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGA 1032                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 GPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1033 PGAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETG 1082                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 PGAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETG 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1083 EQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAP 1132                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 EQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAP 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1133 GKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSF 1182                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 GKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSF 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1183 LPQPPQEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPEG 1232                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 LPQPPQEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPEG 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1233 SRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMETGETCV 1282                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 SRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMETGETCV 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1283 YPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAI 1332                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 YPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAI 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1333 QLTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLKKALLLQGSNEIEIRA 1382                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||:|||||||||  
						                                                            	    1351 QLTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLKKALLLKGSNEIEIRA 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1383 EGNSRFTYSVTVDGCTSHTGAWGKTVIEYKTTKTSRLPIIDVAPLDVGAP 1432                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 EGNSRFTYSVTVDGCTSHTGAWGKTVIEYKTTKTSRLPIIDVAPLDVGAP 1450                                                         
						                                                            	                  .                                          
						                                                            	    1433 DQEFGFDVGPVCFL                                     1446                                                         
						                                                            	         ||||||||||||||                                      
						                                                            	    1451 DQEFGFDVGPVCFL                                     1464                                                         

4528	HMR136_HUMCG1PA1_13_tr0_r1_1_gPRT		Comparison report between HUMCG1PA1_P13 and                  	Sequence name: CA11_HUMAN_V5                                 
						CA11_HUMAN_V5partial WT sequence featuring skipped exon and a	                                                            
						mismatch.1.An isolated chimeric polypeptide encoding for     	Sequence documentation:                                      
						HUMCG1PA1_P13, comprising a first amino acid sequence being  	                                                            
						MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDRDVWKPEPCRI 	Alignment of: 4528 x CA11_HUMAN_V5   ..                      
						CVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSESPTDQETTGVEGPKGDTGPR 	                                                            
						GPRGPAGPPGRDGIPGQPGLPGPPGPPGPPGPPGLGGNFAPQLSYGYDEKSTGGISVPGP 	Alignment segment 1/1:                                       
						MGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGR 	                                                            
						PGERGPPGPQGARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 	                     Quality: 13678.00                      Escore:       0                                              
						MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGP 	             Matching length:    1392                Total length:    1464                                               
						RGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.93                                               
						QGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPGPAGEEGKRGARGEPGPTGL 	    Total Percent Similarity:   95.08      Total Percent Identity:   95.01                                               
						PGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGL 	                        Gaps:       1                        
						TGSPGSPGPDGKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 	                                                            
						PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGE 	Alignment:                                                   
						QGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGS 	                  .         .         .         .         .  
						QGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGD 	       1 MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDR 50                                                           
						KGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPP                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 1 - 	       1 MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDR 50                                                           
						817 of CA11_HUMAN_V5, which also corresponds to amino acids 1	                  .         .         .         .         .  
						- 817 of HUMCG1PA1_P13, a second amino acid sequence being at	      51 DVWKPEPCRICVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSE 100                                                          
						GNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GPQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPP 	      51 DVWKPEPCRICVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSE 100                                                          
						GESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAGKSGDRGET 	                  .         .         .         .         .  
						GPAGPTGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQ 	     101 SPTDQETTGVEGPKGDTGPRGPRGPAGPPGRDGIPGQPGLPGPPGPPGPP 150                                                          
						GPSGASGPAGPRGPPGSAGAPGKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GPPSAGFDFSFLPQPPQEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPE 	     101 SPTDQETTGVEGPKGDTGPRGPRGPAGPPGRDGIPGQPGLPGPPGPPGPP 150                                                          
						GSRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMETGETCVYPTQPSVAQ 	                  .         .         .         .         .  
						KNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAIQLTFLRLMSTEASQNITYH 	     151 GPPGLGGNFAPQLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQG 200                                                          
						CKNSVAYMDQQTGNLKKALLL                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 890 -  	     151 GPPGLGGNFAPQLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQG 200                                                          
						1390 of CA11_HUMAN_V5, which also corresponds to amino acids 	                  .         .         .         .         .  
						818 - 1318 of HUMCG1PA1_P13, a bridging amino acid Q         	     201 FQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQ 250                                                          
						corresponding to amino acid 1319 of HUMCG1PA1_P13, and a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSNEIEIRAEGNSRFTYSVTVDGCTSHTGAWGKTVIEYKTTKTSRLPIIDVAPLDVGAPD 	     201 FQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQ 250                                                          
						QEFGFDVGPVCFL                                                	                  .         .         .         .         .  
						third amino acid sequence being at least 90 % homologous to  	     251 GARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 300                                                          
						corresponding to amino acids 1392 - 1464 of CA11_HUMAN_V5,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 1320 - 1392 of         	     251 GARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 300                                                          
						HUMCG1PA1_P13, wherein said first amino acid sequence, second	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid and third amino acid	     301 MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVG 350                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     301 MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVG 350                                                          
						HUMCG1PA1_P13, comprising a polypeptide having a length "n", 	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     351 AKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGAN 400                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     351 AKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGAN 400                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     401 GAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGE 450                                                          
						at least two amino acids comprise PG, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     401 GAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGE 450                                                          
						817-x to 818; and ending at any of amino acid numbers 818+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     451 PGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 PGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPD 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPD 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 PPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGAN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 PPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGAN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGP 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGP 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 KGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPG 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 KGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPG 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DRGEPGPPGPAGFAGPP................................. 817                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     801 DRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     818 .......................................GNAGPPGPPGP 828                                                          
						                                                            	                                                |||||||||||  
						                                                            	     851 GPIGNVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGP 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     829 AGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPG 878                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPG 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     879 PQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPM 928                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 PQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPM 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     929 GPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGA 978                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 GPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     979 PGAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETG 1028                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 PGAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETG 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1029 EQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAP 1078                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 EQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAP 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1079 GKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSF 1128                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 GKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSF 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1129 LPQPPQEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPEG 1178                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 LPQPPQEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPEG 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1179 SRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMETGETCV 1228                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 SRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMETGETCV 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1229 YPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAI 1278                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 YPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAI 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1279 QLTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLKKALLLQGSNEIEIRA 1328                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||:|||||||||  
						                                                            	    1351 QLTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLKKALLLKGSNEIEIRA 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1329 EGNSRFTYSVTVDGCTSHTGAWGKTVIEYKTTKTSRLPIIDVAPLDVGAP 1378                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 EGNSRFTYSVTVDGCTSHTGAWGKTVIEYKTTKTSRLPIIDVAPLDVGAP 1450                                                         
						                                                            	                  .                                          
						                                                            	    1379 DQEFGFDVGPVCFL                                     1392                                                         
						                                                            	         ||||||||||||||                                      
						                                                            	    1451 DQEFGFDVGPVCFL                                     1464                                                         

4530	HMR136_HUMCG1PA1_44_tr0_r1_1_gPRT		Comparison report between HUMCG1PA1_P44 and                  	Sequence name: CA11_HUMAN                                    
						CA11_HUMANpartial WT sequence followed by a unique tail.1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCG1PA1_P44,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDRDVWKPEPCRI 	Alignment of: 4530 x CA11_HUMAN   ..                         
						CVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSESPTDQETTGVEGPKGDTGPR 	                                                            
						GPRGPAGPPGRDGIPGQPGLPGPPGPPGPPGPPGLGGNFAPQLSYGYDEKSTGGISVPGP 	Alignment segment 1/1:                                       
						MGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGR 	                                                            
						PGERGPPGPQGARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 	                     Quality: 7372.00                      Escore:       0                                               
						MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGP 	             Matching length:     745                Total length:     745                                               
						RGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPGPAGEEGKRGARGEPGPTGL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGL 	                        Gaps:       0                        
						TGSPGSPGPDGKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 	                                                            
						PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGE 	Alignment:                                                   
						QGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGS 	                  .         .         .         .         .  
						QGAPGLQGMPGERGAAGLPGPKGDR                                    	       1 MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDR 50                                                           
						homologous to corresponding to amino acids 1 - 745 of        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CA11_HUMAN, which also corresponds to amino acids 1 - 745 of 	       1 MFSFVDLRLLLLLAATALLTHGQEEGQVEGQDEDIPPITCVQNGLRYHDR 50                                                           
						HUMCG1PA1_P44, and a second amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	      51 DVWKPEPCRICVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSE 100                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence VSSTFPLP     	      51 DVWKPEPCRICVCDNGKVLCDDVICDETKNCPGAEVPEGECCPVCPDGSE 100                                                          
						corresponding to amino acids 746 - 753 of HUMCG1PA1_P44,     	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	     101 SPTDQETTGVEGPKGDTGPRGPRGPAGPPGRDGIPGQPGLPGPPGPPGPP 150                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of HUMCG1PA1_P44,   	     101 SPTDQETTGVEGPKGDTGPRGPRGPAGPPGRDGIPGQPGLPGPPGPPGPP 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     151 GPPGLGGNFAPQLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQG 200                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence VSSTFPLP in             	     151 GPPGLGGNFAPQLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQG 200                                                          
						HUMCG1PA1_P44.                                               	                  .         .         .         .         .  
						                                                            	     201 FQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 MGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 AKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGAN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGAN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 PGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 PGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPD 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPD 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 PPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGAN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 PPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGAN 700                                                          
						                                                            	                  .         .         .         .            
						                                                            	     701 GAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDR      745                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     701 GAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDR      745                                                          

8938	HMR136_HUMCH13C2B_9_tr0_r1_1_gPRT		Comparison report between HUMCH13C2B_P9 and                  	Sequence name: GCP3_HUMAN                                    
						GCP3_HUMANpartial WT sequence (truncation of last part or    	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMCH13C2B_P9, comprising a	                                                            
						MSHYLRVFNFLWRAKRMEYILTDIRKGHMCNAKLLRNMPEFSGVLHQCHILASEMVHFIH 	Alignment of: 8938 x GCP3_HUMAN   ..                         
						QMQYYITFEVLECSWDELWNKVQQAQDLDHIIAAHEVFLDTIISRCLLDSDSRALLNQLR 	                                                            
						AVFDQIIELQNAQDAIYRAALEELQRRLQFEEKKKQREIEGQWGVTAAEEEEENKRIGEF 	Alignment segment 1/1:                                       
						KESIPKMCSQLRILTHFYQGIVQQFLVLLTTSSDESLRFLSFRLDFNEHYKAREPRLRVS 	                                                            
						LGTRGRRSSHT                                                  	                     Quality: 2486.00                      Escore:       0                                               
						first amino acid sequence being at least 90 % homologous to  	             Matching length:     251                Total length:     251                                               
						corresponding to amino acids 657 - 907 of GCP3_HUMAN, which  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 251 of HUMCH13C2B_P9.    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSHYLRVFNFLWRAKRMEYILTDIRKGHMCNAKLLRNMPEFSGVLHQCHI 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     657 MSHYLRVFNFLWRAKRMEYILTDIRKGHMCNAKLLRNMPEFSGVLHQCHI 706                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LASEMVHFIHQMQYYITFEVLECSWDELWNKVQQAQDLDHIIAAHEVFLD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     707 LASEMVHFIHQMQYYITFEVLECSWDELWNKVQQAQDLDHIIAAHEVFLD 756                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TIISRCLLDSDSRALLNQLRAVFDQIIELQNAQDAIYRAALEELQRRLQF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     757 TIISRCLLDSDSRALLNQLRAVFDQIIELQNAQDAIYRAALEELQRRLQF 806                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EEKKKQREIEGQWGVTAAEEEEENKRIGEFKESIPKMCSQLRILTHFYQG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     807 EEKKKQREIEGQWGVTAAEEEEENKRIGEFKESIPKMCSQLRILTHFYQG 856                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 IVQQFLVLLTTSSDESLRFLSFRLDFNEHYKAREPRLRVSLGTRGRRSSH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     857 IVQQFLVLLTTSSDESLRFLSFRLDFNEHYKAREPRLRVSLGTRGRRSSH 906                                                          
						                                                            	                                                             
						                                                            	     251 T                                                  251                                                          
						                                                            	         |                                                   
						                                                            	     907 T                                                  907                                                          

9575	HMR136_HUMCHITO_9_tr0_r1_1_gPRT		Comparison report between HUMCHITO_P9 and DIAC_HUMANpartial  	Sequence name: DIAC_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMCHITO_P9, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MSRPQLRRWRLVSSPPSGVPG corresponding to amino acids 1 - 21 of 	Alignment of: 9575 x DIAC_HUMAN   ..                         
						DIAC_HUMAN, which also corresponds to amino acids 1 - 21 of  	                                                            
						HUMCHITO_P9, a second amino acid sequence being at least 90 %	Alignment segment 1/1:                                       
						LALLALLALRLAAGTDCPCPEPELCRPIRHHPDFEVFVFDVGQKTWKSYDWSQITTVATF 	                                                            
						GKYDSELMCYAHSKGARVVLKGDVSLKDIIDPAFRASWIAQKLNLAKTQYMDGINIDIEQ 	                     Quality: 3097.00                      Escore:       0                                               
						EVNCLSPEYDALTALVKETTDSFHREIEGSQVTFDVAWSPKNIDRRCYNYTGIADACDFL 	             Matching length:     328                Total length:     385                                               
						FVMSYDEQSQIWSECIAAANAPYNQTLTGYNDYIKMSINPKKLVMGVPWYGYDYTCLNLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						E                                                            	    Total Percent Similarity:   85.19      Total Percent Identity:   85.19                                               
						homologous to corresponding to amino acids 25 - 265 of       	                        Gaps:       2                        
						DIAC_HUMAN, which also corresponds to amino acids 22 - 262 of	                                                            
						HUMCHITO_P9, and a third amino acid sequence being at least  	Alignment:                                                   
						DPAGHFHQVWYDNPQSISLKATYIQNYRLRGIGMWNANCLDYSGDAVAKQQTEEMWEVLK 	                  .         .         .         .         .  
						PKLLQR                                                       	       1 MSRPQLRRWRLVSSPPSGVPG...LALLALLALRLAAGTDCPCPEPELCR 47                                                           
						90 % homologous to corresponding to amino acids 320 - 385 of 	         |||||||||||||||||||||   ||||||||||||||||||||||||||  
						DIAC_HUMAN, which also corresponds to amino acids 263 - 328  	       1 MSRPQLRRWRLVSSPPSGVPGLALLALLALLALRLAAGTDCPCPEPELCR 50                                                           
						of HUMCHITO_P9, wherein said first amino acid sequence,      	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	      48 PIRHHPDFEVFVFDVGQKTWKSYDWSQITTVATFGKYDSELMCYAHSKGA 97                                                           
						contiguous and in a sequential order.2.An isolated chimeric  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMCHITO_P9,     	      51 PIRHHPDFEVFVFDVGQKTWKSYDWSQITTVATFGKYDSELMCYAHSKGA 100                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	      98 RVVLKGDVSLKDIIDPAFRASWIAQKLNLAKTQYMDGINIDIEQEVNCLS 147                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     101 RVVLKGDVSLKDIIDPAFRASWIAQKLNLAKTQYMDGINIDIEQEVNCLS 150                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     148 PEYDALTALVKETTDSFHREIEGSQVTFDVAWSPKNIDRRCYNYTGIADA 197                                                          
						comprise GL, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 21-x to 22; and      	     151 PEYDALTALVKETTDSFHREIEGSQVTFDVAWSPKNIDRRCYNYTGIADA 200                                                          
						ending at any of amino acid numbers 22+ ((n-2) - x), in which	                  .         .         .         .         .  
						x varies from 0 to n-2.3.An isolated chimeric polypeptide    	     198 CDFLFVMSYDEQSQIWSECIAAANAPYNQTLTGYNDYIKMSINPKKLVMG 247                                                          
						encoding for an edge portion of HUMCHITO_P9, comprising a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	     201 CDFLFVMSYDEQSQIWSECIAAANAPYNQTLTGYNDYIKMSINPKKLVMG 250                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     248 VPWYGYDYTCLNLSE................................... 262                                                          
						length, more preferably at least about 40 amino acids in     	         |||||||||||||||                                     
						length and most preferably at least about 50 amino acids in  	     251 VPWYGYDYTCLNLSEDHVCTIAKVPFRGAPCSDAAGRQVPYKTIMKQINS 300                                                          
						length, wherein at least two amino acids comprise ED, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     263 ...................DPAGHFHQVWYDNPQSISLKATYIQNYRLRG 293                                                          
						acid numbers 262-x to 263; and ending at any of amino acid   	                            |||||||||||||||||||||||||||||||  
						numbers 263+ ((n-2) - x), in which x varies from 0 to n-2.   	     301 SISGNLWDKDQRAPYYNYKDPAGHFHQVWYDNPQSISLKATYIQNYRLRG 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     294 IGMWNANCLDYSGDAVAKQQTEEMWEVLKPKLLQR                328                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     351 IGMWNANCLDYSGDAVAKQQTEEMWEVLKPKLLQR                385                                                          

5132	HMR136_HUMCIS_5_tr0_r1_1_gPRT		Comparison report between HUMCIS_P5 and ELF1_HUMANpartial WT 	Sequence name: ELF1_HUMAN                                    
						sequence featuring skipped exon plus extra amino acids and a 	                                                            
						mismatch.1.An isolated chimeric polypeptide encoding for     	Sequence documentation:                                      
						HUMCIS_P5, comprising a first amino acid sequence being at   	                                                            
						MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAGLACVEEPNDM 	Alignment of: 5132 x ELF1_HUMAN   ..                         
						ITESSLDVAEEEIIDDDDDDITLT                                     	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 84 	Alignment segment 1/1:                                       
						of ELF1_HUMAN, which also corresponds to amino acids 1 - 84  	                                                            
						of HUMCIS_P5, a second amino acid sequence bridging amino    	                     Quality: 5535.00                      Escore:       0                                               
						acid sequence comprising of D, a third amino acid sequence   	             Matching length:     583                Total length:     619                                               
						NNIFSSPEDDMVVAPVTHVSVTLDGIPEVMETQQVQEKYADSPGASSPEQPKRKKGRKTK 	 Matching Percent Similarity:   99.83   Matching Percent Identity:   99.66                                               
						PPRPDSPATTPNISVKKKNKDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKGIFKLV 	    Total Percent Similarity:   94.02      Total Percent Identity:   93.86                                               
						DSKAVSRLWGKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDLIYIND 	                        Gaps:       1                        
						EDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNSKAAKPKDPVEV 	                                                            
						AQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEAARTSTMQDETLNSSVQSIRTI 	Alignment:                                                   
						QAPTQVPVVVSPRNQQLHTVTLQTVPLTTVIASTDPSAGTGSQKFILQAIPSSQPMTVLK 	                  .         .         .         .         .  
						ENVMLQSQKAGSPPSIVLGPAQVQQVLTSNVQTICNGTVSVASSPSFSATAP         	       1 MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAG 50                                                           
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 122 - 533 of ELF1_HUMAN, which also corresponds to     	       1 MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAG 50                                                           
						amino acids 86 - 497 of HUMCIS_P5, a bridging amino acid V   	                  .         .         .         .         .  
						corresponding to amino acid 498 of HUMCIS_P5, and a fourth   	      51 LACVEEPNDMITESSLDVAEEEIIDDDDDDITLT................ 84                                                           
						VTFSPRSSQLVAHPPGTVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVM 	         ||||||||||||||||||||||||||||||||||                  
						VVSSSNGFTSQVAMKQNELLEPNSF                                    	      51 LACVEEPNDMITESSLDVAEEEIIDDDDDDITLTVEASCHDGDETIETIE 100                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 535 - 619 of ELF1_HUMAN, which  	      85 ....................DNNIFSSPEDDMVVAPVTHVSVTLDGIPEV 114                                                          
						also corresponds to amino acids 499 - 583 of HUMCIS_P5,      	                             :|||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     101 AAEALLNMDSPGPMLDEKRINNNIFSSPEDDMVVAPVTHVSVTLDGIPEV 150                                                          
						sequence, third amino acid sequence, bridging amino acid and 	                  .         .         .         .         .  
						fourth amino acid sequence are contiguous and in a sequential	     115 METQQVQEKYADSPGASSPEQPKRKKGRKTKPPRPDSPATTPNISVKKKN 164                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of HUMCIS_P5, comprising a polypeptide having a length "n",  	     151 METQQVQEKYADSPGASSPEQPKRKKGRKTKPPRPDSPATTPNISVKKKN 200                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     165 KDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKGIFKLVDSKAVSRLW 214                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     201 KDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKGIFKLVDSKAVSRLW 250                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TDN having a structure as  	     215 GKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDLIYIN 264                                                          
						follows (numbering according to HUMCIS_P5): a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 84-x to 84; and      	     251 GKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDLIYIN 300                                                          
						ending at any of amino acid numbers 86 + ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     265 DEDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNS 314                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DEDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     315 KAAKPKDPVEVAQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEA 364                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KAAKPKDPVEVAQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     365 ARTSTMQDETLNSSVQSIRTIQAPTQVPVVVSPRNQQLHTVTLQTVPLTT 414                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ARTSTMQDETLNSSVQSIRTIQAPTQVPVVVSPRNQQLHTVTLQTVPLTT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     415 VIASTDPSAGTGSQKFILQAIPSSQPMTVLKENVMLQSQKAGSPPSIVLG 464                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 VIASTDPSAGTGSQKFILQAIPSSQPMTVLKENVMLQSQKAGSPPSIVLG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     465 PAQVQQVLTSNVQTICNGTVSVASSPSFSATAPVVTFSPRSSQLVAHPPG 514                                                          
						                                                            	         ||||||||||||||||||||||||||||||||| ||||||||||||||||  
						                                                            	     501 PAQVQQVLTSNVQTICNGTVSVASSPSFSATAPGVTFSPRSSQLVAHPPG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     515 TVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVMVVSSSN 564                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVMVVSSSN 600                                                          
						                                                            	                  .                                          
						                                                            	     565 GFTSQVAMKQNELLEPNSF                                583                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     601 GFTSQVAMKQNELLEPNSF                                619                                                          

5130	HMR136_HUMCIS_6_tr0_r1_1_gPRT		Comparison report between HUMCIS_P6 and ELF1_HUMANpartial WT 	Sequence name: ELF1_HUMAN                                    
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for HUMCIS_P6, comprising a    	Sequence documentation:                                      
						MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAGLACVEEPNDM 	                                                            
						ITESSLDVAEEEIIDDDDDDITLT                                     	Alignment of: 5130 x ELF1_HUMAN   ..                         
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 1 - 84 of ELF1_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 84 of HUMCIS_P6, a second     	                                                            
						GRKTKPPRPDSPATTPNISVKKKNKDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKG 	                     Quality: 4993.00                      Escore:       0                                               
						IFKLVDSKAVSRLWGKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDL 	             Matching length:     527                Total length:     619                                               
						IYINDEDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNSKAAKPK 	 Matching Percent Similarity:   99.81   Matching Percent Identity:   99.81                                               
						DPVEVAQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEAARTSTMQDETLNSSVQ 	    Total Percent Similarity:   84.98      Total Percent Identity:   84.98                                               
						SIRTIQAPTQVPVVVSPRNQQLHTVTLQTVPLTTVIASTDPSAGTGSQKFILQAIPSSQP 	                        Gaps:       1                        
						MTVLKENVMLQSQKAGSPPSIVLGPAQVQQVLTSNVQTICNGTVSVASSPSFSATAP    	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 177 - 533 of ELF1_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 85 - 441 of HUMCIS_P6, a     	       1 MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAG 50                                                           
						bridging amino acid V corresponding to amino acid 442 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCIS_P6, and a third amino acid sequence being at least 90 	       1 MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAG 50                                                           
						VTFSPRSSQLVAHPPGTVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVM 	                  .         .         .         .         .  
						VVSSSNGFTSQVAMKQNELLEPNSF                                    	      51 LACVEEPNDMITESSLDVAEEEIIDDDDDDITLT................ 84                                                           
						% homologous to corresponding to amino acids 535 - 619 of    	         ||||||||||||||||||||||||||||||||||                  
						ELF1_HUMAN, which also corresponds to amino acids 443 - 527  	      51 LACVEEPNDMITESSLDVAEEEIIDDDDDDITLTVEASCHDGDETIETIE 100                                                          
						of HUMCIS_P6, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid and third amino acid	      84 .................................................. 84                                                           
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	     101 AAEALLNMDSPGPMLDEKRINNNIFSSPEDDMVVAPVTHVSVTLDGIPEV 150                                                          
						HUMCIS_P6, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	      85 ..........................GRKTKPPRPDSPATTPNISVKKKN 108                                                          
						optionally at least about 20 amino acids in length,          	                                   ||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     151 METQQVQEKYADSPGASSPEQPKRKKGRKTKPPRPDSPATTPNISVKKKN 200                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     109 KDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKGIFKLVDSKAVSRLW 158                                                          
						at least two amino acids comprise TG, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     201 KDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKGIFKLVDSKAVSRLW 250                                                          
						84-x to 85; and ending at any of amino acid numbers 85+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     159 GKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDLIYIN 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDLIYIN 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 DEDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNS 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DEDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 KAAKPKDPVEVAQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEA 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KAAKPKDPVEVAQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 ARTSTMQDETLNSSVQSIRTIQAPTQVPVVVSPRNQQLHTVTLQTVPLTT 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ARTSTMQDETLNSSVQSIRTIQAPTQVPVVVSPRNQQLHTVTLQTVPLTT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 VIASTDPSAGTGSQKFILQAIPSSQPMTVLKENVMLQSQKAGSPPSIVLG 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 VIASTDPSAGTGSQKFILQAIPSSQPMTVLKENVMLQSQKAGSPPSIVLG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     409 PAQVQQVLTSNVQTICNGTVSVASSPSFSATAPVVTFSPRSSQLVAHPPG 458                                                          
						                                                            	         ||||||||||||||||||||||||||||||||| ||||||||||||||||  
						                                                            	     501 PAQVQQVLTSNVQTICNGTVSVASSPSFSATAPGVTFSPRSSQLVAHPPG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     459 TVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVMVVSSSN 508                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVMVVSSSN 600                                                          
						                                                            	                  .                                          
						                                                            	     509 GFTSQVAMKQNELLEPNSF                                527                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     601 GFTSQVAMKQNELLEPNSF                                619                                                          

10336	HMR136_HUMCLC_1_tr0_r1_1_gPRT		Comparison report between HUMCLC_P1 and CLC1_HUMANunique     	Sequence name: CLC1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMCLC_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10336 x CLC1_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MRPCLGSLTSWCRPVQWAWDAALQPLS corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 27 of HUMCLC_P1, and a second amino acid  	                                                            
						EQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFR 	                     Quality: 7111.00                      Escore:       0                                               
						VLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVR 	             Matching length:     731                Total length:     731                                               
						KHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHIL 	                        Gaps:       0                        
						PMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVS 	                                                            
						ASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEM 	Alignment:                                                   
						ARKLSELPYDGKARLAGEGPPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTA 	                  .         .         .         .         .  
						PLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNM 	      28 EQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFF 77                                                           
						SPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGAT 	     258 EQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFF 307                                                          
						GTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRS 	                  .         .         .         .         .  
						TDEEDEDELIL                                                  	      78 AATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGIC 127                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 258 - 988 of CLC1_HUMAN, which also corresponds  	     308 AATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGIC 357                                                          
						to amino acids 28 - 758 of HUMCLC_P1, wherein said first     	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	     128 CGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFP 177                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of HUMCLC_P1, comprising a   	     358 CGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFP 407                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     178 PGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVV 227                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MRPCLGSLTSWCRPVQWAWDAALQPLS of HUMCLC_P1.    	     408 PGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVV 457                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     228 IIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFP 277                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     458 IIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFP 507                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     278 DGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHIL 327                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     508 DGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHIL 557                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     328 PMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVED 377                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     558 PMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVED 607                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     378 IMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSEL 427                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     608 IMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSEL 657                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     428 QALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGPPGAPPGRPES 477                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     658 QALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGPPGAPPGRPES 707                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     478 FAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEA 527                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     708 FAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEA 757                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     528 PEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQ 577                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     758 PEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQ 807                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     578 EQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKL 627                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     808 EQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKL 857                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     628 RGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENW 677                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     858 RGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENW 907                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     678 NLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELV 727                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     908 NLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELV 957                                                          
						                                                            	                  .         .         .                      
						                                                            	     728 ESPGLEEELADILQGPSLRSTDEEDEDELIL                    758                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     958 ESPGLEEELADILQGPSLRSTDEEDEDELIL                    988                                                          

10338	HMR136_HUMCLC_2_tr0_r1_1_gPRT		Comparison report between HUMCLC_P2 and CLC1_HUMANpartial WT 	Sequence name: CLC1_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HUMCLC_P2, comprising a first amino acid        	                                                            
						MDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVT 	Alignment of: 10338 x CLC1_HUMAN   ..                        
						FVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVI 	                                                            
						IIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYK 	Alignment segment 1/1:                                       
						ILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLY 	                                                            
						DSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLP 	                     Quality: 6318.00                      Escore:       0                                               
						LVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGPP 	             Matching length:     650                Total length:     650                                               
						GAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						CCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGV 	                        Gaps:       0                        
						QLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEP 	                                                            
						PLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL           	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 339 - 988 of CLC1_HUMAN, which also corresponds  	       1 MDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAK 50                                                           
						to amino acids 1 - 650 of HUMCLC_P2.                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     339 MDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAK 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     389 HRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAG 438                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     439 DPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVF 488                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     489 VLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSH 538                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     539 TVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLP 588                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     589 YLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLP 638                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     639 LVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDG 688                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KARLAGEGPPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     689 KARLAGEGPPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAP 738                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     739 LSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQ 788                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 DSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTH 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     789 DSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTH 838                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     839 TLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFR 888                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 NTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     889 NTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEP 938                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     939 PLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL 988                                                          

5522	HMR136_HUMCLIP_10_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P10 and REST_HUMANpartial  	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P10, comprising a first amino acid sequence being at 	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5522 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7477.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGL                            	             Matching length:     801                Total length:     943                                               
						least 90 % homologous to corresponding to amino acids 3 - 335	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of REST_HUMAN, which also corresponds to amino acids 1 - 333 	    Total Percent Similarity:   84.94      Total Percent Identity:   84.94                                               
						of HUMCLIP_P10, a second amino acid sequence being at least  	                        Gaps:       2                        
						HVLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLETQTKL 	                                                            
						EHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDLALRVQEVAELRRR 	Alignment:                                                   
						LESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQREITSLKEHFGAREETHQKEIKALY 	                  .         .         .         .         .  
						TATEKLSKENESLKSKLEHANKENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTE 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						TAEFAELKTQIEKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IRSKLDKAEDQHLVEMEDTLNKLQEAEI                                 	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						90 % homologous to corresponding to amino acids 402 - 729 of 	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 334 - 661  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P10, a third amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 662 - 801  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P10, and a fourth amino acid sequence being at    	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 802 - 812 of HUMCLIP_P10,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMCLIP_P10, comprising a polypeptide having a length "n",   	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGL................. 333                                                          
						preferably at least about 50 amino acids in length, wherein  	         |||||||||||||||||||||||||||||||||                   
						at least two amino acids comprise LH, having a structure as  	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						333-x to 334; and ending at any of amino acid numbers 334+   	     334 .................................................H 334                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                                                          |  
						chimeric polypeptide encoding for an edge portion of         	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						HUMCLIP_P10, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     335 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 384                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     385 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 434                                                          
						at least two amino acids comprise IK, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						661-x to 662; and ending at any of amino acid numbers 662+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     435 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 484                                                          
						polypeptide encoding for a tail of HUMCLIP_P10, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     485 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 534                                                          
						to the sequence CRRITAKTYKG in HUMCLIP_P10.                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     535 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 584                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     585 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 634                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     635 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 661                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     661 .................................................. 661                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     662 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 708                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     709 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 758                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     759 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        801                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5508	HMR136_HUMCLIP_11_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P11 and REST_HUMANpartial  	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P11, comprising a first amino acid sequence being at 	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5508 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P11, a second amino acid sequence being at least  	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						90 % homologous to corresponding to amino acids 492 - 729 of 	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P11, a third amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P11, and a fourth amino acid sequence being at    	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P11,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMCLIP_P11, comprising a polypeptide having a length "n",   	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise EV, having a structure as  	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						454-x to 455; and ending at any of amino acid numbers 455+   	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						HUMCLIP_P11, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     451 GDLE...................................VATVSEKSRIM 465                                                          
						at least two amino acids comprise IK, having a structure as  	         ||||                                   |||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						692-x to 693; and ending at any of amino acid numbers 693+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						polypeptide encoding for a tail of HUMCLIP_P11, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						to the sequence CRRITAKTYKG in HUMCLIP_P11.                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5526	HMR136_HUMCLIP_14_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P14 and REST_HUMANpartial  	Sequence name: REST_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCLIP_P14, comprising a first     	                                                            
						MQIMEQMTKEKTETLASLEDTKQTNAKLQNELDTLKENNLKNVEELNKSKELLTVENQKM 	Alignment of: 5526 x REST_HUMAN   ..                         
						EEFRKEIETLKQAAAQKSQQLSALQEENVKLAEELGRSRDEVTSHQKLEEERSVLNNQLL 	                                                            
						EMKKRESKFIKDADEEKASLQKSISITSALLTEKDAELEKLRNEVTVLRGENASAKSLHS 	Alignment segment 1/1:                                       
						VVQTLESDKVKLELKVKNLELQLKENKRQLSSSSGNTDTQADEDERAQESQIDFLNSVIV 	                                                            
						DLQRKNQDLKMKVEMMSEAALNGNGDDLNNYDSDDQEKQSKKKPRLFCDICDCFDLHDTE 	                     Quality: 3397.00                      Escore:       0                                               
						DCPTQAQMSEDPPHSTHHGSRGEERPYCEICEMFGHWATNCNDDETF              	             Matching length:     347                Total length:     347                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1081 - 1427 of REST_HUMAN, which	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 347 of HUMCLIP_P14.      	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQIMEQMTKEKTETLASLEDTKQTNAKLQNELDTLKENNLKNVEELNKSK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1081 MQIMEQMTKEKTETLASLEDTKQTNAKLQNELDTLKENNLKNVEELNKSK 1130                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ELLTVENQKMEEFRKEIETLKQAAAQKSQQLSALQEENVKLAEELGRSRD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1131 ELLTVENQKMEEFRKEIETLKQAAAQKSQQLSALQEENVKLAEELGRSRD 1180                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EVTSHQKLEEERSVLNNQLLEMKKRESKFIKDADEEKASLQKSISITSAL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1181 EVTSHQKLEEERSVLNNQLLEMKKRESKFIKDADEEKASLQKSISITSAL 1230                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LTEKDAELEKLRNEVTVLRGENASAKSLHSVVQTLESDKVKLELKVKNLE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1231 LTEKDAELEKLRNEVTVLRGENASAKSLHSVVQTLESDKVKLELKVKNLE 1280                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LQLKENKRQLSSSSGNTDTQADEDERAQESQIDFLNSVIVDLQRKNQDLK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1281 LQLKENKRQLSSSSGNTDTQADEDERAQESQIDFLNSVIVDLQRKNQDLK 1330                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MKVEMMSEAALNGNGDDLNNYDSDDQEKQSKKKPRLFCDICDCFDLHDTE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1331 MKVEMMSEAALNGNGDDLNNYDSDDQEKQSKKKPRLFCDICDCFDLHDTE 1380                                                         
						                                                            	                  .         .         .         .            
						                                                            	     301 DCPTQAQMSEDPPHSTHHGSRGEERPYCEICEMFGHWATNCNDDETF    347                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	    1381 DCPTQAQMSEDPPHSTHHGSRGEERPYCEICEMFGHWATNCNDDETF    1427                                                         

5530	HMR136_HUMCLIP_15_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P15 and REST_HUMANpartial  	Sequence name: REST_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCLIP_P15, comprising a first     	                                                            
						MKKRESKFIKDADEEKASLQKSISITSALLTEKDAELEKLRNEVTVLRGENASAKSLHSV 	Alignment of: 5530 x REST_HUMAN   ..                         
						VQTLESDKVKLELKVKNLELQLKENKRQLSSSSGNTDTQADEDERAQESQIDFLNSVIVD 	                                                            
						LQRKNQDLKMKVEMMSEAALNGNGDDLNNYDSDDQEKQSKKKPRLFCDICDCFDLHDTED 	Alignment segment 1/1:                                       
						CPTQAQMSEDPPHSTHHGSRGEERPYCEICEMFGHWATNCNDDETF               	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2234.00                      Escore:       0                                               
						corresponding to amino acids 1202 - 1427 of REST_HUMAN, which	             Matching length:     226                Total length:     226                                               
						also corresponds to amino acids 1 - 226 of HUMCLIP_P15.      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKKRESKFIKDADEEKASLQKSISITSALLTEKDAELEKLRNEVTVLRGE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1202 MKKRESKFIKDADEEKASLQKSISITSALLTEKDAELEKLRNEVTVLRGE 1251                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NASAKSLHSVVQTLESDKVKLELKVKNLELQLKENKRQLSSSSGNTDTQA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1252 NASAKSLHSVVQTLESDKVKLELKVKNLELQLKENKRQLSSSSGNTDTQA 1301                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DEDERAQESQIDFLNSVIVDLQRKNQDLKMKVEMMSEAALNGNGDDLNNY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1302 DEDERAQESQIDFLNSVIVDLQRKNQDLKMKVEMMSEAALNGNGDDLNNY 1351                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DSDDQEKQSKKKPRLFCDICDCFDLHDTEDCPTQAQMSEDPPHSTHHGSR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1352 DSDDQEKQSKKKPRLFCDICDCFDLHDTEDCPTQAQMSEDPPHSTHHGSR 1401                                                         
						                                                            	                  .         .                                
						                                                            	     201 GEERPYCEICEMFGHWATNCNDDETF                         226                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	    1402 GEERPYCEICEMFGHWATNCNDDETF                         1427                                                         

5524	HMR136_HUMCLIP_17_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P17 and REST_HUMANpartial  	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P17, comprising a first amino acid sequence being at 	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5524 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P17, a second amino acid sequence being at least  	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						90 % homologous to corresponding to amino acids 492 - 729 of 	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P17, a third amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P17, and a fourth amino acid sequence being at    	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P17,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMCLIP_P17, comprising a polypeptide having a length "n",   	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise EV, having a structure as  	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						454-x to 455; and ending at any of amino acid numbers 455+   	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						HUMCLIP_P17, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     451 GDLE...................................VATVSEKSRIM 465                                                          
						at least two amino acids comprise IK, having a structure as  	         ||||                                   |||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						692-x to 693; and ending at any of amino acid numbers 693+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						polypeptide encoding for a tail of HUMCLIP_P17, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						to the sequence CRRITAKTYKG in HUMCLIP_P17.                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5520	HMR136_HUMCLIP_18_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P18 and REST_HUMANpartial  	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P18, comprising a first amino acid sequence being at 	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5520 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P18, a second amino acid sequence being at least  	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						90 % homologous to corresponding to amino acids 492 - 729 of 	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P18, a third amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P18, and a fourth amino acid sequence being at    	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P18,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMCLIP_P18, comprising a polypeptide having a length "n",   	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise EV, having a structure as  	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						454-x to 455; and ending at any of amino acid numbers 455+   	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						HUMCLIP_P18, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     451 GDLE...................................VATVSEKSRIM 465                                                          
						at least two amino acids comprise IK, having a structure as  	         ||||                                   |||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						692-x to 693; and ending at any of amino acid numbers 693+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						polypeptide encoding for a tail of HUMCLIP_P18, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						to the sequence CRRITAKTYKG in HUMCLIP_P18.                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5514	HMR136_HUMCLIP_19_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P19 and REST_HUMANunique   	Sequence name: REST_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMCLIP_P19, comprising a  	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 5514 x REST_HUMAN   ..                         
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MKLMACRQRPPPELLHRCALLRPAWCLPPPPPLQTSLRNHHSQQQRNLQLRLRSATLQKL 	                                                            
						P                                                            	                     Quality: 6832.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     726                Total length:     737                                               
						1 - 61 of HUMCLIP_P19, a second amino acid sequence being at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VGGTKAGVVRFLGETDFAKGEWCGVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVT 	    Total Percent Similarity:   98.51      Total Percent Identity:   98.51                                               
						KIGFPSTTPAKAKANAVRRVMATTSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTET 	                        Gaps:       1                        
						SSRYARKISGTTALQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGH 	                                                            
						DQHVLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE    	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 220 -  	                  .         .         .         .         .  
						456 of REST_HUMAN, which also corresponds to amino acids 62 -	      62 VGGTKAGVVRFLGETDFAKGEWCGVELDEPLGKNDGAVAGTRYFQCQPKY 111                                                          
						298 of HUMCLIP_P19, a third amino acid sequence being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     220 VGGTKAGVVRFLGETDFAKGEWCGVELDEPLGKNDGAVAGTRYFQCQPKY 269                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence QKSQISEDPEN  	     112 GLFAPVHKVTKIGFPSTTPAKAKANAVRRVMATTSASLKRSPSASSLSSM 161                                                          
						corresponding to amino acids 299 - 309 of HUMCLIP_P19, a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDLALRVQEVA 	     270 GLFAPVHKVTKIGFPSTTPAKAKANAVRRVMATTSASLKRSPSASSLSSM 319                                                          
						ELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQREITSLKEHFGAREETHQKE 	                  .         .         .         .         .  
						IKALYTATEKLSKENESLKSKLEHANKENSDVIALWKSKLETAIASHQQAMEELKVSFSK 	     162 SSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQHIEQLLA 211                                                          
						GLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFTSQLK 	     320 SSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQHIEQLLA 369                                                          
						ATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNAESSKASSITRELQG 	                  .         .         .         .         .  
						RELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQETVNKLHQKEEQ 	     212 ERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEA 261                                                          
						FNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NDELRLKER                                                    	     370 ERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEA 419                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 457 - 945 of REST_HUMAN, which  	     262 ADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLEQKSQISEDPENTQ 311                                                          
						also corresponds to amino acids 310 - 798 of HUMCLIP_P19, and	         |||||||||||||||||||||||||||||||||||||           ||  
						a fifth amino acid sequence being at least 70%, optionally at	     420 ADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE...........TQ 458                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     312 TKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDL 361                                                          
						polypeptide having the sequence CRRITAKTYKG corresponding to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 799 - 809 of HUMCLIP_P19, wherein said first     	     459 TKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDL 508                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .         .         .  
						acid sequence, fourth amino acid sequence and fifth amino    	     362 ALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQRE 411                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of HUMCLIP_P19,     	     509 ALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQRE 558                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     412 ITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDV 461                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKLMACRQRPPPELLHRCALLRPAWCLPPPPPLQTSLRNHHSQQQRNLQLRLRSATLQKL 	     559 ITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDV 608                                                          
						P                                                            	                  .         .         .         .         .  
						about 95% homologous to the sequence of HUMCLIP_P19.3.An     	     462 IALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLD 511                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCLIP_P19, comprising an amino acid sequence being at least	     609 IALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLD 658                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     512 YQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDK 561                                                          
						at least about 95% homologous to the sequence encoding for   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QKSQISEDPEN, corresponding to HUMCLIP_P19.4.An isolated      	     659 YQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDK 708                                                          
						polypeptide encoding for a tail of HUMCLIP_P19, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     562 AEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFTSQLKAT 611                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     709 AEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFTSQLKAT 758                                                          
						to the sequence CRRITAKTYKG in HUMCLIP_P19.                  	                  .         .         .         .         .  
						                                                            	     612 EEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNAESSKAS 661                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     759 EEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNAESSKAS 808                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     662 SITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVS 711                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     809 SITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVS 858                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     712 VQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQL 761                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     859 VQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQL 908                                                          
						                                                            	                  .         .         .                      
						                                                            	     762 IKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER              798                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     909 IKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER              945                                                          

5512	HMR136_HUMCLIP_3_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P3 and REST_HUMANpartial   	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P3, comprising a first amino acid sequence being at  	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5512 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P3, a second amino acid sequence being at least 90	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						% homologous to corresponding to amino acids 492 - 729 of    	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P3, a third amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P3, and a fourth amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P3, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						polypeptide encoding for an edge portion of HUMCLIP_P3,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise EV, having a structure as follows: a sequence       	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						starting from any of amino acid numbers 454-x to 455; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 455+ ((n-2) - x), in     	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						which x varies from 0 to n-2.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMCLIP_P3,      	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     451 GDLE...................................VATVSEKSRIM 465                                                          
						comprise IK, having a structure as follows: a sequence       	         ||||                                   |||||||||||  
						starting from any of amino acid numbers 692-x to 693; and    	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						ending at any of amino acid numbers 693+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						encoding for a tail of HUMCLIP_P3, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						CRRITAKTYKG in HUMCLIP_P3.                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5510	HMR136_HUMCLIP_4_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P4 and REST_HUMANpartial   	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P4, comprising a first amino acid sequence being at  	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5510 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P4, a second amino acid sequence being at least 90	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						% homologous to corresponding to amino acids 492 - 729 of    	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P4, a third amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P4, and a fourth amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P4, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						polypeptide encoding for an edge portion of HUMCLIP_P4,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise EV, having a structure as follows: a sequence       	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						starting from any of amino acid numbers 454-x to 455; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 455+ ((n-2) - x), in     	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						which x varies from 0 to n-2.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMCLIP_P4,      	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     451 GDLE...................................VATVSEKSRIM 465                                                          
						comprise IK, having a structure as follows: a sequence       	         ||||                                   |||||||||||  
						starting from any of amino acid numbers 692-x to 693; and    	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						ending at any of amino acid numbers 693+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						encoding for a tail of HUMCLIP_P4, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						CRRITAKTYKG in HUMCLIP_P4.                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5516	HMR136_HUMCLIP_5_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P5 and REST_HUMANunique    	Sequence name: REST_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMCLIP_P5, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 5516 x REST_HUMAN   ..                         
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MKLMACRQRPPPELLHRCALLRPAWCLPPPPPLQTSLRNHHSQQQRNLQLRLRSATLQKL 	                                                            
						P                                                            	                     Quality: 6832.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     726                Total length:     737                                               
						1 - 61 of HUMCLIP_P5, a second amino acid sequence being at  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VGGTKAGVVRFLGETDFAKGEWCGVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVT 	    Total Percent Similarity:   98.51      Total Percent Identity:   98.51                                               
						KIGFPSTTPAKAKANAVRRVMATTSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTET 	                        Gaps:       1                        
						SSRYARKISGTTALQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGH 	                                                            
						DQHVLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE    	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 220 -  	                  .         .         .         .         .  
						456 of REST_HUMAN, which also corresponds to amino acids 62 -	      62 VGGTKAGVVRFLGETDFAKGEWCGVELDEPLGKNDGAVAGTRYFQCQPKY 111                                                          
						298 of HUMCLIP_P5, a third amino acid sequence being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     220 VGGTKAGVVRFLGETDFAKGEWCGVELDEPLGKNDGAVAGTRYFQCQPKY 269                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence QKSQISEDPEN  	     112 GLFAPVHKVTKIGFPSTTPAKAKANAVRRVMATTSASLKRSPSASSLSSM 161                                                          
						corresponding to amino acids 299 - 309 of HUMCLIP_P5, a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDLALRVQEVA 	     270 GLFAPVHKVTKIGFPSTTPAKAKANAVRRVMATTSASLKRSPSASSLSSM 319                                                          
						ELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQREITSLKEHFGAREETHQKE 	                  .         .         .         .         .  
						IKALYTATEKLSKENESLKSKLEHANKENSDVIALWKSKLETAIASHQQAMEELKVSFSK 	     162 SSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQHIEQLLA 211                                                          
						GLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFTSQLK 	     320 SSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQHIEQLLA 369                                                          
						ATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNAESSKASSITRELQG 	                  .         .         .         .         .  
						RELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQETVNKLHQKEEQ 	     212 ERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEA 261                                                          
						FNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NDELRLKER                                                    	     370 ERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEA 419                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 457 - 945 of REST_HUMAN, which  	     262 ADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLEQKSQISEDPENTQ 311                                                          
						also corresponds to amino acids 310 - 798 of HUMCLIP_P5, and 	         |||||||||||||||||||||||||||||||||||||           ||  
						a fifth amino acid sequence being at least 70%, optionally at	     420 ADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE...........TQ 458                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     312 TKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDL 361                                                          
						polypeptide having the sequence CRRITAKTYKG corresponding to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 799 - 809 of HUMCLIP_P5, wherein said first amino	     459 TKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDL 508                                                          
						acid sequence, second amino acid sequence, third amino acid  	                  .         .         .         .         .  
						sequence, fourth amino acid sequence and fifth amino acid    	     362 ALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQRE 411                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of HUMCLIP_P5,      	     509 ALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQRE 558                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     412 ITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDV 461                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKLMACRQRPPPELLHRCALLRPAWCLPPPPPLQTSLRNHHSQQQRNLQLRLRSATLQKL 	     559 ITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDV 608                                                          
						P                                                            	                  .         .         .         .         .  
						about 95% homologous to the sequence of HUMCLIP_P5.3.An      	     462 IALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLD 511                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCLIP_P5, comprising an amino acid sequence being at least 	     609 IALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLD 658                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     512 YQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDK 561                                                          
						at least about 95% homologous to the sequence encoding for   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QKSQISEDPEN, corresponding to HUMCLIP_P5.4.An isolated       	     659 YQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDK 708                                                          
						polypeptide encoding for a tail of HUMCLIP_P5, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     562 AEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFTSQLKAT 611                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     709 AEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFTSQLKAT 758                                                          
						to the sequence CRRITAKTYKG in HUMCLIP_P5.                   	                  .         .         .         .         .  
						                                                            	     612 EEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNAESSKAS 661                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     759 EEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNAESSKAS 808                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     662 SITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVS 711                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     809 SITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVS 858                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     712 VQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQL 761                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     859 VQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQL 908                                                          
						                                                            	                  .         .         .                      
						                                                            	     762 IKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER              798                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     909 IKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER              945                                                          

5518	HMR136_HUMCLIP_6_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P6 and REST_HUMANpartial   	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P6, comprising a first amino acid sequence being at  	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5518 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P6, a second amino acid sequence being at least 90	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						% homologous to corresponding to amino acids 492 - 729 of    	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P6, a third amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P6, and a fourth amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P6, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						polypeptide encoding for an edge portion of HUMCLIP_P6,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise EV, having a structure as follows: a sequence       	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						starting from any of amino acid numbers 454-x to 455; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 455+ ((n-2) - x), in     	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						which x varies from 0 to n-2.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMCLIP_P6,      	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     451 GDLE...................................VATVSEKSRIM 465                                                          
						comprise IK, having a structure as follows: a sequence       	         ||||                                   |||||||||||  
						starting from any of amino acid numbers 692-x to 693; and    	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						ending at any of amino acid numbers 693+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						encoding for a tail of HUMCLIP_P6, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						CRRITAKTYKG in HUMCLIP_P6.                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5528	HMR136_HUMCLIP_7_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P7 and REST_HUMANpartial   	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P7, comprising a first amino acid sequence being at  	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5528 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P7, a second amino acid sequence being at least 90	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						% homologous to corresponding to amino acids 492 - 729 of    	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P7, a third amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P7, and a fourth amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P7, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						polypeptide encoding for an edge portion of HUMCLIP_P7,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise EV, having a structure as follows: a sequence       	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						starting from any of amino acid numbers 454-x to 455; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 455+ ((n-2) - x), in     	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						which x varies from 0 to n-2.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMCLIP_P7,      	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     451 GDLE...................................VATVSEKSRIM 465                                                          
						comprise IK, having a structure as follows: a sequence       	         ||||                                   |||||||||||  
						starting from any of amino acid numbers 692-x to 693; and    	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						ending at any of amino acid numbers 693+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						encoding for a tail of HUMCLIP_P7, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						CRRITAKTYKG in HUMCLIP_P7.                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5506	HMR136_HUMCLIP_9_tr0_r1_1_gPRT		Comparison report between HUMCLIP_P9 and REST_HUMANpartial   	Sequence name: REST_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCLIP_P9, comprising a first amino acid sequence being at  	                                                            
						MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGE 	Alignment of: 5506 x REST_HUMAN   ..                         
						RVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPS 	                                                            
						KLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSAT 	Alignment segment 1/1:                                       
						PPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWC 	                                                            
						GVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 	                     Quality: 7764.00                      Escore:       0                                               
						TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQ 	             Matching length:     832                Total length:     943                                               
						HIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKVELLNQLEEEKRKVEDLQFRVEEESITKGDLE                           	    Total Percent Similarity:   88.23      Total Percent Identity:   88.23                                               
						least 90 % homologous to corresponding to amino acids 3 - 456	                        Gaps:       2                        
						of REST_HUMAN, which also corresponds to amino acids 1 - 454 	                                                            
						of HUMCLIP_P9, a second amino acid sequence being at least 90	Alignment:                                                   
						VATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVT 	                  .         .         .         .         .  
						RTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIAL 	       1 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 50                                                           
						WKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEI   	       3 MLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQE 52                                                           
						% homologous to corresponding to amino acids 492 - 729 of    	                  .         .         .         .         .  
						REST_HUMAN, which also corresponds to amino acids 455 - 692  	      51 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 100                                                          
						of HUMCLIP_P9, a third amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQE 	      53 EFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGS 102                                                          
						TVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKM 	                  .         .         .         .         .  
						SGDNSSQLTKMNDELRLKER                                         	     101 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 150                                                          
						% homologous to corresponding to amino acids 806 - 945 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REST_HUMAN, which also corresponds to amino acids 693 - 832  	     103 VAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTS 152                                                          
						of HUMCLIP_P9, and a fourth amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     151 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 200                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence CRRITAKTYKG  	     153 TASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEA 202                                                          
						corresponding to amino acids 833 - 843 of HUMCLIP_P9, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     201 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	     203 GSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGK 252                                                          
						polypeptide encoding for an edge portion of HUMCLIP_P9,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     251 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 300                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     253 NDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMAT 302                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     301 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 350                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise EV, having a structure as follows: a sequence       	     303 TSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTA 352                                                          
						starting from any of amino acid numbers 454-x to 455; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 455+ ((n-2) - x), in     	     351 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 400                                                          
						which x varies from 0 to n-2.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMCLIP_P9,      	     353 LQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQH 402                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     401 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 450                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     403 VLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITK 452                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     451 GDLE...................................VATVSEKSRIM 465                                                          
						comprise IK, having a structure as follows: a sequence       	         ||||                                   |||||||||||  
						starting from any of amino acid numbers 692-x to 693; and    	     453 GDLETQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIM 502                                                          
						ending at any of amino acid numbers 693+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     466 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 515                                                          
						encoding for a tail of HUMCLIP_P9, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     503 ELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTR 552                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     516 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 565                                                          
						CRRITAKTYKG in HUMCLIP_P9.                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     553 TDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHAN 602                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 KENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQI 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 EKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAI 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 RSKLDKAEDQHLVEMEDTLNKLQEAEI....................... 692                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     703 RSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFT 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     692 .................................................. 692                                                          
						                                                            	                                                            
						                                                            	     753 SQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNA 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     693 ...KASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 739                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 ESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEA 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     740 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 789                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 SEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKD 902                                                          
						                                                            	                  .         .         .         .            
						                                                            	     790 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        832                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     903 EREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKER        945                                                          

5646	HMR136_HUMCLNA_11_tr0_r1_1_gPRT		Comparison report between HUMCLNA_P11 and CG1C_HUMANpartial  	Sequence name: CG1C_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCLNA_P11, comprising a first     	                                                            
						MAPTCVFLASKVEEFGVVSNTRLIAAATSVLKTRFSYAFPKEFPYRMNHILECEFYLLEL 	Alignment of: 5646 x CG1C_HUMAN   ..                         
						MDCCLIVYHPYRPLLQYVQDMGQEDMLLPLAWRIVNDTYRTDLCLLYPPFMIALACLHVA 	                                                            
						CVVQQKDARQWFAELSVDMEKILEIIRVILKLYEQWKNFDERKEMATILSKMPKPKPPPN 	Alignment segment 1/1:                                       
						SEGEQGPNGSQNSSYSQS                                           	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 1988.00                      Escore:       0                                               
						corresponding to amino acids 106 - 303 of CG1C_HUMAN, which  	             Matching length:     198                Total length:     198                                               
						also corresponds to amino acids 1 - 198 of HUMCLNA_P11.      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAPTCVFLASKVEEFGVVSNTRLIAAATSVLKTRFSYAFPKEFPYRMNHI 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     106 MAPTCVFLASKVEEFGVVSNTRLIAAATSVLKTRFSYAFPKEFPYRMNHI 155                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LECEFYLLELMDCCLIVYHPYRPLLQYVQDMGQEDMLLPLAWRIVNDTYR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     156 LECEFYLLELMDCCLIVYHPYRPLLQYVQDMGQEDMLLPLAWRIVNDTYR 205                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TDLCLLYPPFMIALACLHVACVVQQKDARQWFAELSVDMEKILEIIRVIL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 TDLCLLYPPFMIALACLHVACVVQQKDARQWFAELSVDMEKILEIIRVIL 255                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 KLYEQWKNFDERKEMATILSKMPKPKPPPNSEGEQGPNGSQNSSYSQS   198                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     256 KLYEQWKNFDERKEMATILSKMPKPKPPPNSEGEQGPNGSQNSSYSQS   303                                                          

5644	HMR136_HUMCLNA_4_tr0_r1_1_gPRT		Comparison report between HUMCLNA_P4 and CG1C_HUMANpartial   	Sequence name: CG1C_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCLNA_P4, comprising a first amino	Sequence documentation:                                      
						MAGNFWQSSHYLQWILDKQDLLKERQKDLKFLSEEEYWKLQIFFTNVIQALGEHLKLRQQ 	                                                            
						VIATATVYFKRFYARYSLKSIDPVLMAPTCVFLASKVEEFGVVSNTRLIAAATSVLKTRF 	Alignment of: 5644 x CG1C_HUMAN   ..                         
						SYAFPKEFPYRMNHILECEFYLLELMDCCLIVYHPYRPLLQYVQDMGQEDMLLPLAWRIV 	                                                            
						NDTYRTDLCLLYPPFMIALACLHVACVVQQKDARQWFAELSVDMEKILEIIRVILKLYEQ 	Alignment segment 1/1:                                       
						WKNFDERKEMATILSKMPKPKPPPN                                    	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2653.00                      Escore:       0                                               
						to amino acids 21 - 285 of CG1C_HUMAN, which also corresponds	             Matching length:     265                Total length:     265                                               
						to amino acids 1 - 265 of HUMCLNA_P4, and a second amino acid	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence RNSLSDSPLVAGPEAAR corresponding to amino 	Alignment:                                                   
						acids 266 - 282 of HUMCLNA_P4, wherein said first amino acid 	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MAGNFWQSSHYLQWILDKQDLLKERQKDLKFLSEEEYWKLQIFFTNVIQA 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUMCLNA_P4, comprising a polypeptide being at least  	      21 MAGNFWQSSHYLQWILDKQDLLKERQKDLKFLSEEEYWKLQIFFTNVIQA 70                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 LGEHLKLRQQVIATATVYFKRFYARYSLKSIDPVLMAPTCVFLASKVEEF 100                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RNSLSDSPLVAGPEAAR in HUMCLNA_P4.                             	      71 LGEHLKLRQQVIATATVYFKRFYARYSLKSIDPVLMAPTCVFLASKVEEF 120                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GVVSNTRLIAAATSVLKTRFSYAFPKEFPYRMNHILECEFYLLELMDCCL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 GVVSNTRLIAAATSVLKTRFSYAFPKEFPYRMNHILECEFYLLELMDCCL 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IVYHPYRPLLQYVQDMGQEDMLLPLAWRIVNDTYRTDLCLLYPPFMIALA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 IVYHPYRPLLQYVQDMGQEDMLLPLAWRIVNDTYRTDLCLLYPPFMIALA 220                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CLHVACVVQQKDARQWFAELSVDMEKILEIIRVILKLYEQWKNFDERKEM 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 CLHVACVVQQKDARQWFAELSVDMEKILEIIRVILKLYEQWKNFDERKEM 270                                                          
						                                                            	                  .                                          
						                                                            	     251 ATILSKMPKPKPPPN                                    265                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     271 ATILSKMPKPKPPPN                                    285                                                          

12048	HMR136_HUMCNC_11_tr0_r1_1_gPRT		Comparison report between HUMCNC_P11 and Q14913unique head   	Sequence name: Q14913                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12048 x Q14913   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVI 	Alignment segment 1/1:                                       
						LPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNG 	                                                            
						ETTKTTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMF 	                     Quality:   94.00                      Escore:       0                                               
						IIIALCVYVVPDGETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFF 	             Matching length:      27                Total length:      27                                               
						FFPICVVFAWVADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV 	 Matching Percent Similarity:   70.37   Matching Percent Identity:   40.74                                               
						ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKS 	    Total Percent Similarity:   70.37      Total Percent Identity:   40.74                                               
						RAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLE 	                        Gaps:       0                        
						NCGTVALTIIRRGGDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGII 	                                                            
						DDDIFEEDENFLVHLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIF 	Alignment:                                                   
						TFEEPVTHVSESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND 	                  .         .                                
						EIVKTISVKVIDD                                                	     604 KTISVKVIDDEEYEKNKTFFLEIGEPR                        630                                                          
						homologous to a polypeptide having the sequence corresponding	         | |:::: | |||||  :: | : ||:                         
						to amino acids 1 - 613 of HUMCNC_P11, a second amino acid    	       1 KIITIRIFDREEYEKECSLSLVLEEPK                        27                                                           
						sequence being at least 90 % homologous to EEYEK             	                                                            
						corresponding to amino acids 11 - 15 of Q14913, which also   	                                                            
						corresponds to amino acids 614 - 618 of HUMCNC_P11, and a    	                                                            
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	                                                            
						NKTFFLEIGEPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLE 	                                                            
						VIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSC 	                                                            
						FDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKD 	                                                            
						SVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYH 	                                                            
						AANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVL 	                                                            
						LWLLYIFFSSLEAYCHIKGF                                         	                                                            
						polypeptide having the sequence corresponding to amino acids 	                                                            
						619 - 938 of HUMCNC_P11, wherein said first amino acid       	                                                            
						sequence, second amino acid sequence and third amino acid    	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of HUMCNC_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVI 	                                                            
						LPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNG 	                                                            
						ETTKTTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMF 	                                                            
						IIIALCVYVVPDGETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFF 	                                                            
						FFPICVVFAWVADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV 	                                                            
						ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKS 	                                                            
						RAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLE 	                                                            
						NCGTVALTIIRRGGDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGII 	                                                            
						DDDIFEEDENFLVHLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIF 	                                                            
						TFEEPVTHVSESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND 	                                                            
						EIVKTISVKVIDD                                                	                                                            
						about 95% homologous to the sequence of HUMCNC_P11.3.An      	                                                            
						isolated polypeptide encoding for a tail of HUMCNC_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						NKTFFLEIGEPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLE 	                                                            
						VIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSC 	                                                            
						FDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKD 	                                                            
						SVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYH 	                                                            
						AANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVL 	                                                            
						LWLLYIFFSSLEAYCHIKGF                                         	                                                            
						about 95% homologous to the sequence in HUMCNC_P11.          	                                                            

						Comparison report between HUMCNC_P11 and CAA73378unique head 	Sequence name: CAA73378                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12048 x CAA73378   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P11, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  829.00                      Escore:       0                                               
						WEPQDPSFGDKIARATVYFVAMVY                                     	             Matching length:      84                Total length:      84                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 84 of CAA73378, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 87 of HUMCNC_P11, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                  .         .         .                      
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	      54 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 87                                                           
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	         ||||||||||||||||||||||||||||||||||                  
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	      51 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 84                                                           
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEF 	                                                            
						KSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLT 	                                                            
						VFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVA 	                                                            
						LGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKV 	                                                            
						SPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFS 	                                                            
						SLEAYCHIKGF                                                  	                                                            
						having the sequence corresponding to amino acids 88 - 938 of 	                                                            
						HUMCNC_P11, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P11, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P11.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P11, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	                                                            
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	                                                            
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	                                                            
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                                                            
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	                                                            
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	                                                            
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	                                                            
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEF 	                                                            
						KSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLT 	                                                            
						VFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVA 	                                                            
						LGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKV 	                                                            
						SPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFS 	                                                            
						SLEAYCHIKGF                                                  	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P11.                                               	                                                            

						Comparison report between HUMCNC_P11 and CAA73386unique head 	Sequence name: CAA73386                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12048 x CAA73386   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P11, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  697.00                      Escore:       0                                               
						WEPQDPSFGD                                                   	             Matching length:      70                Total length:      70                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 70 of CAA73386, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 73 of HUMCNC_P11, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                  .         .                                
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	      54 YCKKGVILPIWEPQDPSFGD                               73                                                           
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	         ||||||||||||||||||||                                
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	      51 YCKKGVILPIWEPQDPSFGD                               70                                                           
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGE 	                                                            
						HTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEE 	                                                            
						KLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCT 	                                                            
						IGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSI 	                                                            
						AAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTS 	                                                            
						CLFVLLWLLYIFFSSLEAYCHIKGF                                    	                                                            
						having the sequence corresponding to amino acids 74 - 938 of 	                                                            
						HUMCNC_P11, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P11, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P11.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P11, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	                                                            
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	                                                            
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	                                                            
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                                                            
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	                                                            
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	                                                            
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	                                                            
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGE 	                                                            
						HTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEE 	                                                            
						KLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCT 	                                                            
						IGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSI 	                                                            
						AAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTS 	                                                            
						CLFVLLWLLYIFFSSLEAYCHIKGF                                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P11.                                               	                                                            

						Comparison report between HUMCNC_P11 and CAA73477unique head 	Sequence name: CAA73477                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12048 x CAA73477   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P11, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  697.00                      Escore:       0                                               
						WEPQDPSFGD                                                   	             Matching length:      70                Total length:      70                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 70 of CAA73477, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 73 of HUMCNC_P11, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                  .         .                                
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	      54 YCKKGVILPIWEPQDPSFGD                               73                                                           
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	         ||||||||||||||||||||                                
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	      51 YCKKGVILPIWEPQDPSFGD                               70                                                           
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGE 	                                                            
						HTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEE 	                                                            
						KLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCT 	                                                            
						IGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSI 	                                                            
						AAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTS 	                                                            
						CLFVLLWLLYIFFSSLEAYCHIKGF                                    	                                                            
						having the sequence corresponding to amino acids 74 - 938 of 	                                                            
						HUMCNC_P11, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P11, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P11.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P11, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	                                                            
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	                                                            
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	                                                            
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                                                            
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	                                                            
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	                                                            
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	                                                            
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGE 	                                                            
						HTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEE 	                                                            
						KLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCT 	                                                            
						IGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSI 	                                                            
						AAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTS 	                                                            
						CLFVLLWLLYIFFSSLEAYCHIKGF                                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P11.                                               	                                                            

						Comparison report between HUMCNC_P11 and CAA73478unique head 	Sequence name: CAA73478                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12048 x CAA73478   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P11, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  829.00                      Escore:       0                                               
						WEPQDPSFGDKIARATVYFVAMVY                                     	             Matching length:      84                Total length:      84                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 84 of CAA73478, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 87 of HUMCNC_P11, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                  .         .         .                      
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	      54 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 87                                                           
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	         ||||||||||||||||||||||||||||||||||                  
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	      51 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 84                                                           
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEF 	                                                            
						KSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLT 	                                                            
						VFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVA 	                                                            
						LGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKV 	                                                            
						SPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFS 	                                                            
						SLEAYCHIKGF                                                  	                                                            
						having the sequence corresponding to amino acids 88 - 938 of 	                                                            
						HUMCNC_P11, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P11, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P11.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P11, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	                                                            
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	                                                            
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	                                                            
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                                                            
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	                                                            
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	                                                            
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	                                                            
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITDEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEF 	                                                            
						KSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLT 	                                                            
						VFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVA 	                                                            
						LGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKV 	                                                            
						SPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFS 	                                                            
						SLEAYCHIKGF                                                  	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P11.                                               	                                                            

12050	HMR136_HUMCNC_12_tr0_r1_1_gPRT		Comparison report between HUMCNC_P12 and Q14913unique head   	Sequence name: Q14913                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12050 x Q14913   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVI 	Alignment segment 1/1:                                       
						LPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNG 	                                                            
						ETTKTTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMF 	                     Quality:   94.00                      Escore:       0                                               
						IIIALCVYVVPDGETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFF 	             Matching length:      27                Total length:      27                                               
						FFPICVVFAWVADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV 	 Matching Percent Similarity:   70.37   Matching Percent Identity:   40.74                                               
						ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKS 	    Total Percent Similarity:   70.37      Total Percent Identity:   40.74                                               
						RAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLE 	                        Gaps:       0                        
						NCGTVALTIIRRGGDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGII 	                                                            
						DDDIFEEDENFLVHLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIF 	Alignment:                                                   
						TFEEPVTHVSESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND 	                  .         .                                
						EIVKTISVKVIDD                                                	     604 KTISVKVIDDEEYEKNKTFFLEIGEPR                        630                                                          
						homologous to a polypeptide having the sequence corresponding	         | |:::: | |||||  :: | : ||:                         
						to amino acids 1 - 613 of HUMCNC_P12, a second amino acid    	       1 KIITIRIFDREEYEKECSLSLVLEEPK                        27                                                           
						sequence being at least 90 % homologous to EEYEK             	                                                            
						corresponding to amino acids 11 - 15 of Q14913, which also   	                                                            
						corresponds to amino acids 614 - 618 of HUMCNC_P12, and a    	                                                            
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	                                                            
						NKTFFLEIGEPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDKQPLTS 	                                                            
						KEEEERRIAEMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIE 	                                                            
						AITVSAGEDDDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILM 	                                                            
						IGLLTAFIGDLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNV 	                                                            
						TGSNAVNVFLGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRR 	                                                            
						PEIGGELGGPRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF                  	                                                            
						polypeptide having the sequence corresponding to amino acids 	                                                            
						619 - 961 of HUMCNC_P12, wherein said first amino acid       	                                                            
						sequence, second amino acid sequence and third amino acid    	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of HUMCNC_P12,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVI 	                                                            
						LPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNG 	                                                            
						ETTKTTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMF 	                                                            
						IIIALCVYVVPDGETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFF 	                                                            
						FFPICVVFAWVADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV 	                                                            
						ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKS 	                                                            
						RAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLE 	                                                            
						NCGTVALTIIRRGGDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGII 	                                                            
						DDDIFEEDENFLVHLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIF 	                                                            
						TFEEPVTHVSESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND 	                                                            
						EIVKTISVKVIDD                                                	                                                            
						about 95% homologous to the sequence of HUMCNC_P12.3.An      	                                                            
						isolated polypeptide encoding for a tail of HUMCNC_P12,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						NKTFFLEIGEPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDKQPLTS 	                                                            
						KEEEERRIAEMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIE 	                                                            
						AITVSAGEDDDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILM 	                                                            
						IGLLTAFIGDLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNV 	                                                            
						TGSNAVNVFLGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRR 	                                                            
						PEIGGELGGPRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF                  	                                                            
						about 95% homologous to the sequence in HUMCNC_P12.          	                                                            

						Comparison report between HUMCNC_P12 and CAA73378unique head 	Sequence name: CAA73378                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12050 x CAA73378   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P12, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  829.00                      Escore:       0                                               
						WEPQDPSFGDKIARATVYFVAMVY                                     	             Matching length:      84                Total length:      84                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 84 of CAA73378, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 87 of HUMCNC_P12, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                  .         .         .                      
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	      54 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 87                                                           
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	         ||||||||||||||||||||||||||||||||||                  
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	      51 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 84                                                           
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDKQPLTSKEEEERRIA 	                                                            
						EMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGED 	                                                            
						DDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIG 	                                                            
						DLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVF 	                                                            
						LGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGG 	                                                            
						PRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF                           	                                                            
						having the sequence corresponding to amino acids 88 - 961 of 	                                                            
						HUMCNC_P12, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P12, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P12.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P12, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	                                                            
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	                                                            
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	                                                            
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                                                            
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	                                                            
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	                                                            
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	                                                            
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDKQPLTSKEEEERRIA 	                                                            
						EMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGED 	                                                            
						DDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIG 	                                                            
						DLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVF 	                                                            
						LGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGG 	                                                            
						PRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF                           	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P12.                                               	                                                            

						Comparison report between HUMCNC_P12 and CAA73386unique head 	Sequence name: CAA73386                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12050 x CAA73386   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P12, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  697.00                      Escore:       0                                               
						WEPQDPSFGD                                                   	             Matching length:      70                Total length:      70                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 70 of CAA73386, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 73 of HUMCNC_P12, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                  .         .                                
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	      54 YCKKGVILPIWEPQDPSFGD                               73                                                           
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	         ||||||||||||||||||||                                
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	      51 YCKKGVILPIWEPQDPSFGD                               70                                                           
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDK 	                                                            
						QPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWR 	                                                            
						EQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFI 	                                                            
						VSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADA 	                                                            
						SIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVL 	                                                            
						LYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF             	                                                            
						having the sequence corresponding to amino acids 74 - 961 of 	                                                            
						HUMCNC_P12, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P12, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P12.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P12, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	                                                            
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	                                                            
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	                                                            
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                                                            
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	                                                            
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	                                                            
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	                                                            
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDK 	                                                            
						QPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWR 	                                                            
						EQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFI 	                                                            
						VSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADA 	                                                            
						SIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVL 	                                                            
						LYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF             	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P12.                                               	                                                            

						Comparison report between HUMCNC_P12 and CAA73477unique head 	Sequence name: CAA73477                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12050 x CAA73477   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P12, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  697.00                      Escore:       0                                               
						WEPQDPSFGD                                                   	             Matching length:      70                Total length:      70                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 70 of CAA73477, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 73 of HUMCNC_P12, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                  .         .                                
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	      54 YCKKGVILPIWEPQDPSFGD                               73                                                           
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	         ||||||||||||||||||||                                
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	      51 YCKKGVILPIWEPQDPSFGD                               70                                                           
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDK 	                                                            
						QPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWR 	                                                            
						EQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFI 	                                                            
						VSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADA 	                                                            
						SIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVL 	                                                            
						LYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF             	                                                            
						having the sequence corresponding to amino acids 74 - 961 of 	                                                            
						HUMCNC_P12, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P12, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P12.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P12, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						KIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNET 	                                                            
						VSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDG 	                                                            
						ETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVAD 	                                                            
						RRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVD 	                                                            
						ERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMT 	                                                            
						GAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRG 	                                                            
						GDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLV 	                                                            
						HLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESI 	                                                            
						GIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDD 	                                                            
						EEYEKNKTFFLEIGEPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDK 	                                                            
						QPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWR 	                                                            
						EQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFI 	                                                            
						VSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADA 	                                                            
						SIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVL 	                                                            
						LYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF             	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P12.                                               	                                                            

						Comparison report between HUMCNC_P12 and CAA73478unique head 	Sequence name: CAA73478                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCNC_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12050 x CAA73478   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of HUMCNC_P12, a second   	                                                            
						MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPI 	                     Quality:  829.00                      Escore:       0                                               
						WEPQDPSFGDKIARATVYFVAMVY                                     	             Matching length:      84                Total length:      84                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 84 of CAA73478, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 87 of HUMCNC_P12, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	       4 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 53                                                           
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	       1 MRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSY 50                                                           
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                  .         .         .                      
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	      54 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 87                                                           
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	         ||||||||||||||||||||||||||||||||||                  
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	      51 YCKKGVILPIWEPQDPSFGDKIARATVYFVAMVY                 84                                                           
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDKQPLTSKEEEERRIA 	                                                            
						EMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGED 	                                                            
						DDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIG 	                                                            
						DLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVF 	                                                            
						LGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGG 	                                                            
						PRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF                           	                                                            
						having the sequence corresponding to amino acids 88 - 961 of 	                                                            
						HUMCNC_P12, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of HUMCNC_P12, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MYN of HUMCNC_P12.3.An isolated polypeptide  	                                                            
						encoding for a tail of HUMCNC_P12, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						MFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAP 	                                                            
						EILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVT 	                                                            
						AAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYR 	                                                            
						AGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMA 	                                                            
						RILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQA 	                                                            
						RKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTE 	                                                            
						DGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASED 	                                                            
						GILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGAR 	                                                            
						GNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIG 	                                                            
						EPRLVEMSEKKGGFTITGQPVFRKVHAREHPILSTVITIADEYDDKQPLTSKEEEERRIA 	                                                            
						EMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGED 	                                                            
						DDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIG 	                                                            
						DLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVF 	                                                            
						LGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGG 	                                                            
						PRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF                           	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in HUMCNC_P12.                                               	                                                            

12046	HMR136_HUMCNC_15_tr0_r1_1_gPRT		Comparison report between HUMCNC_P15 and NAC1_HUMANpartial   	Sequence name: NAC1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCNC_P15, comprising a first amino	Sequence documentation:                                      
						MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVI 	                                                            
						LPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNG 	Alignment of: 12046 x NAC1_HUMAN   ..                        
						ETTKTTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMF 	                                                            
						IIIALCVYVVPDGETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFF 	Alignment segment 1/1:                                       
						FFPICVVFAWVADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV 	                                                            
						ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKS 	                     Quality: 6291.00                      Escore:       0                                               
						RAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLE 	             Matching length:     652                Total length:     652                                               
						NCGTVALTIIRRGGDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGII 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DDDIFEEDENFLVHLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TFEEPVTHVSESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND 	                        Gaps:       0                        
						EIVKTISVKVIDDEEYEKNKTFFLEIGEPRLVEMSEKKALLLNELGGFTITG         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 652 of NAC1_HUMAN, which also corresponds 	                  .         .         .         .         .  
						to amino acids 1 - 652 of HUMCNC_P15, and a second amino acid	       1 MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECT 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECT 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence MNFSRPTCLQEGSC corresponding to amino    	      51 GSYYCKKGVILPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFM 100                                                          
						acids 653 - 666 of HUMCNC_P15, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      51 GSYYCKKGVILPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFM 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of HUMCNC_P15, comprising a polypeptide being at least  	     101 SSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAPEIL 150                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     101 SSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAPEIL 150                                                          
						at least about 95% homologous to the sequence MNFSRPTCLQEGSC 	                  .         .         .         .         .  
						in HUMCNC_P15.                                               	     151 LSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAW 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAW 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELAN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELAN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 YQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 TENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTEDGT 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTEDGT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVS 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 ESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 ESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 EIVKTISVKVIDDEEYEKNKTFFLEIGEPRLVEMSEKKALLLNELGGFTI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 EIVKTISVKVIDDEEYEKNKTFFLEIGEPRLVEMSEKKALLLNELGGFTI 650                                                          
						                                                            	                                                             
						                                                            	     651 TG                                                 652                                                          
						                                                            	         ||                                                  
						                                                            	     651 TG                                                 652                                                          

6098	HMR136_HUMCOL18AX_12_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P12 and                 	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMCOL18AX_P12, comprising a first amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6098 x CA1H_HUMAN_V1   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 12807.00                      Escore:       0                                              
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:    1293                Total length:    1293                                               
						HUMCOL18AX_P12, a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.85                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       0                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	                  .         .         .         .         .  
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	                  .         .         .         .         .  
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	                  .         .         .         .         .  
						ELYVRVQNGFRKVQLEARTPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRA 	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						DDILASPPRLPEPQPYPGAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MRGIRGADFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELLFPS 	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						WEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRRLTESYCETWRTEA 	                  .         .         .         .         .  
						PSATGQASSLLGGRLLGQSAASCHHAYIVL                               	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						90 % homologous to corresponding to amino acids 216 - 1505 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CA1H_HUMAN_V1, which also corresponds to amino acids 119 -   	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						1408 of HUMCOL18AX_P12, and a third amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HWLSPRKPISLPSLGLKGNPGVPTGRPAGEQSSHEVQQGPLSVTATPEIRQHQPRVIRSV 	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						EGQVDSGQRQADHSTANTHLPQDCDETGGAGSVIVCDVKPIQTGK                	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						corresponding to amino acids 1409 - 1513 of HUMCOL18AX_P12,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						head of HUMCOL18AX_P12, comprising a polypeptide being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence of  	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						HUMCOL18AX_P12.3.An isolated polypeptide encoding for a tail 	                  .         .         .         .         .  
						of HUMCOL18AX_P12, comprising a polypeptide being at least   	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						HWLSPRKPISLPSLGLKGNPGVPTGRPAGEQSSHEVQQGPLSVTATPEIRQHQPRVIRSV 	                  .         .         .         .         .  
						EGQVDSGQRQADHSTANTHLPQDCDETGGAGSVIVCDVKPIQTGK                	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						at least about 95% homologous to the sequence in             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCOL18AX_P12.                                              	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1165                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1166 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1215                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1216 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1265                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1266 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1315                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1412                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1316 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1365                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1413 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1462                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1366 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVL        1408                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	    1463 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVL        1505                                                         

6092	HMR136_HUMCOL18AX_13_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P13 and                 	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMCOL18AX_P13, comprising a first amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6092 x CA1H_HUMAN_V1   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 11838.00                      Escore:       0                                              
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:    1196                Total length:    1196                                               
						HUMCOL18AX_P13, a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       0                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	                  .         .         .         .         .  
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	                  .         .         .         .         .  
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	                  .         .         .         .         .  
						ELYVRVQNGFRKVQLEARTPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRA 	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						DDILASPPRLPEPQPYPGAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MRGIRGADFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLK        	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						90 % homologous to corresponding to amino acids 216 - 1408 of	                  .         .         .         .         .  
						CA1H_HUMAN_V1, which also corresponds to amino acids 119 -   	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						1311 of HUMCOL18AX_P13, and a third amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least 80%, preferably at least   	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						85%, more preferably at least 90% and most preferably at     	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						APEERVAWLGPQRAQADRELL corresponding to amino acids 1312 -    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1332 of HUMCOL18AX_P13, wherein said first amino acid        	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						isolated polypeptide encoding for a head of HUMCOL18AX_P13,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						about 95% homologous to the sequence of HUMCOL18AX_P13.3.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HUMCOL18AX_P13,  	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence APEERVAWLGPQRAQADRELL in	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						HUMCOL18AX_P13.                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1165                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1166 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1215                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1216 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1265                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1266 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLK     1311                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLK     1408                                                         

6106	HMR136_HUMCOL18AX_14_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P14 and                 	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMCOL18AX_P14, comprising a first amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6106 x CA1H_HUMAN_V1   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 10089.00                      Escore:       0                                              
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:    1020                Total length:    1020                                               
						HUMCOL18AX_P14, a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.80                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       0                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	                  .         .         .         .         .  
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	                  .         .         .         .         .  
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVA    	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 216 - 1232 of	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						CA1H_HUMAN_V1, which also corresponds to amino acids 119 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1135 of HUMCOL18AX_P14, and a third amino acid sequence being	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						at least 70%, optionally at least 80%, preferably at least   	                  .         .         .         .         .  
						85%, more preferably at least 90% and most preferably at     	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						least 95% homologous to a polypeptide having the sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WLGPQRAQADRELL corresponding to amino acids 1136 - 1149 of   	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						HUMCOL18AX_P14, wherein said first amino acid sequence,      	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of HUMCOL18AX_P14, comprising	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						a polypeptide being at least 70%, optionally at least about  	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                  .         .         .         .         .  
						to the sequence of HUMCOL18AX_P14.3.An isolated polypeptide  	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						encoding for a tail of HUMCOL18AX_P14, comprising a          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						to the sequence WLGPQRAQADRELL in HUMCOL18AX_P14.            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .                                
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVA                               1135                                                         
						                                                            	         ||||||||||||||||||||                                
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVA                               1232                                                         

6088	HMR136_HUMCOL18AX_15_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P15 and                 	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						followed by a short unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for HUMCOL18AX_P15, comprising a first  	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment of: 6088 x CA1H_HUMAN_V1   ..                      
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 10764.00                      Escore:       0                                              
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:    1087                Total length:    1087                                               
						HUMCOL18AX_P15, a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.82                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.82                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       0                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	                  .         .         .         .         .  
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	                  .         .         .         .         .  
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	                  .         .         .         .         .  
						ELYVRVQNGFRKVQLEARTPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRA 	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						DDIL                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 216 - 1299 of	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						CA1H_HUMAN_V1, which also corresponds to amino acids 119 -   	                  .         .         .         .         .  
						1202 of HUMCOL18AX_P15, and a third amino acid sequence being	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						at least 70%, optionally at least 80%, preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least 90% and most preferably at     	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						least 95% homologous to a polypeptide having the sequence VL 	                  .         .         .         .         .  
						corresponding to amino acids 1203 - 1204 of HUMCOL18AX_P15,  	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of HUMCOL18AX_P15, comprising a polypeptide being at    	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                  .         .         .         .         .  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						preferably at least about 95% homologous to the sequence of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCOL18AX_P15.                                              	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1165                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .                      
						                                                            	    1166 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDIL              1202                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDIL              1299                                                         

6086	HMR136_HUMCOL18AX_17_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P17 and                 	Sequence name: CA1H_HUMAN                                    
						CA1H_HUMANunique head followed by partial WT sequence        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMCOL18AX_P17, comprising a first amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6086 x CA1H_HUMAN   ..                         
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 2895.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:     303                Total length:     303                                               
						HUMCOL18AX_P17, a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.34                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.34                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       0                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 216 - 515 of 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						CA1H_HUMAN, which also corresponds to amino acids 119 - 418  	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						of HUMCOL18AX_P17, and a third amino acid sequence being at  	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						homologous to a polypeptide having the sequence VRPPPCAPEPF  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 419 - 429 of HUMCOL18AX_P17,    	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of HUMCOL18AX_P17, comprising a polypeptide being at    	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						preferably at least about 95% homologous to the sequence of  	                  .         .         .         .         .  
						HUMCOL18AX_P17.3.An isolated polypeptide encoding for a tail 	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						of HUMCOL18AX_P17, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence VRPPPCAPEPF in 	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						HUMCOL18AX_P17.                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						                                                            	                                                             
						                                                            	     416 VKE                                                418                                                          
						                                                            	         |||                                                 
						                                                            	     513 VKE                                                515                                                          

6096	HMR136_HUMCOL18AX_18_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P18 and                 	Sequence name: CA1H_HUMAN                                    
						CA1H_HUMANunique head followed by partial WT sequence        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMCOL18AX_P18, comprising a first amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6096 x CA1H_HUMAN   ..                         
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 2053.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:     214                Total length:     214                                               
						HUMCOL18AX_P18, a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.07                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.07                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       0                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDG                              	Alignment:                                                   
						90 % homologous to corresponding to amino acids 216 - 426 of 	                  .         .         .         .         .  
						CA1H_HUMAN, which also corresponds to amino acids 119 - 329  	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						of HUMCOL18AX_P18, and a third amino acid sequence being at  	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GPRSQHAPREHGPTASLLGAWAGDAVDVDPQPRSWGRGQETPW corresponding to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 330 - 372 of HUMCOL18AX_P18, wherein said first  	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCOL18AX_P18, comprising a polypeptide being at least 70%, 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						least about 95% homologous to the sequence of                	                  .                                          
						HUMCOL18AX_P18.3.An isolated polypeptide encoding for a tail 	     316 PMHCLDEEGDDSDG                                     329                                                          
						of HUMCOL18AX_P18, comprising a polypeptide being at least   	         ||||||||||||||                                      
						70%, optionally at least about 80%, preferably at least about	     413 PMHCLDEEGDDSDG                                     426                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						GPRSQHAPREHGPTASLLGAWAGDAVDVDPQPRSWGRGQETPW in               	                                                            
						HUMCOL18AX_P18.                                              	                                                            

6100	HMR136_HUMCOL18AX_3_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P3 and                  	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCOL18AX_P3,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 6100 x CA1H_HUMAN_V1   ..                      
						preferably at least 90% and most preferably at least 95%     	                                                            
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	Alignment segment 1/1:                                       
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 12918.00                      Escore:       0                                              
						to amino acids 1 - 118 of HUMCOL18AX_P3, and a second amino  	             Matching length:    1304                Total length:    1304                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.85                                               
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                        Gaps:       0                        
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	                                                            
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	Alignment:                                                   
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	                  .         .         .         .         .  
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	                  .         .         .         .         .  
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	                  .         .         .         .         .  
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						ELYVRVQNGFRKVQLEARTPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRA 	                  .         .         .         .         .  
						DDILASPPRLPEPQPYPGAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGG 	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						MRGIRGADFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELLFPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRRLTESYCETWRTEA 	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						PSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFMTASK                    	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						to amino acids 216 - 1516 of CA1H_HUMAN_V1, which also       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 119 - 1419 of HUMCOL18AX_P3,      	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						isolated polypeptide encoding for a head of HUMCOL18AX_P3,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						about 95% homologous to the sequence of HUMCOL18AX_P3.       	                  .         .         .         .         .  
						                                                            	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1165                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1166 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1215                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1216 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1265                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1266 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1315                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1412                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1316 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1365                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1413 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1462                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1366 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1415                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1463 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1512                                                         
						                                                            	                                                             
						                                                            	    1416 TASK                                               1419                                                         
						                                                            	         ||||                                                
						                                                            	    1513 TASK                                               1516                                                         

6090	HMR136_HUMCOL18AX_5_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P5 and                  	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						featuring a skipped exon.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for HUMCOL18AX_P5, comprising a first amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6090 x CA1H_HUMAN_V1   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 12379.00                      Escore:       0                                              
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:    1260                Total length:    1304                                               
						HUMCOL18AX_P5, a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:   96.63      Total Percent Identity:   96.47                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       1                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	                  .         .         .         .         .  
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	                  .         .         .         .         .  
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMK                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 216 - 1089 of   	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						CA1H_HUMAN_V1, which also corresponds to amino acids 119 -   	                  .         .         .         .         .  
						992 of HUMCOL18AX_P5, and a third amino acid sequence being  	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						GPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSFPGPHRQTISVPGPPGPPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEAR 	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						TPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYPG 	                  .         .         .         .         .  
						APHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGADFQCFQQARAV 	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						GLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELLFPSWEALFSGSEGPLKPGARI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FSFDGKDVLRHPTWPQKSVWHGSDPNGRRLTESYCETWRTEAPSATGQASSLLGGRLLGQ 	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						SAASCHHAYIVLCIENSFMTASK                                      	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 1134	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						- 1516 of CA1H_HUMAN_V1, which also corresponds to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 993 - 1375 of HUMCOL18AX_P5, wherein said first amino  	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						isolated polypeptide encoding for a head of HUMCOL18AX_P5,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						about 95% homologous to the sequence of HUMCOL18AX_P5.3.An   	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						HUMCOL18AX_P5, comprising a polypeptide having a length "n", 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						at least two amino acids comprise KG, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						992-x to 993; and ending at any of amino acid numbers 993+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMK....................... 992                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     993 .....................GPKGESIRGQPGPPGPQGPPGIGYEGRQG 1021                                                         
						                                                            	                              |||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1022 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1071                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1072 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1121                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1122 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1171                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1172 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1221                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1222 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1271                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1412                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1272 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1321                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1413 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1462                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1322 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1371                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1463 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1512                                                         
						                                                            	                                                             
						                                                            	    1372 TASK                                               1375                                                         
						                                                            	         ||||                                                
						                                                            	    1513 TASK                                               1516                                                         

6102	HMR136_HUMCOL18AX_6_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P6 and                  	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCOL18AX_P6,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 6102 x CA1H_HUMAN_V1   ..                      
						preferably at least 90% and most preferably at least 95%     	                                                            
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	Alignment segment 1/1:                                       
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 12918.00                      Escore:       0                                              
						to amino acids 1 - 118 of HUMCOL18AX_P6, and a second amino  	             Matching length:    1304                Total length:    1304                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.85                                               
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                        Gaps:       0                        
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	                                                            
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	Alignment:                                                   
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	                  .         .         .         .         .  
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	                  .         .         .         .         .  
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	                  .         .         .         .         .  
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						ELYVRVQNGFRKVQLEARTPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRA 	                  .         .         .         .         .  
						DDILASPPRLPEPQPYPGAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGG 	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						MRGIRGADFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELLFPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRRLTESYCETWRTEA 	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						PSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFMTASK                    	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						to amino acids 216 - 1516 of CA1H_HUMAN_V1, which also       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 119 - 1419 of HUMCOL18AX_P6,      	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						isolated polypeptide encoding for a head of HUMCOL18AX_P6,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						about 95% homologous to the sequence of HUMCOL18AX_P6.       	                  .         .         .         .         .  
						                                                            	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1165                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1166 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1215                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1216 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1265                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1266 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1315                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1412                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1316 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1365                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1413 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1462                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1366 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1415                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1463 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1512                                                         
						                                                            	                                                             
						                                                            	    1416 TASK                                               1419                                                         
						                                                            	         ||||                                                
						                                                            	    1513 TASK                                               1516                                                         

6094	HMR136_HUMCOL18AX_7_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P7 and                  	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						featuring a skipped exon.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for HUMCOL18AX_P7, comprising a first amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6094 x CA1H_HUMAN_V1   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 12713.00                      Escore:       0                                              
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:    1293                Total length:    1304                                               
						HUMCOL18AX_P7, a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:   99.16      Total Percent Identity:   99.00                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       1                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	                  .         .         .         .         .  
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	                  .         .         .         .         .  
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	                  .         .         .         .         .  
						ELYVRVQNGFRKVQ                                               	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						% homologous to corresponding to amino acids 216 - 1249 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CA1H_HUMAN_V1, which also corresponds to amino acids 119 -   	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						1152 of HUMCOL18AX_P7, and a third amino acid sequence being 	                  .         .         .         .         .  
						DNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYPGAPHHSSY 	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						VHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGADFQCFQQARAVGLAGTFR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AFLSSRLQDLYSIVRRADRAAVPIVNLKDELLFPSWEALFSGSEGPLKPGARIFSFDGKD 	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						VLRHPTWPQKSVWHGSDPNGRRLTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHH 	                  .         .         .         .         .  
						AYIVLCIENSFMTASK                                             	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						at least 90 % homologous to corresponding to amino acids 1261	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 1516 of CA1H_HUMAN_V1, which also corresponds to amino     	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						acids 1153 - 1408 of HUMCOL18AX_P7, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, second amino acid sequence and third amino    	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of HUMCOL18AX_P7,   	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                  .         .         .         .         .  
						about 95% homologous to the sequence of HUMCOL18AX_P7.3.An   	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCOL18AX_P7, comprising a polypeptide having a length "n", 	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise QD, having a structure as  	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1152-x to 1153; and ending at any of amino acid numbers 1153+	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQ...........DN 1154                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||           ||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1155 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1204                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1205 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1254                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1255 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1304                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1412                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1305 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1354                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1413 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1462                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1355 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1404                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1463 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1512                                                         
						                                                            	                                                             
						                                                            	    1405 TASK                                               1408                                                         
						                                                            	         ||||                                                
						                                                            	    1513 TASK                                               1516                                                         

6104	HMR136_HUMCOL18AX_8_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P8 and                  	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMCOL18AX_P8,    	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 6104 x CA1H_HUMAN_V1   ..                      
						preferably at least 90% and most preferably at least 95%     	                                                            
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	Alignment segment 1/1:                                       
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 12918.00                      Escore:       0                                              
						to amino acids 1 - 118 of HUMCOL18AX_P8, and a second amino  	             Matching length:    1304                Total length:    1304                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.85                                               
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                        Gaps:       0                        
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	                                                            
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	Alignment:                                                   
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	                  .         .         .         .         .  
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	                  .         .         .         .         .  
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	                  .         .         .         .         .  
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						ELYVRVQNGFRKVQLEARTPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRA 	                  .         .         .         .         .  
						DDILASPPRLPEPQPYPGAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGG 	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						MRGIRGADFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELLFPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRRLTESYCETWRTEA 	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						PSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFMTASK                    	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						to amino acids 216 - 1516 of CA1H_HUMAN_V1, which also       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 119 - 1419 of HUMCOL18AX_P8,      	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						isolated polypeptide encoding for a head of HUMCOL18AX_P8,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						about 95% homologous to the sequence of HUMCOL18AX_P8.       	                  .         .         .         .         .  
						                                                            	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1165                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1166 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1215                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1216 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1265                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1266 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1315                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1412                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1316 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1365                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1413 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTWPQKSVWHGSDPNGRR 1462                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1366 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1415                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1463 LTESYCETWRTEAPSATGQASSLLGGRLLGQSAASCHHAYIVLCIENSFM 1512                                                         
						                                                            	                                                             
						                                                            	    1416 TASK                                               1419                                                         
						                                                            	         ||||                                                
						                                                            	    1513 TASK                                               1516                                                         

6108	HMR136_HUMCOL18AX_9_tr0_r1_1_gPRT		Comparison report between HUMCOL18AX_P9 and                  	Sequence name: CA1H_HUMAN_V1                                 
						CA1H_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for HUMCOL18AX_P9, comprising a first amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6108 x CA1H_HUMAN_V1   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	                                                            
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                     Quality: 12230.00                      Escore:       0                                              
						having the sequence corresponding to amino acids 1 - 118 of  	             Matching length:    1235                Total length:    1235                                               
						HUMCOL18AX_P9, a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						ERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARYHFPSLFFRDFSLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.84                                               
						FHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGHQDISLLYTEPGAGQTHTAASFRL 	                        Gaps:       0                        
						PAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLARSSRGLELEPGAGLFVAQAGGADPDK 	                                                            
						FQGVIAELKVRRDPQVSPMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLP 	Alignment:                                                   
						APPPVTTPPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGRVKE 	                  .         .         .         .         .  
						GGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPALQTVPGPQGPPGPP 	     116 PAAERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 165                                                          
						GRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVGPKGDKGDPGVGERGPPGPQGPPG 	         |::|||||||||||||||||||||||||||||||||||||||||||||||  
						PPGPSFRHDKLTFIDMEGSGFGGDLEALRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDV 	     213 PSSERISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVARY 262                                                          
						PGPAGLPGVPGREGPPGFPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGP 	                  .         .         .         .         .  
						AGARGESGLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQGPP 	     166 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 215                                                          
						GLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGDRGSRGEKGDPGKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRPGFAGFPGPAGPKGNLGSKGERGS 	     263 HFPSLFFRDFSLLFHIRPATEGPGVLFAITDSAQAMVLLGVKLSGVQDGH 312                                                          
						PGPKGEKGEPGSIFSPDGGALGPAQKGAKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPG 	                  .         .         .         .         .  
						MNGLKGEKGEPGDASLGFGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGN 	     216 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 265                                                          
						QGPPGPKGAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGFFGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQGPPGPPGPPGPPSF 	     313 QDISLLYTEPGAGQTHTAASFRLPAFVGQWTHLALSVAGGFVALYVDCEE 362                                                          
						PGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWATRQAMLGQVHEVPEGWLIFVAEQE 	                  .         .         .         .         .  
						ELYVRVQNGFRKVQLEARTPLPRGTDNEVAALQPPVVQLHDSNPYPRREHPHPTARPWRA 	     266 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 315                                                          
						DDILASPPRLPEPQPYPGAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MRGIRGADFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELLFPS 	     363 FQRMPLARSSRGLELEPGAGLFVAQAGGADPDKFQGVIAELKVRRDPQVS 412                                                          
						WEALFSGSEGPLKPGARIFSFDGKDVLRHPTW                             	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 216 - 1447 of   	     316 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 365                                                          
						CA1H_HUMAN_V1, which also corresponds to amino acids 119 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1350 of HUMCOL18AX_P9, and a third amino acid sequence being 	     413 PMHCLDEEGDDSDGAFGDSGSGLGDARELLREETGAALKPRLPAPPPVTT 462                                                          
						at least 70%, optionally at least 80%, preferably at least   	                  .         .         .         .         .  
						85%, more preferably at least 90% and most preferably at     	     366 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 415                                                          
						least 95% homologous to a polypeptide having the sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TWLPYFPV corresponding to amino acids 1351 - 1358 of         	     463 PPLAGGSSTEDSRSEEVEEQTTVASLGAQTLPGSDSVSTWDGSVRTPGGR 512                                                          
						HUMCOL18AX_P9, wherein said first amino acid sequence, second	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     416 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 465                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of HUMCOL18AX_P9, comprising 	     513 VKEGGLKGQKGEPGVPGPPGRAGPPGSPCLPGPPGLPCPVSPLGPAGPAL 562                                                          
						a polypeptide being at least 70%, optionally at least about  	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     466 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 515                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RCLPLPPSLPVCGHLGISRFWLPNHLHHESGEQVRAGARAWGGLLQTHCHPFLAWFFCLL 	     563 QTVPGPQGPPGPPGRDGTPGRDGEPGDPGEDGKPGDTGPQGFPGTPGDVG 612                                                          
						LVPPCGSVPPPAPPPCCQFCEALQDACWSRLGGGRLPVACASLPTQEDGYCVLIGPAA   	                  .         .         .         .         .  
						to the sequence of HUMCOL18AX_P9.3.An isolated polypeptide   	     516 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 565                                                          
						encoding for a tail of HUMCOL18AX_P9, comprising a           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     613 PKGDKGDPGVGERGPPGPQGPPGPPGPSFRHDKLTFIDMEGSGFGGDLEA 662                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     566 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 615                                                          
						to the sequence TWLPYFPV in HUMCOL18AX_P9.                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     663 LRGPRGFPGPPGPPGVPGLPGEPGRFGVNSSDVPGPAGLPGVPGREGPPG 712                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 665                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     713 FPGLPGPPGPPGREGPPGRTGQKGSLGEAGAPGHKGSKGAPGPAGARGES 762                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     666 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 715                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 GLAGAPGPAGPPGPPGPPGPPGPGLPAGFDDMEGSGGPFWSTARSADGPQ 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     716 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 765                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 GPPGLPGLKGDPGVPGLPGAKGEVGADGVPGFPGLPGREGIAGPQGPKGD 862                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     766 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     863 RGSRGEKGDPGKDGVGQPGLPGPPGPPGPVVYVSEQDGSVLSVPGPEGRP 912                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     816 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 865                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     913 GFAGFPGPAGPKGNLGSKGERGSPGPKGEKGEPGSIFSPDGGALGPAQKG 962                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     866 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 915                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     963 AKGEPGFRGPPGPYGRPGYKGEIGFPGRPGRPGMNGLKGEKGEPGDASLG 1012                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     916 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 965                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1013 FGMRGMPGPPGPPGPPGPPGTPVYDSNVFAESSRPGPPGLPGNQGPPGPK 1062                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     966 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1015                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1063 GAKGEVGPPGPPGQFPFDFLQLEAEMKGEKGDRGDAGQKGERGEPGGGGF 1112                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1065                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1113 FGSSLPGPPGPPGPRGYPGIPGPKGESIRGQPGPPGPQGPPGIGYEGRQG 1162                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1066 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1115                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 PPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVRLWAT 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1116 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1165                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 RQAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFRKVQLEARTPLPRGTDN 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1166 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1215                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 EVAALQPPVVQLHDSNPYPRREHPHPTARPWRADDILASPPRLPEPQPYP 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1216 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1265                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 GAPHHSSYVHLRPARPTSPPAHSHRDFQPVLHLVALNSPLSGGMRGIRGA 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1266 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1315                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 DFQCFQQARAVGLAGTFRAFLSSRLQDLYSIVRRADRAAVPIVNLKDELL 1412                                                         
						                                                            	                  .         .         .                      
						                                                            	    1316 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTW                1350                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	    1413 FPSWEALFSGSEGPLKPGARIFSFDGKDVLRHPTW                1447                                                         

6155	HMR136_HUMCOL2A1B_14_tr0_r1_1_gPRT		Comparison report between HUMCOL2A1B_P14 and                 	Sequence name: CA12_HUMAN_V1                                 
						CA12_HUMAN_V1partial WT sequence followed by unique insertion	                                                            
						with extra amino acids and a featuring a skipped exon.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for HUMCOL2A1B_P14,   	                                                            
						comprising a first amino acid sequence being at least 90 %   	Alignment of: 6155 x CA12_HUMAN_V1   ..                      
						homologous to MIRLGAPQTLVLLTLLVAAVLRCQGQDV corresponding to  	                                                            
						amino acids 1 - 28 of CA12_HUMAN_V1, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 28 of HUMCOL2A1B_P14, a second amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1131.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     137                Total length:    1487                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.27                                               
						QEAGSCVQDGQRYNDKDVWKPEPCRICVCDTGTVLCDDIICEDVKDCLSPEIPFGECCPI 	    Total Percent Similarity:    9.21      Total Percent Identity:    9.15                                               
						CPTDLATASG                                                   	                        Gaps:       2                        
						having the sequence corresponding to amino acids 29 - 98 of  	                                                            
						HUMCOL2A1B_P14, a third amino acid sequence being at least 90	Alignment:                                                   
						% homologous to QPGPKGQKGEPGDIKDIVGPKGPPGPQGPAGEQGPRGDRGDKGEK	                  .         .         .         .         .  
						corresponding to amino acids 30 - 74 of CA12_HUMAN_V1, which 	       1 MIRLGAPQTLVLLTLLVAAVLRCQGQDVQEAGSCVQDGQRYNDKDVWKPE 50                                                           
						also corresponds to amino acids 99 - 143 of HUMCOL2A1B_P14,  	         ||||||||||||||||||||||||||||:                       
						and a fourth amino acid sequence being at least 90 %         	       1 MIRLGAPQTLVLLTLLVAAVLRCQGQDVR..................... 29                                                           
						GNSRFTYTALKDGCTKHTGKWGKTVIEYRSQKTSRLPIIDIAPMDIGGPEQEFGVDIGPV 	                  .         .         .         .         .  
						CFL                                                          	      51 PCRICVCDTGTVLCDDIICEDVKDCLSPEIPFGECCPICPTDLATASGQP 100                                                          
						homologous to corresponding to amino acids 1356 - 1418 of    	                                                         ||  
						CA12_HUMAN_V1, which also corresponds to amino acids 144 -   	      30 ................................................QP 31                                                           
						206 of HUMCOL2A1B_P14, wherein said first amino acid         	                  .         .         .         .         .  
						sequence, second amino acid sequence, third amino acid       	     101 GPKGQKGEPGDIKDIVGPKGPPGPQGPAGEQGPRGDRGDKGEK....... 143                                                          
						sequence and fourth amino acid sequence are contiguous and in	         |||||||||||||||||||||||||||||||||||||||||||         
						a sequential order.2.An isolated polypeptide encoding for an 	      32 GPKGQKGEPGDIKDIVGPKGPPGPQGPAGEQGPRGDRGDKGEKGAPGPRG 81                                                           
						edge portion of HUMCOL2A1B_P14, comprising an amino acid     	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least about 80%,  	     143 .................................................. 143                                                          
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	      82 RDGEPGTLGNPGPPGPPGPPGPPGLGGNFAAQMAGGFDEKAGGAQLGVMQ 131                                                          
						QEAGSCVQDGQRYNDKDVWKPEPCRICVCDTGTVLCDDIICEDVKDCLSPEIPFGECCPI 	                  .         .         .         .         .  
						CPTDLATASG,                                                  	     143 .................................................. 143                                                          
						sequence encoding for corresponding to HUMCOL2A1B_P14.3.A    	                                                            
						bridge portion of HUMCOL2A1B_P14, comprising a polypeptide   	     132 GPMGPMGPRGPPGPAGAPGPQGFQGNPGEPGEPGVSGPMGPRGPPGPPGK 181                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     143 .................................................. 143                                                          
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	     182 PGDDGEAGKPGKAGERGPPGPQGARGFPGTPGLPGVKGHRGYPGLDGAKG 231                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise VQ, having a       	     143 .................................................. 143                                                          
						structure as follows (numbering according to HUMCOL2A1B_P14):	                                                            
						a sequence starting from any of amino acid numbers 28-x to   	     232 EAGAPGVKGESGSPGENGSPGPMGPRGLPGERGRTGPAGAAGARGNDGQP 281                                                          
						28; and ending at any of amino acid numbers 29 + ((n-2) - x),	                  .         .         .         .         .  
						in which x varies from 0 to n-2.4.An isolated chimeric       	     143 .................................................. 143                                                          
						polypeptide encoding for an edge portion of HUMCOL2A1B_P14,  	                                                            
						comprising a polypeptide having a length "n", wherein n is at	     282 GPAGPPGPVGPAGGPGFPGAPGAKGEAGPTGARGPEGAQGPRGEPGTPGS 331                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     143 .................................................. 143                                                          
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	     332 PGPAGASGNPGTDGIPGAKGSAGAPGIAGAPGFPGPRGPPDPQGATGPLG 381                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise KG, having a structure as follows: a sequence       	     143 .................................................. 143                                                          
						starting from any of amino acid numbers 143-x to 144; and    	                                                            
						ending at any of amino acid numbers 144+ ((n-2) - x), in     	     382 PKGQTGKPGIAGFKGEQGPKGEPGPAGPQGAPGPAGEEGKRGARGEPGGV 431                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     432 GPIGPPGERGAPGNRGFPGQDGLAGPKGAPGERGPSGLAGPKGANGDPGR 481                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     482 PGEPGLPGARGLTGRPGDAGPQGKVGPSGAPGEDGRPGPPGPQGARGQPG 531                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     532 VMGFPGPKGANGEPGKAGEKGLPGAPGLRGLPGKDGETGAEGPPGPAGPA 581                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     582 GERGEQGAPGPSGFQGLPGPPGPPGEGGKPGDQGVPGEAGAPGLVGPRGE 631                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     632 RGFPGERGSPGAQGLQGPRGLPGTPGTDGPKGASGPAGPPGAQGPPGLQG 681                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     682 MPGERGAAGIAGPKGDRGDVGEKGPEGAPGKDGGRGLTGPIGPPGPAGAN 731                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     732 GEKGEVGPPGPAGSAGARGAPGERGETGPPGTSGIAGPPGADGQPGAKGE 781                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     782 QGEAGQKGDAGAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPGATGFPG 831                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     832 AAGRVGPPGSNGNPGPPGPPGPSGKDGPKGARGDSGPPGRAGEPGLQGPA 881                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     882 GPPGEKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGP 931                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     932 SGEPGQQGAPGASGDRGPPGPVGPPGLTGPAGEPGREGSPGADGPPGRDG 981                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	     982 AAGVKGDRGETGAVGAPGAPGPPGSPGPAGPTGKQGDRGEAGAQGPMGPS 1031                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	    1032 GPAGARGIQGPQGPRGDKGEAGEPGERGLKGHRGFTGLQGLPGPPGPSGD 1081                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	    1082 QGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRSGETGPAG 1131                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	    1132 PPGNPGPPGPPGPPGPGIDMSAFAGLGPREKGPDPLQYMRADQAAGGLRQ 1181                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	    1182 HDAEVDATLKSLNNQIESIRSPEGSRKNPARTCRDLKLCHPEWKSGDYWI 1231                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	    1232 DPNQGCTLDAMKVFCNMETGETCVYPNPANVPKKNWWSSKSKEKKHIWFG 1281                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     143 .................................................. 143                                                          
						                                                            	                                                            
						                                                            	    1282 ETINGGFHFSYGDDNLAPNTANVQMTFLRLLSTEGSQNITYHCKNSIAYL 1331                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     144 ........................GNSRFTYTALKDGCTKHTGKWGKTVI 169                                                          
						                                                            	                                 ||||||||||||||||||||||||||  
						                                                            	    1332 DEAAGNLKKALLIQGSNDVEIRAEGNSRFTYTALKDGCTKHTGKWGKTVI 1381                                                         
						                                                            	                  .         .         .                      
						                                                            	     170 EYRSQKTSRLPIIDIAPMDIGGPEQEFGVDIGPVCFL              206                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	    1382 EYRSQKTSRLPIIDIAPMDIGGPEQEFGVDIGPVCFL              1418                                                         

6157	HMR136_HUMCOL2A1B_5_tr0_r1_1_gPRT		Comparison report between HUMCOL2A1B_P5 and Q96IT5unique     	Sequence name: Q96IT5                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMCOL2A1B_P5, comprising a first   	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 6157 x Q96IT5   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						PPFFSCPQGAPGIAGAPGFPGPRGPPGPQGATGPLGPKGQTGEPGIAGFKGEQGPKGEPG 	Alignment segment 1/1:                                       
						PAGPQGAPGPAGEEGKRGARGEPGGVGPIGPPGERGAPGNRGFPGQDGLAGPKGAPGERG 	                                                            
						PSGLAGPKGANGDPGRPGEPGLPGARGLTGRPGDAGPQGKVGPSGAPGEDGRPGPPGPQG 	                     Quality: 2685.00                      Escore:       0                                               
						ARGQPGVMGFPGPKGANGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGERG 	             Matching length:     268                Total length:     268                                               
						EQGAPGPSGFQGLPGPPGPPGEGGKPGDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQGPRGLPGTPGTDGPKGASGPAGPPGAQGPPGLQGMPGERGAAGIAGPKGDRGDVGEKG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PEGAPGKDGGRGLTGPIGPPGPAGANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPAG 	                        Gaps:       0                        
						FAGPPGADGQPGAKGEQGEAGQKGDAGAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPG 	                                                            
						ATGFPGAAGRVGPPGSNGNPGPPGPPGPSGKDGPKGARGDSGPPGRAGEPGLQGPAGPPG 	Alignment:                                                   
						EKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGPSGEPGKQGAPGASG 	                  .         .         .         .         .  
						DRGPPGPVGPPGLTGPAGEPGREGSPGADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPG 	     806 MSAFAGLGPREKGPDPLQYMRADQAAGGLRQHDAEVDATLKSLNNQIESI 855                                                          
						SPGPAGPTGKQGDRGEAGAQGPMGPSGPAGARGIQGPQGPRGDKGEAGEPGERGLKGHRG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRSG 	       1 MSAFAGLGPREKGPDPLQYMRADQAAGGLRQHDAEVDATLKSLNNQIESI 50                                                           
						ETGPAGPPGNPGPPGPPGPPGPGID                                    	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1 - 805 of  	     856 RSPEGSRKNPARTCRDLKLCHPEWKSGDYWIDPNQGCTLDAMKVFCNMET 905                                                          
						HUMCOL2A1B_P5, and a second amino acid sequence being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSAFAGLGPREKGPDPLQYMRADQAAGGLRQHDAEVDATLKSLNNQIESIRSPEGSRKNP 	      51 RSPEGSRKNPARTCRDLKLCHPEWKSGDYWIDPNQGCTLDAMKVFCNMET 100                                                          
						ARTCRDLKLCHPEWKSGDYWIDPNQGCTLDAMKVFCNMETGETCVYPNPANVPKKNWWSS 	                  .         .         .         .         .  
						KSKEKKHIWFGETINGGFHFSYGDDNLAPNTANVQMTFLRLLSTEGSQNITYHCKNSIAY 	     906 GETCVYPNPANVPKKNWWSSKSKEKKHIWFGETINGGFHFSYGDDNLAPN 955                                                          
						LDEAAGNLKKALLIQGSNDVEIRAEGNSRFTYTALKDGCTKHTGKWGKTVIEYRSQKTSR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPIIDIAPMDIGGPEQEFGVDIGPVCFL                                 	     101 GETCVYPNPANVPKKNWWSSKSKEKKHIWFGETINGGFHFSYGDDNLAPN 150                                                          
						least 90 % homologous to corresponding to amino acids 1 - 268	                  .         .         .         .         .  
						of Q96IT5, which also corresponds to amino acids 806 - 1073  	     956 TANVQMTFLRLLSTEGSQNITYHCKNSIAYLDEAAGNLKKALLIQGSNDV 1005                                                         
						of HUMCOL2A1B_P5, wherein said first amino acid sequence and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     151 TANVQMTFLRLLSTEGSQNITYHCKNSIAYLDEAAGNLKKALLIQGSNDV 200                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						HUMCOL2A1B_P5, comprising a polypeptide being at least 70%,  	    1006 EIRAEGNSRFTYTALKDGCTKHTGKWGKTVIEYRSQKTSRLPIIDIAPMD 1055                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     201 EIRAEGNSRFTYTALKDGCTKHTGKWGKTVIEYRSQKTSRLPIIDIAPMD 250                                                          
						PPFFSCPQGAPGIAGAPGFPGPRGPPGPQGATGPLGPKGQTGEPGIAGFKGEQGPKGEPG 	                  .                                          
						PAGPQGAPGPAGEEGKRGARGEPGGVGPIGPPGERGAPGNRGFPGQDGLAGPKGAPGERG 	    1056 IGGPEQEFGVDIGPVCFL                                 1073                                                         
						PSGLAGPKGANGDPGRPGEPGLPGARGLTGRPGDAGPQGKVGPSGAPGEDGRPGPPGPQG 	         ||||||||||||||||||                                  
						ARGQPGVMGFPGPKGANGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGERG 	     251 IGGPEQEFGVDIGPVCFL                                 268                                                          
						EQGAPGPSGFQGLPGPPGPPGEGGKPGDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQG 	                                                            
						LQGPRGLPGTPGTDGPKGASGPAGPPGAQGPPGLQGMPGERGAAGIAGPKGDRGDVGEKG 	                                                            
						PEGAPGKDGGRGLTGPIGPPGPAGANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPAG 	                                                            
						FAGPPGADGQPGAKGEQGEAGQKGDAGAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPG 	                                                            
						ATGFPGAAGRVGPPGSNGNPGPPGPPGPSGKDGPKGARGDSGPPGRAGEPGLQGPAGPPG 	                                                            
						EKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGPSGEPGKQGAPGASG 	                                                            
						DRGPPGPVGPPGLTGPAGEPGREGSPGADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPG 	                                                            
						SPGPAGPTGKQGDRGEAGAQGPMGPSGPAGARGIQGPQGPRGDKGEAGEPGERGLKGHRG 	                                                            
						FTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRSG 	                                                            
						ETGPAGPPGNPGPPGPPGPPGPGID                                    	                                                            
						least about 95% homologous to the sequence of HUMCOL2A1B_P5. 	                                                            

14658	HMR136_HUMCP45IV_3_tr0_r1_1_gPRT		Comparison report between HUMCP45IV_P3 and                   	Sequence name: CP4B_HUMAN_V1                                 
						CP4B_HUMAN_V1partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCP45IV_P3, comprising a first amino acid sequence being at	                                                            
						MVPSFLSLSFSSLGLWASGLILVLGFLKLIHLLLRRQTLAKAMDKFPGPPTHWLFGHALE 	Alignment of: 14658 x CP4B_HUMAN_V1   ..                     
						IQETGSLDKVVSWAHQFPYAHPLWFGQFIGFLNIYEPDYAKAVYSRGDPKAPDVYDFFLQ 	                                                            
						WIGRGLLVLEGPKWLQHRKLLTPGFHYDVLKPYVAVFTESTRIMLDKWEEKAREGKSFDI 	Alignment segment 1/1:                                       
						FCDVGHMALNTLMKCTFGRGDTGLGHRDSSYYLAVSDLTLLMQQRLVSFQYHNDFIYWLT 	                                                            
						PHGRRFLRACQVAHDHT                                            	                     Quality: 2572.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 1 - 257	             Matching length:     257                Total length:     257                                               
						of CP4B_HUMAN_V1, which also corresponds to amino acids 1 -  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						257 of HUMCP45IV_P3, and a second amino acid sequence being  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						at least 70%, optionally at least 80%, preferably at least   	                        Gaps:       0                        
						85%, more preferably at least 90% and most preferably at     	                                                            
						GGPFPQGSPSVLLVQTRSSGSGRQPCRMRRCGRRSRTGGTWTSWTFSWVPGMKMTSNCQM 	Alignment:                                                   
						QTSGLKWTHSCLKAMTPPPVVSPGFSTAWPCTLSTSIVVERRSARS               	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	       1 MVPSFLSLSFSSLGLWASGLILVLGFLKLIHLLLRRQTLAKAMDKFPGPP 50                                                           
						corresponding to amino acids 258 - 363 of HUMCP45IV_P3,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	       1 MVPSFLSLSFSSLGLWASGLILVLGFLKLIHLLLRRQTLAKAMDKFPGPP 50                                                           
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HUMCP45IV_P3,    	      51 THWLFGHALEIQETGSLDKVVSWAHQFPYAHPLWFGQFIGFLNIYEPDYA 100                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	      51 THWLFGHALEIQETGSLDKVVSWAHQFPYAHPLWFGQFIGFLNIYEPDYA 100                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						GGPFPQGSPSVLLVQTRSSGSGRQPCRMRRCGRRSRTGGTWTSWTFSWVPGMKMTSNCQM 	     101 KAVYSRGDPKAPDVYDFFLQWIGRGLLVLEGPKWLQHRKLLTPGFHYDVL 150                                                          
						QTSGLKWTHSCLKAMTPPPVVSPGFSTAWPCTLSTSIVVERRSARS               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence in HUMCP45IV_P3.        	     101 KAVYSRGDPKAPDVYDFFLQWIGRGLLVLEGPKWLQHRKLLTPGFHYDVL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KPYVAVFTESTRIMLDKWEEKAREGKSFDIFCDVGHMALNTLMKCTFGRG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 KPYVAVFTESTRIMLDKWEEKAREGKSFDIFCDVGHMALNTLMKCTFGRG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DTGLGHRDSSYYLAVSDLTLLMQQRLVSFQYHNDFIYWLTPHGRRFLRAC 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DTGLGHRDSSYYLAVSDLTLLMQQRLVSFQYHNDFIYWLTPHGRRFLRAC 250                                                          
						                                                            	                                                             
						                                                            	     251 QVAHDHT                                            257                                                          
						                                                            	         |||||||                                             
						                                                            	     251 QVAHDHT                                            257                                                          

14917	HMR136_HUMCPTP_7_tr0_r1_1_gPRT		Comparison report between HUMCPTP_P7 and PTN2_HUMANpartial   	Sequence name: PTN2_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCPTP_P7, comprising a first amino	Sequence documentation:                                      
						MVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLL 	                                                            
						QLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHCSAG 	Alignment of: 14917 x PTN2_HUMAN   ..                        
						IGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCI 	                                                            
						KGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYNGNRIGLEEEKLTGDRCTGLSSKMQD 	Alignment segment 1/1:                                       
						TMEENSESALRKRIREDRKATTAQKVQQMKQRLNENERKRKR                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2791.00                      Escore:       0                                               
						to amino acids 100 - 381 of PTN2_HUMAN, which also           	             Matching length:     282                Total length:     282                                               
						corresponds to amino acids 1 - 282 of HUMCPTP_P7, and a      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence PRLTDT corresponding to amino	Alignment:                                                   
						acids 283 - 288 of HUMCPTP_P7, wherein said first amino acid 	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSED 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUMCPTP_P7, comprising a polypeptide being at least  	     100 MVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSED 149                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 VKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKV 100                                                          
						at least about 95% homologous to the sequence PRLTDT in      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMCPTP_P7.                                                  	     150 VKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKV 199                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     200 RESGSLNPDHGPAVIHCSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLL 249                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     250 NMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSP 299                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AFDHSPNKIMTEKYNGNRIGLEEEKLTGDRCTGLSSKMQDTMEENSESAL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     300 AFDHSPNKIMTEKYNGNRIGLEEEKLTGDRCTGLSSKMQDTMEENSESAL 349                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 RKRIREDRKATTAQKVQQMKQRLNENERKRKR                   282                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     350 RKRIREDRKATTAQKVQQMKQRLNENERKRKR                   381                                                          

15077	HMR136_HUMCRABP_5_tr0_r1_1_gPRT		Comparison report between HUMCRABP_P5 and                    	Sequence name: RET4_HUMAN_V1                                 
						RET4_HUMAN_V1partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCRABP_P5, comprising a first amino acid sequence being at 	                                                            
						MPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVR 	Alignment of: 15077 x RET4_HUMAN_V1   ..                     
						TTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTRELTNDGEL 	                                                            
						IL                                                           	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 122	                                                            
						of RET4_HUMAN_V1, which also corresponds to amino acids 1 -  	                     Quality: 1191.00                      Escore:       0                                               
						122 of HUMCRABP_P5, and a second amino acid sequence being at	             Matching length:     122                Total length:     122                                               
						least 70%, optionally at least 80%, preferably at least 85%, 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						more preferably at least 90% and most preferably at least 95%	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence VSPASS       	                        Gaps:       0                        
						corresponding to amino acids 123 - 128 of HUMCRABP_P5,       	                                                            
						wherein said first amino acid sequence and second amino acid 	Alignment:                                                   
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of HUMCRABP_P5,     	       1 MPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDT 50                                                           
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	       1 MPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDT 50                                                           
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence VSPASS in HUMCRABP_P5.  	      51 FYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKL 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 LKGEGPKTSWTRELTNDGELIL                             122                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     101 LKGEGPKTSWTRELTNDGELIL                             122                                                          

15546	HMR136_HUMCRE_5_tr0_r1_1_gPRT		Comparison report between HUMCRE_P5 and DHCA_HUMAN_V1partial 	Sequence name: DHCA_HUMAN_V1                                 
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMCRE_P5, comprising a first amino 	Sequence documentation:                                      
						MSSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQLQAEGLSPRFH 	                                                            
						QLDIDDLQSIRALRDFLRKEYGGLDVLVNNAGIAFKVADPTPFHIQAEVTMKTNFFGTRD 	Alignment of: 15546 x DHCA_HUMAN_V1   ..                     
						VCTELLPLIKPQGRVVNVSSIMSVRALKSCSPELQQKFRSETITEEELVGLMNKFVEDTK 	                                                            
						KGVHQKEGWPSSAYGVTK                                           	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 198 of DHCA_HUMAN_V1, which also          	                     Quality: 2224.00                      Escore:       0                                               
						corresponds to amino acids 1 - 198 of HUMCRE_P5, and a second	             Matching length:     241                Total length:     277                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MAGPKATKSPEEGAETPVYLALLPPDAEGPHGQFVSEKRVEQW corresponding to 	    Total Percent Similarity:   87.00      Total Percent Identity:   87.00                                               
						amino acids 235 - 277 of DHCA_HUMAN_V1, which also           	                        Gaps:       1                        
						corresponds to amino acids 199 - 241 of HUMCRE_P5, wherein   	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	       1 MSSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQL 50                                                           
						HUMCRE_P5, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	       1 MSSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQL 50                                                           
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      51 QAEGLSPRFHQLDIDDLQSIRALRDFLRKEYGGLDVLVNNAGIAFKVADP 100                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	      51 QAEGLSPRFHQLDIDDLQSIRALRDFLRKEYGGLDVLVNNAGIAFKVADP 100                                                          
						at least two amino acids comprise KM, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     101 TPFHIQAEVTMKTNFFGTRDVCTELLPLIKPQGRVVNVSSIMSVRALKSC 150                                                          
						198-x to 199; and ending at any of amino acid numbers 199+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     101 TPFHIQAEVTMKTNFFGTRDVCTELLPLIKPQGRVVNVSSIMSVRALKSC 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPELQQKFRSETITEEELVGLMNKFVEDTKKGVHQKEGWPSSAYGVTK.. 198                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     151 SPELQQKFRSETITEEELVGLMNKFVEDTKKGVHQKEGWPSSAYGVTKIG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     199 ..................................MAGPKATKSPEEGAET 214                                                          
						                                                            	                                           ||||||||||||||||  
						                                                            	     201 VTVLSRIHARKLSEQRKGDKILLNACCPGWVRTDMAGPKATKSPEEGAET 250                                                          
						                                                            	                  .         .                                
						                                                            	     215 PVYLALLPPDAEGPHGQFVSEKRVEQW                        241                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     251 PVYLALLPPDAEGPHGQFVSEKRVEQW                        277                                                          

15745	HMR136_HUMCRFRA_6_tr0_r1_1_gPRT		Comparison report between HUMCRFRA_P6 and CRF1_HUMANpartial  	Sequence name: CRF1_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMCRFRA_P6, comprising a first amino acid sequence being at 	                                                            
						MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPA 	Alignment of: 15745 x CRF1_HUMAN   ..                        
						GQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYSECQEILNEEKKSKVHYHVAV 	                                                            
						IINYLGHCISLVALLVAFVLFLRL                                     	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 144	                                                            
						of CRF1_HUMAN, which also corresponds to amino acids 1 - 144 	                     Quality: 1722.00                      Escore:       0                                               
						of HUMCRFRA_P6, a second amino acid sequence being at least  	             Matching length:     185                Total length:     214                                               
						90 % homologous to RSIRCLRNIIHWNLISAFILRNATWFVVQLTMSPEVHQSNV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 174 - 214 of CRF1_HUMAN, which  	    Total Percent Similarity:   86.45      Total Percent Identity:   86.45                                               
						also corresponds to amino acids 145 - 185 of HUMCRFRA_P6, and	                        Gaps:       1                        
						a third amino acid sequence being at least 70%, optionally at	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	       1 MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDL 50                                                           
						VCPSPSLWPGPLGSCTTTMRSAGLAKGLGCTPTTSTRAP corresponding to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 186 - 224 of HUMCRFRA_P6, wherein said first     	       1 MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDL 50                                                           
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      51 IGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYS 100                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of HUMCRFRA_P6, comprising a polypeptide having a    	      51 IGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYS 100                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     101 ECQEILNEEKKSKVHYHVAVIINYLGHCISLVALLVAFVLFLRL...... 144                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||        
						preferably at least about 40 amino acids in length and most  	     101 ECQEILNEEKKSKVHYHVAVIINYLGHCISLVALLVAFVLFLRLRPGCTH 150                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise LR, having a structure as  	     145 .......................RSIRCLRNIIHWNLISAFILRNATWFV 171                                                          
						follows: a sequence starting from any of amino acid numbers  	                                |||||||||||||||||||||||||||  
						144-x to 145; and ending at any of amino acid numbers 145+   	     151 WGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFV 200                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .                                          
						polypeptide encoding for a tail of HUMCRFRA_P6, comprising a 	     172 VQLTMSPEVHQSNV                                     185                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||                                      
						80%, preferably at least about 85%, more preferably at least 	     201 VQLTMSPEVHQSNV                                     214                                                          
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VCPSPSLWPGPLGSCTTTMRSAGLAKGLGCTPTTSTRAP in   	                                                            
						HUMCRFRA_P6.                                                 	                                                            

16145	HMR136_HUMCRTR_10_tr0_r1_1_gPRT		Comparison report between HUMCRTR_P10 and S6A8_HUMANpartial  	Sequence name: S6A8_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCRTR_P10, comprising a first     	Sequence documentation:                                      
						MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVPPRETWTRQMD 	                                                            
						FIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALVGGIPIFFLEISLGQFMKAGS 	Alignment of: 16145 x S6A8_HUMAN   ..                        
						INVWNICPLFKGLGYASMVIVFYCNTYYIMVLAWGFYYLVKSFTTTLPWATCGHTWNTPD 	                                                            
						CVEIFRHEDCANASLANLTCDQLADRRSPVIEFWENKVLRLSGGLEVPGALNWEVTLCLL 	Alignment segment 1/1:                                       
						ACWVLVYFCVWKGVKSTGKIVYFTATFPYVVLVVLLVRGVLLPGALDGIIYYLKPDWSKL 	                                                            
						GSPQVWIDAGTQIFFSYAIGLGALTALGSYNRFNNNCY                       	                     Quality: 3350.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     338                Total length:     338                                               
						corresponding to amino acids 1 - 338 of S6A8_HUMAN, which    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 338 of HUMCRTR_P10, and a	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence NCPGHSL corresponding to     	                  .         .         .         .         .  
						amino acids 339 - 345 of HUMCRTR_P10, wherein said first     	       1 MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVP 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVP 50                                                           
						polypeptide encoding for a tail of HUMCRTR_P10, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 PRETWTRQMDFIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALV 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 PRETWTRQMDFIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALV 100                                                          
						to the sequence NCPGHSL in HUMCRTR_P10.                      	                  .         .         .         .         .  
						                                                            	     101 GGIPIFFLEISLGQFMKAGSINVWNICPLFKGLGYASMVIVFYCNTYYIM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GGIPIFFLEISLGQFMKAGSINVWNICPLFKGLGYASMVIVFYCNTYYIM 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VLAWGFYYLVKSFTTTLPWATCGHTWNTPDCVEIFRHEDCANASLANLTC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VLAWGFYYLVKSFTTTLPWATCGHTWNTPDCVEIFRHEDCANASLANLTC 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DQLADRRSPVIEFWENKVLRLSGGLEVPGALNWEVTLCLLACWVLVYFCV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DQLADRRSPVIEFWENKVLRLSGGLEVPGALNWEVTLCLLACWVLVYFCV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 WKGVKSTGKIVYFTATFPYVVLVVLLVRGVLLPGALDGIIYYLKPDWSKL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 WKGVKSTGKIVYFTATFPYVVLVVLLVRGVLLPGALDGIIYYLKPDWSKL 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 GSPQVWIDAGTQIFFSYAIGLGALTALGSYNRFNNNCY             338                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     301 GSPQVWIDAGTQIFFSYAIGLGALTALGSYNRFNNNCY             338                                                          

16147	HMR136_HUMCRTR_15_tr0_r1_1_gPRT		Comparison report between HUMCRTR_P15 and S6A8_HUMANpartial  	Sequence name: S6A8_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCRTR_P15, comprising a first     	                                                            
						MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVPPRETWTRQMD 	Alignment of: 16147 x S6A8_HUMAN   ..                        
						FIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALVGGIPIFFLEISLGQFMKAGS 	                                                            
						INVWNICPLFKGLGYASMVIVFYCNTYYIMVLAWGFYYLVKSFTTTLPWATCGHTWNTPD 	Alignment segment 1/1:                                       
						CVEIFRHEDCANASLANLTCDQLADRRSPVIEFWE                          	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2150.00                      Escore:       0                                               
						corresponding to amino acids 1 - 215 of S6A8_HUMAN, which    	             Matching length:     215                Total length:     215                                               
						also corresponds to amino acids 1 - 215 of HUMCRTR_P15.      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVP 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PRETWTRQMDFIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PRETWTRQMDFIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALV 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GGIPIFFLEISLGQFMKAGSINVWNICPLFKGLGYASMVIVFYCNTYYIM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GGIPIFFLEISLGQFMKAGSINVWNICPLFKGLGYASMVIVFYCNTYYIM 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VLAWGFYYLVKSFTTTLPWATCGHTWNTPDCVEIFRHEDCANASLANLTC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VLAWGFYYLVKSFTTTLPWATCGHTWNTPDCVEIFRHEDCANASLANLTC 200                                                          
						                                                            	                  .                                          
						                                                            	     201 DQLADRRSPVIEFWE                                    215                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     201 DQLADRRSPVIEFWE                                    215                                                          

16143	HMR136_HUMCRTR_5_tr0_r1_1_gPRT		Comparison report between HUMCRTR_P5 and S6A8_HUMANpartial   	Sequence name: S6A8_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCRTR_P5, comprising a first amino	                                                            
						MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVPPRETWTRQMD 	Alignment of: 16143 x S6A8_HUMAN   ..                        
						FIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALVGGIPIFFLEISLGQFMKAGS 	                                                            
						INVWNICPLFKGLGYASMVIVFYCNTYYIMVLAWGFYYLVKSFTTTLPWATCGHTWNTPD 	Alignment segment 1/1:                                       
						CVEIFRHEDCANASLANLTCDQLADRRSPVIEFWENKVLRLSGGLEVPGALNWEVTLCLL 	                                                            
						ACWVLVYFCVWKGVKSTGKIVYFTATFPYVVLVVLLVRGVLLPGALDGIIYYLKPDWSKL 	                     Quality: 3360.00                      Escore:       0                                               
						GSPQVWIDAGTQIFFSYAIGLGALTALGSYNRFNNNCYK                      	             Matching length:     339                Total length:     339                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 339 of S6A8_HUMAN, which also corresponds 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 339 of HUMCRTR_P5.                        	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MAKKSAENGIYSVSGDEKKGPLIAPGPDGAPAKGDGPVGLGTPGGRLAVP 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PRETWTRQMDFIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PRETWTRQMDFIMSCVGFAVGLGNVWRFPYLCYKNGGGVFLIPYVLIALV 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GGIPIFFLEISLGQFMKAGSINVWNICPLFKGLGYASMVIVFYCNTYYIM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GGIPIFFLEISLGQFMKAGSINVWNICPLFKGLGYASMVIVFYCNTYYIM 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VLAWGFYYLVKSFTTTLPWATCGHTWNTPDCVEIFRHEDCANASLANLTC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VLAWGFYYLVKSFTTTLPWATCGHTWNTPDCVEIFRHEDCANASLANLTC 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DQLADRRSPVIEFWENKVLRLSGGLEVPGALNWEVTLCLLACWVLVYFCV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DQLADRRSPVIEFWENKVLRLSGGLEVPGALNWEVTLCLLACWVLVYFCV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 WKGVKSTGKIVYFTATFPYVVLVVLLVRGVLLPGALDGIIYYLKPDWSKL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 WKGVKSTGKIVYFTATFPYVVLVVLLVRGVLLPGALDGIIYYLKPDWSKL 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 GSPQVWIDAGTQIFFSYAIGLGALTALGSYNRFNNNCYK            339                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     301 GSPQVWIDAGTQIFFSYAIGLGALTALGSYNRFNNNCYK            339                                                          

16746	HMR136_HUMCSF_10_tr0_r1_1_gPRT		Comparison report between HUMCSF_P10 and CST2_HUMANunique    	Sequence name: CST2_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMCSF_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 16746 x CST2_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence GTLQHSPVGPAGPASIERVQ corresponding to    	Alignment segment 1/1:                                       
						amino acids 1 - 20 of HUMCSF_P10, and a second amino acid    	                                                            
						GDAPNDPRGGTLLSVTGEVEPRGYLGPPHQGPPMHHVPGHESRGPPPHELRGGPLPEPRP 	                     Quality: 2522.00                      Escore:       0                                               
						LMAEPRGPMLDQRGPPLDGRGGRDPRGIDARGMEARAMEARGLDARGLEARAMEARAMEA 	             Matching length:     255                Total length:     255                                               
						RAMEARAMEARAMEVRGMEARGMDTRGPVPGPRGPIPSGMQGPSPINMGAVVPQGSRQVP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VMQGTGMQGASIQGGSQPGGFSPGQNQVTPQDHEKAALIMQVLQLTADQIAMLPPEQRQS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ILILKEQIQKSTGAP                                              	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 323 - 577 of CST2_HUMAN, which also corresponds  	Alignment:                                                   
						to amino acids 21 - 275 of HUMCSF_P10, wherein said first    	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	      21 GDAPNDPRGGTLLSVTGEVEPRGYLGPPHQGPPMHHVPGHESRGPPPHEL 70                                                           
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of HUMCSF_P10, comprising a  	     323 GDAPNDPRGGTLLSVTGEVEPRGYLGPPHQGPPMHHVPGHESRGPPPHEL 372                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      71 RGGPLPEPRPLMAEPRGPMLDQRGPPLDGRGGRDPRGIDARGMEARAMEA 120                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence GTLQHSPVGPAGPASIERVQ of HUMCSF_P10.          	     373 RGGPLPEPRPLMAEPRGPMLDQRGPPLDGRGGRDPRGIDARGMEARAMEA 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     121 RGLDARGLEARAMEARAMEARAMEARAMEARAMEVRGMEARGMDTRGPVP 170                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 RGLDARGLEARAMEARAMEARAMEARAMEARAMEVRGMEARGMDTRGPVP 472                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     171 GPRGPIPSGMQGPSPINMGAVVPQGSRQVPVMQGTGMQGASIQGGSQPGG 220                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     473 GPRGPIPSGMQGPSPINMGAVVPQGSRQVPVMQGTGMQGASIQGGSQPGG 522                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     221 FSPGQNQVTPQDHEKAALIMQVLQLTADQIAMLPPEQRQSILILKEQIQK 270                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     523 FSPGQNQVTPQDHEKAALIMQVLQLTADQIAMLPPEQRQSILILKEQIQK 572                                                          
						                                                            	                                                             
						                                                            	     271 STGAP                                              275                                                          
						                                                            	         |||||                                               
						                                                            	     573 STGAP                                              577                                                          

16744	HMR136_HUMCSF_9_tr0_r1_1_gPRT		Comparison report between HUMCSF_P9 and CST2_HUMANpartial WT 	Sequence name: CST2_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HUMCSF_P9, comprising a first amino acid        	                                                            
						MHHVPGHESRGPPPHELRGGPLPEPRPLMAEPRGPMLDQRGPPLDGRGGRDPRGIDARGM 	Alignment of: 16744 x CST2_HUMAN   ..                        
						EARAMEARGLDARGLEARAMEARAMEARAMEARAMEARAMEVRGMEARGMDTRGPVPGPR 	                                                            
						GPIPSGMQGPSPINMGAVVPQGSRQVPVMQGTGMQGASIQGGSQPGGFSPGQNQVTPQDH 	Alignment segment 1/1:                                       
						EKAALIMQVLQLTADQIAMLPPEQRQSILILKEQIQKSTGAP                   	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2193.00                      Escore:       0                                               
						amino acids 356 - 577 of CST2_HUMAN, which also corresponds  	             Matching length:     222                Total length:     222                                               
						to amino acids 1 - 222 of HUMCSF_P9.                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MHHVPGHESRGPPPHELRGGPLPEPRPLMAEPRGPMLDQRGPPLDGRGGR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     356 MHHVPGHESRGPPPHELRGGPLPEPRPLMAEPRGPMLDQRGPPLDGRGGR 405                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DPRGIDARGMEARAMEARGLDARGLEARAMEARAMEARAMEARAMEARAM 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     406 DPRGIDARGMEARAMEARGLDARGLEARAMEARAMEARAMEARAMEARAM 455                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EVRGMEARGMDTRGPVPGPRGPIPSGMQGPSPINMGAVVPQGSRQVPVMQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     456 EVRGMEARGMDTRGPVPGPRGPIPSGMQGPSPINMGAVVPQGSRQVPVMQ 505                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GTGMQGASIQGGSQPGGFSPGQNQVTPQDHEKAALIMQVLQLTADQIAML 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     506 GTGMQGASIQGGSQPGGFSPGQNQVTPQDHEKAALIMQVLQLTADQIAML 555                                                          
						                                                            	                  .         .                                
						                                                            	     201 PPEQRQSILILKEQIQKSTGAP                             222                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     556 PPEQRQSILILKEQIQKSTGAP                             577                                                          

17219	HMR136_HUMCSISA_6_tr0_r1_1_gPRT		Comparison report between HUMCSISA_P6 and PDGB_HUMANpartial  	Sequence name: PDGB_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMCSISA_P6, comprising a first     	                                                            
						MLSDHSIRSFDDLQRLLHGDPGEEDGAELDLNMTRSHSGGELESLARGRRSLGSLTIAEP 	Alignment of: 17219 x PDGB_HUMAN   ..                        
						AMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCSGCCNNRNVQCRPTQVQLRPV 	                                                            
						QVRKIEIVRKKPIFKKATVTLEDHLACKCETVAAARPVTRSPGGSQEQRAKTPQTRVTIR 	Alignment segment 1/1:                                       
						TVRVRRPPKGKHRKFKHTHDKTALKETLGA                               	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2059.00                      Escore:       0                                               
						corresponding to amino acids 32 - 241 of PDGB_HUMAN, which   	             Matching length:     210                Total length:     210                                               
						also corresponds to amino acids 1 - 210 of HUMCSISA_P6.      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLSDHSIRSFDDLQRLLHGDPGEEDGAELDLNMTRSHSGGELESLARGRR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      32 MLSDHSIRSFDDLQRLLHGDPGEEDGAELDLNMTRSHSGGELESLARGRR 81                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 SLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      82 SLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCS 131                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     132 GCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCE 181                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TVAAARPVTRSPGGSQEQRAKTPQTRVTIRTVRVRRPPKGKHRKFKHTHD 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     182 TVAAARPVTRSPGGSQEQRAKTPQTRVTIRTVRVRRPPKGKHRKFKHTHD 231                                                          
						                                                            	                  .                                          
						                                                            	     201 KTALKETLGA                                         210                                                          
						                                                            	         ||||||||||                                          
						                                                            	     232 KTALKETLGA                                         241                                                          

26226	HMR136_HUMCYC_11_tr0_r1_1_gPRT		Comparison report between HUMCYC_P11 and CY1_HUMANpartial WT 	Sequence name: CY1_HUMAN                                     
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCYC_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHT            	Alignment of: 26226 x CY1_HUMAN   ..                         
						corresponding to amino acids 60 - 108 of CY1_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 49 of HUMCYC_P11, a      	Alignment segment 1/1:                                       
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	                     Quality: 2542.00                      Escore:       0                                               
						90% and most preferably at least 95% homologous to a         	             Matching length:     266                Total length:     275                                               
						polypeptide having the sequence SFPNPFPPS corresponding to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 50 - 58 of HUMCYC_P11, and a third amino acid    	    Total Percent Similarity:   96.73      Total Percent Identity:   96.73                                               
						SIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPNEDGEMFMRP 	                        Gaps:       1                        
						GKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLR 	                                                            
						EGLYFNPYFPGQAIAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRM 	Alignment:                                                   
						GLKMLMMMALLVPLVYTIKRHKWSVLKSRKLAYRPPK                        	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       1 MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHTS 50                                                           
						amino acids 109 - 325 of CY1_HUMAN, which also corresponds to	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						amino acids 59 - 275 of HUMCYC_P11, wherein said first amino 	      60 MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHT. 108                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	      51 FPNPFPPSSIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAA 100                                                          
						isolated polypeptide encoding for an edge portion of         	                 ||||||||||||||||||||||||||||||||||||||||||  
						HUMCYC_P11, comprising an amino acid sequence being at least 	     109 ........SIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAA 150                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     101 EVEVQDGPNEDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYI 150                                                          
						at least about 95% homologous to the sequence encoding for   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SFPNPFPPS, corresponding to HUMCYC_P11.                      	     151 EVEVQDGPNEDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYI 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLV 300                                                          
						                                                            	                  .         .                                
						                                                            	     251 PLVYTIKRHKWSVLKSRKLAYRPPK                          275                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     301 PLVYTIKRHKWSVLKSRKLAYRPPK                          325                                                          

26228	HMR136_HUMCYC_5_tr0_r1_1_gPRT		Comparison report between HUMCYC_P5 and CY1_HUMANpartial WT  	Sequence name: CY1_HUMAN                                     
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HUMCYC_P5, comprising a first amino acid        	                                                            
						MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQ 	Alignment of: 26228 x CY1_HUMAN   ..                         
						VCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPNEDGEMFMRPGKLFDYFPKPY 	                                                            
						PNSEAARAANNGALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPG 	Alignment segment 1/1:                                       
						QAIAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALL 	                                                            
						VPLVYTIKRHKWSVLKSRKLAYRPPK                                   	                     Quality: 2642.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     266                Total length:     266                                               
						amino acids 60 - 325 of CY1_HUMAN, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 266 of HUMCYC_P5.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHTS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      60 MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHTS 109                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     110 IRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPN 159                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGED 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     160 EDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGED 209                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYTDVLEFDDGT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 YVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYTDVLEFDDGT 259                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLVPLVYTIKRH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     260 PATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLVPLVYTIKRH 309                                                          
						                                                            	                  .                                          
						                                                            	     251 KWSVLKSRKLAYRPPK                                   266                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     310 KWSVLKSRKLAYRPPK                                   325                                                          

26222	HMR136_HUMCYC_6_tr0_r1_1_gPRT		Comparison report between HUMCYC_P6 and CY1_HUMANpartial WT  	Sequence name: CY1_HUMAN                                     
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HUMCYC_P6, comprising a first amino acid        	                                                            
						MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQ 	Alignment of: 26222 x CY1_HUMAN   ..                         
						VCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPNEDGEMFMRPGKLFDYFPKPY 	                                                            
						PNSEAARAANNGALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPG 	Alignment segment 1/1:                                       
						QAIAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALL 	                                                            
						VPLVYTIKRHKWSVLKSRKLAYRPPK                                   	                     Quality: 2642.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     266                Total length:     266                                               
						amino acids 60 - 325 of CY1_HUMAN, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 266 of HUMCYC_P6.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHTS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      60 MLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHTS 109                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     110 IRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPN 159                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGED 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     160 EDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGED 209                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYTDVLEFDDGT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 YVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYTDVLEFDDGT 259                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLVPLVYTIKRH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     260 PATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLVPLVYTIKRH 309                                                          
						                                                            	                  .                                          
						                                                            	     251 KWSVLKSRKLAYRPPK                                   266                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     310 KWSVLKSRKLAYRPPK                                   325                                                          

26224	HMR136_HUMCYC_8_tr0_r1_1_gPRT		Comparison report between HUMCYC_P8 and CY1_HUMANpartial WT  	Sequence name: CY1_HUMAN                                     
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMCYC_P8, comprising a first amino 	Sequence documentation:                                      
						MAAAAASLRGVVLGPRGAGLPGARARGLLCSARPGQLPLRTPQAVALSSKSGLSRGRKVM 	                                                            
						LSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRGLLSSLDHT             	Alignment of: 26224 x CY1_HUMAN   ..                         
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 108 of CY1_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 108 of HUMCYC_P8, a second amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 3086.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     325                Total length:     334                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence SFPNPFPPS corresponding to amino acids   	    Total Percent Similarity:   97.31      Total Percent Identity:   97.31                                               
						109 - 117 of HUMCYC_P8, and a third amino acid sequence being	                        Gaps:       1                        
						SIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPNEDGEMFMRP 	                                                            
						GKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLR 	Alignment:                                                   
						EGLYFNPYFPGQAIAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRM 	                  .         .         .         .         .  
						GLKMLMMMALLVPLVYTIKRHKWSVLKSRKLAYRPPK                        	       1 MAAAAASLRGVVLGPRGAGLPGARARGLLCSARPGQLPLRTPQAVALSSK 50                                                           
						at least 90 % homologous to corresponding to amino acids 109 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 325 of CY1_HUMAN, which also corresponds to amino acids 118	       1 MAAAAASLRGVVLGPRGAGLPGARARGLLCSARPGQLPLRTPQAVALSSK 50                                                           
						- 334 of HUMCYC_P8, wherein said first amino acid sequence,  	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	      51 SGLSRGRKVMLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRG 100                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMCYC_P8,       	      51 SGLSRGRKVMLSALGMLAAGGAGLAVALHSAVSASDLELHPPSYPWSHRG 100                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     101 LLSSLDHTSFPNPFPPSSIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYT 150                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||         |||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence encoding for      	     101 LLSSLDHT.........SIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYT 141                                                          
						SFPNPFPPS, corresponding to HUMCYC_P8.                       	                  .         .         .         .         .  
						                                                            	     151 EDEAKELAAEVEVQDGPNEDGEMFMRPGKLFDYFPKPYPNSEAARAANNG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     142 EDEAKELAAEVEVQDGPNEDGEMFMRPGKLFDYFPKPYPNSEAARAANNG 191                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 ALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQA 241                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 IAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLK 291                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 MLMMMALLVPLVYTIKRHKWSVLKSRKLAYRPPK                 334                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     292 MLMMMALLVPLVYTIKRHKWSVLKSRKLAYRPPK                 325                                                          

18232	HMR136_HUMD3DR_7_tr0_r1_1_gPRT		Comparison report between HUMD3DR_P7 and D3DR_HUMANunique    	Sequence name: D3DR_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMD3DR_P7, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18232 x D3DR_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EHSEDKQYPQKCQDSLLSHL corresponding to    	Alignment segment 1/1:                                       
						amino acids 1 - 20 of HUMD3DR_P7, and a second amino acid    	                                                            
						QTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRK 	                     Quality: 1568.00                      Escore:       0                                               
						LSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHV 	             Matching length:     160                Total length:     160                                               
						SPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 241 - 400 of D3DR_HUMAN, which also corresponds  	                        Gaps:       0                        
						to amino acids 21 - 180 of HUMD3DR_P7, wherein said first    	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of HUMD3DR_P7, comprising a  	      21 QTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTI 70                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     241 QTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTI 290                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence EHSEDKQYPQKCQDSLLSHL of HUMD3DR_P7.          	      71 APKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIV 120                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     291 APKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIV 340                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     121 CWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEF 170                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     341 CWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEF 390                                                          
						                                                            	                  .                                          
						                                                            	     171 RKAFLKILSC                                         180                                                          
						                                                            	         ||||||||||                                          
						                                                            	     391 RKAFLKILSC                                         400                                                          

20207	HMR136_HUMDMC1B_2_tr0_r1_1_gPRT		Comparison report between HUMDMC1B_P2 and DMC1_HUMANpartial  	Sequence name: DMC1_HUMAN                                    
						WT sequence featuring skipped exon plus extra amino          	                                                            
						acids.1.An isolated chimeric polypeptide encoding for        	Sequence documentation:                                      
						HUMDMC1B_P2, comprising a first amino acid sequence being at 	                                                            
						MKEDQVVAEEPGFQDEEESLFQDIDLLQKHGINVADIKKLKSVGICTIKGIQMTTRRALC 	Alignment of: 20207 x DMC1_HUMAN   ..                        
						NVKGLSEAKVDKIKEAANKLIEPGFLTAFEYSEKRKMVFHITTGSQEFDKLLGGGIESMA 	                                                            
						ITEAFGEFRTGKTQLSHTLC                                         	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 140	                                                            
						of DMC1_HUMAN, which also corresponds to amino acids 1 - 140 	                     Quality: 2623.00                      Escore:       0                                               
						of HUMDMC1B_P2, a second amino acid sequence bridging amino  	             Matching length:     285                Total length:     340                                               
						acid sequence comprising of G, and a third amino acid        	 Matching Percent Similarity:   99.65   Matching Percent Identity:   99.65                                               
						EHQMELLDYVAAKFHEEAGIFKLLIIDSIMALFRVDFSGRGELAERQQKLAQMLSRLQKI 	    Total Percent Similarity:   83.53      Total Percent Identity:   83.53                                               
						SEEYNVAVFVTNQMTADPGATMTFQADPKKPIGGHILAHASTTRISLRKGRGELRIAKIY 	                        Gaps:       1                        
						DSPEMPENEATFAITAGGIGDAKE                                     	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 197 - 340 of DMC1_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 142 - 285 of HUMDMC1B_P2, wherein said first  	       1 MKEDQVVAEEPGFQDEEESLFQDIDLLQKHGINVADIKKLKSVGICTIKG 50                                                           
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	       1 MKEDQVVAEEPGFQDEEESLFQDIDLLQKHGINVADIKKLKSVGICTIKG 50                                                           
						order.2.An isolated polypeptide encoding for an edge portion 	                  .         .         .         .         .  
						of HUMDMC1B_P2, comprising a polypeptide having a length "n",	      51 IQMTTRRALCNVKGLSEAKVDKIKEAANKLIEPGFLTAFEYSEKRKMVFH 100                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	      51 IQMTTRRALCNVKGLSEAKVDKIKEAANKLIEPGFLTAFEYSEKRKMVFH 100                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     101 ITTGSQEFDKLLGGGIESMAITEAFGEFRTGKTQLSHTLC.......... 140                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||            
						at least two amino acids comprise CGE having a structure as  	     101 ITTGSQEFDKLLGGGIESMAITEAFGEFRTGKTQLSHTLCVTAQLPGAGG 150                                                          
						follows (numbering according to HUMDMC1B_P2): a sequence     	                  .         .         .         .         .  
						starting from any of amino acid numbers 140-x to 140; and    	     141 .............................................GEHQM 145                                                          
						ending at any of amino acid numbers 142 + ((n-2) - x), in    	                                                       ||||  
						which x varies from 0 to n-2.                                	     151 YPGGKIIFIDTENTFRPDRLRDIADRFNVDHDAVLDNVLYARAYTSEHQM 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     146 ELLDYVAAKFHEEAGIFKLLIIDSIMALFRVDFSGRGELAERQQKLAQML 195                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ELLDYVAAKFHEEAGIFKLLIIDSIMALFRVDFSGRGELAERQQKLAQML 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     196 SRLQKISEEYNVAVFVTNQMTADPGATMTFQADPKKPIGGHILAHASTTR 245                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SRLQKISEEYNVAVFVTNQMTADPGATMTFQADPKKPIGGHILAHASTTR 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     246 ISLRKGRGELRIAKIYDSPEMPENEATFAITAGGIGDAKE           285                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     301 ISLRKGRGELRIAKIYDSPEMPENEATFAITAGGIGDAKE           340                                                          

21001	HMR136_HUMDNASEI_7_tr0_r1_1_gPRT		Comparison report between HUMDNASEI_P7 and DRN1_HUMANpartial 	Sequence name: DRN1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMDNASEI_P7, comprising a first    	Sequence documentation:                                      
						MRGMKLLGALLALAALLQGAVSLKIAAFNIQTFGETKMSNATLVSYIVQILSRYDIALVQ 	                                                            
						EVRDSHLTAVGKLLDNLNQDAPDTYHYVVSEPLGRNSYKERYLFVYRPDQVSAVDSYYYD 	Alignment of: 21001 x DRN1_HUMAN   ..                        
						DGCEPCGNDTFNREPAIVRFFSRFTEVREFAIVPLHAAPGDAVAEIDALYDVYLDVQEKW 	                                                            
						GLEDVMLMGDFNAGCSYVRPSQWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDR      	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 235 of DRN1_HUMAN, which    	                     Quality: 2300.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 235 of HUMDNASEI_P7, and 	             Matching length:     235                Total length:     235                                               
						a second amino acid sequence being at least 70%, optionally  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						at least 80%, preferably at least 85%, more preferably at    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 90% and most preferably at least 95% homologous to a   	                        Gaps:       0                        
						polypeptide having the sequence PKPSVTTIQWR corresponding to 	                                                            
						amino acids 236 - 246 of HUMDNASEI_P7, wherein said first    	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	       1 MRGMKLLGALLALAALLQGAVSLKIAAFNIQTFGETKMSNATLVSYIVQI 50                                                           
						polypeptide encoding for a tail of HUMDNASEI_P7, comprising a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       1 MRGMKLLGALLALAALLQGAVSLKIAAFNIQTFGETKMSNATLVSYIVQI 50                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      51 LSRYDIALVQEVRDSHLTAVGKLLDNLNQDAPDTYHYVVSEPLGRNSYKE 100                                                          
						to the sequence PKPSVTTIQWR in HUMDNASEI_P7.                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 LSRYDIALVQEVRDSHLTAVGKLLDNLNQDAPDTYHYVVSEPLGRNSYKE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RYLFVYRPDQVSAVDSYYYDDGCEPCGNDTFNREPAIVRFFSRFTEVREF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RYLFVYRPDQVSAVDSYYYDDGCEPCGNDTFNREPAIVRFFSRFTEVREF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AIVPLHAAPGDAVAEIDALYDVYLDVQEKWGLEDVMLMGDFNAGCSYVRP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 AIVPLHAAPGDAVAEIDALYDVYLDVQEKWGLEDVMLMGDFNAGCSYVRP 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 SQWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDR                235                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     201 SQWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDR                235                                                          

1524	HMR136_HUMDNSPOLA_11_tr0_r1_1_gPRT		Comparison report between HUMDNSPOLA_P11 and                 	Sequence name: DPO2_HUMAN                                    
						DPO2_HUMANpartial WT sequence followed by a unique tail.1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMDNSPOLA_P11,   	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						homologous to                                                	Alignment of: 1524 x DPO2_HUMAN   ..                         
						MVGELIAFCTSTHKVGLTSEILNSFEHEFLSKRLSKARHSTCKDSGHAGARDIVSIQEL  	                                                            
						corresponding to amino acids 41 - 99 of DPO2_HUMAN, which    	Alignment segment 1/1:                                       
						also corresponds to amino acids 1 - 59 of HUMDNSPOLA_P11, and	                                                            
						a second amino acid sequence being at least 70%, optionally  	                     Quality:  567.00                      Escore:       0                                               
						at least 80%, preferably at least 85%, more preferably at    	             Matching length:      59                Total length:      59                                               
						least 90% and most preferably at least 95% homologous to a   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence YPFLLKVFAPSY corresponding to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 60 - 71 of HUMDNSPOLA_P11, wherein said first    	                        Gaps:       0                        
						amino acid sequence and second amino acid sequence are       	                                                            
						contiguous and in a sequential order.2.An isolated           	Alignment:                                                   
						polypeptide encoding for a tail of HUMDNSPOLA_P11, comprising	                  .         .         .         .         .  
						a polypeptide being at least 70%, optionally at least about  	       1 MVGELIAFCTSTHKVGLTSEILNSFEHEFLSKRLSKARHSTCKDSGHAGA 50                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      41 MVGELIAFCTSTHKVGLTSEILNSFEHEFLSKRLSKARHSTCKDSGHAGA 90                                                           
						to the sequence YPFLLKVFAPSY in HUMDNSPOLA_P11.              	                                                             
						                                                            	      51 RDIVSIQEL                                          59                                                           
						                                                            	         |||||||||                                           
						                                                            	      91 RDIVSIQEL                                          99                                                           

1563	HMR136_HUMDOPADC_8_tr0_r1_1_gPRT		Comparison report between HUMDOPADC_P8 and DDC_HUMANpartial  	Sequence name: DDC_HUMAN                                     
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMDOPADC_P8, comprising a first    	Sequence documentation:                                      
						MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDV 	                                                            
						EKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSW                	Alignment of: 1563 x DDC_HUMAN   ..                          
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 105 of DDC_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 105 of HUMDOPADC_P8, and a    	                                                            
						GSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVK 	                     Quality: 4236.00                      Escore:       0                                               
						LKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKED 	             Matching length:     440                Total length:     480                                               
						IWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLS 	    Total Percent Similarity:   91.67      Total Percent Identity:   91.67                                               
						HEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFV 	                        Gaps:       1                        
						LRFAICSRTVESAHVQRAWEHIKELAADVLRAERE                          	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						corresponding to amino acids 146 - 480 of DDC_HUMAN, which   	                  .         .         .         .         .  
						also corresponds to amino acids 106 - 440 of HUMDOPADC_P8,   	       1 MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEP 50                                                           
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	       1 MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEP 50                                                           
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMDOPADC_P8, comprising a polypeptide having a length "n",  	      51 DTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGC 100                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	      51 DTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGC 100                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     101 IGFSW........................................GSASE 110                                                          
						preferably at least about 50 amino acids in length, wherein  	         |||||                                        |||||  
						at least two amino acids comprise WG, having a structure as  	     101 IGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASE 150                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						105-x to 106; and ending at any of amino acid numbers 106+   	     111 ATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGL 160                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 IGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCS 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 FDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFN 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFN 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     261 PHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQ 310                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     311 IPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEI 360                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     361 CVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAI 410                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 CVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAI 450                                                          
						                                                            	                  .         .         .                      
						                                                            	     411 CSRTVESAHVQRAWEHIKELAADVLRAERE                     440                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     451 CSRTVESAHVQRAWEHIKELAADVLRAERE                     480                                                          

1708	HMR136_HUMDRA_2_tr0_r1_1_gPRT		Comparison report between HUMDRA_P2 and DRA_HUMANunique head 	Sequence name: DRA_HUMAN                                     
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for HUMDRA_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 1708 x DRA_HUMAN   ..                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLLRKIIKRQEDIIRHFWIISKCVV corresponding  	Alignment segment 1/1:                                       
						to amino acids 1 - 25 of HUMDRA_P2, and a second amino acid  	                                                            
						ASWLPAYRLKEWLLSDIVSGISTGIVAVLQGLAFALLVDIPPVYGLYASFFPAIIYLFFG 	                     Quality: 6690.00                      Escore:       0                                               
						TSRHISVGPFPILSMMVGLAVSGAVSKAVPDRNATTLGLPNNSNNSSLLDDERVRVAAAA 	             Matching length:     705                Total length:     705                                               
						SVTVLSGIIQLAFGILRIGFVVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTVPSHTDP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						VSIFKVLYSVFSQIEKTNIADLVTALIVLLVVSIVKEINQRFKDKLPVPIPIEFIMTVIA 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.86                                               
						AGVSYGCDFKNRFKVAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVAFAVAFSVASV 	                        Gaps:       0                        
						YSLKYDYPLDGNQELIALGLGNIVCGVFRGFAGSTALSRSAVQESTGGKTQIAGLIGAII 	                                                            
						VLIVVLAIGFLLAPLQKSVLAALALGNLKGMLMQFAEIGRLWRKDKYDCLIWIMTFIFTI 	Alignment:                                                   
						VLGLGLGLAASVAFQLLTIVFRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEGVKIFRC 	                  .         .         .         .         .  
						PSPIYFANIGFFRRKLIDAVGFSPLRILRKRNKALRKIRKLQKQGLLQVTPKGFICTVDT 	      25 VASWLPAYRLKEWLLSDIVSGISTGIVAVLQGLAFALLVDIPPVYGLYAS 74                                                           
						IKDSDEELDNNQIEVLDQPINTTDLPFHIDWNDDLPLNIEVPKISLHSLILDFSAVSFLD 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						VSSVRGLKSILQEFIRIKVDVYIVGTDDDFIEKLNRYEFFDGEVKSSIFFLTIHDAVLHI 	      60 IASWLPAYRLKEWLLSDIVSGISTGIVAVLQGLAFALLVDIPPVYGLYAS 109                                                          
						LMKKDYSTSKFNPSQEKDGKIDFTINTNGGLRNRVYEVPVETKF                 	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      75 FFPAIIYLFFGTSRHISVGPFPILSMMVGLAVSGAVSKAVPDRNATTLGL 124                                                          
						amino acids 61 - 764 of DRA_HUMAN, which also corresponds to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 26 - 729 of HUMDRA_P2, wherein said first amino  	     110 FFPAIIYLFFGTSRHISVGPFPILSMMVGLAVSGAVSKAVPDRNATTLGL 159                                                          
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	     125 PNNSNNSSLLDDERVRVAAAASVTVLSGIIQLAFGILRIGFVVIYLSESL 174                                                          
						for a head of HUMDRA_P2, comprising a polypeptide being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     160 PNNSNNSSLLDDERVRVAAAASVTVLSGIIQLAFGILRIGFVVIYLSESL 209                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     175 ISGFTTAAAVHVLVSQLKFIFQLTVPSHTDPVSIFKVLYSVFSQIEKTNI 224                                                          
						MLLRKIIKRQEDIIRHFWIISKCVV of HUMDRA_P2.                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 ISGFTTAAAVHVLVSQLKFIFQLTVPSHTDPVSIFKVLYSVFSQIEKTNI 259                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     225 ADLVTALIVLLVVSIVKEINQRFKDKLPVPIPIEFIMTVIAAGVSYGCDF 274                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     260 ADLVTALIVLLVVSIVKEINQRFKDKLPVPIPIEFIMTVIAAGVSYGCDF 309                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     275 KNRFKVAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVAFAVAFSVAS 324                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     310 KNRFKVAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVAFAVAFSVAS 359                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     325 VYSLKYDYPLDGNQELIALGLGNIVCGVFRGFAGSTALSRSAVQESTGGK 374                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     360 VYSLKYDYPLDGNQELIALGLGNIVCGVFRGFAGSTALSRSAVQESTGGK 409                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     375 TQIAGLIGAIIVLIVVLAIGFLLAPLQKSVLAALALGNLKGMLMQFAEIG 424                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     410 TQIAGLIGAIIVLIVVLAIGFLLAPLQKSVLAALALGNLKGMLMQFAEIG 459                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     425 RLWRKDKYDCLIWIMTFIFTIVLGLGLGLAASVAFQLLTIVFRTQFPKCS 474                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     460 RLWRKDKYDCLIWIMTFIFTIVLGLGLGLAASVAFQLLTIVFRTQFPKCS 509                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     475 TLANIGRTNIYKNKKDYYDMYEPEGVKIFRCPSPIYFANIGFFRRKLIDA 524                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     510 TLANIGRTNIYKNKKDYYDMYEPEGVKIFRCPSPIYFANIGFFRRKLIDA 559                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     525 VGFSPLRILRKRNKALRKIRKLQKQGLLQVTPKGFICTVDTIKDSDEELD 574                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     560 VGFSPLRILRKRNKALRKIRKLQKQGLLQVTPKGFICTVDTIKDSDEELD 609                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     575 NNQIEVLDQPINTTDLPFHIDWNDDLPLNIEVPKISLHSLILDFSAVSFL 624                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     610 NNQIEVLDQPINTTDLPFHIDWNDDLPLNIEVPKISLHSLILDFSAVSFL 659                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     625 DVSSVRGLKSILQEFIRIKVDVYIVGTDDDFIEKLNRYEFFDGEVKSSIF 674                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     660 DVSSVRGLKSILQEFIRIKVDVYIVGTDDDFIEKLNRYEFFDGEVKSSIF 709                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     675 FLTIHDAVLHILMKKDYSTSKFNPSQEKDGKIDFTINTNGGLRNRVYEVP 724                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     710 FLTIHDAVLHILMKKDYSTSKFNPSQEKDGKIDFTINTNGGLRNRVYEVP 759                                                          
						                                                            	                                                             
						                                                            	     725 VETKF                                              729                                                          
						                                                            	         |||||                                               
						                                                            	     760 VETKF                                              764                                                          

1706	HMR136_HUMDRA_3_tr0_r1_1_gPRT		Comparison report between HUMDRA_P3 and DRA_HUMANpartial WT  	Sequence name: DRA_HUMAN                                     
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for HUMDRA_P3, comprising a first amino acid        	                                                            
						MMVGLAVSGAVSKAVPDRNATTLGLPNNSNNSSLLDDERVRVAAAASVTVLSGIIQLAFG 	Alignment of: 1706 x DRA_HUMAN   ..                          
						ILRIGFVVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTVPSHTDPVSIFKVLYSVFSQI 	                                                            
						EKTNIADLVTALIVLLVVSIVKEINQRFKDKLPVPIPIEFIMTVIAAGVSYGCDFKNRFK 	Alignment segment 1/1:                                       
						VAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVAFAVAFSVASVYSLKYDYPLDGNQE 	                                                            
						LIALGLGNIVCGVFRGFAGSTALSRSAVQESTGGKTQIAGLIGAIIVLIVVLAIGFLLAP 	                     Quality: 5982.00                      Escore:       0                                               
						LQKSVLAALALGNLKGMLMQFAEIGRLWRKDKYDCLIWIMTFIFTIVLGLGLGLAASVAF 	             Matching length:     630                Total length:     630                                               
						QLLTIVFRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEGVKIFRCPSPIYFANIGFFRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLIDAVGFSPLRILRKRNKALRKIRKLQKQGLLQVTPKGFICTVDTIKDSDEELDNNQIE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VLDQPINTTDLPFHIDWNDDLPLNIEVPKISLHSLILDFSAVSFLDVSSVRGLKSILQEF 	                        Gaps:       0                        
						IRIKVDVYIVGTDDDFIEKLNRYEFFDGEVKSSIFFLTIHDAVLHILMKKDYSTSKFNPS 	                                                            
						QEKDGKIDFTINTNGGLRNRVYEVPVETKF                               	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 135 - 764 of DRA_HUMAN, which also corresponds to	       1 MMVGLAVSGAVSKAVPDRNATTLGLPNNSNNSSLLDDERVRVAAAASVTV 50                                                           
						amino acids 1 - 630 of HUMDRA_P3.                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     135 MMVGLAVSGAVSKAVPDRNATTLGLPNNSNNSSLLDDERVRVAAAASVTV 184                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LSGIIQLAFGILRIGFVVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     185 LSGIIQLAFGILRIGFVVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTV 234                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PSHTDPVSIFKVLYSVFSQIEKTNIADLVTALIVLLVVSIVKEINQRFKD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     235 PSHTDPVSIFKVLYSVFSQIEKTNIADLVTALIVLLVVSIVKEINQRFKD 284                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KLPVPIPIEFIMTVIAAGVSYGCDFKNRFKVAVVGDMNPGFQPPITPDVE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     285 KLPVPIPIEFIMTVIAAGVSYGCDFKNRFKVAVVGDMNPGFQPPITPDVE 334                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TFQNTVGDCFGIAMVAFAVAFSVASVYSLKYDYPLDGNQELIALGLGNIV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     335 TFQNTVGDCFGIAMVAFAVAFSVASVYSLKYDYPLDGNQELIALGLGNIV 384                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 CGVFRGFAGSTALSRSAVQESTGGKTQIAGLIGAIIVLIVVLAIGFLLAP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     385 CGVFRGFAGSTALSRSAVQESTGGKTQIAGLIGAIIVLIVVLAIGFLLAP 434                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LQKSVLAALALGNLKGMLMQFAEIGRLWRKDKYDCLIWIMTFIFTIVLGL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     435 LQKSVLAALALGNLKGMLMQFAEIGRLWRKDKYDCLIWIMTFIFTIVLGL 484                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 GLGLAASVAFQLLTIVFRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     485 GLGLAASVAFQLLTIVFRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEG 534                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VKIFRCPSPIYFANIGFFRRKLIDAVGFSPLRILRKRNKALRKIRKLQKQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     535 VKIFRCPSPIYFANIGFFRRKLIDAVGFSPLRILRKRNKALRKIRKLQKQ 584                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GLLQVTPKGFICTVDTIKDSDEELDNNQIEVLDQPINTTDLPFHIDWNDD 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     585 GLLQVTPKGFICTVDTIKDSDEELDNNQIEVLDQPINTTDLPFHIDWNDD 634                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LPLNIEVPKISLHSLILDFSAVSFLDVSSVRGLKSILQEFIRIKVDVYIV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     635 LPLNIEVPKISLHSLILDFSAVSFLDVSSVRGLKSILQEFIRIKVDVYIV 684                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GTDDDFIEKLNRYEFFDGEVKSSIFFLTIHDAVLHILMKKDYSTSKFNPS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     685 GTDDDFIEKLNRYEFFDGEVKSSIFFLTIHDAVLHILMKKDYSTSKFNPS 734                                                          
						                                                            	                  .         .         .                      
						                                                            	     601 QEKDGKIDFTINTNGGLRNRVYEVPVETKF                     630                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     735 QEKDGKIDFTINTNGGLRNRVYEVPVETKF                     764                                                          

1704	HMR136_HUMDRA_4_tr0_r1_1_gPRT		Comparison report between HUMDRA_P4 and DRA_HUMANpartial WT  	Sequence name: DRA_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMDRA_P4, comprising a first amino 	Sequence documentation:                                      
						MIEPFGNQYIVARPVYSTNAFEENHKKTGRHHKTFLDHLKVCCSCSPQKAKRIVLSLFPI 	                                                            
						ASWLPAYRLKEWLLSDIVSGISTGIVAVLQGLAFALLVDIPPVYGLYASFFPAIIYLFFG 	Alignment of: 1704 x DRA_HUMAN   ..                          
						TSRHISVGPFPILSMMVGLAVSGAVSKAVPDRNATTLGLPNNSNNSSLLDDERVRVAAAA 	                                                            
						SVTVLSGIIQLAFGILRIGFVVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTVPSHTDP 	Alignment segment 1/1:                                       
						VSIFKVLYSVFSQIEKTNIADLVTALIVLLVVSIVKEINQRFKDKLPVPIPIEFIMTVIA 	                                                            
						AGVSYGCDFKNRFKVAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVAFAVAFSVASV 	                     Quality: 7234.00                      Escore:       0                                               
						YSLKYDYPLDGNQELIALGLGNIVCGVFRGFAGSTALSRSAVQESTGGKTQIAGLIGAII 	             Matching length:     758                Total length:     758                                               
						VLIVVLAIGFLLAPLQKSVLAALALGNLKGMLMQFAEIGRLWRKDKYDCLIWIMTFIFTI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VLGLGLGLAASVAFQLLTIVFRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEGVKIFRC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PSPIYFANIGFFRRKLIDAVGFSPLRILRKRNKALRKIRKLQKQGLLQVTPKGFICTVDT 	                        Gaps:       0                        
						IKDSDEELDNNQIEVLDQPINTTDLPFHIDWNDDLPLNIEVPKISLHSLILDFSAVSFLD 	                                                            
						VSSVRGLKSILQEFIRIKVDVYIVGTDDDFIEKLNRYEFFDGEVKSSIFFLTIHDAVLHI 	Alignment:                                                   
						LMKKDYSTSKFNPSQEKDGKIDFTINTNGGLRNRVYEV                       	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	       1 MIEPFGNQYIVARPVYSTNAFEENHKKTGRHHKTFLDHLKVCCSCSPQKA 50                                                           
						to amino acids 1 - 758 of DRA_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 758 of HUMDRA_P4, and a second amino acid 	       1 MIEPFGNQYIVARPVYSTNAFEENHKKTGRHHKTFLDHLKVCCSCSPQKA 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      51 KRIVLSLFPIASWLPAYRLKEWLLSDIVSGISTGIVAVLQGLAFALLVDI 100                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence RFFNRFIFT corresponding to amino acids   	      51 KRIVLSLFPIASWLPAYRLKEWLLSDIVSGISTGIVAVLQGLAFALLVDI 100                                                          
						759 - 767 of HUMDRA_P4, wherein said first amino acid        	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	     101 PPVYGLYASFFPAIIYLFFGTSRHISVGPFPILSMMVGLAVSGAVSKAVP 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of HUMDRA_P4, comprising a polypeptide being at least   	     101 PPVYGLYASFFPAIIYLFFGTSRHISVGPFPILSMMVGLAVSGAVSKAVP 150                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     151 DRNATTLGLPNNSNNSSLLDDERVRVAAAASVTVLSGIIQLAFGILRIGF 200                                                          
						at least about 95% homologous to the sequence RFFNRFIFT in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMDRA_P4.                                                   	     151 DRNATTLGLPNNSNNSSLLDDERVRVAAAASVTVLSGIIQLAFGILRIGF 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTVPSHTDPVSIFKVLYSV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTVPSHTDPVSIFKVLYSV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FSQIEKTNIADLVTALIVLLVVSIVKEINQRFKDKLPVPIPIEFIMTVIA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FSQIEKTNIADLVTALIVLLVVSIVKEINQRFKDKLPVPIPIEFIMTVIA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AGVSYGCDFKNRFKVAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AGVSYGCDFKNRFKVAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FAVAFSVASVYSLKYDYPLDGNQELIALGLGNIVCGVFRGFAGSTALSRS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FAVAFSVASVYSLKYDYPLDGNQELIALGLGNIVCGVFRGFAGSTALSRS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AVQESTGGKTQIAGLIGAIIVLIVVLAIGFLLAPLQKSVLAALALGNLKG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 AVQESTGGKTQIAGLIGAIIVLIVVLAIGFLLAPLQKSVLAALALGNLKG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 MLMQFAEIGRLWRKDKYDCLIWIMTFIFTIVLGLGLGLAASVAFQLLTIV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 MLMQFAEIGRLWRKDKYDCLIWIMTFIFTIVLGLGLGLAASVAFQLLTIV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 FRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEGVKIFRCPSPIYFANIG 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 FRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEGVKIFRCPSPIYFANIG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FFRRKLIDAVGFSPLRILRKRNKALRKIRKLQKQGLLQVTPKGFICTVDT 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FFRRKLIDAVGFSPLRILRKRNKALRKIRKLQKQGLLQVTPKGFICTVDT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 IKDSDEELDNNQIEVLDQPINTTDLPFHIDWNDDLPLNIEVPKISLHSLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 IKDSDEELDNNQIEVLDQPINTTDLPFHIDWNDDLPLNIEVPKISLHSLI 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 LDFSAVSFLDVSSVRGLKSILQEFIRIKVDVYIVGTDDDFIEKLNRYEFF 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 LDFSAVSFLDVSSVRGLKSILQEFIRIKVDVYIVGTDDDFIEKLNRYEFF 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 DGEVKSSIFFLTIHDAVLHILMKKDYSTSKFNPSQEKDGKIDFTINTNGG 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 DGEVKSSIFFLTIHDAVLHILMKKDYSTSKFNPSQEKDGKIDFTINTNGG 750                                                          
						                                                            	                                                             
						                                                            	     751 LRNRVYEV                                           758                                                          
						                                                            	         ||||||||                                            
						                                                            	     751 LRNRVYEV                                           758                                                          

2063	HMR136_HUME2K_13_tr0_r1_1_gPRT		Comparison report between HUME2K_P13 and ODO2_HUMAN_V2unique 	Sequence name: ODO2_HUMAN_V2                                 
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUME2K_P13, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 2063 x ODO2_HUMAN_V2   ..                      
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						VVVRPYIRCPPALGSSAV corresponding to amino acids 1 - 18 of    	                                                            
						HUME2K_P13, a second amino acid sequence being at least 90 % 	                     Quality: 2913.00                      Escore:       0                                               
						MLSRSRCVSRAFSRSLSAFQKGNCPLGRRSLPGVSLCQGPGYPNSRKVVINNSVFSVRFF 	             Matching length:     300                Total length:     300                                               
						RTTAVCKDDLVTVKTPAFAESVTEGDVRWEKAVGDTVAEDEVVCEIETDKTSVQVPSPAN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GVIEALLVPDGGKVEGGTPLFTLRKTGAAPAKAKPAEAPAAAAPKAEPTAAAVPPPAAPI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PTQMPPVPSPSQPPSGKPVSAVKPTVAPPLAEPGAGKGLRSEHREKMNRMRQRIAQRLKE 	                        Gaps:       0                        
						AQNTCAMLTTFNEIDMSNIQEMRARHKEAFLKKHNLKLGFMSAFVKASAFALQEQPVVNA 	                                                            
						homologous to corresponding to amino acids 1 - 300 of        	Alignment:                                                   
						ODO2_HUMAN_V2, which also corresponds to amino acids 19 - 318	                  .         .         .         .         .  
						of HUME2K_P13, and a third amino acid sequence being at least	      19 MLSRSRCVSRAFSRSLSAFQKGNCPLGRRSLPGVSLCQGPGYPNSRKVVI 68                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	       1 MLSRSRCVSRAFSRSLSAFQKGNCPLGRRSLPGVSLCQGPGYPNSRKVVI 50                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						GSGGSSHQECGSYEFCRY corresponding to amino acids 319 - 336 of 	      69 NNSVFSVRFFRTTAVCKDDLVTVKTPAFAESVTEGDVRWEKAVGDTVAED 118                                                          
						HUME2K_P13, wherein said first amino acid sequence, second   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	      51 NNSVFSVRFFRTTAVCKDDLVTVKTPAFAESVTEGDVRWEKAVGDTVAED 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of HUME2K_P13, comprising a  	     119 EVVCEIETDKTSVQVPSPANGVIEALLVPDGGKVEGGTPLFTLRKTGAAP 168                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 EVVCEIETDKTSVQVPSPANGVIEALLVPDGGKVEGGTPLFTLRKTGAAP 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VVVRPYIRCPPALGSSAV of HUME2K_P13.3.An        	     169 AKAKPAEAPAAAAPKAEPTAAAVPPPAAPIPTQMPPVPSPSQPPSGKPVS 218                                                          
						isolated polypeptide encoding for a tail of HUME2K_P13,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     151 AKAKPAEAPAAAAPKAEPTAAAVPPPAAPIPTQMPPVPSPSQPPSGKPVS 200                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     219 AVKPTVAPPLAEPGAGKGLRSEHREKMNRMRQRIAQRLKEAQNTCAMLTT 268                                                          
						about 95% homologous to the sequence GSGGSSHQECGSYEFCRY in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUME2K_P13.                                                  	     201 AVKPTVAPPLAEPGAGKGLRSEHREKMNRMRQRIAQRLKEAQNTCAMLTT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     269 FNEIDMSNIQEMRARHKEAFLKKHNLKLGFMSAFVKASAFALQEQPVVNA 318                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FNEIDMSNIQEMRARHKEAFLKKHNLKLGFMSAFVKASAFALQEQPVVNA 300                                                          

2133	HMR136_HUMEAR1A_7_tr0_r1_1_gPRT		Comparison report between HUMEAR1A_P7 and NRD1_HUMANunique   	Sequence name: NRD1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMEAR1A_P7, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 2133 x NRD1_HUMAN   ..                         
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence ASPAHLLPVSSTE corresponding to amino     	Alignment segment 1/1:                                       
						acids 1 - 13 of HUMEAR1A_P7, and a second amino acid sequence	                                                            
						LNGMVLLCKVCGDVASGFHYGVHACEGCKGFFRRSIQQNIQYKRCLKNENCSIVRINRNR 	                     Quality: 4902.00                      Escore:       0                                               
						CQQCRFKKCLSVGMSRDAVRFGRIPKREKQRMLAEMQSAMNLANNQLSSQCPLETSPTQH 	             Matching length:     492                Total length:     492                                               
						PTPGPMGPSPPPAPVPSPLVGFSQFPQQLTPPRSPSPEPTVEDVISQVARAHREIFTYAH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						DKLGSSPGNFNANHASGSPPATTPHRWENQGCPPAPNDNNTLAAQRHNEALNGLRQAPSS 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.80                                               
						YPPTWPPGPAHHSCHQSNSNGHRLCPTHVYAAPEGKAPANSPRQGNSKNVLLACPMNMYP 	                        Gaps:       0                        
						HGRSGRTVQEIWEDFSMSFTPAVREVVEFAKHIPGFRDLSQHDQVTLLKAGTFEVLMVRF 	                                                            
						ASLFNVKDQTVMFLSRTTYSLQELGAMGMGDLLSAMFDFSEKLNSLALTEEELGLFTAVV 	Alignment:                                                   
						LVSADRSGMENSASVEQLQETLLRALRALVLKNRPLETSRFTKLLLKLPDLRTLNNMHSE 	                  .         .         .         .         .  
						KLLSFRVDAQ                                                   	      12 TELNGMVLLCKVCGDVASGFHYGVHACEGCKGFFRRSIQQNIQYKRCLKN 61                                                           
						being at least 90 % homologous to corresponding to amino     	         |:||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 125 - 614 of NRD1_HUMAN, which also corresponds to     	     123 TKLNGMVLLCKVCGDVASGFHYGVHACEGCKGFFRRSIQQNIQYKRCLKN 172                                                          
						amino acids 14 - 503 of HUMEAR1A_P7, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      62 ENCSIVRINRNRCQQCRFKKCLSVGMSRDAVRFGRIPKREKQRMLAEMQS 111                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of HUMEAR1A_P7, comprising a polypeptide being at 	     173 ENCSIVRINRNRCQQCRFKKCLSVGMSRDAVRFGRIPKREKQRMLAEMQS 222                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     112 AMNLANNQLSSQCPLETSPTQHPTPGPMGPSPPPAPVPSPLVGFSQFPQQ 161                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASPAHLLPVSSTE of HUMEAR1A_P7.                                	     223 AMNLANNQLSSQCPLETSPTQHPTPGPMGPSPPPAPVPSPLVGFSQFPQQ 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     162 LTPPRSPSPEPTVEDVISQVARAHREIFTYAHDKLGSSPGNFNANHASGS 211                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 LTPPRSPSPEPTVEDVISQVARAHREIFTYAHDKLGSSPGNFNANHASGS 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     212 PPATTPHRWENQGCPPAPNDNNTLAAQRHNEALNGLRQAPSSYPPTWPPG 261                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 PPATTPHRWENQGCPPAPNDNNTLAAQRHNEALNGLRQAPSSYPPTWPPG 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     262 PAHHSCHQSNSNGHRLCPTHVYAAPEGKAPANSPRQGNSKNVLLACPMNM 311                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     373 PAHHSCHQSNSNGHRLCPTHVYAAPEGKAPANSPRQGNSKNVLLACPMNM 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     312 YPHGRSGRTVQEIWEDFSMSFTPAVREVVEFAKHIPGFRDLSQHDQVTLL 361                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 YPHGRSGRTVQEIWEDFSMSFTPAVREVVEFAKHIPGFRDLSQHDQVTLL 472                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     362 KAGTFEVLMVRFASLFNVKDQTVMFLSRTTYSLQELGAMGMGDLLSAMFD 411                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     473 KAGTFEVLMVRFASLFNVKDQTVMFLSRTTYSLQELGAMGMGDLLSAMFD 522                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     412 FSEKLNSLALTEEELGLFTAVVLVSADRSGMENSASVEQLQETLLRALRA 461                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     523 FSEKLNSLALTEEELGLFTAVVLVSADRSGMENSASVEQLQETLLRALRA 572                                                          
						                                                            	                  .         .         .         .            
						                                                            	     462 LVLKNRPLETSRFTKLLLKLPDLRTLNNMHSEKLLSFRVDAQ         503                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     573 LVLKNRPLETSRFTKLLLKLPDLRTLNNMHSEKLLSFRVDAQ         614                                                          

24204	HMR136_HUMEGFAA_12_tr0_r1_1_gPRT		Comparison report between HUMEGFAA_P12 and VEGA_HUMANpartial 	Sequence name: VEGA_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMEGFAA_P12, comprising a first    	Sequence documentation:                                      
						MDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNIT 	                                                            
						MQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEK                       	Alignment of: 24204 x VEGA_HUMAN   ..                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 44 - 141 of VEGA_HUMAN, which   	Alignment segment 1/1:                                       
						also corresponds to amino acids 1 - 98 of HUMEGFAA_P12, and a	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1023.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      98                Total length:      98                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence CDKPRR corresponding to amino	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 99 - 104 of HUMEGFAA_P12, wherein said first amino acid	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of HUMEGFAA_P12, comprising a polypeptide being at least	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLE 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence CDKPRR in      	      44 MDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLE 93                                                           
						HUMEGFAA_P12.                                                	                  .         .         .         .            
						                                                            	      51 CVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEK   98                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	      94 CVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEK   141                                                          

24206	HMR136_HUMEGFAA_9_tr0_r1_1_gPRT		Comparison report between HUMEGFAA_P9 and VEGA_HUMANpartial  	Sequence name: VEGA_HUMAN                                    
						WT sequence featuring skipped exon plus extra amino          	                                                            
						acids.1.An isolated chimeric polypeptide encoding for        	Sequence documentation:                                      
						HUMEGFAA_P9, comprising a first amino acid sequence being at 	                                                            
						MDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNIT 	Alignment of: 24206 x VEGA_HUMAN   ..                        
						MQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQE                        	                                                            
						least 90 % homologous to corresponding to amino acids 44 -   	Alignment segment 1/1:                                       
						140 of VEGA_HUMAN, which also corresponds to amino acids 1 - 	                                                            
						97 of HUMEGFAA_P9, a second amino acid sequence bridging     	                     Quality: 1445.00                      Escore:       0                                               
						amino acid sequence comprising of N, and a third amino acid  	             Matching length:     148                Total length:     189                                               
						sequence being at least 90 % homologous to                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.32                                               
						PCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR           	    Total Percent Similarity:   78.31      Total Percent Identity:   77.78                                               
						corresponding to amino acids 183 - 232 of VEGA_HUMAN, which  	                        Gaps:       1                        
						also corresponds to amino acids 99 - 148 of HUMEGFAA_P9,     	                                                            
						wherein said first amino acid sequence, second amino acid    	Alignment:                                                   
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for an 	       1 MDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLE 50                                                           
						edge portion of HUMEGFAA_P9, comprising a polypeptide having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a length "n", wherein n is at least about 10 amino acids in  	      44 MDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLE 93                                                           
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      51 CVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQE... 97                                                           
						preferably at least about 40 amino acids in length and most  	         |||||||||||||||||||||||||||||||||||||||||||||||     
						preferably at least about 50 amino acids in length, wherein  	      94 CVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKS 143                                                          
						at least two amino acids comprise ENP having a structure as  	                  .         .         .         .         .  
						follows (numbering according to HUMEGFAA_P9): a sequence     	      98 ......................................NPCGPCSERRKH 109                                                          
						starting from any of amino acid numbers 97-x to 97; and      	                                               :|||||||||||  
						ending at any of amino acid numbers 99 + ((n-2) - x), in     	     144 VRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKH 193                                                          
						which x varies from 0 to n-2.                                	                  .         .         .                      
						                                                            	     110 LFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR            148                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     194 LFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR            232                                                          

24340	HMR136_HUMEGR2A_2_tr0_r1_1_gPRT		Comparison report between HUMEGR2A_P2 and                    	Sequence name: EGR2_HUMAN_V1                                 
						EGR2_HUMAN_V1unique head followed by partial WT sequence1.An 	                                                            
						isolated chimeric polypeptide encoding for HUMEGR2A_P2,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 24340 x EGR2_HUMAN_V1   ..                     
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						EMRVGLPSEASSCPWSARGPRDPPERRRSGLAHV corresponding to amino    	                                                            
						acids 1 - 34 of HUMEGR2A_P2, and a second amino acid sequence	                     Quality: 4569.00                      Escore:       0                                               
						LSDNIYPVEDLAATSVTIFPNAELGGPFDQMNGVAGDGMINIDMTGEKRSLDLPYPSSFA 	             Matching length:     462                Total length:     462                                               
						PVSAPRNQTFTYMGKFSIDPQYPGASCYPEGIINIVSAGILQGVTSPASTTASSSVTSAS 	 Matching Percent Similarity:   99.57   Matching Percent Identity:   99.35                                               
						PNPLATGPLGVCTMSQTQPDLDHLYSPPPPPPPYSGCAGDLYQDPSAFLSAATTSTSSSL 	    Total Percent Similarity:   99.57      Total Percent Identity:   99.35                                               
						AYPPPPSYPSPKPATDPGLFPMIPDYPGFFPSQCQRDLHGTAGPDRKPFPCPLDTLRVPP 	                        Gaps:       0                        
						PLTPLSTIRNFTLGGPSAGVTGPGASGGSEGPRLPGSSSAAAAAAAAAAYNPHHLPLRPI 	                                                            
						LRPRKYPNRPSKTPVHERPYPCPAEGCDRRFSRSDELTRHIRIHTGHKPFQCRICMRNFS 	Alignment:                                                   
						RSDHLTTHIRTHTGEKPFACDYCGRKFARSDERKRHTKIHLRQKERKSSAPSASVPAPST 	                  .         .         .         .         .  
						ASCSGGVQPGGTLCSSNSSSLGGGPLAPCSSRTRTP                         	      29 SGLAHVLSDNIYPVEDLAATSVTIFPNAELGGPFDQMNGVAGDGMINIDM 78                                                           
						being at least 90 % homologous to corresponding to amino     	         ||: | ||||||||||||||||||||||||||||||||||||||||||||  
						acids 21 - 476 of EGR2_HUMAN_V1, which also corresponds to   	      15 SGFVHQLSDNIYPVEDLAATSVTIFPNAELGGPFDQMNGVAGDGMINIDM 64                                                           
						amino acids 35 - 490 of HUMEGR2A_P2, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      79 TGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDPQYPGASCYPEGIIN 128                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of HUMEGR2A_P2, comprising a polypeptide being at 	      65 TGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDPQYPGASCYPEGIIN 114                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     129 IVSAGILQGVTSPASTTASSSVTSASPNPLATGPLGVCTMSQTQPDLDHL 178                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EMRVGLPSEASSCPWSARGPRDPPERRRSGLAHV of HUMEGR2A_P2.           	     115 IVSAGILQGVTSPASTTASSSVTSASPNPLATGPLGVCTMSQTQPDLDHL 164                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     179 YSPPPPPPPYSGCAGDLYQDPSAFLSAATTSTSSSLAYPPPPSYPSPKPA 228                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     165 YSPPPPPPPYSGCAGDLYQDPSAFLSAATTSTSSSLAYPPPPSYPSPKPA 214                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     229 TDPGLFPMIPDYPGFFPSQCQRDLHGTAGPDRKPFPCPLDTLRVPPPLTP 278                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     215 TDPGLFPMIPDYPGFFPSQCQRDLHGTAGPDRKPFPCPLDTLRVPPPLTP 264                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     279 LSTIRNFTLGGPSAGVTGPGASGGSEGPRLPGSSSAAAAAAAAAAYNPHH 328                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     265 LSTIRNFTLGGPSAGVTGPGASGGSEGPRLPGSSSAAAAAAAAAAYNPHH 314                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     329 LPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRRFSRSDELTRHIRIH 378                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     315 LPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRRFSRSDELTRHIRIH 364                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     379 TGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFACDYCGRKFARSDERK 428                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     365 TGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFACDYCGRKFARSDERK 414                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     429 RHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPGGTLCSSNSSSLGGG 478                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     415 RHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPGGTLCSSNSSSLGGG 464                                                          
						                                                            	                  .                                          
						                                                            	     479 PLAPCSSRTRTP                                       490                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     465 PLAPCSSRTRTP                                       476                                                          

24338	HMR136_HUMEGR2A_3_tr0_r1_1_gPRT		Comparison report between HUMEGR2A_P3 and                    	Sequence name: EGR2_HUMAN_V1                                 
						EGR2_HUMAN_V1partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMEGR2A_P3, comprising a  	                                                            
						MNGVAGDGMINIDMTGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDPQYPGASCYPE 	Alignment of: 24338 x EGR2_HUMAN_V1   ..                     
						GIINIVSAGILQGVTSPASTTASSSVTSASPNPLATGPLGVCTMSQTQPDLDHLYSPPPP 	                                                            
						PPPYSGCAGDLYQDPSAFLSAATTSTSSSLAYPPPPSYPSPKPATDPGLFPMIPDYPGFF 	Alignment segment 1/1:                                       
						PSQCQRDLHGTAGPDRKPFPCPLDTLRVPPPLTPLSTIRNFTLGGPSAGVTGPGASGGSE 	                                                            
						GPRLPGSSSAAAAAAAAAAYNPHHLPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRR 	                     Quality: 4258.00                      Escore:       0                                               
						FSRSDELTRHIRIHTGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFACDYCGRKFARS 	             Matching length:     426                Total length:     426                                               
						DERKRHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPGGTLCSSNSSSLGGGPLAPCS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SRTRTP                                                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						first amino acid sequence being at least 90 % homologous to  	                        Gaps:       0                        
						corresponding to amino acids 51 - 476 of EGR2_HUMAN_V1, which	                                                            
						also corresponds to amino acids 1 - 426 of HUMEGR2A_P3.      	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MNGVAGDGMINIDMTGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 MNGVAGDGMINIDMTGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QYPGASCYPEGIINIVSAGILQGVTSPASTTASSSVTSASPNPLATGPLG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QYPGASCYPEGIINIVSAGILQGVTSPASTTASSSVTSASPNPLATGPLG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VCTMSQTQPDLDHLYSPPPPPPPYSGCAGDLYQDPSAFLSAATTSTSSSL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VCTMSQTQPDLDHLYSPPPPPPPYSGCAGDLYQDPSAFLSAATTSTSSSL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AYPPPPSYPSPKPATDPGLFPMIPDYPGFFPSQCQRDLHGTAGPDRKPFP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AYPPPPSYPSPKPATDPGLFPMIPDYPGFFPSQCQRDLHGTAGPDRKPFP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CPLDTLRVPPPLTPLSTIRNFTLGGPSAGVTGPGASGGSEGPRLPGSSSA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 CPLDTLRVPPPLTPLSTIRNFTLGGPSAGVTGPGASGGSEGPRLPGSSSA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AAAAAAAAAYNPHHLPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AAAAAAAAAYNPHHLPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FSRSDELTRHIRIHTGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFAC 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FSRSDELTRHIRIHTGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFAC 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DYCGRKFARSDERKRHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 DYCGRKFARSDERKRHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPG 450                                                          
						                                                            	                  .         .                                
						                                                            	     401 GTLCSSNSSSLGGGPLAPCSSRTRTP                         426                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     451 GTLCSSNSSSLGGGPLAPCSSRTRTP                         476                                                          

24336	HMR136_HUMEGR2A_5_tr0_r1_1_gPRT		Comparison report between HUMEGR2A_P5 and                    	Sequence name: EGR2_HUMAN_V1                                 
						EGR2_HUMAN_V1partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for HUMEGR2A_P5, comprising a  	                                                            
						MNGVAGDGMINIDMTGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDPQYPGASCYPE 	Alignment of: 24336 x EGR2_HUMAN_V1   ..                     
						GIINIVSAGILQGVTSPASTTASSSVTSASPNPLATGPLGVCTMSQTQPDLDHLYSPPPP 	                                                            
						PPPYSGCAGDLYQDPSAFLSAATTSTSSSLAYPPPPSYPSPKPATDPGLFPMIPDYPGFF 	Alignment segment 1/1:                                       
						PSQCQRDLHGTAGPDRKPFPCPLDTLRVPPPLTPLSTIRNFTLGGPSAGVTGPGASGGSE 	                                                            
						GPRLPGSSSAAAAAAAAAAYNPHHLPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRR 	                     Quality: 4258.00                      Escore:       0                                               
						FSRSDELTRHIRIHTGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFACDYCGRKFARS 	             Matching length:     426                Total length:     426                                               
						DERKRHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPGGTLCSSNSSSLGGGPLAPCS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SRTRTP                                                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						first amino acid sequence being at least 90 % homologous to  	                        Gaps:       0                        
						corresponding to amino acids 51 - 476 of EGR2_HUMAN_V1, which	                                                            
						also corresponds to amino acids 1 - 426 of HUMEGR2A_P5.      	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MNGVAGDGMINIDMTGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 MNGVAGDGMINIDMTGEKRSLDLPYPSSFAPVSAPRNQTFTYMGKFSIDP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QYPGASCYPEGIINIVSAGILQGVTSPASTTASSSVTSASPNPLATGPLG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QYPGASCYPEGIINIVSAGILQGVTSPASTTASSSVTSASPNPLATGPLG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VCTMSQTQPDLDHLYSPPPPPPPYSGCAGDLYQDPSAFLSAATTSTSSSL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VCTMSQTQPDLDHLYSPPPPPPPYSGCAGDLYQDPSAFLSAATTSTSSSL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AYPPPPSYPSPKPATDPGLFPMIPDYPGFFPSQCQRDLHGTAGPDRKPFP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AYPPPPSYPSPKPATDPGLFPMIPDYPGFFPSQCQRDLHGTAGPDRKPFP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CPLDTLRVPPPLTPLSTIRNFTLGGPSAGVTGPGASGGSEGPRLPGSSSA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 CPLDTLRVPPPLTPLSTIRNFTLGGPSAGVTGPGASGGSEGPRLPGSSSA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AAAAAAAAAYNPHHLPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AAAAAAAAAYNPHHLPLRPILRPRKYPNRPSKTPVHERPYPCPAEGCDRR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FSRSDELTRHIRIHTGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFAC 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FSRSDELTRHIRIHTGHKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFAC 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DYCGRKFARSDERKRHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 DYCGRKFARSDERKRHTKIHLRQKERKSSAPSASVPAPSTASCSGGVQPG 450                                                          
						                                                            	                  .         .                                
						                                                            	     401 GTLCSSNSSSLGGGPLAPCSSRTRTP                         426                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     451 GTLCSSNSSSLGGGPLAPCSSRTRTP                         476                                                          

2933	HMR136_HUMELI_0_tr0_r1_1_gPRT		Comparison report between HUMELI_P0 and 41_HUMANunique head  	Sequence name: 41_HUMAN                                      
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for HUMELI_P0, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2933 x 41_HUMAN   ..                           
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence                                          	                                                            
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI corresponding to  	                     Quality: 6516.00                      Escore:       0                                               
						amino acids 1 - 42 of HUMELI_P0, a second amino acid sequence	             Matching length:     674                Total length:     728                                               
						MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGT 	    Total Percent Similarity:   92.58      Total Percent Identity:   92.58                                               
						SLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECS 	                        Gaps:       1                        
						KIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVC 	                                                            
						EHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 	Alignment:                                                   
						TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQT 	                  .         .         .         .         .  
						KELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGL 	      43 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 92                                                           
						LVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRAS 	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						RSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 	                  .         .         .         .         .  
						EPPEQAEPEPTEAWK                                              	      93 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 142                                                          
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 1 - 615 of 41_HUMAN, which also corresponds to amino   	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						acids 43 - 657 of HUMELI_P0, a third amino acid sequence     	                  .         .         .         .         .  
						being at least 90 % homologous to                            	     143 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 192                                                          
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 670 - 728 of 41_HUMAN, which    	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						also corresponds to amino acids 658 - 716 of HUMELI_P0, and a	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	     193 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 242                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     243 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 292                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						717 - 875 of HUMELI_P0, wherein said first amino acid        	                  .         .         .         .         .  
						sequence, second amino acid sequence, third amino acid       	     293 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 342                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						head of HUMELI_P0, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     343 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 392                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI of HUMELI_P0.3.An 	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     393 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 442                                                          
						HUMELI_P0, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     443 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 492                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						at least two amino acids comprise KD, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     493 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 542                                                          
						657-x to 658; and ending at any of amino acid numbers 658+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						polypeptide encoding for a tail of HUMELI_P0, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     543 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 592                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     593 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 642                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in HUMELI_P0.                                	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     643 EPPEQAEPEPTEAWK................................... 657                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 EPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     658 ...................DLDKSQEEIKKHHASISELKKNFMESVPEPR 688                                                          
						                                                            	                            |||||||||||||||||||||||||||||||  
						                                                            	     651 RERLDGENIYIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPR 700                                                          
						                                                            	                  .         .                                
						                                                            	     689 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       716                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     701 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       728                                                          

2935	HMR136_HUMELI_1_tr0_r1_1_gPRT		Comparison report between HUMELI_P1 and 41_HUMANunique head  	Sequence name: 41_HUMAN                                      
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for HUMELI_P1, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2935 x 41_HUMAN   ..                           
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						AGGRAPGSLARSLPPLVRLVSQPAAAGGPASRRGPEPRTPAPPPAIVRRAAAVAGAGARP 	                                                            
						RSHRNI                                                       	                     Quality: 6516.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 66 of   	             Matching length:     674                Total length:     728                                               
						HUMELI_P1, a second amino acid sequence being at least 90 %  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDT 	    Total Percent Similarity:   92.58      Total Percent Identity:   92.58                                               
						PTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGT 	                        Gaps:       1                        
						SLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECS 	                                                            
						KIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVC 	Alignment:                                                   
						EHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 	                  .         .         .         .         .  
						TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQT 	      67 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 116                                                          
						KELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVC 	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						VEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRAS 	                  .         .         .         .         .  
						RSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 	     117 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 166                                                          
						EPPEQAEPEPTEAWK                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 1 - 615 of        	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						41_HUMAN, which also corresponds to amino acids 67 - 681 of  	                  .         .         .         .         .  
						HUMELI_P1, a third amino acid sequence being at least 90 %   	     167 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 216                                                          
						homologous to                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						corresponding to amino acids 670 - 728 of 41_HUMAN, which    	                  .         .         .         .         .  
						also corresponds to amino acids 682 - 740 of HUMELI_P1, and a	     217 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 266                                                          
						fourth amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	     267 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 316                                                          
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						741 - 899 of HUMELI_P1, wherein said first amino acid        	     317 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 366                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fourth amino acid sequence are contiguous and in	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of HUMELI_P1, comprising a polypeptide being at least   	     367 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 416                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						AGGRAPGSLARSLPPLVRLVSQPAAAGGPASRRGPEPRTPAPPPAIVRRAAAVAGAGARP 	                  .         .         .         .         .  
						RSHRNI                                                       	     417 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 466                                                          
						at least about 95% homologous to the sequence of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMELI_P1.3.An isolated chimeric polypeptide encoding for an 	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						edge portion of HUMELI_P1, comprising a polypeptide having a 	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     467 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 516                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     517 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 566                                                          
						at least two amino acids comprise KD, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						681-x to 682; and ending at any of amino acid numbers 682+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     567 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 616                                                          
						polypeptide encoding for a tail of HUMELI_P1, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     617 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 666                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	                  .         .         .         .         .  
						to the sequence in HUMELI_P1.                                	     667 EPPEQAEPEPTEAWK................................... 681                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 EPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     682 ...................DLDKSQEEIKKHHASISELKKNFMESVPEPR 712                                                          
						                                                            	                            |||||||||||||||||||||||||||||||  
						                                                            	     651 RERLDGENIYIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPR 700                                                          
						                                                            	                  .         .                                
						                                                            	     713 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       740                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     701 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       728                                                          

2937	HMR136_HUMELI_11_tr0_r1_1_gPRT		Comparison report between HUMELI_P11 and 41_HUMAN_V1unique   	Sequence name: 41_HUMAN_V1                                   
						head followed by partial WT sequence featuring a skipped exon	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for HUMELI_P11, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2937 x 41_HUMAN_V1   ..                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence                                          	                                                            
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI corresponding to  	                     Quality: 7699.00                      Escore:       0                                               
						amino acids 1 - 42 of HUMELI_P11, a second amino acid        	             Matching length:     810                Total length:    1014                                               
						MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGT 	    Total Percent Similarity:   79.88      Total Percent Identity:   79.88                                               
						SLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECS 	                        Gaps:       2                        
						KIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVC 	                                                            
						EHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 	Alignment:                                                   
						TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQT 	                  .         .         .         .         .  
						KELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGL 	      43 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 92                                                           
						LVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRAS 	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						RSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 	                  .         .         .         .         .  
						EPPEQAEPEPTEAWK                                              	      93 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 142                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 615 of 41_HUMAN_V1, which also corresponds to	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						amino acids 43 - 657 of HUMELI_P11, a third amino acid       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     143 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 192                                                          
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 670 - 728 of 41_HUMAN_V1, which 	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						also corresponds to amino acids 658 - 716 of HUMELI_P11, a   	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	     193 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 242                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     243 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 292                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQ                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						717 - 866 of HUMELI_P11, and a fifth amino acid sequence     	                  .         .         .         .         .  
						PPLVKTQTVTISDNANAVKSEIPTKDVPIVHTETKTITYEAAQTDDNSGDLDPGVLLTAQ 	     293 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 342                                                          
						TITSETPSSTTTTQITKTVKGGISETRIEKRIVITGDADIDHDQVLVQAIKEAKEQHPDM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVTKVVVHQETEIADE                                             	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 729 - 864 of 41_HUMAN_V1, which also corresponds to    	     343 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 392                                                          
						amino acids 867 - 1002 of HUMELI_P11, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence, third amino 	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						acid sequence, fourth amino acid sequence and fifth amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     393 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 442                                                          
						isolated polypeptide encoding for a head of HUMELI_P11,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     443 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 492                                                          
						about 95% homologous to the sequence                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI of HUMELI_P11.3.An	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						HUMELI_P11, comprising a polypeptide having a length "n",    	     493 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 542                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     543 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 592                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise KD, having a structure as  	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						657-x to 658; and ending at any of amino acid numbers 658+   	     593 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 642                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of HUMELI_P11,      	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     643 EPPEQAEPEPTEAWK................................... 657                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||||||                                     
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	     601 EPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKK 650                                                          
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	                  .         .         .         .         .  
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQ,                              	     658 ...................DLDKSQEEIKKHHASISELKKNFMESVPEPR 688                                                          
						least about 95% homologous to the sequence encoding for      	                            |||||||||||||||||||||||||||||||  
						corresponding to HUMELI_P11.                                 	     651 RERLDGENIYIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     689 PSEWDKRLSTHSPFRTLNINGQIPTGEGSINGIRTEEVAVVTKGPSTNPD 738                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     701 PSEWDKRLSTHSPFRTLNINGQIPTGEG...................... 728                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     739 SEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKETEEKEEGAAGYL 788                                                          
						                                                            	                                                            
						                                                            	     728 .................................................. 728                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     789 DIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHVTP 838                                                          
						                                                            	                                                            
						                                                            	     728 .................................................. 728                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     839 GEPPGKQNGSFLDFHVGNQFPTLIRSFQPPLVKTQTVTISDNANAVKSEI 888                                                          
						                                                            	                                     ||||||||||||||||||||||  
						                                                            	     729 ............................PPLVKTQTVTISDNANAVKSEI 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     889 PTKDVPIVHTETKTITYEAAQTDDNSGDLDPGVLLTAQTITSETPSSTTT 938                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 PTKDVPIVHTETKTITYEAAQTDDNSGDLDPGVLLTAQTITSETPSSTTT 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     939 TQITKTVKGGISETRIEKRIVITGDADIDHDQVLVQAIKEAKEQHPDMSV 988                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TQITKTVKGGISETRIEKRIVITGDADIDHDQVLVQAIKEAKEQHPDMSV 850                                                          
						                                                            	                  .                                          
						                                                            	     989 TKVVVHQETEIADE                                     1002                                                         
						                                                            	         ||||||||||||||                                      
						                                                            	     851 TKVVVHQETEIADE                                     864                                                          

2939	HMR136_HUMELI_12_tr0_r1_1_gPRT		Comparison report between HUMELI_P12 and Q8IXV9unique head   	Sequence name: Q8IXV9                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for HUMELI_P12, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2939 x Q8IXV9   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence                                          	                                                            
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI corresponding to  	                     Quality: 6516.00                      Escore:       0                                               
						amino acids 1 - 42 of HUMELI_P12, a second amino acid        	             Matching length:     674                Total length:     714                                               
						MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGT 	    Total Percent Similarity:   94.40      Total Percent Identity:   94.40                                               
						SLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECS 	                        Gaps:       1                        
						KIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVC 	                                                            
						EHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 	Alignment:                                                   
						TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQT 	                  .         .         .         .         .  
						KELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGL 	      43 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 92                                                           
						LVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRAS 	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						RSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 	                  .         .         .         .         .  
						EPPEQAEPEPTEAWK                                              	      93 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 142                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 615 of Q8IXV9, which also corresponds to     	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						amino acids 43 - 657 of HUMELI_P12, a third amino acid       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     143 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 192                                                          
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 656 - 714 of Q8IXV9, which also 	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						corresponds to amino acids 658 - 716 of HUMELI_P12, and a    	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	     193 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 242                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     243 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 292                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQTQTVTISDNANAVKSEIPTKDVPIVHTETK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TITYEAAQTDDNSGDLDPGVLLTAQTITSETPSSTTTTQITKTVKGGISETRIEKRIVIT 	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						GDADIDHDQVLVQAIKEAKEQHPDMSVTKVVVHQETEIADE                    	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     293 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 342                                                          
						717 - 997 of HUMELI_P12, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						sequence and fourth amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     343 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 392                                                          
						head of HUMELI_P12, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	     393 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 442                                                          
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI of HUMELI_P12.3.An	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						HUMELI_P12, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     443 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 492                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     493 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 542                                                          
						at least two amino acids comprise KD, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						657-x to 658; and ending at any of amino acid numbers 658+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     543 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 592                                                          
						polypeptide encoding for a tail of HUMELI_P12, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     593 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 642                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQTQTVTISDNANAVKSEIPTKDVPIVHTETK 	                  .         .         .         .         .  
						TITYEAAQTDDNSGDLDPGVLLTAQTITSETPSSTTTTQITKTVKGGISETRIEKRIVIT 	     643 EPPEQAEPEPTEAWK................................... 657                                                          
						GDADIDHDQVLVQAIKEAKEQHPDMSVTKVVVHQETEIADE                    	         |||||||||||||||                                     
						to the sequence in HUMELI_P12.                               	     601 EPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKKRERLDGENIYIRHS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     658 .....DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPF 702                                                          
						                                                            	              |||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 NLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPF 700                                                          
						                                                            	                  .                                          
						                                                            	     703 RTLNINGQIPTGEG                                     716                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     701 RTLNINGQIPTGEG                                     714                                                          

2943	HMR136_HUMELI_18_tr0_r1_1_gPRT		Comparison report between HUMELI_P18 and 41_HUMANunique head 	Sequence name: 41_HUMAN                                      
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for HUMELI_P18, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2943 x 41_HUMAN   ..                           
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence                                          	                                                            
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI corresponding to  	                     Quality: 6516.00                      Escore:       0                                               
						amino acids 1 - 42 of HUMELI_P18, a second amino acid        	             Matching length:     674                Total length:     728                                               
						MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGT 	    Total Percent Similarity:   92.58      Total Percent Identity:   92.58                                               
						SLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECS 	                        Gaps:       1                        
						KIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVC 	                                                            
						EHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 	Alignment:                                                   
						TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQT 	                  .         .         .         .         .  
						KELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGL 	      43 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 92                                                           
						LVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRAS 	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						RSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 	                  .         .         .         .         .  
						EPPEQAEPEPTEAWK                                              	      93 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 142                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 615 of 41_HUMAN, which also corresponds to   	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						amino acids 43 - 657 of HUMELI_P18, a third amino acid       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     143 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 192                                                          
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 670 - 728 of 41_HUMAN, which    	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						also corresponds to amino acids 658 - 716 of HUMELI_P18, and 	                  .         .         .         .         .  
						a fourth amino acid sequence being at least 70%, optionally  	     193 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 242                                                          
						at least 80%, preferably at least 85%, more preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90% and most preferably at least 95% homologous to a   	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     243 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 292                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						717 - 875 of HUMELI_P18, wherein said first amino acid       	                  .         .         .         .         .  
						sequence, second amino acid sequence, third amino acid       	     293 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 342                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						head of HUMELI_P18, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     343 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 392                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI of HUMELI_P18.3.An	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     393 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 442                                                          
						HUMELI_P18, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     443 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 492                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						at least two amino acids comprise KD, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     493 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 542                                                          
						657-x to 658; and ending at any of amino acid numbers 658+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						polypeptide encoding for a tail of HUMELI_P18, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     543 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 592                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     593 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 642                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in HUMELI_P18.                               	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     643 EPPEQAEPEPTEAWK................................... 657                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 EPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     658 ...................DLDKSQEEIKKHHASISELKKNFMESVPEPR 688                                                          
						                                                            	                            |||||||||||||||||||||||||||||||  
						                                                            	     651 RERLDGENIYIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPR 700                                                          
						                                                            	                  .         .                                
						                                                            	     689 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       716                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     701 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       728                                                          

2941	HMR136_HUMELI_19_tr0_r1_1_gPRT		Comparison report between HUMELI_P19 and 41_HUMANunique head 	Sequence name: 41_HUMAN                                      
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for HUMELI_P19, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2941 x 41_HUMAN   ..                           
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence                                          	                                                            
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI corresponding to  	                     Quality: 6516.00                      Escore:       0                                               
						amino acids 1 - 42 of HUMELI_P19, a second amino acid        	             Matching length:     674                Total length:     728                                               
						MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGT 	    Total Percent Similarity:   92.58      Total Percent Identity:   92.58                                               
						SLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECS 	                        Gaps:       1                        
						KIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVC 	                                                            
						EHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 	Alignment:                                                   
						TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQT 	                  .         .         .         .         .  
						KELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGL 	      43 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 92                                                           
						LVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRAS 	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						RSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 	                  .         .         .         .         .  
						EPPEQAEPEPTEAWK                                              	      93 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 142                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 615 of 41_HUMAN, which also corresponds to   	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						amino acids 43 - 657 of HUMELI_P19, a third amino acid       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     143 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 192                                                          
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 670 - 728 of 41_HUMAN, which    	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						also corresponds to amino acids 658 - 716 of HUMELI_P19, and 	                  .         .         .         .         .  
						a fourth amino acid sequence being at least 70%, optionally  	     193 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 242                                                          
						at least 80%, preferably at least 85%, more preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90% and most preferably at least 95% homologous to a   	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     243 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 292                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						717 - 875 of HUMELI_P19, wherein said first amino acid       	                  .         .         .         .         .  
						sequence, second amino acid sequence, third amino acid       	     293 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 342                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						head of HUMELI_P19, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     343 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 392                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						VALSVQVEAPAGQSGRNLLKGESGAEPERGRPGPRRTQPSNI of HUMELI_P19.3.An	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     393 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 442                                                          
						HUMELI_P19, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     443 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 492                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						at least two amino acids comprise KD, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     493 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 542                                                          
						657-x to 658; and ending at any of amino acid numbers 658+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						polypeptide encoding for a tail of HUMELI_P19, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     543 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 592                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     593 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 642                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in HUMELI_P19.                               	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     643 EPPEQAEPEPTEAWK................................... 657                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 EPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     658 ...................DLDKSQEEIKKHHASISELKKNFMESVPEPR 688                                                          
						                                                            	                            |||||||||||||||||||||||||||||||  
						                                                            	     651 RERLDGENIYIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPR 700                                                          
						                                                            	                  .         .                                
						                                                            	     689 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       716                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     701 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       728                                                          

2947	HMR136_HUMELI_2_tr0_r1_1_gPRT		Comparison report between HUMELI_P2 and 41_HUMANpartial WT   	Sequence name: 41_HUMAN                                      
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMELI_P2, comprising a first amino acid sequence being at   	                                                            
						MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDT 	Alignment of: 2947 x 41_HUMAN   ..                           
						PTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGT 	                                                            
						SLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECS 	Alignment segment 1/1:                                       
						KIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVC 	                                                            
						EHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 	                     Quality: 6516.00                      Escore:       0                                               
						TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQT 	             Matching length:     674                Total length:     728                                               
						KELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVC 	    Total Percent Similarity:   92.58      Total Percent Identity:   92.58                                               
						VEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRAS 	                        Gaps:       1                        
						RSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 	                                                            
						EPPEQAEPEPTEAWK                                              	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 1 - 615	                  .         .         .         .         .  
						of 41_HUMAN, which also corresponds to amino acids 1 - 615 of	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						HUMELI_P2, a second amino acid sequence being at least 90 %  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to                                                	       1 MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCE 50                                                           
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	                  .         .         .         .         .  
						corresponding to amino acids 670 - 728 of 41_HUMAN, which    	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						also corresponds to amino acids 616 - 674 of HUMELI_P2, and a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 70%, optionally at  	      51 QKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGK 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     101 EVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSL 150                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						675 - 833 of HUMELI_P2, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     151 SSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKAS 200                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						HUMELI_P2, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     201 QKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDY 250                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     251 FGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDI 300                                                          
						at least two amino acids comprise KD, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						615-x to 616; and ending at any of amino acid numbers 616+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     301 TRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYV 350                                                          
						polypeptide encoding for a tail of HUMELI_P2, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     351 SDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDL 400                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in HUMELI_P2.                                	     401 HKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIK 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKED 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 EPPEQAEPEPTEAWK................................... 615                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 EPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     616 ...................DLDKSQEEIKKHHASISELKKNFMESVPEPR 646                                                          
						                                                            	                            |||||||||||||||||||||||||||||||  
						                                                            	     651 RERLDGENIYIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPR 700                                                          
						                                                            	                  .         .                                
						                                                            	     647 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       674                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     701 PSEWDKRLSTHSPFRTLNINGQIPTGEG                       728                                                          

2945	HMR136_HUMELI_3_tr0_r1_1_gPRT		Comparison report between HUMELI_P3 and 41_HUMANpartial WT   	Sequence name: 41_HUMAN                                      
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMELI_P3, comprising a first amino acid sequence being at   	                                                            
						MHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDYFGLAIWDNATSKTWLDSAK 	Alignment of: 2945 x 41_HUMAN   ..                           
						EIKKQVRGVPWNFTFNVKFYPPDPAQLTEDITRYYLCLQLRQDIVAGRLPCSFATLALLG 	                                                            
						SYTIQSELGDYDPELHGVDYVSDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLEN 	Alignment segment 1/1:                                       
						AKKLSMYGVDLHKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFI 	                                                            
						KIRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKFLALGSKFRY 	                     Quality: 4470.00                      Escore:       0                                               
						SGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVDSADRSPRPTSAPAITQGQV 	             Matching length:     465                Total length:     519                                               
						AEGGVLDASAKKTVVPKAQKETVKAEVKKEDEPPEQAEPEPTEAWK               	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 210 -  	    Total Percent Similarity:   89.60      Total Percent Identity:   89.60                                               
						615 of 41_HUMAN, which also corresponds to amino acids 1 -   	                        Gaps:       1                        
						406 of HUMELI_P3, a second amino acid sequence being at least	                                                            
						90 % homologous to                                           	Alignment:                                                   
						DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEG  	                  .         .         .         .         .  
						corresponding to amino acids 670 - 728 of 41_HUMAN, which    	       1 MHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDYFGLAIWDNA 50                                                           
						also corresponds to amino acids 407 - 465 of HUMELI_P3, and a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 70%, optionally at  	     210 MHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDYFGLAIWDNA 259                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      51 TSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDITRYYLCLQL 100                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     260 TSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDITRYYLCLQL 309                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     101 RQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQ 150                                                          
						466 - 624 of HUMELI_P3, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     310 RQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQ 359                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     151 TKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGV 200                                                          
						HUMELI_P3, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     360 TKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGV 409                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     201 DIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQY 250                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     410 DIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQY 459                                                          
						at least two amino acids comprise KD, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     251 ESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKFLALGSKFRY 300                                                          
						406-x to 407; and ending at any of amino acid numbers 407+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     460 ESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKFLALGSKFRY 509                                                          
						polypeptide encoding for a tail of HUMELI_P3, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     301 SGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVDSADRSPRPT 350                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     510 SGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVDSADRSPRPT 559                                                          
						SINGIRTEEVAVVTKGPSTNPDSEWEGPKHSVVPSKSQMTTSSESLQSFAFGSLSISSKE 	                  .         .         .         .         .  
						TEEKEEGAAGYLDIKEMPRGPTGGCIGVEEQASALKFSVTPASCQLQPGVKKAESSEEHV 	     351 SAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKEDEPPEQAEPE 400                                                          
						TPGEPPGKQNGSFLDFHVGNQFPTLIRSFQVVIYSMMQV                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in HUMELI_P3.                                	     560 SAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKEDEPPEQAEPE 609                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PTEAWK............................................ 406                                                          
						                                                            	         ||||||                                              
						                                                            	     610 PTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKKRERLDGENI 659                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     407 ..........DLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLS 446                                                          
						                                                            	                   ||||||||||||||||||||||||||||||||||||||||  
						                                                            	     660 YIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLS 709                                                          
						                                                            	                  .                                          
						                                                            	     447 THSPFRTLNINGQIPTGEG                                465                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     710 THSPFRTLNINGQIPTGEG                                728                                                          

25529	HMR136_HUMELK1A_10_tr0_r1_1_gPRT		Comparison report between HUMELK1A_P10 and ELK1_HUMANpartial 	Sequence name: ELK1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for HUMELK1A_P10, comprising a first    	Sequence documentation:                                      
						MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRKNKTNMNYDKL 	                                                            
						SRALRYYYDK                                                   	Alignment of: 25529 x ELK1_HUMAN   ..                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 70 of ELK1_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 70 of HUMELK1A_P10, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  699.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      70                Total length:      70                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence VQSLRPGLEP corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 71 - 80 of HUMELK1A_P10, wherein said first amino	                        Gaps:       0                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	Alignment:                                                   
						for a tail of HUMELK1A_P10, comprising a polypeptide being at	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	       1 MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRK 50                                                           
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	       1 MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRK 50                                                           
						VQSLRPGLEP in HUMELK1A_P10.                                  	                  .         .                                
						                                                            	      51 NKTNMNYDKLSRALRYYYDK                               70                                                           
						                                                            	         ||||||||||||||||||||                                
						                                                            	      51 NKTNMNYDKLSRALRYYYDK                               70                                                           

25527	HMR136_HUMELK1A_3_tr0_r1_1_gPRT		Comparison report between HUMELK1A_P3 and ELK1_HUMANunique   	Sequence name: ELK1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMELK1A_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 25527 x ELK1_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	Alignment segment 1/1:                                       
						EAKHSELYMQVDLGCNFFVDTVVYPWDGVSTPPA                           	                                                            
						having the sequence corresponding to amino acids 1 - 94 of   	                     Quality: 4182.00                      Escore:       0                                               
						HUMELK1A_P3, and a second amino acid sequence being at least 	             Matching length:     428                Total length:     428                                               
						MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRKNKTNMNYDKL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SRALRYYYDKNIIRKVSGQKFVYKFVSYPEVAGCSTEDCPPQPEVSVTSTMPNVAPAAIH 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AAPGDTVSGKPGTPKGAGMAGPGGLARSSRNEYMRSGLYSTFTIQSLQPQPPPHPRPAVV 	                        Gaps:       0                        
						LPSAAPAGAAAPPSGSRSTSPSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGL 	                                                            
						GRALPPEVKVEGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAVVMDTAGQAGGH 	Alignment:                                                   
						AASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSGSGSGLQAPGPALTPSLLPTH 	                  .         .         .         .         .  
						TLTPVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSSGSAQVHIPSISVDGLSTPVV 	      95 MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRK 144                                                          
						LSPGPQKP                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 428 of   	       1 MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRK 50                                                           
						ELK1_HUMAN, which also corresponds to amino acids 95 - 522 of	                  .         .         .         .         .  
						HUMELK1A_P3, wherein said first amino acid sequence and      	     145 NKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFVSYPEVAGCSTEDCP 194                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 NKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFVSYPEVAGCSTEDCP 100                                                          
						HUMELK1A_P3, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     195 PQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGMAGPGGLARSSR 244                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	     101 PQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGMAGPGGLARSSR 150                                                          
						EAKHSELYMQVDLGCNFFVDTVVYPWDGVSTPPA                           	                  .         .         .         .         .  
						least about 95% homologous to the sequence of HUMELK1A_P3.   	     245 NEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPSAAPAGAAAPPSGSRSTS 294                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPSAAPAGAAAPPSGSRSTS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     295 PSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGLGRALPPEVKV 344                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGLGRALPPEVKV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     345 EGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAVVMDTAGQAGGH 394                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAVVMDTAGQAGGH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     395 AASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSGSGSGLQAPGP 444                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSGSGSGLQAPGP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     445 ALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSS 494                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSS 400                                                          
						                                                            	                  .         .                                
						                                                            	     495 GSAQVHIPSISVDGLSTPVVLSPGPQKP                       522                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     401 GSAQVHIPSISVDGLSTPVVLSPGPQKP                       428                                                          

						Comparison report between HUMELK1A_P3 and Q969X8unique head  	Sequence name: Q969X8                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for HUMELK1A_P3, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 25527 x Q969X8   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	Alignment segment 1/1:                                       
						EAKHSELYMQVDLGCNFFVDTVVYPWDGVSTPPA                           	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 4173.00                      Escore:       0                                               
						1 - 94 of HUMELK1A_P3, a second amino acid sequence being at 	             Matching length:     428                Total length:     428                                               
						MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRKNKTNMNYDKL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						SRALRYYYDKNIIRKVSGQKFVYKFVSYPEVAGCSTEDCPPQPEVSVTSTMPNVAPAAIH 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.77                                               
						AAPGDTVSGKPGTPKGAGMAGPGGLARSSRNEYMRSGLYSTFTIQSLQPQPPPHPRPAVV 	                        Gaps:       0                        
						LP                                                           	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 182	Alignment:                                                   
						of Q969X8, which also corresponds to amino acids 95 - 276 of 	                  .         .         .         .         .  
						HUMELK1A_P3, a bridging amino acid S corresponding to amino  	      95 MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRK 144                                                          
						acid 277 of HUMELK1A_P3, and a third amino acid sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAPAGAAAPPSGSRSTSPSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGLGRA 	       1 MDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLRK 50                                                           
						LPPEVKVEGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAVVMDTAGQAGGHAAS 	                  .         .         .         .         .  
						SPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSGSGSGLQAPGPALTPSLLPTHTLT 	     145 NKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFVSYPEVAGCSTEDCP 194                                                          
						PVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSSGSAQVHIPSISVDGLSTPVVLSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GPQKP                                                        	      51 NKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFVSYPEVAGCSTEDCP 100                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 184 - 428 of Q969X8, which also corresponds to amino   	     195 PQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGMAGPGGLARSSR 244                                                          
						acids 278 - 522 of HUMELK1A_P3, wherein said first amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid and	     101 PQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGMAGPGGLARSSR 150                                                          
						third amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     245 NEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPSAAPAGAAAPPSGSRSTS 294                                                          
						HUMELK1A_P3, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||:|||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 NEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPNAAPAGAAAPPSGSRSTS 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	     295 PSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGLGRALPPEVKV 344                                                          
						EAKHSELYMQVDLGCNFFVDTVVYPWDGVSTPPA                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of HUMELK1A_P3.   	     201 PSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGLGRALPPEVKV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     345 EGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAVVMDTAGQAGGH 394                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAVVMDTAGQAGGH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     395 AASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSGSGSGLQAPGP 444                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSGSGSGLQAPGP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     445 ALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSS 494                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSS 400                                                          
						                                                            	                  .         .                                
						                                                            	     495 GSAQVHIPSISVDGLSTPVVLSPGPQKP                       522                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     401 GSAQVHIPSISVDGLSTPVVLSPGPQKP                       428                                                          

						Comparison report between HUMELK1A_P3 and Q8N9S0unique head  	Sequence name: Q8N9S0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						HUMELK1A_P3, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25527 x Q8N9S0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	Alignment segment 1/1:                                       
						EAKHSELYMQVDLGCNFFVDTVVYPWDGVSTPPAMDPSVTLWQFLLQLLREQGNGHIISW 	                                                            
						TSRDGGEFKLVDAEEVARLWGLRKNKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFV 	                     Quality: 1082.00                      Escore:       0                                               
						SYPEVAGCSTEDCPPQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGMAGPGGLA 	             Matching length:     121                Total length:     138                                               
						RSSRNEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPSAAPAGAAAPPSGSRSTSPSPLEA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGLGRALPPEVKVEGPKEELEVAGERGFV 	    Total Percent Similarity:   87.68      Total Percent Identity:   87.68                                               
						PETTKAEPEVPPQEGVPARLPAVV                                     	                        Gaps:       1                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 384 of HUMELK1A_P3, a second amino acid   	Alignment:                                                   
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						MDTAGQAGGHAASSPEISQPQKGRKPRDLELPLSPSLLGGPGPER corresponding  	     385 MDTAGQAGGHAASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSG 434                                                          
						to amino acids 1 - 45 of Q8N9S0, which also corresponds to   	         |||||||||||||||||||||||||||||||||||||||||||||       
						amino acids 385 - 429 of HUMELK1A_P3, a third amino acid     	       1 MDTAGQAGGHAASSPEISQPQKGRKPRDLELPLSPSLLGGPGPER..... 45                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     435 SGSGLQAPGPALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSP 484                                                          
						most preferably at least 95% homologous to a polypeptide     	                     ||||||||||||||||||||||||||||||||||||||  
						having the sequence TPGSGSGSGLQAPGPAL corresponding to amino 	      46 ............TPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSP 83                                                           
						acids 430 - 446 of HUMELK1A_P3, and a fourth amino acid      	                  .         .         .                      
						TPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSSGSAQVHIPSISV 	     485 AKLSFQFPSSGSAQVHIPSISVDGLSTPVVLSPGPQKP             522                                                          
						DGLSTPVVLSPGPQKP                                             	         ||||||||||||||||||||||||||||||||||||||              
						sequence being at least 90 % homologous to corresponding to  	      84 AKLSFQFPSSGSAQVHIPSISVDGLSTPVVLSPGPQKP             121                                                          
						amino acids 46 - 121 of Q8N9S0, which also corresponds to    	                                                            
						amino acids 447 - 522 of HUMELK1A_P3, wherein said first     	                                                            
						amino acid sequence, second amino acid sequence, third amino 	                                                            
						acid sequence and fourth amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a head of HUMELK1A_P3, comprising a polypeptide being at 	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	                                                            
						EAKHSELYMQVDLGCNFFVDTVVYPWDGVSTPPAMDPSVTLWQFLLQLLREQGNGHIISW 	                                                            
						TSRDGGEFKLVDAEEVARLWGLRKNKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFV 	                                                            
						SYPEVAGCSTEDCPPQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGMAGPGGLA 	                                                            
						RSSRNEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPSAAPAGAAAPPSGSRSTSPSPLEA 	                                                            
						CLEAEEAGLPLQVILTPPEAPNLKSEELNVEPGLGRALPPEVKVEGPKEELEVAGERGFV 	                                                            
						PETTKAEPEVPPQEGVPARLPAVV                                     	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						HUMELK1A_P3.3.An isolated polypeptide encoding for an edge   	                                                            
						portion of HUMELK1A_P3, comprising an amino acid sequence    	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for TPGSGSGSGLQAPGPAL, corresponding to HUMELK1A_P3.	                                                            

						Comparison report between HUMELK1A_P3 and AAH48296unique     	Sequence name: AAH48296                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMELK1A_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 25527 x AAH48296   ..                          
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	Alignment segment 1/1:                                       
						EAKHSELYMQVDLGCNFFVDTVV                                      	                                                            
						having the sequence corresponding to amino acids 1 - 83 of   	                     Quality: 4300.00                      Escore:       0                                               
						HUMELK1A_P3, and a second amino acid sequence being at least 	             Matching length:     439                Total length:     439                                               
						YPWDGVSTPPAMDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDAEEVARLWGLR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KNKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFVSYPEVAGCSTEDCPPQPEVSVTS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TMPNVAPAAIHAAPGDTVSGKPGTPKGAGMAGPGGLARSSRNEYMRSGLYSTFTIQSLQP 	                        Gaps:       0                        
						QPPPHPRPAVVLPSAAPAGAAAPPSGSRSTSPSPLEACLEAEEAGLPLQVILTPPEAPNL 	                                                            
						KSEELNVEPGLGRALPPEVKVEGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAV 	Alignment:                                                   
						VMDTAGQAGGHAASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGSGSGSGLQAPG 	                  .         .         .         .         .  
						PALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRSPAKLSFQFPSSGSAQVHIPS 	      84 YPWDGVSTPPAMDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDA 133                                                          
						ISVDGLSTPVVLSPGPQKP                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 16 - 454 of  	      16 YPWDGVSTPPAMDPSVTLWQFLLQLLREQGNGHIISWTSRDGGEFKLVDA 65                                                           
						AAH48296, which also corresponds to amino acids 84 - 522 of  	                  .         .         .         .         .  
						HUMELK1A_P3, wherein said first amino acid sequence and      	     134 EEVARLWGLRKNKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFVSYP 183                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      66 EEVARLWGLRKNKTNMNYDKLSRALRYYYDKNIIRKVSGQKFVYKFVSYP 115                                                          
						HUMELK1A_P3, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     184 EVAGCSTEDCPPQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGM 233                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MATPPKRRAVEATGEKVLRYETFISDVLQRDLRKVLDHRDKVYEQLAKYLQLRNVIERLQ 	     116 EVAGCSTEDCPPQPEVSVTSTMPNVAPAAIHAAPGDTVSGKPGTPKGAGM 165                                                          
						EAKHSELYMQVDLGCNFFVDTVV                                      	                  .         .         .         .         .  
						least about 95% homologous to the sequence of HUMELK1A_P3.   	     234 AGPGGLARSSRNEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPSAAPAGA 283                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     166 AGPGGLARSSRNEYMRSGLYSTFTIQSLQPQPPPHPRPAVVLPSAAPAGA 215                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     284 AAPPSGSRSTSPSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPG 333                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     216 AAPPSGSRSTSPSPLEACLEAEEAGLPLQVILTPPEAPNLKSEELNVEPG 265                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     334 LGRALPPEVKVEGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAV 383                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     266 LGRALPPEVKVEGPKEELEVAGERGFVPETTKAEPEVPPQEGVPARLPAV 315                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     384 VMDTAGQAGGHAASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGS 433                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     316 VMDTAGQAGGHAASSPEISQPQKGRKPRDLELPLSPSLLGGPGPERTPGS 365                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     434 GSGSGLQAPGPALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRS 483                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     366 GSGSGLQAPGPALTPSLLPTHTLTPVLLTPSSLPPSIHFWSTLSPIAPRS 415                                                          
						                                                            	                  .         .         .                      
						                                                            	     484 PAKLSFQFPSSGSAQVHIPSISVDGLSTPVVLSPGPQKP            522                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     416 PAKLSFQFPSSGSAQVHIPSISVDGLSTPVVLSPGPQKP            454                                                          

26026	HMR136_HUMENL_1_tr0_r1_1_gPRT		Comparison report between HUMENL_P1 and Q14768partial WT     	Sequence name: Q14768                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for HUMENL_P1, comprising a first amino 	Sequence documentation:                                      
						MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFP 	                                                            
						KPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCE 	Alignment of: 26026 x Q14768   ..                            
						KLTFNNPTTEFRYKLLRAGG                                         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 140 of Q14768, which also corresponds to  	                                                            
						amino acids 1 - 140 of HUMENL_P1, and a second amino acid    	                     Quality: 5022.00                      Escore:       0                                               
						DANKESSKTSKPHKVTKEHRERPRKDSESKSSSKELEREQAKSSKDTSRKLGEGRLPKEE 	             Matching length:     517                Total length:     559                                               
						KAPPPKAAFKEPKMALKETKLESTSPKGGPPPPPPPPPRASSKRPATADSPKPSAKKQKK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SSSKGSRSAPGTSPRTSSSSSFSDKKPAKDKSSTRGEKVKAESEPREAKKALEVEESNSE 	    Total Percent Similarity:   92.49      Total Percent Identity:   92.49                                               
						DEASFKSESAQSSPSNSSSSSDSSSDSDFEPSQNHSQGPLRSMVEDLQSEESDEDDSSSG 	                        Gaps:       1                        
						EEAAGKTNPGRDSRLSFSDSESDNSADSSLPSREPPPPQKPPPPNSKVSGRRSPESCSKP 	                                                            
						EKILKKGTYDKAYTDELVELHRRLMALRERNVLQQIVNLIEETGHFNVTNTTFDFDLFSL 	Alignment:                                                   
						DETTVRKLQSCLEAVAT                                            	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       1 MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEK 50                                                           
						amino acids 183 - 559 of Q14768, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 141 - 517 of HUMENL_P1, wherein said first amino 	       1 MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEK 50                                                           
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated chimeric polypeptide 	      51 VVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCF 100                                                          
						encoding for an edge portion of HUMENL_P1, comprising a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	      51 VVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCF 100                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     101 TYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGG.......... 140                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||            
						length and most preferably at least about 50 amino acids in  	     101 TYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGADT 150                                                          
						length, wherein at least two amino acids comprise GD, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     141 ................................DANKESSKTSKPHKVTKE 158                                                          
						acid numbers 140-x to 141; and ending at any of amino acid   	                                         ||||||||||||||||||  
						numbers 141+ ((n-2) - x), in which x varies from 0 to n-2.   	     151 VSRPSPDYPMLPTIPLSAFSDPKKTKPSHGSKDANKESSKTSKPHKVTKE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 HRERPRKDSESKSSSKELEREQAKSSKDTSRKLGEGRLPKEEKAPPPKAA 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HRERPRKDSESKSSSKELEREQAKSSKDTSRKLGEGRLPKEEKAPPPKAA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 FKEPKMALKETKLESTSPKGGPPPPPPPPPRASSKRPATADSPKPSAKKQ 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FKEPKMALKETKLESTSPKGGPPPPPPPPPRASSKRPATADSPKPSAKKQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 KKSSSKGSRSAPGTSPRTSSSSSFSDKKPAKDKSSTRGEKVKAESEPREA 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 KKSSSKGSRSAPGTSPRTSSSSSFSDKKPAKDKSSTRGEKVKAESEPREA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 KKALEVEESNSEDEASFKSESAQSSPSNSSSSSDSSSDSDFEPSQNHSQG 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KKALEVEESNSEDEASFKSESAQSSPSNSSSSSDSSSDSDFEPSQNHSQG 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 PLRSMVEDLQSEESDEDDSSSGEEAAGKTNPGRDSRLSFSDSESDNSADS 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 PLRSMVEDLQSEESDEDDSSSGEEAAGKTNPGRDSRLSFSDSESDNSADS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     409 SLPSREPPPPQKPPPPNSKVSGRRSPESCSKPEKILKKGTYDKAYTDELV 458                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 SLPSREPPPPQKPPPPNSKVSGRRSPESCSKPEKILKKGTYDKAYTDELV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     459 ELHRRLMALRERNVLQQIVNLIEETGHFNVTNTTFDFDLFSLDETTVRKL 508                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 ELHRRLMALRERNVLQQIVNLIEETGHFNVTNTTFDFDLFSLDETTVRKL 550                                                          
						                                                            	                                                             
						                                                            	     509 QSCLEAVAT                                          517                                                          
						                                                            	         |||||||||                                           
						                                                            	     551 QSCLEAVAT                                          559                                                          

26774	HMR136_HUMETR103_3_tr0_r1_1_gPRT		Comparison report between HUMETR103_P3 and EGR1_HUMANpartial 	Sequence name: EGR1_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for HUMETR103_P3, comprising a 	Sequence documentation:                                      
						MAAAKAEMQLMSPLQISDPFGSFPHSPTMDNYPKLEEMMLLSNGAPQFLGAAGAPEGSGS 	                                                            
						NSSSSSSGGGGGGGGGSNSSSSSSTFNPQADTGEQPYEHLTAESFPDISLNNEKVLVETS 	Alignment of: 26774 x EGR1_HUMAN   ..                        
						YPSQTTRLPPITYTGRFSLEPAPNSGNTLWPEPLFSLVSGLVSMTNPPASSSSAPSPAAS 	                                                            
						SASASQSPPLSCAVPSNDSSPIYSAAPTFPTPNTDIFPEPQSQAFPGSAGTALQYPPPAY 	Alignment segment 1/1:                                       
						PAAKGGFQVPMIPDYLFPQQQGDLGLGTPDQKPFQGLESRTQQPSLTPLSTIKAFATQSG 	                                                            
						SQDLKALNTSYQSQLIKPSRMRKYPNRPSKTPPHERPYACPVESCDRRFSRSDELTRHIR 	                     Quality: 5338.00                      Escore:       0                                               
						IHTGQKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFACDICGRKFARSDERKRHTKIHLR 	             Matching length:     539                Total length:     539                                               
						QKDKKADKSVVASSATSSLSSYPSPVATSYPSPVTTSYPSPATTSYPSPVPTSFSSPGSS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TYPSPVHSGFPSPSVATTYSSVPPAFPAQVSSFPSSAVTNSFSASTGLSDMTATFSPRT  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						first amino acid sequence being at least 90 % homologous to  	                        Gaps:       0                        
						corresponding to amino acids 1 - 539 of EGR1_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 539 of HUMETR103_P3, and 	Alignment:                                                   
						a second amino acid sequence being at least 70%, optionally  	                  .         .         .         .         .  
						at least 80%, preferably at least 85%, more preferably at    	       1 MAAAKAEMQLMSPLQISDPFGSFPHSPTMDNYPKLEEMMLLSNGAPQFLG 50                                                           
						least 90% and most preferably at least 95% homologous to a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence YSL corresponding to amino   	       1 MAAAKAEMQLMSPLQISDPFGSFPHSPTMDNYPKLEEMMLLSNGAPQFLG 50                                                           
						acids 540 - 542 of HUMETR103_P3, wherein said first amino    	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      51 AAGAPEGSGSNSSSSSSGGGGGGGGGSNSSSSSSTFNPQADTGEQPYEHL 100                                                          
						and in a sequential order.                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 AAGAPEGSGSNSSSSSSGGGGGGGGGSNSSSSSSTFNPQADTGEQPYEHL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TAESFPDISLNNEKVLVETSYPSQTTRLPPITYTGRFSLEPAPNSGNTLW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TAESFPDISLNNEKVLVETSYPSQTTRLPPITYTGRFSLEPAPNSGNTLW 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PEPLFSLVSGLVSMTNPPASSSSAPSPAASSASASQSPPLSCAVPSNDSS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 PEPLFSLVSGLVSMTNPPASSSSAPSPAASSASASQSPPLSCAVPSNDSS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PIYSAAPTFPTPNTDIFPEPQSQAFPGSAGTALQYPPPAYPAAKGGFQVP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PIYSAAPTFPTPNTDIFPEPQSQAFPGSAGTALQYPPPAYPAAKGGFQVP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MIPDYLFPQQQGDLGLGTPDQKPFQGLESRTQQPSLTPLSTIKAFATQSG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MIPDYLFPQQQGDLGLGTPDQKPFQGLESRTQQPSLTPLSTIKAFATQSG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SQDLKALNTSYQSQLIKPSRMRKYPNRPSKTPPHERPYACPVESCDRRFS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SQDLKALNTSYQSQLIKPSRMRKYPNRPSKTPPHERPYACPVESCDRRFS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RSDELTRHIRIHTGQKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFACDI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RSDELTRHIRIHTGQKPFQCRICMRNFSRSDHLTTHIRTHTGEKPFACDI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 CGRKFARSDERKRHTKIHLRQKDKKADKSVVASSATSSLSSYPSPVATSY 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 CGRKFARSDERKRHTKIHLRQKDKKADKSVVASSATSSLSSYPSPVATSY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 PSPVTTSYPSPATTSYPSPVPTSFSSPGSSTYPSPVHSGFPSPSVATTYS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 PSPVTTSYPSPATTSYPSPVPTSFSSPGSSTYPSPVHSGFPSPSVATTYS 500                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 SVPPAFPAQVSSFPSSAVTNSFSASTGLSDMTATFSPRT            539                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     501 SVPPAFPAQVSSFPSSAVTNSFSASTGLSDMTATFSPRT            539                                                          

27058	HMR136_HUMF2K6BP_1_tr0_r1_1_gPRT		Comparison report between HUMF2K6BP_P1 and F261_HUMANunique  	Sequence name: F261_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMF2K6BP_P1, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 27058 x F261_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MEEKTSRIKA corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of HUMF2K6BP_P1, and a second amino acid sequence being 	                                                            
						SIPQFTNSPTMVIMVGLPARGKTYISTKLTRYLNWIGTPTKVFNLGQYRREAVSYKNYEF 	                     Quality: 4334.00                      Escore:       0                                               
						FLPDNMEALQIRKQCALAALKDVHNYLSHEEGHVAVFDATNTTRERRSLILQFAKEHGYK 	             Matching length:     439                Total length:     439                                               
						VFFIESICNDPGIIAENIRQVKLGSPDYIDCDREKVLEDFLKRIECYEVNYQPLDEELDS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						HLSYIKIFDVGTRYMVNRVQDHIQSRTVYYLMNIHVTPRSIYLCRHGESELNIRGRIGGD 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.77                                               
						SGLSVRGKQYAYALANFIQSQGISSLKVWTSHMKRTIQTAEALGVPYEQWKALNEIDAGV 	                        Gaps:       0                        
						CEEMTYEEIQEHYPEEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMELERQENVLVICH 	                                                            
						QAVMRCLLAYFLDKSSDELPYLKCPLHTVLKLTPVAYGCKVESIYLNVEAVNTHREKPEN 	Alignment:                                                   
						VDITREPEEALDTVPAHY                                           	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 34 -	      10 ASIPQFTNSPTMVIMVGLPARGKTYISTKLTRYLNWIGTPTKVFNLGQYR 59                                                           
						471 of F261_HUMAN, which also corresponds to amino acids 11 -	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						448 of HUMF2K6BP_P1, wherein said first amino acid sequence  	      33 SSIPQFTNSPTMVIMVGLPARGKTYISTKLTRYLNWIGTPTKVFNLGQYR 82                                                           
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	      60 REAVSYKNYEFFLPDNMEALQIRKQCALAALKDVHNYLSHEEGHVAVFDA 109                                                          
						head of HUMF2K6BP_P1, comprising a polypeptide being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      83 REAVSYKNYEFFLPDNMEALQIRKQCALAALKDVHNYLSHEEGHVAVFDA 132                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MEEKTSRIKA of  	     110 TNTTRERRSLILQFAKEHGYKVFFIESICNDPGIIAENIRQVKLGSPDYI 159                                                          
						HUMF2K6BP_P1.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     133 TNTTRERRSLILQFAKEHGYKVFFIESICNDPGIIAENIRQVKLGSPDYI 182                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     160 DCDREKVLEDFLKRIECYEVNYQPLDEELDSHLSYIKIFDVGTRYMVNRV 209                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     183 DCDREKVLEDFLKRIECYEVNYQPLDEELDSHLSYIKIFDVGTRYMVNRV 232                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     210 QDHIQSRTVYYLMNIHVTPRSIYLCRHGESELNIRGRIGGDSGLSVRGKQ 259                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     233 QDHIQSRTVYYLMNIHVTPRSIYLCRHGESELNIRGRIGGDSGLSVRGKQ 282                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     260 YAYALANFIQSQGISSLKVWTSHMKRTIQTAEALGVPYEQWKALNEIDAG 309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     283 YAYALANFIQSQGISSLKVWTSHMKRTIQTAEALGVPYEQWKALNEIDAG 332                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     310 VCEEMTYEEIQEHYPEEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMEL 359                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     333 VCEEMTYEEIQEHYPEEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMEL 382                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     360 ERQENVLVICHQAVMRCLLAYFLDKSSDELPYLKCPLHTVLKLTPVAYGC 409                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     383 ERQENVLVICHQAVMRCLLAYFLDKSSDELPYLKCPLHTVLKLTPVAYGC 432                                                          
						                                                            	                  .         .         .                      
						                                                            	     410 KVESIYLNVEAVNTHREKPENVDITREPEEALDTVPAHY            448                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     433 KVESIYLNVEAVNTHREKPENVDITREPEEALDTVPAHY            471                                                          

27060	HMR136_HUMF2K6BP_2_tr0_r1_1_gPRT		Comparison report between HUMF2K6BP_P2 and F261_HUMANunique  	Sequence name: F261_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMF2K6BP_P2, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27060 x F261_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MEEKTSRIKA   	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 10 of HUMF2K6BP_P2, a second	                                                            
						SIPQFTNSPTMVIMVGLPARGKTYISTKLTRYLNWIGTPTKVFNLGQYRREAVSYKNYEF 	                     Quality: 3721.00                      Escore:       0                                               
						FLPDNMEALQIRKQCALAALKDVHNYLSHEEGHVAVFDATNTTRERRSLILQFAKEHGYK 	             Matching length:     377                Total length:     377                                               
						VFFIESICNDPGIIAENIRQVKLGSPDYIDCDREKVLEDFLKRIECYEVNYQPLDEELDS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.73                                               
						HLSYIKIFDVGTRYMVNRVQDHIQSRTVYYLMNIHVTPRSIYLCRHGESELNIRGRIGGD 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.73                                               
						SGLSVRGKQYAYALANFIQSQGISSLKVWTSHMKRTIQTAEALGVPYEQWKALNEIDAGV 	                        Gaps:       0                        
						CEEMTYEEIQEHYPEEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMELERQENVLVICH 	                                                            
						QAVMRCLLAYFLDKSS                                             	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 34 - 409 of F261_HUMAN, which   	      10 ASIPQFTNSPTMVIMVGLPARGKTYISTKLTRYLNWIGTPTKVFNLGQYR 59                                                           
						also corresponds to amino acids 11 - 386 of HUMF2K6BP_P2, and	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 70%, optionally at	      33 SSIPQFTNSPTMVIMVGLPARGKTYISTKLTRYLNWIGTPTKVFNLGQYR 82                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      60 REAVSYKNYEFFLPDNMEALQIRKQCALAALKDVHNYLSHEEGHVAVFDA 109                                                          
						polypeptide having the sequence GTTLISALGMFDGI corresponding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 387 - 400 of HUMF2K6BP_P2, wherein said first 	      83 REAVSYKNYEFFLPDNMEALQIRKQCALAALKDVHNYLSHEEGHVAVFDA 132                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     110 TNTTRERRSLILQFAKEHGYKVFFIESICNDPGIIAENIRQVKLGSPDYI 159                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMF2K6BP_P2, comprising a polypeptide being at least 70%,   	     133 TNTTRERRSLILQFAKEHGYKVFFIESICNDPGIIAENIRQVKLGSPDYI 182                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     160 DCDREKVLEDFLKRIECYEVNYQPLDEELDSHLSYIKIFDVGTRYMVNRV 209                                                          
						least about 95% homologous to the sequence MEEKTSRIKA of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMF2K6BP_P2.3.An isolated polypeptide encoding for a tail of	     183 DCDREKVLEDFLKRIECYEVNYQPLDEELDSHLSYIKIFDVGTRYMVNRV 232                                                          
						HUMF2K6BP_P2, comprising a polypeptide being at least 70%,   	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     210 QDHIQSRTVYYLMNIHVTPRSIYLCRHGESELNIRGRIGGDSGLSVRGKQ 259                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence GTTLISALGMFDGI in 	     233 QDHIQSRTVYYLMNIHVTPRSIYLCRHGESELNIRGRIGGDSGLSVRGKQ 282                                                          
						HUMF2K6BP_P2.                                                	                  .         .         .         .         .  
						                                                            	     260 YAYALANFIQSQGISSLKVWTSHMKRTIQTAEALGVPYEQWKALNEIDAG 309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     283 YAYALANFIQSQGISSLKVWTSHMKRTIQTAEALGVPYEQWKALNEIDAG 332                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     310 VCEEMTYEEIQEHYPEEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMEL 359                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     333 VCEEMTYEEIQEHYPEEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMEL 382                                                          
						                                                            	                  .         .                                
						                                                            	     360 ERQENVLVICHQAVMRCLLAYFLDKSS                        386                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     383 ERQENVLVICHQAVMRCLLAYFLDKSS                        409                                                          

27062	HMR136_HUMF2K6BP_3_tr0_r1_1_gPRT		Comparison report between HUMF2K6BP_P3 and F261_HUMANunique  	Sequence name: F261_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for HUMF2K6BP_P3, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 27062 x F261_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MSFGATPK corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of HUMF2K6BP_P3, and a second amino acid sequence being at 	                                                            
						MSPEMGELTQTRLQKIWIPHSSGSSRLQRRRGSSIPQFTNSPTMVIMVGLPARGKTYIST 	                     Quality: 1054.00                      Escore:       0                                               
						KLTRYLNWIGTPTKVFNLGQYRREAVSYKNYEFFLPDNMEALQIRK               	             Matching length:     106                Total length:     106                                               
						least 90 % homologous to corresponding to amino acids 1 - 106	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of F261_HUMAN, which also corresponds to amino acids 9 - 114 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						of HUMF2K6BP_P3, wherein said first amino acid sequence and  	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a head of       	Alignment:                                                   
						HUMF2K6BP_P3, comprising a polypeptide being at least 70%,   	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	       9 MSPEMGELTQTRLQKIWIPHSSGSSRLQRRRGSSIPQFTNSPTMVIMVGL 58                                                           
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence MSFGATPK of       	       1 MSPEMGELTQTRLQKIWIPHSSGSSRLQRRRGSSIPQFTNSPTMVIMVGL 50                                                           
						HUMF2K6BP_P3.                                                	                  .         .         .         .         .  
						                                                            	      59 PARGKTYISTKLTRYLNWIGTPTKVFNLGQYRREAVSYKNYEFFLPDNME 108                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PARGKTYISTKLTRYLNWIGTPTKVFNLGQYRREAVSYKNYEFFLPDNME 100                                                          
						                                                            	                                                             
						                                                            	     109 ALQIRK                                             114                                                          
						                                                            	         ||||||                                              
						                                                            	     101 ALQIRK                                             106                                                          

3719	HMR136_HUMFBRB_23_tr0_r1_1_gPRT		Comparison report between HUMFBRB_P23 and FIBB_HUMANpartial  	Sequence name: FIBB_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for HUMFBRB_P23, comprising a first     	                                                            
						MYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGK 	Alignment of: 3719 x FIBB_HUMAN   ..                         
						NYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVN 	                                                            
						KYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWW 	Alignment segment 1/1:                                       
						YNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ   	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2478.00                      Escore:       0                                               
						corresponding to amino acids 254 - 491 of FIBB_HUMAN, which  	             Matching length:     238                Total length:     238                                               
						also corresponds to amino acids 1 - 238 of HUMFBRB_P23.      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     254 MYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGF 303                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 GNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVK 353                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 AHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGM 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 FFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYT 453                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 WDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ             238                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     454 WDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ             491                                                          

28946	HMR136_HUMFGFR3_10_tr0_r1_1_gPRT		Comparison report between HUMFGFR3_P10 and FGR3_HUMANpartial 	Sequence name: FGR3_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						HUMFGFR3_P10, comprising a first amino acid sequence being at	                                                            
						MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELS 	Alignment of: 28946 x FGR3_HUMAN   ..                        
						CPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNASHEDSGAYSCRQRLTQRVLCH 	                                                            
						FSVRVTDAPSSGDDEDGEDEAE                                       	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 142	                                                            
						of FGR3_HUMAN, which also corresponds to amino acids 1 - 142 	                     Quality: 6205.00                      Escore:       0                                               
						of HUMFGFR3_P10, a second amino acid sequence being at least 	             Matching length:     649                Total length:     653                                               
						DTGAPYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHRIGGIKL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSPHRPILQAGLPANQTAV 	    Total Percent Similarity:   99.39      Total Percent Identity:   99.39                                               
						LGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGPDGTPYVTVLKTAGANTTDKELEVLSL 	                        Gaps:       1                        
						HNVTFEDAGEYTCLAGNSIGFSHHSAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLF 	                                                            
						ILVVAAVTLCRLRSPPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSG 	Alignment:                                                   
						EGPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVA 	                  .         .         .         .         .  
						VKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREF 	       1 MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLV 50                                                           
						LRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EDNVMKIADFGLARDVHNLDYYKKTTN                                  	       1 MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLV 50                                                           
						90 % homologous to corresponding to amino acids 147 - 653 of 	                  .         .         .         .         .  
						FGR3_HUMAN, which also corresponds to amino acids 143 - 649  	      51 FGSGDAVELSCPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNAS 100                                                          
						of HUMFGFR3_P10, and a third amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	      51 FGSGDAVELSCPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNAS 100                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     101 HEDSGAYSCRQRLTQRVLCHFSVRVTDAPSSGDDEDGEDEAE....DTGA 146                                                          
						VSPALGCGGGGHASRTPGANTAFPHPPRAGCP corresponding to amino acids	         ||||||||||||||||||||||||||||||||||||||||||    ||||  
						650 - 681 of HUMFGFR3_P10, wherein said first amino acid     	     101 HEDSGAYSCRQRLTQRVLCHFSVRVTDAPSSGDDEDGEDEAEDTGVDTGA 150                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     147 PYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHR 196                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMFGFR3_P10, comprising a polypeptide having a length "n",  	     151 PYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHR 200                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     197 IGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSP 246                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     201 IGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSP 250                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise ED, having a structure as  	     247 HRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGP 296                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						142-x to 143; and ending at any of amino acid numbers 143+   	     251 HRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGP 300                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of HUMFGFR3_P10, comprising a	     297 DGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHH 346                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     301 DGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHH 350                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VSPALGCGGGGHASRTPGANTAFPHPPRAGCP in          	     347 SAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRS 396                                                          
						HUMFGFR3_P10.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 PPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPT 446                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 PPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     447 LANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAA 496                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     497 KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGP 546                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     547 LYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQ 596                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     597 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK 646                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK 650                                                          
						                                                            	                                                             
						                                                            	     647 TTN                                                649                                                          
						                                                            	         |||                                                 
						                                                            	     651 TTN                                                653                                                          

28944	HMR136_HUMFGFR3_4_tr0_r1_1_gPRT		Comparison report between HUMFGFR3_P4 and FGR3_HUMANpartial  	Sequence name: FGR3_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMFGFR3_P4, comprising a first     	Sequence documentation:                                      
						MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELS 	                                                            
						CPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNASHEDSGAYSCRQRLTQRVLCH 	Alignment of: 28944 x FGR3_HUMAN   ..                        
						FSVRV                                                        	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 125 of FGR3_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 125 of HUMFGFR3_P4, and a	                     Quality: 7566.00                      Escore:       0                                               
						TGAPYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHRIGGIKLR 	             Matching length:     784                Total length:     806                                               
						HQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSPHRPILQAGLPANQTAVL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGPDGTPYVTVLKTAGANTTDKELEVLSLH 	    Total Percent Similarity:   97.27      Total Percent Identity:   97.27                                               
						NVTFEDAGEYTCLAGNSIGFSHHSAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFI 	                        Gaps:       1                        
						LVVAAVTLCRLRSPPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGE 	                                                            
						GPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAV 	Alignment:                                                   
						KMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFL 	                  .         .         .         .         .  
						RARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 	       1 MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLV 50                                                           
						DNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVED 	       1 MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLV 50                                                           
						LDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPSSGGSRT  	                  .         .         .         .         .  
						second amino acid sequence being at least 90 % homologous to 	      51 FGSGDAVELSCPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNAS 100                                                          
						corresponding to amino acids 148 - 806 of FGR3_HUMAN, which  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 126 - 784 of HUMFGFR3_P4,    	      51 FGSGDAVELSCPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNAS 100                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     101 HEDSGAYSCRQRLTQRVLCHFSVRV......................TGA 128                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         |||||||||||||||||||||||||                      |||  
						HUMFGFR3_P4, comprising a polypeptide having a length "n",   	     101 HEDSGAYSCRQRLTQRVLCHFSVRVTDAPSSGDDEDGEDEAEDTGVDTGA 150                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     129 PYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHR 178                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     151 PYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHR 200                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise VT, having a structure as  	     179 IGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSP 228                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						125-x to 126; and ending at any of amino acid numbers 126+   	     201 IGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSP 250                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     229 HRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGP 278                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     279 DGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHH 328                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     329 SAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRS 378                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     379 PPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPT 428                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 PPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     429 LANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAA 478                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     479 KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGP 528                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     529 LYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQ 578                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     579 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK 628                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     629 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 678                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     679 EELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDR 728                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 EELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDR 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     729 VLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPS 778                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 VLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPS 800                                                          
						                                                            	                                                             
						                                                            	     779 SGGSRT                                             784                                                          
						                                                            	         ||||||                                              
						                                                            	     801 SGGSRT                                             806                                                          

8209	HMR136_HUMFMR1_1_tr0_r1_1_gPRT		Comparison report between HUMFMR1_P1 and FMR1_HUMANpartial   	Sequence name: FMR1_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for HUMFMR1_P1, comprising a first amino	Sequence documentation:                                      
						MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN 	                                                            
						ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP 	Alignment of: 8209 x FMR1_HUMAN   ..                         
						ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR 	                                                            
						AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN 	Alignment segment 1/1:                                       
						IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN 	                                                            
						GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE 	                     Quality: 5586.00                      Escore:       0                                               
						NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH 	             Matching length:     590                Total length:     632                                               
						LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HGRRGPGYTS                                                   	    Total Percent Similarity:   93.35      Total Percent Identity:   93.35                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       2                        
						to amino acids 1 - 490 of FMR1_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 490 of HUMFMR1_P1, a second amino acid    	Alignment:                                                   
						APTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTD 	                  .         .         .         .         .  
						GS                                                           	       1 MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFP 50                                                           
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 516 - 577 of FMR1_HUMAN, which also corresponds  	       1 MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFP 50                                                           
						to amino acids 491 - 552 of HUMFMR1_P1, and a third amino    	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to              	      51 PPVGYNKDINESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACD 100                                                          
						LQNTSSEGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP corresponding to amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 595 - 632 of FMR1_HUMAN, which also corresponds to     	      51 PPVGYNKDINESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACD 100                                                          
						amino acids 553 - 590 of HUMFMR1_P1, wherein said first amino	                  .         .         .         .         .  
						acid sequence, second amino acid sequence and third amino    	     101 ATYNEIVTIERLRSVNPNKPATKDTFHKIKLDVPEDLRQMCAKEAAHKDF 150                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     101 ATYNEIVTIERLRSVNPNKPATKDTFHKIKLDVPEDLRQMCAKEAAHKDF 150                                                          
						HUMFMR1_P1, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     151 KKAVGAFSVTYDPENYQLVILSINEVTSKRAHMLIDMHFRSLRTKLSLIM 200                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     151 KKAVGAFSVTYDPENYQLVILSINEVTSKRAHMLIDMHFRSLRTKLSLIM 200                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     201 RNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGANIQQARKVPGV 250                                                          
						at least two amino acids comprise SA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     201 RNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGANIQQARKVPGV 250                                                          
						490-x to 491; and ending at any of amino acid numbers 491+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     251 TAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN 300                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HUMFMR1_P1, comprising a polypeptide having a length "n",    	     251 TAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN 300                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     301 GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAP 350                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     301 GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAP 350                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise SL, having a structure as  	     351 EEKKHLDIKENSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVP 400                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						552-x to 553; and ending at any of amino acid numbers 553+   	     351 EEKKHLDIKENSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVP 400                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     401 FVFVGTKDSIANATVLLDYHLNYLKEVDQLRLERLQIDEQLRQIGASSRP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 FVFVGTKDSIANATVLLDYHLNYLKEVDQLRLERLQIDEQLRQIGASSRP 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 PPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTS.......... 490                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     451 PPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNAS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     491 ...............APTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGF 525                                                          
						                                                            	                        |||||||||||||||||||||||||||||||||||  
						                                                            	     501 ETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGF 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     526 KGNDDHSRTDNRPRNPREAKGRTTDGS.................LQNTSS 558                                                          
						                                                            	         |||||||||||||||||||||||||||                 ||||||  
						                                                            	     551 KGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS 600                                                          
						                                                            	                  .         .         .                      
						                                                            	     559 EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP                   590                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     601 EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP                   632                                                          

